Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7613439118849523,-2.2606915723225725,0.0,0.0,0.0,18/35,10.85%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;SULF2;HOXA3;PCSK5;RBP4;DYNC2I1;WNT9A;HOXB4;HOXB3;SIX1;KIAA1217;XYLT1;SLC2A10;FUZ
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8325812767101479,-2.1140865266963043,0.0,0.004545588904293184,0.009,9/17,7.49%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1D;SLC8A1;CACNB2;CACNA1G;KCNJ2
prerank,retinoid metabolic process (GO:0001523),-0.6177110216612438,-2.0959889320471317,0.0,0.00393951038372076,0.011,25/71,16.06%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;CYP26B1;AKR1B1;DHRS3;CYP1B1;GPC5;SDC4;APOE;GPC4;STRA6;SCPEP1;SDC1;RDH13;RDH10;RARRES2;GPC1
prerank,collagen fibril organization (GO:0030199),-0.5834918918772706,-2.0858345905072144,0.0,0.003181912233005229,0.011,44/88,11.48%,COL1A2;COL3A1;COL4A5;COL1A1;ADAMTS2;COL8A1;COL4A6;COL5A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;COL6A3;COL11A1;PLOD2;COL6A1;COL8A2;TGFBR1;COL26A1;SERPINH1;COL13A1;COL18A1;COL23A1;LOXL3;COL27A1;CYP1B1;COL5A3;NF1;LUM;COL16A1;P4HB;LOX;COL14A1;COL9A2;DPT;DDR2;COL20A1;COL15A1;ADAMTS14;P4HA1;TGFB2
prerank,diterpenoid metabolic process (GO:0016101),-0.6390223791439182,-2.0641954639134523,0.0,0.0038182946796062748,0.018,20/55,16.06%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;HSPG2;ABCA4;RBP4;AKR1B1;DHRS3;GPC5;SDC4;APOE;GPC4;STRA6;SDC1;RDH10;RARRES2;GPC1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7932893985619289,-2.0474298128646216,0.0,0.005151667424865609,0.031,11/20,12.57%,ATP1A2;ANK2;CACNA1C;DMD;ATP1B1;SLC8A1;PRKACA;ATP2A2;RYR2;SLC9A1;GSTM2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7564310714112781,-2.04225700552432,0.0,0.004204669736471196,0.034,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7564310714112781,-2.04225700552432,0.0,0.004204669736471196,0.034,4/21,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,cotranslational protein targeting to membrane (GO:0006613),0.692556562442339,2.0394785321756737,0.0,0.012637213814496652,0.011,60/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;TRAM1;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;ARL6IP1;RPL11;RPL8;RPLP2;SEC62;SIL1;RPL18A;SSR1;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.62021533454024,-1.9912125743544766,0.0,0.012323596584972634,0.108,22/55,11.64%,GPC6;SDC2;DCN;GPC3;OGN;CEMIP;FMOD;HSPG2;BGN;FGF2;CSPG4;PRELP;LUM;VCAN;ARSB;CD44;GPC5;SDC4;OMD;GPC4;SLC9A1;HEXA
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6797252894114191,1.9770788134146369,0.0,0.0368585402922819,0.057,56/87,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;RPL18A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,regulation of striated muscle contraction (GO:0006942),-0.6962214573412695,-1.9704890020879193,0.0,0.01690959072397065,0.158,7/27,9.11%,ATP1A2;ANK2;DMD;SLC8A3;P2RX4;PRKACA;RYR2
prerank,membrane lipid biosynthetic process (GO:0046467),0.7081763604174268,1.9574419508489447,0.0,0.04668748437022375,0.103,17/58,5.73%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;PPM1L
prerank,protein targeting to ER (GO:0045047),0.6591758972870999,1.9534317955220009,0.0,0.03975456845810406,0.113,61/99,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;SEC63;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;CHMP4A;CHMP4B;ZFAND2B;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RPL13;RPS12;SRP9;RPL6;RPL10;SPCS1;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPLP2;SEC62;RPL18A;ZFAND2A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.793381384004444,-1.9498566250647105,0.0,0.021570885527645838,0.211,7/16,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;PRKACA;RYR2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.8839987919983442,1.9494099793945674,0.0,0.035384198680590624,0.123,3/14,2.38%,IL6ST;PTGS2;OSMR
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6526707912574439,1.9310168235172471,0.0,0.046511967511689074,0.189,62/110,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;RPL31;RPS23;RNPS1;RPL13;RPS12;PNRC2;RPL6;RPL10;UPF2;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;CTIF;RPL11;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;RPL3;RPS3;RPS28;RPL7
prerank,establishment of endothelial barrier (GO:0061028),0.7944937338841358,1.9270718755122567,0.001597444089456869,0.04483202043714289,0.209,14/29,7.53%,TJP1;PECAM1;PPP1R16B;ICAM1;F11R;TJP2;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.771383914244512,-1.92206056536712,0.0,0.03166760269990919,0.315,6/16,3.80%,IGF1;IGFBP2;BMP5;IGFBP5;IGFBP6;IGFBP3
prerank,cytoplasmic translation (GO:0002181),0.6550477039931267,1.9031801411554021,0.0,0.07003122655533561,0.334,54/91,21.42%,RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPS11;RPL32;RPL22;RPS27;DRG2;RPL31;RPS23;RPL13;RPS12;RPL6;RPL10;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;RPL27A;RPS10;RPL11;RPL8;RPL18A;RPL21;RPL3;RWDD1;RPS3;RPS28;RPL7
prerank,membrane depolarization during action potential (GO:0086010),-0.682908382514364,-1.9013249416665972,0.002531645569620253,0.041889350056486425,0.424,7/26,7.49%,ATP1A2;CACNA1C;SCN7A;CACNA1D;SLC8A1;CACNA1G;KCNJ2
prerank,negative regulation of peptidase activity (GO:0010466),-0.6026015061998581,-1.899827891995171,0.0,0.04019599331082116,0.435,13/47,12.41%,LRP1;TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;ECM1;SERPINF1;SERPINE1;CST3;SPOCK3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8458624613423721,-1.8997652890034031,0.0,0.03751626042343308,0.435,6/10,4.97%,PID1;PRKCB;APPL2;ENPP1;GRB10;SELENOS
prerank,cardiac muscle cell action potential (GO:0086001),-0.6720924069339633,-1.8949759021676746,0.0,0.03886478513170673,0.467,11/30,7.49%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;CACNA1D;ATP1B1;SLC8A1;KCND3;CACNA1G;KCNJ2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.7095568013940188,-1.8926272215593638,0.0,0.03866424444475261,0.483,8/21,9.11%,ATP1A2;ANK2;CACNA1C;DMD;SLC8A1;AKAP6;PRKACA;RYR2
prerank,skeletal system morphogenesis (GO:0048705),-0.6101305837076269,-1.8880030676142328,0.0,0.039597130010731736,0.515,16/42,10.85%,FGFR2;PDGFRA;HOXC4;TGFBR1;HOXA3;WWOX;CYP26B1;DYNC2I1;FBN2;SFRP4;HOXB4;HOXB3;SIX1;LRP6;HHIP;FUZ
prerank,sphingolipid metabolic process (GO:0006665),0.6293387265904318,1.8739849124601988,0.0,0.12672317186203588,0.544,23/108,5.73%,ST6GALNAC3;ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;UGCG;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ESYT2;SPTLC3;ELOVL5;SPTSSA;GLTP;ENPP2;ASAH2;PPM1L
prerank,embryonic digestive tract development (GO:0048566),-0.7268372550254388,-1.854241719762512,0.002331002331002331,0.06182000909838731,0.695,12/18,15.46%,GLI3;FGFR2;RARB;GLI2;PDGFRA;PCSK5;SALL1;RBPMS2;TGFB2;STRA6;PKDCC;RARRES2
prerank,sphingolipid biosynthetic process (GO:0030148),0.6518000013965417,1.8492077286166344,0.0,0.1893475869872082,0.704,18/71,5.73%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;SPNS2;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;SPTLC3;ELOVL5;SPTSSA;ASAH2;PPM1L
prerank,renal system development (GO:0072001),-0.5708325392113826,-1.8339069342917727,0.0,0.08095693838546161,0.786,28/52,18.49%,SULF1;GLI2;WNT4;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;RBP4;SALL1;SIX1;TBX18;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;MYOCD;FOXC1;IFT27
prerank,regulation of potassium ion transport (GO:0043266),-0.632230156557927,-1.8303451082626427,0.0,0.08190718292307338,0.801,12/31,10.00%,ANK2;FHL1;KCNIP3;ACTN2;CACNA1D;KCNIP4;ANK3;DLG1;KCNAB1;DPP6;ADRA2A;CD63
prerank,heme catabolic process (GO:0042167),0.8454032438814568,1.825053221046186,0.0,0.24309084907052592,0.845,2/14,0.42%,SLCO2B1;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8454032438814568,1.825053221046186,0.0,0.24309084907052592,0.845,2/14,0.42%,SLCO2B1;ABCG2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.6010818781060842,-1.8248909062398042,0.0028735632183908046,0.08471324776182752,0.815,7/37,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;MAP6
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.8033809732128091,1.8244933722537975,0.0,0.22617372416714526,0.846,6/18,5.39%,JAM2;SLC39A8;VCAM1;SELE;SELP;CX3CR1
prerank,synaptic membrane adhesion (GO:0099560),-0.759091068369251,-1.8237066727762326,0.0,0.08308545979847194,0.822,7/14,6.10%,GPC6;PTPRS;PTPRF;PTPRD;LRFN5;LRRC4C;NTNG1
prerank,negative regulation of blood pressure (GO:0045776),0.8602505382447456,1.8223491286540507,0.0035460992907801418,0.21814238132166844,0.853,3/13,1.82%,NOS3;BMPR2;PRCP
prerank,ureteric bud development (GO:0001657),-0.7262434128395677,-1.820820547179195,0.0,0.0828433577807433,0.835,10/17,10.91%,FGFR2;GPC3;BMP7;OSR1;BMP4;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6615892136804358,-1.820534054711629,0.0,0.07974781173691964,0.835,10/25,9.95%,ANK2;DMD;ACTN2;SLC6A9;ATP1B1;WNK4;ANK3;TRPC6;ATP1B2;WNK1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7670920137871942,-1.819473531459522,0.004395604395604396,0.07772957026341346,0.838,7/13,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7901154963158551,-1.8162318082345588,0.002178649237472767,0.07804944503816001,0.846,7/12,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5694486772868151,-1.8070224099606456,0.0,0.08607397275200879,0.884,21/50,14.21%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;IFT81;GAS1;TULP3;RORA;EVC;GLIS2;ARMC9;BTRC;GLI1;SFRP1;HHIP;SMO;FUZ;SUFU;INTU;KIF7
prerank,endodermal cell differentiation (GO:0035987),-0.6299233492404169,-1.8051861353179015,0.0,0.08573921140166799,0.89,13/31,9.56%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;CTR9;PAF1;MMP2;INHBA;LEO1
prerank,mesonephric tubule development (GO:0072164),-0.7395825097124239,-1.8046075830436896,0.0022522522522522522,0.08351762013488011,0.89,10/15,10.91%,FGFR2;BMP7;OSR1;BMP4;PKD1;ROBO2;SALL1;SIX1;NPNT;SLIT2
prerank,embryonic limb morphogenesis (GO:0030326),-0.5936900526077015,-1.8041591126586145,0.005319148936170213,0.08135137819683416,0.893,12/34,15.46%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;SALL1;LRP6;TGFB2;TBX2;WDPCP;INTU;TBX3
prerank,bile acid and bile salt transport (GO:0015721),0.7683321870433902,1.8014713580940847,0.001639344262295082,0.2917090188846311,0.927,6/24,5.12%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,digestive tract development (GO:0048565),-0.6221178771984079,-1.7919536184189089,0.002717391304347826,0.091707256144115,0.923,17/32,15.46%,GLI3;FGFR2;CLMP;RARB;GLI2;KIT;PCSK5;PKD1;COBL;SALL1;GLI1;SMO;TGFB2;STRA6;CCDC39;PKDCC;RARRES2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6397404786558866,-1.7831063302549057,0.0076726342710997444,0.10055393636769772,0.938,4/26,1.86%,EYA2;EYA1;BCL2;EYA4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7495302967274552,1.7794723255074363,0.013490725126475547,0.3824731743543753,0.972,7/24,3.91%,PECAM1;VCAM1;ICAM1;F11R;MSN;SELE;SELP
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.628471526839648,1.7791647246733937,0.0,0.3615853776236126,0.972,18/75,6.56%,NRP2;TEK;EGFL7;BMPR2;KDR;PPP1R16B;PRKD1;PLCG1;PDGFB;VEGFC;GATA2;PRKD2;JCAD;HIF1A;FLT4;VEGFD;WNT5A;NRAS
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7062890365035165,-1.7769690385629668,0.011337868480725623,0.10601917650307338,0.952,8/17,9.89%,ATP1A2;CACNA1C;GJA1;ATP1B1;SLC8A1;PRKACA;RYR2;ATP1B2
prerank,extracellular structure organization (GO:0043062),-0.44561109866982046,-1.7749057367103174,0.0,0.10571741051699006,0.956,78/204,7.61%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,cell-substrate junction assembly (GO:0007044),0.707908028111996,1.7658083009573176,0.0,0.4215914942002912,0.984,10/33,5.16%,THSD1;ITGA6;PEAK1;BCR;DST;TAOK2;LAMA3;SORBS1;ACTN1;PTPRK
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.7362755994263552,1.7639361593334242,0.003236245954692557,0.4130373567790749,0.988,6/26,5.50%,NOS3;ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,external encapsulating structure organization (GO:0045229),-0.44312977158156147,-1.763369480486113,0.0,0.12000354707334007,0.97,77/205,7.61%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;ADAMTSL3;COL5A1;NID1;COL22A1;ADAMTS6;VTN;COL4A3;LAMC3;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;BGN;MFAP5;COL13A1;VIT;COL18A1;DAG1;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;COL27A1;FGF2;SMOC2;CDH1;RECK;MMP14;NDNF;FBN2;ITGA1;ADAMTS17;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;LOX;ADAMTS1;COL14A1;CD44
prerank,carboxylic acid metabolic process (GO:0019752),0.7057791296583924,1.7611990684516992,0.0,0.40870855678384593,0.989,6/33,4.12%,CSGALNACT1;SLC2A1;ST6GAL1;ST3GAL1;PLA2G4A;GLYAT
prerank,regulation of gastrulation (GO:0010470),-0.7318289294598759,-1.7611330243052608,0.011312217194570135,0.11995440557167203,0.972,4/14,3.02%,PHLDB2;OSR1;PHLDB1;DAG1
prerank,regulation of cell junction assembly (GO:1901888),0.7419625816733078,1.76097621176859,0.0048,0.39044978872885294,0.989,12/27,11.57%,PRKCH;TJP1;MEF2C;CLDN5;OCLN;F11R;RAP1B;RAPGEF2;RAP1A;APLNR;MYO1C;CBFB
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7076340220516855,1.756425063622772,0.0049261083743842365,0.397162738707874,0.993,13/34,5.63%,SEMA6A;FLT1;KDR;ERN1;PRKD1;VEGFC;DAB2IP;PRKD2;NOTCH1;FLT4;VEGFD;DLL4;RAMP2
prerank,relaxation of cardiac muscle (GO:0055119),-0.7463189562483549,-1.7552733355592276,0.011467889908256881,0.12483622580316756,0.978,6/13,7.49%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,granulocyte differentiation (GO:0030851),0.7841616966004238,1.7490287112856882,0.00859106529209622,0.4234382367987864,0.997,4/18,3.41%,LEF1;CBFA2T3;TAL1;LBR
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6234364557138199,1.7487913897206253,0.0013869625520110957,0.4068919572980121,0.997,19/67,5.08%,NRP2;CLEC14A;FLT1;KDR;PRKD1;VEGFC;DOCK1;ELMO1;WASF2;DAB2IP;PRKD2;PTK2B;FYN;NCK1;PXN;FLT4;PAK2;NCKAP1;VEGFD
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7180988090281615,1.7425962771202257,0.003067484662576687,0.4241891437066043,0.999,6/30,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.5477504978308051,-1.742044182764468,0.0031545741324921135,0.1427548023071357,0.989,12/47,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;RECK;SERPINE2;SERPIND1;SERPINF1;BIN1;SERPINE1;SPOCK3
prerank,extracellular matrix organization (GO:0030198),-0.418891749209276,-1.7407435102245379,0.0,0.1413450869789966,0.99,105/276,10.53%,LAMA2;COL1A2;COL3A1;COL4A5;FBN1;SMOC1;ADAMTS12;COL1A1;ADAMTS2;THSD4;DCN;COL8A1;COL4A6;GSN;ADAMTSL3;COL5A1;NID1;COL12A1;COL22A1;ADAMTS6;VTN;COL25A1;COL4A3;LAMC3;TIMP2;ADAMTSL5;LOXL1;COL4A4;ITGA9;COL6A2;COL6A3;COL11A1;ITGB5;HSPG2;SPARC;PLOD2;COL6A1;NID2;ADAMTS10;ADAMTS5;COL8A2;TGFBR1;BGN;MFAP5;COL26A1;SERPINH1;COL13A1;VIT;COL18A1;DAG1;GPM6B;ITGA10;FBLN5;COL23A1;ITGA11;ADAMTSL1;THBS1;DDR1;LOXL3;COL27A1;FGF2;SMOC2;SH3PXD2B;CDH1;SCUBE1;RECK;MMP14;NDNF;HTRA1;FBN2;ITGA1;ADAMTS17;CYP1B1;ADAMTSL4;MMP16;COL5A3;ITGB8;ITGAV;NF1;ADAM19;ADAMTS15;SPP1;LUM;TGFBI;ST7;COL16A1;VCAN;P4HB;LOX;ADAMTS1;COL14A1;CD44;FLRT2;KLK2;COL9A2;TNC;MMP2;NPNT;ADAM12;DPT;DDR2;COL20A1;SERPINE1;COL15A1;ADAMTS14
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6624094672500755,1.737878264758244,0.002902757619738752,0.4367939544087561,1.0,18/48,7.98%,NOS3;HDAC9;KDR;PTGS2;PRKD1;PLCG1;PDGFB;GATA2;PRKD2;JCAD;HDAC7;HIF1A;PIK3C2A;TMSB4X;RHOJ;CD40;TGFB1;MAP3K3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.601212875983111,1.7376275963907644,0.001321003963011889,0.42225455788808874,1.0,20/88,6.56%,NRP2;TEK;EGFL7;BMPR2;KDR;CAV1;TIE1;PPP1R16B;ACVRL1;PRKD1;PTPRM;PDGFB;VEGFC;PRKD2;HIF1A;FLT4;CAV2;VEGFD;WNT5A;NRAS
prerank,amino sugar metabolic process (GO:0006040),0.8601226567219208,1.736019504158584,0.005555555555555556,0.41650150530278557,1.0,3/10,1.50%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,tight junction assembly (GO:0120192),0.6424963831855598,1.7352253957315869,0.0058309037900874635,0.40660598586470986,1.0,9/49,5.63%,PECAM1;ESAM;LSR;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7654351440062197,1.7340317808181067,0.0034782608695652175,0.3995114733966289,1.0,6/19,4.81%,PRKCH;TJP1;CLDN5;OCLN;F11R;IKBKB
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7186529934531265,-1.7337921269159655,0.004672897196261682,0.1489622744343493,0.992,4/14,9.89%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,regulation of protein neddylation (GO:2000434),0.8640738435391246,1.73343557860963,0.003838771593090211,0.38930771589820334,1.0,3/10,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6635473398815533,-1.7324630445099973,0.0069767441860465115,0.14729872616054818,0.992,11/20,10.91%,IGF1;LRP1;BMPR1A;PDGFRB;VTN;NRP1;IGFBP5;IGFBP3;CCN4;SERPINE1;SLIT2
prerank,neurotransmitter uptake (GO:0001504),-0.7482759978736562,-1.7318944430774295,0.0,0.1447400076222844,0.992,4/12,4.31%,ATP1A2;SLC1A3;GLUL;SNAP25
prerank,relaxation of muscle (GO:0090075),-0.7367856446509922,-1.7291274656369222,0.011467889908256881,0.1455828155438626,0.992,6/13,7.49%,ATP1A2;GSN;ATP1B1;SLC8A1;P2RX4;KCNJ2
prerank,sulfur compound catabolic process (GO:0044273),-0.5811480568409203,-1.7275395553739785,0.0,0.14467094286063775,0.993,14/38,11.64%,DCN;OGN;FMOD;BGN;CSPG4;GGT5;PRELP;LUM;VCAN;ARSB;OMD;NUDT7;ACAT1;HEXA
prerank,striated muscle cell development (GO:0055002),0.8193173685597266,1.7243735646026903,0.0017301038062283738,0.42505795215635095,1.0,3/14,3.98%,PGM5;FLII;TMOD3
prerank,filopodium assembly (GO:0046847),0.7796972262813021,1.7243107031784113,0.003355704697986577,0.4125284418686824,1.0,6/16,4.52%,FGD5;DNM3;FGD6;SRGAP2;SPATA13;PPP1R9B
prerank,leukocyte tethering or rolling (GO:0050901),0.7645375354767829,1.7240615378466693,0.011764705882352941,0.401727115622602,1.0,5/17,5.39%,JAM2;VCAM1;SELE;SELP;CX3CR1
prerank,cellular response to increased oxygen levels (GO:0036295),0.8415079312133487,1.7211806803238154,0.00546448087431694,0.40544394321510097,1.0,3/11,2.42%,FOXO1;CAV1;FAS
prerank,regulation of Notch signaling pathway (GO:0008593),0.6057741687342596,1.7125596687343687,0.0014104372355430183,0.4418344385512904,1.0,18/76,7.34%,EGFL7;NOS3;IL6ST;LFNG;MAML2;EPN2;GATA2;STAT3;PRAG1;MFNG;FBXW7;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14;ARRB1;ARRDC1
prerank,organic hydroxy compound transport (GO:0015850),0.6741734193769813,1.708820529601009,0.004451038575667656,0.45109730122963393,1.0,6/36,5.12%,ABCC4;SLCO2B1;ATP8B1;STARD5;NCOA1;CEACAM1
prerank,protein localization to synapse (GO:0035418),-0.7378878801135575,-1.7087638339781384,0.008602150537634409,0.17462966764493293,0.997,8/12,15.55%,NLGN2;DLG4;PCLO;NRXN1;NLGN1;SHANK1;NRXN2;BSN
prerank,response to lipid (GO:0033993),0.5749035330699827,1.7084747107991665,0.0025284450063211127,0.44122166916798516,1.0,33/105,15.63%,FOXO1;NOS3;ACER2;ESR1;PPARD;GCH1;FOXP1;SOCS2;STAT3;TNFRSF11A;SELE;SELP;SOX9;TIRAP;RPS6KA3;PELI1;IFNAR1;WNT9B;HNRNPA0;TGFB1;CITED1;MAPKAPK3;OVCA2;CYP27B1;ASXL1;TRIB1;ADAM17;ABCG1;S100A9;PAQR8;STRN3;TRIM16;IRAK3
prerank,amide transport (GO:0042886),0.7053571713551169,1.7079146138488,0.004709576138147566,0.43247353942944106,1.0,7/26,5.78%,ABCG2;CERT1;PLTP;SLC38A5;AQP11;GLTP;TAP2
prerank,apical junction assembly (GO:0043297),0.6286330123975649,1.7069727181939232,0.0028776978417266188,0.42687455164218485,1.0,10/53,5.63%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PKN2;PAK2;CTNNA1;RAMP2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.561838107705581,-1.7067006741707662,0.002857142857142857,0.17491812962350325,0.999,21/37,20.44%,DYNC2H1;IFT81;WDR35;DYNC2I1;KIF3C;KIF3A;IFT80;IFT88;IFT20;IFT46;DYNC2LI1;IFT43;IFT22;PCM1;TRAF3IP1;KIFAP3;IFT74;IFT140;IFT27;IFT57;TTC21B
prerank,actomyosin structure organization (GO:0031032),0.6072871323092482,1.7062662154313175,0.004070556309362279,0.41944248290798847,1.0,12/75,5.44%,PGM5;FRMD5;FLII;TJP1;FAM171A1;EPB41;F11R;MYH9;TMOD3;SORBS1;PDLIM1;CDC42BPB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6321218457134917,1.7048505365277156,0.002840909090909091,0.416476431465852,1.0,15/54,7.33%,NOS3;KDR;MEF2C;ACVRL1;PRKD1;PRCP;PLCG1;PDGFB;GATA2;PRKD2;HIF1A;TMSB4X;ATP2B4;CD40;TGFB1
prerank,embryonic eye morphogenesis (GO:0048048),-0.7520321099565493,-1.7023252494709704,0.011061946902654867,0.17956970167334868,0.999,7/11,14.85%,FBN1;EFEMP1;MFAP5;FBN2;LRP6;TBX2;MFAP2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5883621182611694,1.6964198338115444,0.0013315579227696406,0.4515109958993417,1.0,23/84,7.41%,NRP2;TEK;NOS3;BMPR2;KDR;PRKD1;PLCG1;PDGFB;FOXP1;GATA2;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;FLT4;TMSB4X;WNT5A;CD40;RAC1;SASH1;TGFB1;PIK3CG
prerank,intestinal absorption (GO:0050892),0.8230108626826845,1.6954351991550909,0.003745318352059925,0.4469457022195274,1.0,4/13,2.39%,UGCG;F11R;TJP2;KCNQ1
prerank,ceramide metabolic process (GO:0006672),0.6357224720128611,1.6927039280427978,0.007267441860465116,0.4522250365765432,1.0,10/49,5.50%,ST6GALNAC3;ACER2;SPTLC2;SGMS1;DEGS2;PLPP1;CERS4;SPTLC3;SPTSSA;ASAH2
prerank,T-helper cell differentiation (GO:0042093),0.7907575645368691,1.6917659606034414,0.019469026548672566,0.44685829066152205,1.0,4/14,9.03%,LEF1;FOXP1;TMEM98;ZFPM1
prerank,skeletal system development (GO:0001501),-0.44128751686711465,-1.6908388961138614,0.0,0.19956062961052037,0.999,40/148,7.61%,BMP6;COL1A2;SOX5;IGF1;SULF1;FBN1;FGFR2;COL1A1;GLI2;CDH11;AKAP13;TRPS1;BMP5;BMP7;GJA1;SULF2;NPR3;TGFBR1;COL13A1;WWOX;PCSK5;PKD1;RBP4;SOX6;SH3PXD2B;EXT1;MMP14;GNAS;MMP16;TNFRSF11B;ITGB8;IGF2;EVC;ALPL;PRELP;PAPSS2;KIAA1217;VCAN;NOTUM;CD44
prerank,odontogenesis (GO:0042476),-0.5767075670575487,-1.68956531644544,0.002652519893899204,0.1980240350266283,0.999,13/35,11.48%,COL1A2;FGFR2;GLI2;EDA;OSR1;WNT6;BMP4;LRP6;AXIN2;BCOR;INHBA;TGFB3;TGFB2
prerank,translation (GO:0006412),0.5330238975338348,1.6889970653762423,0.001152073732718894,0.4516907682383653,1.0,83/208,17.73%,GARS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;FARS2;RPL34;RPS20;RPL39;IARS1;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;NDUFA7;RPL9;DHPS;RPL4;RPL13A;LARS1;RPS11;RPL32;TNIP1;RPL22;RPS27;DRG2;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;EEF2K;MRPL35;APEH;HBS1L;RPL6;RPL10;FASTKD2;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RARS1;RPL29;QRSL1;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;AIMP1;MRPL23;RPL27A;MRPS5;KARS1;RPS10;MRPL37;EEFSEC;RPL11;RPL8;EEF2;WARS2;PTCD3;RPLP2;MRPL11
prerank,keratan sulfate catabolic process (GO:0042340),-0.7501088341179503,-1.6883315420569593,0.01079913606911447,0.19681508663647468,0.999,6/11,11.64%,OGN;FMOD;PRELP;LUM;OMD;HEXA
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6984799723106753,-1.6873033170182894,0.01152073732718894,0.19504073006267217,0.999,5/15,6.10%,PIEZO2;ADGRV1;COL11A1;KIT;WHRN
prerank,kidney development (GO:0001822),-0.5059037083261625,-1.6856931420692383,0.0,0.19485996208592668,0.999,31/65,18.49%,SULF1;GLI2;WNT4;BMP7;OSR1;GREB1L;SULF2;TGFBR1;BMP4;PCSK5;PKD1;ROBO2;KANK2;SALL1;NF1;SIX1;IFT88;AGTR1;PYGO1;ARL3;VEGFA;TGFB2;STRA6;PYGO2;TRAF3IP1;PAX8;ITGA8;NPHP3;FGF10;FOXC1;IFT27
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8016970612080939,1.68317081611966,0.01858736059479554,0.47481698155093155,1.0,7/12,11.40%,ERN1;DAB2IP;XBP1;BOK;BCL2L11;PTPN1;ATF6
prerank,lipid transport (GO:0006869),0.5797989255843193,1.6828884821152374,0.00395778364116095,0.46665276114654053,1.0,17/97,5.76%,ABCC4;SLCO2B1;ATP8B1;CERT1;PPARD;PLTP;ATP8A1;UGCG;SPNS2;SLCO2A1;SCARB1;PRELID2;STARD5;NCOA1;GLTP;CEACAM1;ABCA3
prerank,regulation of GTPase activity (GO:0043087),0.5345714858980233,1.6823899287327904,0.0011668611435239206,0.4598682107095332,1.0,39/177,10.82%,PRKG1;CHN2;LRCH1;FGD5;DOCK9;PKP4;PLXNA4;TGM2;NET1;ITGA6;F11R;TBC1D30;RASIP1;SH3BP4;DAB2IP;FGD6;SRGAP2;PLXND1;ARHGAP27;CAV2;ADRB1;TBC1D15;RAP1GDS1;RAPGEF2;CD40;BCAR3;PTK2;RAP1A;TBC1D2;AGRN;RASA4;RSU1;ARHGEF7;CRK;OCRL;LARS1;CCL14;SEMA4D;EPHA4
prerank,L-serine metabolic process (GO:0006563),0.8208652514366597,1.6814313433078412,0.0149812734082397,0.4550222934906017,1.0,2/10,2.40%,SERINC3;SERINC5
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6351495639182175,-1.6813590067676873,0.00997506234413965,0.2001574314190432,0.999,11/21,10.63%,SULF1;SULF2;EXT1;HS3ST3B1;HS6ST3;HS2ST1;HS3ST4;HS6ST2;XYLT1;HS3ST5;HS6ST1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5781680473686571,-1.6811669952681259,0.002785515320334262,0.19698102899077047,0.999,13/29,16.39%,SNTA1;KCNIP3;CACNA1D;KCNIP4;DLG1;SLMAP;KCNAB1;DPP6;WNK1;CD63;KCNN2;WNK3;DPP10
prerank,diol biosynthetic process (GO:0034312),0.760469611430561,1.6811156006307568,0.02385008517887564,0.44807428789381165,1.0,5/15,5.50%,ACER2;SPTLC2;GCH1;SPTLC3;ASAH2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6993370367175058,1.68044923738774,0.00964630225080386,0.44285883883254934,1.0,4/23,3.88%,CADM1;NECTIN2;PVR;PIK3R6
prerank,dicarboxylic acid transport (GO:0006835),-0.6047065943141757,-1.6795980796285326,0.005763688760806916,0.1971486844776301,0.999,13/28,15.95%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;SLC1A2;SLC25A12;SLC25A13;SLC19A1;SLC26A6;SLC1A1;SLC25A18
prerank,bicellular tight junction assembly (GO:0070830),0.6227195420606586,1.678445969670608,0.010218978102189781,0.44493523638540294,1.0,8/46,5.63%,PECAM1;ESAM;CLDN5;OCLN;F11R;PARD3;PAK2;RAMP2
prerank,calcium ion transmembrane transport (GO:0070588),-0.46878801322953884,-1.6768304390039346,0.0,0.19904894570378578,0.999,23/86,11.67%,SLC24A3;TRPM3;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;SLC8A1;P2RX4;MCU;SLC35G1;CACNA1G;ITGAV;TRPC3;TRPC6;TRPC1;ATP2A2;SLC24A2;TRPC4;GRIN2A;MICU1;YME1L1
prerank,cardiac muscle contraction (GO:0060048),-0.5690036623253167,-1.6765504448234125,0.005208333333333333,0.19629106844297772,0.999,8/34,9.11%,ATP1A2;DMD;GSN;ATP1B1;SLC8A1;TPM1;GAA;RYR2
prerank,regulation of T cell migration (GO:2000404),0.7350692184498594,1.675832729341752,0.014545454545454545,0.4499614009707142,1.0,3/18,1.49%,LRCH1;APP;CD200
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6638662727398121,-1.6757393774025524,0.01735357917570499,0.19450497877590803,0.999,7/17,1.52%,IGF1;DOCK7;DOCK5;PDGFRB;VTN;NRP1;IGFBP5
prerank,modulation by symbiont of entry into host (GO:0052372),0.7732879032625996,1.6751116671737043,0.012750455373406194,0.4456686461157086,1.0,6/16,7.85%,CAV1;TRIM14;NECTIN2;FUCA2;TRIM68;TRIM25
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.5116099920504965,-1.6714927121553318,0.009375,0.19986954412177133,1.0,25/54,18.88%,GPC6;SDC2;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B4GALT7;SDC1;GPC1;HGSNAT;UGDH;B3GAT2;IDUA
prerank,inositol lipid-mediated signaling (GO:0048017),-0.5166793380245807,-1.6697963779002158,0.003236245954692557,0.2005573438854865,1.0,15/50,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;ADAP2;IRS1;PI4KA;GAB2;OGT;PLCD3;NGF;PLCB3;PLCD1;EZR
prerank,modified amino acid transport (GO:0072337),-0.6859490342271409,-1.6694222366859064,0.01152073732718894,0.19798239156698896,1.0,3/15,1.60%,SLC6A13;SLC16A12;PDPN
prerank,hippo signaling (GO:0035329),0.6939197910502503,1.6691657066631134,0.02127659574468085,0.46737368108965177,1.0,7/26,5.85%,TJP1;TEAD4;TJP2;WWTR1;STK3;STK4;TEAD2
prerank,actin filament depolymerization (GO:0030042),-0.7389901672376773,-1.6677610836475512,0.011961722488038277,0.1981443849042848,1.0,3/11,1.04%,MICAL3;GSN;MICAL2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5749775388883432,1.6676082872435463,0.002652519893899204,0.4673771850559747,1.0,24/92,7.41%,NRP2;TEK;BMPR2;KDR;PRKD1;PLCG1;DOCK1;FOXP1;RAB11A;SCARB1;EDN1;PRKD2;PTK2B;HIF1A;PPM1F;RREB1;FLT4;PLCG2;SOX9;ENPP2;WNT5A;RAC1;SASH1;PIK3CG
prerank,lymphocyte differentiation (GO:0030098),0.5935817365943141,1.6640201435198385,0.004149377593360996,0.47819716850872857,1.0,22/68,13.43%,HDAC9;PBX1;LFNG;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;CHD7;PLCG2;TOX;JAK3;DLL4;LYL1;LCK;TCF3;SOX4;RELB;JAG2;DCAF1;KLF6;ADAM17
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.695972398204818,-1.663344101891369,0.013544018058690745,0.204096941802764,1.0,8/15,11.32%,LRP1;PDPN;DPP4;DDR1;FAP;DDR2;FGFR4;CST3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5342275136149048,1.6618886218313094,0.0011976047904191617,0.4815656047615898,1.0,29/151,8.79%,ACER2;CERT1;ELOVL7;SPTLC2;SGMS1;DEGS2;PRKD1;GCH1;SPNS2;PLA2G4A;PLPP1;SGPP2;PRKD2;PRKD3;CERS4;ALAS1;LPCAT3;SPTLC3;ELOVL5;GPHN;SPTSSA;CEPT1;LPIN3;PPM1L;PAM;B4GALT5;GSTO2;GSTA4;B3GNT6
prerank,blood vessel morphogenesis (GO:0048514),0.6165804871089716,1.661422071698125,0.01721664275466284,0.47605351220593606,1.0,18/54,7.50%,EGFL7;FLT1;KDR;ENG;CAV1;TBX1;RASIP1;LRP5;SOX17;SOX18;FLT4;CDH2;ID1;SMAD7;LAMA1;RAMP2;TGFB1;RASA1
prerank,hemopoiesis (GO:0030097),0.5709621086748231,1.6587892155892963,0.002728512960436562,0.482422240267922,1.0,20/87,7.33%,MECOM;TEK;FLT1;KDR;SNRK;ZBTB16;ETV6;KITLG;PDGFB;TAL1;CD34;FLT4;TOX;TIRAP;DLL1;HIPK1;WNT5A;LYL1;LCK;TGFB1
prerank,response to interleukin-4 (GO:0070670),0.816475036503114,1.6574041671136466,0.011131725417439703,0.4818188505146185,1.0,5/10,8.36%,LEF1;JAK3;XBP1;DCSTAMP;CITED1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5689765256995973,-1.6570984714429597,0.0026666666666666666,0.2139224070497362,1.0,10/31,5.77%,FGFR2;PDGFRA;HOXC4;OSR1;TGFBR1;HOXA3;DYNC2I1;HOXB4;HOXB3;SIX1
prerank,monocyte chemotaxis (GO:0002548),0.6791159987983254,1.6540359406386576,0.0030441400304414,0.4914362340934336,1.0,5/32,4.40%,FLT1;PDGFB;IL6R;TNFRSF11A;RPS19
prerank,heart contraction (GO:0060047),-0.5428168778926231,-1.6527561619884539,0.008645533141210375,0.22024066966892036,1.0,9/41,9.11%,ATP1A2;DMD;SGCD;ATP1B1;SLC8A1;TPM1;GAA;SGCZ;RYR2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.666683589992231,1.6516673196508507,0.015337423312883436,0.4954273861967861,1.0,11/33,7.99%,SEMA6A;TJP1;PPP1R16B;EPN2;SMAD1;DLL1;RHOJ;KLF2;CEACAM1;JAK1;ITGA5
prerank,cytosolic calcium ion transport (GO:0060401),-0.5802387373979313,-1.650698051867254,0.005128205128205128,0.22137696410012928,1.0,15/28,18.76%,CACNA1C;CACNA2D1;JPH1;SLC8A1;MCU;SLC35G1;ATP2A2;RYR2;MICU1;ADRA1A;JPH2;SLC25A23;CACNB3;SLC8A2;ATP2A3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5363064771424975,1.6504706559522804,0.001199040767386091,0.49355340619950816,1.0,40/149,14.57%,PRKCH;RPS6KA5;NOD1;CAV1;APP;PRKD1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;TRAF1;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TRIM25;NFKB1;MALT1;IKBKG;PSMA6;MAP3K13;RIPK1;CARD16;RELA;RIPK2;RNF25;MTPN;RAB7B;IL1RAP;NPM1;TRAF6;S100A9;ERC1;NFKB2
prerank,regulation of endothelial cell migration (GO:0010594),0.5664595847637796,1.6485090017722102,0.00788436268068331,0.49678082067286217,1.0,23/85,7.46%,NRP2;TEK;BMPR2;KDR;ACVRL1;PRKD1;PTPRM;PRCP;FOXP1;DAB2IP;SCARB1;EDN1;PRKD2;PTK2B;FLT4;RHOJ;CEACAM1;DLL4;WNT5A;RAC1;SASH1;PIK3CG;PTK2
prerank,positive regulation of angiogenesis (GO:0045766),0.5538268136193308,1.6483346573260926,0.0,0.49041991404860974,1.0,26/108,8.10%,TEK;TJP1;NOS3;FLT1;KDR;TIE1;PRKD1;SMAD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;DLL1;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1;JAK1;ITGA5;GAB1
prerank,regulation of hydrolase activity (GO:0051336),0.5931490142169407,1.6479846588247098,0.002751031636863824,0.48505228531222,1.0,11/71,4.33%,PRKG1;CHN2;FGD5;PLXNA4;CAV1;RASIP1;DAB2IP;FGD6;PLXND1;ARHGAP27;TBC1D15
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.6525693709997011,-1.6459783372264076,0.0049382716049382715,0.22804149982508484,1.0,10/19,13.91%,OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;FBXW8;DBN1;CDKL3;CAMK2B
prerank,T cell proliferation (GO:0042098),0.7955579910213428,1.6455497437967979,0.010582010582010581,0.4907752250672736,1.0,5/13,7.41%,CADM1;CTPS1;MSN;PPP3CB;PIK3CG
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7826247240512416,1.6453902145675623,0.02364864864864865,0.48456002125092856,1.0,6/13,9.42%,EPN2;MMRN2;DAB2IP;HHEX;NEDD4;PTPN1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.7981993954436502,1.6444281473266256,0.02564102564102564,0.4829931418776719,1.0,3/11,4.43%,SEMA6A;EPN2;KLF2
prerank,regulation of transferase activity (GO:0051338),0.7374982274463211,1.6440220942302262,0.020134228187919462,0.47843972164130305,1.0,4/17,8.83%,LDB2;NLRC5;HMBOX1;PINX1
prerank,regulation of lymphocyte migration (GO:2000401),0.8164666429490886,1.6434265478393952,0.02909090909090909,0.47476361493853925,1.0,3/10,2.80%,JAM2;STK10;MSN
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6690745715062284,1.6413109374153894,0.015267175572519083,0.47878190738522985,1.0,12/32,5.28%,HDAC9;KDR;PTGS2;MMRN2;GATA2;JCAD;HDAC7;NOTCH1;PIK3C2A;CARD10;RHOJ;DLL4
prerank,maintenance of blood-brain barrier (GO:0035633),0.6695591029611996,1.64118570363225,0.010703363914373088,0.47296712623927,1.0,9/30,1.93%,TJP1;PECAM1;JAM2;ESAM;LSR;CLDN5;OCLN;F11R;TJP2
prerank,angiogenesis involved in wound healing (GO:0060055),0.8035744109550654,1.6405417622532825,0.02181818181818182,0.47003870603530407,1.0,5/11,3.79%,ADIPOR2;KDR;PRCP;GATA2;CD34
prerank,adenine nucleotide transport (GO:0051503),0.7468699368584277,1.6391364680878253,0.016181229773462782,0.47037167957612064,1.0,2/17,0.57%,ABCC4;LRRC8C
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7755069414213448,1.6390778479434513,0.015734265734265736,0.46464422438617653,1.0,8/14,9.42%,SOCS2;LYN;STAT3;PXN;JAK3;GHR;PTK2;PTPN1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8079797153102605,1.6385150176763732,0.016483516483516484,0.4611398303496169,1.0,4/11,6.10%,MECOM;ETV6;CD34;WNT5A
prerank,heart morphogenesis (GO:0003007),0.6116647937448791,1.6383268749369833,0.015714285714285715,0.45631782969259627,1.0,13/50,7.46%,NOS3;ENG;TBX1;EPHB4;ACVRL1;INSR;NOTCH1;SOX17;CHD7;FKBP1A;SOX9;ACVR1;PTK2
prerank,peripheral nervous system development (GO:0007422),0.6971217492432288,1.6373424276180986,0.026813880126182965,0.45531213553389205,1.0,1/23,0.01%,ADGRG6
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6553407379474857,1.6359641341633615,0.0140625,0.4555487196743854,1.0,11/36,6.10%,LEF1;NFATC1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;TCF7L2;TNRC6C;PPP3CB;WNT5A
prerank,endothelial cell development (GO:0001885),0.6949857067805978,1.6351230968480237,0.011419249592169658,0.45384898541527124,1.0,11/25,7.53%,PECAM1;PPP1R16B;ICAM1;PDE2A;MSN;PDE4D;RAP1B;SOX18;ROBO4;RAPGEF2;RAP1A
prerank,purine ribonucleotide transport (GO:0015868),0.7481656730061739,1.6348574443121826,0.016181229773462782,0.4496741915658392,1.0,2/16,0.57%,ABCC4;LRRC8C
prerank,glial cell differentiation (GO:0010001),0.6673807723226642,1.633838922563544,0.031055900621118012,0.4489027337457682,1.0,8/28,11.52%,ADGRG6;STAT3;SOX9;CDH2;EIF2B5;SOX4;NFIB;PICK1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.6858376249759974,-1.6308961600671323,0.0182648401826484,0.2591907968847986,1.0,7/14,16.59%,SULF1;SULF2;THBS1;FGF2;FUZ;GPC1;CREB3L1
prerank,aminoglycan catabolic process (GO:0006026),-0.5676839146663077,-1.6308663429650845,0.012224938875305624,0.25557898299310167,1.0,10/28,16.75%,GPC6;SDC2;GPC3;HSPG2;GPC5;SDC4;GPC4;SDC1;GPC1;HGSNAT
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6522867573219345,-1.6278983813020076,0.00954653937947494,0.25902174068999106,1.0,8/16,18.29%,ANK2;LRRK2;RYR2;SEC16B;GBF1;MIA3;DDRGK1;SEC16A
prerank,regulation of macrophage migration (GO:1905521),0.8088152204997324,1.6268077569890669,0.03275529865125241,0.47605013878977437,1.0,6/10,11.16%,MTUS1;CD200;PTK2B;CX3CR1;CSF1;P2RY12
prerank,cellular response to sterol (GO:0036315),-0.6807865234859665,-1.626347074836652,0.028888888888888888,0.2589344212787231,1.0,9/13,20.56%,GRAMD1B;GRAMD1C;INSIG2;RORA;LRP6;SMO;INSIG1;GPLD1;PTCH1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5806550178674752,1.6240829765094824,0.012658227848101266,0.48419915544351233,1.0,14/63,11.13%,CD38;IL6ST;MEF2C;VCAM1;IL15;BST1;NCK1;TIRAP;JAK3;CD40;TNFRSF13C;IL23A;CD320;IL7
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7331324693037553,1.623578182337481,0.023608768971332208,0.4810542393523984,1.0,3/16,3.16%,CADM1;NECTIN2;PVR
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.583832725180618,1.623545844408955,0.005555555555555556,0.47584960573531065,1.0,23/70,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,phosphorylation (GO:0016310),0.48771372453197015,1.621486258231839,0.0,0.48021412495087284,1.0,93/385,11.79%,PRKG1;PRKCH;ERG;RPS6KA5;CDK17;BMPR2;APP;SNRK;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DGKZ;LYN;PIM3;PRKD2;BCR;ADAM10;STAT3;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;LIPE;PKN2;PAK2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;HIPK1;DGKH;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PIK3CG;CERKL;CTBP1;HASPIN;CREB1;SGK3;NEK6;PXK;MAP3K11;AURKC;PANK2;CDK2;COPS2;CDK18;NUAK1;PRKAB1;GAS6;AKT3;GK5;DGKE;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1
prerank,negative regulation of protein processing (GO:0010955),-0.7209990991652762,-1.6210514383837498,0.013015184381778741,0.26719345189482263,1.0,6/12,14.30%,GAS1;THBS1;SERPINE2;LRRK2;SERPINE1;CTSZ
prerank,regulation of neurotransmitter transport (GO:0051588),0.7307782175166301,1.6199075452816927,0.021739130434782608,0.4827438570641009,1.0,6/16,13.55%,MCTP1;MEF2C;KCNMB4;SNCAIP;MCTP2;FMR1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5601853906615009,1.6190680218382407,0.0013440860215053765,0.4815956124825651,1.0,27/94,18.42%,IL1R1;RPS6KA5;NOD1;NFKBIA;PLCB1;IKBKB;PELI1;PSMA2;NFKB1;MAP3K3;IKBKG;PSMA8;PSMA6;CUL1;IRAK4;RELA;RIPK2;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3;IRAK2;MAP3K8;PSMA4;PSMF1
prerank,lipid translocation (GO:0034204),0.7042379399291168,1.6187546367221985,0.02356902356902357,0.4779734842036216,1.0,5/21,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,regulation of angiogenesis (GO:0045765),0.5078121733555934,1.6184649040492904,0.0,0.47420590575134897,1.0,37/192,6.84%,SEMA6A;TEK;NOS3;FLT1;KDR;TIE1;PPP1R16B;CLDN5;PRKD1;PTPRM;PLCG1;VEGFC;ECSCR;GATA2;DAB2IP;HHEX;STAB1;PRKD2;NPR1;ADGRA2;HIF1A;PLXND1;CD34;PIK3R6;GTF2I;RHOJ;TSPAN12;HIPK1;XBP1;VEGFD;CEACAM1;ATP2B4;RAMP2;WNT5A;CD40;SASH1;EGLN1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6784105753226538,-1.616783173152866,0.02466367713004484,0.2742955769355512,1.0,4/13,5.06%,ANK2;CACNA1C;GJA1;CACNB2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7247764071430765,1.6167440088905851,0.02711864406779661,0.4772413081594418,1.0,3/17,3.16%,CADM1;NECTIN2;PVR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5802210999819388,1.6163689517478563,0.005547850208044383,0.4741343657274036,1.0,23/71,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.7171652519975333,1.6163688377610195,0.03198653198653199,0.469296259954675,1.0,10/18,16.68%,RNF125;SEC14L1;USP15;PUM1;PUM2;OASL;NOP53;BIRC3;GPATCH3;BIRC2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6623752788073343,-1.6152334336579115,0.018867924528301886,0.274517205108074,1.0,7/16,9.26%,FOXD1;FGF1;BMP4;FGF2;SALL1;SIX1;NPNT
prerank,sulfation (GO:0051923),-0.7310197597608978,-1.6147500943230726,0.01366742596810934,0.2720893821501389,1.0,1/11,0.08%,UST
prerank,cardiac muscle cell contraction (GO:0086003),-0.6136372588190501,-1.6144469528698824,0.029748283752860413,0.2693822245203982,1.0,6/19,7.49%,CACNA1C;GSN;CACNA2D1;CACNA1D;CACNA1G;KCNJ2
prerank,cellular response to interleukin-4 (GO:0071353),0.7997099026298776,1.6137370813954313,0.027079303675048357,0.47653358961432746,1.0,4/10,6.49%,LEF1;JAK3;XBP1;DCSTAMP
prerank,regulation of microtubule-based process (GO:0032886),-0.5438890005049459,-1.6117764518264974,0.015015015015015015,0.2721642218055132,1.0,8/36,7.06%,PHLDB2;EPHA3;EFNA5;PHLDB1;BICD1;PRKAA2;ATF5;MAP6
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.625589473436691,1.611552344348384,0.019548872180451128,0.4816252804934916,1.0,11/38,8.09%,CAV1;PTGS2;INSR;EDN1;CD34;KLF2;CX3CR1;ATP2B4;RAC1;NOS1AP;PKD2
prerank,hemidesmosome assembly (GO:0031581),0.7928127262317404,1.6114100305831496,0.023465703971119134,0.477461464516032,1.0,3/11,3.59%,ITGA6;DST;LAMA3
prerank,nitric oxide biosynthetic process (GO:0006809),0.7542427335910332,1.6112352292135665,0.030852994555353903,0.4736064314530968,1.0,2/13,1.55%,NOS3;GCH1
prerank,determination of bilateral symmetry (GO:0009855),0.6782640703538009,1.6109747897663973,0.018302828618968387,0.4703476918351857,1.0,6/24,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,nitric oxide metabolic process (GO:0046209),0.7493563447754874,1.610060576294306,0.02707581227436823,0.46987550691833996,1.0,2/14,1.55%,NOS3;GCH1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.6474867382208342,-1.6095106094341323,0.022058823529411766,0.27431190559908014,1.0,8/17,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;RTN4;ABCA7;CHRNA7
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7209281066877393,1.608736334629815,0.03257328990228013,0.4709368052854685,1.0,8/18,4.40%,HDAC9;KDR;PTGS2;GATA2;JCAD;HDAC7;PIK3C2A;RHOJ
prerank,regulation of B cell proliferation (GO:0030888),0.6079496654562494,1.6076099479673414,0.014619883040935672,0.4711137414177919,1.0,11/44,11.13%,CD38;MEF2C;AHR;LYN;BST1;TIRAP;CD40;TNFRSF13C;CD320;RC3H1;IL7
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6784094454354661,-1.602785994369485,0.016587677725118485,0.2872243988900256,1.0,6/13,11.28%,ROCK2;AKAP13;ALMS1;FHOD1;ASAP3;SLC9A1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5002237002737816,-1.6012648501423985,0.022727272727272728,0.2876291527168431,1.0,9/53,4.96%,EYA2;EGFR;EYA1;DDX5;EYA4;PLA2R1;PRKCD;SPRED1;FXR2
prerank,cardiac conduction system development (GO:0003161),-0.5845725735264609,-1.6006913864144996,0.023017902813299233,0.28566254562931265,1.0,7/24,5.92%,NOTCH2;BMPR1A;GJB6;GJA1;BMP4;CACNA1G;TBX18
prerank,neuron projection regeneration (GO:0031102),-0.7068077352854338,-1.6004224273113727,0.0378619153674833,0.28312994599295066,1.0,3/10,11.39%,PTN;NREP;GAP43
prerank,endocardial cushion development (GO:0003197),0.6966567506794841,1.6002994291257386,0.032148900169204735,0.498953420202276,1.0,8/21,6.28%,NOS3;BMPR2;ENG;ACVRL1;NOTCH1;SOX9;FOXF1;ACVR1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5727790264572835,1.6000304509660364,0.006887052341597796,0.49564010662875374,1.0,23/73,13.99%,WIPF3;PLCG1;DOCK1;ELMO1;WASF2;LYN;YES1;FYN;NCK1;PLCG2;ARPC3;NCKAP1;ARPC1B;RAC1;PTK2;CRK;FCGR1A;MYO1C;CYFIP1;ACTR2;HSP90AB1;PLD2;ACTR3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.71041083248955,1.5999750936681267,0.023688663282571912,0.4912861792562345,1.0,5/18,2.34%,RPS6KA5;PRKD1;CRTC1;CD200;PRKD2
prerank,platelet degranulation (GO:0002576),0.534066160847668,1.598396650435513,0.0038022813688212928,0.4942682384960858,1.0,23/118,9.14%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;LYN;ACTN4;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;TAGLN2;PPBP;SRGN;TGFB1;APOOL;TMX3;APLP2
prerank,focal adhesion assembly (GO:0048041),0.6896229704984372,1.5977425618193606,0.02626970227670753,0.49269005300347274,1.0,7/21,5.16%,THSD1;PEAK1;BCR;TAOK2;SORBS1;ACTN1;PTPRK
prerank,rRNA metabolic process (GO:0016072),0.5120911842021225,1.5977210200249472,0.0024009603841536613,0.48842267231698566,1.0,82/160,26.57%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;NIFK;RPL9;RPL4;RPL13A;RPL32;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RPL29;RRP9;TRIR;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;RPL3;DIS3L;SBDS;RPS28;DDX47;RPL7;RPL26;NOL6;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7025432092042105,1.5970589169536047,0.024875621890547265,0.48707326165254655,1.0,4/21,2.31%,PRKCH;FOXP1;ELF2;LYN
prerank,regulation of T cell proliferation (GO:0042129),0.5740279550654352,1.596100493586971,0.01764705882352941,0.486957667410363,1.0,10/61,9.61%,IL6ST;VCAM1;IL15;TNFRSF1B;NCK1;JAK3;TNFSF8;PLA2G2D;TNFRSF13C;IL23A
prerank,brain morphogenesis (GO:0048854),0.7741673143632252,1.5946001896379487,0.03710575139146568,0.4892982670552066,1.0,1/12,0.09%,SHANK3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.7827003566061088,1.5945668384158167,0.03745318352059925,0.4852163554191111,1.0,1/10,0.04%,PRKCH
prerank,regulation of plasminogen activation (GO:0010755),-0.7136589399782491,-1.5924052689735828,0.027426160337552744,0.3004417809123305,1.0,8/12,24.82%,CLEC3B;THBS1;SERPINE2;RUNX1;SERPINE1;CTSZ;PLGRKT;ENO1
prerank,lung development (GO:0030324),-0.5456430525787294,-1.5907042580035842,0.011494252873563218,0.3013244145897691,1.0,18/33,17.21%,FGFR2;GLI2;FGF1;PDPN;ERRFI1;BMP4;PKD1;RBP4;LOXL3;FGF2;RCN3;VEGFA;STRA6;FGF7;CCDC39;WNT11;NPHP3;FGF10
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5101341267067344,1.5903065183140241,0.0012004801920768306,0.49925095345348,1.0,76/168,20.57%,CNOT6;PAN3;CNOT6L;RPS15;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;RPL36;RPS18;RPL15;RPS8;RPL14;RPL23;RPL17;SMG7;RPL9;RPL4;RPL13A;CNOT1;RPS11;RPL32;NBDY;RC3H1;RPL22;RPS27;RPL31;RPS23;CNOT2;DCP2;RNPS1;RPL13;RPS12;PNRC2;RPL6;ZFP36;RPL10;CNOT7;UPF2;MTPAP;RPS29;RPS6;RPL29;RPS25;RPL35A;RPS13;RPS21;RPL27;RPL18;XRN2;RPL27A;RPS10;ZFP36L1;CTIF;RPL11;CSDE1;RPL8;RPLP2;HELZ2;PPP2R2A;RPL18A;DHX34;PPP2R1A;RPL21;LSM1;RPL3;PAN2;RPS3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6278140219120675,1.5900823940387359,0.022058823529411766,0.49597494387488494,1.0,6/38,3.69%,NOS3;TNFSF10;ICAM1;ARHGEF2;FAS;CASP8
prerank,L-glutamate transmembrane transport (GO:0015813),-0.7286484537858479,-1.5899554038033965,0.02511415525114155,0.29977630266964217,1.0,7/10,18.52%,SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,regulation of glucose import (GO:0046324),-0.5471561230498925,-1.5888749843553802,0.010256410256410256,0.2993505410144525,1.0,10/30,6.44%,PID1;IGF1;APPL2;IRS1;RHOQ;ENPP1;GRB10;SELENOS;OSBPL8;PRKAG2
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6839094607972497,-1.5884252077491037,0.020179372197309416,0.29712655108267333,1.0,6/13,9.51%,MGAT3;LARGE1;RENBP;PGM3;NAGK;CHST3
prerank,regulation of cell killing (GO:0031341),0.7257981690570258,1.588413809478145,0.0338680926916221,0.4986566694812727,1.0,6/16,7.48%,CFH;ICAM1;MAPK8;WNT5A;RAC1;CR1L
prerank,homeostasis of number of cells (GO:0048872),0.764597763087329,1.5883757600681574,0.035398230088495575,0.4946416107224232,1.0,4/12,5.39%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.7121494304022594,1.5878931124420228,0.03559870550161812,0.49258153599109306,1.0,7/17,5.12%,CAV1;APOLD1;KLF7;MAFF;SOX9;DLL1;CEACAM1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7247204260236115,1.587045347336558,0.029565217391304348,0.4925233236526981,1.0,2/15,2.18%,PLTP;SCARB1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5592997797818986,-1.5865807474637883,0.023054755043227664,0.2982621357673184,1.0,10/28,9.16%,PID1;PRKCB;APPL2;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,regulation of cellular component biogenesis (GO:0044087),0.6221414022451177,1.5851457122032233,0.022189349112426034,0.4971664849459293,1.0,9/39,7.53%,TJP1;TIE1;DAB2IP;NOTCH1;MSN;RAP1B;RAPGEF2;SNCAIP;RAP1A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7529054102668666,1.5846344067894107,0.04896421845574388,0.4952123236043682,1.0,3/12,7.33%,ESR1;STAT3;TGFB1
prerank,positive regulation of vasculature development (GO:1904018),0.5389893466289618,1.5843307814197505,0.005235602094240838,0.49256489525224084,1.0,20/94,6.63%,TEK;NOS3;FLT1;KDR;TIE1;PRKD1;PLCG1;VEGFC;GATA2;PRKD2;HIF1A;CD34;PIK3R6;HIPK1;XBP1;VEGFD;RAMP2;WNT5A;CD40;SASH1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.7572190653380398,1.5839670750285102,0.04954128440366973,0.4900765008113927,1.0,1/12,0.05%,IL1R1
prerank,metanephros development (GO:0001656),-0.5723269337354239,-1.5829420535778491,0.016216216216216217,0.3043625317227954,1.0,8/26,5.77%,FOXD1;BMP7;OSR1;BMP4;PKD1;ROBO2;NF1;SIX1
prerank,regulation of immune response (GO:0050776),0.5171982878620807,1.5821018360900203,0.0,0.4939293163217242,1.0,22/135,6.60%,CLEC2D;VCAM1;IL15;ICAM1;CD200;B2M;AHR;FOXP1;LYN;SAMHD1;NECTIN2;ICAM2;DENND1B;PVR;CASP8;FKBP1A;CD34;TIRAP;SPPL2A;N4BP1;XIAP;CD40
prerank,endothelial cell proliferation (GO:0001935),0.708276415667407,1.5788602133299896,0.037300177619893425,0.5048961831823116,1.0,5/17,3.79%,TEK;BMPR2;ERN1;ACVRL1;CD34
prerank,alpha-amino acid catabolic process (GO:1901606),-0.5487435138555729,-1.5778497691923359,0.017094017094017096,0.3148644516408974,1.0,13/29,24.84%,DDO;ACADSB;ALDH4A1;PRODH;FAH;ACAT1;CBS;HOGA1;BLMH;GSTZ1;GOT2;KYAT1;MTRR
prerank,B cell activation (GO:0042113),0.5674441021394812,1.5777887906612589,0.015068493150684932,0.5058477498717511,1.0,15/68,8.24%,HDAC9;MEF2C;VCAM1;HHEX;CTPS1;TPD52;PTPRJ;ADGRG3;CASP8;PLCG2;JAK3;CD40;LYL1;TCF3;MALT1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5041895197924628,-1.5771138034936023,0.009615384615384616,0.3132602475108657,1.0,21/49,13.11%,GPC6;SDC2;B3GALT1;GPC3;HSPG2;HS3ST3A1;EXT1;PXYLP1;HS3ST3B1;HS2ST1;GPC5;HS6ST2;GCNT2;SDC4;XYLT1;HS3ST5;HS6ST1;GPC4;HEXA;B3GALT5;B4GALT7
prerank,vasculogenesis (GO:0001570),0.6407327891331478,1.576910903612869,0.030911901081916538,0.5058125837033148,1.0,11/32,7.50%,EGFL7;KDR;ENG;CAV1;RASIP1;NOTCH1;SOX17;SOX18;RAMP2;TGFB1;RASA1
prerank,ceramide biosynthetic process (GO:0046513),0.6108896690022844,1.5767438296219982,0.019374068554396422,0.5026266899094076,1.0,9/40,6.93%,ST6GALNAC3;SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;ST8SIA4
prerank,negative regulation of wound healing (GO:0061045),-0.556832360982443,-1.5749266955604808,0.028277634961439587,0.31560072639807624,1.0,11/28,10.33%,PHLDB2;VTN;TFPI;SLC12A2;FGF2;SERPINE2;CD109;CASK;APOE;AJAP1;SERPINE1
prerank,apical protein localization (GO:0045176),0.7762856231220981,1.5747899000452248,0.05,0.5074431721408205,1.0,4/10,4.29%,ATP8B1;CELSR1;SHROOM2;MAL
prerank,regulation of chemokine production (GO:0032642),0.6261032076605836,1.5739649368914888,0.018518518518518517,0.5072067702476267,1.0,10/36,13.43%,APP;FOXP1;IL6R;HIF1A;ACKR1;SIGIRR;WNT5A;LPL;IL7;ADAM17
prerank,sphingoid biosynthetic process (GO:0046520),0.7639404305238228,1.573729469658681,0.04864864864864865,0.5005974827886999,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),0.7639404305238228,1.573729469658681,0.04864864864864865,0.5005974827886999,1.0,4/11,5.50%,ACER2;SPTLC2;SPTLC3;ASAH2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.6184621284702454,-1.5727287348049086,0.014218009478672985,0.31864578219095224,1.0,6/19,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,receptor clustering (GO:0043113),-0.5683762303949658,-1.5725231873899368,0.02040816326530612,0.31575095978348133,1.0,14/27,20.55%,MAGI2;PTN;DLG2;DLG4;DLG1;NRXN1;NLGN1;DLG3;NRXN2;DVL1;LRRC7;ITGA4;MUSK;ITGB2
prerank,mRNA splice site selection (GO:0006376),-0.5547738853652755,-1.5721605622878294,0.016483516483516484,0.31345623485855084,1.0,7/30,12.29%,CELF2;SRSF5;CELF4;LUC7L3;PSIP1;CELF1;SF1
prerank,myeloid leukocyte differentiation (GO:0002573),0.5610795881308908,1.5704580659711478,0.012113055181695828,0.5115671143717656,1.0,12/65,9.46%,LEF1;CBFA2T3;IL15;PIR;FOXP1;MYH9;TNFRSF11A;CASP8;SBNO2;DCSTAMP;CDK2;CSF1
prerank,cellular response to fluid shear stress (GO:0071498),0.7438310335621917,1.570216828694173,0.05871886120996441,0.5089245833432968,1.0,6/12,16.94%,MEF2C;MTSS1;KLF2;PKD2;HAS2;MAP2K5
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7580290002035781,1.56959900579755,0.05807622504537205,0.5079992067736883,1.0,5/11,9.63%,TJP1;F11R;TJP2;RAPGEF2;TJP3
prerank,heterochromatin organization (GO:0070828),0.7265487043843625,1.5695407825690622,0.04981549815498155,0.5046551631796296,1.0,3/14,8.56%,MECOM;SMCHD1;EZH1
prerank,regulation of phospholipase activity (GO:0010517),-0.7161074836144476,-1.5692274937043857,0.019148936170212766,0.317853818763297,1.0,2/10,0.68%,LRP1;FGFR2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6654284925099687,-1.5689873684030489,0.024070021881838075,0.31512063161211257,1.0,6/13,4.62%,FSTL1;FBN1;LTBP1;NBL1;GREM2;FBN2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.6245655786332096,-1.5685731492728912,0.0345679012345679,0.312874261733683,1.0,8/18,13.26%,ASPA;NAALAD2;SMS;ASPG;SLC25A12;GOT1;MTHFD1;SLC25A13
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.40449871320815906,-1.5677243330040487,0.0,0.311991040035067,1.0,32/152,11.62%,RNF220;ZEB2;SULF1;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SULF2;SEMA5A;DAAM2;RSPO3;RSPO2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SALL1;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;SMARCA4;DKK2;SCEL;GPRC5B
prerank,protein autophosphorylation (GO:0046777),0.5098821691159474,1.5675646458200085,0.0024271844660194173,0.5097761786954988,1.0,43/157,12.04%,TEK;FLT1;KDR;EPHB4;ERN1;PRKD1;INSR;DAPK1;PEAK1;LYN;PIM3;PRKD2;PTK2B;STK10;SIK1;TAOK2;STK24;SRMS;FLT4;PAK2;STK4;LMTK2;MARK3;MAP3K9;ULK1;AURKA;DYRK1A;STK26;BMX;TNIK;PTK2;MAP3K3;NEK6;MAP3K11;SLK;MAPKAPK3;EPHA4;MAP3K13;SIK2;PIM1;EEF2K;RIPK1;MKNK2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7415506511615331,1.5648510556410749,0.05150976909413854,0.5182004544192712,1.0,2/12,1.06%,JAM2;APP
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7314637579995112,1.5643762456054902,0.04363636363636364,0.5131253770120532,1.0,5/13,7.27%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.7314637579995112,1.5643762456054902,0.04363636363636364,0.5131253770120532,1.0,5/13,7.27%,IL15;STAT3;PLCB1;JAK3;JAK1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6556406071493093,-1.564047287269554,0.025404157043879907,0.3186952886047613,1.0,10/14,28.87%,GJA1;VEGFA;SYDE1;ACVR1B;ARHGDIB;SMURF2;TIMP1;CALR;C1QBP;ACVR1C
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7519534089471086,1.5630977401156192,0.034482758620689655,0.5151200401919565,1.0,2/11,1.55%,NOS3;GCH1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.6378100043253077,-1.5627952094756816,0.02733485193621868,0.31873491138515403,1.0,6/16,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,spermatid development (GO:0007286),0.6272508353140619,1.5622475895911716,0.029921259842519685,0.5153731778681017,1.0,7/32,11.22%,JAM2;GALNTL5;NECTIN2;CDYL;CEP57;TTC21A;TDRD5
prerank,sodium ion transmembrane transport (GO:0035725),-0.4415938380105878,-1.561882331995898,0.008928571428571428,0.31771459844453875,1.0,13/84,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC9A9;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,negative regulation of platelet activation (GO:0010544),0.6981393777982613,1.5614763761836599,0.03559322033898305,0.5150313801349912,1.0,4/16,5.12%,PRKG1;NOS3;PDGFB;CEACAM1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.5818256680182503,-1.5610785558328018,0.04199475065616798,0.31677509752649313,1.0,7/22,6.34%,CACNA1C;ADGRV1;CACNA1D;NF1;CAP2;GRM3;STIM1
prerank,positive regulation of neuron migration (GO:2001224),0.7726015584948214,1.5609978490949563,0.04317789291882556,0.5136124757463283,1.0,4/11,6.12%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2
prerank,regulation of response to external stimulus (GO:0032101),0.524700218092835,1.5608934058952761,0.010012515644555695,0.5106402095628028,1.0,30/121,11.16%,IL1R1;CAV1;PTGS2;SEMA7A;FOXP1;NMT2;SAMHD1;ADGRA2;CASP4;CNGB1;NLRP6;BST1;SELE;STK24;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;GNAT1;ERAP1;CASP1;GUCA1B;BRD4;CYRIB;PSMA6;CXCR4;P2RY12
prerank,cAMP-mediated signaling (GO:0019933),0.6699386443602258,1.5605894307826058,0.03225806451612903,0.5083863476939285,1.0,7/24,6.12%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,presynapse assembly (GO:0099054),-0.6196019266495534,-1.5603740526631174,0.04157549234135667,0.31557642739748193,1.0,10/16,15.84%,NLGN2;LRRTM3;PTPRD;IL1RAPL1;PCLO;NLGN1;NLGN3;FZD1;BSN;DVL1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7562840912884057,1.5599317482302484,0.03180212014134275,0.507679002974379,1.0,2/10,1.06%,SHANK3;APP
prerank,regulation of platelet activation (GO:0010543),0.6732389210099136,1.5559991055180293,0.04276315789473684,0.5211176895325632,1.0,5/21,3.91%,NOS3;PLA2G4A;PDGFB;LYN;SELP
prerank,positive regulation of cellular senescence (GO:2000774),0.7804726309353398,1.5550742004607807,0.03616636528028933,0.5217700506413064,1.0,2/10,1.56%,ABI3;B2M
prerank,lamellipodium assembly (GO:0030032),0.6459253938260205,1.555029021947716,0.02809917355371901,0.5185800453223349,1.0,10/26,11.69%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,peptide biosynthetic process (GO:0043043),0.5006785229411105,1.553620676355538,0.004920049200492005,0.5209910221239484,1.0,66/153,17.73%,RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;RPL38;RPL34;RPS20;RPL39;RPS7;RPS24;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;RPS8;RPL14;RPL23;RPL17;MRPS18A;RPL9;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RPL22;RPS27;RPL31;RPS23;MRPL13;RPL13;MRPS12;RPS12;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;MRPL41;RPS29;RPS6;MRPL52;RPL29;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;RPL27A;MRPS5;RPS10;MRPL37;RPL11;RPL8;RPLP2;MRPL11
prerank,regulation of defense response (GO:0031347),0.5555780498764361,1.5515155576831496,0.016172506738544475,0.5265709582069538,1.0,19/76,9.15%,IL1R1;PTGS2;SEMA7A;FOXP1;SAMHD1;CASP4;NLRP6;BST1;SELE;CASP8;TMSB4X;TIRAP;N4BP1;SBNO2;XIAP;WNT5A;ERAP1;CASP1;BRD4
prerank,cardiac myofibril assembly (GO:0055003),-0.6207560931589581,-1.548906583448801,0.0430622009569378,0.342111312836511,1.0,4/15,10.84%,PDGFRB;PDGFRA;OBSL1;FHOD3
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6838760013502343,-1.5488849431930898,0.03777777777777778,0.33898198227025267,1.0,2/11,1.21%,PID1;PRKN
prerank,regulation of integrin activation (GO:0033623),0.7225210952730294,1.548853505749525,0.03826086956521739,0.5345838472061913,1.0,5/15,6.14%,PIEZO1;RASIP1;RAP1B;SELP;SKAP1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7325104116845679,1.5486662615499662,0.03907637655417407,0.5318898655171586,1.0,5/13,10.01%,NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,nuclear migration (GO:0007097),-0.6627454000460921,-1.547651046168916,0.03051643192488263,0.3389073238439776,1.0,6/13,17.26%,DOCK7;CLMN;SYNE3;PCM1;SYNE2;DYNC1H1
prerank,regulation of cell morphogenesis (GO:0022604),-0.5381450707412365,-1.547145869746363,0.025495750708215296,0.3372159724577573,1.0,13/30,16.14%,EFNA5;PDPN;SPARC;NTNG1;CD44;ZMYM6;ZMYM3;ZMYM4;MOV10;MFSD2A;CAPZB;MACF1;MYO9A
prerank,monocarboxylic acid transport (GO:0015718),0.5846806899453495,1.5470149306966294,0.018950437317784258,0.5356885609097629,1.0,10/51,5.12%,ABCC4;SLCO2B1;ABCG2;ATP8B1;SLCO2A1;STARD5;SLC16A9;SLC16A2;NCOA1;CEACAM1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.536383270682291,-1.546683961052507,0.031331592689295036,0.3354809905510345,1.0,13/30,15.27%,ANK2;CACNA1C;SNTA1;CACNA2D1;GJA1;CACNA1D;CACNA1G;KCNJ2;RYR2;GPD1L;SCN2B;SCN1A;GJC1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6160556580414486,1.5464888103091121,0.029185867895545316,0.5345382484867751,1.0,6/35,2.59%,TEK;TJP1;ABI3;ESAM;F11R;PTK2B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7161066403466884,1.5462556191194983,0.03614457831325301,0.5320661928834794,1.0,4/18,7.78%,GNAQ;GNB1;PLCB1;AGRN
prerank,glycerophospholipid catabolic process (GO:0046475),0.6622309399781026,1.5458357324182732,0.037096774193548385,0.5305536681788057,1.0,8/27,15.03%,GPCPD1;PLA2G4A;ENPP6;ENPP2;INPP5F;GDPD1;PNPLA6;PNPLA8
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6760412441241206,-1.5455494713051467,0.05482456140350877,0.33541531963516896,1.0,8/12,14.96%,DMD;ATP1B1;WNK4;ANK3;ATP1B2;WNK1;FXYD1;WNK3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6198855705906186,1.544870473899357,0.049079754601226995,0.531380539525926,1.0,6/29,10.01%,CADM1;NECTIN2;PVR;STX7;IL23A;CYRIB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.606962499448525,-1.5442203483766093,0.035443037974683546,0.3359271371503097,1.0,9/19,18.45%,IGF1;NTRK2;RTN1;BIN1;APOE;FLOT2;RTN4;ABCA7;CHRNA7
prerank,camera-type eye development (GO:0043010),-0.550825069270881,-1.5435849975823932,0.0215633423180593,0.3346840679975159,1.0,10/25,13.00%,CACNA1C;FBN1;EFEMP1;TENM3;FBN2;CYP1B1;NF1;VEGFA;STRA6;NES
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.7533651973853339,1.5429422286032572,0.05390334572490706,0.5360801719109713,1.0,2/10,2.20%,RNF125;SEC14L1
prerank,glucose transmembrane transport (GO:1904659),0.6856872852737569,1.542508005889804,0.04697986577181208,0.5346864241319577,1.0,4/18,6.85%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,chordate embryonic development (GO:0043009),-0.474990137302956,-1.5409755161464984,0.006024096385542169,0.3387181458262258,1.0,18/55,10.19%,SULF1;ALDH1A2;FGFR2;COL1A1;ARNT2;BMP5;BMP7;SULF2;TGFBR1;PCSK5;PKD1;RBP4;DACT1;IGF2;KIAA1217;VEGFA;XYLT1;TGFB3
prerank,neuron projection organization (GO:0106027),0.7139264773224082,1.5396082690822641,0.05154639175257732,0.5437001682906698,1.0,7/15,11.84%,APP;INSR;ATP1A3;PSEN1;PICK1;LGMN;ABCD1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.6008696615969102,1.5394947893824515,0.03828483920367534,0.5409577606304941,1.0,8/35,6.61%,NRP2;SEMA6A;PLXNA4;SEMA5B;SEMA7A;PLXND1;SEMA6B;RAC1
prerank,myeloid cell differentiation (GO:0030099),0.5899651595589165,1.5381169453853407,0.02976190476190476,0.5431290362419073,1.0,10/47,5.14%,SNRK;ZBTB16;LYN;TAL1;MFHAS1;TIRAP;RPS19;JAK3;RPS14;KMT2E
prerank,diol metabolic process (GO:0034311),0.6779663208821163,1.537893955182585,0.030035335689045935,0.5407110250122356,1.0,6/19,5.50%,NOS3;DEGS2;GCH1;PLPP1;SGPP2;ASAH2
prerank,embryonic organ morphogenesis (GO:0048562),-0.5080472005528862,-1.5378499484817028,0.029940119760479042,0.34397064141687084,1.0,16/42,10.85%,FBN1;FGFR2;PDGFRA;HOXC4;EFEMP1;MFAP5;HOXA3;RBP4;DYNC2I1;FBN2;HOXB4;HOXB3;SIX1;RBPMS2;RYR2;FUZ
prerank,striated muscle tissue development (GO:0014706),0.624740575587889,1.5374373231590701,0.0421216848673947,0.5395679028518002,1.0,4/29,1.15%,PGM5;BMPR2;CAV1;MEF2C
prerank,lung epithelium development (GO:0060428),-0.7095795253871248,-1.5368931277788638,0.04090909090909091,0.34341924171935007,1.0,6/10,17.21%,ERRFI1;BMP4;PKD1;RCN3;STRA6;FGF10
prerank,positive regulation of developmental growth (GO:0048639),0.5843985434784646,1.5365447897407558,0.03206997084548105,0.5401851381558443,1.0,14/49,12.84%,NTN1;INSR;SEMA7A;SMURF1;NEDD4L;ITSN2;PLCB1;DLL1;GHR;AGRN;TWF2;SEMA4D;MAP3K13;DBNL
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.712125146408721,-1.5361559524774078,0.033402922755741124,0.34224010818733896,1.0,5/10,16.85%,ADGRV1;IFT88;WHRN;PLS1;TSKU
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5831450383304749,-1.536020362431887,0.031746031746031744,0.33965564819435484,1.0,8/22,13.37%,ANK2;ATP1B1;AKAP6;RYR2;SLC9A1;GSTM2;HTT;JPH2
prerank,innate immune response (GO:0045087),0.4810002413483141,1.5358769134544998,0.002325581395348837,0.5397666871273751,1.0,41/217,12.40%,SERINC3;APP;GCH1;B2M;NLRC5;NRROS;LYN;SERINC5;MFHAS1;PTK2B;TRIM14;YES1;FYN;SRMS;PLCG2;LCN2;IKBKB;CX3CR1;TRIM68;RPL39;PTX3;MID2;ADAM15;PGLYRP2;CD40;CFB;LCK;PIK3CG;PTK2;TRIM25;MALT1;CITED1;ANG;DEFA6;RELB;IKBKG;CYP27B1;ADAR;IRAK4;RELA;RIPK2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6343670952466413,1.5355611368872892,0.04595879556259905,0.5379571305150773,1.0,5/29,3.66%,SHANK3;TJP1;KANK3;HIP1R;SSH2
prerank,stress-activated MAPK cascade (GO:0051403),0.5619266955433189,1.5354455353654841,0.02545968882602546,0.5353223603375001,1.0,27/61,18.73%,NOD1;TNFRSF19;MAP4K3;TAOK2;SH2D3C;IKBKB;MAPK8;NFKB1;MAP3K11;IKBKG;MAP2K3;MAPK11;CCM2;MAP3K13;CUL1;RIPK2;ZFP36;TRIB1;TRAF6;MAP3K20;MAP4K2;TAB3;ZFP36L1;IRAK2;MAP3K8;MAP2K4;MINK1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5928613230733469,1.534600728521389,0.034055727554179564,0.5355261446111625,1.0,9/42,6.61%,TEK;KDR;UTRN;CDK6;PTK2B;PTPRJ;PPM1F;SKAP1;RAC1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.772021790371712,1.5342922265594596,0.03488372093023256,0.5337417520365623,1.0,4/11,7.27%,IL6ST;STAT3;IL27RA;JAK1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5907675534941798,1.5342346684563384,0.04054054054054054,0.530990354321052,1.0,14/46,10.77%,PIEZO1;F11R;PDE2A;FAS;CASP8;SOX9;MAPK8;CD40;TNFRSF1A;NFKB1;CASP1;CRADD;TNFRSF8;BNIP3
prerank,B cell differentiation (GO:0030183),0.5776078389469664,1.534064965488536,0.0364963503649635,0.5286805768025159,1.0,10/46,7.70%,HDAC9;VCAM1;HHEX;TPD52;PTPRJ;ADGRG3;PLCG2;JAK3;LYL1;TCF3
prerank,acidic amino acid transport (GO:0015800),-0.6170116209188456,-1.532564819663457,0.05867970660146699,0.3457856218254086,1.0,10/17,18.52%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;PRAF2
prerank,protein phosphorylation (GO:0006468),0.4578223621021888,1.5324038031843359,0.0010330578512396695,0.5327390239420251,1.0,107/479,11.87%,PRKG1;PRKCH;ERG;TEK;RPS6KA5;CDK17;FLT1;BMPR2;ABI3;KDR;APP;SNRK;EPHB4;ERN1;ACVRL1;PRKD1;CDK6;INSR;DAPK1;NEK7;PDGFB;PEAK1;DAB2IP;LYN;PIM3;PRKD2;BCR;ADAM10;PRAG1;PTK2B;FNIP2;STK10;MAP4K3;SIK1;FYN;TAOK2;STK24;STK3;PKN3;SRMS;FLT4;LIPE;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;RPS6KA1;HIPK1;SMAD7;ACVR2A;CDC42BPB;MAPK8;RET;PLK2;MAST2;USP15;ULK1;LIMK2;PPP3CB;AURKA;SIK3;ACVR1;TSSK6;DYRK1A;STK26;BMX;TNIK;LCK;JAK1;TGFB1;PTK2;MAP3K3;CTBP1;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;MAP3K11;AURKC;SLK;CDK2;RICTOR;MAPKAPK3;COPS2;CDK18;NUAK1;PRKAB1;GAS6;EPHA4;AKT3;ABL2;GMFG;PICK1;MAP3K13;SIK2;STK38;PIM1;EEF2K;RIPK1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5010670694202649,-1.5322848867862946,0.02416918429003021,0.34372985696114344,1.0,12/40,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;WNT6;BMP4;GPM6B;SLC8A1;FBN2
prerank,regulation of epithelial cell migration (GO:0010632),0.5697246794622812,1.5307318658770737,0.03671071953010279,0.5366050441370696,1.0,17/51,7.46%,PTPRG;BMPR2;PLCG1;DOCK1;DAB2IP;RAB11A;HIF1A;PPM1F;RREB1;PLCG2;SOX9;EVL;RHOJ;CEACAM1;ENPP2;SASH1;PTK2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5740640533553458,1.5304019063454886,0.03254437869822485,0.5349695342517405,1.0,13/47,13.03%,NANOS3;APP;EDN1;NFKBIA;EIF4E;TGFB1;PM20D2;NFKB1;CSF1;RBM3;CYFIP1;RPL10;MTPN
prerank,phospholipid transport (GO:0015914),0.5638442332432961,1.5295978895993567,0.025677603423680456,0.5353128426411505,1.0,12/52,10.70%,ATP8B1;PLTP;ATP8A1;SCARB1;PRELID2;ATP10A;ATP11C;ATP11B;ABCA3;ATP11A;PITPNC1;SCARB2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.40258563959090954,-1.5277466089034186,0.0,0.35266256527225365,1.0,26/129,11.62%,RNF220;ZEB2;EGFR;WLS;LGR4;FGFR2;COL1A1;GPC3;PTK7;SEMA5A;DAAM2;DACT1;CAPRIN2;LYPD6;LRRK1;PLEKHA4;SFRP4;PSME4;AXIN2;LRRK2;GPC5;SFRP1;WNK1;DKK2;SCEL;GPRC5B
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6895323700818544,1.5272574769477176,0.06282722513089005,0.5420230617486994,1.0,2/17,1.15%,PRKG1;MEF2C
prerank,response to lipopolysaccharide (GO:0032496),0.5030617600849479,1.5270424982664748,0.013480392156862746,0.5400049498746525,1.0,36/138,14.35%,NOS3;MEF2C;GCH1;FOXP1;DAB2IP;SCARB1;TNFRSF11A;TNFRSF1B;SELE;SELP;TIRAP;RPS6KA3;XBP1;CX3CR1;SBNO2;MAPK8;PELI1;IFNAR1;WNT5A;IL36G;PPBP;HNRNPA0;NFKB1;CASP1;CITED1;DEFA6;MAPKAPK3;CYP27B1;CARD16;RELA;GSTP1;ZFP36;TRIB1;ADAM17;TRAF6;S100A9
prerank,ceramide transport (GO:0035627),0.7482413222817499,1.5269049070608554,0.055350553505535055,0.5376367545708207,1.0,4/12,9.21%,CERT1;PLTP;GLTP;PLEKHA8
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6345785941123799,-1.5261615227205425,0.04415011037527594,0.354071568504083,1.0,2/15,1.21%,IGF1;PRKN
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.718474221569794,1.5250289238949277,0.04788213627992634,0.5423243231175273,1.0,2/14,2.21%,NOS3;EDN1
prerank,actin filament polymerization (GO:0030041),-0.5254332398632229,-1.5246399819812797,0.04519774011299435,0.3552137514657336,1.0,5/29,3.85%,ARHGAP6;GAS7;GSN;SPIRE1;COBL
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5792483954225599,1.5238702683681422,0.0344311377245509,0.5440909377892023,1.0,9/45,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,protein localization to cell-cell junction (GO:0150105),0.71146771933559,1.523690550969651,0.05871886120996441,0.5419021998724398,1.0,7/15,9.63%,TJP1;LSR;F11R;TJP2;PAK2;JAK1;TJP3
prerank,inorganic cation transmembrane transport (GO:0098662),-0.36434030661299516,-1.52235687323636,0.0,0.35836836393846916,1.0,44/268,8.01%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC8A3;SLC41A1;SLC12A2;SLC6A1;SCN7A;KCNB2;SCARA5;CACNA1D;SLC9A9;SLC30A10;KCNK5;SLC6A12;SLC6A9;PKD1;ATP1B1;SLC8A1;P2RX4;KCNQ3;ABCC9;KCND2;ATP6V0A4;SLC39A14;KCND3;CACNA1G;ITGAV;TRPC3;SLC39A13;KCNC2;SLC6A15;KCNS3;TRPC6;KCNJ2;KCNQ4;TRPC1;ATP2A2;KCNAB1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5451366582500988,1.5218840415297696,0.02642559109874826,0.5463858478190683,1.0,18/67,7.46%,TEK;FLT1;ABI3;KDR;IL15;INSR;PDGFB;LYN;PTK2B;FYN;SRMS;FLT4;JAK3;GHR;DYRK1A;BMX;LCK;PTK2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6529050037315869,1.521780805792513,0.040268456375838924,0.5438960987982636,1.0,3/24,1.39%,DACH1;BMPR2;ACVRL1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7480348752919879,1.521753162688661,0.07954545454545454,0.5411277125918019,1.0,2/10,1.49%,LRCH1;CD200
prerank,cellular response to drug (GO:0035690),0.6516956394640373,1.5210862936435463,0.03801652892561983,0.5408529022335231,1.0,7/25,7.06%,ACER2;MEF2C;KCNQ1;AIM2;PPM1F;FBP1;KCNE2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6627786854584552,1.5204061151035553,0.05564924114671164,0.5407729260471652,1.0,6/18,6.84%,ERN1;NCK1;XBP1;BOK;ATXN3;BCL2L11
prerank,cytokine-mediated signaling pathway (GO:0019221),0.451908014511397,1.5194202304906406,0.0,0.5421070076356032,1.0,107/532,12.74%,IL1R1;RPS6KA5;FOXO1;ADIPOR2;NOD1;IL6ST;LIFR;INPP5D;MAOA;PTGS2;UGCG;LCP1;VCAM1;IL15;ICAM1;STX3;B2M;PDGFB;IRF2;IL6R;SOCS2;OSMR;STAT3;AIM2;TNFRSF11A;SAMHD1;PTK2B;S1PR1;HIF1A;MSN;PTPRJ;TNFRSF1B;NFKBIA;RAP1B;FYN;ACTN4;PLCB1;TRAF1;TMSB4X;PAK2;TNFRSF25;LCN2;JAK3;EDAR;IKBKB;ISG20;CEACAM1;GHR;CSF2RB;IL27RA;TRIM68;PELI1;IFNAR1;HNRNPF;CISH;IFNAR2;TNFSF8;CA1;IL36G;MTAP;CD40;CDKN1B;JUNB;BCL2L11;PPBP;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;PSMA2;TRIM25;NFKB1;MAP3K3;TNFRSF13C;CASP1;IL7R;CRK;IKBKG;CSF1;TNFRSF8;IL23A;BCL2L1;PSMA8;TNFRSF9;FCGR1A;CCL14;PSMA6;FSCN1;POU2F1;IL4R;CBL;ABL2;IL7;ADAR;CUL1;CEBPD;IL17RB;IRAK4;PIM1;RIPK1;MUC1;OASL;RELA;RIPK2;ADIPOR1;BIRC3
prerank,negative regulation of GTPase activity (GO:0034260),0.6586195115507303,1.5194160130142875,0.04230118443316413,0.5393289266862116,1.0,4/22,2.14%,LRCH1;F11R;SH3BP4;DAB2IP
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6659357090871506,1.5193310456302003,0.05509181969949917,0.5369141710356593,1.0,7/21,9.43%,PRKCH;FOXP1;PRKD2;NECTIN2;TESPA1;LCK;IKBKG
prerank,"phototransduction, visible light (GO:0007603)",0.7060733777230629,1.518701248357413,0.05272407732864675,0.5366248850862472,1.0,4/14,6.96%,GNAQ;GNB1;CNGB1;GNAT1
prerank,sodium ion transport (GO:0006814),-0.42563024305868885,-1.5186223453205012,0.013574660633484163,0.3654362561361845,1.0,12/85,3.39%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC8A3;SLC12A2;SLC6A1;SCN7A;SLC6A12;SLC6A9;ATP1B1;SLC8A1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.7502278417732644,1.5184915911389865,0.055855855855855854,0.5346653347285645,1.0,3/11,5.18%,AHR;CEACAM1;SMAD7
prerank,sphingosine metabolic process (GO:0006670),0.6842862521839372,1.5184455527469307,0.05335628227194492,0.5321724337698197,1.0,6/17,5.50%,ACER2;SPTLC2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5071837771774917,1.517821425035304,0.015037593984962405,0.5319854242587542,1.0,14/110,6.12%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;S1PR1;GNB1;ADGRG3;ADGRE5;ADGRG1;ADRB1;RAMP2;RAPGEF2
prerank,ethanol metabolic process (GO:0006067),-0.6515042971377847,-1.5172861035677114,0.037444933920704845,0.3657683871654582,1.0,2/12,6.08%,ALDH1A1;ALDH2
prerank,membrane fusion (GO:0061025),0.6168523069376717,1.51598447246412,0.045454545454545456,0.5368130463225498,1.0,2/33,0.33%,DNM3;MYOF
prerank,protein hydroxylation (GO:0018126),-0.6298650766190667,-1.5158567344839369,0.036057692307692304,0.3668755542266614,1.0,7/15,19.26%,PLOD2;ASPH;P3H3;EGLN3;P3H4;P3H1;VIPAS39
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6760678224914949,1.5147307695763,0.04576271186440678,0.5391668321816839,1.0,4/20,7.78%,GNAQ;GNB1;PLCB1;AGRN
prerank,protein depolymerization (GO:0051261),-0.5386607386355395,-1.5142377871975077,0.028795811518324606,0.36861885020752544,1.0,3/27,1.04%,MICAL3;GSN;MICAL2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.6670522235714904,1.5141072197360035,0.052364864864864864,0.5389531876769181,1.0,11/20,14.18%,ADAM10;SPPL2A;TGFB1;NFKB1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5310543544702648,-1.5140639570150882,0.03611111111111111,0.366205327494243,1.0,9/27,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;TNS2;PRKCZ;TSC2
prerank,positive regulation of cell migration (GO:0030335),0.468272611831985,1.5133400872351839,0.001128668171557562,0.5395457400561267,1.0,51/253,8.75%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;BMPR2;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PLCG1;PDGFB;NEDD9;DOCK1;DAB2IP;RAB11A;EDN1;ARHGEF2;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;HIF1A;PPM1F;RREB1;ACTN4;PLCG2;NUMB;SOX9;F7;SDCBP;XBP1;ENPP2;SEMA6B;RET;RAPGEF2;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7;GAB1;SEMA6D;AKT2;ARHGEF7
prerank,neuron cell-cell adhesion (GO:0007158),-0.6460863158526216,-1.5131185754116572,0.03255813953488372,0.366108723565472,1.0,9/14,12.65%,NLGN2;NRXN1;NLGN1;NRXN3;NCAM2;ASTN1;NLGN3;CNTN4;NRXN2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5850623629085616,1.51245017957591,0.0441400304414003,0.5405299771602596,1.0,8/39,6.60%,TEK;KDR;ICAM1;PLCG1;ECSCR;GATA2;RAMP2;CD40
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5698632694959407,-1.5122140854700699,0.042606516290726815,0.36552086654827787,1.0,4/21,2.57%,ANK2;SNTA1;CACNA2D1;CACNA1D
prerank,lymphocyte proliferation (GO:0046651),0.6484802559548913,1.5117209080778853,0.04508856682769726,0.5407443242907972,1.0,6/22,7.41%,MEF2C;CTPS1;MSN;PPP3CB;CD40;PIK3CG
prerank,regulation of cardiac conduction (GO:1903779),-0.46321290968494044,-1.510726922781229,0.012738853503184714,0.3668152500646288,1.0,15/54,9.89%,ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;ASPH;DMPK;ABCC9;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2
prerank,positive regulation of vasculogenesis (GO:2001214),0.7392504798248712,1.509789284501645,0.05615942028985507,0.5458898069390762,1.0,5/10,7.53%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6418485842394345,-1.5094472931037262,0.04044943820224719,0.3673382672431815,1.0,8/13,23.99%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;ATR;MSX1;ATM
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6257363113450085,-1.5087390726970453,0.0455531453362256,0.3665372927512591,1.0,6/15,28.59%,MOXD1;SAT1;ASMT;DDC;SRM;SAT2
prerank,regulation of programmed cell death (GO:0043067),0.485934778237993,1.5071688367934952,0.012150668286755772,0.5537633198446643,1.0,37/161,14.20%,MECOM;ACER2;TGM2;PPP1R13B;DAPK1;HIP1;FAS;ANP32A;GLS2;ACTN4;AMIGO2;SOX9;TNFRSF25;ACTN1;JAK3;TOX3;STK26;BCL2L11;TIGAR;BCL3;MALT1;CASP1;CRADD;NF2;CITED1;RBM25;TRIM24;SLK;BNIP3;RIPK1;BID;NOP53;PRDX2;BIRC3;OMA1;ASAH1;BCL2L14
prerank,copper ion homeostasis (GO:0055070),0.6684410221768154,1.5069204190445005,0.06434782608695652,0.5521692863016847,1.0,4/17,10.25%,APP;SLC31A1;XIAP;ATP7B
prerank,striated muscle contraction (GO:0006941),-0.4652496732756759,-1.5051635849908809,0.012307692307692308,0.37335110287839773,1.0,8/53,9.11%,ATP1A2;DMD;ATP1B1;SLC8A1;TPM1;DTNA;GAA;RYR2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5813186076669056,1.5042314409538917,0.03230769230769231,0.5602951612960864,1.0,10/39,5.40%,NOS3;IL6ST;MAML2;EPN2;STAT3;NOTCH1;TSPAN5;DLL1;DLL4;TSPAN14
prerank,glycolipid metabolic process (GO:0006664),0.5742959935534937,1.504194673531223,0.027982326951399118,0.5577975911905863,1.0,6/47,4.87%,ST3GAL6;ST6GALNAC3;UGCG;PGAP1;ESYT2;GLTP
prerank,cellular response to interleukin-1 (GO:0071347),0.4910131290506476,1.503960393236657,0.013157894736842105,0.5561172638493188,1.0,32/143,16.22%,IL1R1;RPS6KA5;NOD1;DAB2IP;HIF1A;NFKBIA;PLCB1;SOX9;IKBKB;PELI1;CD40;PSMA2;NFKB1;MAP3K3;IKBKG;MAPK11;PSMA8;CCL14;PSMA6;RC3H1;CUL1;IRAK4;RELA;RIPK2;HAS2;GBP3;IL1RAP;TRAF6;PSME1;IRAK3;RPS6KA4;TAB3
prerank,positive regulation of cell motility (GO:2000147),0.47224031527216986,1.5034615824430706,0.005807200929152149,0.555635043718759,1.0,37/205,7.60%,SEMA6A;LEF1;TJP1;PECAM1;FLT1;NTN1;KDR;CAV1;ITGA6;SEMA5B;PODXL;INSR;SEMA7A;PDGFB;NEDD9;EDN1;ADAM10;STAT3;PDGFD;PTK2B;PPP3CA;NOTCH1;PPM1F;ACTN4;NUMB;F7;SDCBP;XBP1;CAVIN1;SEMA6B;RET;CBLL1;ACVR1;PDGFC;TGFB1;PTK2;GRB7
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7051357766272325,1.5022676937776387,0.07142857142857142,0.5582177721931708,1.0,4/15,9.46%,PRKCH;NFKB1;LPL;CSF1
prerank,regulation of heart contraction (GO:0008016),-0.42234730576733637,-1.5014753817274942,0.004201680672268907,0.3804123137728184,1.0,22/90,12.08%,CELF2;ATP1A2;ANK2;SLC8A3;ATP1B1;SLC8A1;P2RX4;ASPH;DMPK;ABCC9;TPM1;STIM1;PRKACA;TRPC1;ATP2A2;RYR2;TMEM65;ATP1B2;DES;TGFB2;S100A1;TBX2
prerank,regulation of cell adhesion (GO:0030155),0.49395337614554363,1.501284533536436,0.01673101673101673,0.5595657887977414,1.0,33/129,11.12%,FRMD5;PKP4;PLXNA4;TGM2;STX3;ACVRL1;PODXL;CYTH1;LYN;PRKD2;ADAM10;EFNA1;PTK2B;PPP3CA;PLXND1;PTPRJ;PPP1R12A;ADGRG1;DLL1;RET;CBLL1;ADAMDEC1;ATXN3;PIK3CG;PTK2;RASA1;RSU1;DSCAM;SEMA4D;CXCR4;NUAK1;EPHA4;ABL2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5944435306301328,1.5003534526473923,0.03803486529318542,0.5605388029911561,1.0,9/36,7.94%,NOS3;CAV1;GCH1;SCARB1;HIF1A;NOSTRIN;ATP2B4;NOSIP;NOS1AP
prerank,ribosome assembly (GO:0042255),0.5700210573339174,1.500344361080245,0.03338391502276176,0.5579632178134415,1.0,18/47,21.08%,RPS15;RPS19;RPS14;RPSA;RSL24D1;RRS1;EIF6;RPS27;NOP53;RPL6;RPL10;NPM1;RPL11;MTERF3;RPL3;TRAF7;SBDS;RPS28
prerank,T cell activation involved in immune response (GO:0002286),0.7127877108238128,1.500048916408342,0.10091743119266056,0.5565663849138052,1.0,2/12,1.30%,LCP1;ICAM1
prerank,nuclear transport (GO:0051169),0.6745351303644185,1.4997960442218137,0.0676818950930626,0.555013291121999,1.0,7/16,14.04%,ANP32A;RSRC1;XPO1;CITED1;NUP98;NUP205;NPM1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6315375564064616,-1.4991069720492087,0.06997742663656885,0.3842117547002497,1.0,6/13,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,glycerolipid catabolic process (GO:0046503),0.68078713507383,1.4986917185108024,0.07228915662650602,0.5570087614111131,1.0,5/19,9.99%,GPCPD1;PLA2G4A;ABHD2;ENPP6;GDPD1
prerank,cellular response to cytokine stimulus (GO:0071345),0.4517901720080645,1.4984200632308666,0.0010582010582010583,0.5555060704388342,1.0,83/416,11.87%,IL1R1;LEF1;ST3GAL6;LRCH1;FOXO1;PTPN14;IL6ST;LIFR;INPP5D;MAOA;PTGS2;VCAM1;ICAM1;STX3;DAPK1;PTPN12;IL6R;DAB2IP;ARHGEF2;PDE2A;SOCS2;OSMR;STAT3;GBP5;AIM2;GBP4;S1PR1;HIF1A;PTPRJ;TNFRSF1B;FYN;SIGIRR;SOX9;LCN2;JAK3;GBP7;IKBKB;XBP1;GHR;CSF2RB;IL27RA;SBNO2;MAPK8;ASAH2;IFNAR1;WNT5A;IFNAR2;IL36G;DCSTAMP;CD40;INPP5K;CDKN1B;JUNB;BCL2L11;LCK;JAK1;TNFRSF1A;TGFB1;STX1A;NFKB1;CASP1;CRK;YBX3;CSF1;IL23A;BCL2L1;MAPK11;RPL13A;CCL14;CXCR4;GAS6;FSCN1;POU2F1;RC3H1;IL4R;CBL;RO60;ABL2;IL7;CEBPD;IRAK4;PIM1;RIPK1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5961191804343045,-1.498079038080098,0.04849884526558892,0.384306484522967,1.0,7/18,15.46%,GLI3;OSR1;SALL1;TBX2;WDPCP;INTU;TBX3
prerank,regulation of inflammatory response (GO:0050727),0.47733324615450146,1.4978748328754992,0.011627906976744186,0.5551653829026895,1.0,31/190,10.61%,IL1R1;TEK;PTGS2;APP;PPARD;IL15;CD200;SEMA7A;FOXP1;PDE2A;MFHAS1;CASP4;NFKBIZ;TNFRSF1B;NFKBIA;NLRP6;BST1;SELE;LPCAT3;TMSB4X;SBNO2;XIAP;WNT5A;TNFRSF1A;LPL;CASP1;BRD4;IL23A;TNIP1;PSMA6;NMI
prerank,heart trabecula morphogenesis (GO:0061384),0.6671279885717344,1.496811976337091,0.06293706293706294,0.5568058870563019,1.0,7/18,5.28%,ADGRG6;TEK;ENG;S1PR1;NOTCH1;FKBP1A;DLL4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6625330522617925,1.4963964263577976,0.055,0.5560421302645397,1.0,3/20,3.15%,IL1R1;B2M;DENND1B
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6665310919002218,-1.495955586581127,0.05869074492099323,0.3873626596340549,1.0,6/11,15.32%,BMPR1A;BMP4;ZFPM2;JAG1;TGFB2;HEY2
prerank,calcium ion transport into cytosol (GO:0060402),-0.551889762404163,-1.49539352701158,0.05089058524173028,0.3862257018009225,1.0,9/21,13.75%,CACNA1C;CACNA2D1;JPH1;SLC8A1;RYR2;GRIN2A;ADRA1A;JPH2;GRIN2D
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6164834966303727,1.4952829917670356,0.06259780907668232,0.5579931671186678,1.0,8/28,7.34%,EGFL7;LFNG;GATA2;FBXW7;DLL1;DLL4;ARRB1;ARRDC1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5882795447392007,1.493828430705156,0.046801872074883,0.5611484587583825,1.0,6/36,7.47%,SHANK3;EDN1;FBXW7;HIF1A;GREM1;TGFA
prerank,regulation of fatty acid metabolic process (GO:0019217),0.660548011346276,1.4935580427957382,0.07432432432432433,0.5595974488976888,1.0,3/17,1.07%,ADIPOR2;CAV1;PPARD
prerank,rRNA processing (GO:0006364),0.4743717902827806,1.4934899071956869,0.009501187648456057,0.557378140140492,1.0,88/172,26.57%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;RPS6;RIOK1;RPL29;RRP9;PELP1;RPS25;SRFBP1;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;MAK16;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;RPL21;SART1;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7;THUMPD1;RPL26;MRPL1;NOL6;RIOK3;TEX10;RRP12;LAS1L;LYAR;NOLC1;RPS17;RPL28;WDR46;WDR74;RPL41;DIS3;EXOSC4;RPS2;RPS9
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6020571051275407,-1.4922588212648011,0.060324825986078884,0.39230688919392737,1.0,6/15,8.61%,GPC3;DAAM2;RSPO3;DACT1;SFRP4;SFRP1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.7219920543060262,1.491981642316497,0.0695970695970696,0.5607301743713061,1.0,5/11,13.55%,STAT3;PUM1;PUM2;ZFP36;FMR1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.5957415550424537,-1.4917716460207755,0.0639269406392694,0.3908950368176404,1.0,6/17,10.19%,WNT4;BMP4;LARP6;RUNX1;RGCC;TGFB3
prerank,phospholipid catabolic process (GO:0009395),0.6495853141268093,1.490044826793432,0.054635761589403975,0.565929200747235,1.0,5/24,9.99%,GPCPD1;PLA2G4A;ENPP6;ENPP2;GDPD1
prerank,regulated exocytosis (GO:0045055),0.4797208155700016,1.489391214582442,0.006016847172081829,0.565973188264468,1.0,36/173,12.23%,VWF;ABCC4;PECAM1;PCDH7;APP;PDGFB;VEGFC;MYH9;LYN;ACTN4;RAB11FIP1;SELP;SELENOP;TMSB4X;ACTN1;PROS1;VEGFD;QSOX1;RAB11FIP5;ARHGAP17;TAGLN2;PPP3CB;PPBP;SRGN;TGFB1;STX1A;APOOL;TMX3;APLP2;CYRIB;GAS6;SYT15;ITGB3;RAB26;MMRN1;RAB11B
prerank,cellular response to fatty acid (GO:0071398),-0.6486787065998996,-1.4893264665428303,0.0539906103286385,0.39518014865855156,1.0,2/12,1.40%,PID1;IRS1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6164806174166098,1.4889396162493211,0.06666666666666667,0.5653466396593543,1.0,6/27,4.03%,DACH1;BMPR2;ACVRL1;PDGFB;PRKD2;HMBOX1
prerank,limb morphogenesis (GO:0035108),-0.5595326691249067,-1.488482309449351,0.04176904176904177,0.39460131011810684,1.0,9/20,20.56%,GLI3;PCSK5;CYP26B1;LRP6;TGFB2;TBX3;IQCE;SKI;PTCH1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.643339807548462,1.4884039725927367,0.07142857142857142,0.5650568560596217,1.0,5/23,8.50%,PLA2G4A;LPCAT3;PLA2G2D;MBOAT1;PLAAT3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7330892288249571,1.4881710851563998,0.07578558225508318,0.5636034650358025,1.0,4/10,5.00%,PLPP1;PARD3;PRKD3;DGKH
prerank,ncRNA processing (GO:0034470),0.46620916665820294,1.4880479611814676,0.009324009324009324,0.5616719490400428,1.0,77/200,21.42%,SMAD1;DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;FARS2;RPL34;RPL39;DROSHA;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;RPL14;RPL23;RPL17;DICER1;RPL9;RPL4;RPL13A;RPL32;INTS11;RPL22;RPS27;RPL31;EXOSC1;ADAR;RPL13;RPP30;NOP53;UTP4;RPL6;RPL10;INTS12;RPS6;RPL29;RRP9;ADAT1;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;KARS1;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;SMAD2;RPL21;RPL3;MRPL44;SBDS;INTS8;RPS28;DDX47;PRKRA;RPL7
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6786295425791788,-1.487976078941986,0.04835164835164835,0.3932592728882502,1.0,4/10,9.56%,CPEB1;CPEB3;PAF1;LEO1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5529721777247004,-1.4879409677888635,0.04367816091954023,0.39067779923871054,1.0,12/23,20.56%,GLI3;GPC3;ENPP1;TULP3;GLIS2;BTRC;HHIP;SUFU;KIF7;PTCH2;ULK3;PTCH1
prerank,regulation of blood circulation (GO:1903522),-0.5054585481731351,-1.4867107592827309,0.04864864864864865,0.3915576466632849,1.0,10/34,12.08%,CELF2;DMPK;TPM1;PER2;AGTR1;KCNMB2;BDKRB2;DES;S100A1;TBX2
prerank,hexose biosynthetic process (GO:0019319),-0.4777706017897492,-1.4866139921720611,0.019230769230769232,0.38915769439687314,1.0,17/42,18.72%,RBP4;AKR1B1;PPARGC1A;SLC39A14;CHST15;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,peptidyl-tyrosine modification (GO:0018212),0.5481210456990354,1.486511702370058,0.024216524216524215,0.5653898423168792,1.0,16/56,7.46%,TEK;FLT1;ABI3;KDR;INSR;PDGFB;LYN;TPST2;PTK2B;FYN;SRMS;FLT4;JAK3;DYRK1A;LCK;PTK2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5443830809719106,-1.486494953489312,0.0664819944598338,0.3869302898720222,1.0,5/23,8.66%,ATP1A2;ANK2;CACNA2D1;UBASH3B;CACNB1
prerank,regulation of interleukin-13 production (GO:0032656),0.7041800332647582,1.4860036382756663,0.08960573476702509,0.5650601643113387,1.0,1/13,0.13%,LEF1
prerank,epithelial structure maintenance (GO:0010669),-0.6416287332799524,-1.4858327782837595,0.04291845493562232,0.38618717252354323,1.0,2/11,3.26%,CXADR;RBP4
prerank,positive regulation of bone mineralization (GO:0030501),-0.4981680553446999,-1.4857891819254059,0.02824858757062147,0.38372597194056435,1.0,11/35,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,energy reserve metabolic process (GO:0006112),-0.5954186528069647,-1.4853474747448607,0.0535279805352798,0.3823498182694084,1.0,9/19,12.04%,PID1;LEPR;PHKB;PYGM;PRKAG2;GFPT1;PPP1R3C;GFPT2;UGP2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6644984681196857,1.484932256393261,0.06927175843694494,0.5667550448704006,1.0,7/18,14.68%,ESR1;TMBIM6;PTBP3;TGFB1;NUDT16;RPS13;KAT2B
prerank,lipoxygenase pathway (GO:0019372),0.6894853486645992,1.484045382723296,0.07597173144876325,0.5678206362650252,1.0,4/14,8.64%,PTGS2;ALOX5AP;PON2;LTC4S
prerank,cation transmembrane transport (GO:0098655),-0.47735935091130677,-1.4832791593493633,0.024242424242424242,0.38534115821217946,1.0,7/44,4.22%,ATP1A2;TRPM3;SLC7A2;SLC6A9;ATP1B1;SFXN2;ABCC9
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6934757169910043,1.483076314093304,0.06060606060606061,0.569225406773274,1.0,3/13,5.81%,NOS3;GCH1;MTHFD1L
prerank,respiratory tube development (GO:0030323),-0.5327580763861436,-1.4825185127015197,0.03672316384180791,0.3848401826894451,1.0,13/28,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;PCSK5;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,mesenchyme morphogenesis (GO:0072132),0.67688771782485,1.481999384377783,0.06129597197898424,0.5708773582269596,1.0,6/17,6.28%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,myeloid cell development (GO:0061515),0.6656668037790048,1.4817643344794857,0.0727580372250423,0.5693956245152098,1.0,4/18,2.95%,APP;FOXP1;NRROS;ALAS1
prerank,smoothened signaling pathway (GO:0007224),-0.50643955117182,-1.4815444398024076,0.0326975476839237,0.38513748362775185,1.0,20/32,25.56%,GLI3;GLI2;EVC2;CC2D2A;GLI1;HIPK2;SMO;TMEM231;DISP2;TTBK2;DISP3;PTCH2;IFT27;TCTN2;ULK3;TMEM17;PTCH1;STK36;STIL;MAP3K10
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6924657661344282,1.4796752594828664,0.07308377896613191,0.575437097639859,1.0,2/13,1.06%,SHANK3;APP
prerank,ATP transport (GO:0015867),-0.6448495307474675,-1.479605550085531,0.06306306306306306,0.38755807551565336,1.0,4/10,19.25%,ABCC6;SLC25A42;SLC17A9;SLC25A4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6493659498034516,1.4793378028347404,0.07155025553662692,0.5743865036165149,1.0,5/19,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7402131804886293,1.4784648276133634,0.08190476190476191,0.5752608198357243,1.0,4/10,13.10%,GNB1;CNGB1;GNAT1;PDE6B
prerank,response to molecule of bacterial origin (GO:0002237),0.5325414397108376,1.478223152395594,0.03972602739726028,0.5737810876426971,1.0,15/69,10.26%,NOS3;GCH1;FOXP1;TNFRSF11A;SELE;SELP;TIRAP;RPS6KA3;PELI1;IFNAR1;HNRNPA0;CITED1;MAPKAPK3;CYRIB;CYP27B1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.626377182260954,1.4781500499179074,0.06724137931034482,0.5716840936413707,1.0,5/24,5.63%,TEK;KDR;ICAM1;GATA2;RAMP2
prerank,negative regulation of locomotion (GO:0040013),0.7042668541831845,1.4779428798821292,0.07005253940455342,0.5702265601909718,1.0,2/12,2.30%,FRMD5;CCDC125
prerank,aortic valve development (GO:0003176),0.5908976455996208,1.477642147167679,0.05055292259083728,0.568988853447468,1.0,12/34,7.33%,NOS3;BMPR2;TIE1;NFATC1;EFNA1;NOTCH1;TNFRSF1B;ELN;SOX9;DLL4;TNFRSF1A;TGFB1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6460148542565218,-1.4770875884278742,0.05077262693156733,0.39171974292691125,1.0,6/12,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7003240032669695,1.4758405311699645,0.1001926782273603,0.573690597416738,1.0,2/12,2.87%,CAV1;PDE4D
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6172517372823755,1.475648782202019,0.06896551724137931,0.5721877670927794,1.0,8/28,8.18%,CTSC;SMURF1;ECSCR;DAB2IP;FBXW7;KCNE2;PTK2;RNF139
prerank,regulation of cell migration (GO:0030334),0.4429498277342443,1.4755620161776202,0.0010638297872340426,0.5702521755681033,1.0,72/382,8.63%,FRMD5;SEMA6A;LEF1;TJP1;LIMCH1;PECAM1;MCTP1;FLT1;DACH1;ABI3;PLXNA4;LDB2;KDR;ENG;CAV1;ITGA6;SEMA5B;ACVRL1;CLDN5;PODXL;INSR;SEMA7A;PDGFB;NEDD9;ADARB1;EDN1;ADAM10;STAT3;PDGFD;PTK2B;SRGAP3;SRGAP2;PPP3CA;NOTCH1;PLXND1;PTPRJ;PPM1F;ADGRG3;SPATA13;ACTN4;STK24;SRGAP1;ROBO4;NUMB;TMSB4X;FGF23;F7;SDCBP;XBP1;CEACAM1;PTPRK;SMAD7;ENPP2;SEMA6B;RET;PRR5L;DUSP22;ADAM15;CBLL1;ACVR1;RAC1;SASH1;STK26;PDGFC;TGFB1;PTK2;GRB7;NF2;SEMA6D;GNA12;SGK3;AKT2
prerank,myelination in peripheral nervous system (GO:0022011),0.7074845522792712,1.4751058901940117,0.07130434782608695,0.5698196602056471,1.0,2/13,1.92%,ADGRG6;PARD3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7322930104137866,1.4747785178133102,0.09523809523809523,0.5688827444095051,1.0,1/10,0.83%,KDR
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.41309716913420097,-1.4743949251276784,0.0,0.3964616611044472,1.0,35/95,10.71%,GPC6;UST;DSE;SDC2;DCN;ANGPT1;GPC3;OGN;CEMIP;FMOD;HSPG2;HS3ST3A1;BGN;EXT1;CSPG4;PRELP;CHST15;PXYLP1;HS3ST3B1;LUM;CHSY3;HS2ST1;VCAN;GPC5;CHSY1;HS6ST2;GCNT2;SDC4;CHST3;DSEL;OMD;XYLT1;HS3ST5;HS6ST1;GPC4
prerank,positive regulation of B cell proliferation (GO:0030890),0.597405115121066,1.473903211550317,0.056910569105691054,0.5699847789900728,1.0,8/29,11.13%,CD38;MEF2C;BST1;TIRAP;CD40;TNFRSF13C;CD320;IL7
prerank,adherens junction organization (GO:0034332),0.5510370962643854,1.4737157552209397,0.048484848484848485,0.5685300783570856,1.0,11/48,8.77%,TJP1;CADM1;NECTIN2;PVR;PAK2;CDH2;SMAD7;CTNNA1;RAMP2;CDH15;ANG
prerank,positive regulation of integrin activation (GO:0033625),0.7391385241369264,1.4723818566313023,0.07421150278293136,0.5713896480578077,1.0,5/11,11.16%,PIEZO1;RASIP1;RAP1B;SKAP1;P2RY12
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5818259443645641,1.471324670867499,0.04395604395604396,0.5735713371219744,1.0,19/39,21.08%,RPS15;RPS19;RPS14;RPSA;RPS16;RPS7;RPS24;RPS27;UTP4;RPS6;NPM1;RIOK1;RPS25;SRFBP1;EMG1;NOP14;NOM1;RIOK2;RPS28
prerank,positive regulation of cell projection organization (GO:0031346),-0.39682273813152125,-1.4705492149682002,0.009345794392523364,0.4046431783104763,1.0,44/115,14.97%,ROBO1;PLXNA2;NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;GRIP1;TIAM2;DLG4;TENM3;OBSL1;NDNF;CARMIL1;CUX2;CAPRIN2;PTPRD;NTRK2;ROR2;ROBO2;IL1RAPL1;NGF;CUX1;KIDINS220;MAP6;ARSB;PLXNB1;APOE;ATP1B2;FBXW8;FZD1;SLIT2;CAMK1;PLK5;CDKL3;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6242192020648626,-1.4697524869401937,0.05454545454545454,0.40444945474561644,1.0,5/13,10.45%,ADHFE1;IDH2;GPT2;IDH1;GOT1
prerank,regulation of neuron migration (GO:2001222),0.6326028190197308,1.4677282777464693,0.07107438016528926,0.5849813623464432,1.0,7/26,6.12%,SEMA6A;NEXMIF;DAB2IP;ARHGEF2;SRGAP2;ADGRG1;RAPGEF2
prerank,O-glycan processing (GO:0016266),0.538444624225885,1.4671790420969508,0.046176046176046176,0.5847435627703966,1.0,12/54,12.17%,ST6GAL1;ST3GAL1;GALNT14;GALNT15;B3GNT3;B3GNT4;ST6GALNAC2;B4GALT5;B3GNT6;ST6GALNAC4;C1GALT1;MUC1
prerank,negative regulation of angiogenesis (GO:0016525),0.5050724118507959,1.4666950945714847,0.03125,0.5843739295834356,1.0,13/84,5.49%,SEMA6A;TEK;CLDN5;EPN2;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;KLF2;ATP2B4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6466984193201833,-1.466621764124125,0.08742004264392324,0.41040174107332755,1.0,6/11,12.48%,RENBP;PGM3;NAGK;GFPT1;GFPT2;GNPDA1
prerank,axonal fasciculation (GO:0007413),-0.6406971773715802,-1.4661852976357714,0.07333333333333333,0.40919840263499524,1.0,7/12,17.35%,EPHA3;SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3
prerank,dephosphorylation (GO:0016311),0.4728489434495722,1.4658909227101702,0.016270337922403004,0.5853628452592325,1.0,26/147,8.37%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PLPP1;PTPN12;PPP2R5A;SGPP2;PPP3CA;PTPRJ;PPM1F;MTM1;SSH2;PPP1R12A;PTPRK;PPM1L;PPP3CB;MTMR6;FBP1;INPP5K;PPM1D;DUSP23;DUSP16;PPP2R5E;PPP2R5B
prerank,receptor metabolic process (GO:0043112),0.55007957410827,1.464989546495887,0.03427719821162444,0.5864889128819452,1.0,16/53,13.42%,DNM3;CALCRL;CAV1;SMURF1;LMTK2;RAMP2;SH3GLB1;SNX25;TGFB1;NEDD4;EHD3;PICALM;LGMN;RAB11B;KIF16B;RAB31
prerank,apoptotic process (GO:0006915),0.4666926982792345,1.4649856699461097,0.005747126436781609,0.5842749337630209,1.0,46/203,12.98%,SEMA6A;FOXO1;TBX1;APP;PPARD;ZBTB16;TNFRSF19;DAPK1;AHR;ELMO1;HIP1;FAS;PAEP;PTK2B;DDIT4;CASP4;BIK;NFKBIA;TAOK2;STK3;CASP8;TNFRSF25;MAL;STK4;IER3;NCKAP1;BOK;ADAM15;JADE1;BCL2L11;CASP7;BNIP2;CASP1;IKBKG;BCL2L1;SIAH1;CXCR4;BNIP3;CSRNP1;RIPK1;BID;RHOB;GLRX2;FASTKD2;TGFBR2;MAGI3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5605190864053976,-1.4648199773804855,0.04534005037783375,0.4102686800133771,1.0,5/19,10.45%,DDO;ASPA;ALDH7A1;PHYKPL;GOT1
prerank,bone development (GO:0060348),-0.47967103498045355,-1.4646147365434419,0.05965909090909091,0.40839898944633135,1.0,12/39,7.12%,RANBP3L;SULF1;FGFR2;AKAP13;GJA1;SULF2;CYP26B1;SH3PXD2B;GNAS;SFRP4;LRP6;NOTUM
prerank,regulation of AMPA receptor activity (GO:2000311),0.6085165669657888,1.4644804601405552,0.0757825370675453,0.5841161161838887,1.0,2/25,1.15%,SHANK3;MEF2C
prerank,positive regulation of cell adhesion (GO:0045785),0.5142962971042858,1.4644347276514564,0.037868162692847124,0.5820788110222542,1.0,17/74,11.16%,FRMD5;TGM2;STX3;MAGI1;PDGFB;PRKD2;PPP3CA;PTPRJ;PPM1F;ADGRG1;SMAD7;RET;RAC1;RSU1;SFRP2;EPHA4;P2RY12
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6018052869823163,1.4641381983787611,0.06270096463022508,0.5810663758000232,1.0,10/30,16.50%,DACH1;BMPR2;ACVRL1;PINX1;ACD;DCP2;HNRNPC;ERCC4;NIBAN2;TERF1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6768360779022623,1.4633970023579226,0.06797853309481217,0.5795867929094567,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6768360779022623,1.4633970023579226,0.06797853309481217,0.5795867929094567,1.0,8/15,19.01%,NANOS3;NANOS2;TNRC6C;CNOT1;ZFP36;CNOT7;ZFP36L1;DHX36
prerank,receptor catabolic process (GO:0032801),0.6228832261591147,1.4628359641244177,0.0722495894909688,0.5794405256145135,1.0,11/24,12.65%,SMURF1;ZNRF3;AP2B1;SH3GLB1;SNX25;TGFB1;AP2A1;NEDD4;LGMN;KIF16B;MYLIP
prerank,regulation of acute inflammatory response (GO:0002673),0.6582453129134102,1.4622164550937806,0.06571936056838366,0.5797945897341797,1.0,3/18,6.32%,IL6ST;OSMR;PLA2G2D
prerank,regulation of vasculogenesis (GO:2001212),0.6753834320661399,1.4612355111698672,0.07407407407407407,0.5813079494847383,1.0,7/14,13.27%,KDR;CD34;CEACAM1;RAPGEF2;RAP1A;XDH;ASB4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7351977261964945,1.4605366743225328,0.07142857142857142,0.5817261068755933,1.0,3/11,4.28%,LYN;MFHAS1;TIRAP
prerank,activation of adenylate cyclase activity (GO:0007190),-0.48554379587837304,-1.459828517321828,0.04678362573099415,0.41903166951430937,1.0,8/35,5.97%,LGR4;ADCY5;ADCY1;ADCY2;EDNRA;ADCY7;ADCY6;CAP2
prerank,glial cell development (GO:0021782),0.6122239029957254,1.4594843325904887,0.07679738562091504,0.5836687761385975,1.0,11/25,14.35%,APP;CDK6;NRROS;DLL1;EIF2B5;PRDM8;SOX4;PICK1;CSPG5;EIF2B2;S100A9
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6214393031596871,1.4592928778768948,0.08843537414965986,0.582364936618054,1.0,8/21,6.61%,CAV1;CNKSR3;DDIT4;PDE4D;PPM1F;NCK1;SMAD7;INPP5K
prerank,regulation of leukocyte activation (GO:0002694),0.6885911639554194,1.4592851602796233,0.0918918918918919,0.5802740521505646,1.0,4/14,7.19%,CD200;LYN;MFHAS1;LCK
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5333327362366919,-1.4588764276009187,0.04292929292929293,0.4190156711656283,1.0,10/24,20.34%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;SLC25A13;MT3;SDHAF4;NR4A3;MRAP2
prerank,lipoprotein transport (GO:0042953),-0.6611800262261819,-1.4588655580398928,0.05895196506550218,0.41651203910943213,1.0,4/10,15.06%,LRP1;PRKCB;MIA3;UNC119B
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5427975449519458,1.4584491732885985,0.050872093023255814,0.5811897367826481,1.0,9/51,8.27%,APP;STAT3;GBP5;AIM2;CASP8;WNT5A;LPL;MALT1;CASP1
prerank,regulation of platelet aggregation (GO:0090330),0.6664037154676349,1.4584092071503396,0.06932409012131716,0.5792398494473212,1.0,4/17,5.12%,PRKG1;F11R;LYN;CEACAM1
prerank,positive regulation of T cell activation (GO:0050870),0.5264453956115652,1.4579697622901941,0.05056179775280899,0.5788078791324989,1.0,12/62,11.30%,IL6ST;VCAM1;IL15;NCK1;JAK3;XBP1;LCK;TNFRSF13C;IL23A;CYRIB;IL7;ZMIZ1
prerank,positive regulation of cholesterol transport (GO:0032376),0.5946806908201671,1.4576864860432084,0.06699346405228758,0.5778014982961526,1.0,6/27,5.76%,CAV1;PLTP;NFKBIA;LPCAT3;EEPD1;ABCA3
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5474127626158136,1.4575324352572359,0.038348082595870206,0.5763885875849484,1.0,11/45,13.03%,NANOS3;APP;EIF4E;PUM1;RBM3;YTHDC1;RC3H1;CYFIP1;PUM2;RPL10;MTPN
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4694721091311399,-1.4575187486680998,0.06050955414012739,0.4178207915349774,1.0,12/43,9.16%,PID1;PRKCB;IRS1;ENPP1;GRB10;PRKCD;OGT;TNS2;IGF2;PRKCZ;NUCKS1;TSC2
prerank,positive regulation of cell aging (GO:0090343),0.7171480740454699,1.4560177781036638,0.07295373665480427,0.5800451159326527,1.0,2/11,1.56%,ABI3;B2M
prerank,establishment of epithelial cell polarity (GO:0090162),0.6484382469096117,1.4558922001894974,0.07666098807495741,0.5783952680941742,1.0,5/19,5.94%,PARD3;CYTH1;MSN;SIPA1L3;OPHN1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5866327119292097,-1.4555590416971034,0.06352941176470588,0.42074401249749954,1.0,6/17,8.68%,FGFR2;NPR3;MN1;CCN1;SFRP1;PLXNB1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.616743997329084,1.4553191139153931,0.05737704918032787,0.5785507009997211,1.0,6/25,8.09%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5315716920323438,-1.4551929604323577,0.03431372549019608,0.41927442502869916,1.0,8/25,10.20%,ANK2;CACNA1C;CXADR;DLG1;TBX18;ATP2A2;RYR2;CTNNA3
prerank,endothelial cell differentiation (GO:0045446),0.7096556116762611,1.4540016566803629,0.09306569343065693,0.5815454459334872,1.0,5/12,3.69%,BMPR2;KDR;TIE1;ACVRL1;SOX18
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5802807143810412,1.45311932494936,0.05451713395638629,0.5828194329043649,1.0,9/32,13.03%,NANOS3;APP;EIF4E;TIGAR;RBM3;CYFIP1;PICALM;RPL10;MTPN
prerank,regulation of water loss via skin (GO:0033561),0.6688607923792068,1.4523617366125394,0.10106382978723404,0.5814879638823791,1.0,5/15,15.26%,UGCG;LSR;SFN;MET;FA2H
prerank,establishment of skin barrier (GO:0061436),0.6688607923792068,1.4523617366125394,0.10106382978723404,0.5814879638823791,1.0,5/15,15.26%,UGCG;LSR;SFN;MET;FA2H
prerank,organic substance transport (GO:0071702),0.48149717213476795,1.4522011042303515,0.03282828282828283,0.5800685910522254,1.0,28/121,14.28%,CALCRL;SLCO2B1;ABCG2;SLC6A2;PLTP;ATP8A1;SPNS2;SLCO2A1;MYH9;SCAMP1;RAMP2;ABCA3;TAP2;CHMP2B;ARRDC1;RAB38;PLEKHA8;CD320;SLCO1B1;PICK1;ABCD1;RILP;CHKA;RAB7A;ABCG1;TXNIP;TCN2;SLC22A5
prerank,plasma membrane tubulation (GO:0097320),0.6885215226563607,1.4520000344131692,0.08098591549295775,0.5787865790731188,1.0,4/13,9.19%,FNBP1L;CAVIN2;EHD2;CHMP4A
prerank,muscle tissue development (GO:0060537),0.6971169989174893,1.4519612156062507,0.08967851099830795,0.5769723324472129,1.0,3/13,5.61%,PGM5;ENG;SRPK3
prerank,negative regulation of potassium ion transport (GO:0043267),0.6946876137904058,1.4514826576143616,0.09347442680776014,0.5766904946761495,1.0,3/13,2.59%,CAV1;NEDD4L;PTK2B
prerank,vasodilation (GO:0042311),0.6896800354500282,1.4511358144535182,0.07908611599297012,0.5759814125165532,1.0,3/13,4.43%,NOS3;ADRB1;KLF2
prerank,icosanoid biosynthetic process (GO:0046456),0.7190166816880854,1.4500580003114745,0.09869646182495345,0.5783322421072847,1.0,3/10,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6196833659525783,1.449545108620814,0.0812603648424544,0.5784247622427859,1.0,5/24,6.61%,TEK;KDR;PTPRJ;PPM1F;RAC1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5449236948145338,-1.4491298344628307,0.07547169811320754,0.43345778825254694,1.0,5/20,3.90%,SULF1;SULF2;THBS1;FGF2;SMOC2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6092644677403012,-1.448941636533991,0.08008658008658008,0.43146095611331703,1.0,8/13,18.88%,DCN;BGN;CSPG4;VCAN;ARSB;HEXA;HYAL1;IDUA
prerank,sodium ion import across plasma membrane (GO:0098719),-0.5880147330273057,-1.448927054180217,0.06279069767441861,0.42899849224379005,1.0,4/17,3.39%,SLC12A2;SLC6A1;SLC9A9;SLC8A1
prerank,regulation of metal ion transport (GO:0010959),-0.5842334944426018,-1.4488274937192755,0.08008658008658008,0.4268673718169576,1.0,7/16,6.34%,ANK2;BCL2;CACNA2D1;SLC30A10;IL16;DLG1;STIM1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.648991638596714,1.4486324960818056,0.10069444444444445,0.5798803318680853,1.0,4/17,2.82%,PBX1;MAML2;NOTCH1;PLXND1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6076947211352534,1.4484427910272757,0.05475040257648953,0.5787146603304207,1.0,6/26,8.09%,PTGS2;INSR;EDN1;KLF2;NOS1AP;PKD2
prerank,potassium ion transport (GO:0006813),-0.39230257381619876,-1.4482872919579375,0.004784688995215311,0.4259346677291408,1.0,31/120,16.33%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNB2;SLC9A9;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;KCNQ5;SLC9A1;KCNA6;ABCB8;KCNJ10;KCNN2;CCDC51;KCNJ8;KCNJ15;LRRC38
prerank,macromolecule catabolic process (GO:0009057),0.6103076328212248,1.4467018066352735,0.09134615384615384,0.5831379199546312,1.0,11/26,12.55%,SMURF1;SH3GLB1;SNX25;TGFB1;NEDD4;CTRL;TRIM24;SIAH1;LGMN;CLN6;KIF16B
prerank,organic anion transport (GO:0015711),0.5135769210130354,1.4466912441185218,0.044058744993324434,0.5812164202618708,1.0,6/76,1.65%,ABCC4;SLCO2B1;ABCG2;LRRC8C;SLC39A8;SLCO2A1
prerank,neuron projection morphogenesis (GO:0048812),-0.3820736981983177,-1.4466845308329195,0.01,0.42771408868430516,1.0,41/137,11.40%,ALCAM;DCLK1;GAS7;DOCK7;SDC2;FGFR2;NBL1;CTNND2;EPB41L3;BMP7;DCDC2;DLG4;NRK;MAP2;BRSK1;ALS2;IMPACT;FARP1;CNTNAP2;S100A6;ANK3;TAOK3;SHTN1;DOCK10;RYK;NGF;NLGN1;NTNG1;MAP6;S100B;LRRK2;CTNNA2;FLRT1;DCC;PLXNB1;NRCAM;DTNBP1;SHANK1;BAIAP2;RAB10;CNTN4
prerank,anion transport (GO:0006820),0.5740421292753098,1.446401769713479,0.0724191063174114,0.580392573257932,1.0,4/33,2.47%,SLCO2B1;ABCG2;LRRC8C;LRRC8B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6106149574314983,-1.4463712172611731,0.09230769230769231,0.42618619765269067,1.0,2/12,2.50%,NUPR1;IL18
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7135219799526509,1.4462455130956002,0.08592321755027423,0.5790968127121384,1.0,4/11,16.67%,PXDN;CAT;PRDX2;PRDX1
prerank,positive regulation of cytokine production (GO:0001819),0.44366179968653796,1.4457672537329385,0.00546448087431694,0.5788277762729667,1.0,42/292,10.01%,IL1R1;NOD1;IL6ST;CADM1;PTGS2;APP;IL15;SPTBN1;CD200;LRRFIP1;FOXP1;IL6R;ARHGEF2;PRKD2;STAT3;GBP5;PAEP;HIF1A;PDE4D;AFAP1L2;PLCB1;CD34;FLT4;PLCG2;TIRAP;XBP1;WNT5A;TIGIT;CD40;TGFB1;PIK3CG;AGPAT1;NFKB1;LPL;MALT1;ZFPM1;G3BP1;CGAS;RFTN1;IL23A;MAPK11;CYRIB
prerank,long-term memory (GO:0007616),-0.5589266155590746,-1.4455374429078183,0.061124694376528114,0.4260340432040629,1.0,9/19,24.13%,RASGRF1;CPEB3;LDLR;APOE;SHANK1;NFATC4;PJA2;CAMK4;CALB1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7145695026260042,1.4453115860237273,0.10299625468164794,0.5785709828017813,1.0,4/11,8.72%,FOXO1;NOTCH1;ATP2B4;GLRX3
prerank,cellular response to interferon-gamma (GO:0071346),0.4991942216127037,1.4445830032532303,0.030183727034120734,0.5794802040916427,1.0,16/88,10.41%,VCAM1;ICAM1;B2M;DAPK1;IRF2;GBP5;GBP4;GBP7;TRIM68;WNT5A;JAK1;TRIM25;CASP1;RPL13A;FCGR1A;CCL14
prerank,protein oxidation (GO:0018158),-0.6376351711942533,-1.4435119690112423,0.08677685950413223,0.4290020151595941,1.0,3/11,6.86%,LOXL1;LOXL3;LOX
prerank,positive regulation of hydrolase activity (GO:0051345),0.46813774790256146,1.4423903751056752,0.01597051597051597,0.5853822099822061,1.0,27/137,10.43%,DOCK9;PKP4;TGM2;NET1;ITGA6;F11R;CD200;TBC1D30;SRGAP2;ARHGAP27;CAV2;ADRB1;PLIN5;MAPK8;RAP1GDS1;CHP2;RAPGEF2;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;LARS1;CCL14;SEMA4D
prerank,cochlea morphogenesis (GO:0090103),0.7159501938566538,1.442332276926238,0.10163339382940109,0.5836424691621426,1.0,2/10,4.17%,TBX1;SOX9
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5878671184680573,-1.4422900184550411,0.07322654462242563,0.4299217985680494,1.0,6/15,12.48%,MGAT3;LARGE1;RENBP;NAGK;CHST3;GNPDA1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5756205096599706,1.4417934868090856,0.06461538461538462,0.5837002413457297,1.0,9/34,7.46%,TEK;FLT1;PRKD1;PDGFB;DAB2IP;PTK2B;PIK3IP1;TGFB1;PTK2
prerank,myelination (GO:0042552),0.5535222808790469,1.4415778192062452,0.05057803468208093,0.5825844756202603,1.0,13/46,13.79%,ADGRG6;MPZ;PARD3;MAL;MALL;B4GALT5;EIF2B5;PLLP;CXCR4;DEGS1;ABCD1;CMTM8;EIF2B2
prerank,negative regulation of cell adhesion (GO:0007162),0.5099151793622325,1.4414833172751687,0.05089408528198074,0.5810212069023893,1.0,17/72,9.25%,SEMA6A;ACER2;PLXNA4;NEXMIF;ACVRL1;PODXL;FZD4;ADAM10;NOTCH1;PLXND1;CBLL1;ADAMDEC1;TGFB1;PTK2;RASA1;NF2;DSCAM
prerank,gluconeogenesis (GO:0006094),-0.4640378156948487,-1.4407535785988517,0.024691358024691357,0.4317556046552952,1.0,20/39,28.11%,RBP4;PPARGC1A;SLC39A14;PER2;ENO2;SLC25A12;GOT1;TPI1;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2;ALDOA;GOT2;ENO1;ALDOC;MDH2
prerank,response to axon injury (GO:0048678),-0.5677884557097516,-1.4400612386717195,0.05486284289276808,0.4312515082013712,1.0,5/18,11.39%,DPYSL3;P2RX4;APOD;NREP;GAP43
prerank,phospholipid translocation (GO:0045332),0.5966259951262622,1.4393103773094738,0.08239095315024232,0.5871907982041725,1.0,5/28,2.88%,ATP8B1;ATP8A1;ATP10A;ATP11C;ATP11B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6630660963840632,1.4392816759732052,0.08347826086956522,0.5854053415546063,1.0,2/15,1.44%,STOX2;NR5A2
prerank,intraciliary retrograde transport (GO:0035721),-0.6295889445987483,-1.4392737620791596,0.08,0.43108079954222595,1.0,7/12,20.44%,DYNC2H1;WDR35;DYNC2I1;DYNC2LI1;IFT43;IFT140;TTC21B
prerank,cell junction assembly (GO:0034329),0.4863835840931954,1.4392018241382563,0.030927835051546393,0.5838311514041413,1.0,10/100,4.22%,SHANK3;DNM3;TJP1;PKP4;ITGA6;CLDN5;LIMS2;PLXND1;PCDHB4;CDH2
prerank,ribosome biogenesis (GO:0042254),0.45494192605171246,1.4389968015802113,0.02028639618138425,0.5827969781159856,1.0,71/187,21.42%,DDX54;RPS15;IMP3;RPS19;RPLP1;RPS14;RPS16;RPL38;RPL34;RPL39;RPS7;RPS24;MTREX;FCF1;RPL37A;RPF1;RPL36;RPL15;XPO1;RRS1;RPL14;RPL23;RPL17;RPL9;RPL4;RPL13A;RPL32;EIF6;RPL22;RPS27;RPL31;EXOSC1;RPL13;NOP53;UTP4;RPL6;RPL10;NOP16;RPS6;NPM1;RIOK1;RPL29;RRP9;PELP1;RPS25;RPL35A;RPL27;RPL18;XRN2;EMG1;RPL27A;RRP1B;UTP6;PIH1D1;PDCD11;RPL11;WDR18;HEATR1;ESF1;RPL8;NOP14;RPLP2;RPL18A;NOM1;RPL21;RPL3;SBDS;RIOK2;RPS28;DDX47;RPL7
prerank,negative regulation of reproductive process (GO:2000242),-0.5665657524466625,-1.4385454636057045,0.09133489461358314,0.43074889811433054,1.0,3/17,2.01%,IGF1;SULF1;GJA1
prerank,mesoderm development (GO:0007498),0.643380450581837,1.4382755679669783,0.09598603839441536,0.5834483186330349,1.0,5/18,9.32%,TBX1;TIE1;MESD;BMX;TCF15
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6084444582250151,1.4381320018962591,0.060655737704918035,0.5821167535442027,1.0,8/26,6.61%,PDE8A;PLCG1;PTPN12;IQGAP1;DAB2IP;SOX9;DUSP22;INPP5K
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5238200619629901,-1.4371604698792857,0.053824362606232294,0.4323862448767013,1.0,14/27,23.99%,DDX5;PLA2R1;SPRED1;KMT5A;CD44;MDM2;SPRED2;SPRED3;SNAI1;ATR;CD74;MSX1;TWIST1;ATM
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4778086651648036,1.4362764225791462,0.03526448362720403,0.5871523678832284,1.0,18/113,8.41%,UNC13B;ESR1;PIEZO1;LCP1;RASIP1;DAB2IP;TAL1;GBP5;FNIP2;BIK;RAP1B;TIRAP;SKAP1;SH3GLB1;BCL2L11;RPA1;TGFB1;CDT1
prerank,metanephric mesenchyme development (GO:0072075),-0.6467315999750306,-1.4356903401493089,0.0891304347826087,0.4343970041602761,1.0,3/10,5.77%,WNT4;OSR1;SIX1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6124562457177846,-1.4352281595014824,0.066815144766147,0.4334109634414303,1.0,8/13,22.68%,SLC4A10;GRIK2;SHISA7;SYP;SLC8A2;PPFIA3;RAB3GAP1;CLN3
prerank,vesicle transport along actin filament (GO:0030050),0.6240786499759953,1.4344480884152033,0.0847750865051903,0.5921494460482656,1.0,5/19,10.61%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.6734382438774666,1.4342296151595078,0.10915492957746478,0.5910555126797584,1.0,5/12,10.95%,SMCHD1;CDYL;PCGF5;YTHDC1;RBM15
prerank,heart looping (GO:0001947),0.567908360770674,1.4339216559425583,0.0629800307219662,0.5903393629454409,1.0,13/39,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,cellular protein modification process (GO:0006464),0.41750855606491777,1.4336392006128862,0.0,0.589597991860364,1.0,178/983,11.79%,PTPRB;PRKG1;PRKCH;ERG;ST3GAL6;RPS6KA5;PTPRG;EPAS1;CDK17;PTPN14;BMPR2;TGM2;DCUN1D3;KLHL3;APP;SNRK;KLHL5;UGCG;ZBTB16;ERN1;ACVRL1;PRKD1;CTTNBP2NL;ST3GAL1;CDK6;INSR;MGAT4A;STT3B;PTPRM;DAPK1;GALNTL5;NEK7;PDGFB;PTPN12;PPP2R5A;PEAK1;RAB11A;SOCS2;LYN;PIM3;PRKD2;BCR;KLHL2;ADAM10;PRAG1;PTK2B;FNIP2;STK10;PPP3CA;NEURL2;YES1;FBXW7;HIF1A;PTPRJ;MAP4K3;PPM1F;SIK1;PGAP1;MTM1;MAN2A1;FYN;BTBD1;TAOK2;B3GNT3;FUCA2;STK24;STK3;SSH2;PKN3;LIPE;PPP1R12A;PKN2;PAK2;FGF23;CPE;UBA7;PTP4A2;CDH2;PKN1;STK4;LMTK2;MARK3;JAK3;MAP3K9;IKBKB;PADI4;HIPK1;PTPRK;ACVR2A;QSOX1;ALG10B;CDC42BPB;MAPK8;SPARCL1;FBXL4;RET;PLK2;MAST2;PPM1L;ULK1;LIMK2;KCTD6;PPP3CB;AURKA;MTMR6;VWA1;CISH;SIK3;ACVR1;TSSK6;B3GNT4;DYRK1A;STK26;ST8SIA4;BMX;TNIK;PPM1D;LCK;GOLM1;RNF7;JAK1;SIRT5;ST6GALNAC2;TGFB1;B4GALT5;PSMA2;FBXL7;PIGU;DUSP16;PPP2R5E;RAB2A;CTBP1;PPP2R5B;RAB38;HASPIN;CREB1;SGK3;AKT2;NEK6;PXK;PGGT1B;B3GNT6;MAP3K11;AURKC;RHBDD1;APLP2;FBXL2;CDK2;FBXW2;PTPN1;CSF1;ERO1A;COPS2;PARP2;PSMA8;PTAR1;ASB10;UBE2D3;PSMA6;CDK18;NUAK1;PRKAB1;ICMT;GAS6;COPS4;FBXO30;PPP2R3A;AKT3;ABL2;PIGK;GMFG;PICK1;MAP3K13;CUL1;SIK2;STK38;NUS1;PIM1
prerank,cation transport (GO:0006812),-0.3679739266076312,-1.4333678231312466,0.018072289156626505,0.43614441963405415,1.0,26/167,8.01%,ATP1A2;TRPM3;PIEZO2;SLC47A1;SLC8A3;SLC41A1;SLC12A2;SCN7A;KCNB2;KCNK5;SLC6A9;ATP1B1;SLC8A1;SLC22A4;KCNMA1;ANO1;ABCC9;KCND3;KCNMB2;KCNS3;TRPC6;KCNJ2;KCNQ4;SLC5A5;KCNJ13;KCNAB1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5563316334332529,1.4332177847635523,0.0637329286798179,0.589219966924199,1.0,13/42,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5884917548819123,1.4331324101027703,0.0724191063174114,0.5876632492635402,1.0,6/29,2.59%,TEK;FLT1;PRKD1;PDGFB;DGKZ;PTK2B
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6967891645466908,1.4330879691862977,0.09107468123861566,0.5860017331402384,1.0,2/12,3.85%,RAB27A;PLCG2
prerank,lamellipodium organization (GO:0097581),0.5806800649159313,1.4328789624708613,0.08860759493670886,0.584911289556424,1.0,9/29,11.69%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;RAC1;ARHGEF7;P2RY12;CYFIP1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5840160490390958,-1.432007731828372,0.07672634271099744,0.437728186115962,1.0,6/17,10.91%,FSTL1;SULF1;TWSG1;SFRP4;CASK;SLIT2
prerank,cellular copper ion homeostasis (GO:0006878),0.6672118031080613,1.4318024105892946,0.09074733096085409,0.5870226339936132,1.0,3/14,10.25%,APP;SLC31A1;ATP7B
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6388106303265105,-1.4310263282964857,0.07982261640798226,0.43819477037386295,1.0,5/11,16.87%,WNT4;BMP5;FGFR4;DGKQ;NR1H4
prerank,positive regulation of protein binding (GO:0032092),0.5219319791637392,1.4304382276259755,0.05694444444444444,0.5901676060706971,1.0,15/56,6.76%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3
prerank,protein localization to chromatin (GO:0071168),0.6454918136173926,1.430391837542807,0.10193321616871705,0.5884832604842751,1.0,9/18,22.93%,ESR1;TASOR;PPHLN1;MCM9;PIH1D1;RAD21;MSH2;PLK1;NIPBL
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6440755322084087,1.4299139654663904,0.10471204188481675,0.5883099663585131,1.0,1/15,0.26%,ENTPD1
prerank,positive regulation of ion transport (GO:0043270),-0.4600520088065215,-1.4298498749012092,0.042682926829268296,0.43880402208040703,1.0,10/48,8.32%,ANK2;FHL1;ACTN2;CACNA1D;P2RX4;ANK3;DLG1;CACNB2;TRPC6;ADRA2A
prerank,ameboidal-type cell migration (GO:0001667),0.5240494036115966,1.4296091995331641,0.06835066864784546,0.5876079676544039,1.0,10/51,5.55%,SEMA6A;TBX1;SEMA5B;SEMA7A;SRGAP2;PKN3;PKN2;PDLIM1;PKN1;SEMA6B
prerank,signal release from synapse (GO:0099643),-0.457499683664938,-1.429582849487908,0.04559270516717325,0.43730932753521423,1.0,16/43,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,hexose transmembrane transport (GO:0008645),0.6327976905062471,1.4292143268510729,0.08907563025210084,0.5872911453466536,1.0,4/21,6.85%,SLC2A1;PPARD;SLC2A9;PPBP
prerank,negative regulation of cell activation (GO:0050866),0.6775073615429339,1.4291596777326512,0.07913669064748201,0.5856550799116769,1.0,3/14,1.89%,NOS3;CD200;PDGFB
prerank,cardiac muscle tissue development (GO:0048738),-0.4463005055276816,-1.4291217941300207,0.04792332268370607,0.4363482720832071,1.0,12/50,5.92%,NOTCH2;BMPR1A;GJB6;AKAP13;BMP5;SGCD;BMP7;GJA1;BMP4;RBP4;CACNA1G;TBX18
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5665787441708704,1.4291125620665215,0.07142857142857142,0.5840034474726528,1.0,2/36,0.30%,MECOM;FOXO1
prerank,substrate-dependent cell migration (GO:0006929),0.6584169652444389,1.4290319138339387,0.09026548672566372,0.5825330521632771,1.0,8/14,11.17%,NTN1;ANKS1A;CD2AP;VEGFC;SDCBP;OPHN1;P2RY12;ITGA2
prerank,negative regulation of proteolysis (GO:0045861),-0.4769824814955844,-1.4288508497297645,0.05337078651685393,0.4348254111757322,1.0,9/34,11.32%,TIMP3;TIMP2;GAS1;SERPINE2;LRRK2;ECM1;CAMK2N1;PLAT;CST3
prerank,regulation of anoikis (GO:2000209),0.6324490082801307,1.4288034721396425,0.10463121783876501,0.5815648327404096,1.0,6/19,9.01%,CAV1;NOTCH1;SIK1;PTK2;ITGA5;MYBBP1A
prerank,embryonic hemopoiesis (GO:0035162),0.6794997291573952,1.4284779272488013,0.1125,0.5810501366777734,1.0,3/12,2.32%,KDR;KITLG;TAL1
prerank,neurotransmitter secretion (GO:0007269),-0.45656089881405487,-1.4283436900074866,0.03987730061349693,0.43389161287779876,1.0,16/44,16.70%,SYT1;BRSK1;SNAP25;NAAA;PCLO;NRXN1;LIN7A;SNPH;PTPRN2;NRXN2;GAD2;SNCA;RIMS1;DVL1;SYN1;PDZD11
prerank,regulation of cell communication (GO:0010646),-0.48663840265336156,-1.4282113023374645,0.0641399416909621,0.43201184179281926,1.0,13/35,9.29%,ANK2;CXADR;GRK3;SLC8A1;ANXA1;IGFBP7;YWHAG;MTCH1;TBX18;MGLL;RYR2;SCG5;GRK5
prerank,lipoprotein localization (GO:0044872),-0.6283921718726064,-1.4280946827115906,0.0650759219088937,0.43009116213433113,1.0,8/11,30.46%,LRP1;PRKCB;MIA3;UNC119B;PPARG;ZDHHC3;CD36;UNC119
prerank,smooth muscle cell differentiation (GO:0051145),0.7087544690811104,1.4280553859821945,0.0867992766726944,0.5806925491182251,1.0,3/12,4.28%,MRTFB;MEF2C;MRTFA
prerank,response to muramyl dipeptide (GO:0032495),0.6890694937425698,1.4278483769862167,0.10575139146567718,0.5796663649180835,1.0,2/12,2.26%,NOD1;ARHGEF2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7135287327357283,1.4268107933289567,0.11313868613138686,0.5816243283900532,1.0,5/10,9.42%,LYN;STAT3;JAK3;GHR;PTPN1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4237291543922826,1.4260257718822587,0.0010351966873706005,0.5824739855538301,1.0,83/476,9.80%,MECOM;LEF1;FLI1;FOXO1;CD38;TBX1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ACVRL1;NR5A2;AHR;ZIC3;NFATC1;PDGFB;ELF2;MLLT3;FZD4;HHEX;LRP5;TAL1;STAT3;NOTCH1;HIF1A;RREB1;AFAP1L2;KDM3A;SOX17;PLCB1;SOX18;SOX9;NCOA1;KLF2;FOXF1;IKBKB;RPS6KA1;DTX3L;FOXL2;EPC1;KMT2E;SPIN1;FOXF2;ARID1B;RET;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;ATMIN;ACVR1;SOST;INPP5K;HNF1B;DYRK1A;ETS2;LYL1;TGFB1;BCL3;TCF3;HNRNPD;NFKB1;PCBD2;ARID1A;NEUROD1;CITED1;KAT6B;PSEN1;CREB1;FOXK1;BRD4;SOX4;MAP2K3;MAFB;RNF4;EDRF1;NFIB
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5232992043037393,1.4258868281615036,0.061079545454545456,0.5812372796331322,1.0,13/57,8.27%,NOD1;TNFSF10;SOX7;DAPK1;AIM2;PPM1F;FYN;CASP8;FOXL2;CYCS;GRAMD4;MALT1;CASP1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.41690936100412046,-1.4253217305382728,0.041379310344827586,0.4355271065825556,1.0,16/69,7.82%,PLCL1;IGF1;PLCE1;PDGFRB;PDGFRA;IRS1;PI4KA;GAB2;OGT;PLCD3;SIRT2;NF1;NGF;PLCB3;PLCD1;EZR
prerank,protein localization to cilium (GO:0061512),-0.49892096783777024,-1.42456777437509,0.08266666666666667,0.4353166588063206,1.0,19/32,29.88%,TULP3;WDR35;INVS;ARL3;IFT20;RAB29;EHD1;BBS9;TCTN1;IFT140;TULP1;TCTN2;TTC21B;TULP2;IFT122;BBS1;ARL6;ODAD4;NPHP4
prerank,regulation of adaptive immune response (GO:0002819),0.6474340357668198,1.4233161950353959,0.09683098591549295,0.5888477034106377,1.0,4/18,8.07%,IL6ST;AHR;SKAP1;SAMSN1
prerank,JNK cascade (GO:0007254),0.5602123126411634,1.4231168227115516,0.08125,0.5877941208521414,1.0,16/40,18.73%,NOD1;TNFRSF19;MAP4K3;SH2D3C;MAPK8;MAP3K11;IKBKG;MAP3K13;RIPK2;TRIB1;TRAF6;MAP4K2;TAB3;IRAK2;MAP2K4;MINK1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5743788439516084,-1.423040942714839,0.08333333333333333,0.4373401996598559,1.0,6/16,10.31%,OGT;ARHGAP24;RASGRF1;AUTS2;ALS2;CADM4
prerank,regulation of cytokine production (GO:0001817),0.47161715177884433,1.4227001261157888,0.04230769230769231,0.5875041934056746,1.0,18/126,8.31%,RPS6KA5;HDAC9;CADM1;IL15;FOXP1;LYN;TNFRSF1B;AFAP1L2;ACKR1;CASP8;IGF2BP3;N4BP1;MAST2;BTN2A2;SRGN;PIK3CG;AGPAT1;POLA1
prerank,regulation of ruffle assembly (GO:1900027),0.6046352849662572,1.422345416328322,0.10465116279069768,0.5870440216164247,1.0,4/23,4.23%,ABI3;CAV1;EPS8;EVL
prerank,positive regulation of chromatin organization (GO:1905269),0.6984246644828397,1.4219779504970826,0.10869565217391304,0.586656936077338,1.0,6/12,16.50%,TAL1;H3-3A;ACD;MIER1;ATRX;TERF1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5530546784484057,1.4215737928094436,0.06896551724137931,0.5863697734597496,1.0,14/43,14.03%,ENG;MEF2C;ZIC3;NOTCH1;SOX17;SOX18;DLL1;ACVR1;PKD2;IHH;APLNR;VANGL2;TGFBR2;SETDB2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4551595705279639,1.4215326097274252,0.01734820322180917,0.5847968089296589,1.0,41/163,16.38%,CD38;INPP5D;MEF2C;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;SH2B2;IKBKB;SKAP1;BTN2A2;BMX;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;SLA2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.429343781270669,1.4206680736012922,0.0031914893617021275,0.586149424040407,1.0,65/417,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GATAD2A;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;COPS2;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;EID1;SP3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6887381894916642,1.4205962315155842,0.0924956369982548,0.5847253357500722,1.0,2/12,2.40%,SERINC3;SERINC5
prerank,Golgi localization (GO:0051645),-0.6307997638036031,-1.4197165548135098,0.08388520971302428,0.44391633252702806,1.0,3/11,12.74%,ARHGAP21;COPG1;ARCN1
prerank,regulation of cellular senescence (GO:2000772),0.5822667678174982,1.4195774673552055,0.0946372239747634,0.5866286384136329,1.0,12/28,18.44%,ABI3;B2M;CDK6;MAP3K3;NEK6;CGAS;NUAK1;AKT3;YBX1;PNPT1;RBL1;YPEL3
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5398013809468704,1.4194193145903882,0.08071748878923767,0.5855122046299501,1.0,8/41,7.27%,TJP1;PIEZO1;PODXL;MAGI1;SMAD7;SKAP1;LCK;JAK1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6475869696380412,1.4192940764883262,0.12027491408934708,0.584240116730604,1.0,1/15,0.04%,PRKCH
prerank,regulation of cellular localization (GO:0060341),-0.441159020348754,-1.4189021199265994,0.04923076923076923,0.44385650388039843,1.0,10/46,7.59%,ADCY5;GSN;EFNA5;PRKN;PARD6G;MAP2;BRSK1;HSP90AA1;STXBP4;LRRK2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6666612602119056,1.4187182449757414,0.1048951048951049,0.5845519165655912,1.0,3/15,2.79%,STAT3;GBP5;HIF1A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6671505590297105,1.4181492058196143,0.1059245960502693,0.5849365320637803,1.0,2/13,2.21%,KDR;EDN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5503451760385609,-1.4180870658988438,0.07692307692307693,0.44382861356755837,1.0,11/19,8.79%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBP4;ERBB4;FGF2;ZFPM2;RBPJ;GLI1;RUNX1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6352648117560161,1.4180209619010147,0.09401709401709402,0.5837303982802138,1.0,5/19,7.86%,APP;PDGFB;KLF2;MAPK8;NFKB1
prerank,regulation of phagocytosis (GO:0050764),0.5236113090850432,1.4179430522836554,0.06559766763848396,0.5823174729041969,1.0,5/53,2.18%,RAB27A;TGM2;IL15;GATA2;SCARB1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5185609621213315,-1.4179041074210863,0.053613053613053616,0.44220112765323505,1.0,6/25,4.96%,ARHGAP6;PHLDB2;ROCK2;THBS1;APOD;ROBO2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6982631417216204,1.417861416547864,0.1259124087591241,0.5809893971930211,1.0,2/10,5.12%,PRKG1;CEACAM1
prerank,skeletal muscle tissue development (GO:0007519),0.5765612438208696,1.4174574249272454,0.0867579908675799,0.5805802694010208,1.0,4/32,4.96%,CAV1;MEF2C;CAV2;FOXL2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4284348073171934,1.4173364432372522,0.005405405405405406,0.579361539200782,1.0,60/348,7.99%,TEK;RPS6KA5;LIMCH1;PECAM1;BMPR2;KDR;ENG;CAV1;TBX1;APP;PDE8A;RBPMS;IL15;ACVRL1;PRKD1;INSR;PDGFB;VEGFC;IQGAP1;IL6R;ARHGEF2;LYN;PRKD2;FAS;EFNA1;PDGFD;PTK2B;FNIP2;PTPRJ;TAOK2;FLT4;PLCG2;PAK2;FGF23;SOX9;SH2D3C;STK4;RALB;SDCBP;VEGFD;GHR;ACVR2A;CX3CR1;ENPP2;ATP2B4;LIMK2;RAPGEF2;ACVR1;KRAS;CD40;RAC1;BCAR3;PDGFC;ARRB1;TNIK;TGFB1;PTK2;RAP1A;NIBAN1;ITGA5
prerank,regulation of muscle contraction (GO:0006937),-0.5108654912045264,-1.4166247613092096,0.06060606060606061,0.4438091270107753,1.0,7/26,9.30%,ATP1A2;PLCE1;KCNB2;TPM1;ANXA6;MYL9;PPP1R12B
prerank,positive regulation by host of viral transcription (GO:0043923),0.6415557858078101,1.4150436314618173,0.1079646017699115,0.5854831720602106,1.0,6/15,16.05%,LEF1;CHD1;TFAP4;SNW1;RRP1B;CTDP1
prerank,establishment of vesicle localization (GO:0051650),0.6249431206870663,1.4149879395445828,0.11150442477876106,0.5840177203692557,1.0,6/18,12.51%,RAB27A;RAB11A;LIMK2;SYNJ1;IKBKG;CCDC186
prerank,regulation of interleukin-4 production (GO:0032673),0.6097020993626701,1.4148998901370498,0.11054421768707483,0.582677074632401,1.0,1/21,0.13%,LEF1
prerank,T cell receptor signaling pathway (GO:0050852),0.4574353190970361,1.414883600566808,0.02122347066167291,0.5811401974339143,1.0,46/138,21.40%,INPP5D;PLCG1;PRKD2;PDE4D;PTPRJ;NFKBIZ;DENND1B;FYN;NCK1;PLCG2;PAK2;IKBKB;SKAP1;BTN2A2;LCK;PSMA2;NFKB1;MALT1;EIF2B5;IKBKG;ICOSLG;RFTN1;PSMA8;PSMA6;RC3H1;CUL1;RELA;RIPK2;BTN3A3;EIF2B2;TRAF6;PSME1;SPPL3;ERMAP;LAT;NFKBID;PSMA4;PSMF1;PAK1;BCAR1;CD276;BCL10;PSMB7;PSMB1;PSMD2;BTNL9
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5812911152612227,1.4145663796105348,0.07188498402555911,0.5805401415103135,1.0,5/29,6.76%,DCUN1D3;FBXW7;DTX3L;SMAD7;TRIB3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6980368611092775,1.412952322140186,0.12994350282485875,0.5846042231318866,1.0,5/11,18.16%,NFKBIZ;MALT1;IL23A;NFKBID;CARD9
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4574360687163122,1.4126896794894972,0.02875,0.5838594746901795,1.0,24/138,5.60%,TEK;PTPRG;FLT1;BMPR2;KDR;IL6ST;TIE1;LIFR;EPHB4;INSR;NEDD9;LYN;NPR1;PTK2B;YES1;MPZL1;MTSS1;FYN;SRMS;FLT4;LMTK2;JAK3;ACVR2A;RET
prerank,negative regulation of cell death (GO:0060548),0.48811971067654764,1.412149130672733,0.051181102362204724,0.5840740679946049,1.0,19/88,10.77%,MECOM;PDE8A;PRKD1;CD200;SRGAP2;TNFRSF1B;FYN;NCK1;CD34;AMIGO2;TIGAR;CHMP4A;CHMP4B;SOX4;IKBKG;CSF1;BTBD10;RAD18;BNIP3
prerank,muscle cell differentiation (GO:0042692),0.5595838028973739,1.410405380224997,0.07655502392344497,0.5885343302831694,1.0,5/32,6.81%,MRTFB;TBX1;MEF2C;MRTFA;SYNE1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7020680768198432,1.4102640607652335,0.10271317829457365,0.5874759112269063,1.0,2/10,2.14%,SEMA6A;DAB2IP
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.41639603438699424,1.4098721339263138,0.004153686396677051,0.5871880828119338,1.0,109/509,12.95%,VWF;TEK;FLT1;NOD1;TNFSF10;TGM2;KDR;ENG;CAV1;TBX1;ESR1;APP;TNFRSF19;PRKD1;INSR;KITLG;PDGFB;HIP1;IQGAP1;DAB2IP;LYN;PRKD2;JCAD;MFHAS1;PDGFD;TRIM14;RASD2;PTPRJ;FYN;ACTN4;CASP8;FKBP1A;FLT4;PLCG2;CAV2;SELP;RPS15;FGF23;SOX9;PLEKHG5;TIRAP;F7;EDAR;IKBKB;CX3CR1;TRIM68;PELI1;RET;PLK2;TCF7L2;USP15;BOK;RPS20;WNT5A;RAPGEF2;MID2;CD40;RAC1;SASH1;TRIB3;BCL2L11;BCAR3;PDGFC;LCK;TNFRSF1A;TGFB1;ATP2C1;PIK3CG;PTK2;TGFA;NEDD4;TRIM25;NOS1AP;MAP3K3;GAB1;MALT1;CASP1;RPTOR;AKT2;NEK6;RPL23;BRD4;IKBKG;RICTOR;CGAS;PUM1;IL23A;BCL2L1;SIAH1;LARS1;SEMA4D;NMI;GAS6;CBL;MC1R;P2RY12;PUM2;IRAK4;RIPK1;BID;OASL;CARD16;MIER1;RELA;RIPK2;RACK1;BIRC3;MET;HSP90AB1
prerank,negative regulation of protein kinase activity (GO:0006469),0.4806687146990014,1.4094799816046775,0.056241426611796985,0.5869701194900937,1.0,23/88,14.04%,PTPRB;GNAQ;CAV1;ADARB1;DAB2IP;LRP5;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;PTPN1;SFN;ADAR;RB1;CORO1C;GSTP1;WARS1;TRIB1;GSKIP;NPM1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5515399903400938,1.4093862669253754,0.0928462709284627,0.5857967406391068,1.0,15/37,19.51%,ENTPD1;ISG20;RNASEH2A;MTREX;HNRNPD;NUDT16;RNASEH2C;RNASEH2B;NUDT15;XRN2;PNPT1;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,cellular metal ion homeostasis (GO:0006875),-0.3852376429469171,-1.4092496475575862,0.013215859030837005,0.46173032923463536,1.0,19/102,9.89%,ATP1A2;SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC12A2;ATP1B1;SLC8A1;KCNMA1;DMPK;STIM1;KCNJ2;ATP2A2;RYR2;CXCL12;SLC24A2;ATP1B2
prerank,response to interleukin-1 (GO:0070555),0.5058696133724087,1.408651348789857,0.06334231805929919,0.5867868290862988,1.0,17/73,14.18%,IL1R1;APP;DAB2IP;TNFRSF11A;HIF1A;SELE;SOX9;CD40;NFKB1;CITED1;MAPK11;CCL14;RC3H1;RELA;HAS2;GBP3;TRAF6
prerank,regulation of cell motility (GO:2000145),0.47133360962229204,1.4086434795210216,0.03078817733990148,0.585239083995882,1.0,28/121,10.01%,FRMD5;ABI3;PLXNA4;NTN1;LDB2;CDK6;CCDC125;PRAG1;PLXND1;ADGRG3;SPATA13;ROBO4;TMSB4X;PKN2;FGF23;PKN1;CAVIN1;CEACAM1;ENPP2;RAC1;TGFB1;SGK3;AKT2;SLK;CRK;SST;INPP5F;CYRIB
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.585577301580119,-1.4084302886120124,0.07209302325581396,0.4619416295096246,1.0,8/14,20.84%,IRS1;PPARGC1A;IRS2;SLC45A3;PTPN2;DDB1;GPLD1;NNMT
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5596435252614824,1.4082799372193477,0.08136094674556213,0.585028663059345,1.0,7/35,6.12%,ADGRG6;AHR;PDE2A;PDE7B;PDE4D;SOX9;RAPGEF2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4727126076968973,1.4082597126147678,0.04475703324808184,0.58355845125609,1.0,20/113,6.56%,NRP2;TEK;EGFL7;BMPR2;KDR;TBX1;PPP1R16B;PRKD1;PDGFB;VEGFC;PRKD2;HIF1A;RREB1;FLT4;SOX9;XBP1;VEGFD;TCF7L2;WNT5A;NRAS
prerank,ganglioside biosynthetic process (GO:0001574),0.6466710608649999,1.4081525797747767,0.12050359712230216,0.582320123803109,1.0,5/15,10.19%,ST6GALNAC3;ST3GAL1;ST8SIA4;B4GALT5;ST6GALNAC4
prerank,regulation of protein localization to membrane (GO:1905475),-0.5015436582831575,-1.4070737735367989,0.059782608695652176,0.4633615981728247,1.0,8/28,7.82%,GPC6;GSN;PRKN;GPC3;AR;MMP14;SLC5A3;GPC5
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5147059645079076,-1.4070298975937292,0.07908163265306123,0.46123590379591184,1.0,5/22,9.84%,AEBP1;AKAP13;MAP2;EFEMP2;APOE
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.576956302889599,1.406813541517918,0.08362369337979095,0.585191828832968,1.0,8/25,11.77%,APP;ANKRD13A;RIN3;SDCBP;RAC1;PSEN1;PICALM;ITGB3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5149504344907149,-1.4064350116099391,0.08571428571428572,0.4607625370006062,1.0,8/26,9.89%,ANK2;FHL1;ACTN2;CACNA1D;ATP1B1;DLG1;KCNAB1;ATP1B2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6300630574845346,-1.4059031963488775,0.08297872340425531,0.4600006712692448,1.0,3/11,2.95%,EGFR;DDX5;BMP4
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5970829765787744,1.4056496737251265,0.1264559068219634,0.5875997965733979,1.0,5/21,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,muscle cell migration (GO:0014812),-0.6397705676478456,-1.4052248260949889,0.08668076109936575,0.4596190743039089,1.0,4/10,8.17%,DDR1;SIX1;CCN3;PLAT
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6540829316142008,1.4050667810829591,0.11310592459605028,0.5880694660730148,1.0,8/15,21.70%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM;ARPC4
prerank,multivesicular body organization (GO:0036257),0.5687288039814306,1.404619082281956,0.08482871125611746,0.5879907138205602,1.0,6/31,9.89%,RAB27A;RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28
prerank,positive regulation of locomotion (GO:0040017),0.5819557107768867,1.4044466850716697,0.09936908517350158,0.58704446483064,1.0,8/27,11.16%,NTN1;STX3;PDGFB;PPM1F;CAVIN1;TGFB1;AKT2;P2RY12
prerank,regulation of dendrite development (GO:0050773),-0.4645372511467787,-1.4041863929491238,0.06896551724137931,0.4604873627185796,1.0,9/37,3.85%,CAMK1D;SDC2;PTN;BMP5;BMP7;HECW2;ADGRB3;CSMD3;COBL
prerank,endocardial cushion morphogenesis (GO:0003203),0.6354081616401247,1.4040072592908968,0.10683012259194395,0.5869164287663382,1.0,6/18,6.28%,NOS3;ENG;ACVRL1;NOTCH1;SOX9;ACVR1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5016849783810632,1.4035241118650326,0.06451612903225806,0.5869512883679628,1.0,15/67,13.55%,TBC1D8;ATP8B1;CAV1;PPP1R16B;PODXL;TBC1D22A;TBC1D15;RAC1;TBC1D2;TWF2;FSCN1;TBC1D5;EVI5;RAB5A;FMR1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6005983738573719,-1.403318116569968,0.07710280373831775,0.46074428991030053,1.0,6/13,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,epithelial tube morphogenesis (GO:0060562),0.568301208866872,1.402347298810515,0.0843558282208589,0.589366413803039,1.0,12/32,12.88%,MEF2C;ACVRL1;PODXL;RASIP1;PRKD2;SOX17;MTSS1;ACVR1;PKD2;CCM2;RHOB;MET
prerank,glucose import (GO:0046323),0.6597568631045627,1.4021713224660188,0.12126537785588752,0.5884756586227262,1.0,1/13,0.52%,SLC2A1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5890238429022499,-1.4020160215794573,0.09388646288209607,0.4619967424131805,1.0,5/13,14.40%,DDO;GLUL;ASPA;GOT1;QPRT
prerank,positive regulation of DNA repair (GO:0045739),-0.4527723250672334,-1.4017797191124388,0.06705539358600583,0.46045973824766934,1.0,5/46,2.95%,EYA2;EGFR;EYA1;EYA4;SPIRE1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.43033712605668406,-1.4015402969121515,0.06109324758842444,0.4589662263991953,1.0,19/51,14.51%,DCLK1;GAS7;NBL1;EPB41L3;BMP7;NRK;ALS2;CNTNAP2;TAOK3;SHTN1;NGF;LRRK2;PLXNB1;DTNBP1;WASF1;DBN1;ANKRD27;CTTN;CNTNAP1
prerank,clathrin coat assembly (GO:0048268),0.659539377066783,1.4014910998434098,0.11233885819521179,0.5892237353075283,1.0,4/15,3.93%,HIP1;HIP1R;PIK3C2A;FCHO2
prerank,amide biosynthetic process (GO:0043604),0.5332739315415841,1.4012858801833263,0.06656804733727811,0.588329788616628,1.0,8/47,5.90%,SPTLC2;SGMS1;DEGS2;CERS4;SPTLC3;SPTSSA;ASAH2;PAM
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5034444004222771,1.4007948484367918,0.06302521008403361,0.5884202682375004,1.0,16/66,15.21%,APP;FOXP1;STAT3;GBP5;AIM2;CASP8;CX3CR1;WNT5A;LPL;MALT1;CASP1;CARD16;RIPK2;GSTP1;PANX1;TRIM16
prerank,presynapse organization (GO:0099172),-0.6365247865220582,-1.4006837667754277,0.12205567451820129,0.45931299258610214,1.0,6/10,15.84%,NLGN2;LRRTM3;NLGN1;NLGN3;FZD1;DVL1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6023407097778579,1.4003021439346728,0.13020833333333334,0.5884940394621031,1.0,6/20,10.43%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,response to estrogen (GO:0043627),0.56574293517974,1.3995372690111738,0.09119496855345911,0.5894963215932861,1.0,10/31,14.57%,CAV1;ESR1;SERPINB9;NCOA4;TRIM25;CITED1;TRIM24;CYP27B1;ASH2L;PELP1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6396440933338688,1.3992698331889757,0.1128747795414462,0.5888828516715668,1.0,10/16,25.23%,CAV1;BCL3;NF2;INPP5F;ADIPOR1;PPP2R1A;PIBF1;LEPROT;VHL;PPP2CA
prerank,stabilization of membrane potential (GO:0030322),-0.572027213648327,-1.3990193336171906,0.10981308411214953,0.46158691053431233,1.0,2/16,2.75%,KCNK2;KCNK5
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.43722919031341734,1.3974910723995466,0.017937219730941704,0.5933687690551668,1.0,34/234,8.26%,PRKCH;RPS6KA5;NOD1;CAV1;ESR1;APP;PRKD1;CRTC1;CD200;FZD4;EDN1;ARHGEF2;PRKD2;STAT3;AIM2;TNFRSF11A;TRIM14;NFKBIA;STK3;TRAF1;JMY;PLCG2;TIRAP;IKBKB;CX3CR1;TRIM68;WNT5A;MID2;CD40;TCF3;TRIM25;NFKB1;MALT1;NEUROD1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6290185396588839,1.3973442170541628,0.12224108658743633,0.5923466205576216,1.0,5/18,10.90%,IL6ST;IL6R;STAT3;JAK1;CBL
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6042694841952756,1.3971839392487329,0.09849749582637729,0.5914045003068502,1.0,8/23,18.67%,NMT2;CNGB1;GNAT1;GUCA1B;PDE6B;CALM1;FNTA;CAMKMT
prerank,regulation of endopeptidase activity (GO:0052548),-0.4259502592279344,-1.3970246899721763,0.04961832061068702,0.46474514192848454,1.0,11/59,12.41%,TIMP3;SERPING1;VTN;TIMP2;SERPINH1;SERPINE2;SERPIND1;SERPINF1;APH1B;SERPINE1;SPOCK3
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5266499710950427,-1.3967012662186264,0.08148148148148149,0.46355134051509667,1.0,12/22,24.16%,DMD;CACNB2;GNB5;CACNB1;AHNAK;PDE4B;CACNB3;STAC3;CBARP;HPCA;CACNB4;GPR35
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4179377511111069,1.3958632313548036,0.002098635886673662,0.5944902632906977,1.0,76/497,11.57%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;NANOS3;CD38;HDAC9;ATP8B1;DACH1;ZHX3;BMPR2;SMARCA2;PPARD;CBFA2T3;ZBTB16;SOX7;ACVRL1;DAPK1;AHR;PDGFB;FOXP1;DAB2IP;SOX13;HHEX;NR3C1;NOTCH1;PPM1F;PLCB1;SOX18;HMBOX1;SOX9;IGF2BP3;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;NANOS2;SBNO2;TCF7L2;WNT5A;ATF7IP;RCOR1;KLF10;INPP5K;CDKN1B;TRIB3;TGFB1;BCL3;GRB7;GATAD2A;RNF139;CTBP1;CITED1;KAT6B;FOXK1;MYBBP1A;YEATS2;BTG2;RPL13A;CNOT1;SFRP2;FOXN3;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;RB1;ZMYND11;MRPL13;EID1;SP3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.698530823749428,1.3958553256675896,0.13493530499075784,0.5930182780618406,1.0,3/11,6.12%,MEF2C;LYN;RAPGEF2
prerank,neural crest cell development (GO:0014032),0.5246492610470489,1.3953246398029933,0.09117647058823529,0.5932885399950687,1.0,8/44,8.32%,SEMA6A;TBX1;SEMA5B;SEMA7A;CDH2;SEMA6B;CYP26C1;SEMA6D
prerank,positive regulation of potassium ion transport (GO:0043268),-0.46348226433589124,-1.3951385060461994,0.05246913580246913,0.4655215404264291,1.0,16/38,18.63%,ANK2;FHL1;ACTN2;KCNMA1;DLG1;AKAP6;KCNMB2;KCNJ2;ADRA2A;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4206671449886196,1.3948609201823872,0.0021551724137931034,0.5933272433252273,1.0,94/366,18.01%,RPS6KA5;NANOS3;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;EIF4E;SBNO2;MTF2;JMJD1C;TEAD2;CCDC88A;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;FOXN3;RBM3;BTG1;RB1;SP3;CYFIP1;PRDM2;RELA;UTP4;GLRX2;RPL6;RPL10;MTPN;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;ORC5;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ORC3;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5
prerank,modulation by host of symbiont process (GO:0051851),0.5585056048012553,1.3947681764533997,0.09302325581395349,0.5922017987497645,1.0,11/31,19.88%,LEF1;CX3CR1;INPP5K;CHD1;TFAP4;SNW1;RRP1B;CTDP1;CARD9;SAP30BP;SP1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6176190250626024,1.3947460460508863,0.13109243697478992,0.5907897458277186,1.0,7/18,12.88%,HEG1;RASIP1;CCDC125;KCTD10;ITGA3;ABL2;MET
prerank,cell-cell junction maintenance (GO:0045217),0.682773612683634,1.3946058719133307,0.12546125461254612,0.589744523238739,1.0,1/11,0.28%,TJP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.46965961986596844,-1.3943791884393566,0.055710306406685235,0.465553915787954,1.0,10/38,10.20%,ANK2;CACNA1C;CACNA2D1;CACNA1D;KCND3;CACNB2;CACNA1G;KCNJ2;BIN1;CTNNA3
prerank,regulation of protein import into nucleus (GO:0042306),-0.4730338205709764,-1.3936690588900753,0.08771929824561403,0.465403366815275,1.0,15/36,21.72%,ZIC1;PRKCD;BMP4;CDH1;APOD;SMAD3;SUFU;RAB23;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,regulation of intracellular signal transduction (GO:1902531),0.41809722192723253,1.393013802851622,0.006396588486140725,0.5937211393307081,1.0,78/420,10.69%,VWF;CHN2;TEK;ARHGAP31;NET1;SGMS1;PPP1R16B;PPP1R13B;MCF2L;ARHGEF3;ARAP3;RASGRF2;PIP5K1B;DAB2IP;ARHGEF2;PDE2A;LYN;PRKD2;BCR;SRGAP3;SRGAP2;DDIT4;RASD2;NFKBIA;BST1;TAOK2;STK3;SRGAP1;PRKAR2B;TRAF1;JMY;PLCG2;TMSB4X;PAK2;PLEKHG5;RHOJ;KALRN;STK4;ARHGAP8;IER3;PREX1;HIPK1;CEACAM1;ARHGAP17;PHF20;XIAP;OPHN1;AURKA;WNT5A;RAC1;TNIK;RPA1;BCL3;PTPMT1;NF2;WWC2;PPP2R5B;GNA12;SLC15A2;DEPDC1B;TAF3;RRS1;TAF4B;ARHGEF7;CRK;ARHGEF26;FBXL2;CDK2;IKBKG;RICTOR;ARHGAP28;BRIP1;MAPK11;OCRL;ARAP2;NUAK1;PRKAB1;HUS1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5180609368912142,-1.3929617462230253,0.0891566265060241,0.4650602109291033,1.0,7/22,13.19%,NTRK3;MAGI2;NTRK2;NGF;KIDINS220;WASF1;EHD1
prerank,cellular response to interleukin-6 (GO:0071354),0.589590430926096,1.3928452407227798,0.10333863275039745,0.592796648269723,1.0,7/26,7.86%,ST3GAL6;IL6ST;IL6R;STAT3;SBNO2;JAK1;NFKB1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.48619688499267977,1.3925903000879587,0.06438356164383562,0.5922312431955851,1.0,11/75,5.49%,SEMA6A;TEK;CLDN5;PTPRM;ECSCR;DAB2IP;HHEX;STAB1;NPR1;GTF2I;ATP2B4
prerank,ganglion development (GO:0061548),0.688123466805303,1.3923520319355769,0.13176895306859207,0.5915178157594179,1.0,1/11,0.07%,NRP2
prerank,cellular glucose homeostasis (GO:0001678),0.5422212605706666,1.3921977478546765,0.0858433734939759,0.5906081766637172,1.0,12/41,13.47%,FOXO1;UNC13B;ERN1;HIF1A;KCNB1;XBP1;FOXA3;FOXK1;SOX4;GAS6;RACK1;IGF1R
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5518203126546285,1.392034794034343,0.0998439937597504,0.5896719578736107,1.0,9/35,9.93%,CDK6;LYN;TAL1;STAT3;HIF1A;ACVR2A;ZFPM1;MAFB;MAPK11
prerank,receptor internalization (GO:0031623),0.5264627813945677,1.3913223101781256,0.08071748878923767,0.5904748479344651,1.0,11/44,13.44%,DNM3;CALCRL;CAV1;CEACAM1;RAMP2;ARRB1;NEDD4;SCYL2;PICALM;RAB31;RAB5A
prerank,cellular response to inorganic substance (GO:0071241),0.6037510186478263,1.3911721880063967,0.10291595197255575,0.5894997612879748,1.0,9/21,16.92%,FOXO1;CDK2;AOC1;FMR1;DDI1;ATRX;MTR;DDI2;SPIDR
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.626918738360187,-1.3909518092481654,0.1019522776572668,0.46845310642527294,1.0,3/10,4.58%,ACTN2;SEMA5A;CARMIL1
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3952971320173478,-1.3907031163075878,0.05,0.4669301011124564,1.0,19/85,8.33%,EYA1;ROR1;COL1A1;PIEZO2;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;CACNA1D;GRM7;P2RX4;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.527398228779669,-1.390099666228425,0.08838383838383838,0.46646913083030417,1.0,9/20,20.34%,GRK3;BICD1;GPRASP1;RPGRIP1L;SNCA;PLEK;CRY1;RNF157;MRAP2
prerank,actin filament-based transport (GO:0099515),0.5977955297217549,1.3897463328120105,0.1076388888888889,0.5928188919483389,1.0,5/21,10.61%,FNBP1L;MYO1D;ACTN4;MYO1E;MYO1C
prerank,response to cytokine (GO:0034097),0.4536395902215202,1.3880917666505315,0.049443757725587144,0.5968905580929895,1.0,30/141,10.51%,IL1R1;LEF1;PTPN14;IL6ST;LIFR;APP;GCH1;PTPN12;IL6R;OSMR;ADAM10;STAT3;TNFRSF11A;MAP4K3;SELE;CASP8;SIGIRR;SELP;JAK3;MAPK8;ASAH2;IFNAR2;CD40;CASP1;CITED1;RELB;BCL2L1;MAPKAPK3;CYP27B1;CXCR4
prerank,defense response to bacterium (GO:0042742),0.46508121136670777,1.3874917358636738,0.05997392438070404,0.5975275483388458,1.0,16/105,9.61%,NOD1;IL6R;STAB1;GBP4;SELP;TIRAP;RPS19;LCN2;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6;IL23A
prerank,glycoprotein metabolic process (GO:0009100),0.5063275375101827,1.3868451944725178,0.07555555555555556,0.5982277508109483,1.0,11/53,13.21%,ST6GALNAC3;MGAT4A;STT3B;HIF1A;MAN2A1;ST8SIA4;B4GALT5;B3GNT6;TNIP1;OGA;ERP44
prerank,regulation of actin filament-based movement (GO:1903115),-0.6254668180666292,-1.3868282671416625,0.12133891213389121,0.47303899204458905,1.0,2/10,1.60%,ANK2;PDPN
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6556169257521176,1.3862675769070987,0.14788732394366197,0.5987007230747162,1.0,3/14,3.22%,PRKD1;LIMS2;BST1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6389586166375234,1.385959795300116,0.11169284467713787,0.5983263974399786,1.0,2/16,1.82%,BMPR2;PRCP
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5267233571688363,1.3849382013940144,0.06932153392330384,0.6002119633392483,1.0,10/47,7.86%,CAV1;FBXW7;SIK1;FYN;CD34;CEACAM1;ATP2B4;RAPGEF2;TRIB3;NFKB1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.41960693083349054,1.3837311708609439,0.00972972972972973,0.6027728752341507,1.0,88/327,18.08%,RPS6KA5;ENG;SLC39A8;APBB2;ESR1;SMARCA2;MEF2C;SOX7;ACVRL1;NR5A2;INSR;AHR;IRF2;SOX13;STAT3;NR3C1;NOTCH1;HIF1A;RREB1;SOX17;ACTN4;WWTR1;CHD7;SOX18;TCF7L1;LIN54;SPIN1;SBNO2;MTF2;JMJD1C;TEAD2;PITX3;ESRRG;CNBP;ASCC1;LYL1;FOXN2;TCF3;HNRNPD;WWC2;ZNF2;CREM;KAT6B;PRDM8;MYBBP1A;HINT1;SOX4;MAFB;BACH1;COPS2;FOXN3;BTG1;ZMIZ1;RB1;SP3;PRDM2;RELA;UTP4;GLRX2;RPL6;ESRRB;DMTF1;ZSCAN21;ACVR2B;ERC1;NFKB2;RYBP;ZNF423;YBX1;ATRX;HMG20A;DDIT3;RPS6KA4;NR2C2;ZFPL1;GPBP1L1;ACTR5;HP1BP3;CHEK2;CASZ1;CXXC1;RFX3;ZSCAN26;PHF19;MLXIPL;MLX;PFDN5;RALY
prerank,positive regulation of dendrite development (GO:1900006),-0.6257997843143054,-1.383578274046076,0.10782241014799154,0.4799904721773379,1.0,5/10,10.02%,PTN;BMP5;BMP7;COBL;ALK
prerank,cellular response to growth factor stimulus (GO:0071363),0.4513223279561038,1.3826255459022216,0.038605230386052306,0.6050973090758299,1.0,32/151,7.53%,SEMA6A;FLT1;BMPR2;KDR;TBX1;PDE8A;MEF2C;ERN1;ACVRL1;PRKD1;PLCG1;PDGFB;PTPN12;IQGAP1;DAB2IP;PDE2A;PRKD2;NR3C1;NOTCH1;FLT4;SOX9;SMAD7;ACVR2A;DLL4;RAMP2;DUSP22;WNT5A;RAPGEF2;ACVR1;INPP5K;TGFB1;RAP1A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.553866503960507,1.382272927684493,0.09752321981424149,0.6048369590355989,1.0,8/33,7.33%,MEF2C;ACVRL1;MMRN2;NOTCH1;CARD10;DLL4;ATP2B4;TGFB1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5954704980285096,1.3818095226615366,0.11074918566775244,0.6049138381723732,1.0,10/26,18.29%,NOD1;CASP8;IKBKG;RIPK2;IFIH1;TRAF6;TAB3;IRAK2;TIFA;AAMP
prerank,regulation of myotube differentiation (GO:0010830),0.5787928972923236,1.381792486540104,0.1064516129032258,0.6035195124749817,1.0,6/24,8.15%,HDAC9;PIEZO1;NOTCH1;SIK1;XBP1;ATP11A
prerank,triglyceride biosynthetic process (GO:0019432),-0.5502988416905679,-1.3810704727230754,0.09090909090909091,0.4848273962846595,1.0,5/18,6.99%,AGMO;MOGAT3;LPGAT1;GK;LPIN1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5383888413362166,1.3807937454490544,0.10572687224669604,0.6053659634206243,1.0,16/40,18.26%,SMURF1;PTK2B;FBXW7;FOXF2;RPS7;PTK2;RNF139;XPO1;GNA12;RPL23;RAD23A;UBE3A;RPL11;DESI1;CSNK2A2;CSNK2A1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5141942693176131,1.3801633120457923,0.10112359550561797,0.6060485093164991,1.0,5/48,10.01%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5421750639847851,1.3799957788170754,0.10785824345146379,0.6052649191985688,1.0,8/35,7.50%,HEG1;RASIP1;DAB2IP;CCDC125;KCTD10;FBP1;ITGA3;SYNGAP1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6485367775671066,1.3798686978342962,0.13286713286713286,0.60426696267812,1.0,4/13,3.07%,ESR1;PLPP1;NR3C1;ABHD2
prerank,macrophage activation (GO:0042116),0.549628957081878,1.3796664493856217,0.09854604200323101,0.603530786516278,1.0,5/34,5.42%,APP;CD93;FOXP1;PLCG2;SBNO2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5699223856655173,-1.3792744371489272,0.11409395973154363,0.48757318915230985,1.0,5/14,13.23%,SEC24D;SEC31A;SEC23A;MIA3;TBC1D20
prerank,positive regulation of B cell activation (GO:0050871),0.5130137362851221,1.378559912694701,0.08211143695014662,0.6057995200812366,1.0,11/50,11.13%,CD38;MEF2C;BST1;TIRAP;XBP1;SHLD1;CD40;TNFRSF13C;MAD2L2;CD320;IL7
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5700368747072403,1.378540003374518,0.12074303405572756,0.6044357714926716,1.0,7/27,7.46%,TEK;FLT1;PRKD1;PDGFB;PTK2B;TGFB1;PTK2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5034455250923519,1.3781724867106184,0.08357771260997067,0.6042640400444574,1.0,18/55,15.95%,TNFSF10;CAV1;DAB2IP;FAS;TPD52L1;PAK2;BOK;BCL2L11;LCK;CRADD;BCL2L1;SIAH1;RIPK1;BID;RACK1;S100A9;DDIT3;BMF
prerank,defense response to protozoan (GO:0042832),0.6673785544156463,1.378164956643203,0.16842105263157894,0.6028881637043878,1.0,3/12,6.60%,GBP4;GBP7;CD40
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6583412159918118,1.377346558262285,0.13214285714285715,0.604250382120074,1.0,7/14,19.51%,ENTPD1;NUDT16;NUDT15;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,detection of visible light (GO:0009584),0.6370866973198624,1.376936667999059,0.1057347670250896,0.604160717620256,1.0,3/16,6.96%,GNAQ;CNGB1;GNAT1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3922867471068433,-1.3766017602104774,0.04680851063829787,0.4932139541845395,1.0,32/85,14.97%,NTRK3;MAGI2;ROR1;DPYSL3;CAMK1D;EPHA3;PTN;PTK7;BMP5;BMP7;COBL;TENM3;NDNF;CUX2;CAPRIN2;NTRK2;ROR2;KIDINS220;ARSB;APOE;ATP1B2;ALK;FZD1;CAMK1;PLK5;DBN1;PRKCI;CAMK2B;FUT9;P3H1;PLPPR5;CBFA2T2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.537960518276636,1.3765812375356368,0.10179640718562874,0.6039352694357545,1.0,8/36,7.33%,MEF2C;ACVRL1;PTPRM;DAB2IP;NOTCH1;DLL4;ATP2B4;TGFB1
prerank,amino acid import (GO:0043090),-0.5170169348507448,-1.3763695773735982,0.09898477157360407,0.4918443748006874,1.0,6/21,3.63%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,ribosomal small subunit assembly (GO:0000028),0.6357367145858999,1.3761641611348572,0.13028169014084506,0.6039195392129415,1.0,5/16,10.96%,RPS15;RPS19;RPS14;RPSA;RPS27
prerank,peptidyl-serine phosphorylation (GO:0018105),0.449064422158054,1.3758338957601046,0.0430622009569378,0.6034995873078157,1.0,38/153,13.03%,PRKCH;RPS6KA5;ERN1;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;GAS6;AKT3;MAP3K13;STK38;RIPK1;MKNK2;TGFBR2;TOP1;UHMK1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5160028659082048,1.3747460295376244,0.09078212290502793,0.6057626220578533,1.0,9/46,7.27%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5765112301252544,1.3743925894934057,0.10969793322734499,0.6056175064304259,1.0,11/28,18.29%,NOD1;CASP8;IKBKG;RELA;RIPK2;TRAF6;OTULIN;TAB3;IRGM;IRAK2;AAMP
prerank,regulation of lymphocyte proliferation (GO:0050670),0.612045879856818,1.3743578891625217,0.12784588441331,0.6043742698101969,1.0,4/16,10.91%,AHR;TNFRSF1B;TNFSF8;LST1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6380239298932587,-1.373286815639016,0.12814645308924486,0.4982932585680711,1.0,3/10,2.47%,ATP1A2;OSR1;HECW2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5437837768267073,-1.372908451814979,0.07623318385650224,0.49732980026352797,1.0,4/18,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,lipid oxidation (GO:0034440),0.653277456884428,1.3727335326895047,0.1494661921708185,0.608267866528634,1.0,1/12,0.58%,ADIPOR2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.49926142409651353,-1.3725142861670536,0.09848484848484848,0.4963974880488339,1.0,9/27,13.37%,ANK2;DMD;JPH1;CACNB2;PRKACA;ADRA2A;CACNB1;AHNAK;JPH2
prerank,eye morphogenesis (GO:0048592),-0.5359353705006477,-1.372133704264085,0.10526315789473684,0.4952591003244814,1.0,8/19,9.30%,FBN1;COL5A1;EFEMP1;MFAP5;TENM3;FBN2;NF1;VEGFA
prerank,T cell homeostasis (GO:0043029),0.6755931371142277,1.3720576291491342,0.1436265709156194,0.6090323298606909,1.0,2/10,4.62%,FAS;JAK3
prerank,chromatin organization (GO:0006325),0.4495898566739262,1.371825494342715,0.04516129032258064,0.6084656068736188,1.0,34/132,18.55%,MECOM;ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;TCF7L1;MTF2;CHD1;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SMARCE1;RB1;PADI1;TOP1;SETDB2;NPM1;KAT2B;ATRX;HMG20A;JARID2;PIH1D1;HP1BP3;KDM5C;BAZ1A;KDM4A;PHF19;EHMT1;CHRAC1;PAK1
prerank,endocrine system development (GO:0035270),-0.5183700177966022,-1.3714772476475474,0.09487179487179487,0.4950279451178332,1.0,11/21,16.96%,GLI2;WNT4;DKK3;TGFBR1;SALL1;NF1;SIX1;STRA6;WNT11;PAX8;MDK
prerank,blood circulation (GO:0008015),0.518087372814904,1.3712298752070058,0.09453471196454949,0.6090379397578146,1.0,7/49,5.28%,TBC1D8;NOS3;MYOF;ACVRL1;NPR1;ELN;DLL4
prerank,positive regulation of DNA replication (GO:0045740),-0.5500351600540574,-1.3706447270474393,0.11330049261083744,0.4952343351412353,1.0,3/16,8.40%,EGFR;GLI2;GLI1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.6070414273149122,-1.3705476788068767,0.09777777777777778,0.4934057572645145,1.0,6/11,26.92%,WIPI1;PACS2;ATG9A;STX17;WDR45;WIPI2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5939890123050197,-1.3695814804633557,0.1137855579868709,0.4940491636209961,1.0,6/12,25.99%,INSIG2;KDELR3;GPAA1;INSIG1;RER1;HSPA5
prerank,regulation of DNA repair (GO:0006282),-0.43693875775158336,-1.3695131417051312,0.08059701492537313,0.49225173669331335,1.0,4/44,1.86%,EYA2;EGFR;EYA1;EYA4
prerank,response to muscle stretch (GO:0035994),-0.5534458371772925,-1.3692325585822367,0.13842482100238662,0.49096086058910887,1.0,5/15,11.28%,DMD;GSN;SLC8A1;RYR2;SLC9A1
prerank,positive regulation of JNK cascade (GO:0046330),0.4829211405014121,1.368820971862172,0.08695652173913043,0.6157194789489802,1.0,14/70,6.08%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,regulation of Rho protein signal transduction (GO:0035023),0.48476728288388515,1.3685739439555822,0.0955585464333782,0.6151818454651591,1.0,16/72,7.33%,NET1;HEG1;F11R;EPS8;ARHGEF3;RASIP1;ARHGEF2;CCDC125;BCR;PRAG1;ADGRG1;KCTD10;OPHN1;RAC1;ARRB1;ITGA3
prerank,positive regulation of ERAD pathway (GO:1904294),0.640026113111549,1.368482866041573,0.1400709219858156,0.6141141614373963,1.0,2/13,6.79%,CAV1;ATXN3
prerank,icosanoid secretion (GO:0032309),0.6611692053585718,1.3682037388846053,0.15439856373429084,0.6137218498199442,1.0,1/12,0.17%,ABCC4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5252190281605034,-1.3680432121212334,0.1172069825436409,0.49238190079785754,1.0,9/20,11.80%,ATP1A2;SLC12A2;ATP1B1;SLC8A1;KCNMA1;KCNJ2;ATP1B2;SLC9A1;LACC1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5378893824563837,-1.3678501730748305,0.11442786069651742,0.4909162104621935,1.0,8/16,20.81%,PYGB;PHKB;PYGM;GAA;AGL;AOAH;PHKA2;PHKG1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5320889940097072,1.3677622976387542,0.11353032659409021,0.6137365136415138,1.0,14/36,14.10%,NLRC5;EDN1;HIF1A;CASP4;WNT5A;AGPAT1;CASP1;CSF1;CXCR4;GAS6;IL7;RIPK1;ADAM17;UBE2K
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.5977690545220118,-1.3675009475658313,0.10368663594470046,0.4898120487494157,1.0,5/12,13.82%,NINL;BICD1;KIF3A;PCM1;BICD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4583818881945066,1.3671241090134973,0.0610079575596817,0.6130010329144452,1.0,32/104,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,cellular response to lectin (GO:1990858),0.4583818881945066,1.3671241090134973,0.0610079575596817,0.6130010329144452,1.0,32/104,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,cellular response to peptide (GO:1901653),0.49792922323523264,1.3666770033295597,0.07845934379457917,0.6130265616916718,1.0,17/56,12.40%,NOD1;CAV1;APP;VCAM1;ICAM1;ARHGEF2;CASP4;FYN;XBP1;ATP1A3;CACNA1A;PSEN1;RPL23;EPHA4;GRIN1;LGMN;RIPK2
prerank,negative regulation of cytokine production (GO:0001818),0.44006435307073355,1.3664910594979331,0.038600723763570564,0.6123094358710299,1.0,24/163,7.85%,LEF1;RPS6KA5;HDAC9;RNF125;CD200;NLRC5;HDAC7;CD34;SIGIRR;HOMER2;TMSB4X;UBA7;DLL1;JAK3;CEACAM1;N4BP1;CUEDC2;BTN2A2;TIGIT;RAC1;SRGN;ARRB1;BCL3;TRIM25
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5754533622159835,1.3660424957398054,0.11682242990654206,0.6123480311200374,1.0,8/24,14.53%,CTSC;EFNA1;PTK2B;UCHL5;EPHA4;UBE3A;NUDT15;PSME1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5374629978362246,-1.3657084046734305,0.12471131639722864,0.49288480332801626,1.0,5/17,3.81%,ATP1A2;BMP7;TFPI;BMP4;AR
prerank,positive regulation of nervous system process (GO:0031646),0.6144419784583531,1.3652817856235042,0.13893653516295026,0.6135116236464989,1.0,3/18,3.04%,UNC13B;PARD3;TNFRSF1B
prerank,cellular component maintenance (GO:0043954),0.6593041875090703,1.36450664667075,0.14522058823529413,0.6147280803661923,1.0,5/12,13.47%,INSR;FYN;ITGA3;PICK1;IGF1R
prerank,negative regulation of cellular component movement (GO:0051271),0.625722126632873,1.363683416821154,0.1317157712305026,0.6161220361573276,1.0,3/15,4.27%,FRMD5;CCDC125;ACTN1
prerank,negative regulation of cell motility (GO:2000146),0.45479115907393425,1.3625604944758765,0.060209424083769635,0.6183551303470591,1.0,19/108,6.77%,FRMD5;LIMCH1;MCTP1;DACH1;ENG;ACVRL1;CLDN5;ADARB1;CCDC125;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;PTPRK;SMAD7;DUSP22;ADAM15;STK26
prerank,prostanoid biosynthetic process (GO:0046457),0.6266313184946862,1.3619424932823603,0.14897260273972604,0.6190598660093825,1.0,4/15,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.456935172662559,1.3619413893902692,0.06391478029294274,0.6177105062607838,1.0,32/105,21.23%,RPS6KA5;LYN;ICAM2;FYN;PLCG2;PAK2;IKBKB;KRAS;NRAS;PSMA2;NFKB1;MALT1;RELB;IKBKG;PSMA8;PSMA6;CUL1;MUC1;RELA;TRAF6;PSME1;TAB3;PSMA4;CARD9;PRKACB;PSMF1;PAK1;BCL10;PSMB7;PSMB1;MUC6;PSMD2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.6052223986359041,1.3616920426423524,0.1306532663316583,0.6172090481287223,1.0,5/19,16.67%,MAOB;PXDN;CAT;PRDX2;PRDX1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.6263717886396747,-1.36087163486359,0.12244897959183673,0.5044033721332627,1.0,4/11,12.35%,ITGB5;KIT;CCN3;PLEKHA7
prerank,replicative senescence (GO:0090399),-0.6012843204651046,-1.3598357023994925,0.10805084745762712,0.5054113026194271,1.0,8/12,23.99%,PLA2R1;SERPINE1;WNT16;ATR;TP53;CHEK1;TERT;ATM
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.4239868582773533,1.359434477020879,0.017937219730941704,0.6233672010053068,1.0,48/259,11.69%,ABCC4;FGD5;DNM3;PARVB;ABLIM1;FNBP1L;EXOC6;NTN1;EHD4;CD2AP;FGD6;RAB11A;SRGAP2;S1PR1;NOTCH1;CNGB1;SPATA13;RAP1B;MTSS1;SSX2IP;PPP1R9B;DISC1;SDCBP;CEP41;CCDC88A;OPHN1;RAPGEF2;PCNT;INPP5K;RAC1;BBIP1;STK26;TNIK;RAP1A;EHD2;DYNLL1;EXOC5;ARHGEF7;TEKT5;EXOC4;OCRL;CEP83;ANO6;FSCN1;ARL13B;P2RY12;EHD3;CYFIP1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5453986785430539,-1.3589879385048131,0.1378504672897196,0.50588963620752,1.0,3/17,1.99%,ANK2;SNTA1;CACNA2D1
prerank,spinal cord development (GO:0021510),-0.581166671411729,-1.3587471356749898,0.133630289532294,0.5045315074946114,1.0,5/12,5.63%,GLI2;VIT;PKD1;LOXL3;NF1
prerank,determination of left/right symmetry (GO:0007368),0.534497708435786,1.3587285348844798,0.11975116640746501,0.6242468379331267,1.0,6/36,8.36%,TBX1;ZIC3;NOTCH1;DLL1;PKD2;CFAP53
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5604669879621995,1.358012008729703,0.11947626841243862,0.6253323753632313,1.0,7/26,11.70%,GCH1;SCARB1;HIF1A;FGF23;NOS1AP;CYP27B1;NUS1
prerank,positive regulation of GTPase activity (GO:0043547),0.4294238249864576,1.3575670865861118,0.036773428232502965,0.6253828676608142,1.0,36/188,10.43%,TBC1D8;DOCK9;PKP4;TGM2;NET1;ITGA6;RALGAPA2;F11R;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;TBC1D22A;CAV2;ADRB1;TBC1D15;SIPA1L3;RAP1GDS1;RAPGEF2;TBC1D12;CD40;BCAR3;RAP1A;TBC1D2;AGRN;RSU1;ARHGEF7;ARHGEF26;LARS1;CCL14;SEMA4D
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5741640479895016,-1.3573240325170965,0.11818181818181818,0.5065618648347975,1.0,7/14,14.96%,DMD;ATP1B1;WNK4;ANK3;WNK1;SLC9A1;WNK3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6156509598698536,1.3572087353815898,0.13392857142857142,0.625233416238782,1.0,6/17,11.16%,PIEZO1;PODXL;RET;SKAP1;SFRP2;P2RY12
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.644036126673671,1.3571285102293342,0.15736040609137056,0.6241492726175994,1.0,3/13,2.82%,NRP2;PLXNA4;PLXND1
prerank,negative regulation of endocytosis (GO:0045806),0.560085838853655,1.3568423571171555,0.1386986301369863,0.623768082951279,1.0,3/24,1.41%,MCTP1;CAV1;PRKD1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.629024550445216,1.3567939294816729,0.16047297297297297,0.6226105388570481,1.0,7/15,20.73%,DTX3L;SMAD7;RPS7;RPL23;MAD2L2;RPL11;BAG2
prerank,protein polymerization (GO:0051258),-0.41096793449815555,-1.355612543818508,0.06620209059233449,0.5093028134932273,1.0,6/55,3.85%,ARHGAP6;GAS7;GSN;PRKN;SPIRE1;COBL
prerank,electron transport chain (GO:0022900),0.6282337951243308,1.3550887029842056,0.13051146384479717,0.6267459494498414,1.0,6/15,19.21%,PDIA5;CYB561;ENOX2;ETFDH;ETFA;ETFB
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5487167788226637,1.3535873034197516,0.11690363349131122,0.6304281138922725,1.0,11/33,13.84%,DGKZ;PRKD2;NECTIN2;PTPRJ;TESPA1;CEACAM1;LCK;IKBKG;RC3H1;RELA;SLA2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5392795117873359,1.3527291001622723,0.10702875399361023,0.6319055035397777,1.0,4/31,3.49%,SHANK3;ABI3;EFNA1;PPFIA2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5606421627769413,-1.3515657034899045,0.1162280701754386,0.5188353001199081,1.0,7/13,12.17%,BMP6;BMPR1A;TGFBR1;BMP4;DAB2;TGFB3;NUP93
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5345019580936211,-1.3513946272389337,0.11645569620253164,0.5172276462059292,1.0,5/18,8.61%,PRKN;IRS1;CCN3;ADRA2A;SFRP1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.5204042502481264,-1.3510816561351044,0.10319410319410319,0.5160782185496008,1.0,9/20,16.62%,ADGRV1;AKAP12;AKAP7;AKAP6;LRRK2;PRKAR1B;PRKAR1A;TCIM;PJA2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6699556296269708,1.350886322793937,0.14568345323741008,0.6366834915383268,1.0,2/10,5.47%,PLA2G4A;ENPP2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5837855003010423,1.3505110627818042,0.14185639229422067,0.636599645905269,1.0,7/18,13.92%,TEK;PTK2B;RAP1B;LLGL1;CYRIB;RACK1;CDH5
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.44141752186423455,1.3504252146629967,0.04495747266099635,0.6355075822378956,1.0,16/152,6.96%,ADGRG6;ADGRL4;CALCRL;GNAQ;ADGRL2;ADCY4;WASF2;PDE2A;S1PR1;ADGRG3;ADGRE5;ADGRG1;GNAI2;RAMP2;MCHR1;GNAT1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.6154236697753417,-1.35036746517472,0.13800904977375567,0.5159948148838547,1.0,2/10,9.62%,ALDH7A1;HNMT
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5661803335118274,1.3501234671551463,0.13725490196078433,0.6351777371778995,1.0,7/27,13.77%,PRKCH;NFKBIA;NFKB1;LPL;CSF1;ITGB3;ABCG1
prerank,response to exogenous dsRNA (GO:0043330),0.6089653613403259,1.3493823124705029,0.13582342954159593,0.6364167388632169,1.0,7/18,15.63%,CAV1;SLC3A2;RALB;CGAS;RFTN1;IFIH1;IRAK3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6486896534432549,1.348963781124238,0.15949820788530467,0.6364403532941618,1.0,4/13,7.27%,IL6ST;STAT3;IL27RA;JAK1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5877087122783863,1.3488958866084937,0.1440677966101695,0.6353334959886697,1.0,8/21,7.33%,NOS3;PTK2B;NOTCH1;FGF23;SOX9;GREM1;SRGN;TGFB1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5900962947899688,-1.3482888863821043,0.15384615384615385,0.5196152184232721,1.0,6/11,11.88%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH;DIABLO
prerank,sphingoid metabolic process (GO:0046519),0.652040922297633,1.3476841174404106,0.15819209039548024,0.637989827550483,1.0,5/12,5.50%,DEGS2;PLPP1;SGPP2;SPTLC3;ASAH2
prerank,positive regulation of inflammatory response (GO:0050729),0.46974426209140024,1.347567840540515,0.09103260869565218,0.6370624387911339,1.0,16/86,11.87%,IL6ST;APP;IL15;PDE2A;OSMR;NFKBIZ;NFKBIA;RPS19;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;VAMP8;NMI;RIPK1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5377286423590611,1.3471801329484767,0.11885895404120443,0.6370274682479472,1.0,6/33,5.65%,TEK;KDR;ICAM1;GATA2;RAMP2;TCF7L2
prerank,regulation of viral entry into host cell (GO:0046596),0.5520482771228579,1.34674099168442,0.11513157894736842,0.6371371434782868,1.0,8/30,7.85%,LY6E;TRIM14;NECTIN2;TRIM68;PTX3;MID2;SNX3;TRIM25
prerank,secondary palate development (GO:0062009),0.6271067153356676,1.3465726215351785,0.1602112676056338,0.6363986390465322,1.0,3/14,6.10%,LEF1;CHD7;WNT5A
prerank,vesicle organization (GO:0016050),0.5070771098063288,1.3464765910811132,0.11326378539493294,0.6353448638917695,1.0,7/46,7.03%,FNBP1L;CAV1;CD34;CAV2;ALS2CL;CHMP2B;SRGN
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6352454951999035,1.3464132811897263,0.15717092337917485,0.634206234197978,1.0,2/12,7.33%,ESR1;TGFB1
prerank,prostaglandin biosynthetic process (GO:0001516),0.606129672423686,1.3463697473804268,0.1373534338358459,0.6330310443753505,1.0,5/18,7.17%,PTGS2;PLA2G4A;EDN1;PTGS1;CBR1
prerank,cellular response to hormone stimulus (GO:0032870),0.47600865212309285,1.3462311284849147,0.09154929577464789,0.6321640531963741,1.0,16/69,6.62%,CAV1;MEF2C;LMO2;SOCS2;STAT3;NR3C1;NCOA1;XBP1;GHR;SERPINB9;RAMP2;ATP1A3;ATP1A1;SOST;INPP5K;NCOA4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.42593867300210286,-1.345856214458392,0.05714285714285714,0.5242637479732297,1.0,14/43,9.22%,IGF1;BMPR1A;PDGFRB;IGFBP5;GJA1;IL18;BMP4;CDH13;THBS1;FGF2;ADAMTS1;RBPMS2;CCN4;MMP2
prerank,neutrophil activation (GO:0042119),0.6351561783262135,1.3444894848457025,0.17625899280575538,0.6366785744309755,1.0,3/12,5.14%,IL15;PREX1;KMT2E
prerank,positive regulation of cartilage development (GO:0061036),0.6100755816008996,1.3444571862454384,0.13859649122807016,0.6354861209175161,1.0,4/17,4.17%,BMPR2;ZBTB16;ACVRL1;SOX9
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5856727103339493,1.3444371829999586,0.14983164983164984,0.6342597800549876,1.0,6/21,8.50%,PLA2G4A;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,stress fiber assembly (GO:0043149),0.6117650877381351,1.3435814526599552,0.16815742397137745,0.6345331225667986,1.0,4/15,7.06%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.6117650877381351,1.3435814526599552,0.16815742397137745,0.6345331225667986,1.0,4/15,7.06%,FAM171A1;SORBS1;PDLIM1;ARRB1
prerank,positive regulation of synapse assembly (GO:0051965),-0.4871172452979685,-1.343397005945933,0.09210526315789473,0.5293782388310178,1.0,10/27,12.92%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3;SRPX2;GRID2
prerank,pyroptosis (GO:0070269),0.6211431132899392,1.3432630142602002,0.1375,0.6343714379816763,1.0,4/15,8.27%,AIM2;CASP4;CASP8;CASP1
prerank,cellular response to alcohol (GO:0097306),-0.43470472713078956,-1.3428053095185906,0.07780979827089338,0.5290232704950678,1.0,13/42,9.49%,ADCY5;ADCY1;ADCY2;GRAMD1B;ADCY7;CDH1;GRAMD1C;ADCY6;LRP6;GNAI1;SFRP1;PTGFR;SMO
prerank,calcium ion transport (GO:0006816),-0.3608160916442879,-1.3426266552405102,0.0136986301369863,0.5275510237396264,1.0,21/113,7.92%,SLC24A3;TRPM3;ANK2;CACNA1C;NALCN;SLC8A3;CACNA2D1;CACNA1D;PKD1;GRIN3A;SLC8A1;P2RX4;RAMP1;CACNB2;CACNA1G;ITGAV;TRPC3;STIM1;TRPC6;TRPC1;ATP2A2
prerank,negative regulation of hydrolase activity (GO:0051346),0.5091779827377548,1.3422366376904504,0.09896602658788774,0.6364704113826561,1.0,9/49,8.00%,LRCH1;F11R;SH3BP4;DAB2IP;PLIN5;PTX3;EGLN1;GNAT1;RASA4
prerank,regulation of protein transport (GO:0051223),0.5521983739344521,1.3420982685497667,0.128,0.6356232889675093,1.0,12/27,18.66%,LCP1;PPM1F;DNAJA1;SNX3;LLGL1;PTPN1;GAPVD1;RHBDF2;NDEL1;CHP1;NDFIP2;STXBP5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5923925544153636,1.3419051372405337,0.15397350993377484,0.6349987194077253,1.0,4/19,2.97%,TJP1;NEXMIF;NOTCH1;PPM1F
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5403912446150684,-1.3415947902040752,0.1358313817330211,0.5284935826832386,1.0,4/16,5.51%,SOX5;PTN;SOX6;HOXB4
prerank,histone H3 acetylation (GO:0043966),0.5253759290113659,1.3415571445438024,0.1301859799713877,0.6348013058345567,1.0,10/40,15.21%,LEF1;JADE2;JADE1;KAT6B;JADE3;YEATS2;KAT2B;MBIP;KAT6A;TRIM16
prerank,positive regulation of cell communication (GO:0010647),-0.4759627475909743,-1.3414018653592188,0.10459183673469388,0.5270378766791314,1.0,6/28,6.83%,WLS;CLSTN2;DLG4;SYT1;ANK3;PTPN23
prerank,regulation of mast cell activation (GO:0033003),0.6597268174288422,1.3411574938902484,0.16448598130841122,0.6349352375465688,1.0,2/10,2.79%,LYN;NECTIN2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6799935850169984,1.3411060100594154,0.1590909090909091,0.6338188667610148,1.0,3/10,6.14%,PIEZO1;PODXL;SKAP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6086008678609385,-1.3403081124685112,0.12836438923395446,0.5282316080390507,1.0,6/10,22.93%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,positive regulation of autophagy (GO:0010508),0.4651563353225083,1.3396791177168805,0.09203296703296704,0.6372528218697957,1.0,16/81,11.40%,FOXO1;KDR;PRKD1;DAPK1;SH3BP4;TRIM14;PIK3C2A;TRIM68;PLK2;ULK1;MID2;SH3GLB1;IKBKG;NPRL2;BNIP3;ATF6
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5386262036199588,1.3392272534993943,0.1205564142194745,0.6374947818837957,1.0,7/33,7.33%,PDGFB;GATA2;STAT3;NR3C1;HIF1A;FOSL1;TGFB1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5680139190825697,1.3392181437835788,0.12248322147651007,0.6362517651856583,1.0,11/25,18.42%,EFNA1;OPHN1;RPS7;RPL23;EPHA4;HSP90AB1;PRKCG;RPL11;CSNK2A2;CSNK2A1;PSMF1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5314225952865055,1.3387141956235729,0.1278538812785388,0.6366667758591308,1.0,10/36,8.28%,SGMS1;DAB2IP;FAS;TPD52L1;TRAF1;TMBIM6;CX3CR1;ASAH2;PTPMT1;CRADD
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4814842766877858,1.337819148005629,0.09015256588072122,0.6382107022389759,1.0,15/64,9.46%,LIMCH1;ACER2;UTRN;NEXMIF;CDK6;PEAK1;PTK2B;BST1;SKAP1;ADAM15;PTK2;RASA1;NF2;SLK;CSF1
prerank,positive regulation of cellular process (GO:0048522),0.3992148893534178,1.3377697777236763,0.008385744234800839,0.6371094805895839,1.0,111/565,13.64%,FRMD5;LEF1;TJP1;TBC1D8;RAB27A;FLT1;ACER2;TGM2;KDR;IL6ST;CAV1;TBX1;LIFR;IL15;STX3;CLDN5;INSR;KITLG;PDGFB;PARD3;VEGFC;GATA2;IL6R;EDN1;LRP5;LYN;TAL1;PRKD2;OSMR;ADAM10;FASN;PDGFD;TNFRSF11A;PTK2B;PPP3CA;NOTCH1;CNOT6;PTPRJ;ACACB;TNFRSF1B;BST1;AQP11;ACTN4;WWTR1;CNOT6L;FLT4;ADGRG1;FGF23;SOX9;DLL1;RPS19;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;VEGFD;GNAI2;GREM1;MAPK8;H3-3A;CHP2;WNT5A;CNBP;FOSL1;KRAS;RAC1;CDKN1B;PDGFC;TGFB1;PTK2;TGFA;AGPAT1;KDM4C;NEUROD1;RPTOR;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1;DICER1;RAD18;DHPS;RAD23A;SFRP2;CCL14;GAS6;EPHA4;MCTS1;IL7;GRIN1;SINHCAF;LGMN;RPRD1B;RELA;RIPK2;PA2G4;ZFP36;PHIP;TGFBR2;HSP90AB1;MTPN;CNOT7;HAS2;ADAM17;IGF1R;NSMCE4A;FMR1;RPS6
prerank,regulation of cellular component size (GO:0032535),0.5409586430240145,1.3375999072328029,0.12603648424543948,0.6363921536982488,1.0,10/30,16.64%,EPS8;RIN3;MSN;RAC1;RPTOR;LARS1;PICALM;MTPN;RDX;HP1BP3
prerank,phasic smooth muscle contraction (GO:0014821),0.6707627663657489,1.3369412459988368,0.15471698113207547,0.6373925936100323,1.0,2/10,15.59%,EDN1;HTR1D
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5194820836940316,1.3363390452776596,0.11078286558345643,0.6381149068319085,1.0,9/40,9.16%,GBP4;TIRAP;GBP7;RPL39;DROSHA;PGLYRP2;LYG2;ANG;DEFA6
prerank,membrane protein proteolysis (GO:0033619),0.5273793570015786,1.3362981872025796,0.11162790697674418,0.6369914492863287,1.0,15/37,15.15%,MYH9;ADAM10;SPPL2A;RET;TGFB1;NFKB1;ERAP1;PSEN1;RHBDD1;MBTPS2;APH1A;RELA;ADAM17;TRAF6;SPPL3
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6787274747620198,1.3362112864395859,0.17032967032967034,0.6360379229925911,1.0,2/10,1.50%,ST6GAL1;ST3GAL1
prerank,regulation of dopamine secretion (GO:0014059),-0.4920333352745488,-1.3361515095589955,0.09186351706036745,0.5382079410748395,1.0,12/25,26.67%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3;SYT2;SYT6;SYT5;KCNA2
prerank,organic acid transport (GO:0015849),0.45586480861616263,1.3360637862295461,0.0880503144654088,0.6352904966310221,1.0,14/94,6.70%,ABCC4;SLCO2B1;ABCG2;ATP8B1;PPARD;SLC7A7;SLC38A5;SLC3A2;STARD5;NCOA1;SLC6A6;CEACAM1;SLC43A2;SLC26A1
prerank,adipose tissue development (GO:0060612),0.647387746046032,1.3359346970028323,0.17490494296577946,0.6345274478474613,1.0,3/11,4.97%,SPTLC2;LRP5;XBP1
prerank,positive regulation of protein modification process (GO:0031401),0.42070962135177736,1.3357941609289767,0.04491725768321513,0.6337303566358641,1.0,34/203,7.94%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;PPP1R16B;INSR;VEGFC;PPP2R5A;LYN;FAS;EFNA1;FLT4;FGF23;SOX9;STK4;RALB;VEGFD;ACVR2A;ALG10B;LIMK2;KRAS;CD40;RAC1;DYRK1A;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;NOS1AP
prerank,protein-containing complex subunit organization (GO:0043933),0.4405064725251594,1.3357737766878435,0.06607369758576874,0.6325340185564043,1.0,26/109,14.30%,SLC2A1;OCLN;CD2AP;MAGI1;PARD3;FAS;PTK2B;TRAF1;CARD10;SOX9;TEAD2;CD40;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;PICALM;NUP98;NUP133;NUP205;CAPZA1;PEX14;IL1RAP;NUP54;APC
prerank,regulation of cell cycle (GO:0051726),0.4147708450706827,1.3355378978160564,0.03687150837988827,0.6320635253823611,1.0,54/271,13.03%,MECOM;NANOS3;DCUN1D3;APBB2;ERN1;PPP1R13B;CDK6;NEK7;ADARB1;IQGAP1;DAB2IP;PIM3;ADAM10;STAT3;NOTCH1;SIK1;AFAP1L2;TTC28;JMY;SOX9;PPP1R9B;SDCBP;UHRF2;LIN54;PTPRK;ASAH2;XIAP;TCF7L2;LIN9;CDKN1B;JUNB;TGFB1;RNF167;PKD2;NF2;CTBP1;AKT2;NEK6;MYBBP1A;RPL23;PUM1;DDIAS;RAD23A;TFAP4;CDC26;RB1;RNF112;RPRD1B;NOP53;RHOB;RACK1;BIRC3;HSP90AB1;UHMK1
prerank,rRNA transcription (GO:0009303),0.600863931295814,1.3354654408423288,0.15384615384615385,0.6310120752340533,1.0,10/17,24.55%,CAVIN1;SPIN1;TAF1B;ANG;NIFK;POLR1G;GTF3C1;TCOF1;SIRT7;BRF1
prerank,B cell receptor signaling pathway (GO:0050853),0.5343469058694718,1.334529151948269,0.13584288052373159,0.6328505241712201,1.0,7/32,9.58%,CD38;MEF2C;PLCG2;SH2B2;BMX;LCK;RFTN1
prerank,negative regulation of growth (GO:0045926),0.4399379329669045,1.3343799898563924,0.07079646017699115,0.632156047914243,1.0,18/121,7.33%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;NOTCH1;PTPRJ;SOX17;PPP1R9B;VGLL4;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.47525656793822657,1.3341381320511472,0.09129213483146068,0.6317244787998695,1.0,11/70,6.61%,TEK;PARVB;MEF2C;PEAK1;EFNA1;SRGAP2;PXN;ACTN1;SIPA1L3;OPHN1;RAC1
prerank,amino acid import across plasma membrane (GO:0089718),-0.4835511640211353,-1.334001009479912,0.09392265193370165,0.5423769542758423,1.0,7/24,3.63%,SLC7A2;SLC6A13;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4325776203425278,-1.3339382207518105,0.08306709265175719,0.5405837379905666,1.0,18/44,18.63%,ANK2;ACTN2;ATP1B1;KCNMA1;WNK4;AKAP6;KCNMB2;KCNJ2;ATP1B2;WNK1;GABBR1;KCNJ10;KCNN2;GNG2;WNK3;KCNJ15;KCNJ6;KCNN3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4853934589369978,-1.3338114903089182,0.10975609756097561,0.5389384889045682,1.0,5/25,6.95%,ERRFI1;CBLB;SLC6A9;PPARA;SNX6
prerank,negative regulation of inflammatory response (GO:0050728),0.42571293903800306,1.3336955462654392,0.0498220640569395,0.631889098077659,1.0,21/182,5.63%,TEK;CALCRL;CYSLTR1;PPARD;ADCY4;CD200;PLCG1;MYH9;LYN;MFHAS1;YES1;GNB1;TNFRSF1B;LPCAT3;FYN;PRKAR2B;PLCG2;ADRB1;RPS19;RAMP2;PLK2
prerank,retinal metabolic process (GO:0042574),-0.5898194953351752,-1.3334477297463887,0.1628440366972477,0.5379394160501354,1.0,4/12,15.16%,ABCA4;CYP1B1;RDH13;RDH10
prerank,spliceosomal complex assembly (GO:0000245),-0.42730790445262373,-1.3330450311762225,0.08256880733944955,0.5371549146961516,1.0,8/46,12.29%,CELF2;SRSF5;CELF4;DDX39B;LUC7L3;SRPK2;CELF1;SF1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5822611679051223,1.332675034014032,0.13696369636963696,0.6339972709450722,1.0,8/24,18.29%,NOD1;CASP8;IKBKG;RIPK2;TRAF6;TAB3;IRAK2;AAMP
prerank,regulation of sensory perception of pain (GO:0051930),-0.588221062163415,-1.3323322041865773,0.17391304347826086,0.53706216156768,1.0,3/11,6.82%,CCN3;TMEM100;MGLL
prerank,cellular response to interleukin-12 (GO:0071349),0.49931981885791443,1.3319936342188172,0.11748251748251748,0.6349512697271303,1.0,9/48,7.27%,LCP1;MSN;RAP1B;PLCB1;PAK2;HNRNPF;CA1;MTAP;JAK1
prerank,inorganic anion transport (GO:0015698),-0.41573159330454557,-1.331991740044363,0.0847457627118644,0.5360510138441688,1.0,9/53,8.65%,SLC4A10;SLC13A4;ENPP1;SLC26A7;ANO1;CLCN2;ANO4;SLC5A5;ENPP3
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5488820716156135,1.331518688206805,0.15614617940199335,0.635249981786192,1.0,7/24,10.43%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;DSCAM;SEMA4D
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6528599307492853,1.3313481647520973,0.1690909090909091,0.634601170011246,1.0,4/11,12.61%,CAV1;BCL3;NF2;ADIPOR1
prerank,mesoderm formation (GO:0001707),0.5872192579276547,1.3310869851822544,0.15294117647058825,0.6341638470593449,1.0,4/17,11.77%,BMPR2;ITGA3;ITGA2;ITGB3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5473282572698962,-1.3306457114751233,0.15555555555555556,0.5378770556328829,1.0,6/15,24.58%,GGT5;ALDH4A1;PRODH;HOGA1;GGT1;GOT2
prerank,cartilage development (GO:0051216),-0.4180786884161151,-1.330628708677809,0.07309941520467836,0.5359941038212317,1.0,14/49,8.79%,SOX5;SULF1;OSR1;SULF2;BMP4;PKD1;SOX6;RUNX2;FGF2;SLC39A14;ITGB8;CCN3;CD44;RUNX1
prerank,sprouting angiogenesis (GO:0002040),0.4923567530414125,1.3305390038321208,0.10882352941176471,0.6346729722752968,1.0,13/51,5.63%,TEK;KDR;ENG;EPHB4;ACVRL1;VEGFC;PTK2B;ADGRA2;FLT4;DLL1;VEGFD;GREM1;RAMP2
prerank,protein glycosylation (GO:0006486),0.4341027589223286,1.3294263148706773,0.06973848069738481,0.6371382090415332,1.0,24/125,12.80%,ST3GAL6;SLC39A8;ST3GAL1;MGAT4A;STT3B;GALNTL5;GALNT18;EOGT;AQP11;B3GNT3;TET3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;NUS1;MGAT5;DPAGT1;TET2;OGA;PMM2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5308338519196507,1.329354045709099,0.12241653418124006,0.6361830015219162,1.0,6/33,5.28%,PTPRG;ACVRL1;PTPRM;DAB2IP;EVL;DLL4
prerank,neutrophil mediated immunity (GO:0002446),0.3969399754205382,1.3292751803014036,0.01567398119122257,0.6352373957418691,1.0,83/432,15.53%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;KMT2E;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;IRAK4;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;ADAM17;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;ACE;CEP290;APAF1
prerank,calcineurin-mediated signaling (GO:0097720),0.6711031516625544,1.3290641608309601,0.17032967032967034,0.6335218087671156,1.0,3/10,5.98%,NFATC1;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6711031516625544,1.3290641608309601,0.17032967032967034,0.6335218087671156,1.0,3/10,5.98%,NFATC1;PPP3CA;PPP3CB
prerank,regulation of macrophage cytokine production (GO:0010935),0.6234600323468173,1.3288735532602218,0.1559633027522936,0.632957423185507,1.0,5/13,7.33%,SEMA7A;PLCG2;CUEDC2;WNT5A;TGFB1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.4035463168179953,1.3288345091538225,0.035398230088495575,0.6319081990474437,1.0,97/306,17.73%,ALAS1;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;RPL34;RPS20;RPL39;RPS7;PWP1;RNASEH2A;RPS24;TAF1B;MCM10;RPA1;RPL37A;B4GALT5;BCL3;SRBD1;RPL36;RPS18;RSL24D1;RPL15;POLA1;B3GNT6;RPS8;RPL14;RPL23;RPL17;DUT;CDK2;MRPS18A;BRIP1;RPL9;DHPS;RPL4;RPL13A;HELB;RPS11;RPL32;TNIP1;HUS1;RPL22;RPS27;RPL31;RPS23;MMS19;RNPS1;MRPL13;RPL13;MRPS12;RPS12;MCM9;EEF2K;RMI1;MRPL35;HBS1L;RPL6;RPL10;WARS1;PTMA;TOP1;MRRF;MRPL41;GRWD1;RPS29;RPS6;MEF2A;MRPL52;RPL29;TOPORS;RPS25;RPL35A;RPS13;RPS21;MRPS16;RPL27;RPL18;MRPL23;ORC5;RPL27A;MRPS5;RPS10;MRPL37;ORC3;EEFSEC;RPL11;RPL8;EEF2;RFC3;RPLP2;MRPL11
prerank,modulation by symbiont of host process (GO:0044003),0.6806707572422007,1.3279046956765075,0.17985611510791366,0.6335579025238716,1.0,1/10,1.56%,B2M
prerank,response to interferon-gamma (GO:0034341),0.4765033534588866,1.3278456741768423,0.11173184357541899,0.6325765628557101,1.0,12/67,10.41%,GCH1;DAPK1;GBP5;GBP4;GBP7;WNT5A;CD40;CASP1;CITED1;RPL13A;CYP27B1;CCL14
prerank,phosphatidylserine metabolic process (GO:0006658),0.5359354458519466,1.3272368275801292,0.15085536547433903,0.6333527480568246,1.0,7/32,8.50%,PLA2G4A;SERINC5;LPCAT3;PLA2G2D;OSBPL10;MBOAT1;PLAAT3
prerank,regulation of monooxygenase activity (GO:0032768),0.5743727803704206,1.3271209718308343,0.1520979020979021,0.6325326321310138,1.0,5/23,7.94%,NOS3;CAV1;NOSTRIN;NOSIP;NOS1AP
prerank,regulation of transmembrane transport (GO:0034762),0.5279237383157674,1.3270676544563984,0.13636363636363635,0.6315528008165652,1.0,6/31,7.82%,SLC2A1;CTTNBP2NL;OCLN;NEDD4L;TRIB3;NEDD4
prerank,endoderm development (GO:0007492),0.6489591885566636,1.3270507451053892,0.1794871794871795,0.6304278467793228,1.0,4/13,14.85%,SOX7;SOX17;KIF16B;DUSP2
prerank,sympathetic nervous system development (GO:0048485),0.6157097724484917,1.3267649857989976,0.1693121693121693,0.6301589261558118,1.0,1/15,0.07%,NRP2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.6064315443046224,-1.326535584478529,0.15286624203821655,0.5459038943168909,1.0,3/10,16.21%,PRKN;SNCA;MT3
prerank,retinol metabolic process (GO:0042572),-0.5441979647095556,-1.3260505644220646,0.12608695652173912,0.5453104283307861,1.0,3/14,4.73%,RBP4;DHRS3;CYP1B1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.39103381902911566,1.3256826900655898,0.0010050251256281408,0.6323618888653151,1.0,149/834,12.41%,ERG;LEF1;MRTFB;ELK3;RPS6KA5;FOXO1;EPAS1;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;PLXND1;KLF7;RREB1;NFKBIA;CCNK;SOX17;NCK1;WWTR1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;SOX9;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;XBP1;TET3;EPC1;SMAD7;ACVR2A;GREM1;FOXF2;SBNO2;HOXA10;MTF2;LPIN3;TCF7L2;TCF4;PPP3CB;CHP2;WNT5A;CNBP;SKAP1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;BTBD18;FOXA3;FOSL1;IRF2BPL;CD40;HNF1B;JUNB;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;TCF3;AGRN;NFKB1;PKD2;NEUROD1;CITED1;NRL;KAT6B;SMARCA5;CREB1;ZFPM1;SUB1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;RNF4;NFIB;CREB3L4;NRIP1;SMAD5;SFRP2;USF2;TNIP1;GLYR1;POU2F1;GABPB1;CSRNP1;MC1R;GLMP;ZMIZ1;ATF6;SP3;GRIN1;RIPK1;PRDM2;ACTR2;RPRD1B;MUC1;ASXL1;RELA;RIPK2;MAX;TET2
prerank,regulation of lamellipodium assembly (GO:0010591),0.5165883443195408,1.3255943339302678,0.1435257410296412,0.6314927866257969,1.0,11/34,15.76%,ABI3;OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,cell-cell junction organization (GO:0045216),0.4651809498360467,1.3252501531392191,0.0958904109589041,0.6313671709971448,1.0,16/79,9.63%,TJP1;PKP4;CADM1;CLDN5;OCLN;LIMS2;TJP2;NECTIN2;PVR;CDH2;CTNNA1;TGFB1;TRPV4;CDH15;ANG;TJP3
prerank,negative regulation of response to stimulus (GO:0048585),0.4803091020560142,1.3251763261660865,0.10733695652173914,0.6304197070133271,1.0,13/60,9.42%,MCTP1;CDK6;LYN;PIM3;KLF7;AQP11;LPCAT3;KIF26A;SRMS;CD34;ACVR1;MAP3K3;PTPN1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.48668394203845367,-1.3248324413975558,0.13350125944584382,0.5468164235097865,1.0,9/23,16.96%,GJA1;BMP4;FGF2;SIX1;VEGFA;SMO;PIK3CD;PAX8;MDK
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6344043076710154,1.3246497465650562,0.16666666666666666,0.6310166611257026,1.0,3/13,3.41%,NOS3;GLS2;GLS
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.48204295372312717,-1.3243720645246468,0.14600550964187328,0.5459999049376106,1.0,5/25,7.90%,ANK2;CEMIP;CACNB2;AKAP6;TRPC1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6627722926310959,1.3241576164890014,0.18181818181818182,0.6313273771143126,1.0,2/10,1.12%,ACER2;NEXMIF
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6677353429141974,1.3240889061151766,0.18267419962335216,0.6304121944527498,1.0,5/10,16.38%,NFKBIZ;SMAD7;MALT1;RC3H1;NFKBID
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5037196449667544,1.3240196620565494,0.11093990755007704,0.6294541524451067,1.0,13/47,12.67%,PTGS2;PPARD;ZBTB16;SOX13;LRP5;RREB1;XBP1;LPL;CREB1;SFRP2;CCDC71L;PIM1;ZFP36
prerank,regulation of T cell cytokine production (GO:0002724),0.6095360372759198,1.3239829813080668,0.17375886524822695,0.6284131296568267,1.0,4/15,8.24%,B2M;TNFRSF1B;SMAD7;MALT1
prerank,regulation of interleukin-2 production (GO:0032663),0.5085774110679937,1.3236929176388457,0.13696612665684832,0.628244851617315,1.0,7/43,3.95%,SPTBN1;PRKD2;HDAC7;PDE4D;CD34;PLCG2;HOMER2
prerank,regulation of interleukin-12 production (GO:0032655),0.5030878016427158,1.3234959981088132,0.12121212121212122,0.6276942396247804,1.0,11/47,12.40%,FOXP1;PLCB1;PLCG2;TIRAP;JAK3;MAST2;TIGIT;CD40;IL23A;MAPK11;RIPK2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.568409527102324,1.3230609637764716,0.15584415584415584,0.6278604353537283,1.0,9/24,9.42%,EPN2;MMRN2;DAB2IP;HHEX;PRKD2;HIF1A;NEDD4;ITGA5;PTPN1
prerank,sodium-independent organic anion transport (GO:0043252),0.647480859562084,1.3224903473498602,0.18840579710144928,0.6283827860171293,1.0,3/10,4.03%,SLCO2B1;SLCO2A1;SLC16A2
prerank,glycoprotein biosynthetic process (GO:0009101),0.45501746562465945,1.3220740346268556,0.09358288770053476,0.628543326881425,1.0,11/79,8.79%,ST3GAL6;CSGALNACT1;BMPR2;GALNTL5;B3GNT3;ALG10B;B3GNT4;ST8SIA4;ST6GALNAC2;B4GALT5;B3GNT6
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5903554891560527,1.3220042366213243,0.15881326352530542,0.6275893580772434,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,respiratory system development (GO:0060541),-0.4468806759263723,-1.3211488386826151,0.11014492753623188,0.5532644931916535,1.0,12/32,12.70%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;FGF2;VEGFA;STRA6;FGF7;CCDC39
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42815233790986307,1.3208971434021315,0.07926829268292683,0.6298816195523822,1.0,30/132,11.84%,FOXO1;APP;PRKD1;INSR;DAPK1;SH3BP4;TRIM14;HIF1A;MSN;PFKFB3;TNFRSF1B;PIK3C2A;PLIN5;VGLL4;DTX3L;TRIM68;PLK2;ULK1;PRR5L;MID2;SH3GLB1;PSEN1;AKT2;PTPN1;NPRL2;CNOT1;BNIP3;RC3H1;ATF6;ABCD1
prerank,positive regulation of cell population proliferation (GO:0008284),0.39775123291266584,1.3208619823498853,0.024312896405919663,0.6288699592180746,1.0,64/423,9.46%,PRKCH;LEF1;TJP1;TBC1D8;FLT1;ACER2;KDR;IL6ST;TBX1;LIFR;MEF2C;IL15;STX3;CLDN5;CDK6;INSR;KITLG;PDGFB;VEGFC;FOXP1;IL6R;EDN1;LRP5;LYN;OSMR;ADAM10;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;BST1;AQP11;WWTR1;CNOT6L;FLT4;FGF23;TOX;SOX9;DLL1;SDCBP;XBP1;VEGFD;GNAI2;GREM1;DLL4;TCF7L2;CHP2;WNT5A;CNBP;FOSL1;KRAS;PDGFC;TGFB1;PTK2;TGFA;MAP3K3;KDM4C;AKT2;IL7R;RPL23;CDK2;SOX4;CSF1
prerank,membrane organization (GO:0061024),0.4101764514565262,1.3208304830808122,0.052690582959641255,0.6278581500837062,1.0,44/227,12.04%,DNM3;MYOF;FNBP1L;CERT1;SPTBN1;EPN2;HIP1;HIP1R;FZD4;REEP1;LPCAT3;PIK3C2A;FCHO2;ARPC3;GLTP;AP2B1;VAMP4;CCDC88A;CHMP2B;WNT5A;DCSTAMP;SH3GLB1;ARRB1;ATP2C1;TGFA;SNX3;AP2A1;IL7R;SYNJ1;CHMP4A;CHMP4B;PLEKHA8;SNAP23;GAPVD1;OCRL;VAMP8;A4GALT;SCARB2;CBL;PICK1;PICALM;M6PR;CORO1C;ACTR2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5463595231215669,1.3197984822500988,0.14195583596214512,0.6299545398955851,1.0,12/29,17.56%,RPS19;RPS14;RPS16;RRS1;RPS8;HELB;UTP4;NOL10;RPS21;UTP6;HEATR1;NOP14
prerank,regulation of JNK cascade (GO:0046328),0.4473410051195181,1.3195895592409557,0.07476635514018691,0.6295133489817105,1.0,15/101,6.08%,MECOM;APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22
prerank,magnesium ion transport (GO:0015693),-0.5707893436535943,-1.3195616689438645,0.15945330296127563,0.5558610465566977,1.0,6/12,19.17%,SLC41A1;TUSC3;MAGT1;CNNM4;MRS2;NIPA1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5977992035825277,-1.319434121523828,0.15841584158415842,0.5542727275948736,1.0,4/11,9.36%,CACNA2D1;CACNB2;CACNB1;BIN1
prerank,regulation of cation channel activity (GO:2001257),-0.3722260006886582,-1.3191262716141021,0.06201550387596899,0.5532109741282673,1.0,30/89,15.47%,ANK2;DMD;DLG2;NLGN2;ACTN2;DLG4;FGF14;JPH1;GRIA2;ANK3;DLG1;GRIA3;GRIA1;SLMAP;CACNB2;NLGN1;PRKACA;KCNAB1;CACNB1;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;AHNAK;JPH2;CAMK2B;CACNG4;SHISA7;NETO1
prerank,potassium ion transmembrane transport (GO:0071805),-0.35133108213426373,-1.3190662386326863,0.016042780748663103,0.5514548964340973,1.0,26/135,12.45%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;SLC12A2;KCNB2;SLC9A9;KCNK5;ATP1B1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNS3;KCNJ2;KCNQ4;KCNJ13;KCNAB1;SLC24A2;ATP1B2;KCNQ5;SLC9A1;KCNA6;ABCB8
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5492873694237314,1.3190205746548882,0.16612377850162866,0.6301494013541196,1.0,11/26,15.10%,LYN;STAT3;EFNA1;AIM2;FYN;APH1A;EPHA4;GRIN1;PICALM;PSME1;VSIR
prerank,cellular response to hydroxyurea (GO:0072711),0.642561319774297,1.318872808321396,0.18691588785046728,0.6294841736884167,1.0,8/10,28.06%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11
prerank,response to hydroxyurea (GO:0072710),0.6337566436720373,1.3180965763119714,0.17025089605734767,0.630856309555709,1.0,9/11,29.26%,FMR1;DDI1;ATRX;DDI2;SPIDR;RTF2;TIMELESS;DDX11;KAT7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.47519982640285324,1.3180101228162888,0.11673699015471167,0.6300088787537919,1.0,15/67,9.46%,UTRN;CDK6;LIMS2;PDGFB;NEDD9;DOCK1;PTK2B;PPM1F;RREB1;SKAP1;RAC1;RSU1;ARHGEF7;CRK;CSF1
prerank,glucan catabolic process (GO:0009251),-0.5240759663073501,-1.31779712422611,0.15920398009950248,0.5530900927134974,1.0,7/15,20.81%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,gliogenesis (GO:0042063),0.609326800781578,1.3177259377624484,0.16845878136200718,0.6297731604286437,1.0,7/15,17.83%,CDK6;CDH2;NFIB;NDUFS2;CD9;MMP24;METTL14
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4365662318629313,1.3170885377563706,0.08463541666666667,0.6306715251770968,1.0,31/114,18.42%,AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;CD40;TNFRSF1A;PSMA2;TNFRSF13C;TNFRSF8;PSMA8;TNFRSF9;PSMA6;RIPK1;RELA;BIRC3;ADAM17;TRAF6;PSME1;BAG4;BIRC2;STAT1;PSMA4;PSMF1
prerank,cellular response to nutrient levels (GO:0031669),0.48167984216389115,1.317050417960032,0.11047345767575323,0.6296521552716808,1.0,11/62,8.46%,FOXO1;BMPR2;STK24;KCNB1;RALB;XBP1;ULK1;KLF10;STK26;LPL;RPTOR
prerank,dendritic spine organization (GO:0097061),0.5433552713898276,1.3166102387586938,0.1495176848874598,0.6299235046565611,1.0,7/26,13.47%,SHANK3;INSR;FYN;ITGA3;PICK1;LGMN;IGF1R
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5867643566380835,1.3165807559201013,0.15151515151515152,0.6289349977378497,1.0,5/20,10.54%,RPS6KA5;DIP2B;ARRB1;SOX4;GLYR1
prerank,negative regulation of viral transcription (GO:0032897),0.6082930156781424,1.3159622601967218,0.1684027777777778,0.6297415328722259,1.0,5/13,19.39%,TRIM14;MID2;ZFP36;IFITM3;TRIM62
prerank,negative regulation of vascular permeability (GO:0043116),0.6250936482007775,1.3157957672691838,0.20677361853832443,0.6291706639245539,1.0,5/12,5.63%,CLDN5;PDE2A;PTPRJ;CEACAM1;RAMP2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5917899461356673,1.3154100377944167,0.20068027210884354,0.6292565246556456,1.0,4/19,3.91%,KDR;VCAM1;PTPRJ;SELP
prerank,neural crest cell migration (GO:0001755),0.515425820037156,1.3153327415735931,0.14037854889589904,0.6283957670070467,1.0,4/36,1.68%,SEMA6A;TBX1;SEMA5B;SEMA7A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5397624806113143,-1.3153180663291977,0.16590909090909092,0.5582394969982524,1.0,7/15,9.73%,UST;DSE;DCN;BGN;CSPG4;VCAN;DSEL
prerank,protein dephosphorylation (GO:0006470),0.4253838894556505,1.3144388281982562,0.07914572864321608,0.6300577374450158,1.0,24/135,8.37%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRM;PTPN12;PPP2R5A;PPP3CA;PTPRJ;PPM1F;MTM1;NCK1;SSH2;PPP1R12A;PTPRK;PPP2R2C;PPM1L;PPP3CB;MTMR6;DUSP22;PPM1D;DUSP16;PPP2R5E;PPP2R5B
prerank,sensory perception of sound (GO:0007605),-0.3728345133199665,-1.3139221295940384,0.072,0.5603164356102452,1.0,18/88,8.33%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;ADGRV1;COL11A1;EML2;DCDC2;KIT;CACNA1D;GRM7;GSDME;ATP6V0A4;PCDH15;WHRN;ALDH7A1;RIPOR2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6524224820405214,1.313451363796494,0.1834862385321101,0.6319707709845409,1.0,2/11,2.36%,CAV1;NEDD4L
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5989131260968747,1.313251090787013,0.19400352733686066,0.631463259507768,1.0,6/15,22.83%,ERN1;TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,neutrophil degranulation (GO:0043312),0.391976147932246,1.312670027888696,0.022988505747126436,0.6321294509144639,1.0,79/425,15.53%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,calcium ion import (GO:0070509),-0.46603544772218497,-1.3121137535051866,0.0987012987012987,0.5635523605718445,1.0,9/28,11.30%,CACNA1C;CACNA1D;SLC8A1;MCU;CACNB2;CACNA1G;ATP2A2;TRPC4;MICU1
prerank,neuronal action potential (GO:0019228),-0.4903830575002657,-1.3109075690972576,0.10772833723653395,0.5651609056930205,1.0,12/22,27.57%,SCN7A;ANK3;CACNA1G;KCNMB2;GPER1;SCN1A;SCN8A;SCN2A;SCN5A;KCNA2;SCN9A;CACNA1H
prerank,regulation of postsynapse organization (GO:0099175),0.5417415190434887,1.3107365205933932,0.1435483870967742,0.6370185136941809,1.0,4/28,6.10%,SHANK3;ABI3;PPFIA2;WNT5A
prerank,regulation of protein binding (GO:0043393),0.43992683362260204,1.3106475530030246,0.07964601769911504,0.6361897016855079,1.0,25/114,9.03%,CAV1;APP;EPB41;CLDN5;B2M;PDGFB;HIP1R;BTBD1;STK3;FKBP1A;TMBIM6;STK4;MARK3;RALB;DISC1;DTX3L;MAPK8;TCF7L2;AURKA;RAPGEF2;TRIB3;CTNNBIP1;PSEN1;CRK;ZFPM1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4611103598483327,-1.3104486192819746,0.1402116402116402,0.5643840672963443,1.0,3/27,6.12%,LPAR1;GRM1;AGTR1
prerank,endoderm formation (GO:0001706),-0.4477229906557261,-1.3102049989534543,0.10495626822157435,0.5631206298154822,1.0,10/35,9.38%,COL8A1;COL12A1;VTN;COL11A1;ITGB5;COL6A1;MMP14;ITGAV;MMP2;INHBA
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4850585810067627,-1.3092792561473063,0.12709832134292565,0.563895041835109,1.0,9/21,12.17%,BMP6;BMPR1A;TGFBR1;BMP4;CCN3;DAB2;SLC2A10;TGFB3;NUP93
prerank,myofibril assembly (GO:0030239),0.5100867187872657,1.30919533054189,0.12138728323699421,0.6395088605708256,1.0,3/42,3.98%,PGM5;FLII;TMOD3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5385038172791671,-1.3091420183570386,0.15690866510538642,0.5623635611574636,1.0,10/16,8.40%,IGF1;BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;AKAP6;RBPJ;GLI1
prerank,positive regulation of histone deacetylation (GO:0031065),0.6366994953399024,1.3088249790493462,0.20205479452054795,0.6396118783360519,1.0,4/12,10.44%,PRKD1;PRKD2;CTBP1;APLNR
prerank,neutrophil activation involved in immune response (GO:0002283),0.3906373668528182,1.3085944709474917,0.025052192066805846,0.6391490207231246,1.0,79/428,15.53%,PTPRB;CTSC;RAB27A;PECAM1;LRG1;ATP8A1;CD93;B2M;PRCP;OSTF1;IQGAP1;ADAM10;STK10;ATP11B;PTPRJ;STOM;TNFRSF1B;ADGRG3;BST1;RAP1B;ADGRE5;FUCA2;CAT;ENPP4;LCN2;SDCBP;MCEMP1;CEACAM1;QSOX1;TSPAN14;SCAMP1;PTX3;NRAS;RAC1;PPBP;RAP1A;ATP6V0A1;PSMA2;NFKB1;ARMC8;DYNLL1;ATP11A;DYNC1LI1;PSEN1;GDI2;SNAP23;VAMP8;ANO6;SPTAN1;CPPED1;PGM2;GMFG;DEGS1;CYFIP1;ACTR2;APEH;PA2G4;GSTP1;STXBP3;DBNL;HSP90AB1;ACTR10;IMPDH1;PFKL;ERP44;AOC1;RAB31;RAB7A;RAB5B;ASAH1;RAB18;S100A9;HMOX2;SVIP;DGAT1;GGH;RAB6A;CEP290;APAF1
prerank,negative regulation of anoikis (GO:2000811),0.6141062002408219,1.3085360068528484,0.18525179856115107,0.6382462473616252,1.0,4/14,7.99%,CAV1;NOTCH1;PTK2;ITGA5
prerank,regulation of bone mineralization (GO:0030500),-0.40375184235428857,-1.3077159835814707,0.10069444444444445,0.5643741548466631,1.0,17/55,7.75%,BMP6;BMPR1A;PTN;WNT4;BMP7;ENPP1;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2;BMP2K;CCN1;NOTUM;BCOR;ECM1
prerank,negative regulation of developmental process (GO:0051093),0.4641674539554253,1.3076794230708426,0.12338593974175036,0.6399856460904139,1.0,16/69,11.75%,NOS3;TBX1;CDK6;ARHGEF15;NOTCH1;KLF7;SOX9;DLL1;GREM1;WNT9B;TGFB1;NFIB;GAS6;BNIP3;RC3H1;SINHCAF
prerank,negative regulation of cell growth (GO:0030308),0.43041142114400854,1.3075300078877843,0.0980891719745223,0.6393604299163982,1.0,19/121,7.33%,BMPR2;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;NPR1;PTPRJ;SOX17;DIP2B;PPP1R9B;VGLL4;ULK1;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1
prerank,negative regulation of DNA binding (GO:0043392),0.537780962485112,1.3073197696066627,0.15522875816993464,0.6389893754407026,1.0,4/28,10.60%,LEF1;NFKBIA;MAD2L2;TFAP4
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5391185510701275,1.3057969215348038,0.16775244299674266,0.6424114703472602,1.0,2/28,1.06%,SHANK3;APP
prerank,positive regulation of exocytosis (GO:0045921),0.5185364082442974,1.3056713738437498,0.1518987341772152,0.6416902328159211,1.0,4/35,4.85%,RAB27A;CADPS2;EXPH5;SDCBP
prerank,cardiac atrium morphogenesis (GO:0003209),0.6096037989896176,1.30555528013958,0.1702127659574468,0.6409159278345401,1.0,5/16,9.03%,BMPR2;ENG;NOTCH1;DLL4;ZFPM1
prerank,positive regulation of cell differentiation (GO:0045597),0.40488113343728177,1.305452139984174,0.05133928571428571,0.6401621315483624,1.0,48/237,10.36%,PRKCH;LEF1;ZHX3;BMPR2;KDR;IL6ST;PPARD;MEF2C;ZBTB16;ACVRL1;PRKD1;KITLG;IL6R;ARHGEF2;LRP5;WWTR1;PLCB1;CD34;SOX9;CDH2;RPS6KA3;SLC6A6;SDCBP;RPS6KA1;XBP1;CEACAM1;ACVR2A;CTNNA1;TCF4;RAPGEF2;ACVR1;TGFB1;RAP1A;BRINP2;TCF3;BNIP2;NFKB1;CTNNBIP1;CDH15;LPL;NEUROD1;CREB1;TCF15;CSF1;SPAG9;MAPK11;SFRP2;CCDC71L
prerank,nucleosome assembly (GO:0006334),0.5311837643208188,1.3049924841343183,0.1375579598145286,0.6404443575657811,1.0,11/31,16.51%,SOX9;PADI4;H3-3A;KAT6B;SMARCA5;HAT1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B
prerank,negative regulation of programmed cell death (GO:0043069),0.39448517748954737,1.304476277036645,0.024261603375527425,0.6409252009722022,1.0,78/355,14.50%,MECOM;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NFKBIA;FLT4;AMIGO2;PAK2;BABAM2;CAT;SOX9;RPS6KA3;TMBIM6;IKBKB;RPS6KA1;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;WNT5A;DNAJA1;AVEN;TIGAR;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;MALT1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;CBL;IL7;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;MET;PTMA;IGF1R;RAB7A;HIGD1A;NPM1;TRAF6;PROC;ERC1;TOPORS
prerank,cellular response to light stimulus (GO:0071482),0.46326753579361357,1.3044525690185578,0.12129760225669958,0.639911933647751,1.0,20/66,19.01%,POLK;GNB1;CNGB1;PTPRK;N4BP1;OPN4;GNAT1;NEDD4;RHBDD1;OPN5;EIF2AK4;ERCC4;PDE6B;FMR1;NPM1;YY1;BMF;KDM1A;BAK1;DHX36
prerank,oogenesis (GO:0048477),0.6118673517929292,1.3038236364520537,0.19301470588235295,0.6408324732137081,1.0,4/15,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,axon guidance (GO:0007411),0.4068927651449291,1.3033013084645877,0.07398843930635839,0.641425473066192,1.0,39/201,10.82%,NRP2;SHANK3;SEMA6A;RPS6KA5;PLXNA4;NTN1;SEMA5B;EPHB4;SPTBN1;PTPRM;SEMA7A;PLCG1;EFNA1;NOTCH1;PLXND1;KLF7;BSG;FYN;LAMA3;ROBO4;EVL;LAMA1;SEMA6B;RET;OPHN1;WNT5A;RAC1;PTK2;GRB7;GAB1;SEMA6D;FEZ2;DSCAM;NFIB;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3897754383682328,1.3031215557943814,0.025559105431309903,0.6409102809536172,1.0,74/390,9.65%,NRP2;TEK;FOXO1;PTPRG;FLT1;KDR;TIE1;EPHB4;ANKS1A;PRKD1;INSR;PDGFB;NEDD9;VEGFC;DOCK1;ELMO1;WASF2;SOCS2;LYN;PRKD2;STAT3;EFNA1;PDGFD;PTK2B;DDIT4;YES1;PTPRJ;MPZL1;MTSS1;FYN;PIK3C2A;NCK1;PLCB1;PXN;SRMS;FLT4;CAV2;PAK2;FGF23;SH2B2;SORBS1;KALRN;LMTK2;GRB14;ARPC3;SDCBP;AP2B1;NCKAP1;VEGFD;GHR;RET;ARPC1B;HNRNPF;RAPGEF2;GTF2F2;RAC1;BCAR3;PDGFC;LCK;PTK2;RASA1;AP2A1;GRB7;ATP6V0A1;GAB1;SHOC2;PSEN1;AKT2;ARHGEF7;CRK;ATP6V1G2;CEP57;CSF1;MAPKAPK3
prerank,positive regulation of programmed cell death (GO:0043068),0.4009322745391354,1.3027928852925814,0.05333333333333334,0.6408385547337053,1.0,54/272,12.71%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,aortic valve morphogenesis (GO:0003180),0.5264695416822888,1.3020909972931336,0.16246056782334384,0.6418625056785172,1.0,9/30,7.33%,NOS3;TIE1;NFATC1;EFNA1;NOTCH1;ELN;SOX9;DLL4;TGFB1
prerank,regulation of cell differentiation (GO:0045595),-0.34536344065272484,-1.3020597167174837,0.05405405405405406,0.5786903236427734,1.0,30/148,11.46%,PHLDB2;SMOC1;FGFR2;EPHA3;ZFHX3;DDX5;PRKCB;TRPS1;CCN2;PHLDB1;TGFBR1;DAG1;RUNX2;AR;IGF2;YWHAG;NF1;NGF;SIX1;DDX17;NLGN1;ST7;PRKACA;BCL6;RUNX1;BIN1;ALK;NREP;FLOT2;CAMK1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.573777950529234,1.30165541488864,0.1783876500857633,0.6420711931908933,1.0,3/20,2.79%,EPAS1;DCUN1D3;HIF1A
prerank,regulation of chromatin binding (GO:0035561),0.6562507638108506,1.3014626967160163,0.18625678119349007,0.6415601215281963,1.0,8/10,29.96%,HMBOX1;DTX3L;CDT1;PARP9;MED25;GMNN;DDX11;BTAF1
prerank,response to progesterone (GO:0032570),0.5644067315617123,1.300921073144963,0.18530884808013356,0.6422600645930122,1.0,5/18,11.54%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5415491781079185,1.3008042708124326,0.1583198707592892,0.6415698978443732,1.0,8/26,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,cellular response to interferon-beta (GO:0035458),0.5996982828793322,1.3003615684480927,0.19525547445255476,0.6418406609368625,1.0,6/14,17.70%,AIM2;UBE2K;IRGM;PNPT1;CDC34;STAT1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4772990103885021,-1.2997201299641168,0.13947990543735225,0.5833322100351838,1.0,7/21,9.22%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;ADAMTS1;MMP2
prerank,regulation of interleukin-10 production (GO:0032653),0.5056561440067868,1.2995297638460308,0.14984709480122324,0.6433836781140048,1.0,7/44,9.61%,STAT3;CD34;PLCG2;DLL1;JAK3;TIGIT;IL23A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5968964645678906,1.2990354992880844,0.17989417989417988,0.6438493058170621,1.0,6/15,13.14%,TENT4A;TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,error-prone translesion synthesis (GO:0042276),0.5612958811231814,1.298860987017061,0.15824915824915825,0.6433072910063934,1.0,4/21,10.15%,POLK;RPA1;PRIMPOL;MAD2L2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6004307564742506,1.2988070299721892,0.18938053097345134,0.6423917022369132,1.0,2/15,2.58%,NLRC5;SAMHD1
prerank,glycogen catabolic process (GO:0005980),-0.5152375156206378,-1.298551682185649,0.15827338129496402,0.5848250959416131,1.0,7/15,20.81%,PYGB;PHKB;PYGM;GAA;AGL;PHKA2;PHKG1
prerank,negative regulation of ossification (GO:0030279),0.5530897554351416,1.2979838184574712,0.17495987158908508,0.6438889448950559,1.0,8/23,7.03%,MEF2C;PTK2B;NOTCH1;FGF23;SOX9;GREM1;SOST;SRGN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.43121855962034755,1.2979533160647807,0.09363295880149813,0.6429269131838264,1.0,20/117,11.15%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;PLA2G2D;CREB1;INSL3;FCGR1A;MC4R;MC1R
prerank,ureteric bud morphogenesis (GO:0060675),-0.5331916622495645,-1.2978026946961867,0.17266187050359713,0.5848971911385733,1.0,7/16,15.88%,BMP4;FGF2;SALL1;SIX1;NPNT;WNT11;PAX8
prerank,positive regulation of organelle assembly (GO:1902117),0.48777238269849965,1.2977651906038925,0.14684287812041116,0.6424366622203802,1.0,11/44,11.14%,LCP1;CNOT6;CNOT6L;RALB;SDCBP;CCDC88A;SH3GLB1;G3BP1;CNOT1;FSCN1;CNOT2
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5089628510047376,-1.297435894803946,0.15839243498817968,0.5840718094904399,1.0,6/18,9.97%,PDPN;SMAD3;EFEMP2;RUNX1;RGCC;DDR2
prerank,positive regulation of lipid transport (GO:0032370),-0.5519182940485299,-1.2971661738924276,0.1735357917570499,0.5829589405949741,1.0,3/12,9.84%,LRP1;SPP1;APOE
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5615570761809047,1.2969168747005062,0.19095477386934673,0.6439385524524582,1.0,3/21,3.70%,PPP1R16B;MFHAS1;FKBP1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.607448232954862,1.2966878789610787,0.21052631578947367,0.6435551118556783,1.0,3/14,6.10%,ADAM10;PTK2B;WNT5A
prerank,positive regulation of signal transduction (GO:0009967),0.4008056155025895,1.296566606608735,0.05221339387060159,0.6429199735660323,1.0,40/238,9.08%,VWF;SHANK3;TEK;NOS3;IL6ST;ERN1;MAML2;EPN2;LIMS2;DAB2IP;HHEX;PRKD2;JCAD;FAS;STAT3;PTK2B;NOTCH1;HIF1A;TSPAN5;TPD52L1;CAV2;SORBS1;DLL1;KLF2;F7;DISC1;XBP1;SPIN1;DLL4;TSPAN14;UCHL5;SASH1;AGPAT1;ITGA5;PKD2;CRADD;DEPDC1B;IL7R;ZRANB1;IHH
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42460753453784955,1.2958919144119088,0.09147095179233622,0.6439103668660615,1.0,34/140,12.57%,CHN2;ARHGAP31;TGM2;NET1;MCF2L;ARHGEF3;ARAP3;CD2AP;RASGRF2;ARHGEF2;BCR;SRGAP3;SRGAP2;SRGAP1;PLEKHG5;RHOJ;KALRN;ARHGAP8;PREX1;ARHGAP17;OPHN1;RAC1;DEPDC1B;ARHGEF7;ARHGEF26;ARHGAP28;OCRL;CYRIB;ARAP2;ARHGAP23;RHOB;TRIO;GNA13;ARHGEF9
prerank,positive regulation of histone acetylation (GO:0035066),0.5564303471037854,1.2958757408161605,0.18284789644012944,0.642919967960972,1.0,6/23,16.33%,RPS6KA5;ARRB1;GLYR1;MUC1;RPS6KA4;PIH1D1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3801653096178807,1.2954442585232941,0.002002002002002002,0.6431845247296113,1.0,185/1082,12.41%,MECOM;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;EPAS1;CD38;PBX1;BMPR2;LDB2;ENG;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;MEF2C;ZBTB16;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;SMAD1;ZIC3;NFATC1;PDGFB;NLRC5;IRF2;GATA2;DAB2IP;ELF2;MLLT3;FZD4;EDN1;HHEX;ARHGEF2;LRP5;TAL1;PRKD2;STAT3;NR3C1;PPP3CA;NOTCH1;HIF1A;KLF7;RREB1;AFAP1L2;NFKBIA;CCNK;KDM3A;SOX17;NCK1;WWTR1;PLCB1;SOX18;TCF12;PPP1R12A;FOSL2;MAFF;SOX9;MRTFA;NCOA1;DLL1;RPS6KA3;KLF2;FOXF1;SS18;ELK4;IKBKB;RPS6KA1;DTX3L;FOXL2;XBP1;TET3;EPC1;KMT2E;SMAD7;ACVR2A;SPIN1;GREM1;FOXF2;SBNO2;ARID1B;HOXA10;RET;MTF2;LPIN3;TCF7L2;TCF4;TEAD2;PITX3;PPP3CB;ESRRG;CHP2;WNT5A;CNBP;SKAP1;ATF7IP;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FOXA3;FOSL1;IRF2BPL;SOST;CD40;INPP5K;HNF1B;DYRK1A;ETS2;JUNB;LYL1;ARRB1;RBM14;TNFRSF1A;TGFB1;HOXD8;BCL3;TCF3;AGRN;HNRNPD;NFKB1;PCBD2;ARID1A;PKD2;NEUROD1;CITED1;NRL;RPTOR;KAT6B;SMARCA5;PSEN1;CREB1;FOXK1;ZFPM1;BRD4;PCGF5;IER2;TCF15;SOX4;IKBKG;MAP2K3;MAFB;RNF4;EDRF1;NFIB;CREB3L4;NRIP1;MAD2L2;SMAD5;SFRP2;USF2;TNIP1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;MC1R;MMS19;GLMP;ZMIZ1;ENY2;ATF6;SP3;GRIN1;PICALM;RIPK1;PRDM2;ACTR2;RPRD1B;ASXL1;RELA;RIPK2;MAX;TET2
prerank,T cell activation (GO:0042110),0.45870428233788857,1.2953335833125728,0.11261872455902307,0.6424549566891773,1.0,16/69,10.70%,LFNG;LCP1;CTPS1;PPP3CA;MSN;NCK1;CHD7;CASP8;FKBP1A;DLL4;PPP3CB;LCK;PIK3CG;SOX4;ICOSLG;JAG2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6135454063899589,1.2953161761413887,0.20212765957446807,0.6414922138954438,1.0,6/14,12.36%,PRKD2;NECTIN2;TESPA1;LCK;IKBKG;RELA
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.48721919298311234,1.2946861912847496,0.15022091310751104,0.6423559172463381,1.0,9/45,12.18%,VCAM1;ICAM1;B2M;IRF2;TRIM68;JAK1;TRIM25;FCGR1A;OASL
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6339844768989576,1.2933480866668194,0.2140077821011673,0.645493161685463,1.0,4/12,3.19%,PRKG1;MEF2C;PDGFB;DOCK4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5140521845474572,1.2930353947806785,0.15384615384615385,0.6454507912261482,1.0,14/32,15.76%,OCLN;WASF2;RREB1;NCKAP1;ENPP2;RAC1;ARHGEF7;TWF2;FSCN1;CYFIP1;CORO1C;ACTR2;ACTR3;ARPC2
prerank,positive regulation of signaling (GO:0023056),-0.4282668423392251,-1.2930043548783208,0.1225071225071225,0.5929103609276035,1.0,10/37,15.20%,WLS;CLSTN2;DLG4;SYT1;ANXA2;PTPN23;RAB29;GRIK2;SNCA;RIMS1
prerank,negative regulation of binding (GO:0051100),0.4490231465284421,1.2929244664193837,0.11819389110225764,0.644740406092667,1.0,18/81,15.04%,LEF1;CAV1;PDGFB;NFKBIA;TMBIM6;RALB;DISC1;MAPK8;AURKA;CTNNBIP1;ZFPM1;ARHGAP28;TFAP4;CARD16;RACK1;PEX14;ILRUN;STYX
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5236284819535968,1.292881091807362,0.1693548387096774,0.6438613032003354,1.0,10/33,12.17%,ACER2;NEXMIF;LYN;EFNA1;RET;PIK3CG;PTK2;SFRP2;P2RY12;MUC1
prerank,positive regulation of ossification (GO:0045778),-0.42684466371502927,-1.2923442011744382,0.1299093655589124,0.5929638214960777,1.0,11/39,4.62%,BMP6;BMPR1A;PTN;WNT4;BMP7;ADGRV1;OSR1;BMP4;GPM6B;SLC8A1;FBN2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5833776678881871,-1.2922594289495846,0.1925601750547046,0.5912704672449519,1.0,4/10,13.12%,ATP1A2;ADRA2A;BIN1;VDAC1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5470784558241752,1.2922179789831918,0.15993537964458804,0.6447446987095964,1.0,9/27,18.42%,CTPS1;GSR;AK4;DCTD;DUT;RRM2B;CMPK1;TXNRD1;GLRX
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4628940427130864,1.2921340640889714,0.1357142857142857,0.6439595403290163,1.0,29/72,19.72%,LIFR;CASP8;TRAF1;SIGIRR;SPPL2A;IKBKB;HIPK1;IFNAR2;JAK1;TNFRSF1A;AGPAT1;PTPN1;IKBKG;GAS6;IL7;CBFB;RIPK1;RACK1;BIRC3;HSP90AB1;IRAK3;OTULIN;BIRC2;IRAK2;STAT1;IFNGR1;CDC37;MADD;TAX1BP1
prerank,ribosomal large subunit assembly (GO:0000027),0.5416872687033679,1.292069701058515,0.18107667210440456,0.6431196057526283,1.0,9/24,20.42%,RSL24D1;RRS1;NOP53;RPL6;RPL10;FASTKD2;RPL11;RPL3;TRAF7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4556023856069952,1.2919186233578748,0.1307277628032345,0.6425380597451482,1.0,13/73,8.28%,ACER2;NOD1;TNFSF10;HIP1;HIP1R;FAS;CASP4;CASP8;BOK;CYCS;LCK;CASP1;CRADD
prerank,peptidyl-serine modification (GO:0018209),0.41692696608680285,1.2915953561149645,0.08778173190984578,0.6424068185213803,1.0,38/166,13.03%,PRKCH;RPS6KA5;PRKD1;PDGFB;PRKD2;PKN3;PKN2;PAK2;PKN1;RPS6KA3;STK4;LMTK2;MARK3;IKBKB;RPS6KA1;HIPK1;MAPK8;PLK2;MAST2;ULK1;AURKA;DYRK1A;SGK3;AKT2;NEK6;CDK2;RICTOR;MAPKAPK3;PARP2;GAS6;AKT3;MAP3K13;STK38;MKNK2;NAA11;TGFBR2;TOP1;UHMK1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5791996778309596,1.2915809168901249,0.15862068965517243,0.6414190928934409,1.0,4/18,5.74%,ELOVL7;ACSL4;ELOVL5;ACSL5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4288465631296754,1.2907821965821775,0.0958904109589041,0.6428085896560719,1.0,14/116,5.63%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2
prerank,cellular response to cAMP (GO:0071320),0.5342185054771335,1.2903313163333658,0.1747269890795632,0.6431088139732121,1.0,8/30,8.09%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5991535944805666,1.2902781286760032,0.1875,0.6422231392951192,1.0,8/14,14.62%,KDR;VEGFC;FLT4;VEGFD;GAB1;MYO1C;NUS1;PGF
prerank,maturation of SSU-rRNA (GO:0030490),0.5163537006817702,1.289676407203625,0.17363344051446947,0.6430482241571284,1.0,18/34,26.03%,RPS19;RPS14;RPS16;RPS8;HELB;UTP4;NOL10;RIOK1;SRFBP1;UTP6;HEATR1;NOP14;RIOK2;RPS28;NGDN;RIOK3;MRPS11;WDR46
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5218563249167908,1.2889925366113262,0.17329093799682035,0.6440620238100774,1.0,10/32,17.07%,CDK17;POLA1;CDT1;BRD4;BACH1;CDK18;RB1;ESRRB;E2F7;KLF11
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5425200450189384,1.2889095857846558,0.17932148626817448,0.6432737159771206,1.0,9/26,20.57%,OCLN;RAC1;TRPV4;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4172776477256972,-1.288466502302346,0.12012987012987013,0.6005333988948595,1.0,15/40,21.75%,EGFR;TIMP3;SNRNP70;TIMP2;SIRT2;MDM4;CST3;RGP1;AZIN1;SNCA;PTPN3;CDK5RAP3;AGAP2;CYP51A1;BANP
prerank,regulation of fibrinolysis (GO:0051917),-0.5628831619337016,-1.2880823838492967,0.1630901287553648,0.5997028122138539,1.0,3/13,10.33%,THBS1;FAP;SERPINE1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5582895157111134,1.2879635687241402,0.16695957820738136,0.6451032303978977,1.0,6/20,13.78%,ENTPD1;APP;CASP1;ANO6;HSP90AB1;TXNIP
prerank,regulation of apoptotic process (GO:0042981),0.38051877417682956,1.2879419970485526,0.012244897959183673,0.6441584615582009,1.0,131/676,12.98%,LEF1;TEK;TJP1;FOXO1;CD38;ACER2;TNFSF10;UNC13B;TGM2;NET1;KDR;IL6ST;DCUN1D3;ITGA6;MEF2C;PPP1R13B;MCF2L;DAPK1;ARHGEF3;RASGRF2;RNF144B;HIP1;HIP1R;DAB2IP;ARHGEF2;SOCS2;PIM3;ADAM10;FAS;ANP32A;PTK2B;NFKBIA;GLS2;ACTN4;STK3;CASP8;JMY;FLT4;PAK2;BABAM2;CAT;SOX9;TNFRSF25;PLEKHG5;ACTN1;RPS6KA3;TMBIM6;KALRN;STK4;JAK3;IKBKB;RPS6KA1;PREX1;FOXL2;XBP1;GREM1;MAPK8;SERPINB9;PLK2;XIAP;BOK;WNT5A;TOX3;CTNNBL1;STK26;DNAJA1;BCL2L11;AVEN;SPDEF;HNRNPK;PTK2;RASA1;BCL3;BNIP2;STPG1;NFKB1;MALT1;NEUROD1;CASP1;CRADD;NF2;CITED1;RBM25;PSEN1;AKT2;TRIM24;ARHGEF7;MAP3K11;SLK;ARHGEF26;RHBDD1;SOX4;TNFRSF8;BCL2L1;HIGD2A;SIAH1;SFRP2;EGR3;SEMA4D;ANO6;TFAP4;GAS6;APH1A;BNIP3;CBL;IL7;ATF6;RNPS1;PIM1;THOC6;RIPK1;TMBIM4;TMIGD1;BID;NOP53;RHOB;RELA;TNFAIP8;RIPK2;TRIO;GNA13;PRDX2;ARHGEF9;PA2G4;GSTP1;RPL10;RACK1;BIRC3;PHIP;PTMA;SIGMAR1
prerank,regulation of actin filament polymerization (GO:0030833),0.4616601130696938,1.2877497396073425,0.12805755395683452,0.6436630284304438,1.0,13/69,10.19%,KANK3;ESAM;HIP1R;PTK2B;NCK1;SSH2;EVL;NCKAP1;CDC42EP3;RASA1;ARHGAP28;CYRIB;TWF2
prerank,ceramide catabolic process (GO:0046514),0.6061980875460247,1.2876900316901916,0.19464285714285715,0.6428010581702982,1.0,2/14,5.50%,ACER2;ASAH2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.31366304814216694,-1.2874174129157894,0.025423728813559324,0.5996949541350599,1.0,41/248,8.61%,RNF220;BICC1;RBMS3;ZEB2;EGFR;WLS;LGR4;GLI3;FGFR2;COL1A1;IGFBP2;PRKN;GPC3;PTK7;CTNND2;DKK3;SEMA5A;IGFBP6;DAAM2;DACT1;CAPRIN2;LYPD6;INVS;LRRK1;LZTS2;PLEKHA4;SFRP4;PSME4;TMEM64;LRP6;SIAH2;AXIN2;NOTUM;AMFR;DAB2;LRRK2;GPC5;BTRC;GLI1;TLE2;SFRP1
prerank,cellular response to superoxide (GO:0071451),0.6203121978590598,1.2867439981320008,0.22282608695652173,0.6447072063330749,1.0,1/10,0.31%,NOS3
prerank,regulation of glucose metabolic process (GO:0010906),-0.4279499166436748,-1.2863048267355985,0.12640449438202248,0.6011718426794138,1.0,6/34,4.97%,PRKN;IRS1;PDK1;OGT;RORA;SELENOS
prerank,positive regulation of vascular permeability (GO:0043117),0.6140622940732778,1.2859973199541461,0.20976491862567812,0.6459080727996188,1.0,7/12,9.63%,TJP1;OCLN;TJP2;PDE2A;TGFB1;TRPV4;TJP3
prerank,positive regulation of defense response (GO:0031349),0.440933933109249,1.2857589183979874,0.12827225130890052,0.6456413653836988,1.0,14/89,11.87%,APP;MEF2C;IL15;PDE2A;GBP5;NFKBIZ;NFKBIA;WNT5A;TNFRSF1A;LPL;IL23A;TNIP1;NMI;RIPK1
prerank,negative regulation of neuron projection development (GO:0010977),-0.39190716112346347,-1.2853437668341765,0.0924092409240924,0.6019536560780433,1.0,17/56,16.85%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;NLGN1;SEMA3A;DCC;RAB29;APOE;NGEF;RTN4;CBFA2T2;STX1B;MT3;TSKU
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5118501242566184,1.2848515218522742,0.16352201257861634,0.6474292001113058,1.0,10/32,17.28%,MCTP1;MEF2C;KCNMB4;SNCAIP;PNKD;MCTP2;RAB5A;FMR1;RIMS4;CPLX2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5298120047644146,-1.284826622330055,0.15536105032822758,0.5996347950795862,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5298120047644146,-1.284826622330055,0.15536105032822758,0.5996347950795862,1.0,4/16,4.51%,ARHGAP6;PHLDB2;THBS1;APOD
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5104201404799191,-1.2846234451906295,0.16666666666666666,0.5983422779180025,1.0,3/17,4.64%,MAGI2;PDGFRB;ITGA1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5900461267075107,1.2845880120219615,0.18612521150592218,0.6471920746695583,1.0,5/18,4.50%,MTUS1;IL6R;LYN;PTK2B;F7
prerank,regulation of cell development (GO:0060284),0.505530450911771,1.2834743042982641,0.17754172989377845,0.6496031557723597,1.0,6/36,5.39%,FOXO1;HDAC9;ADGRA2;DLL1;RPS19;CX3CR1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5092192310328811,1.2833273327926265,0.17357910906298002,0.649048281141526,1.0,17/36,20.12%,AQP11;SDCBP;N4BP1;EIF3H;UCHL5;OPHN1;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;PRKCG;RPL11;USP7;PSMF1;USP25;TAF9
prerank,smooth muscle contraction (GO:0006939),-0.5422054624981112,-1.2832460759981676,0.18287037037037038,0.6003546608062518,1.0,7/14,16.82%,ROCK2;EDNRA;SLC8A1;BDKRB2;ACTA2;ADRA1A;MYH11
prerank,defense response to symbiont (GO:0140546),0.4406247492498697,1.2831423965948259,0.10533159947984395,0.6485701130156725,1.0,29/92,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,keratan sulfate metabolic process (GO:0042339),0.5130433855246748,1.2830210694382491,0.16908212560386474,0.6479404222129075,1.0,8/31,10.18%,ST3GAL6;ST3GAL1;B3GNT3;B4GALT4;B3GNT4;B4GALT5;B4GAT1;SLC35D2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6201197321104469,1.2829966946047235,0.20428015564202334,0.6470087707100337,1.0,5/12,16.24%,INSR;BNIP3;IGF1R;FYCO1;IRGM
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5017480863155759,1.28286272592554,0.15644171779141106,0.646391539429098,1.0,5/39,9.89%,MYRIP;ACSL4;TCF7L2;SOX4;UCN
prerank,regulation of fat cell differentiation (GO:0045598),0.4495093911535826,1.2828321194079948,0.1539528432732316,0.6454780986877614,1.0,18/74,12.67%,FOXO1;PPARD;ZBTB16;GATA2;LRP5;WWTR1;XBP1;WNT5A;TRIB3;TGFB1;LPL;CREB1;ZFPM1;SFRP2;CCDC71L;ASXL1;TRIO;ZFP36
prerank,regulation of cell population proliferation (GO:0042127),0.37964745852364223,1.2826990743054663,0.02129817444219067,0.6448893799288721,1.0,109/691,10.70%,LEF1;TJP1;TBC1D8;NOS3;FLT1;ACER2;PTPN14;BMPR2;KDR;IL6ST;ENG;TBX1;LIFR;SMARCA2;APP;CBFA2T3;IL15;STX3;SOX7;ACVRL1;CLDN5;CD200;CDK6;INSR;KITLG;PLPP1;PDGFB;VEGFC;SH3BP4;ADARB1;IL6R;DAB2IP;EDN1;HHEX;ARHGEF2;LRP5;LYN;OSMR;ADAM10;STAT3;PDGFD;TNFRSF11A;PTK2B;NOTCH1;CNOT6;PTPRJ;BST1;AQP11;WWTR1;CNOT6L;ELN;FLT4;ADGRG1;FGF23;SOX9;TES;DLL1;PPP1R9B;SDCBP;XBP1;VEGFD;GNAI2;BTG3;PTPRK;GREM1;DLL4;XIAP;TCF7L2;BOK;CCDC88A;DUSP22;CHP2;CNBP;RAPGEF2;KLF10;FOSL1;KRAS;CDKN1B;JUNB;PDGFC;PPM1D;TGFB1;PTK2;TGFA;PKD2;KDM4C;RNF139;NF2;CTBP1;SGK3;AKT2;IL7R;PINX1;RPL23;CDK2;SOX4;CSF1;SST;TNFRSF8;BTG2;TNFRSF9;DHPS;CYP27B1;SFRP2;CCL14;NUAK1;TFAP4;NMI;JAG2
prerank,eye development (GO:0001654),-0.39278454683095143,-1.2826863757379587,0.08540925266903915,0.6001016984738498,1.0,14/54,11.96%,CACNA1C;FBN1;SMOC1;COL5A1;EFEMP1;MEIS1;RBP4;SH3PXD2B;FBN2;HIPK2;PBX4;PBX3;TGFB2;STRA6
prerank,regulation of cholesterol efflux (GO:0010874),0.5158514531812165,1.2826156903369663,0.18078175895765472,0.6441247966161253,1.0,5/30,5.76%,CAV1;PLTP;NFKBIA;EEPD1;ABCA3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.33819995886061915,-1.282160428453854,0.04216867469879518,0.5997377848119597,1.0,29/142,13.08%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;EDNRA;DLG4;ADRA1B;CCR9;SLC8A1;SLC35G1;CD55;SMAD3;TRPC3;AGTR1;PRKACA;TRPC6;TRPC1;BDKRB2;PTGDR;RYR2;PTGFR;TRPC4;TBXA2R;S1PR3;ADRA1A;TRPC5;GPER1
prerank,heterocycle biosynthetic process (GO:0018130),0.5934981000369743,1.282020329602384,0.1912568306010929,0.6448897936354144,1.0,3/14,9.92%,GCH1;GPHN;MOCOS
prerank,ion transport (GO:0006811),-0.34492675159462394,-1.2819982149420694,0.05504587155963303,0.5983347166901108,1.0,22/111,11.28%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC8A3;SLC26A7;SLC12A2;SLC9A9;SLC26A2;SLC8A1;WNK4;GLRB;ANO1;TRPC6;SLC1A2;SLC5A5;SLC20A1;SLC24A2;WNK1;SLC4A2;GABRB1;SLC9A1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.44276002113919194,1.2817406882299605,0.12043301759133965,0.6447458824862499,1.0,25/80,21.01%,DCUN1D3;CAV1;FBXW7;FKBP1A;SMAD7;XIAP;MYCBP2;TRIB3;MALT1;UBE3A;RIPK2;PRICKLE1;BIRC3;TRAF6;TOPORS;NDFIP2;BIRC2;CUL3;KDM1A;PTTG1IP;BCL10;PDCD6;UBE2L3;PLK1;PEF1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.43212970753922497,1.2812971919055236,0.11439588688946016,0.6450783160135065,1.0,19/108,8.28%,ACER2;NOD1;TNFSF10;SOX7;DAPK1;HIP1;HIP1R;FAS;CASP4;PPM1F;CASP8;FOXL2;BOK;CYCS;LCK;GRAMD4;MALT1;CASP1;CRADD
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.503248892556338,1.2807847675433246,0.1674491392801252,0.6456890646829213,1.0,6/35,5.28%,FLT1;CAV1;MEF2C;PTPRM;CAV2;DLL4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.41262680202242785,-1.2807632170593723,0.11014492753623188,0.5998972844304352,1.0,15/41,19.06%,ANK2;ACTN2;KCNMA1;ANK3;AKAP6;KCNMB2;KCNJ2;GABBR1;KCNJ10;KCNN2;GNG2;KCNJ15;KCNJ6;KCNN3;ACE2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4903906251910211,1.2805779213380688,0.1581259150805271,0.6453618642356781,1.0,10/43,6.28%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;IL6R;LRP5;WWTR1;ACVR2A;ACVR1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.445475756108569,-1.2802913452388534,0.13709677419354838,0.5994316688727506,1.0,13/30,11.64%,DSE;DCN;BGN;CSPG4;NDNF;CHST15;CHSY3;VCAN;ARSB;CHSY1;CHST3;DSEL;HEXA
prerank,positive regulation of MAPK cascade (GO:0043410),0.3951938642833871,1.279947611207691,0.07013574660633484,0.6463096226292496,1.0,39/245,7.53%,TEK;FLT1;KDR;TBX1;APP;PDE8A;ICAM1;INSR;SEMA7A;PDGFB;HTR2A;IQGAP1;DAB2IP;EDN1;PRKD2;JCAD;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;PTPRJ;TPD52L1;TAOK2;FLT4;PLCG2;CAV2;PIK3R6;TIRAP;ARHGAP8;RET;RAPGEF2;CD40;BCAR3;PDGFC;ARRB1;TGFB1;PIK3CG;RAP1A
prerank,positive regulation of dendrite extension (GO:1903861),0.584354612940204,1.2795816970297735,0.19966722129783693,0.6463979610928746,1.0,3/17,2.93%,SMURF1;NEDD4L;ITSN2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4545473954999498,1.2794917483974668,0.13513513513513514,0.6456914191773652,1.0,9/68,8.24%,APP;IL6R;ARHGEF2;STAT3;PLCG2;TIRAP;XBP1;WNT5A;LPL
prerank,carboxylic acid transport (GO:0046942),-0.38545823800353785,-1.2791842410826573,0.11913357400722022,0.6006304636516051,1.0,13/55,11.59%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC6A9;SLC16A11;PSAP;SLC6A15;SLC66A1;SLC7A6;SLC6A7
prerank,negative regulation of axon extension (GO:0030517),0.5108699696976469,1.279180137376062,0.18608414239482202,0.6456434109352727,1.0,5/30,5.55%,SEMA6A;SEMA5B;SEMA7A;DIP2B;SEMA6B
prerank,supramolecular fiber organization (GO:0097435),-0.29778018985826704,-1.2788065663550532,0.013888888888888888,0.5998813676995716,1.0,93/333,14.84%,COL1A2;COL3A1;CGNL1;COL4A5;COL1A1;ADAMTS2;COL8A1;TNXB;COL4A6;GSN;COL5A1;COL12A1;COL22A1;PRKN;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;FAT1;COL6A3;CLIP4;COL11A1;HSPG2;PLOD2;COL6A1;COL8A2;TGFBR1;MYO5A;COL26A1;SERPINH1;COL13A1;COL18A1;FBLN5;COL23A1;PPP1R9A;RHOBTB2;LOXL3;COL27A1;RND3;TPM1;CARMIL1;CYP1B1;DLG1;COL5A3;TMOD2;NF1;CLIP3;LUM;TGFBI;COL16A1;P4HB;LOX;SIAH2;COL14A1;SHROOM3;EFEMP2;MPRIP;RHOBTB3;COL9A2;KIF24;GGA2;APH1B;TUBGCP5;MDM2;KATNAL1;DPT;DDR2;COL20A1;TPM2;COL15A1;MYO1B;ADAMTS14;P4HA1;CST3;DES;TGFB2;MAP7D3;MFAP4;LMOD1;WDR73;B4GALT7;TSPAN15;DBN1;PCM1;TPM4;COL19A1;LAMC2;P3H4;GGA1;P3H1;HOOK2;SNCA
prerank,response to nitric oxide (GO:0071731),0.6050229439843118,1.2787382413515125,0.20363636363636364,0.6459327946275313,1.0,3/13,9.31%,FOXO1;EGLN1;CDK2
prerank,response to retinoic acid (GO:0032526),0.4701044916864161,1.278282432828479,0.14542936288088643,0.6463118434754976,1.0,15/59,12.24%,ACER2;TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;OVCA2;TWF2;ABL2;ASXL1
prerank,regulation of cellular component organization (GO:0051128),0.4211768863802727,1.2777252126774847,0.10776942355889724,0.6469990197734484,1.0,27/135,11.71%,TJP1;NET1;HIP1;HIP1R;DAB2IP;MLLT3;SOCS2;RAP1B;TAOK2;CEACAM1;OPHN1;AURKA;WNT5A;RAPGEF2;CISH;SNCAIP;RAP1A;NEDD4;CAMSAP2;RPTOR;SGK3;PTPN1;MAD2L2;SEMA4D;ABL2;IL17RB;PICALM
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4198606786517635,1.2775148642971885,0.11829268292682926,0.646605690452499,1.0,41/136,19.86%,ESR1;CD200;NLRC5;DAB2IP;FZD6;AIM2;SIK1;ADGRG3;NFKBIA;SIGIRR;TMSB4X;ID1;SMAD7;TCF7L2;EGLN1;ARRB1;CTNNBIP1;PKD2;TAF3;MAD2L2;GAS6;RB1;NFKBIE;PIM1;EIF2AK4;TRIB1;LRRC14;PEX14;IRAK3;DDIT3;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;KDM1A;NLRP3;HAVCR2;TAX1BP1;HES1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6129751011659189,1.277478748446196,0.21189591078066913,0.6457170351513134,1.0,5/11,7.92%,TBX1;LRP5;SOX9;WNT5A;CTNNBIP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4697399848678459,1.276983624517628,0.15083798882681565,0.6462378107891513,1.0,16/54,16.77%,DCUN1D3;CAV1;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1;CTNNB1;RPL11
prerank,vascular transport (GO:0010232),-0.36512327357799,-1.2769785189191538,0.0759493670886076,0.6031387565333864,1.0,19/81,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,melanosome localization (GO:0032400),0.5532838194544691,1.2768208014549371,0.18302828618968386,0.6457559505253533,1.0,3/21,3.64%,RAB27A;RAB11A;SHROOM2
prerank,glycine transport (GO:0015816),0.6439591725338718,1.2761906891310066,0.21453900709219859,0.6467064260866311,1.0,2/10,2.68%,SLC6A5;SLC38A5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5296820862914426,1.2761718854999617,0.175,0.6457710566773569,1.0,9/27,14.48%,ERN1;RNASE1;RNASE4;KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;TRIR
prerank,plasma membrane repair (GO:0001778),0.6190194479507846,1.276150066138006,0.21516754850088182,0.6448714337106967,1.0,2/13,2.11%,MYOF;MYH9
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5097037752559014,1.27592447256801,0.18210862619808307,0.6446420791016971,1.0,7/33,7.47%,HIP1;HIP1R;FBXW7;AFAP1L2;CCDC88A;BCAR3;TGFA
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4768849410915168,1.2757316235481697,0.16395864106351551,0.644261621814467,1.0,5/49,4.28%,NOD1;PRKD2;STAT3;AFAP1L2;TIRAP
prerank,regulation of amyloid-beta formation (GO:1902003),-0.440425665938273,-1.2744467336185759,0.09826589595375723,0.608668471020585,1.0,8/34,9.84%,IGF1;ROCK2;SLC2A13;LRRTM3;NTRK2;RTN1;BIN1;APOE
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.45812288101570803,-1.2742091844390544,0.14736842105263157,0.6074201494956731,1.0,7/24,4.01%,SOX5;ADAMTS12;TRPS1;EFEMP1;TGFBR1;SOX6;WNT9A
prerank,regulation of aerobic respiration (GO:1903715),0.5903943040487353,1.2740069604862803,0.19473684210526315,0.6483837540394101,1.0,4/15,12.25%,CBFA2T3;AK4;ABCD1;NOP53
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4323635427174267,1.2737852164246737,0.12258064516129032,0.6481065311508023,1.0,22/100,9.18%,TEK;FLT1;KDR;PPP1R16B;INSR;PDGFB;PIP5K1B;DAB2IP;LYN;PDGFD;SELP;SOX9;PIK3IP1;IER3;CEACAM1;PDGFC;PIK3CG;PTK2;NEDD4;GAB1;PPP2R5B;FBXL2
prerank,regulation of stress fiber assembly (GO:0051492),-0.3772566551737276,-1.2732422898074196,0.08267716535433071,0.6083877919725686,1.0,26/74,11.29%,ARHGAP6;PHLDB2;LPAR1;CGNL1;ROCK2;PPM1E;TMEFF2;ARHGEF10L;NRP1;CCN2;TGFBR1;ARAP1;ARHGEF10;TPM1;RHPN2;CARMIL1;ALMS1;SFRP1;FHOD1;ASAP3;RGCC;TGFB3;S100A10;PFN2;SLC9A1;ARHGEF18
prerank,regulation of dendrite extension (GO:1903859),0.5800030833223954,1.2729888371598002,0.19430485762144054,0.6494175693847658,1.0,3/18,2.93%,SMURF1;NEDD4L;ITSN2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.593711120468158,1.2728942250558914,0.2082616179001721,0.6487694196962235,1.0,5/15,7.99%,TJP1;SMAD1;DLL1;JAK1;ITGA5
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6291298894799946,1.2713462352439477,0.22262773722627738,0.651474118056463,1.0,2/10,6.96%,CNGB1;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6291298894799946,1.2713462352439477,0.22262773722627738,0.651474118056463,1.0,2/10,6.96%,CNGB1;GNAT1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5888224657806511,1.2711617271780884,0.22661870503597123,0.6510704946653983,1.0,4/14,12.18%,USP15;PUM1;PUM2;OASL
prerank,positive regulation of cell junction assembly (GO:1901890),0.46087167236190213,1.2711282244579154,0.14534883720930233,0.6501964034265565,1.0,6/56,2.97%,TEK;KDR;CAV1;CLDN5;PTPRJ;PPM1F
prerank,mitochondrial fission (GO:0000266),0.5683372356685991,1.2709059789806532,0.21428571428571427,0.6498730439929293,1.0,1/16,0.27%,DNM3
prerank,regulation of synapse assembly (GO:0051963),-0.4100397468295865,-1.270783983822711,0.09667673716012085,0.614046122046719,1.0,15/46,12.92%,GPC6;NLGN2;CLSTN2;CUX2;PTPRD;ROBO2;IL1RAPL1;LRFN5;NRXN1;NLGN1;NLGN3;GPC4;MDGA1;SRPX2;GRID2
prerank,sulfate transport (GO:0008272),-0.5301520092820198,-1.2704022581983903,0.17763157894736842,0.6133616880704076,1.0,3/14,3.03%,SLC13A4;SLC26A7;SLC26A2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4593982914259782,-1.2701810714541382,0.17010309278350516,0.6120725815373518,1.0,12/24,15.22%,DPYSL3;DOCK11;NRP1;RHOQ;ARAP1;TENM2;NLGN1;RIPOR2;TGFB3;PALM;PLPPR5;RALA
prerank,endochondral bone morphogenesis (GO:0060350),0.6305297734582709,1.270163893560874,0.23776223776223776,0.6510909653337154,1.0,2/11,1.15%,BMPR2;MEF2C
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3510938345414724,-1.2697500420470826,0.07339449541284404,0.6115147492539004,1.0,18/107,9.52%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;SLC41A1;SLC30A10;ATP1B1;SLC8A1;DMPK;SLC39A14;SLC39A13;STIM1;ATP2A2;SLC39A10;RYR2;CXCL12;SLC24A2
prerank,vitamin D metabolic process (GO:0042359),0.6036883491265661,1.2693869971077822,0.20255474452554745,0.6524300348478438,1.0,4/13,11.80%,FGF23;CYP27B1;CYP2R1;LGMN
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5770133688692602,1.268929756909785,0.21693121693121692,0.6527935743377508,1.0,4/16,15.10%,DLL1;JAK3;IL23A;VSIR
prerank,protein O-linked glycosylation (GO:0006493),0.429182586292064,1.2684337436564042,0.12402088772845953,0.6533218482960989,1.0,20/96,12.66%,ST6GAL1;TMTC2;ST3GAL1;GALNT18;GALNT14;GALNT15;EOGT;B3GNT3;TET3;B3GNT4;ST6GALNAC2;B4GALT5;B4GAT1;B3GNT6;RXYLT1;ST6GALNAC4;C1GALT1;MUC1;TET2;OGA
prerank,receptor-mediated endocytosis (GO:0006898),0.41948841182726737,1.268326094768562,0.10275689223057644,0.6526651868299211,1.0,15/132,5.63%,DNM3;CALCRL;FNBP1L;CAV1;INSR;HIP1R;SCARB1;STAB1;ARHGAP27;CAV2;FCHO2;DLL1;AP2B1;SCARF1;RAMP2
prerank,regulation of dendritic spine development (GO:0060998),0.5575552005217137,1.2681572982367466,0.20695364238410596,0.6522063600589278,1.0,3/19,3.49%,SHANK3;MEF2C;PPFIA2
prerank,ncRNA transcription (GO:0098781),0.6040843686702291,1.2681108417521887,0.21228070175438596,0.6514263624760871,1.0,7/13,16.50%,CAVIN1;SPIN1;ANG;NIFK;SNAPC3;POLR1G;GTF3C1
prerank,establishment of melanosome localization (GO:0032401),0.5586049702550139,1.2680903969116546,0.20508474576271185,0.650541789407132,1.0,3/19,3.64%,RAB27A;RAB11A;SHROOM2
prerank,positive regulation of myelination (GO:0031643),0.6268008250266933,1.2674258126853513,0.21543985637342908,0.6515206109138109,1.0,3/11,9.47%,PARD3;TNFRSF1B;DICER1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3983460337900736,-1.2673693591906334,0.12804878048780488,0.6166222604280364,1.0,10/46,7.09%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5290968045986154,-1.2668253071496165,0.18316831683168316,0.6164397083718468,1.0,5/14,27.02%,MOXD1;DAGLA;SLC22A2;DAGLB;SLC5A7
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5197960184087514,1.2665510989233695,0.2032,0.6531464216525018,1.0,7/29,9.03%,ENG;S1PR1;NOTCH1;FKBP1A;SMAD7;TGFB1;ZFPM1
prerank,chromatin remodeling (GO:0006338),0.4314926358562546,1.2665202189330556,0.125,0.652279911747607,1.0,31/100,19.41%,ESR1;SMARCA2;BAZ2B;SOX9;KDM6A;PADI4;ARID1B;CECR2;ARID1A;KDM4C;SMARCA5;EZH1;NPM3;SRCAP;SMARCE1;RB1;HNRNPC;TOP1;NPM1;KAT2B;ATRX;JARID2;PIH1D1;ACTR5;KDM5C;BAZ1A;KDM4A;CHRAC1;PAK1;BAHD1;CHD1L
prerank,actin filament organization (GO:0007015),0.410205460682112,1.2665171913900068,0.10827250608272507,0.6513506492062682,1.0,24/151,8.54%,FLII;SHROOM4;LCP1;EPS8;MYO1D;CD2AP;NEDD9;ELMO1;HIP1;HIP1R;ARHGEF2;SHROOM2;SHROOM1;TMOD3;EVL;ACTN1;PLS3;PPP1R9B;ARHGAP17;RAC1;TPM3;TRPV4;RHOBTB1;MYO1E
prerank,regulation of membrane repolarization (GO:0060306),0.6122539954646212,1.2664893570833275,0.2277580071174377,0.650480125179573,1.0,4/13,7.06%,CAV1;NEDD4L;KCNQ1;KCNE2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4024915715589802,1.2663004354891751,0.09272300469483569,0.6501174701651723,1.0,30/198,9.24%,PTPRB;INPP5D;PLCB4;PLA2G4A;PLPP1;PLCG1;GPD2;STAT3;PPP3CA;PFKFB3;PLCB1;PLCG2;PAK2;LIMK2;PPP3CB;ITPKB;PLA2G2D;FBP1;INPP5K;TIGAR;TGFB1;PIK3CG;AGPAT1;CERKL;DUSP23;DUSP16;LPL;PLAAT3;SYNJ1;PANK2
prerank,negative regulation of MAPK cascade (GO:0043409),0.4373133790481454,1.2661377454079026,0.14361001317523056,0.6496833323025232,1.0,7/87,2.90%,SEMA6A;FOXO1;CAV1;CNKSR3;DAB2IP;LYN;PTPRJ
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5263667159775068,1.2660795522043593,0.1691542288557214,0.6489230416116691,1.0,5/25,11.99%,TNFSF10;BIK;BCL2L11;BNIP3;BID
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5071418469720645,1.265732054613592,0.18512396694214875,0.6490206651343602,1.0,7/33,11.87%,LEF1;CASP8;DCSTAMP;CTNNBIP1;CSF1;IL23A;RIPK1
prerank,actin polymerization or depolymerization (GO:0008154),-0.39109975753680126,-1.2655927881354743,0.09854014598540146,0.6179776180526054,1.0,9/50,6.67%,ARHGAP6;GAS7;MICAL3;GSN;MICAL2;SPIRE1;COBL;ABI2;VILL
prerank,glucose homeostasis (GO:0042593),0.4358776748029851,1.2654121243952277,0.14097496706192358,0.6489660622808834,1.0,13/83,9.33%,FOXO1;ADIPOR2;INSR;STAT3;HIF1A;KLF7;KCNB1;TCF7L2;FOXA3;INPP5K;NEUROD1;FOXK1;SOX4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.33190917712350587,-1.2650805887633765,0.05263157894736842,0.6177482704000127,1.0,21/140,9.25%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CACNA2D1;EDNRA;DLG4;ADRA1B;CCR9;JPH1;SLC8A1;P2RX4;CD55;TRPC3;GRM1;AGTR1;BDKRB2;PTGDR;RYR2;PTGFR
prerank,signal transduction by p53 class mediator (GO:0072331),0.517959743423368,1.2641541916549341,0.17405063291139242,0.6516217357219664,1.0,8/30,9.32%,ACER2;PPP1R13B;JMY;GREM1;BOK;BCL3;MYBBP1A;HINT1
prerank,transport across blood-brain barrier (GO:0150104),-0.36307482958446874,-1.26384509434661,0.1,0.619559672530022,1.0,19/83,5.16%,ATP1A2;SLC24A3;SLC7A2;LRP1;SLC6A13;SLCO3A1;SLC1A3;SLC16A12;SLC13A3;LEPR;SLC2A13;SLC22A8;SLC12A2;SLC6A1;SLC1A5;SLC6A9;ABCC9;SLCO1C1;SLC5A3
prerank,synaptic vesicle transport (GO:0048489),0.6154729889055824,1.2636720637558387,0.23473282442748092,0.6520496298885906,1.0,1/11,0.41%,RAB27A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.570898421643468,1.2633534281532641,0.21291448516579406,0.6521137882558894,1.0,3/18,1.87%,FLT1;MEF2C;PLCG1
prerank,negative regulation of cartilage development (GO:0061037),-0.5380046173752145,-1.2632974323446637,0.1842696629213483,0.6192099194171024,1.0,4/13,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,positive regulation of interleukin-10 production (GO:0032733),0.5195495398146704,1.2627625355405068,0.2106969205834684,0.6528404402215556,1.0,5/30,9.61%,STAT3;CD34;PLCG2;TIGIT;IL23A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5402195979998007,-1.2623886740590295,0.19909502262443438,0.61995862328834,1.0,8/13,8.40%,BMPR1A;FGFR2;TGFBR3;ERBB4;FGF2;ZFPM2;RBPJ;GLI1
prerank,actin filament capping (GO:0051693),0.575574278003182,1.2617191708500224,0.2179054054054054,0.6539071992444574,1.0,2/18,1.54%,FLII;EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.575574278003182,1.2617191708500224,0.2179054054054054,0.6539071992444574,1.0,2/18,1.54%,FLII;EPS8
prerank,dendritic spine morphogenesis (GO:0060997),0.5787421092251737,1.2616730667752578,0.22401433691756273,0.6531014579330744,1.0,1/15,0.09%,SHANK3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4183109376687503,1.2616240580713571,0.10891089108910891,0.6523054298821134,1.0,21/124,10.43%,LEF1;SMURF1;NFATC1;CELSR1;FZD6;FZD4;PPP3CA;GNB1;PLCB1;AP2B1;TCF7L2;TNRC6C;PPP3CB;WNT5A;WNT9B;RAC1;AP2A1;PSMA2;PSMA8;SFRP2;PSMA6
prerank,neuron projection fasciculation (GO:0106030),-0.573243721102036,-1.2606505720480987,0.20430107526881722,0.6232895271320728,1.0,7/10,23.19%,SEMA5A;NRCAM;CNTN4;RTN4;ARHGAP35;EPHB3;EPHB2
prerank,cellular response to purine-containing compound (GO:0071415),-0.5702418040138588,-1.2605368258888432,0.19827586206896552,0.6217529340621841,1.0,4/10,18.30%,SLC8A1;RYR2;GSTM2;CASQ2
prerank,regulation of coagulation (GO:0050818),0.6206929038101102,1.2604438299054972,0.21217712177121772,0.6547927480922531,1.0,3/11,14.29%,CAV1;PROCR;PROC
prerank,regulation of interleukin-6 production (GO:0032675),0.4280167094654827,1.26012444294401,0.12857142857142856,0.6548598265707933,1.0,12/96,8.24%,APP;CD200;IL6R;ARHGEF2;STAT3;AFAP1L2;PLCG2;TIRAP;XBP1;WNT5A;ARRB1;LPL
prerank,response to cAMP (GO:0051591),0.4983936498279482,1.259345147438743,0.18862275449101795,0.6562153211458088,1.0,9/37,8.36%,AHR;PDE2A;KCNQ1;RAP1B;RAPGEF2;INPP5K;RAP1A;PKD2;CITED1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6124688327245904,1.2593142094141283,0.2188034188034188,0.6553705822956922,1.0,7/13,18.14%,KDR;ENG;DLL4;SFRP2;TGFBR2;CTNNB1;NRARP
prerank,neuron remodeling (GO:0016322),0.6339749950967757,1.2590688514215764,0.21561338289962825,0.6551382140671033,1.0,3/10,5.30%,APP;ANKS1A;SCARF1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5709483598590269,1.259068414631042,0.21658206429780033,0.654222128474784,1.0,5/17,7.31%,CLDN5;F11R;PPP1R12A;IKBKB;TNFRSF1A
prerank,protein neddylation (GO:0045116),0.5806004847305223,1.2587631520580291,0.2275132275132275,0.6541304661182115,1.0,2/13,7.26%,DCUN1D3;RNF7
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6340116298448032,1.2586080315269976,0.2306338028169014,0.653662532015834,1.0,5/10,16.57%,PPM1F;DNAJA1;SNX3;TERF1;NDFIP2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.574383479247244,1.2585711821840633,0.21005385996409337,0.65286690085674,1.0,5/16,11.70%,GCH1;SCARB1;HIF1A;NOS1AP;NUS1
prerank,primary alcohol metabolic process (GO:0034308),-0.45967825292229225,-1.258024720186824,0.17412935323383086,0.627081472381492,1.0,5/25,4.89%,IGF1;RBP4;DHRS3;CYP1B1;NAAA
prerank,negative regulation of heart contraction (GO:0045822),-0.5597848454517285,-1.2576930034196887,0.20361990950226244,0.6261059293849682,1.0,1/11,0.03%,ATP1A2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4596965719855078,1.2575471784815793,0.17037037037037037,0.6549189124492641,1.0,23/57,21.42%,RPS15;RPS19;RPS16;RPL38;TGS1;RPS7;RPS24;XPO1;RRS1;RPL14;NOP16;RPS6;NPM1;RIOK1;RPS25;RPL35A;EMG1;RPL11;NOP14;NOM1;RIOK2;RPS28;RPL7
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5706653529226442,-1.2575216810243994,0.19782608695652174,0.624732369626925,1.0,5/11,16.45%,ATP9A;LRRK2;SRC;MAP2K2;MAP2K1
prerank,regulation of calcium ion transport (GO:0051924),-0.3904863603366875,-1.2574403066119948,0.11009174311926606,0.6231909076576777,1.0,11/54,8.88%,ANK2;BCL2;CACNA2D1;CACNA1D;P2RX4;IL16;CACNB2;STIM1;TRPC6;ADRA2A;EFHB
prerank,response to chemokine (GO:1990868),0.6038975760793538,1.2573432811456902,0.22084805653710246,0.6546305245171559,1.0,1/13,0.16%,LRCH1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.43566079652543305,1.257096058404057,0.15167785234899328,0.6544497104182454,1.0,20/76,17.22%,DCUN1D3;CAV1;FBXW7;RASD2;FKBP1A;SMAD7;XIAP;MYCBP2;MALT1;TNIP1;UBE3A;SAE1;RIPK2;PRICKLE1;BIRC3;TRAF6;NDFIP2;BIRC2;WDR48;CUL3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6207575923206878,1.2569431362229808,0.244140625,0.6540064877492662,1.0,3/11,3.79%,PTGS2;CD200;CD34
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5525019607519661,1.2563288150096745,0.21960072595281308,0.6548028347793361,1.0,2/18,2.58%,STT3B;SAMHD1
prerank,nucleotide catabolic process (GO:0009166),0.5754071323260865,1.2559430041943138,0.23102866779089376,0.6549735663366851,1.0,5/16,14.45%,GDA;SAMHD1;NT5C2;XDH;NUDT15
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.48215839352788514,1.2558200493376872,0.17201166180758018,0.6544150918997389,1.0,9/43,7.33%,PPARD;PDGFB;GATA2;STAT3;NR3C1;HIF1A;SOX9;FOSL1;TGFB1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4049860000772903,1.2557068628442405,0.12274368231046931,0.653861063188553,1.0,23/151,7.53%,TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;PDGFB;HTR2A;PRKD2;MFHAS1;PDGFD;TNFRSF11A;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6154739126744309,1.2556487254893032,0.2345679012345679,0.6531431977365745,1.0,4/12,13.34%,CAV1;RALB;CGAS;IFIH1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5416827994111496,-1.254138708198694,0.20607375271149675,0.6311324243285434,1.0,4/12,9.11%,ANK2;ANXA6;UBASH3B;RYR2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5087765609022479,-1.2540475095800268,0.18615751789976134,0.6295388835976143,1.0,6/16,17.43%,DPYSL3;DPYD;UPB1;NT5E;NT5C1A;DPYSL2
prerank,import into cell (GO:0098657),-0.40574332161729143,-1.253777148754748,0.12844036697247707,0.6284884500562065,1.0,9/41,5.16%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;GLUL;SLC22A4;SNAP25;SLC39A14;SLC5A3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4358499646017346,1.2536766769741965,0.16337285902503293,0.6579332734216604,1.0,21/73,22.49%,LMO2;KITLG;GATA2;TAL1;TCF12;PSMA2;TCF3;PSMA8;PSMA6;CBFB;PSME1;PSMA4;METTL14;PSMF1;DHX36;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5664251319430487,1.2535981752006593,0.22344322344322345,0.6572696491327578,1.0,4/18,3.79%,PTGS2;CD200;HIF1A;CD34
prerank,anterograde axonal transport (GO:0008089),-0.417369548238697,-1.2534355057808835,0.17378048780487804,0.627628564664778,1.0,17/37,28.47%,DLG2;KIF3A;KIF1A;KIF5C;RAB27B;AP3D1;DTNBP1;KIF1B;TRAK1;HSPB1;KIF5A;RAB21;SNAPIN;MAP1A;SPAST;BLOC1S4;AP3B2
prerank,outflow tract septum morphogenesis (GO:0003148),0.5371189275630781,1.2530430158746457,0.2157190635451505,0.6580033128557136,1.0,4/24,0.88%,NRP2;BMPR2;ENG;TBX1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5642193804384632,1.252908955657278,0.21280276816608998,0.6574597043250887,1.0,4/18,10.50%,PPP1R16B;MFHAS1;INPP5K;GPATCH2
prerank,chromatin assembly (GO:0031497),0.4960708062178225,1.2528338344167116,0.19145802650957292,0.6567836044264734,1.0,15/38,22.14%,SOX9;PADI4;LIN54;H3-3A;KAT6B;SMARCA5;EZH1;NAP1L4;GRWD1;NPM1;ATRX;ANP32B;BAHD1;SART3;PRDM9
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5240635234913081,1.2526671878111555,0.20751633986928106,0.6563481698159697,1.0,6/26,9.69%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,negative regulation of cell projection organization (GO:0031345),-0.39731313922229416,-1.2525751206328684,0.12658227848101267,0.628313369418916,1.0,10/48,9.84%,LPAR1;DPYSL3;PTPN9;PTPRS;EFNB2;ADCY6;SEMA3A;DCC;RAB29;APOE
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.45256901709181785,-1.2522936537327085,0.1514360313315927,0.6273646269995604,1.0,11/28,21.72%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5559117029256372,1.2519334557181954,0.21634615384615385,0.6575876788758321,1.0,6/22,14.18%,B2M;STX7;MALT1;IL23A;CYRIB;TRAF6
prerank,positive regulation of apoptotic process (GO:0043065),0.38325364687214747,1.2516504474435968,0.07423580786026202,0.6574263711245278,1.0,58/293,12.71%,FOXO1;TNFSF10;UNC13B;TGM2;NET1;DCUN1D3;ITGA6;MCF2L;DAPK1;ARHGEF3;RASGRF2;HIP1R;DAB2IP;ARHGEF2;FAS;SIK1;TPD52L1;STK3;CASP8;JMY;PLEKHG5;KALRN;STK4;PREX1;FOXL2;MAPK8;BOK;CTNNBL1;DNAJA1;BCL2L11;SPDEF;STPG1;NEUROD1;CRADD;PSEN1;ARHGEF7;MAP3K11;MYBBP1A;ARHGEF26;SOX4;TNFRSF8;SIAH1;SFRP2;ANO6;TFAP4;APH1A;BNIP3;BTG1;ATF6;RNPS1;RIPK1;BID;RHOB;TNFAIP8;TRIO;GNA13;ARHGEF9;RACK1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4217853688003454,1.251187023855301,0.13997477931904162,0.657797067648871,1.0,23/112,7.46%,ENG;MEF2C;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PDE2A;NR3C1;PXN;FKBP1A;SOX9;ID1;PTPRK;SMAD7;USP15;DUSP22;WNT5A;ACVR1;TGFB1;PTK2
prerank,defense response to virus (GO:0051607),0.42587196242799563,1.2507552715246795,0.12339331619537275,0.6581767727533905,1.0,30/100,19.42%,SERINC3;NLRC5;IRF2;SERINC5;SAMHD1;DDIT4;ISG20;IFNAR2;RNASE1;CD40;MLKL;G3BP1;CGAS;BCL2L1;BNIP3;NT5C3A;ZMYND11;OASL;RELA;CNOT7;IFIH1;IFITM3;STAT1;PLSCR1;ZDHHC1;BST2;ATG7;IFITM1;EIF2AK2;BNIP3L
prerank,cellular response to glucose stimulus (GO:0071333),0.5127339169792845,1.2506732262042413,0.21293375394321767,0.657513777519457,1.0,10/30,13.47%,UNC13B;ERN1;KCNB1;XBP1;RAB11FIP5;SOX4;GAS6;RAB11B;RACK1;IGF1R
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.562516842944565,1.250590948767853,0.22654867256637168,0.6569068037410979,1.0,11/16,26.73%,CHMP4A;CHMP4B;VPS28;TMEM50B;STAM;VTA1;LEPROT;VPS36;VPS25;TMEM50A;CHMP4C
prerank,positive regulation of protein import (GO:1904591),-0.4389714256549707,-1.2504024886894152,0.1649214659685864,0.6310609726941232,1.0,11/30,21.72%,ZIC1;PRKCD;CDH1;SMAD3;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;BAG3
prerank,cellular response to metal ion (GO:0071248),-0.3346422713534988,-1.2501339352839862,0.06190476190476191,0.63005509104315,1.0,21/123,7.59%,BMP6;EGFR;PRKN;ADCY1;SLC41A1;ADGRV1;DLG2;SLC12A2;DLG4;SYT1;P2RX4;ADCY7;CDH1;ANK3;PRKAA2;RASGRP2;NLGN1;SYT9;SYT12;SYT11;LRRK2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4973785093016504,1.2500149020678821,0.21840873634945399,0.6576353057747651,1.0,4/37,1.89%,PRKG1;MEF2C;ERN1;PDGFB
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5046813857954703,-1.2498121174687868,0.1811926605504587,0.6292367808434969,1.0,6/16,15.07%,APPL2;PPARA;ADCY7;APOD;CHID1;SIRPA
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5802627269516383,1.2497240951129984,0.23170731707317074,0.6575691668012834,1.0,3/13,3.01%,PTGS2;SOX13;RREB1
prerank,positive regulation of chemokine production (GO:0032722),0.4782211688815849,1.2494237217407655,0.17293233082706766,0.657496100394861,1.0,8/44,13.43%,APP;IL6R;HIF1A;TIRAP;WNT5A;LPL;IL7;ADAM17
prerank,B cell proliferation (GO:0042100),0.5685636131904088,1.2490966365005367,0.21963394342762063,0.6575765125021086,1.0,3/17,6.60%,MEF2C;CTPS1;CD40
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.47305624215031655,1.2489438077143393,0.17510853835021709,0.6571280315358501,1.0,9/49,7.31%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A
prerank,negative regulation of apoptotic process (GO:0043066),0.37529240462738883,1.248916364662036,0.045454545454545456,0.6563240606123715,1.0,82/444,12.91%,PRKCH;LEF1;TEK;TJP1;FOXO1;CD38;KDR;IL6ST;CAV1;TBX1;MEF2C;RNF144B;SOCS2;PIM3;ADAM10;FAS;PTK2B;NOTCH1;NFKBIA;FLT4;PAK2;BABAM2;CAT;SOX9;DLL1;RPS6KA3;TMBIM6;FOXQ1;IKBKB;RPS6KA1;XBP1;GREM1;CX3CR1;MAPK8;ASAH2;SERPINB9;PLK2;XIAP;WNT5A;TOX3;DNAJA1;AVEN;HNRNPK;PTK2;RASA1;BCL3;BNIP2;NFKB1;ITGA5;MALT1;CITED1;PSEN1;AKT2;RHBDD1;BCL2L1;HIGD2A;EGR3;SEMA4D;GAS6;BNIP3;SFN;CBL;IL7;RB1;PIM1;LGMN;THOC6;RIPK1;TMBIM4;TMIGD1;BID;CARD16;RELA;TNFAIP8;RIPK2;PRDX2;PA2G4;GSTP1;RPL10;BIRC3;PHIP;PTMA
prerank,negative regulation of complement activation (GO:0045916),-0.5709348171801358,-1.248851733195994,0.20668058455114824,0.6304252645612314,1.0,2/10,5.12%,SERPING1;CD55
prerank,skeletal muscle organ development (GO:0060538),0.5266180126798584,1.2487693049420787,0.20634920634920634,0.6558600885036385,1.0,3/26,4.96%,CAV1;MEF2C;FOXL2
prerank,muscle contraction (GO:0006936),-0.3336313767406631,-1.2487165770326532,0.09340659340659341,0.6290449363299679,1.0,29/126,15.27%,CALD1;DMD;ROCK2;SNTA1;ITGB5;EDNRA;ACTN2;SLC8A1;ASPH;GNAO1;SNTB1;TPM1;DTNA;ITGA1;TMOD2;BDKRB2;MYL9;SSPN;TPM2;MYOM1;ACTA2;DES;ADRA1A;TLN1;LMOD1;TPM4;ARHGEF11;FXYD1;GJC1
prerank,protein modification process (GO:0036211),0.4384159469236112,1.2487032354639884,0.1523545706371191,0.6551545541244093,1.0,15/76,11.60%,ST3GAL6;ST3GAL1;YES1;CPE;UBA7;PADI4;ST8SIA4;AKT2;FBXL2;FBXW2;ERO1A;UBE2D3;ICMT;ABL2;STK38
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5623755709648705,1.248460775983515,0.22071307300509338,0.6549161341342792,1.0,4/18,6.76%,SLC2A1;OCLN;INPP5K;TRIB3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5158252593686823,1.2483852679939804,0.21052631578947367,0.6542616164158371,1.0,5/30,7.33%,FLT1;KDR;MLLT3;FLT4;TGFB1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.38996706233196693,1.247132508229866,0.11136890951276102,0.6569945173990586,1.0,29/199,7.33%,RPS6KA5;NOS3;PTPRG;HDAC9;BMPR2;NOVA2;MEF2C;IL15;DAB2IP;PAEP;EFNA1;NOTCH1;KLF7;RAB11FIP1;LAMA4;SOX9;EVL;RPS19;ID1;SMAD7;RAB11FIP5;N4BP1;ATP2B4;PGAM5;BTN2A2;WNT9B;SOST;SRGN;TGFB1
prerank,regulation of axonogenesis (GO:0050770),-0.3821513591178834,-1.2468574305047078,0.11458333333333333,0.6327717295223948,1.0,13/51,10.91%,ROBO1;PLXNA2;KIF13B;TIAM2;BRSK1;NTRK2;ROBO2;LRRC4C;NGF;MAP6;PLXNB1;SIPA1L1;SLIT2
prerank,regulation of nervous system process (GO:0031644),0.5591658586464373,1.246807711716423,0.23102866779089376,0.657125289409748,1.0,2/18,1.06%,NOS3;APP
prerank,clathrin-dependent endocytosis (GO:0072583),0.5319281677214303,1.2465470870148616,0.1932367149758454,0.6570509824429439,1.0,8/26,11.71%,FNBP1L;ITSN2;FCHO2;DLL1;AP2B1;AP2A1;INPP5F;PICALM
prerank,acylglycerol metabolic process (GO:0006639),0.49470374825687546,1.2464313021975402,0.18009478672985782,0.6565483505581395,1.0,10/37,15.00%,CAV1;DGKZ;ABHD2;DGKH;LPL;PLAAT3;GK5;DGKE;PNPLA2;DGAT1
prerank,sodium ion homeostasis (GO:0055078),-0.4740053910075226,-1.245864713816838,0.18719211822660098,0.6339838138120008,1.0,4/21,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5051217813134402,-1.2447575429507556,0.1896551724137931,0.6354579634492431,1.0,5/15,7.51%,GRM7;GRM5;GRM1;GRM3;DAGLA
prerank,negative regulation of cellular process (GO:0048523),0.37081515872016213,1.2447504578338344,0.04033092037228542,0.6603853269533048,1.0,85/521,10.77%,NOS3;PTPN14;BMPR2;JAM2;PLXNA4;DCUN1D3;TBX1;APBB2;SMARCA2;APP;PDE8A;CBFA2T3;SOX7;ACVRL1;PRKD1;PPP1R13B;CTTNBP2NL;PODXL;CD200;CDK6;PLPP1;SH3BP4;ADARB1;MYH9;DAB2IP;LYN;ADAM10;NPR1;PTK2B;SRGAP2;NOTCH1;PLXND1;PTPRJ;TNFRSF1B;SOX17;AQP11;LPCAT3;NCK1;CD34;ADGRG1;TES;ACTN1;DLL1;TMBIM6;PPP1R9B;VGLL4;BTG3;PTPRK;DLL4;TMEM98;RAPGEF2;ADAM15;CBLL1;JADE1;KLF10;BTN2A2;FBP1;BTBD18;DCSTAMP;ADAMDEC1;CDKN1B;PPM1D;TGFB1;RASA1;SNX3;RNF167;PKD2;RNF139;NF2;CTBP1;PINX1;CHMP4B;DSCAM;SOX4;SST;TNFRSF8;BTG2;RAD18;CYP27B1;SFRP2;SEMA4D;VAMP8;TFAP4;NMI;BNIP3
prerank,neural crest cell differentiation (GO:0014033),0.5648168610782148,1.2447200600891442,0.21661237785016288,0.6595974755548603,1.0,3/18,6.57%,MEF2C;CDH2;CYP26C1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6103770607839076,1.244643499639363,0.24314442413162707,0.6589553792840598,1.0,2/10,6.15%,ESR1;ATF7IP
prerank,pancreas development (GO:0031016),0.6074354785020768,1.2441855237484114,0.24682395644283123,0.6593959426506655,1.0,3/12,5.65%,ZIC3;FOXF1;TCF7L2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5963877113012528,1.2440981226768173,0.22621184919210055,0.6587572001798611,1.0,9/14,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;DAZL;ELAVL1;MAPK14
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.508925773656281,-1.2435173582884902,0.205607476635514,0.6371562181954282,1.0,7/16,27.27%,LRP1;APOE;ABCA7;MYOCD;CYP51A1;HMGCR;TREM2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5097197054034583,1.2434383816753194,0.22258064516129034,0.6597623139698344,1.0,3/26,4.28%,CAV1;MFHAS1;TIRAP
prerank,sphingolipid catabolic process (GO:0030149),0.5706402340186083,1.2432996601628656,0.2222222222222222,0.6592704578422439,1.0,3/15,5.50%,ACER2;ENPP2;ASAH2
prerank,prostaglandin metabolic process (GO:0006693),0.5288560977989816,1.2430535131775455,0.20588235294117646,0.6591069116935222,1.0,4/26,5.09%,PTGS2;PLA2G4A;EDN1;PTGS1
prerank,carbohydrate derivative transport (GO:1901264),0.550543940364844,1.2427865203011808,0.23117338003502627,0.6590157549694524,1.0,4/18,8.48%,PLTP;SCARB1;SLC10A7;SLC15A2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.5792016950416562,1.2422425767060201,0.22982456140350876,0.6596780397688164,1.0,7/13,28.67%,IRAK4;TRAF6;IRAK2;PIK3R4;TNIP2;PIK3AP1;IRAK1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5397386730874505,1.2420371615115218,0.22184300341296928,0.6594193679019902,1.0,7/23,8.58%,APP;INSR;PDGFB;HIF1A;PFKFB3;NFKB1;PSEN1
prerank,response to UV-A (GO:0070141),-0.5145874957389076,-1.2413805911710782,0.23094170403587444,0.641725105156344,1.0,3/14,13.53%,EGFR;MMP2;CERS1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4443599131398147,1.2408009801269373,0.17891816920943135,0.6620904830640262,1.0,10/68,6.38%,LEF1;CAV1;DIXDC1;FZD6;FZD4;LRP5;TCF7L1;TCF7L2;WNT5A;WNT9B
prerank,regulation of B cell apoptotic process (GO:0002902),0.5984460174281718,1.2404605737295338,0.23601398601398602,0.6621955102908728,1.0,2/12,2.31%,FOXP1;LYN
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5934119865047314,1.2401853608975015,0.2611111111111111,0.6621531590873891,1.0,3/12,5.49%,SEMA6A;DAB2IP;ATP2B4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5947562379603206,1.2400716937422895,0.24150268336314848,0.6615850542483048,1.0,1/13,0.26%,ENTPD1
prerank,regulation of cellular respiration (GO:0043457),0.5676286443530557,1.2399255231958384,0.21761658031088082,0.6611445815909776,1.0,4/17,16.25%,CBFA2T3;IFNAR1;NOP53;PNPT1
prerank,gene expression (GO:0010467),0.375417811699025,1.2397512913927244,0.07832618025751073,0.6607915293729749,1.0,116/348,18.60%,RBPMS;ADARB1;HHEX;TSPAN5;DDX54;RPS15;IGF2BP3;RPS19;RPLP1;RPS14;RPSA;RPS16;EPC1;RPL38;EIF4E;TSPAN14;RPL34;RPS20;RPL39;DROSHA;HNRNPF;RPS7;PWP1;NXF2;RPS24;TAF1B;HNRNPK;RPL37A;BCL3;SRBD1;HNRNPD;RPL36;RPS18;WDR33;RSL24D1;RPL15;THOC2;RPS8;RPL14;RPL23;RPL17;MRPS18A;SMG7;RPL9;RNGTT;DHPS;RPL4;RPL13A;RPS11;RPL32;TNIP1;RBM3;YTHDC1;RPL22;RPS27;RPL31;RPS23;MMS19;ADAR;NUP214;RNPS1;MRPL13;RPL13;MRPS12;RPS12;THOC6;NUP98;MRPL35;HBS1L;RPL6;RPL10;FASTKD2;WARS1;PTMA;MRRF;UPF2;MRPL41;NUP133;NUP205;RPS29;RPS6;MEF2A;MRPL52;NUP54;RPL29;TOPORS;RPS25;RPL35A;RPS13;NUP43;NUP153;RPS21;MRPS16;RPL27;RPL18;XRN2;MRPL23;RPL27A;TSPAN33;MRPS5;RPS10;DDX20;HNRNPUL1;MRPL37;AGFG1;RPL11;ALYREF;CDC40;RPL8;THOC3;RPLP2;MRPL11;THOC1;PRPF4;RPL18A;CPSF1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5738151639867284,-1.2395775899790955,0.22608695652173913,0.6450876302680385,1.0,2/10,2.95%,GLI3;BMP4
prerank,vasculature development (GO:0001944),0.5757424102070454,1.2395260852295358,0.2152777777777778,0.6605679545739976,1.0,6/16,4.47%,BMPR2;ACVRL1;FBXW7;SOX18;FLT4;FOXF1
prerank,positive regulation of heart rate (GO:0010460),0.5531931961977259,1.2394507136029038,0.2637931034482759,0.6599269974109845,1.0,4/17,4.08%,EDN1;KCNQ1;PDE4D;ADRB1
prerank,negative regulation of phosphorylation (GO:0042326),-0.3436813833403375,-1.2394060934805713,0.11297071129707113,0.6437592156696843,1.0,13/85,4.40%,PID1;PTPN13;NTRK3;PLPP3;PRKN;BMP7;FBLN1;NUPR1;HDAC4;PPARA;BMP4;IGFBP3;IMPACT
prerank,positive regulation of insulin secretion (GO:0032024),0.4813641470800522,1.2393922174679466,0.20489296636085627,0.659248141259553,1.0,4/36,5.98%,MYRIP;ACSL4;TCF7L2;PPP3CB
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5043361567900662,1.2389141543928532,0.2077922077922078,0.6597317687991074,1.0,6/26,12.61%,ADIPOR2;ELOVL5;CEACAM1;TRIB3;EIF6;ADIPOR1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6298187957239152,1.2387142409241985,0.26717557251908397,0.6594345252602105,1.0,5/10,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,positive chemotaxis (GO:0050918),-0.4971068317194538,-1.2381838604846154,0.19724770642201836,0.645460997773787,1.0,8/17,18.65%,ANGPT1;NRP1;SEMA5A;TSC2;VEGFA;FGF7;FGF10;SCG2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5114310994151878,-1.2373263916080426,0.2119815668202765,0.6460603957197155,1.0,4/14,4.01%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,cell junction maintenance (GO:0034331),-0.5160066955115433,-1.237064716193444,0.20416666666666666,0.6450517133953111,1.0,7/14,32.38%,NLGN2;CLDN1;CHCHD10;MYADM;PRTN3;DCTN1;PARD6A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.47437755572251866,1.2364854943329582,0.19760479041916168,0.6648030535748157,1.0,8/39,8.29%,ACER2;NEXMIF;FZD4;NOTCH1;ACTN4;ADAM15;RASA1;NF2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4174272787160315,1.2362933863136463,0.16796875,0.6645298969271929,1.0,24/93,12.95%,CAV1;APP;PRKD1;CNKSR3;PRKD2;FNIP2;DDIT4;PDE4D;PPM1F;NCK1;SH2D3C;STK4;SMAD7;ATP2B4;INPP5K;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;RACK1;HSP90AB1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.45765900093744155,1.2362492932882234,0.18518518518518517,0.6638061143206806,1.0,12/57,9.97%,IL6ST;IL15;IL6R;LYN;STAT3;GHR;CD40;STAP2;TNFRSF1A;NF2;IL23A;INPP5F
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5065778812551792,1.2358228237913875,0.2064516129032258,0.6641440614913007,1.0,8/29,14.10%,NLRC5;SAMHD1;WNT5A;IFNAR2;PTPN1;HSP90AB1;CNOT7;UBE2K
prerank,positive regulation of phosphorylation (GO:0042327),0.3810664144619583,1.235540499180795,0.10985277463193659,0.6640769340296326,1.0,41/240,8.77%,TEK;LIMCH1;PECAM1;FLT1;KDR;ENG;ITGA6;TBX1;TIE1;APP;PDE8A;EPHB4;INSR;VEGFC;LYN;FAS;EFNA1;HIF1A;PFKFB3;FLT4;FGF23;SOX9;STK4;LMTK2;RALB;SDCBP;VEGFD;ACVR2A;RET;LIMK2;KRAS;CD40;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PSEN1;AKT2;ANG
prerank,positive regulation of cellular component movement (GO:0051272),0.5365387453429945,1.2354962759487302,0.2197092084006462,0.6633524655349966,1.0,6/24,8.63%,NTN1;LYN;ACTN4;RPS19;CAVIN1;AKT2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5637402124525946,1.235449126087212,0.24201680672268908,0.662624458669534,1.0,4/16,5.28%,PPP1R16B;GATA2;JCAD;DLL4
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4625688039033473,1.2351106439961548,0.18686131386861313,0.6627170931258942,1.0,4/46,2.31%,SEMA6A;CNKSR3;DAB2IP;LYN
prerank,negative regulation of gene expression (GO:0010629),0.3790747228609082,1.2350638434022518,0.09201773835920177,0.6620011719490633,1.0,56/302,11.80%,RPS6KA5;NANOS3;HDAC9;KDR;ENG;ESR1;APP;MEF2C;ERN1;ACVRL1;CLDN5;OCLN;DAPK1;PDGFB;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;IGF2BP3;TMBIM6;PTBP3;EPC1;DLL4;NANOS2;N4BP1;ATP2B4;H3-3A;MTF2;TNRC6C;AURKA;BTN2A2;TASOR;SRGN;PPM1D;TGFB1;GRB7;NFKB1;RNF139;PSEN1;NUDT16;DICER1;AEBP2;BTG2;RPL13A;CNOT1;SFRP2;APLNR;PPHLN1;DCP2;RB1;MRPL13;PICALM;LGMN
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4125489578173577,1.2349246770305098,0.16080402010050251,0.6615637848022099,1.0,39/109,23.11%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,cellular component assembly (GO:0022607),0.3812542726532363,1.2349060882625171,0.09028571428571429,0.6607813972442508,1.0,49/253,13.87%,PARVB;SLC2A1;LCP1;SPTBN1;OCLN;EPS8;LIMS2;CD2AP;MAGI1;NEDD9;PARD3;FAS;PTK2B;SHROOM2;TRAF1;SHROOM1;CARD10;SOX9;RHOJ;PLS3;RAD21L1;NCKAP1;QSOX1;STX7;ABCA3;TEAD2;OPHN1;WNT5A;RP1L1;CD40;RAC1;TGFB1;TRIP13;LLGL1;SKAP2;NIFK;IKBKG;TFAP4;GAS6;FSCN1;ACD;CYFIP1;PICALM;HAS2;LIMA1;CAPZA1;CFAP46;PEX14;IL1RAP
prerank,positive regulation of response to stimulus (GO:0048584),0.4852136100273655,1.2344822144479326,0.20833333333333334,0.6610768786424444,1.0,13/40,20.12%,ABI3;IL15;B2M;WNT5A;CGAS;IFIH1;NSMCE4A;FMR1;NSMCE1;YPEL3;IER5;HOMER1;TAF9
prerank,positive regulation of binding (GO:0051099),0.4319124055478121,1.2342698335013484,0.14790575916230367,0.660821641443506,1.0,18/84,8.58%,CAV1;APP;EPB41;CLDN5;B2M;HIP1R;STK3;FKBP1A;HMBOX1;STK4;MARK3;RALB;DTX3L;TCF7L2;RAPGEF2;TRIB3;CDT1;PSEN1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5670020382358469,-1.2337373182588398,0.2267818574514039,0.6533301050668044,1.0,4/10,15.88%,BMP4;SALL1;FZD7;PAX8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4196695722864711,1.2336619146198113,0.15775401069518716,0.6617524590612167,1.0,15/93,6.63%,APP;TNFRSF19;DAB2IP;MFHAS1;PTK2B;TPD52L1;TAOK2;PLCB1;TRAF1;FLT4;TIRAP;EDAR;SDCBP;DUSP22;SASH1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5800569823977794,1.233291754909776,0.2481060606060606,0.6619708413840246,1.0,1/14,1.32%,ERN1
prerank,regulation of presynapse assembly (GO:1905606),-0.48514649459599446,-1.23288331035338,0.22894736842105262,0.652253401394556,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.48514649459599446,-1.23288331035338,0.22894736842105262,0.652253401394556,1.0,6/18,11.15%,GPC6;PTPRD;IL1RAPL1;LRFN5;GPC4;MDGA1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5558596992413738,1.2324836351589579,0.2453151618398637,0.663413734078117,1.0,4/16,10.01%,CEACAM1;STX7;IL23A;CYRIB
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4613275130643654,-1.2323491878258288,0.1980440097799511,0.6520734220701278,1.0,6/23,6.99%,AGMO;PLCE1;MOGAT3;LPGAT1;GK;LPIN1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49112060177472266,-1.2322335343353712,0.18306636155606407,0.6506682292773721,1.0,6/17,7.09%,NOTCH2;BMPR1A;BMP4;JAG1;HEYL;RBPJ
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3702682077297977,-1.232177686999276,0.13245033112582782,0.649068098244277,1.0,11/57,8.32%,LPAR1;ADCY5;ADCY1;ADCY2;AKAP12;GRM7;ADCY7;ADCY6;PSAP;GNAI1;ADRA2A
prerank,nitrogen compound transport (GO:0071705),0.4018966903246963,1.2321197515262645,0.14161490683229813,0.6635895233867674,1.0,32/141,15.49%,CALCRL;ABCG2;CERT1;SLC6A2;MYH9;SEC14L1;EDN1;SLC7A7;SLC38A5;ATP11B;SLC3A2;SLC6A6;SCAMP1;RAMP2;SLC43A2;CHMP2B;SLC52A3;ARRDC1;SLC15A2;RAB38;SLC38A1;SCARB2;CD320;PICK1;RILP;RAB7A;TXNIP;TCN2;SLC22A5;SLC18A2;SLC7A5;CEP290
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4896689510612038,1.2318621426374414,0.21792890262751158,0.6634085163732699,1.0,2/33,1.15%,PRKG1;MEF2C
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3235776482175089,-1.2317218339932168,0.07,0.6485976388977859,1.0,22/133,10.29%,SLC24A3;ANK2;ATP13A5;ATP13A3;BCL2;SLC8A3;ATP1B1;SLC8A1;MCU;DMPK;SLC35G1;TRPC3;STIM1;PRKACA;TRPC6;ANXA6;TRPC1;ATP2A2;RYR2;CXCL12;SLC24A2;TRPC4
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.48140603906961543,1.2316504112262017,0.19398496240601504,0.6631974219544121,1.0,9/39,13.90%,FNBP1L;MYO1D;ACTN4;PPFIA2;BICDL1;MYO1E;MYO1C;CCDC186;NDEL1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3485483675552236,-1.231371857671409,0.11538461538461539,0.6477980174385303,1.0,23/80,17.02%,PLPP3;ATP9A;KIF3C;KIF3A;COPZ2;COPB1;KDELR3;COPA;COPG1;ERGIC1;TMED9;GBF1;ERGIC2;ARFGAP1;ARCN1;HTT;BICD2;KIFAP3;KLC1;GOLPH3L;ARFGAP2;KIF5A;SCFD1
prerank,positive regulation of phagocytosis (GO:0050766),0.46632467583828674,1.2313653707542447,0.19461077844311378,0.6631407128282215,1.0,4/47,2.90%,RAB27A;IL15;GATA2;PTPRJ
prerank,positive regulation of T cell migration (GO:2000406),0.537229957677128,1.231342523188279,0.24707846410684475,0.6623595597882468,1.0,3/20,6.10%,APP;ADAM10;WNT5A
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.41279568201477973,-1.230836993812768,0.18285714285714286,0.6476104187624859,1.0,9/32,5.84%,SDC2;HECW2;ADGRB3;OBSL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1
prerank,response to interferon-beta (GO:0035456),0.5190936082911929,1.2306534122139852,0.2134251290877797,0.6634100665450066,1.0,11/22,19.12%,AIM2;IFNAR2;UBE2K;IFITM3;IRGM;PNPT1;CDC34;STAT1;PLSCR1;BST2;IFITM1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6029427856629217,1.230409063216897,0.23550724637681159,0.663248918889133,1.0,5/13,16.25%,PRR5L;CNOT1;RC3H1;CNOT7;PNPT1
prerank,regulation of MAPK cascade (GO:0043408),0.3977840740548503,1.2302228091046568,0.12345679012345678,0.6629456501442634,1.0,23/157,5.60%,TEK;FLT1;KDR;CAV1;TBX1;INSR;PDGFB;IQGAP1;DAB2IP;LYN;JCAD;FAS;PTPRJ;TAOK2;STK3;FLT4;PLCG2;CAV2;PAK2;STK4;CEACAM1;GREM1;RET
prerank,exit from mitosis (GO:0010458),0.5834569812113864,1.2301353909854065,0.2459016393442623,0.6623610833907971,1.0,6/12,23.45%,EPS8;CHMP4B;PPP2R2D;CTDP1;SIRT7;CLASP2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3679261397973382,-1.229331189951761,0.13815789473684212,0.6501047485890061,1.0,8/61,4.55%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;SMOC2;PARP3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5065565604479247,1.2290412543047535,0.22749590834697217,0.664595023633696,1.0,9/29,10.61%,IL15;SOCS2;STAT3;JAK3;GHR;IFNAR1;IFNAR2;PKD2;NMI
prerank,carboxylic acid catabolic process (GO:0046395),-0.5211514778990092,-1.2286744556535194,0.22877358490566038,0.6501508282205376,1.0,4/12,12.64%,RENBP;NAGK;GNPDA1;PON3
prerank,regulation of stem cell proliferation (GO:0072091),-0.49071026798754447,-1.2286309135618734,0.21445221445221446,0.6485485816095953,1.0,7/17,24.56%,FBLN1;GJA1;AGO3;HNRNPU;HMGB2;TERT;PTPRC
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5839479849293365,1.2285948852109412,0.23118279569892472,0.664939373576761,1.0,2/12,6.76%,CEACAM1;TRIB3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3588348659418447,1.2274135533354995,0.003,0.667314220753034,1.0,272/1668,12.44%,MECOM;DACH2;ERG;LEF1;MRTFB;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;TEAD4;HDAC9;DACH1;ZHX3;PBX1;BMPR2;LDB2;ENG;CAV1;ITGA6;TBX1;ESR1;SMARCA2;APP;PPARD;TSHZ2;MEF2C;ZBTB16;TOX4;LMO2;ACVRL1;PRKD1;NR5A2;CRTC1;MAML2;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;NLRC5;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MED13L;EDN1;HHEX;ARHGEF2;PDE2A;LRP5;TAL1;PRKD2;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;PPP3CA;NOTCH1;HIF1A;EBF1;KLF7;RREB1;KLF8;NFKBIA;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;NCK1;WWTR1;ARID3B;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;PPP1R12A;HMBOX1;FOSL2;MAFF;TOX;SOX9;RIPPLY3;MRTFA;PKN1;ZBTB46;NCOA1;DLL1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;SS18;ELK4;RPS14;IKBKB;MCPH1;SDCBP;RPS6KA1;SP6;FOXL2;XBP1;ZFP92;TET3;ID1;EPC1;TCF7L1;SMAD7;ACVR2A;GREM1;DLL4;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;MTF2;LPIN3;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;TNRC6C;PITX3;PPP3CB;ESRRG;DUSP22;CHP2;WNT5A;CNBP;SKAP1;RCOR1;TOX3;ATMIN;KLF10;ACVR1;NR1I3;FBP1;FOXA3;ELF5;FOSL1;IRF2BPL;CD40;HNF1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;PPM1D;HNRNPK;RBM14;TNFRSF1A;TGFB1;HOXD8;HOXD1;TGFA;GMEB2;TCF3;AGRN;NFKB1;GATAD2A;MAMSTR;ARID1A;PKD2;KDM4C;NEUROD1;CTBP1;WWC2;BACH2;CITED1;NRL;ZNF2;CREM;KAT6B;PHF6;SMARCA5;EZH1;PSEN1;CREB1;TAF3;FOXK1;CRK;ZFPM1;SUB1;RPL23;BRD4;PCGF5;CHD2;IER2;TCF15;SOX4;RELB;IKBKG;DICER1;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;NFIB;CREB3L4;NRIP1;MAMLD1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SMAD5;SRCAP;SFRP2;UBE2D3;USF2;EGR3;TNIP1;SEMA4D;SMARCE1;ZBTB10;PHF20L1;GLYR1;TFAP4;POU2F1;GABPB1;CSRNP1;SPEN;CNOT2;MC1R;GLMP;ZMIZ1;ENY2;RB1;ATF6;EID1;CBFB;SP3;CEBPD;GRIN1;RIPK1;PRDM2;DCAF1;ACTR2;ZNF319;RPRD1B;MUC1;ASXL1;NOP53;MIER1;SIRT6;RELA;RIPK2;MAX;TET2;LCORL
prerank,Notch signaling pathway (GO:0007219),0.44178436218297085,1.2271956659889884,0.19525801952580196,0.6670628589698222,1.0,9/59,5.28%,SORBS2;PBX1;MAML2;ADAM10;NOTCH1;PLXND1;DLL1;DTX3L;DLL4
prerank,cellular response to dsRNA (GO:0071359),0.5762883242065991,1.2267616459629367,0.2395104895104895,0.6675024014530943,1.0,5/15,14.04%,CAV1;RALB;CGAS;IFIH1;NPM1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.45674519182567247,1.2265207626949306,0.20562130177514792,0.6672762862099314,1.0,7/52,5.49%,PRKCH;EPB41;STX3;SPTBN1;NKD2;SORBS1;ATP2B4
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5630773569596106,1.226073939675178,0.23754152823920266,0.667647837786357,1.0,6/16,17.01%,RAD21L1;HASPIN;RB1;PDS5A;RAD21;PDS5B
prerank,natural killer cell activation (GO:0030101),0.5288751278024786,1.2258234786087405,0.22625215889464595,0.6675004001927921,1.0,3/23,4.17%,PBX1;CASP8;TOX
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5013150013772772,1.225458904396316,0.22764227642276422,0.6676804666390047,1.0,4/29,5.60%,TNFSF10;CAV1;PAK2;RET
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5554337625491127,1.2250607535622193,0.2521891418563923,0.6679733386071737,1.0,3/17,7.63%,RAB27A;KCNB1;STX1A
prerank,superoxide anion generation (GO:0042554),-0.5151445795610405,-1.2247738771042955,0.24145785876993167,0.6578958097672847,1.0,6/13,24.49%,NOX4;ALOX12;CYBB;NOX1;NCF2;TAFA4
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3399965314975399,-1.2245705944209597,0.09803921568627451,0.6566683460196734,1.0,30/108,10.26%,TRABD2B;SULF1;WLS;LRP1;FGFR2;PRKN;GPC3;PTK7;CTNND2;RNF43;SULF2;DCDC2;GRB10;WWOX;DAAM2;RSPO3;RSPO2;DACT1;SALL1;SFRP4;CXXC4;NOTUM;LRRK2;FOXL1;BTRC;SFRP1;RUNX1;TSC2;SMARCA4;APCDD1
prerank,neuron development (GO:0048666),0.4002360021894687,1.2242714448955971,0.15936739659367397,0.6693432909585711,1.0,19/141,7.82%,FRY;FRYL;PBX1;APP;MEF2C;UGCG;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;XBP1;ULK1;OPHN1;RAPGEF2;RP1L1;B4GALT5;NEDD4
prerank,regulation of neuron apoptotic process (GO:0043523),-0.3377832223435112,-1.2241701297054575,0.09473684210526316,0.6561250123089759,1.0,39/96,24.17%,EPHA7;PRKN;BCL2;NUPR1;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NF1;NGF;SIX1;TRIM2;EGLN3;SNX6;CPEB4;SRPK2;RETREG1;APOE;TGFB3;NFATC4;TGFB2;GRID2;PRKCI;MT3;MDK;CLCF1;PPT1;TYRO3;BACE1;NTF3;CRLF1;AGAP2;FAIM2;CLN3;BAX;NSMF;AKT1S1;ERBB3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.544612693881339,1.2239121331239786,0.23834196891191708,0.6694619854665486,1.0,8/19,20.12%,LIFR;WNT5A;CBFB;IFIH1;MAP2K5;IRAK2;PARP9;TAF9
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5086456030709758,1.223779909605665,0.23427672955974843,0.6689954755309168,1.0,6/29,16.63%,PLA2G4A;LPCAT3;PLA2G2D;PLAAT3;PNPLA8;TMEM86B
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5553229143360437,-1.2236977854721178,0.26593406593406593,0.655702401981039,1.0,7/10,30.28%,NINL;KIF3A;PCM1;CCDC68;CEP19;DCTN1;NIN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5893812911910348,1.2236858329917533,0.24504504504504504,0.6684161244127078,1.0,3/12,8.24%,FOXP1;TIRAP;LPL
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5691088275195468,1.2227533390419882,0.26306306306306304,0.670200558803519,1.0,4/15,4.20%,SCARB1;FBXW7;SIK1;PLIN5
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5153635260079963,1.222552196534766,0.2267536704730832,0.6699144685200195,1.0,10/24,15.76%,OCLN;WASF2;NCKAP1;RAC1;TWF2;FSCN1;CYFIP1;ACTR2;ACTR3;ARPC2
prerank,positive regulation of transferase activity (GO:0051347),0.39228507177129374,1.2220732573767044,0.14145141451414514,0.6703982562594205,1.0,21/142,7.80%,TEK;FLT1;KDR;DCUN1D3;TIE1;EPHB4;CD200;INSR;NEK7;SERINC5;FBXW7;FLT4;HMBOX1;LMTK2;DTX3L;GREM1;RET;TRIB3;TGFB1;HNRNPD;WRAP53
prerank,sensory perception (GO:0007600),-0.395333599866695,-1.2215018203438683,0.1529051987767584,0.6603025587665401,1.0,22/45,32.20%,ADGRV1;P2RX4;GNAS;PCDH15;WHRN;PTGES;ADORA2A;RETREG1;TTC8;CHRNA7;TRPA1;TMEM150C;CCR2;CCL2;KCNA2;SCN9A;GNAL;CHRNB2;ALOXE3;P2RX7;TRPV2;CLRN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4580634743758678,-1.2211859642133738,0.18114143920595532,0.6594812154804935,1.0,11/22,26.52%,TIMP3;TIMP2;ADRA2A;APOE;ADAM9;GPLD1;PTPN3;PACSIN3;SNX33;NRDC;TIMP1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3763067541689436,1.2206732638701163,0.10363836824696802,0.673496211269718,1.0,48/291,10.32%,FOXO1;TGM2;TBX1;ESR1;MEF2C;PRKD1;DAPK1;AHR;PDGFB;SH3BP4;DAB2IP;FZD4;PDE2A;LYN;KCNQ1;PTK2B;GNB1;TNFRSF1B;RAP1B;PXN;SOX9;TIRAP;XBP1;PTPRK;CX3CR1;SBNO2;MAPK8;ATP2B4;RET;WNT5A;RAPGEF2;WNT9B;IL36G;INPP5K;PPBP;RAP1A;BRINP2;NFKB1;PKD2;LPL;CASP1;RPTOR;CREB1;DEFA6;CDK2;NRIP1;TWF2;LARS1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.40364164939427444,1.2204982895445515,0.15228426395939088,0.6731440582257968,1.0,29/121,10.82%,PECAM1;IL6ST;IL15;PDGFB;NEDD9;IL6R;ARHGEF2;LYN;STAT3;EFNA1;PTK2B;PTPRJ;PLCG2;PAK2;GHR;GREM1;ENPP2;ACVR1;CD40;STAP2;TNFRSF1A;TGFB1;ITGA5;PTPN1;IL23A;FCGR1A;SEMA4D;GAS6;EPHA4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5902715016177594,1.2203529994675943,0.2509433962264151,0.6727053281706493,1.0,3/10,4.17%,TBX1;LRP5;SOX9
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5710242321878396,1.2198358895528647,0.2534013605442177,0.6733965412521142,1.0,4/15,4.00%,KDR;PRKD1;PRKD2;TMSB4X
prerank,histone acetylation (GO:0016573),0.4397561820078311,1.2198061797772726,0.20080862533692723,0.6726686810105001,1.0,16/69,15.21%,LEF1;EPC1;PHF20;JADE2;JADE1;KAT6B;HAT1;JADE3;YEATS2;EP400;PHF20L1;KAT2B;MBIP;KAT6A;ZZZ3;TRIM16
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5199110590430674,1.219159491127755,0.24324324324324326,0.6736157670267462,1.0,5/25,8.24%,SPTBN1;PRKD2;PDE4D;PLCG2;MALT1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5559157889420213,1.2191045469974697,0.23752151462994836,0.6729316356219468,1.0,7/16,22.36%,INSR;BNIP3;IGF1R;IRAK3;GLE1;TBC1D25;HDAC6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.607287507305909,1.21848800460796,0.2831215970961887,0.673832650563211,1.0,3/11,7.50%,NOVA2;IGF2BP3;RASA1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5160848302692413,1.2183696918977533,0.22128378378378377,0.6733567055411616,1.0,6/24,9.69%,HTR2A;PLCG2;LCK;ITPR3;PKD2;ERO1A
prerank,erythrocyte differentiation (GO:0030218),0.4704552540796618,1.2180327992924085,0.23485967503692762,0.6735066339502698,1.0,8/44,5.14%,LYN;TAL1;MFHAS1;ALAS1;RPS19;JAK3;RPS14;KMT2E
prerank,regulation of hemopoiesis (GO:1903706),-0.553094001296005,-1.2173263273251014,0.256,0.6690033105961073,1.0,4/10,14.21%,PTN;PRKCB;RUNX1;IL17D
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4680057890088565,-1.2172013403001596,0.1891891891891892,0.667616116119341,1.0,8/19,17.50%,RENBP;PGM3;NAGK;GFPT1;GFPT2;UGP2;GNPDA1;UGDH
prerank,intestinal lipid absorption (GO:0098856),0.6065125502545018,1.2171022981611381,0.27121771217712176,0.6751957394270833,1.0,3/11,13.49%,UGCG;SOAT2;LIMA1
prerank,Golgi ribbon formation (GO:0090161),0.5798712111501332,1.2169566805025833,0.24865831842576028,0.6748216215044289,1.0,5/13,8.42%,STX6;VAMP4;VTI1A;GCC2;TMED5
prerank,cellular response to hexose stimulus (GO:0071331),0.5194749927303649,1.2168356461778964,0.2504118616144975,0.6743264547582875,1.0,8/23,13.47%,UNC13B;ERN1;KCNB1;XBP1;SOX4;GAS6;RACK1;IGF1R
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.40116913662770465,1.2166380320031236,0.172544080604534,0.674051982991244,1.0,26/118,10.82%,SHANK3;ABI3;TBX1;LFNG;MEF2C;NEDD4L;ADGRA2;PLXND1;LZTS1;PPFIA2;FLT4;PAK2;CDH2;DLL1;TSPAN12;CEACAM1;FMNL2;EGLN1;TNIK;TGFB1;NEDD4;ZRANB1;CYRIB;SEMA4D;RC3H1;EPHA4
prerank,regulation of activated T cell proliferation (GO:0046006),-0.417546948113413,-1.2165249184282798,0.1693121693121693,0.6677624389325111,1.0,4/30,5.19%,IGF1;IGFBP2;IL18;IGF2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5183609768365118,-1.216512874154844,0.21945701357466063,0.6660660891437687,1.0,5/13,12.06%,IRS1;IGF2;PRKCZ;ECHDC3;SNX5
prerank,artery development (GO:0060840),0.5127978406778341,1.2164115112202902,0.23809523809523808,0.6739036315100053,1.0,6/23,5.18%,BMPR2;ENG;TBX1;ACVRL1;PDE2A;SMAD7
prerank,morphogenesis of an epithelium (GO:0002009),-0.44445909251017607,-1.2161247363014291,0.2020460358056266,0.6654718542436368,1.0,5/25,6.69%,FGFR2;DAG1;TBX18;LRP6;AHI1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.42114881614715743,1.2159717246580315,0.18855656697009102,0.674330285588395,1.0,19/87,8.36%,ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;USP15;DUSP22;ACVR1;TGFB1;PTK2;CITED1
prerank,Rap protein signal transduction (GO:0032486),0.6187538875044273,1.2158928652583907,0.26353790613718414,0.6737028141360367,1.0,4/10,7.53%,RAP1B;PLK2;RAPGEF2;RAP1A
prerank,metal ion homeostasis (GO:0055065),0.4702542342151758,1.2158796933893634,0.20121951219512196,0.6729278474883094,1.0,7/40,11.63%,TMTC2;CAV1;SLC12A7;TRPV6;SLC12A9;CYP27B1;GRIN1
prerank,negative regulation of metabolic process (GO:0009892),-0.36852037967212614,-1.215769587722738,0.13291139240506328,0.6646993457701219,1.0,10/54,7.09%,PLCL1;ALDH1A1;DOCK7;LGR4;NPR3;ADAMTS5;FOXC2;ACOT11;NOVA1;RBPJ
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4653698102180915,1.2157465238024248,0.22340425531914893,0.6725053503655296,1.0,6/46,3.63%,TEK;PARVB;PEAK1;EFNA1;SRGAP2;PXN
prerank,axon development (GO:0061564),-0.347973441851068,-1.2155312507362876,0.11538461538461539,0.6637147085656201,1.0,20/78,11.40%,DOCK7;FGFR2;SEMA5A;GRM7;BRSK1;PLP1;S100A6;ANK3;SHTN1;RYK;NTNG1;S100B;CTNNA2;DCC;NRCAM;BAIAP2;NREP;RAB10;GAP43;CNTN4
prerank,regulation of keratinocyte migration (GO:0051547),-0.536587934925234,-1.2151040989007897,0.2482758620689655,0.6633420063602197,1.0,11/12,46.22%,IQSEC1;ADAM9;FGF7;FGF10;PTEN;MTOR;EPB41L4B;MAP4K4;ARF6;EPPK1;MMP9
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4227521268095584,1.214877614648066,0.1742627345844504,0.6740930701451691,1.0,16/83,12.41%,CDK17;CDK6;EIF4E;PLK2;ACVR1;CDKN1B;POLA1;CDT1;BRD4;CDK2;BACH1;CDK18;RB1;EIF4EBP1;CUL1;MAX
prerank,muscle organ development (GO:0007517),-0.3769453457262895,-1.2145748160268925,0.15680473372781065,0.6631885672860035,1.0,14/54,7.50%,LAMA2;IGF1;DMD;SGCD;COL6A3;FHL1;VAMP5;LARGE1;SGCE;ITGA11;SOX6;EVC;SPEG;MKX
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5740585989119884,1.2141262688797763,0.2596491228070175,0.6753813225292372,1.0,5/15,7.03%,KDR;PTK2B;SRMS;DYRK1A;BMX
prerank,central nervous system myelination (GO:0022010),-0.5319788879889851,-1.2140338471651662,0.25877192982456143,0.6629403411582828,1.0,8/11,22.52%,PLP1;B4GALT6;CNTNAP1;MYRF;TENM4;PTEN;ABCA2;SOX10
prerank,negative regulation of JNK cascade (GO:0046329),0.48582282655370124,1.213193613798598,0.2363919129082426,0.6771503236465357,1.0,1/31,0.03%,MECOM
prerank,regulation of intracellular protein transport (GO:0033157),0.49417965539738323,1.2131510082071177,0.2285276073619632,0.6764637293519818,1.0,10/32,15.49%,PTPN14;LCP1;PRR5L;PCNT;TGFB1;GCC2;PTPN1;UHMK1;NDEL1;CEP290
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5729255911358007,1.2128485487547844,0.2669039145907473,0.6764695540132671,1.0,5/13,12.94%,NOTCH1;CPE;FOXF1;SFRP2;TGFBR2
prerank,negative regulation of receptor internalization (GO:0002091),0.5807469364376886,1.2126751868012777,0.2593283582089552,0.6761372705174197,1.0,3/12,4.85%,ANKRD13A;RIN3;SDCBP
prerank,protein acetylation (GO:0006473),0.49268032483585056,1.2120209984317671,0.2340764331210191,0.6771177752336967,1.0,6/30,15.40%,FOXO1;HAT1;NAA11;KAT2B;KAT6A;NAA16
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.43108348402502117,1.2119514897361354,0.20445062586926285,0.6764894435444149,1.0,14/72,8.10%,TEK;FLT1;KDR;INSR;PDGFB;LYN;PDGFD;SELP;SOX9;PDGFC;PIK3CG;PTK2;NEDD4;GAB1
prerank,regulation of filopodium assembly (GO:0051489),-0.39962958540099847,-1.2109921422403607,0.19197707736389685,0.6702267392306579,1.0,16/38,15.29%,DPYSL3;DOCK11;NRP1;RHOQ;PRKCD;ARAP1;TENM2;FXR2;NLGN1;RIPOR2;TGFB3;GAP43;PALM;PLPPR5;RALA;CAPZB
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.353516859463028,1.2107783808895367,0.005,0.6789919582421097,1.0,240/1646,11.61%,MECOM;DACH2;ERG;LEF1;ELK3;FLI1;RPS6KA5;FOXO1;LHX6;EPAS1;CDK17;CD38;TEAD4;HDAC9;ATP8B1;DACH1;ZHX3;PBX1;ENG;TBX1;SLC39A8;APBB2;ESR1;SMARCA2;PPARD;TSHZ2;MEF2C;CBFA2T3;ZBTB16;TOX4;SOX7;ACVRL1;NR5A2;INSR;AHR;ETV6;SMAD1;ZIC3;NFATC1;LRRFIP1;PDGFB;IRF2;FOXP1;GATA2;DAB2IP;SOX13;ELF2;MLLT3;MED13L;FZD4;HHEX;LRP5;TAL1;STAT3;NR3C1;NOTCH1;HIF1A;EBF1;PPM1F;KLF7;RREB1;AFAP1L2;KLF8;CCNK;KDM3A;SOX17;TGIF1;PKNOX2;PITX1;WWTR1;PLCB1;ARID3B;CHD7;ZFP57;SOX18;BAZ2B;JMY;TCF12;TSHZ1;HMBOX1;FOSL2;MAFF;TOX;SOX9;PKN1;ZBTB46;NCOA1;RPS6KA3;KLF2;ZNF292;FOXF1;FOXQ1;ELK4;IKBKB;RPS6KA1;SP6;VGLL4;DTX3L;SCMH1;FOXL2;ZFP92;ID1;EPC1;TCF7L1;LIN54;KMT2E;PTPRK;SMAD7;SPIN1;FOXF2;SBNO2;ARID1B;ATP2B4;HOXA10;PHF20;RET;MTF2;TCF7L2;TCF4;JMJD1C;LIN9;TEAD2;PITX3;PPP3CB;ESRRG;WNT5A;CNBP;SKAP1;ATF7IP;RCOR1;TOX3;ATMIN;KLF10;ACVR1;FOXA3;ELF5;FOSL1;IRF2BPL;SOST;INPP5K;ASCC1;HNF1B;DYRK1A;CDKN1B;ETS2;JUNB;TRIB3;ASCL4;KLF13;LYL1;CHD1;SPDEF;ARRB1;HNRNPK;TGFB1;FOXN2;HOXD8;HOXD1;TGFA;BCL3;ZNF326;GMEB2;TCF3;HNRNPD;NFKB1;GATAD2A;MAMSTR;PCBD2;ARID1A;KDM4C;NEUROD1;CTBP1;POLA1;WWC2;BACH2;CITED1;NRL;CDT1;ZNF2;CREM;KAT6B;PHF6;SMARCA5;PSEN1;CREB1;FOXK1;PRDM8;CRK;MYBBP1A;SUB1;BRD4;PCGF5;CHD2;HINT1;TCF15;SOX4;RELB;MAP2K3;AEBP2;MAFB;BRIP1;BACH1;MED27;RNF4;YEATS2;EDRF1;NFIB;CREB3L4;MAMLD1;MAD2L2;SP2;KLF12;SMAD5;SRCAP;SFRP2;USF2;EGR3;FOXN3;SMARCE1;ZBTB10;CDK18;PHF20L1;TFAP4;GAS6;POU2F1;CSRNP1;SPEN;RBM15;BTG1;CNOT2;MMS19;ZMIZ1;ENY2;RB1;ZMYND11;ATF6;EID1;CBFB;SP3;CEBPD
prerank,regulation of myeloid cell differentiation (GO:0045637),0.43605203818367005,1.2105588014554496,0.19827586206896552,0.6787754123059877,1.0,13/62,11.57%,MEF2C;ZBTB16;CDK6;LYN;PTK2B;KMT2E;H3-3A;TNRC6C;ZFPM1;MAFB;EIF6;RBM15;CBFB
prerank,cAMP biosynthetic process (GO:0006171),-0.5672029443600586,-1.2099637633808114,0.24416135881104034,0.671511035954785,1.0,5/10,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5116875956615248,-1.209399868914797,0.2013129102844639,0.6714540361063838,1.0,6/13,23.99%,RNF152;CASTOR2;SZT2;SESN2;ITFG2;ATM
prerank,cellular response to retinoic acid (GO:0071300),0.4749412515716629,1.2092104824547332,0.23609022556390977,0.6817485569623802,1.0,12/42,11.12%,TBX1;FZD4;LYN;PTK2B;SOX9;RET;WNT5A;WNT9B;BRINP2;CREB1;TWF2;ABL2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5917673000995674,1.209055165455074,0.2697495183044316,0.6813763381237238,1.0,5/11,14.03%,ATF7IP;TASOR;PPHLN1;SIRT6;SETDB2
prerank,fatty acid biosynthetic process (GO:0006633),0.4383748414565147,1.2089109667965061,0.21794871794871795,0.6809727086809941,1.0,10/63,11.84%,ELOVL7;PTGS2;ABHD2;ELOVL5;XBP1;ASAH2;LPL;LTC4S;DEGS1;ABCD1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5910127351758018,1.2088646212367542,0.2560296846011132,0.6802983820730948,1.0,4/12,11.57%,ELF2;LYN;RC3H1;CBFB
prerank,regulation of protein phosphorylation (GO:0001932),0.3714329605864972,1.2085422095716787,0.12121212121212122,0.680326883588489,1.0,42/256,8.63%,TEK;LIMCH1;PECAM1;KDR;ENG;TBX1;APP;PDE8A;OCLN;INSR;VEGFC;PPP2R5A;DAB2IP;LYN;FAS;EFNA1;FNIP2;BST1;FYN;WWTR1;FLT4;FGF23;SOX9;STK4;RALB;VEGFD;ACVR2A;LIMK2;CCDC88A;PRR5L;KRAS;CD40;INPP5K;RAC1;ARRB1;TNIK;TGFB1;PTK2;NIBAN1;PPP2R5E;PPP2R5B;AKT2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5197899769633217,1.2084750548083785,0.26121794871794873,0.679680887888326,1.0,7/24,10.44%,PDE2A;RASD2;PDE4D;PRKAR2B;RAPGEF2;CGAS;APLNR
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4390675352420755,1.2083696431330864,0.21805555555555556,0.6791488877235624,1.0,24/59,23.27%,DAB2IP;NFKBIA;IKBKB;TNFRSF1A;BCL3;RELB;IKBKG;RIPK1;RELA;RIPK2;BIRC3;NKIRAS1;TRAF6;ERC1;TBKBP1;TAB3;BIRC2;IRAK2;TIFA;BCL10;REL;NLRC3;TANK;TRAF2
prerank,cell junction organization (GO:0034330),0.4283404202594699,1.2079898863862315,0.19889502762430938,0.6793946889942495,1.0,13/71,9.63%,TJP1;APBB2;APP;OCLN;PPFIBP1;LIMS2;TJP2;PPFIA2;OPHN1;TGFB1;AGRN;PSEN1;TJP3
prerank,C4-dicarboxylate transport (GO:0015740),-0.49722635118261277,-1.2078827060046249,0.220873786407767,0.674108527101144,1.0,10/14,32.78%,SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC25A14;SLC13A5;SLC25A10;LRRC8E;LRRC8D
prerank,small GTPase mediated signal transduction (GO:0007264),0.4085666085245642,1.2074501602105876,0.1784776902887139,0.6801381029845461,1.0,22/103,10.11%,ARHGAP31;RAPGEF5;NTN1;PRKD1;BCR;GNB1;RREB1;GRAP;RASGRP3;RALB;PLK2;CCDC88A;RAPGEF2;KRAS;NRAS;RAC1;SHOC2;RAB38;CDK2;G3BP1;MAPK11;RGL2
prerank,protein N-linked glycosylation (GO:0006487),0.42850098368452233,1.2074135240396717,0.19722222222222222,0.6794239118418505,1.0,5/66,1.62%,ST6GAL1;SLC39A8;ST3GAL1;MGAT4A;STT3B
prerank,icosanoid metabolic process (GO:0006690),0.47204757462043534,1.2072508329739058,0.22664624808575803,0.679078006359605,1.0,7/40,8.64%,PTGS2;PLA2G4A;PTGS1;EPHX1;ALOX5AP;PON2;LTC4S
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.473334574633252,1.206959277895877,0.2132132132132132,0.6791175296653322,1.0,7/35,8.29%,CAV1;NOTCH1;JAK3;GHR;BCL3;PIGU;NF2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4465912458154512,1.2064756267932177,0.23088235294117648,0.6796037310275027,1.0,8/52,7.37%,PRKCH;STX3;SPTBN1;NKD2;SORBS1;ATP2B4;ITGA3;ATP2C1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.4858890119808523,-1.2064455145755804,0.26410835214446954,0.6765585478229911,1.0,9/15,10.72%,LRP1;AEBP1;DDR1;FAP;EFEMP2;RUNX1;DDR2;SLC2A10;FGFR4
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5618994398912666,1.2061992548738758,0.2698412698412698,0.6795591848925296,1.0,5/14,11.40%,PPP3CA;PPM1F;NCK1;PPP2R2C;PPP2R2D
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3549562141074463,1.2058158222119761,0.045454545454545456,0.6797657722787982,1.0,135/807,12.75%,MECOM;LEF1;ELK3;RPS6KA5;FOXO1;CD38;HDAC9;ATP8B1;DACH1;ZHX3;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;CBFA2T3;ZBTB16;SOX7;AHR;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;PPM1F;KLF7;RREB1;KLF8;TGIF1;PLCB1;ZFP57;SOX18;HMBOX1;SOX9;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;VGLL4;SCMH1;FOXL2;ID1;EPC1;PTPRK;SMAD7;DLL4;SBNO2;MTF2;TCF7L2;DUSP22;WNT5A;CNBP;ATF7IP;RCOR1;KLF10;NR1I3;FBP1;IRF2BPL;INPP5K;CDKN1B;ETS2;TRIB3;SPDEF;TGFB1;BCL3;TCF3;NFKB1;GATAD2A;CTBP1;WWC2;CITED1;CREM;KAT6B;PHF6;EZH1;PSEN1;CREB1;TAF3;FOXK1;MYBBP1A;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;SFRP2;UBE2D3;FOXN3;SEMA4D;SMARCE1;TFAP4;GAS6;POU2F1;SPEN;RBM15;CNOT2;RB1;ZMYND11;EID1;CBFB;SP3;SAMD1;PRDM2;DCAF1;MUC1;NOP53;MIER1;SIRT6;RELA;MAX;PRICKLE1;PA2G4;ZFP36;RPL10;MIDEAS
prerank,regulation of cell growth (GO:0001558),0.3746229927436855,1.2057359209399339,0.13387660069848661,0.6791817481453767,1.0,36/204,11.67%,BMPR2;NET1;DCUN1D3;APBB2;SMARCA2;ACVRL1;SH3BP4;SOCS2;ADAM10;NPR1;PTPRJ;SOX17;KIF26A;TAOK2;RPS6KA3;PPP1R9B;SDCBP;RPS6KA1;VGLL4;CEACAM1;H3-3A;CISH;ADAM15;JADE1;FBP1;DCSTAMP;CDKN1B;TGFB1;RPTOR;SGK3;MAD2L2;CYP27B1;SFRP2;BTG1;RB1;IL17RB
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37826160294628397,1.2054532323887839,0.14285714285714285,0.6791512852284436,1.0,27/214,7.53%,SEMA6A;TEK;KDR;APP;PDE8A;ICAM1;SEMA7A;CNKSR3;PDGFB;HTR2A;DAB2IP;LYN;PRKD2;MFHAS1;PDGFD;PTK2B;FBXW7;NOTCH1;FLT4;TIRAP;ARHGAP8;CEACAM1;RAPGEF2;PDGFC;ARRB1;TGFB1;RAP1A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5353947143667135,1.2050588420768604,0.2696817420435511,0.6794820956215816,1.0,3/16,3.01%,PTGS2;SOX13;RREB1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4138012835394371,1.205041324490192,0.19463087248322147,0.678739537225542,1.0,15/88,10.49%,EXOC6;CLINT1;APP;EXOC6B;SCAMP1;DOP1B;ARRB1;AP2A1;EXOC5;AP1S2;LLGL1;SNAP23;PUM1;EXOC4;VAMP8
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.47000341024912967,1.203683167516954,0.22065727699530516,0.6817423790107245,1.0,13/37,15.95%,CAV1;NCK1;BOK;RPS7;BCL2L11;LCK;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF
prerank,negative regulation of myoblast differentiation (GO:0045662),0.575483208882449,1.2034102831136886,0.26306620209059234,0.6816714023352636,1.0,5/13,12.49%,NOTCH1;SOX9;DLL1;TGFB1;PRICKLE1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.46030661551618846,1.2033185848115255,0.2220609579100145,0.6811280907180852,1.0,14/44,19.01%,NANOS3;NANOS2;TNRC6C;PRR5L;PUM1;BTG2;CNOT1;RC3H1;ZFP36;CNOT7;PNPT1;ZFP36L1;METTL14;DHX36
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3828380081010153,1.203091951116332,0.17969661610268378,0.6809548590239501,1.0,22/166,8.71%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;CAVIN1;TEAD2;ESRRG;NR1I3;GTF2F2;TAF1B;POLR1A;GTF2E2;RRN3;SMARCA5;TAF3;TAF4B
prerank,regulation of biomineral tissue development (GO:0070167),0.49895176838774263,1.2030350377378396,0.25316455696202533,0.6803396993012734,1.0,8/26,10.66%,NOS3;S1PR1;NOTCH1;SOX9;TGFB1;ANKH;CYP27B1;GAS6
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4854660648947883,-1.2025860329525286,0.22654462242562928,0.6864160650758769,1.0,4/16,6.44%,APPL2;PPARA;PPARGC1A;PRKAG2
prerank,regulation of synapse maturation (GO:0090128),0.5885397897026228,1.2024456811708863,0.2846580406654344,0.6811312990682495,1.0,2/10,2.14%,ARHGEF15;DAB2IP
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4061711447998865,-1.202384245473036,0.24719101123595505,0.6852503897837242,1.0,9/34,12.60%,ANK2;ATP1B1;SLC8A1;P2RX4;PRKACA;ATP2A2;RYR2;SLC9A1;ADRA1A
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5207906673721813,1.2022437183241046,0.2928082191780822,0.6809272245001775,1.0,8/21,15.15%,MYH9;ADAM10;SPPL2A;ERAP1;PSEN1;APH1A;ADAM17;SPPL3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4607200936462418,-1.201917024792736,0.2379746835443038,0.6849745635663871,1.0,3/19,3.57%,CAMK1D;IL34;THBS1
prerank,melanosome transport (GO:0032402),0.5326815855120665,1.2018467192579698,0.2611683848797251,0.6804336242351917,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,pigment granule transport (GO:0051904),0.5326815855120665,1.2018467192579698,0.2611683848797251,0.6804336242351917,1.0,2/18,2.16%,RAB27A;RAB11A
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4992112634084832,-1.2015568380319448,0.2662037037037037,0.6843287259559538,1.0,4/15,3.39%,ATP1A2;SLC12A2;ATP1B1;SLC8A1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4474716327819206,1.2008774350551996,0.2127659574468085,0.6822348324051017,1.0,2/53,1.96%,CALCRL;HTR2A
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5138969129572918,1.2004465479050441,0.24921135646687698,0.6826117414038513,1.0,7/22,11.96%,KANK3;HIP1R;SSH2;TMSB4X;CYRIB;TWF2;PFN4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5943484803474297,1.1996882177103143,0.2764811490125673,0.6838473416184869,1.0,7/11,16.68%,ARHGEF2;CASP8;PELI1;YBX3;RIPK1;BIRC3;BIRC2
prerank,dopamine metabolic process (GO:0042417),0.5346554516911581,1.199395014029395,0.2584070796460177,0.6838769229574786,1.0,4/18,7.01%,MAOA;GCH1;MAOB;SNCAIP
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.47699223286484704,-1.1987940287263061,0.23222748815165878,0.6907317803352273,1.0,3/16,4.15%,PID1;PPARA;PPARGC1A
prerank,N-glycan processing (GO:0006491),0.5295630272608443,1.198788397315341,0.26252158894645944,0.6847784238571198,1.0,5/18,15.08%,MGAT4A;MAN2A1;ST8SIA4;GNPTAB;MAN1A2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.5786336273852627,1.198759402086465,0.28308823529411764,0.6840700672519595,1.0,3/13,12.73%,PTGS2;NAXE;SLC5A8
prerank,acylglycerol catabolic process (GO:0046464),0.4992543148426712,1.1979785346887268,0.2440944881889764,0.6853761797940066,1.0,6/30,15.26%,ABHD2;LIPE;LPL;FABP12;PNPLA2;FAAH
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3876628303896176,-1.1978726902149377,0.19122257053291536,0.6917275420282804,1.0,16/44,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4879988830790477,-1.1978666021604822,0.2511415525114155,0.6900294416197736,1.0,1/15,0.03%,ATP1A2
prerank,negative regulation of response to wounding (GO:1903035),-0.4627941327731237,-1.1974683619915927,0.22911694510739858,0.6895398942143285,1.0,8/19,16.96%,PTPRS;FGF2;CD109;CASK;AJAP1;SERPINE1;CERS2;MDK
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3357433152304888,-1.1967611345637614,0.1346153846153846,0.6899236331356239,1.0,24/86,13.54%,BMP6;ZEB2;SULF1;BMPR1A;FOXD1;BMP5;BMP7;TGFBR1;BMP4;THBS1;TWSG1;CCN1;RBPJ;TGFB1I1;DAB2;INHBA;HIPK2;SLC2A10;TGFB3;TGFB2;ACVR1B;NUP93;GDF11;GDF1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5046436370780292,-1.1963801791095054,0.2550335570469799,0.6892931014470185,1.0,5/12,23.79%,IDH2;IDH1;IDH3A;ACO2;IDH3G
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5034977774256673,1.196372144279689,0.26904376012965964,0.6888417109029675,1.0,5/25,9.93%,TAL1;STAT3;HIF1A;ACVR2A;MAPK11
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.546636808316021,-1.1962766620590142,0.2662192393736018,0.687897628045464,1.0,5/10,25.61%,GALNT13;POGLUT2;GALNT1;GALNT3;GALNT16
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.47565060466123604,1.1961997837906826,0.23919753086419754,0.6885323381635391,1.0,6/34,9.42%,PTPRB;PTPN12;PTPRJ;DUSP22;DUSP16;PTPN1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.37574906498800714,1.196071694178345,0.15339578454332553,0.6880960536713358,1.0,40/208,12.74%,NOD1;TNFSF10;ESR1;TNFRSF19;PRKD1;DAB2IP;TRIM14;CASP8;FKBP1A;TRAF1;PLCG2;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;WNT5A;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;TNIP1;ZMYND11;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;GSTP1;BIRC3
prerank,positive regulation of interleukin-12 production (GO:0032735),0.48702123188533364,1.195798676157294,0.24345146379044685,0.6880753254795902,1.0,7/31,12.40%,PLCB1;PLCG2;TIRAP;CD40;IL23A;MAPK11;RIPK2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3897563233123506,1.1949584436015495,0.18635809987819732,0.6895218460740855,1.0,17/138,8.71%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;MAML2;NR3C1;HDAC7;NOTCH1;WWTR1;TEAD2;ESRRG;NR1I3;GTF2F2;GTF2E2;TAF3;TAF4B
prerank,nuclear membrane disassembly (GO:0051081),-0.504360522262028,-1.1948807234112195,0.25158562367864695,0.6901633527674669,1.0,5/14,13.50%,PRKCB;LPIN1;PRKCA;AKAP8L;CNEP1R1
prerank,epithelial cell differentiation (GO:0030855),-0.3371727662416649,-1.1948712561049477,0.1346938775510204,0.6885007429105642,1.0,18/88,13.12%,FSTL1;MAF;FGFR2;BMP4;ERBB4;SCUBE1;ANXA1;SIX1;JAG1;DAB2;BDH2;GLI1;VEGFA;TAGLN;ANXA4;RAB10;FZD7;VDAC1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5099843868687034,1.194810374444991,0.2730210016155089,0.6891168256625789,1.0,6/23,8.15%,PIEZO1;MEF2C;EDN1;GREM1;TGFB1;ATP11A
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4264959259981664,1.1943900917716728,0.2078804347826087,0.6894963112269691,1.0,18/76,13.37%,CBFA2T3;SMURF1;RNF144B;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;PTK2;RNF139;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1
prerank,heme biosynthetic process (GO:0006783),0.5175386275121523,1.19416399397445,0.2634228187919463,0.6892902812072665,1.0,2/22,2.95%,ABCG2;ALAS1
prerank,regulation of response to biotic stimulus (GO:0002831),0.49868875263894685,1.194048424537954,0.24311183144246354,0.6888158126034415,1.0,11/28,16.96%,FOXP1;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;ERAP1;BIRC3;ZMPSTE24;BIRC2;ELMOD2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.47591324636738114,1.1940113536512813,0.2467948717948718,0.6881341565103974,1.0,10/35,11.54%,ESR1;PLPP1;NR3C1;KDM3A;DDX54;NCOA4;NEDD4;ARID1A;ZMIZ1;UBE3A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.43666760104239705,1.1939607057006578,0.23032904148783978,0.6874906703925201,1.0,19/54,16.68%,CASP4;CASP8;TRAF1;SPPL2A;IKBKB;HIPK1;TNFRSF1A;CASP1;IKBKG;GAS6;RIPK1;CARD16;GSTP1;RACK1;BIRC3;ADAM17;UBE2K;OTULIN;BIRC2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4990211854500325,1.1939413377799464,0.2549019607843137,0.6867872355216975,1.0,3/26,2.59%,SHANK3;APP;PTK2B
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3135153174964173,-1.1937929780128338,0.057971014492753624,0.6901270892009993,1.0,23/122,11.57%,SAMD4A;IGF1;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;THBS1;AR;FGF2;SMOC2;CPEB3;FXR2;IGF2;PRR16;GLI1;LARP6;RGCC;CIRBP;FGFR4;TGFB2;IRS2
prerank,synaptic vesicle localization (GO:0097479),0.5623579418264414,1.1936985595239544,0.2692307692307692,0.6866372812875011,1.0,1/13,0.41%,RAB27A
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5325268535368486,-1.1935291365930556,0.25165562913907286,0.6892177111920204,1.0,6/10,29.92%,DLGAP4;NPTXR;DLGAP1;DLGAP2;NPTX2;BEGAIN
prerank,negative regulation of nuclear division (GO:0051784),-0.5339511127934387,-1.1932459049736595,0.2290249433106576,0.6883260301725869,1.0,3/11,7.22%,BMP7;BMP4;TOM1L2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5028709472352162,-1.1928371384577985,0.26303854875283444,0.687844691468,1.0,4/14,7.11%,CPEB1;CPEB2;CPEB3;CPEB4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.32118459787982157,-1.1923313872833963,0.10619469026548672,0.6877420980852921,1.0,18/101,10.72%,SAMD4A;PLD1;CYFIP2;OGT;THBS1;ASPH;CPEB3;HSP90AA1;DACT1;FXR2;AGTR1;PRR16;EZR;BTRC;LARP6;INHBA;CIRBP;FGFR4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4910801314451078,1.1922141255821237,0.25,0.6898613556948351,1.0,8/28,12.61%,ADIPOR2;TNFRSF1B;CX3CR1;RAC1;SIRT5;NOS1AP;EIF6;ADIPOR1
prerank,axonogenesis (GO:0007409),0.36761096699725726,1.1921290320940123,0.16780045351473924,0.6892929445689279,1.0,41/237,10.82%,NRP2;SHANK3;SEMA6A;RPS6KA5;APP;SEMA5B;EPHB4;SPTBN1;SEMA7A;PLCG1;PARD3;EFNA1;NOTCH1;KLF7;BSG;FYN;TAOK2;LAMA3;ROBO4;EVL;LMTK2;LAMA1;SEMA6B;RET;ULK1;OPHN1;PPP3CB;WNT5A;PTK2;B4GALT5;GRB7;GAB1;SEMA6D;FEZ2;LLGL1;DSCAM;SIAH1;SEMA4D;CXCR4;SPTAN1;EPHA4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5824126692786645,1.1918626842068942,0.28651685393258425,0.6892053393492088,1.0,3/10,11.87%,PDE8A;STK26;RIPK1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5885627467989979,1.1917124058395936,0.25688073394495414,0.6888068126193105,1.0,3/10,4.17%,ZBTB16;ACVRL1;SOX9
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5569215486967471,1.1912006953079153,0.27797202797202797,0.689343830066442,1.0,4/14,5.28%,MMRN2;NOTCH1;CARD10;DLL4
prerank,intracellular lipid transport (GO:0032365),0.5171551622973406,1.1905941800825897,0.2616984402079723,0.6902568481095632,1.0,6/21,11.84%,CERT1;ACACB;ABCD4;PLEKHA8;CPT1A;ABCD1
prerank,Fc receptor signaling pathway (GO:0038093),0.3979447850617053,1.1904468324916209,0.1972187104930468,0.6898467803351286,1.0,39/110,23.11%,NFATC1;PLCG1;LYN;PPP3CA;PLCG2;PAK2;IKBKB;MAPK8;PPP3CB;RAC1;PSMA2;NFKB1;MALT1;IKBKG;PSMA8;PSMA6;CUL1;RELA;TRAF6;PSME1;LAT;SOS1;TAB3;CALM1;MAP2K4;PSMA4;GRB2;PSMF1;PAK1;BCL10;PSMB7;MAP3K1;PSMB1;MAP2K7;PSMD2;PSMA5;PSMC3;JUN;FCER1G
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4414243860742718,-1.1902201688754672,0.22762148337595908,0.6922866023138458,1.0,6/22,11.45%,BMP7;CD44;MBP;GCNT2;WNK1;FLOT2
prerank,cardiac ventricle development (GO:0003231),0.5235473678518094,1.190141768251846,0.25945017182130586,0.689954238470109,1.0,4/20,5.28%,ENG;PDE2A;NOTCH1;DLL4
prerank,endothelial cell migration (GO:0043542),0.47662708278404436,1.1900574200053782,0.25972006220839816,0.6894029782397331,1.0,8/37,5.02%,NOS3;MYH9;ADGRA2;PLXND1;PXN;SOX18;PLEKHG5;ID1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.37563112412689387,-1.1897913312023232,0.16778523489932887,0.6917970089735762,1.0,16/51,11.20%,LPAR1;ROCK2;PPM1E;ARHGEF10L;NRP1;CCN2;TGFBR1;ARHGEF10;TPM1;CARMIL1;SFRP1;FHOD1;RGCC;TGFB3;S100A10;PFN2
prerank,organophosphate ester transport (GO:0015748),0.501312264330428,1.1895871005644074,0.25742574257425743,0.6898430639648792,1.0,5/24,9.85%,PLTP;SCARB1;PRELID2;ABCA3;PITPNC1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49498460666267147,1.189538466496563,0.23434991974317818,0.6892116008743059,1.0,5/29,5.74%,ELOVL7;ACSL4;FASN;ELOVL5;ACSL5
prerank,keratinocyte differentiation (GO:0030216),0.49007543643754753,1.1895140336205898,0.2442622950819672,0.6885105507737407,1.0,7/29,14.08%,UGCG;BCR;EXPH5;WNT5A;CLIC4;TXNIP;ASAH1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4883154719214746,1.1894524780933575,0.26812816188870153,0.6879017125826626,1.0,4/29,5.65%,LEF1;TLE4;TCF7L1;TCF7L2
prerank,blood vessel diameter maintenance (GO:0097746),0.4724477159774847,1.1889291321800184,0.23510971786833856,0.6885226414195452,1.0,5/34,5.56%,NOS3;EDN1;NPR1;KLF2;KCNMB4
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5100327113955794,1.1888075030550147,0.2638655462184874,0.688055467132688,1.0,2/24,2.95%,ABCG2;ALAS1
prerank,negative regulation of cell migration (GO:0030336),0.3860875484366032,1.1885787172921962,0.18030690537084398,0.6879635249915008,1.0,23/137,6.77%,PTPRG;LIMCH1;MCTP1;DACH1;ENG;NEXMIF;ACVRL1;CLDN5;ADARB1;DAB2IP;SRGAP3;SRGAP2;PTPRJ;STK24;SRGAP1;ADGRG1;EVL;PTPRK;SMAD7;DUSP22;ADAM15;RAC1;STK26
prerank,membrane repolarization (GO:0086009),-0.49304132894067154,-1.1882429505334697,0.2557603686635945,0.694701478091415,1.0,5/15,9.89%,ATP1A2;ATP1B1;KCND3;KCNJ2;ATP1B2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5306536332900885,1.1879833390544927,0.30017152658662094,0.6880253148001285,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,cellular response to interleukin-7 (GO:0098761),0.5306536332900885,1.1879833390544927,0.30017152658662094,0.6880253148001285,1.0,7/17,11.13%,SOCS2;STAT3;JAK3;CISH;JAK1;IL7R;IL7
prerank,mesonephros development (GO:0001823),-0.530413037639958,-1.1878485469070503,0.2781316348195329,0.6942302432372642,1.0,4/11,2.95%,FGF1;BMP7;OSR1;BMP4
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.30721389582479314,-1.1876103468295274,0.1103448275862069,0.693267555592332,1.0,30/166,10.72%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;IRS1;SLC6A9;LPGAT1;THBS1;P2RX4;FGF2;SMOC2;CPEB3;PPARGC1A;HSP90AA1;FXR2;SMAD3;IGF2;LDLR;SREBF1;PRR16;GLI1;LARP6;RGCC;ARNT;CIRBP;SLC27A1;FGFR4
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.5406194141099882,-1.1875013515724189,0.29978118161925604,0.6919232507882043,1.0,2/10,7.15%,IL18;PRKCZ
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5016898239488188,-1.1874522632441433,0.2597402597402597,0.6904078530116428,1.0,3/13,6.95%,ERRFI1;CBLB;SNX6
prerank,regulation of ossification (GO:0030278),0.48055549298053474,1.1869663871323621,0.23501577287066247,0.6898828690646378,1.0,11/36,10.26%,BMPR2;MEF2C;ZBTB16;S1PR1;NOTCH1;SOX9;WNT5A;ACVR1;SOST;ANKH;CYP27B1
prerank,regulation of interleukin-1 production (GO:0032652),0.5558658757967339,1.186686168210942,0.2869269949066214,0.6898481542239373,1.0,3/15,10.66%,FOXP1;CEACAM1;GAS6
prerank,regulation of osteoblast differentiation (GO:0045667),0.41410011758021675,1.186151025351765,0.22251308900523561,0.6906108304404768,1.0,19/82,8.36%,ZHX3;BMPR2;IL6ST;MEF2C;PRKD1;CDK6;IL6R;LRP5;HDAC7;NOTCH1;WWTR1;FGF23;SOX9;ACVR2A;GREM1;ACVR1;PTK2;CTNNBIP1;CITED1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.53354624101535,-1.1861155624343829,0.2542016806722689,0.6925231688498887,1.0,4/11,10.12%,IGF1;IRS1;TSC2;EIF2AK3
prerank,regulation of cholesterol storage (GO:0010885),0.5442053650937446,1.1859288393679697,0.26245847176079734,0.6904407370572782,1.0,5/15,15.52%,PPARD;SCARB1;LPL;ABCG1;TTC39B
prerank,pyruvate metabolic process (GO:0006090),-0.3645416138312645,-1.1859262875170957,0.1619718309859155,0.691412078340982,1.0,21/52,27.79%,ME1;ENO2;ME2;HK2;TPI1;LDHB;VDAC1;HOGA1;PDHA1;DLAT;ENO3;PFKFB1;PFKM;PCK2;NR4A3;HAGH;ALDOA;PKM;ENO1;ALDOC;LDHAL6B
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5529390898001033,1.185685872566177,0.2924187725631769,0.6902928588581836,1.0,2/14,1.15%,PRKG1;MEF2C
prerank,response to cholesterol (GO:0070723),-0.466802551147946,-1.185439482886035,0.2531328320802005,0.6912089113521187,1.0,8/17,20.95%,TGFBR1;GRAMD1B;GRAMD1C;LRP6;SMO;GPLD1;PTCH1;ABCA2
prerank,limb development (GO:0060173),-0.41179294342443495,-1.185167161011308,0.21372031662269128,0.6903763238594943,1.0,5/28,5.42%,SMOC1;GLI3;PCSK5;RSPO2;SALL1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5119382530176488,1.1849502020120515,0.25370675453047775,0.6915348913999395,1.0,5/22,7.04%,PDGFB;PDGFD;TAOK2;GREM1;PDGFC
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5535688811675104,1.1848313093273117,0.2893772893772894,0.6911027927408308,1.0,2/13,2.87%,CAV1;PDE4D
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.516910058065273,1.1844021564531004,0.2708688245315162,0.6915196157892437,1.0,4/22,4.28%,DAB2IP;LYN;MFHAS1;TIRAP
prerank,gene silencing by miRNA (GO:0035195),0.46696522798922474,1.1840402995840305,0.24845679012345678,0.6917558186997907,1.0,10/32,13.14%,CNOT6;TNRC6C;DICER1;PUM1;CNOT1;EIF6;ADAR;PUM2;ZFP36;CNOT7
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.41630232829279,1.1836540337666484,0.22159887798036465,0.6920063733032201,1.0,12/78,7.33%,PRKCH;ABI3;STX3;SPTBN1;PPP2R5A;NKD2;NUMB;SORBS1;STX7;ATP2B4;TGFB1;ITGA3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5001465738010417,1.1835091775433744,0.28125,0.6916407428418903,1.0,4/25,5.85%,ABI3;TBC1D30;EVL;LIMK2
prerank,glycerophospholipid metabolic process (GO:0006650),0.4191644210562665,1.1834313160177359,0.21216216216216216,0.691109325265551,1.0,16/75,14.63%,GPCPD1;PLA2G4A;PLCG1;SERINC5;PLCB1;DGKH;ENPP6;ABCA3;PLA2G2D;SYNJ1;GDPD1;PIGQ;PIGG;PDXP;PNPLA6;PIGF
prerank,positive regulation of response to external stimulus (GO:0032103),0.3897848389685824,1.183308329942154,0.18546365914786966,0.6906896107701858,1.0,24/128,12.18%,APP;IL15;STX3;PDGFB;PDE2A;GBP5;PPM1F;NFKBIZ;NFKBIA;SCARF1;USP15;WNT5A;SASH1;TNFRSF1A;TGFB1;LPL;PUM1;IL23A;TNIP1;NMI;P2RY12;PUM2;RIPK1;OASL
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4914044963450116,1.1832954918530343,0.29489291598023065,0.6899918742715173,1.0,6/25,10.90%,HIP1;HIP1R;AFAP1L2;CCDC88A;BCAR3;CBL
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4159222382749865,-1.1828573492155672,0.20671834625322996,0.6953980947330668,1.0,6/28,9.84%,PRKN;PDK1;PPARA;RORA;EPHX2;APOE
prerank,purine nucleotide catabolic process (GO:0006195),0.5643588150553271,1.1827603315910415,0.296551724137931,0.6906341977382585,1.0,5/13,14.45%,GDA;NT5C2;HINT1;XDH;NUDT15
prerank,lipoprotein biosynthetic process (GO:0042158),0.5808709483716136,1.182452641526308,0.302367941712204,0.6907400645823971,1.0,1/11,1.17%,UGCG
prerank,microvillus assembly (GO:0030033),0.5723734985038027,1.1824431424401705,0.2862190812720848,0.6900172939544775,1.0,5/14,7.53%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,negative regulation of cilium assembly (GO:1902018),0.5661807313968406,1.1822848405576538,0.30124777183600715,0.6896644947101945,1.0,2/12,5.85%,TBC1D30;LIMK2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5302879320972563,-1.1821836317902454,0.2807017543859649,0.6957205214761031,1.0,6/10,21.14%,IRS1;IRS2;SLC45A3;SNCA;GPLD1;PTH1R
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4289593138801148,-1.1814306391496348,0.25252525252525254,0.6961521502592297,1.0,6/27,10.20%,ANK2;CACNA1C;DLG1;ATP2A2;RYR2;CTNNA3
prerank,microvillus organization (GO:0032528),0.5824801868068058,1.1813655445357338,0.2880143112701252,0.6913291994968687,1.0,5/13,7.53%,RAP1B;RAPGEF2;STK26;TNIK;RAP1A
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4395688781795931,-1.1812983680748732,0.24390243902439024,0.6949313309739137,1.0,2/22,1.34%,ALDH1A2;RBP1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5911723429569766,1.1812952740938214,0.2851782363977486,0.6907596992569522,1.0,2/10,0.86%,ENG;CAV1
prerank,chondrocyte differentiation (GO:0002062),-0.40735879058204816,-1.1811265182007575,0.20435967302452315,0.6938285184041132,1.0,11/32,10.12%,SOX5;SULF1;OSR1;SULF2;BMP4;SOX6;RUNX2;SLC39A14;CCN3;RUNX1;EIF2AK3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.417611112305693,1.1806970252064284,0.22655122655122656,0.6916298307401774,1.0,11/69,9.61%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,response to glucose (GO:0009749),0.4527248857331905,1.1805863808282502,0.2571428571428571,0.6911481409588672,1.0,14/46,13.79%,UNC13B;ERN1;KCNB1;XBP1;TCF7L2;LPL;NEUROD1;EIF2B5;SOX4;GAS6;RACK1;PFKL;IGF1R;EIF2B2
prerank,regulation of neuron differentiation (GO:0045664),-0.3313389635017154,-1.180575601020368,0.1527777777777778,0.6936737806143187,1.0,29/76,20.78%,ZFHX3;NBL1;BMP7;IMPACT;YWHAG;VWC2;NGF;SIX1;NLGN1;HEYL;LRRK2;DTX1;NRCAM;BIN1;ALK;NREP;CNTN4;BRINP3;GPRC5B;MMD2;DISP3;HEY1;CDK5RAP3;SOX2;REST;NTF3;ID2;TIAM1;KCTD11
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.3796626680496343,-1.1792923459250781,0.21686746987951808,0.6957704074364864,1.0,10/46,4.51%,IGF1;PDGFRB;OGN;IGFBP5;IL18;BMP4;CDH13;THBS1;IGFBP3;APOD
prerank,rRNA 3'-end processing (GO:0031125),-0.5435466081413126,-1.179004880263595,0.28817204301075267,0.695024752345043,1.0,4/10,19.18%,ERI3;EXOSC7;EXOSC3;EXOSC9
prerank,positive regulation of protein metabolic process (GO:0051247),0.39859607461452684,1.178995957709241,0.2169934640522876,0.694605900535943,1.0,18/110,9.89%,FOXO1;APP;SMURF1;DAB2IP;NEDD4L;PAEP;NFKBIA;KLF2;MAPK8;PLK2;WNT5A;CDKN1B;TGFB1;NEDD4;PSEN1;CSF1;IL23A;VPS28
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4529626716787818,1.178759153121002,0.22932917316692666,0.6944396779572078,1.0,9/38,10.82%,CAV1;APP;PDGFB;NEDD9;EFNA1;PTPN1;FCGR1A;GAS6;EPHA4
prerank,superoxide metabolic process (GO:0006801),0.47003398087637643,1.178035726429149,0.2669826224328594,0.6956441921811743,1.0,3/29,4.90%,NOS3;NRROS;PREX1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4192290072029397,-1.1770662998214991,0.24871794871794872,0.6988890180882109,1.0,10/26,17.21%,EGFR;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;CDK10;HYAL1;FGF10
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3838495123364073,-1.1767121949038288,0.19314641744548286,0.6982757716495024,1.0,13/45,13.85%,GLUL;ASPA;NOX4;NAALAD2;ASPG;SLC25A12;GPT2;GOT1;MTHFD1;RIMKLA;OAT;SLC25A13;CBS
prerank,cellular macromolecule catabolic process (GO:0044265),0.43913214118850613,1.1765550338306736,0.2318181818181818,0.6987635212776201,1.0,16/49,16.65%,STT3B;DAB2IP;ISG20;RNASEH2A;MTREX;UBE2G1;HNRNPD;RAB12;RNASEH2C;RIPK1;RNASEH2B;OGA;XRN2;RNF5;PNPT1;CHEK2
prerank,regulation of muscle cell differentiation (GO:0051147),0.48071972631948584,1.1765505191063939,0.25236593059936907,0.6980264297923119,1.0,9/31,9.93%,HDAC9;MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.44315548260076476,-1.1756652061282318,0.2619047619047619,0.6996215154079458,1.0,9/21,20.14%,DCDC2;EVC;ARMC9;GLI1;SFRP1;SMO;KIF7;ULK3;GAS8
prerank,leukotriene biosynthetic process (GO:0019370),0.5556652456562631,1.1754950329783092,0.3151183970856102,0.7000610465353897,1.0,3/14,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,triglyceride catabolic process (GO:0019433),0.5328908023665351,1.1753703431472649,0.281195079086116,0.6996557578144117,1.0,3/19,13.66%,LPL;FABP12;PNPLA2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5253564320144528,-1.1749791862255239,0.2600896860986547,0.6999331156951044,1.0,5/12,11.08%,NBL1;BMP5;CCN3;SLIT2;MIA3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5323145578533401,1.1749656970375952,0.3132328308207705,0.6999865987786469,1.0,5/18,12.67%,HDAC7;CD34;HOMER2;HOMER3;ZFP36
prerank,I-kappaB phosphorylation (GO:0007252),0.578066297047304,1.174634089908209,0.2937956204379562,0.7001043283833724,1.0,2/10,14.41%,DAB2IP;ERC1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5009973475775873,-1.1744949591809117,0.2823529411764706,0.6997356817966707,1.0,4/13,11.28%,ATP1A2;ATP1B1;ATP1B2;SLC9A1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4586519419047349,1.1744753291372763,0.26127527216174184,0.69977622254956,1.0,9/37,7.86%,ANKRD13A;RIN3;EDN1;PLIN5;SDCBP;PTX3;BTN2A2;SIRT5;NFKB1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5039640399803363,1.1742548209792312,0.2659758203799655,0.6996551929071045,1.0,5/23,8.93%,DAB2IP;EDN1;TNFRSF11A;SASH1;MAP3K11
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5678853944949042,1.173261683847301,0.3018181818181818,0.7015759869348059,1.0,5/12,13.03%,PTPN14;TGFB1;NEDD4;NUP214;UHMK1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.34567602108340617,-1.1728725661868666,0.1906474820143885,0.7028020104993937,1.0,18/72,17.23%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;RBFOX2;FLRT2;FLRT1;TIA1;FGFBP1;FGFR4;SPRED2;FGF7;POLR2B;POLR2K;HNRNPA1;FGF10;GTF2F1
prerank,regulation of nervous system development (GO:0051960),-0.38424431264454706,-1.1721234118191166,0.21766561514195584,0.7033465298854306,1.0,12/37,18.37%,DOCK7;PTN;SIRT2;PER2;HEYL;LGI4;BHLHE41;HEY2;NPHP3;TENM4;HMGB2;HEY1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4155895210934728,1.1718456617700022,0.24661246612466126,0.7046170669822373,1.0,18/75,13.24%,HEG1;RASIP1;DAB2IP;HHEX;LRP5;LYN;PTPRJ;PRKAR2B;PKIG;INPP5K;CDKN1B;PTPN1;TFAP4;RB1;STK38;GSTP1;INCA1;DUSP7
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.40611812786583223,1.1717741426963666,0.20427236315086783,0.7040787424267899,1.0,22/86,10.43%,PECAM1;APP;IL15;PDGFB;IL6R;ARHGEF2;EFNA1;PTK2B;PTPRJ;BST1;FYN;PLCG2;PAK2;GHR;ENPP2;ACVR1;TGFB1;ITGA5;SAMSN1;IL23A;SFRP2;SEMA4D
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.48153218995272673,1.1710897844655923,0.290625,0.7050745489238508,1.0,5/27,4.01%,SHANK3;TJP1;F11R;WASF2;PAK2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5376200833222797,1.1709636285823921,0.30286738351254483,0.704678917850515,1.0,4/15,7.33%,JAK3;SMAD7;CUEDC2;TGFB1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.46329377074307476,1.1709162434331482,0.26015037593984963,0.7040701738718776,1.0,11/39,12.94%,KDR;ENG;TIE1;RASIP1;LRP5;DLL4;PKD2;CITED1;SFRP2;MET;TGFBR2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5635612193092648,1.1706305950961922,0.30526315789473685,0.7040994431949246,1.0,5/13,12.36%,PPARD;PDGFB;SOX9;NFIB;RELA
prerank,cellular protein metabolic process (GO:0044267),0.34971355432250667,1.170328335107293,0.14149947201689547,0.7041717927766387,1.0,112/396,15.90%,ST3GAL6;APP;ST3GAL1;MGAT4A;MSRB3;DAB2IP;ADAM10;YES1;FUCA2;RPS15;FGF23;CPE;UBA7;CDH2;IGF2BP3;RPS19;RPLP1;RPS14;PADI4;RPSA;RPS16;RPL38;QSOX1;CSF2RB;SPARCL1;RPL34;ABCA3;RPS20;RPL39;VWA1;RPS7;RPS24;ST8SIA4;GOLM1;UBE2G1;RPL37A;SRBD1;RPL36;RPS18;RSL24D1;RPL15;PSEN1;AKT2;RPS8;RPL14;RPL23;RPL17;APLP2;FBXL2;FBXW2;CSF1;MRPS18A;ERO1A;RPL9;DHPS;RPL4;RAB12;RPL13A;UBE2D3;RPS11;RPL32;TNIP1;ICMT;GAS6;APH1A;RPL22;RPS27;RPL31;RPS23;ABL2;MRPL13;RPL13;MRPS12;RPS12;STK38;LGMN;RIPK1;MRPL35;HBS1L;RPL6;RPL10;WARS1;MRRF;OMA1;MRPL41;SPCS1;ADAM17;RPS29;RPS6;PNPLA2;MRPL52;PROC;RPL29;RPS25;RPL35A;RPS13;MSRB2;RPS21;MRPS16;RPL27;LAMB1;RPL18;MRPL23;SPPL3;EVA1A;RPL27A;MRPS5;TMEM132A;RNF5;RPS10;NAGPA;CP
prerank,lymphocyte migration (GO:0072676),0.4827691292905587,1.1700786410688626,0.2724505327245053,0.7041268565019084,1.0,4/32,10.41%,S1PR1;MSN;RET;CCL14
prerank,ribosomal subunit export from nucleus (GO:0000054),0.549725407580269,1.1684042358403695,0.30492424242424243,0.7077998809712223,1.0,5/13,14.04%,RPS15;XPO1;RRS1;EIF6;NPM1
prerank,nucleoside salvage (GO:0043174),0.5766272788103053,1.1679638829817862,0.3061594202898551,0.708189021074905,1.0,3/10,9.72%,UCK2;UPP1;HPRT1
prerank,protein targeting to lysosome (GO:0006622),0.5196191903296801,1.1679347816251449,0.2833333333333333,0.7075286522077119,1.0,9/20,18.80%,NCOA4;GCC2;NEDD4;SCARB2;M6PR;GNPTAB;RAB7A;NAGPA;GGA3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.44185740309618676,1.1676419561512823,0.24622356495468278,0.7075684295983572,1.0,11/45,8.10%,RPS6KA5;PLCG1;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,cellular protein catabolic process (GO:0044257),0.4113517155936724,1.1672419300938648,0.24528301886792453,0.7078972320912847,1.0,17/59,13.71%,CTSC;DAB2IP;CASP8;AP2B1;UBE2G1;AP2A1;CTSK;CTSO;MALT1;RAB12;PSMA6;BNIP3;LONP1;LGMN;RIPK1;MYLIP;RAB7A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5378480558338459,1.1666594071628762,0.3119584055459272,0.708688757296229,1.0,5/16,10.24%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.35424897166060276,-1.166619964139926,0.22695035460992907,0.7178910541853466,1.0,10/62,5.64%,ROBO1;NOTCH2;IGF1;LPAR1;COL3A1;AKAP13;RASGRF1;AUTS2;ALS2;NGF
prerank,dendritic cell migration (GO:0036336),0.5298442607738412,1.1664742135358288,0.2974910394265233,0.7084419870446093,1.0,3/16,10.51%,EPS8;PIK3CG;CXCR4
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.44441113953977895,-1.1662865644493063,0.2751322751322751,0.715642296567986,1.0,7/20,17.72%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.44441113953977895,-1.1662865644493063,0.2751322751322751,0.715642296567986,1.0,7/20,17.72%,ACADSB;MCCC2;IVD;BCKDHB;ACAT1;ACAD8;ALDH6A1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4363947786363336,-1.1661645956697098,0.2740740740740741,0.7127442450680322,1.0,10/23,18.64%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4363947786363336,-1.1661645956697098,0.2740740740740741,0.7127442450680322,1.0,10/23,18.64%,ZEB2;THBS1;TGFB1I1;DAB2;HIPK2;SLC2A10;CITED2;CDKN1C;FLCN;MEN1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.4742638138294159,-1.1658971860779095,0.2751196172248804,0.7119045971740823,1.0,6/16,24.15%,SLC39A14;PRKCA;GPER1;MRAP2;ACP3;C3
prerank,positive regulation of T cell differentiation (GO:0045582),0.4646410920354004,1.165893329877328,0.26605504587155965,0.7092707482912602,1.0,8/36,11.30%,LEF1;TESPA1;XBP1;IHH;SOX4;IL23A;IL7;ZMIZ1
prerank,regulation of mitotic cell cycle (GO:0007346),0.3737686807948806,1.1658763829063492,0.21385176184690158,0.7085630175041412,1.0,37/171,14.53%,APP;NEK7;IQGAP1;TAL1;PIM3;SIK1;AFAP1L2;TTC28;CAV2;PKN2;SDCBP;BTG3;EIF4E;ASAH2;CDKN1B;TGFB1;BRINP2;PSMA2;NEK6;ANAPC7;ANAPC1;BTG2;PSMA8;ANGEL2;PSMA6;TFAP4;BTG1;CDC26;RB1;EIF4EBP1;CUL1;LGMN;ANAPC16;CDC25C;BUB3;PDXP;PSME1
prerank,basement membrane organization (GO:0071711),-0.4884791056344072,-1.165774845557454,0.2789115646258503,0.7106182323882446,1.0,5/14,7.94%,NID1;NID2;NTN4;NTNG1;FLRT2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5805290645847452,1.1657103412578773,0.29944547134935307,0.7082766847477989,1.0,2/10,5.39%,CEACAM1;CX3CR1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.46703594038041885,-1.1654415398589544,0.2725118483412322,0.7100352235943671,1.0,3/16,4.93%,PRKN;PDK1;RORA
prerank,peptide catabolic process (GO:0043171),-0.43650053779158277,-1.1649731234841594,0.26356589147286824,0.7099316984971182,1.0,4/23,7.33%,CPQ;GGT5;NPEPPS;ENPEP
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4058252959867082,1.164922151161211,0.2237017310252996,0.70968639519912,1.0,20/85,13.55%,CBFA2T3;ECSCR;RNF144B;DAB2IP;FBXW7;NKD2;SMAD7;RNF144A;TRIB3;ATXN3;KCNE2;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;TRIB1;FMR1
prerank,positive regulation of macrophage migration (GO:1905523),-0.4501267678633305,-1.1646118528135938,0.2608695652173913,0.7094338061012657,1.0,3/19,3.65%,IL34;THBS1;P2RX4
prerank,regulation of myelination (GO:0031641),0.49572147482133944,1.164527103471671,0.28139904610492844,0.709971331138167,1.0,4/25,5.32%,JAM2;PARD3;TNFRSF1B;TMEM98
prerank,cell-cell junction assembly (GO:0007043),0.42512931926740016,1.1644093410772833,0.2546230440967283,0.7095666917154733,1.0,9/63,5.63%,TJP1;PKP4;CLDN5;PKN2;PAK2;CDH2;SMAD7;CTNNA1;RAMP2
prerank,regulation of acrosome reaction (GO:0060046),0.5691313321066017,1.1643998375609628,0.30397236614853196,0.7088677594974002,1.0,1/10,3.54%,PLCB1
prerank,regulation of phosphorylation (GO:0042325),0.3824986461121323,1.1632357883027407,0.20875,0.7113034648618841,1.0,30/120,14.81%,LDB2;ITGA6;APP;NLRC5;LYN;FNIP2;HIF1A;IKBKB;SDCBP;CCDC88A;CDKN1B;PTK2;DYNLL1;PSEN1;ANG;DSCAM;BTBD10;EIF6;NUP214;NUP98;CORO1C;NOP53;PHIP;SLC2A6;NUP133;NUP205;CDH5;NUP54;NUP43;NUP153
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4050867782291642,1.163145456590928,0.22192866578599735,0.7108258883983374,1.0,16/78,13.37%,CAV1;CBFA2T3;RNF144B;NKD2;SMAD7;RNF144A;TRIB3;RAD23A;SUMO2;HECTD1;COP1;NOP53;SIRT6;PRICKLE1;RACK1;TRIB1
prerank,cellular senescence (GO:0090398),-0.41401329824670197,-1.1627807349256523,0.24316939890710382,0.7132008788218653,1.0,13/27,28.81%,PRKCD;ECRG4;TBX2;CDKN1A;TBX3;MAP2K1;ULK3;TERF2;SMC6;ID2;CALR;CDKN2B;SMC5
prerank,cholesterol homeostasis (GO:0042632),0.4180292028835416,1.1626421929624777,0.2556179775280899,0.7113871983816792,1.0,9/64,8.24%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.39811621006803183,-1.1626282693016643,0.25067385444743934,0.7120246743764789,1.0,2/33,1.21%,IGF1;PRKN
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.49843617564051546,1.1619416697376024,0.26622296173044924,0.7125395182605855,1.0,5/23,9.38%,ELOVL7;ACSL4;ELOVL5;ACSL5;FAR2
prerank,regulation of necroptotic process (GO:0060544),0.5017082738733555,1.161692321966903,0.30317460317460315,0.7124413472280211,1.0,8/23,12.74%,ARHGEF2;CASP8;SDCBP;PELI1;MLKL;YBX3;RIPK1;BIRC3
prerank,positive regulation of T cell proliferation (GO:0042102),0.4244815296519288,1.1606246440232872,0.2585438335809807,0.7145026141592028,1.0,9/55,9.61%,IL6ST;VCAM1;IL15;NCK1;JAK3;IL27RA;TNFRSF13C;ICOSLG;IL23A
prerank,fatty acid elongation (GO:0030497),0.5377360928442794,1.1605830835066424,0.3196428571428571,0.7138749974227133,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,mammary gland epithelium development (GO:0061180),-0.4769832516875603,-1.16035261721614,0.29310344827586204,0.7169278683980923,1.0,2/14,3.30%,WNT4;ERBB4
prerank,regulation of cytokinesis (GO:0032465),0.40799434878905183,1.1602212512779349,0.24629878869448182,0.7141332730721852,1.0,22/78,21.87%,PKP4;RAB11A;PKN2;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;KIF23;PDXP;GIPC1;E2F7;CALM1;RHOA;CUL3;PRPF40A;CETN2;PRKCE;GIT1;PLK1;RACGAP1;PIK3R4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.406692859884335,1.1598551807754833,0.24108416547788872,0.7143953354566016,1.0,11/73,9.61%,APP;ARHGEF2;STAT3;PTPRJ;PLCG2;TIRAP;WNT5A;LPL;PSEN1;TNFRSF8;IL23A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5755482860356447,1.1594927921854177,0.3131868131868132,0.71459757728003,1.0,4/10,16.11%,DAB2IP;EFNA1;EPHA4;RIC1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.33516797581368774,-1.1593019700369844,0.1625441696113074,0.7183595837147624,1.0,21/74,11.51%,PHLDB2;COL1A1;EPHA3;BMP5;PDPN;PHLDB1;TGFBR1;SPRED1;DAG1;SMAD3;AXIN2;TGFB1I1;DAB2;VASN;SFRP1;GCNT2;RGCC;TGFB3;SPRED2;TGFB2;SPRED3
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5363263166444641,-1.1592167844708854,0.2962138084632517,0.717019591793549,1.0,3/10,6.71%,MAGI2;NGF;KIDINS220
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5035692871794134,1.1590157075028715,0.2847571189279732,0.7151321337988332,1.0,6/20,12.36%,SMAD1;NOTCH1;HIF1A;XBP1;SMAD5;RELA
prerank,negative regulation of developmental growth (GO:0048640),-0.39812572503185145,-1.1590115202841536,0.2594594594594595,0.7160291564484896,1.0,15/30,20.56%,PTPRS;MAP2;DCC;DUSP10;WWC1;CDKN1A;CDKL3;RTN4;SEMA3G;BBS2;ULK2;MT3;NKD1;PTEN;PTCH1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.48288316802710457,-1.1588062541691075,0.27314814814814814,0.7150968944603894,1.0,8/13,35.42%,SEC16B;CD81;SEC16A;EDEM2;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5404085258401703,-1.1587715183339016,0.2951945080091533,0.7136415434395729,1.0,6/10,32.74%,IQSEC1;ADAM9;FGF7;FGF10;MTOR;EPB41L4B
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4882825450736805,1.158573609480832,0.29595015576323985,0.7156010568323348,1.0,8/24,9.93%,MEF2C;CDH2;CTNNA1;TCF3;BNIP2;CDH15;SPAG9;MAPK11
prerank,regulation of cilium assembly (GO:1902017),0.41322730173765826,1.1582099558733898,0.2565880721220527,0.7158680739869151,1.0,7/62,7.59%,TBC1D8;TBC1D30;TBC1D22A;TBC1D15;LIMK2;CCDC88A;TBC1D2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3661957868347279,1.1579874472423208,0.20677570093457945,0.7157437936355333,1.0,51/193,18.42%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;ZNRF3;DTX3L;XBP1;KCTD10;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;RNF167;FBXL7;NEDD4;TRIM25;UBE2H;ANAPC7;RNF146;ANAPC1;SIAH1;RC3H1;CBL;CDC26;LONP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;ELOC;ARIH2;RNF5;AREL1;NDFIP2;NEDD8;UBE2I;CUL3;CDC34;RNF40;PSMF1
prerank,amino acid transport (GO:0006865),-0.3600755362609017,-1.1579277379393478,0.2082018927444795,0.7144593871955734,1.0,11/49,11.23%,SLC7A11;SLC7A2;PDPN;SLC1A5;SLC6A12;SLC38A11;SLC25A47;SLC6A15;SLC7A14;SLC7A6;SLC43A1
prerank,actin-myosin filament sliding (GO:0033275),-0.3879640533523764,-1.1578496678863623,0.2564102564102564,0.711540794619031,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,muscle filament sliding (GO:0030049),-0.3879640533523764,-1.1578496678863623,0.2564102564102564,0.711540794619031,1.0,6/38,13.64%,DMD;ACTN2;TPM1;TPM2;DES;TPM4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.41520514701700734,1.1576889724009323,0.2791666666666667,0.7157345136750702,1.0,13/64,15.26%,PTGS2;PLA2G4A;ACSL4;ELOVL5;EPHX1;ASAH2;ACSL5;LTC4S;CPT1A;ABCD1;GSTP1;PNPLA8;FAAH
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4078720029288526,1.1576631727182405,0.2543741588156124,0.7150781792533569,1.0,18/79,10.32%,BMPR2;EPN2;SMAD1;SMURF1;MMRN2;DAB2IP;HHEX;NOTCH1;SMAD7;ACVR2A;GREM1;ATP2B4;SOST;NEDD4;PTPN1;SKIL;SMAD5;UBE2D3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5724933571336441,1.1576342208266421,0.3537037037037037,0.7144381619911561,1.0,5/10,17.61%,PDE2A;PDE4D;APLNR;PDE3A;CDC34
prerank,neurotransmitter transport (GO:0006836),-0.33065315040078525,-1.1575395460740132,0.18076923076923077,0.7109084120162925,1.0,25/73,16.70%,ATP1A2;SLC1A3;GLUL;SYT1;APBA1;BRSK1;SNAP25;NAAA;NRXN1;SLC6A15;SLC1A2;LIN7A;GABRA2;SNPH;CASK;PTPRN2;SLC29A1;NRXN2;GAD2;SLC1A1;SLC22A2;RIMS1;DVL1;SYN1;PDZD11
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5587790115601038,1.157278115055987,0.31866197183098594,0.7146857598445654,1.0,4/12,7.56%,LY6E;PTX3;MID2;SNX3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5277604664392772,1.1572476126660671,0.32081911262798635,0.7140335540823317,1.0,5/19,10.12%,NFATC1;EDN1;PPP3CA;PPP3CB;NMUR2
prerank,sterol homeostasis (GO:0055092),0.414883159735142,1.1572097848207334,0.2542134831460674,0.7134232148401288,1.0,13/65,13.77%,HDAC9;CAV1;SCARB1;LRP5;MALL;XBP1;CNBP;SOAT2;LPL;CYP39A1;ABCD1;LIMA1;ABCG1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5475751987291403,1.1571272243149546,0.30824372759856633,0.712926029747077,1.0,2/13,3.86%,ELOVL7;ELOVL5
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5554141789153603,1.156721248517775,0.32196969696969696,0.7132327199201495,1.0,1/12,0.47%,CSGALNACT1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4028207655288328,1.15617578577943,0.2462787550744249,0.7139419474224762,1.0,13/80,8.27%,NOD1;TNFSF10;SOX7;DAPK1;PPM1F;RPS6KA3;RPS6KA1;FOXL2;XIAP;CYCS;GRAMD4;MALT1;CASP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.49613218468328046,-1.1559523415586614,0.291196388261851,0.7140254342186633,1.0,5/13,19.82%,BMP5;DKK3;APOE;PLEK;REST
prerank,epithelial to mesenchymal transition (GO:0001837),0.44025147433106937,1.155801616216303,0.25801749271137026,0.7141842962575641,1.0,9/47,7.33%,LEF1;ENG;NOTCH1;HIF1A;SOX9;FOXF2;WNT5A;TASOR;TGFB1
prerank,myotube cell development (GO:0014904),-0.5145938589579452,-1.1557372636517587,0.31235955056179776,0.7130958862994606,1.0,2/10,5.77%,IGF1;SIX1
prerank,negative regulation of chemotaxis (GO:0050922),0.46535247369135063,1.155533814288786,0.2903225806451613,0.7142106529239367,1.0,5/31,5.55%,SEMA6A;SEMA5B;SEMA7A;NOTCH1;SEMA6B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4369303138196308,1.1554987258305236,0.26500732064421667,0.7135720074401178,1.0,19/48,22.77%,ARID1B;TAF1B;POLR1A;ARID1A;SMARCA5;MYBBP1A;MYO1C;ZMIZ1;POLR1G;CDCA4;KAT2B;POLR1B;SERTAD2;TAF1A;ATAD2;DEK;POLR2L;ERCC6;PHF2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48883127186096914,1.1554714658262701,0.2912621359223301,0.7129314685835767,1.0,7/26,11.80%,APP;TAL1;PKN2;EIF4E;PPP1R10;EIF4EBP1;LGMN
prerank,cellular response to osmotic stress (GO:0071470),0.5052294041293225,1.1553167703028042,0.287758346581876,0.7126224358947642,1.0,6/21,16.39%,ARHGEF2;TRPV4;PKD2;YBX3;MYLK;ZFP36L1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5099641145192644,1.1551715923922103,0.313893653516295,0.712287590491692,1.0,8/20,17.66%,ZBTB16;CDK6;PTK2B;MAFB;ZFP36;ZFP36L1;CDC73;CIB1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4814094776726207,1.1543964666324116,0.28363047001620745,0.7136687992113561,1.0,9/28,20.87%,OCLN;RAC1;MET;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3;GIT1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5201412867085555,1.1537235576878262,0.30442477876106194,0.714635707463675,1.0,5/19,4.59%,SEMA6A;DAB2IP;JCAD;DLL1;TSPAN12
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4138575208616539,1.1536293554273955,0.251088534107402,0.7141438373301339,1.0,12/65,8.75%,HIP1;HIP1R;PTPN12;DAB2IP;MVB12B;PTPRJ;AFAP1L2;CEACAM1;CCDC88A;BCAR3;TGFA;ARHGEF7
prerank,actin crosslink formation (GO:0051764),0.5653694203489384,1.1534891420922684,0.33094812164579607,0.7137866947830632,1.0,2/12,1.54%,LCP1;EPS8
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.41345467191580176,1.1533732931197151,0.26449787835926447,0.7133934440889416,1.0,11/56,7.33%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;SMAD7;ACVR2A;GREM1;ACVR1;SNX25;TGFB1
prerank,plasma membrane organization (GO:0007009),0.42611714560878555,1.1533539960525294,0.26025459688826025,0.7127308715440492,1.0,14/61,11.84%,MYOF;FNBP1L;UGCG;SPTBN1;CAVIN2;MYH9;EHD2;CHMP4A;ARL8B;CXCR4;ANO6;A4GALT;DEGS1;ABCD1
prerank,positive regulation of vasoconstriction (GO:0045907),0.5412416097365178,1.1529171020486564,0.3252788104089219,0.7131615695299107,1.0,1/13,0.86%,CAV1
prerank,RNA catabolic process (GO:0006401),0.43818063512198147,1.1521438882907113,0.26626323751891073,0.7145039573619668,1.0,13/46,16.25%,ERN1;ISG20;NANOS2;RNASEH2A;MTREX;HNRNPD;NUDT16;DCP2;RNASEH2C;RNASEH2B;ZFP36;XRN2;PNPT1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.40645996542212215,1.1520468721164077,0.2563758389261745,0.7140371599598468,1.0,22/70,24.92%,LMO2;GATA2;TAL1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB;PSME1;PSMA4;PSMF1;EIF2AK2;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PUS7;PSMD3;PSMA3
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3868300925554355,1.1514781412752435,0.2480719794344473,0.7148201471185575,1.0,21/109,9.97%,INPP5D;PLA2G4A;PLCG1;PIP5K1B;PITPNM2;PGAP1;MTM1;PIK3C2A;PLCB1;PLCG2;PIK3R6;MTMR6;PLA2G2D;INPP5K;BMX;PIK3CG;PLAAT3;SYNJ1;PLEKHA8;OCRL;INPP5F
prerank,cGMP metabolic process (GO:0046068),0.5609561326556809,1.1510308838173309,0.3157894736842105,0.7152575173427448,1.0,2/12,2.54%,PDE2A;NPR1
prerank,regulation of interleukin-8 production (GO:0032677),0.41191557931594114,1.1507868699302581,0.26556016597510373,0.7151852298277588,1.0,8/69,7.51%,NOD1;PRKD2;STAT3;AFAP1L2;TMSB4X;TIRAP;ARRB1;BCL3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5272576984713357,1.1504766645261804,0.2885662431941924,0.7153072152455326,1.0,3/17,5.12%,DGKZ;PTPRJ;CEACAM1
prerank,multivesicular body assembly (GO:0036258),0.4713971639791502,1.1504443041952332,0.2883031301482702,0.7146636360931855,1.0,15/30,26.73%,RAB11A;CHMP2B;CHMP4A;CHMP4B;VPS28;VPS37C;STAM;VTA1;TSG101;VPS36;STAM2;PDCD6IP;VPS25;CHMP3;CHMP4C
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4613538303819226,1.1503175650083899,0.28700906344410876,0.7142723660760965,1.0,9/31,10.43%,CDK6;LRP5;HDAC7;NOTCH1;FGF23;SOX9;GREM1;CITED1;SEMA4D
prerank,protein localization to chromosome (GO:0034502),0.4544484042796971,1.150288687695913,0.28391167192429023,0.7136394063078242,1.0,12/34,20.94%,ESR1;RPA1;HASPIN;PINX1;ACD;RB1;MCM9;ATRX;RAD21;XRCC4;MSH2;PLK1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.51556752120067,1.15009029681143,0.3185689948892675,0.7134567975927192,1.0,9/17,25.08%,NUS1;DPAGT1;ALG6;ALG8;MPDU1;DOLK;ALG12;ALG14;DOLPP1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.48312837815456433,1.1500045371783028,0.30390492359932086,0.7129795976453529,1.0,1/24,0.04%,PRKCH
prerank,cell chemotaxis (GO:0060326),-0.34462911784867695,-1.1499424130485676,0.22929936305732485,0.7285305464966547,1.0,11/60,6.12%,LPAR1;PDGFRB;PDGFRA;NRP1;KIT;CCR9;PRKCD;SEMA5A;PARVA;CCN3;AGTR1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5171176798455102,1.1491520227769794,0.3176043557168784,0.7144964486451447,1.0,2/17,8.24%,HDAC9;LPL
prerank,second-messenger-mediated signaling (GO:0019932),0.39910225339163785,1.1490864581455371,0.25034387895460797,0.7139735580463898,1.0,8/82,5.39%,NOS3;MCTP1;PLCG1;EDN1;SELE;PLCG2;PPP1R9B;CX3CR1
prerank,chromatin assembly or disassembly (GO:0006333),-0.5075524045453864,-1.1487060169388388,0.31556503198294245,0.7304888450179267,1.0,5/11,28.03%,HDAC8;MTA2;TP53;RBBP4;HIRIP3
prerank,positive regulation of catabolic process (GO:0009896),0.41439251155660134,1.1485627758286243,0.27023319615912206,0.7145979916910813,1.0,14/65,15.10%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;NEDD4;VPS28;RILP;ASB11;RAB7A;APC;VSIR
prerank,sterol transport (GO:0015918),0.5184620431242885,1.148191759399091,0.30782029950083195,0.7148922337509263,1.0,1/19,0.86%,CAV1
prerank,osteoclast differentiation (GO:0030316),0.4990915215159726,1.148029773131215,0.30960264900662254,0.7145968230724904,1.0,5/22,9.46%,FOXP1;TNFRSF11A;SBNO2;DCSTAMP;CSF1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5010772220518824,-1.1475595800212466,0.2942430703624733,0.7320817247603582,1.0,3/11,9.32%,AXL;SELENOS;CXCL12
prerank,lipoprotein catabolic process (GO:0042159),-0.5116328680171809,-1.1475297152732966,0.319910514541387,0.7305763929492813,1.0,6/11,18.96%,NOTUM;APOE;CTSD;ABHD10;ABHD17C;PPT1
prerank,regulation of vasoconstriction (GO:0019229),0.47128303083573064,1.1468369108226206,0.29642248722316866,0.7169182252749546,1.0,3/27,5.56%,BMPR2;CAV1;KCNMB4
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3295711069721159,-1.146482764505893,0.20622568093385213,0.73204961000217,1.0,15/75,9.89%,ATP1A2;SLC8A3;CACNA2D1;SLC12A2;SLC6A1;SLC9A9;ATP1B1;SLC8A1;ABCC9;SLC39A14;KCNJ2;KCNJ13;SLC39A10;SLC24A2;ATP1B2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3684825425414574,1.1464423733135465,0.22439024390243903,0.7172443992440823,1.0,32/158,12.74%,NOD1;TNFSF10;TNFRSF19;PRKD1;TRIM14;CASP8;FKBP1A;PLEKHG5;TIRAP;EDAR;IKBKB;TRIM68;PELI1;PLK2;MID2;CD40;TNFRSF1A;ATP2C1;TRIM25;MAP3K3;MALT1;CASP1;NEK6;BRD4;IKBKG;IRAK4;RIPK1;CARD16;MIER1;RELA;RIPK2;BIRC3
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5310051107932984,1.1463366394637433,0.31338028169014087,0.7168002024618494,1.0,1/16,0.31%,NOS3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4320127000600328,1.1463193525449635,0.2774566473988439,0.7161376067044035,1.0,12/60,12.36%,LEF1;SOX9;TCF7L2;TNRC6C;ATF7IP;HNF1B;PPM1D;NFKB1;SUB1;MED27;CBFB;RELA
prerank,histone deubiquitination (GO:0016578),0.5143839026656911,1.146201030941412,0.328881469115192,0.7157478077198421,1.0,8/18,21.21%,USP3;USP15;BRCC3;ENY2;USP7;USP21;TRRAP;ATXN7
prerank,protein localization to lysosome (GO:0061462),0.47650334628206925,1.1460267214166584,0.2896440129449838,0.7154954156143832,1.0,13/28,22.90%,SH3BP4;NCOA4;GCC2;NEDD4;SCARB2;GLMP;M6PR;RAB7A;NAGPA;GGA3;KPTN;MFSD1;LMBRD1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3990120329605618,-1.1459829942172088,0.24719101123595505,0.73197162597734,1.0,10/33,9.53%,EGFR;ANXA1;CCND2;STXBP4;ADAMTS1;GLI1;PAF1;UBE2E2;TFDP1;RGCC
prerank,regulation of response to oxidative stress (GO:1902882),0.5527379052850308,1.1455746031665408,0.3443830570902394,0.7159537942504903,1.0,1/11,0.56%,MCTP1
prerank,covalent chromatin modification (GO:0016569),0.5121717667494979,1.145456323103032,0.29422382671480146,0.7155817195383991,1.0,6/14,22.75%,CHD1;AURKC;PARP2;SETD5;SIRT7;HLCS
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4936043933887536,1.1452112660689362,0.3121869782971619,0.7155135962759013,1.0,4/21,6.57%,PPARD;CYP26A1;LPIN3;CYP26C1
prerank,positive regulation of immune response (GO:0050778),0.4101396204763108,1.145043774054087,0.27092198581560284,0.7152736705383033,1.0,13/64,19.90%,IL6ST;IL15;GBP5;XBP1;SKAP1;IL23A;NMI;EIF2AK4;KARS1;POLR3B;PLSCR1;NLRP3;SLC15A4
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4684927726532228,-1.144744389492724,0.30930232558139537,0.7341068051638969,1.0,6/15,10.32%,PTN;NF1;LRRK2;SMARCD3;VEGFA;FZD3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5227819169707333,1.1446809467697703,0.3101694915254237,0.7155096398364209,1.0,3/17,8.50%,PLA2G4A;PLA2G2D;PLAAT3
prerank,heart development (GO:0007507),0.3728514971353708,1.1439972185924705,0.22766217870257038,0.7166205225661475,1.0,26/150,7.46%,TEK;HDAC9;BMPR2;TBX1;MEF2C;EPHB4;HEG1;ACVRL1;INSR;PDGFB;NOTCH1;SOX17;CHD7;CASP8;SOX18;FKBP1A;SOX9;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PTK2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.45254604852848684,-1.1438795407939557,0.29782082324455206,0.7349918079354536,1.0,5/17,6.69%,BMP4;FGF2;SFRP4;TMEM100;AHI1
prerank,neutrophil migration (GO:1990266),0.4181683153979335,1.143603350934427,0.2849002849002849,0.7169302425372934,1.0,7/58,11.77%,PECAM1;EDN1;BSG;PPBP;PIK3CG;CCL14;IRAK4
prerank,embryonic heart tube development (GO:0035050),0.5193918003346195,1.1435408278599932,0.3046594982078853,0.7164023870146502,1.0,3/14,6.28%,SOX17;SOX18;ACVR1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4454966100227999,1.143245360790502,0.2978723404255319,0.7164357126759623,1.0,7/38,12.62%,ESR1;DAB2IP;CASP8;TNIP1;ZMYND11;RIPK1;GSTP1
prerank,regulation of cell projection organization (GO:0031344),-0.48659322953454287,-1.1432302790987845,0.30660377358490565,0.7353568667010498,1.0,9/13,32.62%,NTNG1;MOV10;MFSD2A;MACF1;MYO9A;CCL19;TREM2;SPRY2;ERMN
prerank,response to ATP (GO:0033198),-0.4437971259184291,-1.1431671755687418,0.29396984924623115,0.7340059356610287,1.0,4/18,8.19%,P2RX4;ABCC9;TRPC3;TAF1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.49826673305504643,1.1431050148732307,0.31802721088435376,0.7161382900034916,1.0,3/22,9.07%,ESR1;HNF1B;SUB1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4091403853422754,-1.1429534595617559,0.2608695652173913,0.7330347089023312,1.0,8/27,6.87%,ROBO1;BMPR1A;TGFBR3;TGFBR1;BMP4;ZFPM2;ROBO2;HEYL
prerank,oligosaccharide metabolic process (GO:0009311),0.4362130504712049,1.142911793327517,0.30197268588770865,0.7159817194586383,1.0,2/46,0.45%,ST3GAL6;ST6GALNAC3
prerank,histone H4 acetylation (GO:0043967),0.4362933252664224,1.1426261930179549,0.27876106194690264,0.7159930127817107,1.0,8/47,10.09%,LEF1;EPC1;PHF20;JADE2;JADE1;HAT1;JADE3;EP400
prerank,cellular response to interleukin-2 (GO:0071352),0.5497764546553391,1.1424350691649168,0.32452830188679244,0.7150941974005345,1.0,3/11,7.27%,PTK2B;JAK3;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5497764546553391,1.1424350691649168,0.32452830188679244,0.7150941974005345,1.0,3/11,7.27%,PTK2B;JAK3;JAK1
prerank,glutamate receptor signaling pathway (GO:0007215),0.45237459744978425,1.141779656638669,0.29185867895545314,0.7160794175009145,1.0,6/37,4.04%,GNAQ;APP;PTK2B;PLCB1;HOMER2;KCNB1
prerank,ephrin receptor signaling pathway (GO:0048013),0.396292428750674,1.1415845577718267,0.26287262872628725,0.7159034230388688,1.0,23/82,12.04%,EPHB4;ANKS1A;LYN;EFNA1;YES1;FYN;KALRN;ARPC3;SDCBP;AP2B1;ARPC1B;RAC1;PTK2;RASA1;AP2A1;PSEN1;ARHGEF7;CRK;APH1A;EPHA4;ANKS1B;GRIN1;ACTR2
prerank,nucleocytoplasmic transport (GO:0006913),0.43524873715229434,1.1414835235311027,0.30303030303030304,0.7154872307984512,1.0,10/40,15.88%,ANP32A;RSRC1;XPO1;MALT1;BACH2;CITED1;NUP98;NUP205;NPM1;DDX20
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.47642235606424016,1.1414257539002974,0.3118811881188119,0.7149486550911432,1.0,12/25,27.39%,CHMP2B;CHMP4A;CHMP4B;RILP;TMEM50B;VTA1;LEPROT;CHMP3;TMEM50A;CHMP4C;LYST;SORT1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5772874801942256,1.1411300823872503,0.33519553072625696,0.7150627426933135,1.0,3/10,5.23%,LYN;FAS;GREM1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5337715322482205,1.1407278897291222,0.33447098976109213,0.715430565525053,1.0,4/14,10.58%,PLCG1;ECSCR;CD40;ANO6
prerank,cellular response to chemokine (GO:1990869),0.440476421888131,1.1403598998289233,0.28718703976435933,0.7157211691090343,1.0,3/46,6.85%,LRCH1;PTK2B;PPBP
prerank,positive regulation of cell development (GO:0010720),0.4697718433317115,1.1400776309640508,0.3059581320450886,0.715791947231572,1.0,9/31,17.57%,TGM2;NUMB;CX3CR1;SPEN;PDE3A;SNW1;NIBAN2;RASSF10;RFX3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.42195999755102126,-1.1400236155362813,0.2864321608040201,0.7399548859929723,1.0,8/24,12.16%,IGF1;IRS1;ENPP1;SELENOS;IGF2;IRS2;PPP1R3C;PPP1R3F
prerank,inhibitory synapse assembly (GO:1904862),-0.5162636857855714,-1.1400080817461518,0.3419354838709677,0.7384404670589494,1.0,5/11,12.88%,GABRG2;GABRA2;PLXNB1;LGI2;GABRB3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.39596503291916196,1.1397962706378448,0.2702702702702703,0.715832444256036,1.0,11/86,8.58%,APP;OCLN;EDN1;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3;TRPV4;PSEN1
prerank,negative regulation of hormone secretion (GO:0046888),0.5715128279912348,1.1395977646445847,0.35181975736568455,0.715684129068416,1.0,3/10,5.36%,RAB11FIP1;FGF23;RAB11FIP5
prerank,inflammatory response (GO:0006954),0.3577013425797735,1.13948067219374,0.20848056537102475,0.715273322574852,1.0,31/195,12.40%,HDAC9;NOD1;F11R;NRROS;STAT3;MFHAS1;AFAP1L2;SELE;ADGRE5;ACKR1;IKBKB;PTX3;PLA2G2D;IL36G;CD40;RAC1;PPBP;HNRNPA0;TNFRSF1A;TGFB1;PIK3CG;LY75;NFKB1;PXK;RELB;IKBKG;CCL14;CXCR4;TACR1;RELA;RIPK2
prerank,protein localization to cell surface (GO:0034394),-0.41024173128074154,-1.1386309982367142,0.2593516209476309,0.7408452255714061,1.0,11/26,17.79%,ANK2;ANGPT1;FBLN5;GGA2;PRRT1;FGF7;JAM3;GGA1;WNT11;FGF10;UNC50
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5394768400111338,1.1382806859942378,0.30685920577617326,0.7176398375874579,1.0,3/14,9.42%,DAB2IP;BCL2L11;PTPN1
prerank,vascular process in circulatory system (GO:0003018),0.5402019696072454,1.1380680589701029,0.33212996389891697,0.7168128504477358,1.0,2/13,2.54%,NOS3;NPR1
prerank,regulation of tube diameter (GO:0035296),0.5402019696072454,1.1380680589701029,0.33212996389891697,0.7168128504477358,1.0,2/13,2.54%,NOS3;NPR1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3316047042606174,-1.1375726781352218,0.20300751879699247,0.7422528258301171,1.0,13/80,10.10%,SAMD4A;PLD1;ROCK2;SLC2A13;PRKCD;THBS1;CPEB3;LRRTM3;FXR2;PRR16;LARP6;SMPD3;CIRBP
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.49098325862972036,-1.1374686892623909,0.2873051224944321,0.7394517810105171,1.0,4/12,16.72%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.49098325862972036,-1.1374686892623909,0.2873051224944321,0.7394517810105171,1.0,4/12,16.72%,IGF1;AKAP6;SLC9A1;CAMTA1
prerank,regulation of autophagy (GO:0010506),0.3580016913207118,1.1373105308034968,0.22337962962962962,0.7180291437442683,1.0,35/216,11.40%,FOXO1;ACER2;ERN1;PRKD1;DAPK1;RASIP1;SH3BP4;STAT3;TRIM14;FBXW7;PIK3C2A;EIF4E;TRIM68;MAPK8;PLK2;ULK1;BOK;DRAM2;MID2;SH3GLB1;TRIB3;ATP6V0A1;NEDD4;RPTOR;ATG101;FOXK1;FBXL2;ATP6V1G2;NPRL2;EXOC4;DEPP1;PRKAB1;BNIP3;ABL2;ATF6
prerank,regulation of cell-substrate adhesion (GO:0010810),0.43942413491703186,1.137176914748755,0.31762917933130697,0.7176849408477874,1.0,9/42,8.35%,PDGFB;FZD4;NOTCH1;PPM1F;BST1;RAC1;ATXN3;PTK2;RSU1
prerank,positive regulation of secretion by cell (GO:1903532),0.4033632585487239,1.1366605039627085,0.28116343490304707,0.7183296694348675,1.0,10/70,8.77%,RAB27A;UNC13B;CADPS2;CD2AP;EDN1;KCNB1;EXPH5;TGFB1;STX1A;ANG
prerank,negative regulation of defense response to virus (GO:0050687),-0.5226523518968985,-1.1365142471561132,0.33640552995391704,0.7407155248155524,1.0,7/10,31.51%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;MUL1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.45531238712058775,1.1363389525694636,0.30126182965299686,0.7184670519084302,1.0,8/31,14.12%,PPP1R13B;HIP1R;CASP8;MAPK8;BOK;SFN;BID;YWHAQ
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5671392665987155,1.1361634588486593,0.33271375464684017,0.7182080175359361,1.0,3/10,12.39%,CAV1;KCNE2;KCNRG
prerank,MAPK cascade (GO:0000165),0.34686331025747613,1.1358872842676002,0.21255506607929514,0.7182885729286046,1.0,51/295,12.08%,SHANK3;TEK;RASAL2;KDR;MEF2C;SPTBN1;KITLG;RASGRF2;PDGFB;DAB2IP;FYN;TAOK2;RASGRP3;FGF23;SOX9;MARK3;JAK3;IKBKB;CSF2RB;MAPK8;RET;RAPGEF2;KRAS;NRAS;TNIK;JAK1;TGFB1;PTK2;TGFA;SYNGAP1;RASA1;PSMA2;NFKB1;MAP3K3;RASA4;SHOC2;IKBKG;ZDHHC9;BCL2L1;MAPK11;PSMA8;RGL2;PSMA6;RASA2;SPTAN1;ICMT;CCM2;CUL1;GRIN1;ABHD17B;PEBP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4196762781483543,1.1357982759424206,0.2708638360175695,0.7178454062293183,1.0,10/54,7.46%,TEK;LIMCH1;KDR;ACVRL1;PEAK1;PTPRJ;PPM1F;DUSP22;RAC1;PTK2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.473090114965954,1.135776195347294,0.29519071310116085,0.7172254075105524,1.0,8/23,18.52%,NLRC5;JAK1;HSP90AB1;IRGM;STAT1;IFNGR1;PARP9;CDC37
prerank,cellular response to zinc ion (GO:0071294),-0.46674570674273325,-1.1356829157753017,0.2894736842105263,0.7415175798434551,1.0,2/15,16.21%,P2RX4;MT3
prerank,regulation of lipid storage (GO:0010883),0.49006135814885404,1.1355440223803135,0.31925675675675674,0.7171123029392008,1.0,6/22,11.77%,FBXW7;NFKBIA;PLIN5;NFKB1;LPL;ITGB3
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4525683320785361,-1.1351532896847834,0.2850356294536817,0.741572832317538,1.0,4/17,2.89%,PID1;NUPR1;HDAC4;PPARA
prerank,regulation of protein dephosphorylation (GO:0035304),0.4471382356984733,1.1349054762071062,0.3074581430745814,0.7180485495703625,1.0,4/37,2.51%,PPP1R16B;PPP2R5A;PPP1R2;MFHAS1
prerank,mRNA methylation (GO:0080009),0.5323135905106801,1.1348345015688943,0.3257443082311734,0.7175241349325931,1.0,9/15,27.21%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.36272269990725037,1.1347512040414909,0.2439903846153846,0.717082777782923,1.0,25/150,8.63%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;AKT2
prerank,negative regulation of protein modification process (GO:0031400),-0.33015543857647844,-1.1342119446337144,0.1991869918699187,0.7427473486189838,1.0,12/79,6.16%,PID1;PTPN13;NTRK3;DMD;PLPP3;PRKN;SNTA1;FBLN1;IGFBP3;IMPACT;PRKAA2;LRP6
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5203727405617233,1.1340774195814278,0.32274247491638797,0.7180914976530667,1.0,3/18,4.89%,CTSC;MSN;VGLL4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3993599606690566,1.133988268917946,0.26881720430107525,0.7176198398622451,1.0,20/76,19.72%,CD200;NLRC5;DAB2IP;AIM2;NFKBIA;TMSB4X;ARRB1;LRRC14;IRAK3;DDIT3;G3BP2;OTULIN;CHP1;MAP2K5;ERBIN;IRAK2;USP7;NLRP3;HAVCR2;TAX1BP1
prerank,cellular response to ketone (GO:1901655),-0.3824035026788499,-1.1338072127002474,0.2824858757062147,0.7423687096223016,1.0,11/35,9.25%,ADCY5;ROCK2;ADCY1;ADCY2;AR;ADCY6;SPP1;GNAI1;SFRP1;SRC;PTGFR
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3471788319572377,-1.1336015520281713,0.23411371237458195,0.7414510217353418,1.0,8/52,6.61%,CELF2;DDX5;RBFOX1;CELF4;FXR2;DDX17;RBFOX2;NOVA1
prerank,regulation of intracellular pH (GO:0051453),-0.3778658308552952,-1.133253612396669,0.26,0.7409664600606439,1.0,12/34,22.68%,SLC4A10;SLC9A9;LRRK2;SLC4A3;SLC4A2;SLC9A1;SLC26A6;CFTR;SLC4A8;SLC9A8;NOX1;CLN3
prerank,anterior/posterior pattern specification (GO:0009952),-0.3442635863736546,-1.133206813602437,0.2188449848024316,0.7395859441912235,1.0,12/53,6.87%,WLS;HOXC4;HOXC6;TGFBR1;HOXA3;HOXA5;PCSK5;HOXA7;HOXC5;HOXB4;HOXB3;HEYL
prerank,mitochondrion morphogenesis (GO:0070584),-0.4940830250940139,-1.1331979852200025,0.3111111111111111,0.738095808136375,1.0,1/11,0.15%,PID1
prerank,regulation of developmental growth (GO:0048638),0.4608772338402562,1.133135633107857,0.319047619047619,0.7191941325425725,1.0,5/29,5.16%,APP;INSR;PLCB1;DLL1;GHR
prerank,cellular response to organic substance (GO:0071310),0.37787660866585354,1.1328947656847137,0.2480916030534351,0.7191075105149077,1.0,18/116,7.33%,LEF1;PTPN14;BMPR2;ACVRL1;PDGFB;PTPN12;SOCS2;STAT3;SIGIRR;NCOA1;GHR;ACVR2A;MAPK8;ASAH2;RAMP2;ACVR1;INPP5K;TGFB1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.38856623959165965,-1.1323765799288168,0.26869806094182824,0.7390459635113149,1.0,8/36,9.32%,ANK2;PDGFRB;CACNA1D;P2RX4;CACNB2;TRPC3;TRPC6;CXCL12
prerank,regulation of protein export from nucleus (GO:0046825),0.48798894213738814,1.132290950394112,0.3344370860927152,0.7199875413606461,1.0,6/23,16.75%,PTPN14;TCF7L2;GAS6;UHMK1;ANP32B;RAPGEF3
prerank,regulation of secretion by cell (GO:1903530),0.417179055019046,1.1307403572325463,0.2775453277545328,0.7233172651179348,1.0,14/54,17.28%,MCTP1;MEF2C;KCNMB4;SNCAIP;LLGL1;RAB12;VAMP8;RAB26;RHBDF2;MCTP2;FMR1;RIC1;RAB8B;CPLX2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.43734135466504115,1.1304255535311196,0.30261136712749614,0.7234461079132428,1.0,16/42,22.56%,SMCHD1;SHLD1;WRAP53;CGAS;MAD2L2;HELB;MMS19;ACTR2;SIRT6;SPIDR;WDR48;KDM1A;FUS;RMI2;RIF1;ERCC6
prerank,regulation of neutrophil migration (GO:1902622),0.5707363175818239,1.1304217876854696,0.3352272727272727,0.7227866022369659,1.0,2/10,6.61%,BST1;RAC1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5061881235202121,1.1302567345886527,0.3269230769230769,0.722528385462966,1.0,2/18,2.59%,SHANK3;PTK2B
prerank,regulation of peptidase activity (GO:0052547),0.49043386353603996,1.130071171113207,0.3394039735099338,0.7223441212656065,1.0,1/19,0.86%,CAV1
prerank,response to interleukin-6 (GO:0070741),0.5739807254070741,1.1295441644843895,0.35231316725978645,0.7230155995724764,1.0,4/10,8.36%,ST3GAL6;SBNO2;NFKB1;CITED1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3958122417659494,1.129180435917221,0.29624478442280944,0.7232115931857995,1.0,20/72,16.65%,ACER2;CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;BCL3;CRADD;SOX4;BTG2;CNOT1;TFAP4;SFN;CNOT2;MUC1;CNOT7;CDC25C;ATRX;E2F7;CHEK2
prerank,engulfment of apoptotic cell (GO:0043652),-0.4534565615791398,-1.1286393541852935,0.30414746543778803,0.7483890900175051,1.0,3/15,3.82%,RHOBTB2;THBS1;XKR4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.357362521770487,1.128487364979869,0.23933649289099526,0.7242649437782822,1.0,23/182,5.99%,KDR;ENG;ESR1;APP;MEF2C;ACVRL1;CLDN5;OCLN;ANKRD13A;PDGFB;RIN3;FOXP1;GATA2;ADAM10;FBXW7;NOTCH1;HIF1A;CD34;SDCBP;DLL4;ATP2B4;TNRC6C;AURKA
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5113505479509687,-1.1281326563428495,0.3225806451612903,0.7483443664745957,1.0,1/10,0.36%,ZEB2
prerank,protein-containing complex assembly (GO:0065003),0.3460803540328636,1.1280197228686757,0.22462941847206386,0.7247229355189397,1.0,42/259,14.30%,LEF1;CTSC;SLC2A1;OCLN;CD2AP;MAGI1;PARD3;ADAM10;FAS;AIM2;PTK2B;TLE4;CASP8;TRAF1;CARD10;SOX9;TCF7L1;TCF7L2;BOK;TEAD2;CD40;TNFRSF1A;TGFA;FBXL7;LLGL1;SKAP2;NIFK;IKBKG;ANO6;TFAP4;CUL1;PICALM;RIPK1;TRAPPC3;PREB;DBNL;CAPZA1;PEX14;IL1RAP;ASH2L;BCL9L;APC
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.31958355863296145,-1.1277804551970363,0.22709163346613545,0.7478701601814748,1.0,17/84,12.29%,CELF2;SON;DDX5;RBFOX1;CELF4;FXR2;DAZAP1;DDX17;RBFOX2;NOVA1;SRPK2;TIA1;U2AF2;CIRBP;RBM4;CELF1;SF1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36093052175184287,1.1277496414262256,0.24327628361858192,0.7247490877296757,1.0,43/175,17.83%,DAB2IP;ARHGEF2;AIM2;TNFRSF11A;PTK2B;TNFRSF1B;NFKBIA;ACTN4;TRAF1;TMSB4X;TNFRSF25;EDAR;IKBKB;TNFSF8;DCSTAMP;CD40;INPP5K;TNFRSF1A;PSMA2;TNFRSF13C;YBX3;TNFRSF8;PSMA8;TNFRSF9;CCL14;PSMA6;RIPK1;RELA;ZFP36;BIRC3;HAS2;ADAM17;GBP3;ASAH1;TRAF6;PSME1;BAG4;ZFP36L1;BIRC2;ERBIN;CIB1;STAT1;PSMA4
prerank,regulation of innate immune response (GO:0045088),0.41131675175923327,1.1275142626194954,0.3130434782608696,0.7246875143085614,1.0,18/57,18.52%,GBP5;SAMHD1;CASP8;TIRAP;N4BP1;XIAP;IFNAR2;ERAP1;PTPN1;NMI;BIRC3;HSP90AB1;IRAK3;BIRC2;POLR3B;PLSCR1;PARP9;CDC37
prerank,regulation of JUN kinase activity (GO:0043506),0.44752097831846066,1.127004126234007,0.3094098883572568,0.7253336374528541,1.0,13/33,20.57%,DAB2IP;EDN1;TNFRSF11A;SASH1;DNAJA1;MAP3K11;AIDA;GSTP1;TRAF6;PAK1;HIPK3;DUSP19;RPS3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5570312533103452,1.1268104879066352,0.35271317829457366,0.725166619592948,1.0,3/11,7.33%,MEF2C;GREM1;TGFB1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4091742791943543,1.1264467017649282,0.2972972972972973,0.725419595951715,1.0,15/63,12.79%,TNFSF10;CAV1;ITGA6;FAS;CASP8;TRAF1;PAK2;TCF7L2;ACVR1;ZMYND11;RIPK1;BID;RELA;GSTP1;PHIP
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.45256112480662103,1.1263847409044176,0.30757575757575756,0.7249121260854928,1.0,7/30,7.06%,NET1;F11R;ARHGEF3;PRAG1;ADGRG1;RAC1;ARRB1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.35940314131523166,-1.1263615280164456,0.2607361963190184,0.7503258219084599,1.0,12/48,14.84%,ANK2;DMD;CEMIP;JPH1;AKAP6;PRKACA;UBASH3B;TRPC1;GSTM2;GPER1;JPH2;SNCA
prerank,positive regulation of DNA binding (GO:0043388),-0.3871389781924648,-1.1261473254505427,0.29745042492917845,0.7494124174846479,1.0,4/31,5.64%,IGF1;PRKN;SIRT2;NGF
prerank,circulatory system development (GO:0072359),0.37740309548903367,1.1252765792337627,0.2770618556701031,0.7270907078099036,1.0,25/118,9.33%,TEK;HDAC9;TBX1;MEF2C;HEG1;ACVRL1;PDGFB;FBXW7;NOTCH1;SOX17;CASP8;SOX18;FLT4;SOX9;PDLIM1;KDM6A;FOXF1;RBM20;RAMP2;ACVR1;CDKN1B;TGFB1;PKD2;ZFPM1;SOX4
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.33710201982953086,-1.1252545830828007,0.25461254612546125,0.7504913912888187,1.0,19/65,9.53%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;EGLN3;LMNA;P4HB;NPEPPS;CPEB4;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.39686585148818293,1.1247683691580779,0.29645390070921984,0.7277442426430121,1.0,12/66,5.16%,CAV1;B2M;CDK6;PTPRM;DAB2IP;FBXW7;AQP11;MTSS1;CAV2;SOX9;CEACAM1;PTPRK
prerank,aorta development (GO:0035904),-0.4677699738913291,-1.1245559239449883,0.3340909090909091,0.7509422622541941,1.0,6/14,7.87%,ROBO1;LRP1;PDGFRB;ROBO2;JAG1;EFEMP2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.42075953645021635,1.1244159768135575,0.3186646433990895,0.7279813367927253,1.0,14/49,16.69%,CAV1;SGMS1;BOK;BCL2L11;LCK;PTPMT1;BCL2L1;SIAH1;BID;RACK1;S100A9;DDIT3;BMF;BCL2L10
prerank,positive regulation of glycolytic process (GO:0045821),0.5001809452726724,1.1242549979272844,0.3333333333333333,0.7270726285681826,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5001809452726724,1.1242549979272844,0.3333333333333333,0.7270726285681826,1.0,4/20,2.85%,APP;INSR;HIF1A;PFKFB3
prerank,positive regulation of histone modification (GO:0031058),0.453800824147659,1.123563770083135,0.3142857142857143,0.7281185761517526,1.0,11/33,21.38%,RPS6KA5;ARRB1;CTBP1;APLNR;GLYR1;FMR1;RPS6KA4;KDM1A;SAP30BP;SART3;TADA2B
prerank,regulation of monocyte differentiation (GO:0045655),0.5296822991261143,1.1235169258562545,0.33826247689463956,0.727577170083534,1.0,5/14,9.46%,CDK6;FOXP1;DCSTAMP;CTNNBIP1;CSF1
prerank,base conversion or substitution editing (GO:0016553),0.5567408143523772,1.1234433561490094,0.33515482695810567,0.7270762580311763,1.0,3/11,11.22%,ADARB1;NUDT16;ADAR
prerank,hyaluronan catabolic process (GO:0030214),-0.4390060406517577,-1.1230468916179241,0.29931972789115646,0.7538667516310427,1.0,6/18,16.42%,CEMIP;FGF2;CD44;SLC9A1;HEXA;HYAL1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5610912416408034,1.1227800136209756,0.3574144486692015,0.7281058574535666,1.0,1/10,0.52%,SLC2A1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.48219106039005666,-1.1226534704417124,0.34065934065934067,0.7534636992445317,1.0,4/12,12.06%,IRS1;IGF2;PRKCZ;SNX5
prerank,regulation of interleukin-17 production (GO:0032660),0.46144502796389136,1.1225284985697523,0.3289902280130293,0.7280775899692251,1.0,8/31,18.16%,IL15;TGFB1;RFTN1;IL23A;VSIR;SLC7A5;DDIT3;CARD9
prerank,positive regulation of dendritic spine development (GO:0060999),0.49177781720633157,1.1224841418892966,0.3385416666666667,0.7275170583399927,1.0,1/20,0.09%,SHANK3
prerank,Rac protein signal transduction (GO:0016601),0.49623372811428207,1.1224506201807962,0.3487972508591065,0.7269345090586449,1.0,6/18,12.84%,EPS8;ELMO1;NCKAP1;RAC1;CYFIP1;DBNL
prerank,cellular response to topologically incorrect protein (GO:0035967),0.444466808449873,1.1221501511200438,0.3338533541341654,0.7270464563445888,1.0,6/31,9.42%,ERN1;DAB2IP;TMBIM6;ATXN3;RHBDD1;PTPN1
prerank,neuromuscular process controlling balance (GO:0050885),-0.4714248620736169,-1.1215528113802995,0.34763948497854075,0.7550877734833197,1.0,5/12,22.68%,NRXN1;PCDH15;SHANK1;TPP1;CLN3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5635011269920486,1.1207942699052789,0.36462093862815886,0.7298383854552432,1.0,3/10,13.43%,ADAM10;WNT5A;ADAM17
prerank,carbohydrate catabolic process (GO:0016052),-0.3640181982986682,-1.12067141099694,0.29393939393939394,0.7561918307950408,1.0,20/38,38.84%,ENO2;HK2;TPI1;ENO3;PFKFB1;NEU1;PFKM;ALDOA;NAGA;PKM;ENO1;MAN2C1;ALDOC;NEU2;HKDC1;GAPDH;NEU3;ALDOB;ENO4;HK3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3562270530727096,1.1205141446478957,0.2720763723150358,0.7299149389138145,1.0,40/190,12.71%,CAV1;ESR1;CD2AP;SH3BP4;DAB2IP;PDE2A;LYN;DDIT4;HDAC7;PDE4D;PTPRJ;ADGRG3;CASP8;TMSB4X;MARK3;PIK3IP1;TNFAIP8L1;VGLL4;ATP2B4;INPP5K;TRIB3;WWC2;PPP2R5B;UBR1;MAP2K3;BCL2L1;NPRL2;CYRIB;TNIP1;APLNR;NMI;ZMYND11;RIPK1;PEBP1;NOP53;RELA;XDH;ADIPOR1;GSTP1;RACK1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4461030603782909,1.1204945375191335,0.3292307692307692,0.7292873728862769,1.0,9/34,12.50%,FOXO1;GATA2;WWTR1;WNT5A;TRIB3;TGFB1;ZFPM1;ASXL1;TRIO
prerank,lipid modification (GO:0030258),0.4394101010090058,1.1204404659180889,0.3046153846153846,0.7287622422980159,1.0,6/37,8.05%,PLPP1;DGKZ;SGPP2;LPCAT3;DGKH;MBOAT1
prerank,cardiac muscle cell development (GO:0055013),-0.4294924320998979,-1.1203361766737379,0.3095823095823096,0.7556018343136055,1.0,7/20,10.84%,PDGFRB;PDGFRA;CXADR;SLC8A1;OBSL1;VEGFA;FHOD3
prerank,B cell homeostasis (GO:0001782),0.5704460896829135,1.1200762066598071,0.35714285714285715,0.7290238320258209,1.0,2/10,2.31%,MEF2C;LYN
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46363671349909447,1.1200407337994422,0.33075734157650694,0.7284541044690627,1.0,9/27,14.40%,TAOK2;IKBKB;MAPK8;NFKB1;IKBKG;MAPK11;CCM2;CUL1;MAP3K20
prerank,positive regulation of nuclear division (GO:0051785),0.467214259054884,1.1200268647725262,0.3283582089552239,0.7278244139995772,1.0,6/25,7.47%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA
prerank,polyol metabolic process (GO:0019751),0.4223232793322683,1.1194724912451004,0.3019145802650957,0.7285422320370961,1.0,9/46,10.62%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4625022705519748,-1.1193606673739351,0.30823529411764705,0.7570258101642944,1.0,4/15,8.94%,PRKN;BCL2;CD44;MDM2
prerank,protein targeting to membrane (GO:0006612),0.3889920080669654,1.1193012657267707,0.28879892037786775,0.7283026857629267,1.0,26/83,19.74%,PARD3;AQP11;TAOK2;SDCBP;SEC63;TRAM1;ZDHHC18;PEX26;CHMP4A;CHMP4B;ZDHHC9;MYO1C;ICMT;ABCD1;PEX14;ALDH3A2;VPS37C;ARL6IP1;RAB8B;ZDHHC24;SEC62;SIL1;ZDHHC1;NACA;SSR1;ZDHHC6
prerank,regulation of tumor necrosis factor production (GO:0032680),0.36800463173975123,1.1191991117781062,0.2727272727272727,0.7279057968005334,1.0,24/112,15.63%,APP;FOXP1;ARHGEF2;STAT3;PTPRJ;CD34;PLCG2;TIRAP;CX3CR1;WNT5A;LPL;PSEN1;DICER1;TNFRSF8;IL23A;GAS6;MC1R;RIPK1;GSTP1;ZFP36;IFIH1;ILRUN;VSIR;IRAK3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41821533261273597,1.1191920549291785,0.3056379821958457,0.7272693759956415,1.0,8/45,7.33%,BMPR2;ENG;RBPMS;ACVRL1;SDCBP;ACVR2A;ACVR1;TGFB1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4457274561665287,1.1191050060950902,0.31317829457364343,0.7268342859876095,1.0,8/36,8.37%,ENG;PDGFB;PPP2R5A;PDGFD;TAOK2;PDGFC;PPP2R5E;PPP2R5B
prerank,organelle assembly (GO:0070925),0.3390444618862965,1.1191024901116378,0.21656050955414013,0.726184809137716,1.0,55/384,12.97%,PGM5;ABCC4;FLII;ABLIM1;FNBP1L;EXOC6;EHD4;NEK7;RAB11A;NOTCH1;STARD9;CNGB1;CD34;TMOD3;SSX2IP;DISC1;STX7;CEP41;EDC3;ULK1;ABCA3;CHMP2B;PCNT;BBIP1;CDS2;RBM14;GRB7;EHD2;DYNLL1;RAB38;EXOC5;NEK6;ATG101;CHMP4A;CHMP4B;TEKT5;G3BP1;VPS28;EXOC4;OCRL;CEP83;RC3H1;RPS23;ARL13B;LSM3;EMC6;EHD3;GABARAPL1;ACTR2;RAB43;RILP;MYH6;WDR11;DBNL;EXOC8
prerank,positive regulation of secretion (GO:0051047),0.5628656052640938,1.1187098519751193,0.368705035971223,0.7265640316608089,1.0,2/11,4.97%,NPR1;XBP1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.44156940645157605,1.118593644573834,0.32919254658385094,0.7262140121969505,1.0,7/37,3.99%,CADM1;VCAM1;ICAM1;PVR;SELE;SELP;AMIGO2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.47784228805786333,1.1185073813130952,0.3399014778325123,0.7257663064846201,1.0,6/26,11.84%,RAB27A;PLCG2;ABCB7;GRIN1;COA8;ABCD1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4893809014454607,-1.11825916682988,0.3380281690140845,0.7586082815831514,1.0,2/12,2.80%,PLEKHH2;SEMA5A
prerank,cardiac ventricle morphogenesis (GO:0003208),0.43837491115357585,1.117719439894035,0.3168469860896445,0.727059145823366,1.0,13/41,12.94%,ENG;MEF2C;NOTCH1;FKBP1A;CPE;FOXF1;SMAD7;DLL4;TGFB1;SOX4;SFRP2;MYH6;TGFBR2
prerank,pulmonary valve development (GO:0003177),0.5057597229340965,1.1176452265194399,0.3597122302158273,0.7265888378262411,1.0,5/18,3.04%,NOS3;BMPR2;NFATC1;NOTCH1;TNFRSF1B
prerank,positive regulation of protein catabolic process (GO:0045732),0.38711960164323334,1.1172168207661348,0.31704095112285335,0.7270272827607255,1.0,11/84,7.82%,FOXO1;SMURF1;DAB2IP;NEDD4L;MSN;TNFRSF1B;VGLL4;PLK2;WNT5A;CDKN1B;NEDD4
prerank,cellular amino acid catabolic process (GO:0009063),-0.31069881334574023,-1.1167808000389758,0.23552123552123552,0.7614590509149,1.0,24/87,17.72%,DDO;GLUL;ABAT;ACADSB;ASPA;ALDH4A1;MCCC2;IVD;PRODH;HMGCLL1;ALDH7A1;FAH;BCKDHB;HNMT;PHYKPL;ACAT1;GOT1;CBS;HOGA1;ACAD8;CARNS1;BLMH;GSTZ1;ALDH6A1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.41687484090673943,1.1166442198420388,0.30633284241531666,0.7278388978805056,1.0,8/50,14.18%,NOD1;APP;ACTN4;SASH1;IL23A;NMI;RELA;TRAF6
prerank,neuron maturation (GO:0042551),0.4989732819321158,1.1165072733961836,0.34523809523809523,0.7275601990930584,1.0,4/18,7.51%,APP;ANKS1A;SCARF1;B4GALT5
prerank,activation of protein kinase A activity (GO:0034199),-0.4580610683715584,-1.1164069996679529,0.33488372093023255,0.7610268063778598,1.0,9/16,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3404571311936515,1.116137332606146,0.2429193899782135,0.7278076082887366,1.0,52/308,13.47%,PRKCH;LEF1;EPAS1;ADIPOR2;BMPR2;CAV1;CADM1;ZBTB16;IL15;PDGFB;NPR1;RREB1;KDM3A;WWTR1;PLCB1;ADRB1;SOX9;RPS19;LCN2;SDCBP;XBP1;GHR;SHLD1;GATM;ESRRG;WNT5A;ACVR1;INPP5K;PDGFC;TGFB1;PIK3CG;B4GALT5;AGPAT1;IL23A;UCN;MAD2L2;CYP27B1;VAMP8;CXCR4;PRKAB1;GAS6;IL4R;MAP3K13;UCP2;PEMT;SIRT6;ADIPOR1;TGFBR2;HADH;OMA1;ESRRB;IGF1R
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.3027817553510361,-1.116124077585537,0.21052631578947367,0.7603093658726475,1.0,37/117,19.57%,IGF1;ALDH1A2;ABAT;ACADSB;PPARA;ME1;CYP26B1;ACOT11;GGT5;ALDH4A1;CPT1C;NAAA;MCCC2;CKB;PER2;ME2;PCCB;ACSL3;ECHDC3;MECR;AASDH;SLC5A6;LDHB;VDAC1;GPAM;SCPEP1;HOGA1;SCP2;PDHA1;ALOX12;DLAT;PDZD11;ACSF2;ANGPTL3;AOAH;SLC27A4;CYP2S1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5494105610778539,1.1153909752870896,0.35714285714285715,0.7283883927691196,1.0,3/10,12.65%,AP2B1;AP2A1;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5494105610778539,1.1153909752870896,0.35714285714285715,0.7283883927691196,1.0,3/10,12.65%,AP2B1;AP2A1;MYLIP
prerank,defense response to tumor cell (GO:0002357),0.545571315460209,1.115066608076278,0.36036036036036034,0.7285012420496288,1.0,2/10,1.66%,ABI3;DAPK1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.45368975711077547,-1.1148599824285754,0.32,0.762651390034201,1.0,9/17,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,positive regulation of heart contraction (GO:0045823),-0.4341778501621093,-1.1146670427789425,0.3278301886792453,0.7616942413064327,1.0,5/19,12.60%,ATP1A2;ATP2A2;RYR2;TGFB2;ADRA1A
prerank,negative regulation of blood coagulation (GO:0030195),0.4362978542421691,1.114542065433843,0.3159509202453988,0.72918728724293,1.0,5/38,4.50%,NOS3;PDGFB;EDN1;CD34;F7
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3258233163831143,-1.1143616088880128,0.2490842490842491,0.7610670589538658,1.0,20/75,11.40%,DOCK7;SDC2;FGFR2;DCDC2;MAP2;BRSK1;FARP1;S100A6;ANK3;SHTN1;RYK;NTNG1;MAP6;S100B;CTNNA2;DCC;NRCAM;BAIAP2;RAB10;CNTN4
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.47647911812907495,1.1138435008595504,0.33878887070376434,0.7302896089011667,1.0,5/25,5.18%,BMPR2;ENG;ACVRL1;NOTCH1;ACVR2A
prerank,postreplication repair (GO:0006301),0.42670429796001297,1.1138026446953633,0.3225331369661267,0.7297429822729077,1.0,16/45,26.60%,POLK;RPA1;TRIM25;WDR33;PRIMPOL;RAD18;USP43;RFC3;NSMCE1;MSH2;UBE2V2;RFC5;ZBTB1;POLN;UBE2N;RPA3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.455398798677972,1.1136183324431879,0.3203732503888025,0.7295748348978384,1.0,4/27,5.49%,UTRN;NEDD4L;FXYD6;ATP2B4
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4445233343841126,1.1133214454701768,0.33893129770992364,0.7296908001510646,1.0,8/32,9.32%,PPP1R13B;DDIT4;JMY;HIPK1;BOK;BCL3;MYBBP1A;HINT1
prerank,response to metal ion (GO:0010038),0.394787789440546,1.1132728812189034,0.31875881523272215,0.7291685429791953,1.0,9/67,7.82%,CAV1;NEDD4L;PPP3CA;HIF1A;GPHN;PAM;TRPV6;ITPR3;NEDD4
prerank,regulation of protein processing (GO:0070613),-0.42121421618600485,-1.1131350145180123,0.32926829268292684,0.763235511201403,1.0,5/21,8.79%,CCBE1;GAS1;SERPINE2;LRRK2;RUNX1
prerank,negative regulation of immune response (GO:0050777),0.358390881272809,1.1128250621263909,0.2781065088757396,0.729698447411668,1.0,22/154,11.15%,CALCRL;CYSLTR1;ADCY4;PLCG1;MYH9;LYN;YES1;GNB1;FYN;PRKAR2B;PLCG2;ADRB1;RAMP2;PLK2;SAMSN1;CREB1;INSL3;FCGR1A;NMI;MC4R;RC3H1;MC1R
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4008892710870626,-1.1124956138861557,0.27832512315270935,0.76361099416328,1.0,3/26,8.32%,ATP1A2;GNB5;ADRA2A
prerank,fatty acid metabolic process (GO:0006631),0.36753804906957066,1.1114976658685236,0.285,0.7323485150745448,1.0,14/115,8.64%,ADIPOR2;PTGS2;PPARD;ACSL4;FASN;CRAT;XBP1;ALOX5AP;LPIN3;ACSL5;CYP4B1;PON2;LPL;LTC4S
prerank,positive regulation of innate immune response (GO:0045089),0.4482762429705692,1.1109977464069216,0.3459715639810427,0.732881186227069,1.0,10/30,19.90%,NLRC5;GBP5;RPS19;WNT5A;NMI;UBE2K;POLR3B;PLSCR1;TRIM62;SLC15A4
prerank,protein K48-linked ubiquitination (GO:0070936),0.4143978492697243,1.1109025411434101,0.31408450704225355,0.7324806483796225,1.0,17/54,17.61%,KLHL3;NEDD4L;ZNRF1;DTX3L;PELI1;UBE2G1;UBE2H;RNF146;RNF4;UBE2D3;UBE3A;UBE2K;TOPORS;ARIH2;RNF5;CUL3;CDC34
prerank,regulation of lamellipodium organization (GO:1902743),-0.4622273146821789,-1.1108562531094834,0.34065934065934067,0.7668523671904699,1.0,3/14,7.61%,PDPN;CARMIL1;CD44
prerank,negative regulation of cell communication (GO:0010648),0.48176168290717564,1.1105920621166603,0.34782608695652173,0.73257672172304,1.0,5/21,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,negative chemotaxis (GO:0050919),0.43875559419478605,1.1103940810514163,0.33226324237560195,0.7324221083197502,1.0,3/33,1.68%,SEMA6A;NTN1;SEMA7A
prerank,positive regulation of cell killing (GO:0031343),0.5257068058910752,1.1102300858444354,0.34935304990757854,0.7322056564038507,1.0,3/13,6.61%,MAPK8;WNT5A;RAC1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4897156145592725,-1.110203479274588,0.3422680412371134,0.767306019314505,1.0,4/12,13.50%,PRKCB;LPIN1;PRKCA;CNEP1R1
prerank,protein localization to cell junction (GO:1902414),0.4769962633410045,1.109913899494008,0.33448275862068966,0.7323628479952239,1.0,6/22,9.63%,TJP1;HEG1;TJP2;PAK2;JAK1;TJP3
prerank,regulation of histone acetylation (GO:0035065),0.44575069343500145,1.1097712616695583,0.3328125,0.7320977825495727,1.0,4/33,10.54%,RPS6KA5;ARRB1;CTBP1;GLYR1
prerank,digestive tract morphogenesis (GO:0048546),-0.47192121071331294,-1.109255382610811,0.3211009174311927,0.7684922650163831,1.0,5/14,11.96%,FGFR2;PDGFRA;RBPMS2;GLI1;STRA6
prerank,inositol phosphate metabolic process (GO:0043647),0.419672766569938,1.1090049863010323,0.30415430267062316,0.7334696961807691,1.0,9/46,10.62%,INPP5D;PLCB4;PLCG1;PLCB1;PLCG2;ITPKB;SYNJ1;OCRL;INPP1
prerank,homocysteine metabolic process (GO:0050667),-0.48852976720075636,-1.1087968737993437,0.3548387096774194,0.7684177094214472,1.0,6/11,24.84%,NOX4;CBS;BLMH;CTH;MMUT;MTRR
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5459014484779469,1.108167006795317,0.372848948374761,0.7348586021776787,1.0,2/10,3.44%,TBX1;ACTN4
prerank,positive regulation of histone methylation (GO:0031062),-0.40597346164087433,-1.1078780745369008,0.31746031746031744,0.7694987427882406,1.0,5/24,8.64%,OGT;AUTS2;TET1;CTR9;PAF1
prerank,activation of GTPase activity (GO:0090630),0.3810143974632098,1.1074892414232886,0.29521276595744683,0.7358325090277138,1.0,14/89,7.59%,TBC1D8;RALGAPA2;TBC1D30;ARHGEF15;TBC1D4;CCDC125;BCR;RALGAPA1;SGSM1;TBC1D22A;TBC1D15;SIPA1L3;TBC1D12;TBC1D2
prerank,response to growth factor (GO:0070848),0.4313160227211777,1.107309643237806,0.321875,0.7356354175647613,1.0,13/41,17.66%,BMPR2;ACVRL1;PDGFB;ACVR2A;ACVR1;TWF2;RACK1;TGFBR2;ERBB2;ACVR2B;CTNNB1;MAP2K5;CIB1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5052776598407893,1.1062317512013216,0.37043478260869567,0.7376333227116979,1.0,5/16,16.72%,SELE;SELP;RELA;TRAF6;RHOA
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4887347826710513,-1.1061881726002496,0.34772182254196643,0.7728957831812144,1.0,5/13,23.37%,GAB2;STX4;SYK;ITGB2;SPHK2
prerank,protein localization to cell periphery (GO:1990778),0.36616694072855543,1.10581463449245,0.2956204379562044,0.7380600503491932,1.0,24/133,7.65%,CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,negative regulation of viral life cycle (GO:1903901),0.5222973063555636,1.1057798688045215,0.34912280701754383,0.7375111092744128,1.0,4/15,7.56%,LY6E;PTX3;MID2;SNX3
prerank,regulation of type I interferon production (GO:0032479),0.3809051340218503,1.105347605404821,0.30423280423280424,0.7379546586222354,1.0,23/84,20.69%,RNF125;LRRFIP1;NLRC5;UBA7;TIRAP;TRIM25;NFKB1;POLA1;G3BP1;CGAS;RELA;IFIH1;ILRUN;NFKB2;GPATCH3;STAT6;CTNNB1;POLR3B;DHX36;TAX1BP1;NLRP4;POLR3A;POLR2L
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3751500855113211,1.1051401610215004,0.30244530244530243,0.7378024829093095,1.0,19/101,12.67%,MEF2C;DAB2IP;LYN;TNFRSF1B;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;TGFB1;NFKB1;CASP1;DEFA6;CARD16;RELA;GSTP1;ZFP36
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.40353893969788956,-1.104978408058885,0.31565656565656564,0.7748661335357705,1.0,5/24,11.48%,EPHA7;NUPR1;NF1;SRPK2;TGFB2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.39459311134986497,-1.1049440964834993,0.3076923076923077,0.7734669181339799,1.0,10/27,9.78%,DCN;BGN;CSPG4;CHST15;PXYLP1;CHSY3;VCAN;CHSY1;CHST3;XYLT1
prerank,protein localization to organelle (GO:0033365),-0.2991411583072457,-1.1047832902673471,0.235,0.7724726670366427,1.0,38/133,18.17%,ANK2;COL1A1;BMP7;BICD1;BMP4;TULP3;WDR35;MICALL1;OBSL1;SIX1;LMNA;ARL3;LAMP2;LRRK2;IFT20;OPTN;TIA1;PAF1;MDM2;GBF1;GET4;EHD1;CNEP1R1;BICD2;MTCH2;BBS9;SYS1;BBS2;ARFRP1;DVL1;ABCA7;GET1;SCG3;IFT140;DDRGK1;FAM83H;TULP1;RAB35
prerank,amino acid transmembrane transport (GO:0003333),-0.35881373386305215,-1.1041222354374673,0.29545454545454547,0.7730009048418024,1.0,6/45,3.68%,SLC7A11;SLC6A13;SLC47A1;SFXN2;SLC22A4;SLC38A11
prerank,muscle cell development (GO:0055001),-0.38403437266327994,-1.1040339887998154,0.31117021276595747,0.7717871094265991,1.0,9/30,9.36%,ANK2;IGF1;DMD;CXADR;SLC8A1;EFEMP2;SGCZ;VEGFA;BIN1
prerank,detection of calcium ion (GO:0005513),-0.4739799754426671,-1.10389598721276,0.35076252723311546,0.7707028637653123,1.0,4/13,9.11%,SYT1;KCNMB2;STIM1;RYR2
prerank,positive regulation of chemotaxis (GO:0050921),0.42957705735466634,1.103639365934066,0.3303303303303303,0.7409006919787495,1.0,9/43,4.50%,KDR;STX3;PRKD1;PDGFB;IL6R;PRKD2;PPM1F;TMSB4X;F7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.5414215625818475,1.1034707423706354,0.368705035971223,0.7406958076102562,1.0,4/11,20.72%,WRAP53;TERF1;CCT7;CCT2
prerank,innate immune response in mucosa (GO:0002227),0.5510318461865846,1.1031922509473173,0.37781954887218044,0.7406854164702785,1.0,2/10,9.16%,RPL39;DEFA6
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.45878502840201874,-1.1030869373228689,0.3421686746987952,0.7716349292519881,1.0,5/15,15.88%,BMP4;SIX1;VEGFA;SMO;PAX8
prerank,protein autoubiquitination (GO:0051865),-0.33616931754370394,-1.1027396115274108,0.2847222222222222,0.7711548367113384,1.0,13/61,13.27%,RNF220;PRKN;SH3RF1;SH3RF3;RNF13;SH3RF2;AMFR;RNF181;MDM2;LRSAM1;ITCH;DDB2;UBE2B
prerank,epithelial cell migration (GO:0010631),0.43702655303544136,1.102546022683273,0.3420647149460709,0.741661353586845,1.0,8/37,4.32%,NOS3;ADGRA2;PLXND1;PXN;PKN3;PKN2;PLEKHG5;PKN1
prerank,cytoskeleton organization (GO:0007010),0.3676797887078437,1.1023344740671372,0.3269476372924649,0.7415459292047368,1.0,18/114,9.23%,SEMA6A;FGD5;ARAP3;NEDD9;FGD6;NECTIN2;DST;FMNL3;SIPA1L3;CDC42BPB;MAST2;CECR2;RAC1;FMNL2;TNIK;RHOBTB1;ZRANB1;ANK1
prerank,cAMP metabolic process (GO:0046058),-0.47643613443439076,-1.1022270648833636,0.35683760683760685,0.7711647641271675,1.0,5/13,5.09%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5317125289033902,1.1020467456652212,0.35150375939849626,0.7417083657061773,1.0,7/14,24.26%,WRAP53;MMS19;ACTR2;WDR48;FUS;ERCC6;ARID2
prerank,positive regulation of cytokinesis (GO:0032467),0.4456799070369878,1.1011169686333808,0.3369734789391576,0.7434328336615738,1.0,7/32,17.22%,PKP4;PKN2;AURKC;KIF23;GIPC1;RHOA;CUL3
prerank,carbohydrate biosynthetic process (GO:0016051),0.47492295322357037,1.1010376115170606,0.3655737704918033,0.7429897595659929,1.0,1/21,0.14%,ST3GAL6
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.45061032351405517,-1.1002854733972718,0.35714285714285715,0.7753328346981897,1.0,12/15,51.94%,FAH;GSTZ1;KYAT1;HGD;HAAO;KYNU;AADAT;TDO2;KMO;QDPR;IDO1;ACMSD
prerank,regulation of kinase activity (GO:0043549),0.3721278674941289,1.0997919514082115,0.31471389645776565,0.7454516790848087,1.0,11/89,5.60%,TEK;FLT1;LDB2;KDR;TIE1;EPHB4;INSR;NLRC5;FLT4;LMTK2;RET
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5328573914501505,1.0997537211969224,0.38271604938271603,0.7449147856161464,1.0,7/12,15.21%,CYP26A1;KLF2;CYP26C1;CNOT1;ASXL1;SNW1;TRIM16
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3721100482077008,1.0995052139730044,0.3262316910785619,0.7449108264828849,1.0,11/98,5.49%,PRKCH;STX3;SPTBN1;PPP1R13B;FYN;CASP8;NKD2;KCNB1;SORBS1;MAPK8;ATP2B4
prerank,organelle organization (GO:0006996),0.32773299891641805,1.0993278747228772,0.2565720294426919,0.7447215138409262,1.0,63/388,13.91%,SEMA6A;FGD5;NOS3;FNBP1L;ATP8B1;CAV1;PRKD1;ARAP3;NEDD9;FGD6;NECTIN2;DST;ALAS1;VPS13D;FMNL3;CAV2;PLIN5;SIPA1L3;STX7;CDC42BPB;MAST2;DOP1B;ABCA3;CYCS;CHMP2B;CECR2;CYP26C1;FMNL2;SYNE1;TNIK;TMEM135;SIRT5;TMED7;PKD2;RAB2A;TMED5;RAB38;PLAAT3;ABCD4;ARHGEF7;ZRANB1;CHMP4A;CHMP4B;ANK1;MREG;HPS3;GABPB1;TFB2M;RNF112;LONP1;ABCD1;RAB43;SNX11;PHIP;BRWD3;CSPG5;PLD2;RAB31;RAB7A;ATL1;PITPNB;PEX14;RANBP10
prerank,endothelial tube morphogenesis (GO:0061154),0.5678381522048244,1.099269106567321,0.39325842696629215,0.744216597254712,1.0,7/10,19.68%,ACVRL1;PRKD2;CCM2;RHOB;RHOA;CTNNB1;STARD13
prerank,regulation of microglial cell activation (GO:1903978),-0.456237686280881,-1.0992144596616422,0.3288590604026846,0.77692449386161,1.0,12/15,47.17%,LDLR;SYT11;SPHK1;TTBK1;PTPRC;TREM2;GRN;STAP1;CST7;TAFA3;CCL3;NR1D1
prerank,peptide metabolic process (GO:0006518),-0.31937730892596394,-1.0990446300465075,0.26199261992619927,0.7759251646965759,1.0,12/75,10.56%,AEBP1;DMD;CPQ;MGAT3;PCSK5;GSTT1;NPEPPS;ENPEP;CPXM2;CPXM1;GSTM1;SPCS3
prerank,metal ion transport (GO:0030001),0.37880425748667307,1.0987108563416457,0.3205298013245033,0.7449597632835567,1.0,16/86,10.26%,CALCRL;CAV1;SLC39A8;SLC3A2;CACNA1E;FYN;RAMP2;CACNA1A;TRPV6;ATP2C1;TRPV4;PKD2;PSEN1;CDH23;NMUR2;CYP27B1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5324442611097931,1.0987097645359192,0.38294010889292196,0.7443222870712687,1.0,6/13,19.49%,BCL2L11;BNIP3;BMF;RHOT1;BNIP3L;RHOT2
prerank,cellular response to amyloid-beta (GO:1904646),0.4365782698085905,1.0986314288971442,0.3395931142410016,0.7438769684645951,1.0,11/35,11.80%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36431741931077505,1.0983521766041133,0.2953105196451204,0.7439390616121222,1.0,15/124,8.09%,FRY;FRYL;APP;STX3;PTPRM;RAB11A;LYN;PPP1R9B;BICDL1;ULK1;OPHN1;RAPGEF2;RAC1;NEDD4;PKD2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5015138388413001,-1.0982801669934343,0.3463203463203463,0.7765766264232858,1.0,2/10,8.79%,SH3RF1;RUNX1
prerank,regulation of cell-cell adhesion (GO:0022407),0.4254145940217044,1.0971473984075437,0.3515151515151515,0.7463947064009402,1.0,8/39,8.29%,PTPRG;PODXL;MAGI1;CEACAM1;SMAD7;TGFB1;PTK2;NF2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4143623873231833,1.0968063517360775,0.34375,0.7466044606692814,1.0,8/42,12.58%,SMARCA2;ARID1B;CECR2;ARID1A;SMARCA5;SRCAP;SMARCE1;HNRNPC
prerank,negative regulation of cell population proliferation (GO:0008285),0.33516908913175947,1.0965815227522067,0.2592986184909671,0.746517868162873,1.0,53/351,10.61%,NOS3;PTPN14;BMPR2;SMARCA2;APP;CBFA2T3;SOX7;ACVRL1;CD200;B2M;CDK6;PLPP1;SH3BP4;GATA2;ADARB1;DAB2IP;LYN;PTK2B;NOTCH1;PTPRJ;AQP11;MTSS1;ADGRG1;SLC16A2;SOX9;TES;DLL1;VGLL4;BTG3;PTPRK;GREM1;DLL4;WNT5A;RAPGEF2;KLF10;CDKN1B;PPM1D;TGFB1;CTNNBIP1;PKD2;RNF139;NF2;CTBP1;ANG;PINX1;SOX4;SST;TNFRSF8;BTG2;CYP27B1;SFRP2;TFAP4;NMI
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3771618648815621,1.0965627365229176,0.30609597924773024,0.7459265124204509,1.0,19/95,12.67%,MEF2C;DAB2IP;TNFRSF1B;TIRAP;XBP1;CX3CR1;SBNO2;MAPK8;WNT5A;IL36G;PPBP;NFKB1;CASP1;DEFA6;CYRIB;CARD16;RELA;GSTP1;ZFP36
prerank,postsynaptic membrane organization (GO:0001941),0.4947367845123284,1.0962553786772231,0.379746835443038,0.746038836412355,1.0,2/17,4.30%,SHANK3;GPHN
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4469801407326,1.0962120655054592,0.3613312202852615,0.7455128071015323,1.0,14/30,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;SVIP;STYX;RPL11;USP7;TAF9
prerank,organelle fission (GO:0048285),0.4589987221025446,1.096194586181459,0.3410981697171381,0.7449184287471389,1.0,1/24,0.27%,DNM3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4949197473863485,-1.09619097698475,0.35864978902953587,0.7811321113146376,1.0,5/11,22.58%,STX4;TICAM1;MAVS;ITGB2;CAMK4
prerank,regulation of T cell mediated immunity (GO:0002709),0.5461531829858838,1.0961887947614712,0.3769230769230769,0.7442972096256988,1.0,1/10,3.04%,TNFRSF1B
prerank,regulation of protein secretion (GO:0050708),-0.2980124889715099,-1.0960760315459486,0.2073732718894009,0.7799855314153992,1.0,23/119,11.83%,CACNA1C;BMP6;IGF1;RAPGEF4;SLC12A2;CACNA1D;DPP4;FRMD4A;SNAP25;KCNC2;PER2;KCNS3;PRKCA;ERP29;EZR;ADRA2A;RHBDF1;APOE;TGFB3;STXBP5L;MYOM1;TGFB2;ADAM9
prerank,response to insulin (GO:0032868),0.38387503264310907,1.095739640331983,0.32882273342354534,0.7447310486370473,1.0,15/80,10.83%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;CITED1;AKT2;RAB12;EIF6
prerank,nervous system development (GO:0007399),0.3266381295861261,1.0956500869893477,0.2551867219917012,0.7443209500332696,1.0,40/429,7.33%,ADGRG6;SHANK3;SEMA6A;MPZ;DNM3;SLC2A1;RAPGEF5;LDB2;MEF2C;ZBTB16;ZIC3;CELSR1;NAV1;STAT3;GDA;ADGRA2;SNTG2;PLXND1;HAPLN3;BTBD1;WWTR1;CHD7;PCDHB4;CDH2;EVL;MAL;IGF2BP3;RPS6KA3;KALRN;MBNL1;NCKAP1;SEMA6B;OPHN1;CYP26C1;IRF2BPL;DYRK1A;ATXN3;ST8SIA4;PDGFC;TGFB1
prerank,response to alcohol (GO:0097305),-0.3909643643042173,-1.0955345944682402,0.30749354005167956,0.7801047744289225,1.0,5/27,10.91%,TGFBR3;TGFBR1;GRIN3A;GRIN2A;SLIT2
prerank,mitochondrion localization (GO:0051646),0.4856087149562553,1.0954651507814386,0.3548387096774194,0.7441427835947849,1.0,7/19,18.92%,NECTIN2;MTM1;MEF2A;MFN1;MSTO1;TRAK2;ZBED3
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4763786683293808,1.0949658236444284,0.3667763157894737,0.744794147767606,1.0,1/20,0.14%,ST3GAL6
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5039574530029313,1.0948125847463575,0.3704974271012007,0.7445398297040489,1.0,1/16,1.41%,CLDN5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5098798306892136,1.094740878463435,0.3765541740674956,0.7440883752073086,1.0,1/17,0.19%,TEK
prerank,cell projection assembly (GO:0030031),0.4726941514374414,1.09441599306748,0.3415032679738562,0.7442343545341481,1.0,4/22,6.61%,PARVB;RHOJ;NCKAP1;RAC1
prerank,neuron migration (GO:0001764),0.41316450403785193,1.0942307212133686,0.34545454545454546,0.7440489842967911,1.0,8/48,6.61%,MEF2C;CELSR1;NAV1;DDIT4;CEP85L;DISC1;RAPGEF2;RAC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5407707694352092,1.0936602915086093,0.37476099426386233,0.7448653103619585,1.0,4/10,7.33%,NOTCH1;TNFRSF1B;TNFRSF1A;TGFB1
prerank,leukotriene metabolic process (GO:0006691),0.4820294903504776,1.0934534934318418,0.37649063032367974,0.7447135760200267,1.0,3/19,8.64%,PLA2G4A;ALOX5AP;LTC4S
prerank,camera-type eye morphogenesis (GO:0048593),-0.4965280487662928,-1.0934095136930646,0.3830275229357798,0.7845635470242885,1.0,5/10,12.08%,TENM3;NF1;LRP6;VEGFA;TBX2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4591592854188185,-1.0933096469480454,0.36343115124153497,0.783410198156514,1.0,5/14,17.07%,IL18;CD55;PTPN22;CD81;SYK
prerank,endosome organization (GO:0007032),0.4227609027517676,1.0932605662744632,0.3353566009104704,0.7445905844553754,1.0,9/41,12.97%,RAB27A;ALS2CL;CLCN3;CHMP2B;EEA1;SNX3;CORO1C;RILP;EXOC8
prerank,glycogen metabolic process (GO:0005977),-0.3967685989578414,-1.0932398270070167,0.31728045325779036,0.7821426378419526,1.0,12/27,20.81%,PYGB;PHKB;PYGM;PER2;PRKAG2;GAA;PPP1R3C;UGP2;AGL;GYS1;PHKA2;PHKG1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.49977604534403547,-1.0931140213120178,0.3714902807775378,0.7810470808376776,1.0,4/10,17.33%,CACNA2D1;CACNB2;PDE4B;CACNB3
prerank,response to ethanol (GO:0045471),-0.4568251478402522,-1.0926800682390183,0.3426124197002141,0.780819166538056,1.0,3/14,10.70%,GRIN3A;ADCY7;GRIN2A
prerank,negative regulation of hippo signaling (GO:0035331),0.5331165224946788,1.0918038354658375,0.3696027633851468,0.7476333302051485,1.0,4/12,9.51%,MARK3;VGLL4;WWC2;MAP2K3
prerank,microglial cell activation (GO:0001774),0.47625387137680425,1.091679185659512,0.345679012345679,0.7473027942211007,1.0,2/21,5.39%,APP;CX3CR1
prerank,positive regulation of ruffle assembly (GO:1900029),0.5221145910400528,1.0912747528071967,0.3825136612021858,0.7476183506560209,1.0,3/13,13.90%,EPS8;P2RY12;NDEL1
prerank,regulation of exosomal secretion (GO:1903541),-0.4286884284118591,-1.0903551900262176,0.3394495412844037,0.7860518537049601,1.0,7/19,17.70%,PRKN;ATP9A;SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,regulation of TORC1 signaling (GO:1903432),-0.36983242529249055,-1.0896028716305743,0.31007751937984496,0.7866473485684753,1.0,14/33,26.17%,RNF152;KLHL22;CASTOR2;SZT2;SMCR8;GPR137B;SESN2;DGKQ;FLCN;GPR137C;ITFG2;PIP4P1;ATM;RRAGD
prerank,regulation of histone modification (GO:0031056),-0.46090049353396667,-1.0894407838403581,0.3577586206896552,0.7856387872134534,1.0,6/13,20.84%,IGF2;AKAP8L;CDK9;MYOCD;FLCN;NNMT
prerank,post-translational protein modification (GO:0043687),0.3301214945999641,1.088865145597626,0.29360780065005415,0.7528555364709181,1.0,60/332,15.53%,EPAS1;DCUN1D3;KLHL3;APP;KLHL5;ZBTB16;MGAT4A;STT3B;RAB11A;SOCS2;KLHL2;ADAM10;NEURL2;FBXW7;HIF1A;BTBD1;FUCA2;FGF23;PTP4A2;CDH2;QSOX1;SPARCL1;FBXL4;KCTD6;VWA1;CISH;GOLM1;RNF7;PSMA2;FBXL7;RAB2A;RAB38;RHBDD1;APLP2;FBXW2;CSF1;COPS2;PSMA8;ASB10;PSMA6;ICMT;GAS6;COPS4;FBXO30;CUL1;COP1;RAB11B;ASB11;ASB4;RAB5A;PNPLA2;FBXL3;PROC;PSME1;ELOC;SOCS6;LAMB1;EVA1A;DCAF17;TMEM132A
prerank,cellular response to cadmium ion (GO:0071276),-0.3930461784281266,-1.0887600455962456,0.3230769230769231,0.7861876446859581,1.0,1/24,0.38%,EGFR
prerank,neuron projection extension (GO:1990138),0.4452822767208063,1.0887428484549984,0.3610223642172524,0.7524895272210812,1.0,5/32,5.98%,NRP2;SEMA5B;IQGAP1;ULK1;PPP3CB
prerank,fatty acid transmembrane transport (GO:1902001),0.47955121762673103,1.0886446241223757,0.3685152057245081,0.7521099623783768,1.0,5/19,11.84%,SLC2A1;ACACB;ABCD4;CPT1A;ABCD1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.457883072620649,-1.0881014976874699,0.3595238095238095,0.786722786093369,1.0,2/14,3.57%,IL34;THBS1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.47124959898247076,1.0868367113844575,0.3677966101694915,0.7560124668627564,1.0,3/22,5.12%,DGKZ;PTPRJ;CEACAM1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5376418409777162,1.0864297128337979,0.3850267379679144,0.7563671332954508,1.0,3/11,13.43%,ADAM10;WNT5A;ADAM17
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4883616777266561,1.086008303551213,0.3683304647160069,0.7567609609856444,1.0,6/19,9.33%,BMPR2;EFNA1;NOTCH1;ACVR1;ZFPM1;SOX4
prerank,sensory perception of light stimulus (GO:0050953),-0.3106641533128087,-1.0859764198710988,0.31225296442687744,0.7914145519867721,1.0,11/87,6.10%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3;PCDH15;WHRN
prerank,regulation of signal transduction (GO:0009966),0.34092524941783847,1.0859435436763614,0.31560283687943264,0.7562987596138924,1.0,33/190,10.22%,RGS3;LIFR;ESR1;LFNG;APP;UGCG;PRKD1;SOCS2;PRAG1;GIT2;MFNG;BST1;FYN;KIF26A;NCK1;WWTR1;PLCB1;PXN;SRMS;DLL1;TSPAN12;TCF7L1;ACVR1;VWA2;TGFB1;ITGA3;SNX3;LLGL1;CRK;PTPN1;ZFAND2B;CDC42SE2;RGS12
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4242758842875525,1.0858883310860643,0.35130970724191063,0.7558117546151375,1.0,6/42,11.81%,POLK;RPA1;TRIM25;PRIMPOL;POLA1;USP43
prerank,mitochondrion transport along microtubule (GO:0047497),0.5190550482894515,1.0851482426890509,0.3801498127340824,0.7569832075874453,1.0,6/13,24.26%,HIF1A;RHOT1;RHOT2;UXT;OPA1;NEFL
prerank,hyaluronan metabolic process (GO:0030212),-0.4037251700146861,-1.085106931074802,0.32997481108312343,0.792514267683673,1.0,7/23,16.42%,CEMIP;FGF2;CD44;SLC9A1;HEXA;ABCC5;HYAL1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4295960307664754,1.0850528502668448,0.3684210526315789,0.7565800940363397,1.0,16/37,20.12%,SDCBP;N4BP1;EIF3H;UCHL5;RPS7;RPL23;NOP53;HSP90AB1;UBXN1;GIPC1;RYBP;RPL11;USP7;CSNK2A2;CSNK2A1;TAF9
prerank,cell proliferation in forebrain (GO:0021846),-0.49034361229176004,-1.084911861361801,0.3644251626898048,0.7916371602776979,1.0,3/10,15.23%,DOCK7;PCM1;NUMBL
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5191487648535857,1.0846958242078424,0.3970037453183521,0.7568093387589766,1.0,3/11,7.33%,MEF2C;GREM1;TGFB1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4378359501642076,1.0846521929980124,0.3524590163934426,0.7562918878498764,1.0,2/30,1.62%,ST6GAL1;STT3B
prerank,ketone body metabolic process (GO:1902224),-0.4906543465509342,-1.0844450004534294,0.3952483801295896,0.7915744923053941,1.0,6/10,14.65%,OXCT1;HMGCLL1;BDH2;ACAT1;BDH1;AACS
prerank,regulation of cell cycle process (GO:0010564),0.3656386562043491,1.0843068102411844,0.327455919395466,0.756494641064761,1.0,29/104,21.87%,DCUN1D3;RAB11A;CAV2;SOX9;PLK2;AURKA;SH3GLB1;AURKC;NUDT16;BCL2L1;RPRD1B;MAD1L1;CDC25C;APC;PDXP;CALM1;CTNNB1;PRPF40A;CSNK2A2;CSNK2A1;CETN2;NUMA1;RMI2;DBF4;GIT1;PLK1;RACGAP1;TIPIN;PIK3R4
prerank,cellular response to insulin stimulus (GO:0032869),0.35917899606828885,1.083865432772846,0.30711610486891383,0.7568804714747897,1.0,22/124,10.12%,FOXO1;HDAC9;INSR;TBC1D4;DENND4C;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2;RAB12
prerank,mRNA polyadenylation (GO:0006378),0.4573601294887072,1.0837518402228639,0.3572649572649573,0.7558874446919424,1.0,12/26,27.56%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.4573601294887072,1.0837518402228639,0.3572649572649573,0.7558874446919424,1.0,12/26,27.56%,APP;WDR33;MTPAP;PNPT1;CDC73;CPSF1;TENT4B;CPSF2;PCF11;CPSF3;TUT1;PAPOLA
prerank,protein deacetylation (GO:0006476),0.41261145373367153,1.0834671258580102,0.3470948012232416,0.7560250806542159,1.0,8/41,12.75%,HDAC9;HDAC7;RCOR1;RBM14;SIRT5;MIER1;SIRT6;MIDEAS
prerank,T cell mediated immunity (GO:0002456),0.5126090552174739,1.0831681618755438,0.3934142114384749,0.7561353732546855,1.0,1/13,0.90%,CADM1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.44373918266052964,1.0831125610334555,0.35266457680250785,0.7556398403920944,1.0,1/26,0.09%,SHANK3
prerank,Golgi to plasma membrane transport (GO:0006893),0.40698713188709135,1.0822841816757427,0.3535660091047041,0.7570330270607115,1.0,11/47,13.42%,EXOC6;SPTBN1;EXOC6B;VAMP4;GCC2;EXOC5;LLGL1;EXOC4;RAB26;EXOC8;RAB31
prerank,ERBB signaling pathway (GO:0038127),0.3880957593007511,1.0822324715429557,0.3389830508474576,0.7565288466425338,1.0,12/64,8.10%,RPS6KA5;PLCG1;PTPN12;IQGAP1;PTK2B;PIK3C2A;SOX9;TGFB1;PTK2;TGFA;GRB7;GAB1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4205697827514945,-1.0815831426438336,0.3403755868544601,0.7983726627703253,1.0,4/17,13.10%,CPEB1;CPEB3;CTR9;CDK9
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5132705366581652,1.0811955201235834,0.387719298245614,0.7583984656402707,1.0,4/14,6.12%,PRKAR2B;PKIG;ATP2B4;RAPGEF2
prerank,regulation of actin filament-based process (GO:0032970),-0.32020190912416513,-1.081059014632961,0.29435483870967744,0.7984351704512275,1.0,14/70,8.24%,LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;EZR;CNN2;RHOBTB3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3849182476455463,1.080683736901182,0.35252808988764045,0.7590185172390215,1.0,13/66,7.41%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TNFRSF11A;TPD52L1;PIK3R6;CD40;SASH1;PDGFC;TGFB1;PIK3CG
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3976602801690467,1.0803538994295856,0.3816568047337278,0.7591762682482368,1.0,4/52,5.12%,PDIA5;ERN1;XBP1;EXTL3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5187915653505647,1.0800320872215052,0.36460176991150445,0.7593415852428712,1.0,4/12,8.54%,PODXL;IQGAP1;PROM1;MYO1E
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4675389485403382,-1.0799205505783658,0.36574074074074076,0.8003651850514948,1.0,2/12,2.41%,DPYSL3;DPYD
prerank,positive regulation of protein secretion (GO:0050714),0.38037619216402474,1.0798330832012237,0.34173669467787116,0.7592068605451326,1.0,9/69,9.33%,MYRIP;UNC13B;CD2AP;ACSL4;EXPH5;TCF7L2;TGFB1;ANG;SOX4
prerank,response to cadmium ion (GO:0046686),-0.38052994736397877,-1.0797294401462654,0.3486005089058524,0.7994999162601059,1.0,1/26,0.38%,EGFR
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3801223118325348,1.079716300767769,0.3542234332425068,0.7588709404494678,1.0,16/73,12.95%,CAV1;APP;PRKD1;PRKD2;FNIP2;SH2D3C;STK4;ATP2B4;BCAR3;TGFB1;RPTOR;MAD2L2;SFRP2;GAS6;RIPK2;HSP90AB1
prerank,epithelium development (GO:0060429),-0.29102191371498776,-1.079434510120878,0.32075471698113206,0.798918896434557,1.0,22/107,12.08%,ALDH1A2;FGFR2;WNT4;ERRFI1;OSR1;MEOX2;DAG1;PKD1;LOXL3;DACT1;KANK2;SALL1;SIX1;RCN3;AHI1;BDH2;VEGFA;SMO;TAGLN;ANXA4;MTHFD1;TBX2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4322565187819368,1.0792124650731894,0.3667180277349769,0.7594949888162636,1.0,7/34,8.99%,LIMS2;NEDD9;DOCK1;RREB1;RAC1;ARHGEF7;CRK
prerank,negative regulation of kinase activity (GO:0033673),0.38238490810979286,1.0790267044549335,0.3226744186046512,0.7593561367644212,1.0,16/62,13.61%,GNAQ;PPP2R5A;PPM1F;WWTR1;PAK2;CEACAM1;INPP5K;CDKN1B;TRIB3;NPRL2;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.47904345759961775,-1.0789640520955035,0.3875802997858672,0.7988322762009012,1.0,2/11,7.61%,BCL2;CD44
prerank,negative regulation of immune system process (GO:0002683),0.48715663612238724,1.078808356417463,0.370242214532872,0.7592677432412578,1.0,3/16,4.17%,CD200;LYN;SOX9
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4079669419004377,1.0781979573596847,0.3661119515885023,0.7601581781396742,1.0,5/47,5.23%,FOXO1;DAB2IP;FAS;TAOK2;GREM1
prerank,Notch signaling involved in heart development (GO:0061314),-0.4773665831808324,-1.0781142922544176,0.38784067085953877,0.7996812946939797,1.0,7/11,18.37%,NOTCH2;JAG1;HEYL;RBPJ;SNAI1;HEY2;HEY1
prerank,negative regulation of organelle assembly (GO:1902116),0.4188518200218709,1.0778090733306511,0.35769828926905134,0.7604756403527496,1.0,8/35,10.45%,TBC1D30;MTM1;LIMK2;RBM14;FEZ2;CHMP4A;CHMP4B;NBDY
prerank,potassium ion homeostasis (GO:0055075),-0.3985087122054407,-1.0777647215253003,0.3533834586466165,0.7992387972728449,1.0,6/23,9.89%,ATP1A2;SLC12A2;ATP1B1;KCNMA1;KCNJ2;ATP1B2
prerank,blood vessel endothelial cell migration (GO:0043534),0.47750680376010257,1.0776478487560808,0.3741830065359477,0.7602301790433784,1.0,6/22,5.23%,KDR;EPHB4;MYH9;SOX18;ID1;GREM1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.416381074137947,-1.077635183162008,0.34032634032634035,0.7981727682265274,1.0,8/19,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.47157657431002664,1.0775326052232905,0.36515912897822445,0.7598996635607688,1.0,6/20,13.14%,CNOT6;TNRC6C;HELZ;CNOT1;EIF6;CNOT7
prerank,motor neuron axon guidance (GO:0008045),0.4953952260921167,1.0762140510499336,0.4007352941176471,0.7625349325079858,1.0,3/15,10.82%,NTN1;RAC1;EPHA4
prerank,regulation of interferon-gamma production (GO:0032649),0.38442659848291555,1.0761092995679413,0.3510928961748634,0.7621901451434059,1.0,6/71,10.66%,IL1R1;PDE4D;ZFPM1;IL23A;CYRIB;GAS6
prerank,regulation of chemotaxis (GO:0050920),0.44608796578272636,1.0757619528673112,0.3744075829383886,0.7624107902644528,1.0,10/30,11.16%,STX3;PDGFB;ADGRA2;PPM1F;ZSWIM6;MYCBP2;TGFB1;CYRIB;CXCR4;P2RY12
prerank,DNA replication initiation (GO:0006270),0.4259445707143737,1.0749956261301143,0.35118110236220473,0.7636721307308592,1.0,16/37,26.60%,MCM10;RPA1;POLA1;CDT1;CDK2;PRIM2;ORC5;ORC3;CDC34;PURA;DBF4;ORC6;GMNN;PRIM1;MCM6;RPA3
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.40979484271537636,-1.0749352017241085,0.36104513064133015,0.8045741237898982,1.0,3/23,4.25%,FGFR2;TGFBR3;TPM1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.4378533858255857,-1.0749219853802192,0.37272727272727274,0.8031640880050425,1.0,4/15,6.16%,GLI2;EDA;WNT6;LRP6
prerank,ether lipid biosynthetic process (GO:0008611),0.5390066716909819,1.0747963968766563,0.39776951672862454,0.7635370199742513,1.0,1/10,1.67%,PLA2G4A
prerank,atrioventricular valve development (GO:0003171),0.5098432552934498,1.0747824432683457,0.3648148148148148,0.7629520276664852,1.0,6/14,12.94%,BMPR2;NOTCH1;ACVR1;ZFPM1;APLNR;TGFBR2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5061662404517988,1.0744078911705623,0.4213381555153707,0.7632322699503101,1.0,4/14,14.18%,CARD10;TIRAP;MALT1;TRAF6
prerank,positive regulation of RNA splicing (GO:0033120),0.439815782945091,1.0743965725842013,0.38009049773755654,0.7626407603984713,1.0,8/29,14.92%,ERN1;RBM20;SF3B4;DYRK1A;HNRNPLL;RBM3;NUP98;SNW1
prerank,apoptotic DNA fragmentation (GO:0006309),0.4899866889044908,1.0742556833760448,0.4013377926421405,0.7623741127296759,1.0,6/16,22.76%,FOXL2;CECR2;DICER1;ENDOG;KPNB1;HMGB1
prerank,cellular response to unfolded protein (GO:0034620),0.4523531120755895,1.0741307991696791,0.37898089171974525,0.7620453975090915,1.0,5/26,9.42%,ERN1;DAB2IP;TMBIM6;RHBDD1;PTPN1
prerank,cellular response to heat (GO:0034605),-0.357829789601017,-1.073960660032869,0.34831460674157305,0.8044848179802425,1.0,6/35,8.91%,FGF1;THBS1;ANO1;HSP90AA1;PRKACA;RBBP7
prerank,regulation of B cell activation (GO:0050864),0.4558729374329161,1.0739230964798192,0.35968992248062015,0.7619259545154249,1.0,2/25,8.07%,AHR;SAMSN1
prerank,nucleoside catabolic process (GO:0009164),-0.4738627795955527,-1.073649263285626,0.40486725663716816,0.8039177826768185,1.0,4/11,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4225817885095034,1.0736399992480663,0.3669724770642202,0.761990485250246,1.0,9/35,11.71%,B2M;HIP1;HIP1R;RAC1;SMAP1;HNRNPK;CBL;MKLN1;PICALM
prerank,positive regulation of cellular component organization (GO:0051130),0.35963132287507543,1.072998883626091,0.3569553805774278,0.7629465881994968,1.0,15/107,7.33%,SHANK3;INSR;DAB2IP;TAL1;NEDD4L;ATP10A;FNIP2;BIK;ABCB7;TIRAP;DLL1;CBLL1;SH3GLB1;BCL2L11;TGFB1
prerank,visual perception (GO:0007601),-0.30995035057532205,-1.0728280109321549,0.3053435114503817,0.8048830596354926,1.0,9/84,4.63%,COL1A1;SLC4A10;ADGRV1;EYA4;COL11A1;EFEMP1;EML2;COL18A1;DHRS3
prerank,atrial septum development (GO:0003283),-0.4565480605020192,-1.0726616370444069,0.367170626349892,0.8039556219271649,1.0,2/13,0.29%,ANK2;NOTCH2
prerank,negative regulation of double-strand break repair (GO:2000780),0.44053101993114413,1.072498327607486,0.3726993865030675,0.7635683137947203,1.0,7/30,12.11%,RNF169;SMCHD1;SHLD1;CGAS;MAD2L2;HELB;CYREN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.43226077542264274,1.0722494222835313,0.3875968992248062,0.7635512028617706,1.0,6/32,14.35%,RPS19;RPL39;PPBP;ANG;DEFA6;S100A9
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4735300987067893,-1.07189641351384,0.37303370786516854,0.8047304271557906,1.0,2/11,4.18%,NRP1;SIRT2
prerank,regulation of protein localization to nucleus (GO:1900180),0.41321489868860384,1.071833788578457,0.37664233576642336,0.7640035846118155,1.0,7/43,7.33%,MFHAS1;WWTR1;CARD10;DTX3L;CTNNA1;LIMK2;TGFB1
prerank,acute-phase response (GO:0006953),0.5290330956781155,1.0715894077548798,0.40325497287522605,0.7639810414590932,1.0,5/12,17.97%,IL6R;SIGIRR;ITIH4;IL22;PLSCR1
prerank,lipid phosphorylation (GO:0046834),0.5210305431643405,1.0714366100783648,0.4011090573012939,0.7637467235888062,1.0,3/10,11.26%,DGKZ;DGKH;DGKE
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37101109152581696,1.0709228343381108,0.34419817470664926,0.7643618945690416,1.0,19/87,11.12%,ABI3;ESAM;F11R;EPS8;HIP1R;CELSR1;IQGAP1;PTK2B;BST1;TAOK2;ARHGAP17;CCDC88A;RAC1;RHOBTB1;CRK;RICTOR;TWF2;FSCN1;ABL2
prerank,positive regulation of dephosphorylation (GO:0035306),0.44841018236628444,1.0706120000508483,0.3852596314907873,0.7645132183965602,1.0,8/27,16.26%,PPP1R16B;PPP2R5A;CHP2;TGFB1;CDH5;PPP1R7;SPPL3;CALM1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.42814810481510945,-1.070594001535771,0.36711711711711714,0.807035922003356,1.0,8/17,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.3036050544049828,-1.0704583198509305,0.28708133971291866,0.8059987675527632,1.0,33/94,23.27%,NINL;HSP90AA1;YWHAG;ALMS1;CC2D2A;AHI1;IQCB1;PRKACA;KIF24;SDCCAG8;NPHP1;CEP63;RPGRIP1L;CEP89;CEP192;ODF2;MKS1;RAB3IP;CEP152;PCM1;CEP43;TTBK2;TCTN1;DCTN3;DYNC1H1;TCTN2;C2CD3;TMEM67;CKAP5;HAUS6;B9D2;HAUS2;SFI1
prerank,mesenchymal cell differentiation (GO:0048762),0.40393658053570514,1.0703353753788134,0.362043795620438,0.7645421012785275,1.0,9/51,7.33%,LEF1;ENG;MEF2C;NOTCH1;HIF1A;SOX9;FOXF2;WNT5A;TGFB1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4355806825136954,-1.0701464816200723,0.3548387096774194,0.8054639233997862,1.0,8/15,25.10%,NLGN2;NLGN1;CNTNAP4;ADRA1A;CLN3;BAIAP3;ZDHHC12;ZDHHC3
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3205925335476085,-1.07006504435668,0.32269503546099293,0.8042523252841718,1.0,8/59,5.16%,EGFR;PDGFRA;MAP3K5;PRKCD;TPM1;IMPACT;CYP1B1;ANXA1
prerank,calcium ion homeostasis (GO:0055074),-0.3003521007981908,-1.0698530463076827,0.2936170212765957,0.803394892353512,1.0,14/95,9.52%,SLC24A3;ANK2;ATP13A5;ATP13A3;SLC8A3;ATP1B1;SLC8A1;DMPK;FAM20A;STIM1;ATP2A2;RYR2;CXCL12;SLC24A2
prerank,nucleotide biosynthetic process (GO:0009165),-0.42029581972090785,-1.0698479467397592,0.3627450980392157,0.8019981871778864,1.0,8/18,21.55%,NMNAT2;ME1;PRPS2;MTHFD1;NMNAT1;PRPSAP2;NMNAT3;PRPSAP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.38114125812756083,1.0696793416507226,0.34048257372654156,0.7655036359322863,1.0,13/70,11.99%,IL6R;DAB2IP;FAS;TNFRSF1B;CASP8;HIPK1;BOK;TNFRSF1A;TGFB1;CRADD;BCL2L1;RIPK1;BID
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4790453446081523,-1.069498473195441,0.38293216630196936,0.8002477478673156,1.0,3/10,18.26%,MBP;WNK1;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4790453446081523,-1.069498473195441,0.38293216630196936,0.8002477478673156,1.0,3/10,18.26%,MBP;WNK1;MYADM
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3842280132451772,-1.0692910334571277,0.36486486486486486,0.7994445407157864,1.0,2/26,1.35%,LGR4;APPL2
prerank,gland development (GO:0048732),-0.32593173975328327,-1.0691654086488935,0.3046594982078853,0.7984255638091086,1.0,23/59,17.35%,FGFR2;GLI2;TGFBR3;WNT4;DKK3;TGFBR1;IGSF3;COBL;ANXA1;SALL1;NF1;SIX1;EZR;TGFB3;STRA6;CITED2;WNT11;TBX3;PAX8;MDK;FGF10;ARHGAP35;EPHB3
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.38409524625983543,1.0688806048126476,0.3732394366197183,0.7667482911954566,1.0,13/72,14.30%,SHANK3;KANK3;HIP1R;ARHGEF2;SSH2;DYRK1A;CAMSAP2;CYRIB;TWF2;PFDN1;LIMA1;CDH5;APC
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.325070279224155,-1.0686052497745093,0.31724137931034485,0.7987413958159894,1.0,22/57,16.31%,DLG2;NLGN2;ACTN2;DLG4;GRIA2;DLG1;GRIA3;GRIA1;NLGN1;DLGAP4;DLG3;GRIA4;SHANK1;GRIN2A;PRRT1;CAMK2B;CACNG4;SHISA7;NPTXR;NETO1;DLGAP1;LRRC7
prerank,epidermal cell differentiation (GO:0009913),0.4126598143525814,1.0685096083814722,0.3562691131498471,0.7670487415616648,1.0,7/41,14.08%,UGCG;BCR;WNT5A;USH2A;CLIC4;TXNIP;ASAH1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3325925586951978,-1.0682647609153053,0.3010033444816054,0.7983427262587004,1.0,19/52,24.84%,ME1;ADHFE1;IDH2;ME2;ALDH1L1;GCLC;FPGS;GPT2;IDH1;GOT1;MTHFD1;SLC19A1;HOGA1;MTHFD2L;MDH1;ALDH18A1;GGT1;GOT2;MTRR
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3983699908969502,-1.0681939744285074,0.3640661938534279,0.7971371588115224,1.0,10/23,21.06%,CAMK1D;DPP4;MCU;RIPOR2;DAPK2;SLIT2;JAM3;MDK;CCL19;CD74
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5402005662414402,1.0679666432774926,0.4331450094161959,0.7677961715328981,1.0,3/10,16.94%,SIGIRR;IRAK3;MAP2K5
prerank,negative regulation of protein localization to membrane (GO:1905476),0.44989297329601496,1.0678454202494636,0.37244897959183676,0.767447886535627,1.0,7/24,11.71%,ABI3;PPP2R5A;NUMB;INPP5K;TGFB1;BCL2L1;PICALM
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4352114900444925,-1.0675765886188673,0.4050925925925926,0.7975589627912311,1.0,3/16,5.96%,DDX5;CELF4;DDX17
prerank,amyloid fibril formation (GO:1990000),0.3954079078292667,1.0671588461341128,0.3884180790960452,0.7685206221528917,1.0,11/51,11.87%,APP;B2M;ADAM10;TSPAN5;FKBP1A;TSPAN14;H3-3A;SNCAIP;SIAH1;APH1A;RIPK1
prerank,response to interferon-alpha (GO:0035455),0.4805398358589082,1.067060480790068,0.39823008849557523,0.7681469998838565,1.0,9/16,19.35%,IFNAR1;IFNAR2;GAS6;RO60;ADAR;IFITM3;BST2;IFITM1;EIF2AK2
prerank,peptidyl-asparagine modification (GO:0018196),0.4323292131273897,1.0668949826387668,0.36920529801324503,0.767975490040503,1.0,2/31,1.62%,ST6GAL1;STT3B
prerank,positive regulation of lipid storage (GO:0010884),0.4657699324173127,1.0665862129670525,0.37881219903691815,0.768129452248392,1.0,4/21,8.24%,SCARB1;PLIN5;NFKB1;LPL
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.40717289089721787,1.0663501153787682,0.38288288288288286,0.7680836599420907,1.0,6/46,5.94%,SHANK3;MEF2C;DGKZ;PTK2B;CDH2;OPHN1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4019441245972243,1.066345308446423,0.3558368495077356,0.7674827916172712,1.0,14/50,16.45%,CAV1;DTX3L;SMAD7;N4BP1;DNAJA1;ARRB1;PINX1;SOX4;SPOPL;VPS28;NXN;UBXN1;PRKCG;CHP1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3635678138380354,-1.0662231246537526,0.3562005277044855,0.7999545604848616,1.0,9/32,9.80%,PID1;IGF1;NUPR1;ZBTB20;PPARA;PPARGC1A;PRKAA2;PFKFB4;ARNT
prerank,cellular response to DNA damage stimulus (GO:0006974),0.32123860605649834,1.0662091746528588,0.3256830601092896,0.7672098228012064,1.0,95/336,22.93%,FOXO1;ACER2;POLK;FOXP1;LYN;SAMHD1;FNIP2;TNFRSF1B;CCNK;TAOK2;USP3;BABAM2;UBA7;RNF169;DTX3L;HERC2;XIAP;BOK;BCL2L11;MCM10;RPA1;TIGAR;MTREX;BCL3;POLA1;PSEN1;RAD51D;IKBKG;CGAS;BCL2L1;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;SFN;MMS19;UNG;MCM9;BID;NOP53;WDR76;ERCC4;NSMCE4A;FMR1;NPM1;ASH2L;APC;SUSD6;TOPORS;YY1;OARD1;ENDOV;DDIT3;GTF2H4;CHEK2;BCL2L10;PDS5A;SPIDR;WDR48;PDS5B;RFC3;CIB1;GRB2;KMT5B;PAK1;MGMT;BAK1;NUDT1;CHD1L;RBBP5;GTF2H1;TAF9;MSH2;HIC1;RAD17;RPS3;RMI2;TRRAP;SETX;RIF1;MAP2K6;SIRT7;CASP2;MBD4;RFC5;TAOK1;SUV39H1;PHF1;NIPBL;MAPK14
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.41738339088352744,-1.066128695236047,0.37320574162679426,0.7987885009291926,1.0,6/21,7.01%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;GUCY1A1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.48302852346750874,1.065984967784884,0.3813868613138686,0.7671732713385081,1.0,4/16,10.66%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;A4GALT
prerank,insulin receptor signaling pathway (GO:0008286),0.3786362456612054,1.0659182113888386,0.37986577181208053,0.7667272854065953,1.0,13/69,9.30%,FOXO1;INSR;PIK3C2A;CAV2;SH2B2;SORBS1;GRB14;BCAR3;GRB7;ATP6V0A1;GAB1;AKT2;ATP6V1G2
prerank,cell cycle G1/S phase transition (GO:0044843),0.38357318518900746,1.0657326956636082,0.3588317107093185,0.7665377388241909,1.0,23/61,24.17%,CDK6;EIF4E;PLK2;ACVR1;CDKN1B;MAP3K11;CDK2;RB1;EIF4EBP1;CUL1;MAX;CUL3;CDC34;CUL2;E2F3;TRIM71;DBF4;CCNH;CRLF3;LATS1;CCNA2;CUL4B;PLK3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3613495517254191,1.065376882123325,0.3771353482260184,0.7667807931066932,1.0,16/102,8.63%,FOXO1;HDAC9;CAV1;ADCY4;INSR;TBC1D4;DENND4C;PRKAR2B;SORBS1;XBP1;CEACAM1;LPIN3;INPP5K;TRIB3;NFKB1;AKT2
prerank,cardiolipin metabolic process (GO:0032048),0.5090403020195438,1.0647956113028978,0.4229390681003584,0.7675449888110063,1.0,3/13,7.72%,PLA2G4A;HADHA;PTPMT1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.42127418383011433,1.0646690808484818,0.3637795275590551,0.7672347943894982,1.0,9/34,12.79%,INSR;PDGFB;EDN1;LRP5;AURKA;TGFA;ANAPC7;RB1;PHIP
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.404151971082562,-1.064472055544116,0.3725,0.8021470083064184,1.0,3/19,2.89%,IRS1;PRKCD;PPARA
prerank,tRNA aminoacylation (GO:0043039),0.4238865429095624,1.0642448690644783,0.3799392097264438,0.7676948591339472,1.0,10/37,17.58%,GARS1;FARS2;IARS1;LARS1;WARS1;RARS1;QRSL1;AIMP1;KARS1;WARS2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.42381284768252,-1.0640864510748227,0.3761467889908257,0.8018278241949334,1.0,3/17,7.36%,BMP6;CD55;PRKCA
prerank,ganglioside metabolic process (GO:0001573),0.4753986159956008,1.0639677904906595,0.4163763066202091,0.7677850659574422,1.0,4/20,12.36%,ST6GALNAC3;ST8SIA4;ST6GALNAC4;CLN6
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44820763960490895,1.063930411653198,0.39933993399339934,0.7672818216461067,1.0,5/25,8.79%,CSGALNACT1;B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,regulation of cytoskeleton organization (GO:0051493),-0.28870872051859103,-1.0635030549565634,0.29015544041450775,0.802067992628509,1.0,19/108,8.68%,PHLDB2;LRP1;EPHA3;PDGFRB;ROCK2;EFNA5;RHOQ;PHLDB1;BICD1;PRKCD;GPM6B;RHOBTB2;RND3;ARHGAP18;PRKAA2;MAP6;EZR;RHOBTB3;PLXNB1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.46707964494298315,1.063321899733332,0.3913793103448276,0.7680692772314789,1.0,4/22,9.61%,IL15;TGFB1;RFTN1;IL23A
prerank,neural tube development (GO:0021915),-0.4388397321029273,-1.0633061806002464,0.3922902494331066,0.8012254261398861,1.0,3/15,4.70%,ALDH1A2;PKD1;DACT1
prerank,positive regulation of cell cycle process (GO:0090068),0.3635167698412824,1.0631946031731707,0.35348226018396844,0.7677773912022671,1.0,24/91,19.31%,PKP4;INSR;PDGFB;EDN1;LRP5;PKN2;AURKA;TGFA;DYNC1LI1;AURKC;NUDT16;KIF23;PHIP;MAP3K20;GIPC1;ATRX;E2F7;CEP295;RHOA;RAD21;CUL3;PLSCR1;NUMA1;BTC
prerank,positive regulation of protein kinase activity (GO:0045860),0.34455447488631685,1.0628959211731355,0.3460591133004926,0.7678880598197684,1.0,38/148,16.72%,INSR;PDGFB;NEDD9;IQGAP1;IL6R;DAB2IP;EFNA1;PTK2B;TAOK2;STK3;PAK2;STK4;RALB;CCDC88A;RAPGEF2;TNIK;PTK2;RAP1A;RPTOR;PTPN1;CSF1;MAP2K3;IL23A;FCGR1A;GAS6;EPHA4;ITGB3;TGFBR2;HSP90AB1;TRAF6;PAK4;ACE;MMD;LAT;IRGM;CALM1;PIH1D1;RHOA
prerank,methylguanosine-cap decapping (GO:0110156),0.5387158429305127,1.0628603894401416,0.41651376146788993,0.7673588736801497,1.0,7/10,28.00%,EDC3;DCP2;PNRC2;LSM1;DCP1B;PATL2;DCPS
prerank,positive regulation of leukocyte migration (GO:0002687),0.4432789131910878,1.062801224721577,0.3902439024390244,0.7669028352693661,1.0,4/27,9.46%,ICAM1;IL6R;F7;CSF1
prerank,heart process (GO:0003015),-0.4327719550460307,-1.0625507113235197,0.3778280542986425,0.8019444498515683,1.0,3/14,7.91%,SGCD;NOX4;SGCZ
prerank,negative regulation of B cell proliferation (GO:0030889),0.5313340076240377,1.0624049125394441,0.427536231884058,0.7672664102749175,1.0,2/11,10.79%,LYN;RC3H1
prerank,histone H4 deacetylation (GO:0070933),0.5232515060766723,1.0622426458380676,0.41414141414141414,0.7670717416842334,1.0,2/10,6.18%,HDAC9;RCOR1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.507992456568049,1.062163049435385,0.42401500938086306,0.7666609549334832,1.0,3/13,12.88%,PDE8A;RACK1;MET
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3646402274922018,1.061927992880249,0.3893229166666667,0.7666195242691132,1.0,26/100,15.35%,CBFA2T3;RNF144B;NKD2;SDCBP;SMAD7;N4BP1;FOXF2;EIF3H;UCHL5;RNF144A;TRIB3;XPO1;GNA12;RAD23A;SUMO2;HECTD1;COP1;NOP53;PRICKLE1;RACK1;HSP90AB1;TRIB1;UBXN1;GIPC1;RYBP;ARIH2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.32232532421346305,-1.0617642274789036,0.34397163120567376,0.8027308323562801,1.0,10/59,15.09%,ALDH1A2;CYP7B1;CYP27A1;ABCD3;PER2;ACACA;OSBPL3;OSBPL6;HOGA1;SCP2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.47220628502979334,-1.0616390415872021,0.3668903803131991,0.8003545165520354,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.47220628502979334,-1.0616390415872021,0.3668903803131991,0.8003545165520354,1.0,2/12,1.76%,EFNA5;FBLN1
prerank,protein localization to plasma membrane (GO:0072659),0.3533600757980225,1.0615684497978775,0.37576499388004897,0.7668728946040816,1.0,24/129,7.65%,EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;IKBKB;TSPAN14;RAMP2;CCDC88A;RAPGEF2;TMEM88;INPP5K;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5082034121222627,1.0615475114182893,0.40391459074733094,0.7663184617463958,1.0,7/13,23.52%,UBA7;SAE1;DESI2;DESI1;ATG7;UBA3;SENP6
prerank,central nervous system neuron development (GO:0021954),0.49772900943783693,1.060704322836104,0.4123134328358209,0.767721485160786,1.0,3/15,7.51%,LHX6;RAPGEF2;B4GALT5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33008600597747684,-1.0606839196854867,0.34615384615384615,0.8018156433246614,1.0,7/55,6.12%,PID1;PDGFRB;PRKN;THBS1;SIRT2;CYP1B1;AGTR1
prerank,positive regulation of macroautophagy (GO:0016239),0.4004580054892946,1.0606596715909755,0.3915574963609898,0.7672292035670213,1.0,13/48,17.16%,KDR;SPTLC2;VPS13D;RALB;SH3GLB1;IKBKG;BNIP3;GNAI3;FYCO1;IRGM;RAB3GAP2;EPM2A;HSPB8
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3501525096938705,1.0598415886994186,0.3701863354037267,0.7685740180740601,1.0,28/119,14.80%,INPP5D;PIP5K1B;SOCS2;PITPNM2;MTM1;PIK3C2A;PLCG2;PIK3R6;MTMR6;CISH;ITPKB;INPP5K;BMX;PIK3CG;PIGU;SYNJ1;PLEKHA8;OCRL;INPP5F;MTMR12;PIGQ;RAB5A;SLA2;PGAP4;PIGG;PIGF;SOCS6;SOCS4
prerank,regulation of chromosome segregation (GO:0051983),0.4765377662728611,1.059358053580511,0.4113597246127367,0.7691374150267484,1.0,7/16,20.62%,PUM1;RAD18;PUM2;CSNK2A2;CSNK2A1;NUMA1;RMI2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4815008762772021,-1.0591208064549187,0.41200828157349895,0.8021060182887834,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,t-circle formation (GO:0090656),-0.4815008762772021,-1.0591208064549187,0.41200828157349895,0.8021060182887834,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4815008762772021,-1.0591208064549187,0.41200828157349895,0.8021060182887834,1.0,8/10,32.55%,SMARCAL1;DNA2;SLX4;XRCC3;EXO1;ERCC1;BLM;WRN
prerank,long-chain fatty acid transport (GO:0015909),-0.3653105992209229,-1.0591203664739626,0.37275064267352187,0.8007564604764275,1.0,19/30,31.71%,ACSL1;ABCD3;PRKAA2;PRKAG2;ACACA;ACSL3;APOE;SLC27A1;MFSD2A;PRKAB2;SLC27A4;CPT2;PPARG;RPS6KB1;ABCD2;SLC27A6;CD36;CPT1B;FABP5
prerank,in utero embryonic development (GO:0001701),-0.38326137692261597,-1.0589321701781356,0.380352644836272,0.7998935545438615,1.0,7/25,10.19%,FGFR2;ARNT2;TGFBR1;PKD1;IGF2;VEGFA;TGFB3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37543542271628433,-1.0588390714868572,0.35396039603960394,0.7988242228564844,1.0,6/26,6.09%,IGF1;IRS1;RHOQ;C2CD5;CLIP3;OSBPL8
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.509571038003766,1.0587492722305079,0.40636042402826855,0.7700196511443532,1.0,5/11,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,detection of mechanical stimulus (GO:0050982),0.4721171448340939,1.0584822709041521,0.3993174061433447,0.7700565446878973,1.0,5/19,8.29%,PIEZO1;CDH2;PTK2;PKD2;PKDREJ
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4296142630936928,-1.0582909453082887,0.38344226579520696,0.7990458879315562,1.0,8/15,23.37%,PRKCD;SMPD3;SPHK1;NSMAF;ORMDL2;PLA2G6;SMPD2;SPHK2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5198171674513211,1.0580937991811827,0.40630797773654914,0.770380515196039,1.0,4/12,4.39%,LFNG;PTK2B;MFNG;DLL1
prerank,regulation of protein metabolic process (GO:0051246),0.40825972874748206,1.057316377211377,0.41025641025641024,0.7717250194190783,1.0,13/44,17.17%,APP;NEDD4L;FKBP1A;KLF2;MAPK8;PM20D2;SPOPL;HSP90AB1;MTPN;ACE;CHEK2;MAP2K5;NEDD8
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.36561207136183005,1.0572477103771956,0.3692722371967655,0.7713185553430786,1.0,25/86,22.49%,EPAS1;HIF1A;KLF2;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;MUC1;HIGD1A;PSME1;ELOC;DDIT3;PSMA4;PSMF1;CUL2;DNAJB1;PSMB7;PSMB1;EGLN2;PSMD2;ANKRD2;GCN1;PSMA5;PSMC3
prerank,calcium ion import across plasma membrane (GO:0098703),-0.44028390325581457,-1.0571897253584501,0.3967136150234742,0.8009144912122207,1.0,4/14,9.52%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,ventricular septum development (GO:0003281),-0.34892523667126696,-1.0570741404476587,0.3524590163934426,0.7998609789239083,1.0,12/37,11.96%,ROBO1;BMPR1A;TGFBR3;TGFBR1;ZFPM2;ROBO2;SALL1;HEYL;MDM4;SLIT2;TGFB2;STRA6
prerank,regulation of receptor internalization (GO:0002090),0.4167624767879449,1.0569490735628184,0.39346811819595645,0.7714101366496076,1.0,11/35,11.52%,ANKRD13A;INSR;RIN3;SELE;SDCBP;GREM1;ARRB1;SCYL2;MKLN1;TBC1D5;PICK1
prerank,negative regulation of cell development (GO:0010721),-0.3859674414175367,-1.0569062586089089,0.3791208791208791,0.7989703454195138,1.0,3/25,1.35%,IGF1;FBN1;APPL2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.48570751213037144,1.0560647423493437,0.4203935599284436,0.7728942277630977,1.0,5/14,15.90%,NFKBIA;TMSB4X;PKD2;NFKBIE;G3BP2
prerank,sensory perception of pain (GO:0019233),-0.3996491291635597,-1.0559796435382716,0.3935643564356436,0.8002978976861594,1.0,11/21,31.71%,P2RX4;PTGES;RETREG1;TRPA1;CCR2;CCL2;KCNA2;SCN9A;CHRNB2;ALOXE3;P2RX7
prerank,phosphatidylcholine metabolic process (GO:0046470),0.376722034930452,1.0558060190535112,0.38482384823848237,0.7729221557447044,1.0,15/70,18.26%,PLA2G4A;LPCAT3;CEPT1;ENPP2;LPIN3;ABCA3;PLA2G2D;MBOAT1;PLAAT3;PEMT;CHKA;PNPLA8;TMEM86B;CSNK2A2;CSNK2A1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4792017810503982,-1.0550681803029063,0.4152173913043478,0.8015907786380789,1.0,4/10,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,axon extension (GO:0048675),0.45830433259440717,1.0547676314723193,0.4126984126984127,0.7748236759331548,1.0,4/23,5.98%,NRP2;SEMA5B;ULK1;PPP3CB
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3691423608285097,1.054735304191788,0.37415881561238223,0.7743100094594929,1.0,9/74,6.28%,NOS3;TNFSF10;ITGA6;ICAM1;ARHGEF2;FAS;CASP8;TCF7L2;ACVR1
prerank,epithelial cell morphogenesis (GO:0003382),-0.4194195060660393,-1.0546287674058938,0.37616822429906543,0.8014824640597689,1.0,4/17,13.06%,COL22A1;COL18A1;COL15A1;DACT2
prerank,regulation of neuroinflammatory response (GO:0150077),0.46344868043334336,1.0545478984202576,0.39752650176678445,0.7741707952832299,1.0,3/19,3.04%,PTGS2;CD200;TNFRSF1B
prerank,response to prostaglandin E (GO:0034695),-0.4792871226467347,-1.0542992375170412,0.40997830802603036,0.8010533775773689,1.0,5/10,18.91%,TGFBR3;ADCY6;SFRP1;GNG2;CCL19
prerank,regulation of sodium ion transport (GO:0002028),-0.35233129657683043,-1.0542593098289819,0.34324324324324323,0.799859584509717,1.0,8/34,5.31%,SNTA1;P2RX4;WNK4;NKAIN4;ANK3;DLG1;SLMAP;NKAIN2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.47299778938592635,1.054119738989803,0.39600665557404324,0.7745383314111572,1.0,5/18,18.99%,LYN;SH2B2;SLA2;FPR3;BCAR1
prerank,positive regulation of metabolic process (GO:0009893),0.3557471304768961,1.0540120860243467,0.3865435356200528,0.7741893522043051,1.0,23/103,13.47%,EPAS1;ADIPOR2;CAV1;INSR;FASN;ACACB;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;AGPAT1;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R
prerank,cellular transition metal ion homeostasis (GO:0046916),0.36119711419080286,1.053738735969134,0.36436170212765956,0.7742585649012736,1.0,6/91,4.60%,ABCG2;SLC39A8;APP;SLC31A1;ABCB7;LCN2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.31027746673167034,-1.0535728691327464,0.3358208955223881,0.8004053263561592,1.0,17/65,11.51%,FBN1;LTBP1;TGFBR1;HTRA3;SPRED1;PPARA;SMAD6;FBN2;SMAD3;CD109;SNX6;ASPN;TGFB1I1;VASN;SLC2A10;SPRED2;SPRED3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4915981820467562,1.0532885706104242,0.4200351493848858,0.7747238060302027,1.0,6/14,13.77%,ADAM10;DYRK1A;PSEN1;APH1A;ADAM17;ABCG1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4502790574636095,1.0532189338388693,0.4181523500810373,0.7742777574690248,1.0,5/24,7.33%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.46003772084475925,1.0529491717378934,0.4184027777777778,0.7742791931652933,1.0,6/20,8.82%,LCP1;FMNL3;IKBKB;NCKAP1;FMNL2;LLGL1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.4475193234219687,1.0525774298186399,0.3945578231292517,0.7745449184389747,1.0,4/24,6.96%,PLA2G4A;ABCA3;PLA2G2D;CDS2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4160765610598017,-1.0525457416562594,0.3787528868360277,0.8019994031248922,1.0,8/18,23.69%,CAMK1D;MCU;RIPOR2;DAPK2;MDK;CCL19;CD74;DNM1L
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4544934960158139,1.0524238937347412,0.4208754208754209,0.7743267497037705,1.0,3/20,8.58%,TGM2;RAP1GDS1;PSEN1
prerank,negative regulation of cellular component organization (GO:0051129),-0.30124405832285817,-1.0523846683241278,0.3473684210526316,0.8010825372232563,1.0,20/74,16.87%,BMP6;EPHA3;TMEFF2;AR;FAP;IMPACT;CARMIL1;SYT11;PRKCZ;RTEL1;SRC;VEGFA;SCAMP5;LRSAM1;RUBCN;TRAF3IP1;XRCC5;LCMT1;ABCA7;NR1H4
prerank,tyrosine metabolic process (GO:0006570),-0.47224069711762107,-1.05238220168685,0.40969162995594716,0.799769453039242,1.0,6/11,45.23%,FAH;GSTZ1;HGD;THAP4;DCT;IYD
prerank,regulation of cellular protein localization (GO:1903827),-0.3271507213939701,-1.0523416719931233,0.3793103448275862,0.7985875694787761,1.0,9/45,11.12%,GPC6;GPC3;MAP2;HSP90AA1;PRKAA2;GPC5;GBF1;GPC4;CCDC66
prerank,regulation of gene expression (GO:0010468),0.3091532177675334,1.0521485381940026,0.33198789101917253,0.7744052797023064,1.0,123/903,10.79%,LEF1;RPS6KA5;NOS3;RAB27A;NOVA2;KDR;ENG;SLC39A8;APBB2;ESR1;SMARCA2;APP;MEF2C;SOX7;ACVRL1;CLDN5;OCLN;NR5A2;CDK6;INSR;AHR;SMAD1;PDGFB;IRF2;FOXP1;GATA2;SOX13;PDE2A;LYN;ADAM10;STAT3;NR3C1;TRIM14;FBXW7;NOTCH1;HIF1A;MSN;PPM1F;NFKBIZ;RREB1;SOX17;WWTR1;CHD7;CASP8;SOX18;CD34;PLCG2;FGF23;SOX9;KDM6A;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;TCF7L1;LIN54;SPIN1;DLL4;TRIM68;SBNO2;MAPK8;ATP2B4;SERPINB9;MTF2;RAMP2;JMJD1C;TEAD2;TNRC6C;PITX3;AURKA;ESRRG;HNRNPF;WNT5A;CNBP;RPS7;UBAP2;BTN2A2;IL36G;KRAS;ASCC1;AFF1;MBNL3;LYL1;HNRNPK;TGFB1;FOXN2;ZNF326;TCF3;HNRNPD;NFKB1;NOS1AP;MARF1;WWC2;CITED1;ZNF2;CREM;KAT6B;PSEN1;PRDM8;MYBBP1A;IHH;YBX3;RPL23;CDK2;HINT1;SOX4;CSF1;DICER1;ICOSLG;PUM1;MAFB;BACH1;HNRNPLL;MAPK11;ATXN7L3B;SFRP2;FOXN3;APLNR;PRKAB1;GAS6;YTHDC1;RC3H1
prerank,response to purine-containing compound (GO:0014074),-0.4063573128269271,-1.0518933809432427,0.4028436018957346,0.7985005022834077,1.0,4/17,9.11%,P2RX4;ABCC9;TRPC3;RYR2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.38203944589951866,1.0518793147936272,0.3851744186046512,0.7744341978131534,1.0,7/57,6.84%,TNFSF10;KDR;HIP1R;BIK;BOK;AURKA;BCL2L11
prerank,glycosphingolipid metabolic process (GO:0006687),0.4086525450200844,1.0517524284748536,0.39819004524886875,0.7741501406502603,1.0,4/42,4.87%,ST6GALNAC3;UGCG;ESYT2;GLTP
prerank,response to calcium ion (GO:0051592),0.35705805014716974,1.0512981008356563,0.38212435233160624,0.7746441951946638,1.0,16/102,8.09%,CAV1;MEF2C;CPNE8;IQGAP1;PPP3CA;PLCG2;ALOX5AP;KCNMB4;CHP2;WNT5A;ITPKB;TRPV6;ITPR3;NEDD4;RASA4;PKD2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.44000599955833597,1.0511731550061956,0.3937908496732026,0.7743337012746259,1.0,4/23,12.62%,PTGS2;ASAH2;LTC4S;GSTP1
prerank,nucleosome organization (GO:0034728),0.38803539812513194,1.0507468537245002,0.3888888888888889,0.7747508255748459,1.0,21/55,24.69%,SOX9;PADI4;LIN54;H3-3A;ARID1A;KAT6B;SMARCA5;NAP1L4;SRCAP;SMARCE1;GRWD1;NPM1;ATRX;ANP32B;VPS72;SART3;PRDM9;SMARCC1;ARID2;SMARCD1;SET
prerank,erythrocyte development (GO:0048821),0.5272540706288819,1.0505778585549672,0.40429338103756707,0.7745619583087919,1.0,1/10,2.95%,ALAS1
prerank,glycerolipid metabolic process (GO:0046486),0.5071942404977268,1.0495736136260643,0.4323308270676692,0.776369750383473,1.0,1/11,2.23%,DGKZ
prerank,sulfur amino acid metabolic process (GO:0000096),-0.3799171217147379,-1.049482696308147,0.3957845433255269,0.8039934118680896,1.0,10/24,28.00%,NOX4;SMS;GCLC;MTHFD1;CBS;CTH;MMUT;ADI1;MTRR;CDO1
prerank,renal absorption (GO:0070293),0.5087203358491663,1.0494056031850547,0.43169398907103823,0.7761452321290828,1.0,3/10,8.48%,KLHL3;KCNQ1;SLC15A2
prerank,protein localization to mitochondrion (GO:0070585),-0.4620153822720986,-1.0492451684370718,0.4191343963553531,0.8033451951261886,1.0,6/11,21.90%,LRRK2;HK2;MTCH2;RALA;COX18;MAIP1
prerank,negative regulation of receptor binding (GO:1900121),0.519896271913405,1.04923102496271,0.42105263157894735,0.7759670200018963,1.0,2/10,6.17%,B2M;ADAM15
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.45457728974702444,-1.0492174979531503,0.4088785046728972,0.8021192155476938,1.0,2/13,2.50%,AXL;IL18
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3583823806928321,1.0487026600905751,0.385989010989011,0.7766625018855465,1.0,27/94,17.24%,ERN1;PPP1R13B;DAB2IP;FNIP2;CASP4;PPM1F;TNFRSF1B;STK24;JMY;BOK;TRIB3;BCL2L11;MYBBP1A;HINT1;BCL2L1;ERO1A;BNIP3;SFN;CUL1;GSKIP;TOPORS;APAF1;DDIT3;CHEK2;BCL2L10;CUL3;ARL6IP5
prerank,protein acylation (GO:0043543),0.4081803874278691,1.0484571651151136,0.394856278366112,0.7766258684717472,1.0,10/38,20.92%,FOXO1;ZDHHC18;ZDHHC9;HHAT;KAT2B;KAT6A;ZDHHC1;ZDHHC6;SELENOK;ZDHHC8
prerank,protein prenylation (GO:0018342),0.5209864704238848,1.0482490141510565,0.42830188679245285,0.7765072311995861,1.0,6/10,27.17%,PGGT1B;PTAR1;FNTA;FNTB;RABGGTB;CHML
prerank,neuropeptide signaling pathway (GO:0007218),0.3838324091800059,1.0481756407682747,0.4171195652173913,0.7761234900302079,1.0,13/58,19.80%,CYSLTR1;NXPH2;CPE;RAPGEF2;HCRTR1;MCHR1;NMUR2;LTB4R;AGRP;HCRTR2;OPRL1;GLRA3;PPY
prerank,phagosome-lysosome fusion (GO:0090385),0.5328975498024512,1.047803844691441,0.4394213381555154,0.7763925983018057,1.0,4/10,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,L-amino acid transport (GO:0015807),-0.3607360005119949,-1.047471354845352,0.41620111731843573,0.8056560315829396,1.0,9/28,18.52%,SLC7A2;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC36A1;PRAF2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.47950750092043126,1.0474274356341675,0.4193011647254576,0.7766829683985098,1.0,5/18,13.30%,HHEX;NXF2;THOC2;ENY2;NUP133
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3469385504858356,1.0474120008875134,0.40293040293040294,0.7761315381541549,1.0,20/128,7.46%,BMPR2;ENG;ACVRL1;CLDN5;F11R;SMAD1;SMURF1;PARD3;NRROS;PXN;FKBP1A;ID1;PTPRK;SMAD7;ACVR2A;USP15;DUSP22;ACVR1;TGFB1;PTK2
prerank,renal filtration (GO:0097205),-0.46762613051565877,-1.0472738592367155,0.39711934156378603,0.8048914924440029,1.0,2/10,2.03%,SULF1;SULF2
prerank,calcium ion import into cytosol (GO:1902656),-0.4287255581153641,-1.047054829309552,0.39485981308411217,0.8042017517621115,1.0,4/15,9.52%,SLC8A3;CACNA2D1;SLC8A1;SLC24A2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4446625730749222,1.0467368350866093,0.4203152364273205,0.7771605989520524,1.0,10/25,24.49%,SF3B4;SCAF11;PRPF4;SRSF10;LSM1;PRPF3;TRA2B;DBR1;SRSF4;SLU7
prerank,mitotic metaphase plate congression (GO:0007080),0.38699809880459,1.0465467150622074,0.39465875370919884,0.7770252787665658,1.0,9/51,12.46%,RAB11A;CHMP2B;CDT1;KIF22;RRS1;PINX1;CHMP4A;CHMP4B;MAD1L1
prerank,mitochondrial protein processing (GO:0034982),0.504685742120506,1.0464171040761017,0.43386243386243384,0.7767413216709323,1.0,2/11,13.22%,IMMP2L;OMA1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.36657059176039525,1.046206773350039,0.40355677154582764,0.7766377105686266,1.0,14/85,7.47%,TBX1;TIE1;ACVRL1;PRKD1;B2M;CDK6;DAB2IP;SGPP2;AQP11;MTSS1;SOX9;TCF7L2;TGFB1;TGFA
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.34398065143659307,-1.0460463927323673,0.3691860465116279,0.8057553621759248,1.0,2/40,1.56%,PID1;BCL2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.39219265663094754,-1.045965270019071,0.3746898263027295,0.8046751526945568,1.0,9/23,25.43%,ZWINT;PLK5;CHFR;ZFYVE19;VPS4A;SETMAR;CDK5RAP3;CHEK1;BUB1B
prerank,long-term synaptic potentiation (GO:0060291),-0.3952126183527439,-1.0458867211423166,0.3856041131105398,0.8035896212621025,1.0,8/21,13.75%,SLC8A3;TSHZ3;PRKCZ;SLC24A2;STX4;GRIN2A;NFATC4;GRIN2D
prerank,cholesterol transport (GO:0030301),0.405545183805,1.045779802115326,0.39730134932533734,0.7770592092376021,1.0,11/45,19.36%,CAV1;SCARB1;STARD5;SOAT2;LIMA1;ABCG1;STAR;STX12;CEL;OSBPL2;ABCA1
prerank,macrophage activation involved in immune response (GO:0002281),0.49599918699683915,1.0456279456404949,0.4200743494423792,0.7768125990667384,1.0,4/13,10.61%,PLCG2;CX3CR1;SBNO2;NMI
prerank,membrane lipid metabolic process (GO:0006643),0.45707473655513076,1.0456236679908009,0.39327731092436974,0.7762312849086277,1.0,4/22,10.19%,ST3GAL6;B4GALT4;CERKL;ST6GALNAC4
prerank,regulation of cartilage development (GO:0061035),0.47113328299733714,1.0452082584017766,0.425531914893617,0.7765771972198738,1.0,3/18,4.17%,BMPR2;ZBTB16;SOX9
prerank,phospholipid dephosphorylation (GO:0046839),0.40743867777252946,1.0443203891935475,0.4024390243902439,0.7780633130287805,1.0,15/37,20.46%,PLPP1;SGPP2;MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;PLPP6;PLPP5;MTMR9;MTMR2;SACM1L;PLPPR2
prerank,artery morphogenesis (GO:0048844),0.42473932671154935,1.043967944313133,0.39717425431711145,0.7783062263234384,1.0,6/30,5.18%,BMPR2;ENG;TBX1;NOTCH1;FOXF1;SMAD7
prerank,regulation of organelle organization (GO:0033043),0.36772342956681153,1.0439522998698643,0.39577836411609496,0.7777541744544664,1.0,19/80,17.31%,TJP1;F11R;PDE2A;MSN;MTM1;PAK2;PTK2;CAMSAP2;CDT1;SCARB2;PJVK;EHD3;PREB;CLIC4;S100A9;RDX;ARL6IP1;RHOT1;ARMH3
prerank,response to amyloid-beta (GO:1904645),0.40388881766832835,1.0428185795749443,0.4170542635658915,0.7797987508598968,1.0,11/44,11.80%,APP;VCAM1;ICAM1;CASP4;FYN;ATP1A3;CACNA1A;PSEN1;EPHA4;GRIN1;LGMN
prerank,response to glucagon (GO:0033762),-0.4142337332532752,-1.042410789208963,0.42890995260663506,0.8122307528421298,1.0,9/19,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,carbohydrate homeostasis (GO:0033500),0.369919576180692,1.0421478627138023,0.4067796610169492,0.7807974668095603,1.0,13/67,14.55%,ADIPOR2;INSR;STAT3;KLF7;KCNB1;TCF7L2;INPP5K;NEUROD1;SOX4;ADIPOR1;IGF1R;RPS6;MBD5
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5180059099133258,1.0421269235966029,0.4446428571428571,0.7802638319283423,1.0,4/11,16.37%,LPCAT3;ATL1;MOSPD3;ARL6IP1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4367299418775396,1.0418980397982116,0.4040066777963272,0.7802258313755253,1.0,2/24,7.13%,POLK;RPA1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.400689802008169,-1.0415795961622076,0.41687979539641945,0.8132446498591984,1.0,3/20,1.10%,BMPR1A;GLI2;NBL1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4540809988759492,-1.0415626808589744,0.4397463002114165,0.8119868771175425,1.0,5/12,10.20%,CACNA1C;DLG1;RYR2;BIN1;CTNNA3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4365594447471343,1.0408173190499477,0.40932642487046633,0.7821490808982128,1.0,7/24,10.84%,EPC1;H3-3A;MTF2;TASOR;PPM1D;AEBP2;PPHLN1
prerank,axonal transport of mitochondrion (GO:0019896),0.5068337386931292,1.0391595741801412,0.4208566108007449,0.7855414045119155,1.0,6/11,27.15%,HIF1A;ACTR10;TRAK2;OPA1;NEFL;HAP1
prerank,response to ketone (GO:1901654),0.42832639911045056,1.0388956007902572,0.40858505564387915,0.7855731070666394,1.0,5/24,11.54%,CAV1;ABHD2;TGFB1;CATSPERD;UBE3A
prerank,T cell differentiation in thymus (GO:0033077),-0.43017337318921867,-1.0387728704020307,0.42663656884875845,0.8184117581613783,1.0,1/14,0.67%,GLI3
prerank,response to iron ion (GO:0010039),-0.44785641731395254,-1.0387711923124043,0.4040632054176072,0.8171045716151943,1.0,2/12,1.56%,BMP6;BCL2
prerank,monocyte differentiation (GO:0030224),0.5162341272059724,1.0386451028247181,0.44802867383512546,0.7855581156476165,1.0,2/10,2.11%,PIR;MYH9
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.40557506460003545,-1.0382900417039476,0.40096618357487923,0.8171572445007746,1.0,5/17,9.53%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,cellular response to chemical stress (GO:0062197),0.35320880076318806,1.0382112781436734,0.39197930142302717,0.7860108405559405,1.0,14/96,12.62%,FOXO1;CAV1;PRKD1;FAS;CAT;GSR;CYCS;PRR5L;TRPV4;PKD2;ERO1A;LONP1;PRDX2;GSTP1
prerank,myelin assembly (GO:0032288),-0.4751454839236815,-1.0380290613806897,0.43478260869565216,0.8165170187805391,1.0,6/10,23.47%,EPB41L3;CNTNAP1;GPC1;TENM4;ABCA2;NCMAP
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.41667397519144905,-1.0380021963034527,0.43115124153498874,0.8152814564187192,1.0,4/15,17.07%,GLI3;CD55;HSPH1;SYK
prerank,negative regulation of protein polymerization (GO:0032272),0.434095260043051,1.038002022836589,0.4364820846905538,0.7858913385652455,1.0,6/27,10.19%,KANK3;HIP1R;SSH2;DYRK1A;CYRIB;TWF2
prerank,metal ion export (GO:0070839),-0.3601261789179028,-1.0378926568627644,0.40161725067385445,0.8142843466129865,1.0,4/31,4.91%,ATP1A2;KCNK5;ATP1B1;KCND3
prerank,protein localization to membrane (GO:0072657),0.3314582446511156,1.0378315469593766,0.39327146171693733,0.7857041753797771,1.0,39/187,12.23%,SHANK3;CAV1;EHD4;SPTBN1;F11R;SMURF1;RAB11A;TSPAN5;DENND4C;BSG;PACS1;NKD2;FCHO2;KCNB1;CPE;IKBKB;TSPAN14;RAMP2;RAPGEF2;TMEM88;INPP5K;SH3GLB1;ATP1B3;TNIK;TNFRSF1A;RAP1A;EHD2;AGRN;RAB38;ARL5A;ANK1;RFTN1;RAB12;TM9SF1;GAS6;PICK1;EHD3;BID;RAB11B
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.31551131070111527,1.03769590911896,0.40525739320920046,0.7854219142055922,1.0,90/341,21.23%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;MVB12B;FBXW7;ZNRF1;ZNRF3;DTX3L;XBP1;KCTD10;PELI1;FBXL4;KCTD6;UBL7;AURKA;RNF144A;UBE3B;ATXN3;ARRB1;RNF7;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;ARMC8;UBE2H;ANAPC7;RNF146;ZRANB1;SPOPL;RNF4;ANAPC1;ZFAND2B;VPS28;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;CDC26;COP1;MYLIP;ANAPC16;RNF215;KLHL8;UBE2K;BUB3;TOPORS;UBXN1;PSME1;ELOC;ARIH2;RNF5;DDIT3;VPS37C;UBE3D;AREL1;CRBN;NDFIP2;BIRC2;NHLRC1;CTNNB1;MAEA;NEDD8;UBE2I;CUL3;CDC34;PSMA4;RNF40;PSMF1;ZFAND2A;TSG101;FBXO8;APPBP2;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;KCTD2;ARIH1;PSMD2
prerank,reverse cholesterol transport (GO:0043691),0.49377356641679504,1.0375547227106616,0.44206773618538325,0.7851731569735905,1.0,4/13,23.47%,SCARB1;ABCG1;ABCA1;CLU
prerank,DNA double-strand break processing (GO:0000729),-0.406027446429609,-1.036994066119219,0.41204819277108434,0.8154772040919129,1.0,12/18,38.38%,RAD50;SETMAR;KAT5;DNA2;SLX4;BARD1;RAD52;ATM;BLM;EXD2;RNF138;NBN
prerank,translesion synthesis (GO:0019985),0.39903342494179556,1.036729050802334,0.42330383480825956,0.7865185905828896,1.0,6/42,11.81%,POLK;RPA1;TRIM25;PRIMPOL;MAD2L2;USP43
prerank,mitochondrial translation (GO:0032543),0.3524951668104912,1.036335416302866,0.40485312899106,0.7868553159466587,1.0,46/104,26.45%,MRPS18A;NDUFA7;MRPL13;MRPS12;MRPL35;FASTKD2;MRRF;MRPL41;MRPL52;MRPL4;QRSL1;MTIF3;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;NOA1;AURKAIP1;MRPL1;MRPL50;RARS2;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;MTIF2;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4887555620086341,1.0362450037527926,0.4527272727272727,0.7864913050593424,1.0,3/14,10.15%,NECTIN2;SHLD1;MAD2L2
prerank,proton transmembrane transport (GO:1902600),-0.3428859180436818,-1.036075314359795,0.38726790450928383,0.8167066799564048,1.0,5/36,11.94%,ATP1A2;ATP6V0A4;SLC9A1;SLC25A27;ATP6V0D1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.43298917163695283,1.035970222909297,0.43156199677938806,0.7865424809204324,1.0,7/25,9.87%,ITGA6;APP;SDCBP;PSEN1;ANG;DSCAM;BTBD10
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.43254441104885366,1.035849074209698,0.43659711075441415,0.7862530097984026,1.0,5/26,7.33%,IL6ST;PTGS2;HIF1A;FLT4;TGFB1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.41753344511453383,1.035805421545529,0.41823899371069184,0.7857561724345071,1.0,4/33,3.41%,SLC39A8;DGLUCY;GLS2;GLS
prerank,necroptotic process (GO:0070266),0.46562469622216435,1.0357353201709232,0.4308231173380035,0.7853384301523441,1.0,5/16,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,mitotic recombination (GO:0006312),-0.42349475002056364,-1.0349125394304968,0.4004474272930649,0.8186036517545752,1.0,10/15,30.90%,TEP1;RAD50;DMC1;SMC6;TPRKB;RAD52;GEN1;XRCC3;SMC5;ERCC1
prerank,Wnt signaling pathway (GO:0016055),0.3566807277959077,1.034905622481005,0.4119170984455959,0.7866916151470922,1.0,12/92,7.56%,LEF1;DIXDC1;FZD6;FZD4;LRP5;PLCG2;CPE;TCF7L1;TCF7L2;WNT5A;WNT9B;SNX3
prerank,chloride transport (GO:0006821),-0.2982917445741096,-1.0347483186056439,0.3816793893129771,0.8178147368924036,1.0,18/74,15.13%,SLC4A10;SLC1A3;SLC26A7;SLC12A2;SLC6A1;GLRB;ANO1;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC26A6;FXYD1;SLC1A1
prerank,response to unfolded protein (GO:0006986),0.39125255152411537,1.0346573451156538,0.43128654970760233,0.78667047191806,1.0,15/48,19.09%,ERN1;STT3B;DAB2IP;TMBIM6;DNAJA1;RHBDD1;DNAJB5;PTPN1;HSP90AB1;ERP44;DDIT3;HSPB8;HSPE1;BAK1;DNAJB1
prerank,cell part morphogenesis (GO:0032990),-0.43580880907608954,-1.0342650432620901,0.40930232558139534,0.8178483877215349,1.0,1/13,0.15%,PID1
prerank,cardiac cell development (GO:0055006),-0.4681257140153226,-1.034171111367743,0.43429844097995546,0.8168064776085492,1.0,4/11,9.30%,CXADR;SLC8A1;JAG1;VEGFA
prerank,positive regulation of viral life cycle (GO:1903902),-0.3870436556978726,-1.0340759752233082,0.3804878048780488,0.8157778708730311,1.0,8/22,21.06%,AXL;P4HB;LGALS1;DDB1;KPNA2;VPS4A;TYRO3;CD74
prerank,pinocytosis (GO:0006907),-0.4716501349999417,-1.0340743326870354,0.4456066945606695,0.8145037778475784,1.0,7/10,29.29%,CARMIL1;SNX5;PPT1;PYCARD;DOCK2;SNX33;AHSG
prerank,cyclooxygenase pathway (GO:0019371),0.521748179592848,1.0336302125837762,0.43783783783783786,0.7885968544901545,1.0,3/10,7.17%,PTGS2;PTGS1;CBR1
prerank,negative regulation of innate immune response (GO:0045824),0.40952187706265863,1.0326360510448318,0.43260188087774293,0.7902961652554675,1.0,7/34,15.63%,NLRC5;SAMHD1;RPS19;USP15;NMI;CNOT7;IRAK3
prerank,cellular response to organonitrogen compound (GO:0071417),0.3539286582439391,1.0325636622949996,0.4125159642401022,0.7898875350079277,1.0,23/99,16.75%,MEF2C;AHR;SH3BP4;PDE2A;KCNQ1;RAP1B;SOX9;XBP1;CTNNA1;RAPGEF2;INPP5K;RAP1A;PKD2;RPTOR;LARS1;P2RY12;RELA;AOC1;PDE3A;PDXP;ZFP36L1;CTNNB1;RAPGEF3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4517434430417298,-1.0319652067568124,0.4063926940639269,0.8191279652318544,1.0,9/12,33.02%,LRRK2;ATP6AP2;PPT1;CLN3;TMEM199;TMEM165;TMEM9;CCDC115;GRN
prerank,regulation of macrophage chemotaxis (GO:0010758),0.45548894515925453,1.0314886144853923,0.4228855721393035,0.7918251954434824,1.0,4/21,9.46%,MTUS1;PTK2B;PTK2;CSF1
prerank,negative regulation of signal transduction (GO:0009968),0.32003681048485527,1.0312708694471664,0.4191011235955056,0.791791756154632,1.0,40/249,8.36%,SEMA6A;EGFL7;NTN1;EPN2;NFATC1;MMRN2;GATA2;PTPN12;DAB2IP;HHEX;LYN;DDIT4;FBXW7;PTPRJ;KIF26A;NCK1;SRMS;SIGIRR;NKD2;CYP26A1;PLIN5;DLL1;TMBIM6;GRB14;VGLL4;DLL4;CX3CR1;ASAH2;KCTD6;ACVR1;CYP26C1;SOST;INPP5K;ARRB1;ARRDC1;GRB7;NEDD4;CTNNBIP1;MOSMO;CITED1
prerank,positive regulation of developmental process (GO:0051094),0.33145280694470486,1.0306143047160532,0.4221165279429251,0.7927826474075097,1.0,24/164,8.75%,SHANK3;BMPR2;KDR;ZBTB16;INSR;PDGFB;DAB2IP;FZD4;RREB1;PLCB1;SOX9;RPS6KA3;SLC6A6;RPS6KA1;XBP1;ENPP2;SHLD1;AURKA;WNT5A;ACVR1;B4GALT5;NEUROD1;PSEN1;ARHGEF7
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3617640004207162,1.0305585910486357,0.4157458563535912,0.7923165682721648,1.0,27/72,24.92%,CARD10;TIRAP;PSMA2;MALT1;RELB;DICER1;PSMA8;PSMA6;CUL1;RELA;BIRC3;TRAF6;PSME1;NFKB2;BIRC2;PSMA4;PSMF1;PSMB7;PSMB1;REL;PSMD2;PSMA5;PSMC3;TRAF2;COPS8;PSMD3;PSMA3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.38378700078366085,1.030321386005391,0.41448382126348227,0.7922812846278753,1.0,17/48,20.20%,FNIP2;DDIT4;TNFRSF1B;HIPK1;BOK;BCL2L11;BCL3;BCL2L1;SFN;TOPORS;SNW1;TMEM109;CHEK2;BCL2L10;BAK1;MSH2;HIC1
prerank,regulation of protein ubiquitination (GO:0031396),0.34714702620558996,1.0302443645914572,0.4262086513994911,0.7919033094408593,1.0,29/108,17.22%,CAV1;FBXW7;FKBP1A;SMAD7;N4BP1;FOXF2;XIAP;MYCBP2;SASH1;DNAJA1;ARRB1;MALT1;PINX1;SOX4;SPOPL;VPS28;UBE3A;RIPK2;PRICKLE1;NXN;BIRC3;HSP90AB1;TRAF6;UBXN1;PRKCG;CHP1;NDFIP2;BIRC2;CUL3
prerank,striated muscle cell differentiation (GO:0051146),0.4626397946927442,1.0300666492294506,0.42657342657342656,0.7917254839192082,1.0,2/16,3.05%,MEF2C;SIK1
prerank,DNA dealkylation (GO:0035510),0.5103907801580436,1.0299992604753343,0.43223443223443225,0.7907060326303568,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5103907801580436,1.0299992604753343,0.43223443223443225,0.7907060326303568,1.0,4/10,18.55%,ASCC1;ASCC3;MPG;MGMT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4482648522108442,-1.0294922164287124,0.42207792207792205,0.8245883515822807,1.0,2/12,7.61%,BCL2;CD44
prerank,oxoacid metabolic process (GO:0043436),-0.3618914223527644,-1.0293751602807462,0.4297752808988764,0.823620873311033,1.0,4/27,8.00%,DDO;ENPP1;TPST1;ABHD14B
prerank,cellular response to catecholamine stimulus (GO:0071870),0.43939813001188655,1.0291391252024,0.4509493670886076,0.7921738372751803,1.0,4/23,5.49%,TGM2;KCNQ1;GNB1;ATP2B4
prerank,positive regulation of neurogenesis (GO:0050769),0.36994748732869376,1.0289461955862336,0.4271978021978022,0.7920474422316407,1.0,7/68,5.39%,SHANK3;PLXNA4;TGM2;PLXND1;NUMB;DISC1;CX3CR1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3451947324156888,1.0287183105350481,0.4040920716112532,0.7919970623996411,1.0,19/101,9.05%,FLT1;PDGFB;DAB2IP;EDN1;PDGFD;TPD52L1;PIK3R6;RALB;ATP2B4;WNT5A;RAPGEF2;CD40;PDGFC;TGFB1;PIK3CG;CCNYL1;PKD2;RPTOR;CCNY
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.36346954483175287,1.0286179147484702,0.4167812929848693,0.7916823214560046,1.0,7/76,6.68%,TEK;EDN1;PTK2B;NCK1;EVL;NCKAP1;CDC42EP3
prerank,positive regulation of telomerase activity (GO:0051973),0.4135434152116528,1.028574397083655,0.4108527131782946,0.7912111974956344,1.0,6/33,12.95%,NEK7;HMBOX1;GREM1;WRAP53;ACD;HSP90AB1
prerank,extracellular transport (GO:0006858),0.4864450051161722,1.0281882982351345,0.46415770609318996,0.7915591567230952,1.0,4/12,19.56%,ARRDC1;SPA17;CABYR;TSG101
prerank,Ras protein signal transduction (GO:0007265),0.3337813191886785,1.0279908429819424,0.4197080291970803,0.7914413900072347,1.0,33/137,12.84%,NTN1;PRKD1;EPS8;ARHGEF3;ELMO1;CELSR1;GNB1;RREB1;GRAP;RAP1B;RASGRP3;ADGRG1;PLEKHG5;RALB;NCKAP1;PLK2;RAPGEF2;KRAS;NRAS;RAC1;CDC42EP3;RAP1A;GNA12;SHOC2;CDK2;G3BP1;MAPK11;RGL2;RB1;CYFIP1;RHOB;GNA13;DBNL
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4183334968455048,1.0279729510770672,0.4274447949526814,0.7908982380043793,1.0,2/29,1.06%,MCTP1;APP
prerank,positive regulation of telomere capping (GO:1904355),0.4688306021877663,1.0275670647675683,0.42931034482758623,0.7912210105785631,1.0,2/17,7.80%,NEK7;HNRNPD
prerank,synapse assembly (GO:0007416),0.3653631655967742,1.027266129193694,0.4119278779472954,0.7913462397025582,1.0,6/67,6.10%,SHANK3;DNM3;PLXND1;PCDHB4;CDH2;WNT5A
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4227068175173343,1.0272659897280942,0.4500768049155146,0.790768192778013,1.0,14/29,26.28%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,aorta morphogenesis (GO:0035909),0.4696455468195835,1.027114715758887,0.44601769911504424,0.7905576534030846,1.0,4/17,5.28%,ENG;TBX1;ACVRL1;DLL4
prerank,positive regulation of DNA recombination (GO:0045911),0.4303382217075723,1.0269523974064263,0.4364207221350079,0.7903650880655215,1.0,12/27,24.26%,SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;WDR48;KMT5B;FUS;RIF1;PRDM9;ERCC6;ARID2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3273003136170718,1.026745229958053,0.425531914893617,0.7902925437995791,1.0,17/159,5.12%,MPZ;PECAM1;CADM1;VCAM1;ICAM1;CLDN5;PTPRM;NECTIN2;PVR;SELE;BSG;PCDHB4;SELP;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,cellular response to starvation (GO:0009267),0.32923266809676094,1.0263153566791554,0.4189675870348139,0.7906956497902141,1.0,24/147,13.27%,FOXO1;BMPR2;PRKD1;FAS;SIK1;STK24;RALB;XBP1;MAPK8;KLF10;SH3GLB1;STK26;RPTOR;MYBBP1A;ATP6V1G2;NPRL2;LARS1;NUAK1;PICK1;SIK2;GABARAPL1;XPR1;EIF2AK4;AOC1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3626707060102077,-1.02630024279788,0.39572192513368987,0.8308626268781646,1.0,8/31,9.11%,BMPR1A;FGFR2;TGFBR3;TGFBR1;ZFPM2;TPM1;RBPJ;RYR2
prerank,positive regulation of endocytosis (GO:0045807),-0.32770621599015953,-1.0262448324318043,0.3776435045317221,0.8297082573792687,1.0,11/45,10.33%,LRP1;GPC3;VTN;APPL2;AXL;BICD1;NLGN1;CLIP3;DAB2;APOE;SERPINE1
prerank,negative regulation of ATPase activity (GO:0032780),-0.412439119050826,-1.026089527481336,0.4325581395348837,0.8288520268794637,1.0,8/16,27.63%,IFIT1;TSC1;VCPKMT;ATP5IF1;TP53;PPIF;PAM16;PLN
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3321390071518991,-1.0257452703031078,0.4043887147335423,0.8285625933556496,1.0,12/45,12.53%,BMP7;BMP4;GAS1;ZWINT;SMAD3;TOM1L2;BCL6;TRIM35;RGCC;FZD3;BRINP3;CHFR
prerank,neuron projection development (GO:0031175),0.3283638762290088,1.0256959854168983,0.4184652278177458,0.7915089857699803,1.0,20/168,8.13%,SHANK3;FRY;FRYL;APP;STX3;PTPRM;DAB2IP;RAB11A;LYN;SRGAP2;TAOK2;PPP1R9B;BICDL1;NCKAP1;ULK1;OPHN1;RAPGEF2;TNIK;NEDD4;CAMSAP2
prerank,central nervous system development (GO:0007417),0.31736332061970957,1.0254523237870685,0.42046718576195774,0.7915085275727347,1.0,36/250,10.51%,SLC2A1;PBX1;ADGRL2;SHROOM4;ZBTB16;LSR;ZIC3;CELSR1;STAT3;DDIT4;ADGRA2;SNTG2;HAPLN3;CHD7;SHROOM2;ADGRG1;AMIGO2;SOX9;CDH2;MAL;DLL1;RPS6KA3;NCKAP1;CX3CR1;SEMA6B;CYP26C1;PDGFC;DNAJC30;PKD2;EIF2B5;SYNJ1;SOX4;NFIB;NMUR2;SCYL2;CXCR4
prerank,regulation of viral life cycle (GO:1903900),0.45173444075146896,1.0253472299141562,0.42985611510791366,0.7911828026074158,1.0,4/21,7.85%,TRIM14;NECTIN2;TRIM68;TRIM25
prerank,regulation of translation (GO:0006417),0.3270256893946448,1.0245815891069499,0.41840490797546015,0.7924528804390109,1.0,44/173,18.22%,NANOS3;APP;DAPK1;IGF2BP3;RPS6KA3;RPS6KA1;NANOS2;EIF4E;EIF3H;BCL3;GRB7;NIBAN1;HNRNPD;EIF1;RNF139;SOX4;BTG2;RPL13A;CNOT1;RBM3;EIF6;MRPL13;CYFIP1;EIF5B;RPL10;RACK1;EIF2AK4;MTPN;CNOT7;FMR1;EIF2B2;PAIP1;NPM1;ERBB2;LARP4B;LSM14A;YBX1;PAIP2B;EIF5;CTIF;CSDE1;EEF2;METTL14;LARP4
prerank,positive regulation of axon extension (GO:0045773),0.437160221689177,1.0242024575581266,0.42694805194805197,0.792740615068383,1.0,6/22,12.84%,NTN1;SEMA7A;DSCAM;TWF2;MAP3K13;DBNL
prerank,proteoglycan biosynthetic process (GO:0030166),0.41039586101016695,1.0237479164547278,0.45754716981132076,0.7932096858868262,1.0,3/31,5.12%,CSGALNACT1;BMPR2;EXTL3
prerank,pentose-phosphate shunt (GO:0006098),-0.44821633548795414,-1.023683233976533,0.4369747899159664,0.8331852710533494,1.0,3/11,9.97%,H6PD;PGD;TKT
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.29332173173729403,-1.0235776104252565,0.398406374501992,0.8322317873267644,1.0,10/77,6.94%,IGF1;PRKN;BCL2;TGFBR1;SH3RF1;BMP4;THBS1;AR;ITGAV;SIAH2
prerank,regulation of viral transcription (GO:0046782),0.3989835456362686,1.0235045623794463,0.42569659442724456,0.7931934977395778,1.0,13/39,22.30%,TRIM14;MID2;GTF2F2;NELFE;ZFP36;NELFCD;IFITM3;CTDP1;TRIM62;NELFB;POLR2L;NELFA;POLR2J
prerank,histone H3 deacetylation (GO:0070932),0.46738817183643133,1.0231722426736714,0.4410058027079304,0.7933710243415704,1.0,2/15,4.62%,HDAC9;ELK4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3589918948440833,1.023137526187956,0.42302357836338417,0.7928746750601534,1.0,13/76,12.61%,NOD1;APP;HDAC7;ADGRG3;NFKBIA;ACTN4;TMSB4X;SASH1;BCL3;IL23A;NMI;RELA;ADIPOR1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3639310760099458,1.0223539685074123,0.4090909090909091,0.7941166985376802,1.0,20/74,22.49%,EPAS1;NOTCH1;HIF1A;EGLN1;PSMA2;BACH1;PSMA8;PSMA6;HIGD1A;PSME1;ELOC;PSMA4;PSMF1;CUL2;PSMB7;PSMB1;EGLN2;PSMD2;PSMA5;PSMC3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.43715672285560314,-1.0222628237561016,0.4504310344827586,0.8345574571006316,1.0,3/12,8.88%,BMP7;CD44;GCNT2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.41742299041863484,1.0222078994071326,0.4258373205741627,0.793893694875953,1.0,12/28,22.56%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;ACTR2;CYREN;KMT5B;PARP9;RIF1;SIRT7;ERCC6
prerank,thyroid hormone generation (GO:0006590),-0.4716433264070696,-1.0221102150026746,0.45434298440979953,0.8336891076062838,1.0,2/10,7.88%,CPQ;SLC5A5
prerank,response to hydrogen peroxide (GO:0042542),0.39407136633480894,1.022068301963746,0.44144144144144143,0.7936527645569651,1.0,9/45,12.46%,NET1;FYN;STK24;CAT;STK26;RIPK1;RHOB;RELA;GLRX2
prerank,protein insertion into ER membrane (GO:0045048),0.39690775088916747,1.0220609459872092,0.4142640364188164,0.7931006584722072,1.0,7/37,14.26%,APP;STX1A;TRAM1;TRAM1L1;EMC6;EMC3;ALDH3A2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.43522729642786345,-1.0214457598803346,0.443010752688172,0.8342306066199451,1.0,4/13,10.04%,IGF1;RAMP1;SOAT1;SLC2A10
prerank,regulation of dephosphorylation (GO:0035303),0.48098414997058103,1.0214387681718442,0.45454545454545453,0.7940192863751268,1.0,3/15,9.83%,PPP1R16B;INPP5K;SMG7
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.471125479427863,-1.0211522606691172,0.46021505376344085,0.8337562592986772,1.0,3/10,6.16%,BMP5;BMP7;LRP6
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3529625396000959,1.0208890987607053,0.45157068062827227,0.7947044227736688,1.0,20/88,16.11%,NANOS3;DAPK1;DAB2IP;EDN1;IGF2BP3;NANOS2;GRB7;NFKB1;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B;RIC1
prerank,neuron apoptotic process (GO:0051402),0.4463985288552525,1.0208263828427244,0.44804088586030666,0.7942793667625535,1.0,5/19,11.99%,APP;FAS;SIAH1;BNIP3;BID
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3414597717573824,-1.0207567603830447,0.42337662337662335,0.8335812824112024,1.0,12/33,12.93%,NLGN2;LRRC4C;NGF;NLGN1;NRG3;GRIK4;NLGN3;IQSEC2;GRIK2;GRIK5;GRID2;GRIK1
prerank,fatty acid oxidation (GO:0019395),0.3736798113213031,1.0203778481752697,0.45734265734265733,0.7947966523650883,1.0,9/57,14.26%,ADIPOR2;PPARD;HADHA;ECI1;ABCD4;ABCD1;ADIPOR1;HADH;ALDH3A2
prerank,negative regulation of cell differentiation (GO:0045596),0.32409973886895127,1.02022935748983,0.41898148148148145,0.7945689825378298,1.0,36/181,12.83%,FOXO1;CAV1;TBX1;ZBTB16;CDK6;GATA2;DAB2IP;LRP5;EFNA1;PTK2B;HDAC7;NOTCH1;NFKBIA;WWTR1;FGF23;SOX9;DLL1;SMAD7;GREM1;WNT5A;TRIB3;TGFB1;CITED1;ZFPM1;USH2A;MAD2L2;SFRP2;SEMA4D;RB1;SINHCAF;ITGB3;ASXL1;TRIO;XDH;ADIPOR1;EIF2AK4
prerank,establishment of protein localization to membrane (GO:0090150),0.3679024578003024,1.0199401797674483,0.4281729428172943,0.7946510639393778,1.0,14/66,12.23%,PARD3;RAB11A;REEP1;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;RFTN1;MYO1C;ICMT;BID;RAB11B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4039229724034544,1.01982927000106,0.42518518518518517,0.7943285701229074,1.0,8/39,10.15%,NEXMIF;PODXL;NOTCH1;PPM1F;TGFB1;PTK2;NF2;MAD2L2
prerank,atrial septum morphogenesis (GO:0060413),0.5153001425640574,1.0195211821894041,0.4646840148698885,0.7944703869911393,1.0,4/10,9.33%,BMPR2;ACVR1;ZFPM1;SOX4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.402863097461742,1.0194462215344104,0.4522760646108664,0.7940760135718482,1.0,6/40,3.22%,GNAQ;FLT1;ESR1;PLCG1;HTR2A;SELE
prerank,actin filament bundle assembly (GO:0051017),0.409933918519463,1.018966016880715,0.4358161648177496,0.794608572072702,1.0,6/33,4.52%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,regulation of cellular metabolic process (GO:0031323),-0.32269615465269574,-1.0187381076394422,0.43260188087774293,0.8382638502174314,1.0,6/45,6.99%,PID1;PRKN;PPARA;TBC1D16;CYP1B1;ACACA
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4639185536012512,1.0185089478676925,0.44919786096256686,0.7951139840758508,1.0,2/17,6.32%,PLA2G4A;PLA2G2D
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4798334380711199,1.0182539923595708,0.4309090909090909,0.7951328001801901,1.0,1/13,1.30%,STX3
prerank,embryonic appendage morphogenesis (GO:0035113),-0.43197596798937726,-1.0181327769817856,0.4642082429501085,0.838636054498449,1.0,5/12,20.56%,CYP26B1;LRP6;TGFB2;SKI;PTCH1
prerank,calcium-mediated signaling (GO:0019722),0.34834290501575715,1.0181157764911908,0.4370860927152318,0.7948813511340704,1.0,13/93,5.98%,MCTP1;KDR;VCAM1;PLCG1;EDN1;PPP3CA;PTPRJ;SELE;PLCG2;SELP;PPP1R9B;CX3CR1;PPP3CB
prerank,BMP signaling pathway (GO:0030509),0.36762049471565317,1.0180814774540403,0.41217150760719223,0.7943850391756636,1.0,10/62,7.33%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SMAD7;ACVR2A;USP15;ACVR1;TGFB1
prerank,regulation of receptor recycling (GO:0001919),-0.4001439293954101,-1.0174680563559824,0.43400447427293065,0.8393064454782762,1.0,5/16,14.84%,TBC1D16;ANXA2;OPTN;RAB29;SNCA
prerank,glycolytic process (GO:0006096),-0.3523797868064524,-1.0169260083841345,0.4017094017094017,0.8395146670889536,1.0,15/28,38.84%,ENO2;HK2;TPI1;ENO3;PFKFB1;PFKM;ALDOA;PKM;ENO1;ALDOC;HKDC1;GAPDH;ALDOB;ENO4;HK3
prerank,regulation of viral genome replication (GO:0045069),0.3713753655737252,1.016521732496973,0.4339080459770115,0.7973990212207597,1.0,16/56,19.35%,NR5A2;ADARB1;PKN2;ISG20;N4BP1;RAD23A;TNIP1;ADAR;OASL;CNOT7;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,plasma membrane invagination (GO:0099024),0.42493778221482015,1.0159958999330057,0.4377952755905512,0.7979862706148314,1.0,3/29,2.11%,DOCK1;ELMO1;MYH9
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.44934267861536953,1.015810700306062,0.4520547945205479,0.7978228268165687,1.0,3/20,2.77%,ENG;ACVRL1;NOTCH1
prerank,peptide cross-linking (GO:0018149),-0.3701669015441018,-1.0156483657743365,0.428927680798005,0.841869436430573,1.0,4/25,5.16%,COL3A1;THBS1;NDNF;ANXA1
prerank,regulation of spindle organization (GO:0090224),-0.4027041665499177,-1.0156144690909985,0.4354066985645933,0.8406678640413048,1.0,9/18,30.07%,PARP3;GNAI1;GPSM2;RAE1;DYNC1H1;TPX2;FSD1;DCTN1;MAP9
prerank,actin filament bundle organization (GO:0061572),0.40586100035245287,1.0151870168751589,0.43106180665610144,0.7986692128168265,1.0,6/33,4.52%,LCP1;EPS8;NEDD9;SHROOM2;SHROOM1;PLS3
prerank,chromatin remodeling at centromere (GO:0031055),-0.3461753042289291,-1.0147653853712915,0.4166666666666667,0.8417046909836428,1.0,14/31,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPX;CENPQ;CENPA
prerank,neuromuscular junction development (GO:0007528),-0.3649836716045082,-1.0146757878530026,0.43507972665148065,0.8406438033216246,1.0,7/24,8.66%,PDZRN3;UNC13C;PPFIBP2;ANK3;CACNB2;LRRK2;CACNB1
prerank,regulation of cell division (GO:0051302),0.35931107773042215,1.0145368907021932,0.4317862165963432,0.7996440641033179,1.0,19/72,18.52%,RAB11A;MLLT3;TAL1;DLL1;PLK2;AURKA;SH3GLB1;AURKC;BCL2L1;SFRP2;SFN;RACK1;ESRRB;TXNIP;PDXP;CALM1;PRPF40A;CIB1;CETN2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.4165320181305724,-1.0143729885482906,0.4513064133016627,0.8402041698950369,1.0,2/14,3.16%,NMNAT2;ME1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.44368220651192586,1.0141742056836855,0.4265975820379965,0.7999396790851037,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.44317219814169534,-1.0138192394166345,0.4439746300211416,0.8404504619289642,1.0,4/11,21.30%,PARP3;PARP11;PARP8;TIPARP
prerank,centromere complex assembly (GO:0034508),-0.33868469372216237,-1.013761409985296,0.425414364640884,0.8393398966013266,1.0,23/36,41.08%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;HELLS;KNL1;CENPF;CENPX;CENPQ;CENPA;NASP;DLGAP5;CENPC;CENPW;MIS12;CENPM;CENPL;CENPS
prerank,negative regulation of protein binding (GO:0032091),0.36011684156512536,1.013398531101968,0.44536652835408025,0.8011248079537572,1.0,11/71,9.03%,CAV1;B2M;PDGFB;TMBIM6;RALB;DISC1;MAPK8;AURKA;ADAM15;CTNNBIP1;ZFPM1
prerank,bone morphogenesis (GO:0060349),0.4700185352671422,1.0133890423076646,0.4514991181657848,0.8005842490303139,1.0,2/14,2.28%,BMPR2;LRP5
prerank,peptidyl-lysine modification (GO:0018205),-0.2825289995632965,-1.0128810022431456,0.4152542372881356,0.8405082274874925,1.0,18/99,12.17%,EYA1;LOXL1;HDAC4;PLOD2;LOXL3;SIRT2;NNAT;P3H3;SENP3;LOX;SENP7;RAE1;POM121;PIAS1;PIAS3;NDC1;SENP5;NUP93
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3016053613000078,1.0127144623173894,0.4467425025853154,0.8016431680914564,1.0,93/572,12.68%,HDAC9;DACH1;LDB2;CAV1;ESR1;SMARCA2;PPARD;MEF2C;ZBTB16;ETV6;LRRFIP1;PDGFB;IRF2;FOXP1;DAB2IP;SOX13;EDN1;HHEX;PDE2A;NEDD4L;STAT3;EFNA1;NR3C1;FNIP2;NOTCH1;KLF7;RREB1;KLF8;TGIF1;ZFP57;SOX18;HMBOX1;SOX9;RIPPLY3;KLF2;ELK4;RPS14;MCPH1;SDCBP;ID1;EPC1;SMAD7;DLL4;MTF2;TCF7L2;DUSP22;CNBP;KLF10;NR1I3;FBP1;IRF2BPL;ETS2;TRIB3;SPDEF;TCF3;NEDD4;NFKB1;GATAD2A;CTBP1;WWC2;CREM;PHF6;EZH1;PSEN1;TAF3;ZFPM1;RPL23;DICER1;BACH1;YEATS2;NFIB;NRIP1;MAD2L2;SP2;SKIL;CNOT1;KLF12;UBE2D3;SEMA4D;SPEN;CNOT2;RB1;EID1;CBFB;PRDM2;DCAF1;NOP53;MIER1;SIRT6;RELA;MAX;ZFP36;RPL10
prerank,mononuclear cell differentiation (GO:1903131),0.42678336909450865,1.0126837675516718,0.4538087520259319,0.8011425929401575,1.0,3/24,2.31%,PIR;MYH9;LYN
prerank,intracellular protein transport (GO:0006886),0.3110644728564233,1.0124238241450958,0.44924406047516197,0.8011368116318085,1.0,80/304,19.28%,TBC1D8;RASSF9;STX3;TBC1D30;SMURF1;TBC1D4;ARHGEF2;STAT3;IPO11;SGSM1;TBC1D22A;TBC1D15;STX6;HERC2;STX7;PPP1R10;TBC1D12;ARL4A;TGFB1;AP2A1;TBC1D2;STX1A;TMED7;XPO1;TMED5;RAB38;AKT2;ARL5A;VPS28;AP3B1;IPO8;MYO1C;HOMER3;ACD;NUP214;TBC1D5;PICK1;STX8;RAB43;PRICKLE1;WDR11;STXBP3;PREB;EVI5;TBC1D8B;NUP133;RAB31;RAB5A;RAB7A;RABGAP1L;RAB5B;NPM1;SNX13;RAB18;STX11;GIPC1;TNPO3;RAB32;NUP153;AP1S3;RAB6A;STX12;RIC1;RAB3GAP2;CHP1;RPL11;TLK1;DESI1;SNX1;RAB1A;TRAK2;SIL1;CDC37;STAM;COG7;GGA3;VPS26B;PTTG1IP;ARL5B;MYO6
prerank,protein trimerization (GO:0070206),-0.4185912410392355,-1.0121515280621622,0.4343675417661098,0.8400508434257845,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,protein homotrimerization (GO:0070207),-0.4185912410392355,-1.0121515280621622,0.4343675417661098,0.8400508434257845,1.0,4/14,12.21%,SLC1A5;SCARA5;SLC1A2;CLYBL
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.47018022710856716,-1.0119737097817445,0.46325167037861914,0.8392961681942862,1.0,5/10,30.42%,MIA3;TICAM1;TREM2;CD36;TLR6
prerank,regulation of phospholipase C activity (GO:1900274),0.46372173744285783,1.0117352562540771,0.46440129449838186,0.8021983102880454,1.0,3/15,1.87%,FLT1;ESR1;PLCG1
prerank,arachidonic acid metabolic process (GO:0019369),0.4049402308154037,1.0112480671047404,0.4552352048558422,0.8027447985476123,1.0,5/35,7.17%,PTGS2;PLA2G4A;PTGS1;EPHX1;CBR1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.513185107598345,1.011177814017999,0.47794117647058826,0.8023387010591148,1.0,3/10,2.97%,NEXMIF;NOTCH1;PPM1F
prerank,vasoconstriction (GO:0042310),0.4913130237844984,1.0111390056494283,0.45265151515151514,0.8018602419325669,1.0,2/11,3.43%,EDN1;PIK3C2A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.36920608841219893,1.0105362278510988,0.45518207282913165,0.8026906541642308,1.0,10/59,5.12%,PECAM1;CADM1;PTPRM;NECTIN2;PVR;BSG;ROBO4;AMIGO2;CDH2;CEACAM1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.35858268178310876,-1.010422996797054,0.43799472295514513,0.842294893882101,1.0,16/28,33.68%,GJA1;GPSM2;HTT;UBXN2B;NUSAP1;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;ESPL1;PKHD1
prerank,protein homotetramerization (GO:0051289),0.3778526146248868,1.0103835856529724,0.4306784660766962,0.8024935480371922,1.0,5/49,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,myotube differentiation (GO:0014902),0.4659030836061781,1.0103564705556707,0.4607142857142857,0.8019825719703036,1.0,2/17,1.15%,JAM2;MEF2C
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.40784792080051746,1.0095121188594387,0.4654895666131621,0.8033276740078225,1.0,3/31,6.76%,DCUN1D3;FBXW7;TRIB3
prerank,retina homeostasis (GO:0001895),0.430453428727379,1.0094276127452035,0.45484949832775917,0.8029577381133937,1.0,2/23,3.14%,B2M;CNGB1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3752048976580413,1.009414081916667,0.4415954415954416,0.8024141647110514,1.0,15/53,14.86%,ECSCR;DAB2IP;FBXW7;FOXF2;UCHL5;OPHN1;KCNE2;XPO1;GNA12;RAD23A;HSP90AB1;FMR1;NUDT15;PSME1;PRKCG
prerank,regulation of histone methylation (GO:0031060),-0.43690634587727667,-1.0092540999516235,0.44150110375275936,0.8441260819910471,1.0,5/13,22.22%,TET1;CTR9;PAF1;NNMT;AASS
prerank,regulation of vasculature development (GO:1901342),0.41873576408215873,1.0090855779014536,0.43543046357615894,0.8025645363328551,1.0,8/26,16.74%,ADGRA2;PLXND1;TSPAN12;EGLN1;WARS1;ERBB2;PROK2;CTNNB1
prerank,cellular response to alkaloid (GO:0071312),0.4612805456151565,1.0090446679506968,0.44773519163763065,0.8020982291056074,1.0,2/17,7.68%,TGM2;CASP7
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.28113271588978517,-1.0089144111918584,0.43636363636363634,0.8438368638010826,1.0,22/95,11.51%,ZEB2;TGFBR3;DKK3;TGFBR1;HTRA3;SPRED1;PPARA;THBS1;SMAD6;SMAD3;CD109;SNX6;ASPN;TGFB1I1;DAB2;BCL9;VASN;HIPK2;SLC2A10;SPRED2;NREP;SPRED3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.44104112658067096,1.008822715330705,0.45567375886524825,0.8020467177064011,1.0,6/20,11.71%,ABI3;PPP2R5A;NUMB;TGFB1;BCL2L1;PICALM
prerank,toll-like receptor signaling pathway (GO:0002224),0.3545309145098362,1.0084233537817493,0.4431057563587684,0.8023795681467927,1.0,23/84,17.54%,CASP8;PLCG2;TIRAP;RPS6KA3;IKBKB;CTSK;IKBKG;RFTN1;MAPKAPK3;UBE2D3;TNIP1;NMI;IRAK4;LGMN;RIPK1;RIPK2;BIRC3;TRAF6;S100A9;IRAK3;TAB3;BIRC2;IRAK2
prerank,regulation of blood coagulation (GO:0030193),0.4179947647802992,1.0083300617181095,0.47217806041335453,0.8020406551598847,1.0,4/27,4.57%,CAV1;EDN1;CD34;ENPP4
prerank,regulation of BMP signaling pathway (GO:0030510),0.3603167340020821,1.0078282507970575,0.44141689373297005,0.8025361374966199,1.0,15/73,10.32%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;XIAP;SOST;ITGA3;SKIL;SMAD5;UBE2D3
prerank,cellular response to organic cyclic compound (GO:0071407),0.3280488830682143,1.0077715776012093,0.46568627450980393,0.802106881242923,1.0,21/141,8.09%,TGM2;ESR1;MEF2C;AHR;PDGFB;PDE2A;KCNQ1;NR3C1;MSN;GNB1;RAP1B;CTNNA1;ATP1A3;ATP1A1;RAPGEF2;INPP5K;NCOA4;TGFB1;RAP1A;CASP7;PKD2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3971488893033347,-1.007747814859545,0.4244604316546763,0.8457866522201676,1.0,5/18,11.08%,PPARA;WNK1;PAG1;PTPN22;MIA3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.44107987537699694,1.0071396496346428,0.4387755102040816,0.8029892593212811,1.0,5/21,10.01%,CD2AP;DAB2IP;FBP1;SYNGAP1;CYRIB
prerank,response to tumor necrosis factor (GO:0034612),0.34468132334183316,1.007099343150772,0.446524064171123,0.8025183097983981,1.0,20/91,14.08%,GCH1;DAB2IP;ARHGEF2;ADAM10;TNFRSF11A;MAP4K3;SELE;CASP8;IKBKB;DCSTAMP;CD40;INPP5K;YBX3;CCL14;RIPK1;RELA;ZFP36;HAS2;GBP3;ASAH1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3800237937188635,-1.0069469802468705,0.44923857868020306,0.8466776720201713,1.0,8/21,9.51%,DCN;BGN;CSPG4;CHST15;CHSY3;VCAN;CHSY1;CHST3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2929813838963698,-1.0064008128498345,0.4485049833887043,0.8469346665959125,1.0,26/63,22.93%,SLC1A3;SLC12A2;SLC6A1;SLC26A2;GLRB;ANO1;GABRG2;ANO4;SLC5A5;GABRA2;SLC20A1;GABRB1;ANO3;SLC5A6;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;SLC25A3;SLC25A14;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.35671063751369,-1.0063675755235162,0.4418604651162791,0.8457676940665723,1.0,3/27,2.95%,EGFR;DDX5;BMP4
prerank,membrane assembly (GO:0071709),-0.3398383701184678,-1.0061924735245993,0.4512820512820513,0.8450040392314264,1.0,17/34,17.70%,NLGN2;ANK3;PTPRD;IL1RAPL1;TLCD2;NRXN1;NLGN1;ANXA2;STX4;S100A10;NLGN3;FLOT2;STX2;NRXN2;UBXN2B;TLCD1;VPS4A
prerank,regulation of gluconeogenesis (GO:0006111),-0.3578096265349743,-1.005934000924853,0.4639175257731959,0.8444652089415505,1.0,10/27,20.84%,OGT;PPARGC1A;SELENOS;C1QTNF3;PTPN2;DDB1;DGKQ;CRY1;PDK2;NNMT
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4642478258749586,1.005906899236686,0.47643979057591623,0.8046774597250693,1.0,3/16,6.76%,SOX9;CEACAM1;TRIB3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.4249474959268763,1.0057476819586697,0.4533551554828151,0.8044913265047776,1.0,6/25,15.20%,B2M;PLCG2;WNT5A;MALT1;TRAF6;SLC7A5
prerank,positive regulation of cyclase activity (GO:0031281),0.48114517540984264,1.0056157638348273,0.4630281690140845,0.8042540105809659,1.0,3/14,5.46%,NOS3;ORAI1;MAPK8
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3882892493296595,-1.0055886854103417,0.4322250639386189,0.8442215865580553,1.0,5/19,8.00%,ENPP1;SLC26A2;TPST1;PAPSS2;ABHD14B
prerank,iron ion transmembrane transport (GO:0034755),0.5198319322059048,1.0052065332060232,0.47950089126559714,0.8046471238200443,1.0,2/10,4.23%,SLC39A8;ABCB7
prerank,protein secretion (GO:0009306),-0.30709637030485987,-1.0052000827055776,0.43859649122807015,0.8440566861805612,1.0,9/56,11.37%,WLS;PCSK5;ANXA1;TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3216602739880606,-1.0045666632999102,0.44610778443113774,0.8444603037086185,1.0,7/41,9.89%,ATP1A2;SLC12A2;ATP1B1;ABCC9;KCNJ2;KCNJ13;ATP1B2
prerank,protein transport (GO:0015031),0.3056432989599531,1.0043463368815155,0.4591947769314472,0.8060524275554216,1.0,87/332,20.13%,TBC1D8;CALCRL;STX3;SPTBN1;TBC1D30;TBC1D4;MYH9;ARHGEF2;SGSM1;TBC1D22A;TBC1D15;LMTK2;STX6;HERC2;STX7;SCAMP1;SLC10A7;RAMP2;VAMP4;CHMP2B;TBC1D12;ARL4A;ARRDC1;AP2A1;TBC1D2;GCC2;ATP6V0A1;STX1A;TMED7;TMED5;RAB38;ARL5A;NEURL1B;ATP6V1G2;AFM;RAB12;AP3B1;ACD;TBC1D5;PICK1;STX8;RAB26;RAB43;RAB11B;RILP;WDR11;STXBP3;PREB;EVI5;TBC1D8B;RAB31;RAB5A;RAB7A;RABGAP1L;ABCG1;TXNIP;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32;RAB6A;CEP290;STX12;COPG2;RIC1;RAB3GAP2;RAB8B;TLK1;ARL6IP5;SNX4;SNX1;RAB1A;SIL1;COG7;GGA3;VPS26B;ARL5B;MYO6;ABCA1;ATP6V1F;PPY;PDCD6;MIA2;VPS35;TVP23B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.42794671214511315,1.0039888724798027,0.4519867549668874,0.8063300705146322,1.0,10/23,20.08%,MTM1;MTMR6;INPP5K;SYNJ1;OCRL;INPP5F;MTMR12;MTMR9;MTMR2;SACM1L
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4751006294760523,1.0037454068473475,0.4742268041237113,0.8062944013809521,1.0,7/15,24.34%,REEP1;ATL1;RAB18;ZFYVE27;ARL6IP1;REEP3;LNPK
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.31026131134048374,-1.003720510694039,0.42138364779874216,0.8453937197708407,1.0,12/48,10.53%,DOCK5;NRP1;OBSL1;CARMIL1;CUX2;CAPRIN2;PTPRD;IL1RAPL1;CUX1;P4HB;FBXW8;S100A10
prerank,regulation of neurogenesis (GO:0050767),0.3710057984867239,1.0031042049726964,0.47493036211699163,0.8071441777480214,1.0,6/55,5.39%,TGM2;B2M;NOTCH1;NUMB;DLL1;CX3CR1
prerank,RNA transport (GO:0050658),-0.29411860616968655,-1.0029820205259685,0.464,0.8462427131279718,1.0,13/71,11.22%,RBFOX1;SRSF5;SIDT1;HNRNPA2B1;DDX39B;SIDT2;KIF5C;SRSF2;ATXN2;SRSF11;U2AF2;RAE1;POM121
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4008064658117236,1.0028103989904873,0.45553822152886114,0.8072477716796052,1.0,11/32,20.99%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,negative regulation of transport (GO:0051051),0.37389757051901207,1.0027859881757977,0.45454545454545453,0.8067420319675641,1.0,4/51,2.97%,MCTP1;PRKD1;CTTNBP2NL;PPM1F
prerank,regulation of neuron projection arborization (GO:0150011),-0.40815273785132733,-1.002758223219686,0.45227272727272727,0.8456212516173132,1.0,8/15,16.14%,GRIP1;DLG4;NTNG1;MOV10;MFSD2A;MACF1;DVL1;MYO9A
prerank,type I interferon signaling pathway (GO:0060337),0.3903649180981909,1.0026611504355118,0.46048632218844987,0.8059320303885252,1.0,12/41,19.12%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,cellular response to type I interferon (GO:0071357),0.3903649180981909,1.0026611504355118,0.46048632218844987,0.8059320303885252,1.0,12/41,19.12%,IRF2;SAMHD1;ISG20;IFNAR1;IFNAR2;JAK1;ADAR;OASL;IFITM3;STAT1;BST2;IFITM1
prerank,defense response to fungus (GO:0050832),0.45502030192038406,1.0025335402429922,0.46324786324786327,0.8056493832677823,1.0,5/17,19.53%,PLCG2;CX3CR1;S100A9;CARD9;BCL10
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.43556045025527607,1.0024357873039302,0.4689655172413793,0.8053168063096491,1.0,4/21,14.04%,RAB11A;BRD4;CDC25C;NPM1
prerank,"phagocytosis, engulfment (GO:0006911)",0.4048585857173866,1.00236917841897,0.4788732394366197,0.8049190985904829,1.0,6/36,10.39%,DOCK1;ELMO1;MYH9;RAC1;RHOBTB1;FCGR1A
prerank,regulation of MAP kinase activity (GO:0043405),0.34358184347006343,1.0021300851160335,0.4720744680851064,0.8048860838111801,1.0,15/92,7.41%,FLT1;PDGFB;DAB2IP;EDN1;LYN;PDGFD;PTPRJ;TPD52L1;PIK3R6;CD40;INPP5K;TRIB3;PDGFC;TGFB1;PIK3CG
prerank,response to laminar fluid shear stress (GO:0034616),0.4940733697712918,1.0020168626055501,0.4717314487632509,0.8045678239581282,1.0,4/10,19.36%,KLF2;SMAD7;MAP2K5;ABCA1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.44887427152364423,1.001841732629141,0.4532871972318339,0.8044005506092241,1.0,7/17,19.35%,LYN;TAOK2;KLHDC10;MID1;ARL6IP5;CARD9;EIF2AK2
prerank,ear morphogenesis (GO:0042471),-0.38099142383274576,-1.001695770696427,0.4534005037783375,0.8472176732773545,1.0,4/20,5.77%,ZIC1;FGFR2;OSR1;SIX1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3769777408828071,1.0015334783177339,0.4603399433427762,0.8045489297422539,1.0,10/59,12.36%,LEF1;SOX9;TCF7L2;TNRC6C;FOSL1;PPM1D;NFKB1;MED27;CBFB;RELA
prerank,actin filament network formation (GO:0051639),0.48694181974099693,1.0014382723097068,0.47992700729927007,0.8042075937482629,1.0,3/11,4.52%,LCP1;ACTN1;PLS3
prerank,microtubule anchoring (GO:0034453),-0.4372756253751009,-1.0013016959070151,0.4696969696969697,0.8469965098563287,1.0,4/12,13.82%,BICD1;DAG1;PCM1;BICD2
prerank,positive regulation of isotype switching (GO:0045830),0.4588468184566753,1.0011040992536866,0.49328859060402686,0.8044146892092339,1.0,4/15,10.15%,SHLD1;CD40;TGFB1;MAD2L2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4265400742389072,-1.0010279835694755,0.4679334916864608,0.846512443076931,1.0,3/13,8.00%,ENPP1;TPST1;ABHD14B
prerank,positive regulation of transport (GO:0051050),0.34477174360983065,1.0008417251390826,0.4645669291338583,0.8044322023069906,1.0,9/85,6.61%,RAB27A;IL15;HIP1R;GATA2;NEDD4L;DLL1;BOK;CBLL1;INPP5K
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.47527307718344336,1.0006612858897825,0.45863309352517984,0.8042924146642051,1.0,5/13,16.06%,ARID1B;ARID1A;ZMIZ1;CDCA4;SERTAD2
prerank,positive regulation of cell growth (GO:0030307),0.33976202800643823,1.0003662396690116,0.45348837209302323,0.804411386778137,1.0,21/96,14.35%,NTN1;SEMA7A;SMURF1;EDN1;NEDD4L;ADAM10;ITSN2;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;TWF2;SFRP2;SEMA4D;MAP3K13;DBNL;MTPN;ADAM17;ERBB2;S100A9
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.39261735667534037,-1.0003089343343925,0.4382284382284382,0.8472180245864901,1.0,7/18,12.93%,UNC13C;GRIA2;GRIK4;GRIK2;GRIK5;GRID2;GRIK1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.44360613980645613,1.0002807444126263,0.47126436781609193,0.8040676993870175,1.0,3/18,11.99%,HIP1R;BOK;BID
prerank,negative regulation of signaling (GO:0023057),0.4179382308819404,0.999767847910929,0.4697452229299363,0.8046539037226043,1.0,5/25,9.42%,KIF26A;SRMS;FGF23;ACVR1;PTPN1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3441265085719943,0.9993762054315564,0.4629878869448183,0.80499211011558,1.0,21/87,18.42%,DCUN1D3;CDK6;AURKA;JADE1;AVEN;PSMA2;FBXL7;PKD2;PINX1;PSMA8;PSMA6;RB1;CUL1;APC;PSME1;E2F7;ZFP36L1;CDC73;PSMA4;RBL1;PSMF1
prerank,sensory organ development (GO:0007423),0.36827474461648013,0.9990579885814489,0.42773722627737226,0.8051536134264702,1.0,7/51,5.03%,PBX1;CHD7;SHROOM2;FREM2;SMCHD1;HIPK1;SIPA1L3
prerank,regulation of insulin secretion (GO:0050796),0.33538006459990477,0.9986348117295833,0.4589308996088657,0.8055963959987378,1.0,13/101,8.26%,MYRIP;SLC2A1;ACSL4;LRP5;CACNA1E;KCNB1;TCF7L2;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,mammary gland development (GO:0030879),-0.3796013266848228,-0.9986158181432244,0.47297297297297297,0.8506077567901204,1.0,8/21,17.21%,GLI2;WNT4;ERBB4;VEGFA;TGFB3;PRLR;TBX3;ARHGAP35
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.37152583187883637,0.9985000687711887,0.4703328509406657,0.8053756953360021,1.0,12/56,17.80%,NOD1;PLCG2;RPS6KA3;CTSK;MAPKAPK3;IRAK4;LGMN;TRAF6;S100A9;TAB3;IRAK2;TIFA
prerank,positive regulation of kinase activity (GO:0033674),0.3356411180409846,0.9984232665781273,0.462787550744249,0.8049895108516013,1.0,15/107,7.53%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;IQGAP1;PTK2B;FLT4;LMTK2;RET;RAPGEF2;TIGAR;PTK2;RAP1A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28561886334795633,-0.9979449274390844,0.45703125,0.8511608597066096,1.0,23/87,17.23%,FGFR2;FGF1;HNRNPH1;SPRED1;FGF2;NDNF;RBFOX2;CD44;FLRT2;FLRT1;TIA1;SFRP1;FGFBP1;FGFR4;SPRED2;FGF7;NR4A1;POLR2B;POLR2K;HNRNPA1;HYAL1;FGF10;GTF2F1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3213760046234803,0.9977360917299133,0.4833729216152019,0.8059638101855656,1.0,26/170,11.20%,NOVA2;APP;CDK6;AHR;FOXP1;TRIM14;HIF1A;NFKBIZ;KDM6A;IGF2BP3;TRIM68;UBAP2;AFF1;HNRNPK;RASA1;HNRNPD;MARF1;PSEN1;IHH;YBX3;CDK2;ATXN7L3B;APLNR;SCARB2;RO60;MKLN1
prerank,glycolipid biosynthetic process (GO:0009247),-0.3283712121700525,-0.9975830716202394,0.4642857142857143,0.8508627838441407,1.0,13/38,21.02%,LARGE1;ST6GALNAC5;PIGN;GBGT1;ST3GAL5;B4GALT6;PIGA;ST8SIA1;PIGH;PGAP3;SCCPDH;PIGW;ST3GAL4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.40823327025531303,0.9975723606984304,0.46365105008077545,0.8057836210418107,1.0,5/28,9.69%,ERN1;DAB2IP;CASP4;TRIB3;ERO1A
prerank,transcription by RNA polymerase II (GO:0006366),0.30488075251517444,0.9973012148983178,0.47878128400435255,0.8058655146831154,1.0,50/305,14.92%,TEAD4;HDAC9;ESR1;PPARD;NR5A2;PIR;MAML2;MLLT3;NR3C1;HDAC7;NOTCH1;RREB1;CCNK;WWTR1;GTF2I;XBP1;TEAD2;ESRRG;NR1I3;GTF2F2;KLF13;GTF2E2;GMEB2;NFKB1;WDR33;TRIP13;NELFE;TAF3;TRIM24;TAF4B;MED27;COPS2;RNGTT;EAF1;POU2F1;INTS11;CBFB;CEBPD;SNAPC3;RPRD1B;RNMT;GTF2A2;BTF3;INTS12;ESRRB;RPRD2;NRBP1;KAT2B;ELOC;SNW1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4928140469120539,0.9972606756754837,0.48532289628180036,0.8054067285612864,1.0,4/12,14.45%,STX3;STX1A;SNAP23;STX11
prerank,regulation of T cell activation (GO:0050863),0.3856936657473654,0.9971408056078224,0.4813153961136024,0.805111633799326,1.0,6/42,10.01%,TNFRSF1B;JAK3;TNFSF8;TIGIT;LCK;CYRIB
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4463360833962583,-0.9971296808663328,0.4989339019189765,0.8508734588460105,1.0,2/10,11.17%,CD55;CD81
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.37450906076940077,-0.997065272684666,0.46115288220551376,0.8498047728975957,1.0,5/21,15.22%,HK2;H6PD;PGD;TKT;G6PC3
prerank,actin nucleation (GO:0045010),0.4333228882133341,0.9964852051031552,0.4602649006622517,0.8060014109453532,1.0,7/21,17.86%,JMY;ARPC3;ARPC1B;ACTR2;ACTR3;ARPC2;WHAMM
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4081850224042215,-0.996435589105492,0.4739454094292804,0.8503347521731178,1.0,2/17,1.71%,ANK2;SNTA1
prerank,mitotic sister chromatid segregation (GO:0000070),0.3353137810093561,0.9962736873572943,0.4895287958115183,0.8059351545855558,1.0,22/98,18.26%,TENT4A;RAB11A;RAD21L1;MCPH1;CHMP2B;KIF22;HASPIN;RRS1;PINX1;CHMP4A;CHMP4B;NCAPH;KIF23;RB1;PDS5A;RAD21;PDS5B;CUL3;WRAP73;SMC4;CSNK2A2;CSNK2A1
prerank,antibacterial humoral response (GO:0019731),0.46204495901564585,0.996217390367448,0.4868189806678383,0.8054940586142119,1.0,3/16,9.16%,RPL39;ANG;DEFA6
prerank,cellular response to BMP stimulus (GO:0071773),0.356556437049195,0.9961073138409641,0.44959128065395093,0.805193259864928,1.0,11/66,7.33%,BMPR2;ENG;ACVRL1;SMAD1;SMURF1;SOX9;SMAD7;ACVR2A;USP15;ACVR1;TGFB1
prerank,protein-DNA complex assembly (GO:0065004),0.3304047646219089,0.9960077528936581,0.46446700507614214,0.8048635178459627,1.0,40/116,26.60%,SOX9;PADI4;H3-3A;TCF4;RPA1;PSMA2;CDT1;KAT6B;SMARCA5;NAP1L4;PSMA8;PSMA6;GRWD1;NPM1;PSME1;ORC5;ATRX;ORC3;GTF2H4;ANP32B;PSMA4;PSMF1;CETN2;CHD1L;GTF2H1;PSMB7;PSMB1;SART3;CCNH;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;GTF2H5;ORC6;GMNN;MCM6;RPA3
prerank,negative regulation of transferase activity (GO:0051348),0.41489427304526716,0.9959027639706729,0.487012987012987,0.8045463860196665,1.0,8/28,12.93%,DTX3L;SMAD7;INPP5K;CDKN1B;PINX1;NPRL2;ZFP36;ERCC4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4661181642795536,0.9958604220071852,0.45598591549295775,0.8041017111910528,1.0,2/14,4.39%,CAV1;DLL1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.35243141163987546,0.9955388224023507,0.4645776566757493,0.8043185071321299,1.0,28/70,25.41%,B2M;IKBKB;MFSD6;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;LNPEP;PSMA5;PSMC3;TAP1;CYBA;FCER1G;PSMD3;PSMA3;VAMP3;TAPBP
prerank,regulation of glycolytic process (GO:0006110),0.3550840505459563,0.9946816593181573,0.4797202797202797,0.8056288063761012,1.0,17/68,14.81%,APP;CBFA2T3;INSR;HIF1A;PFKFB3;FBP1;TIGAR;PSEN1;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,regulation of NMDA receptor activity (GO:2000310),0.406103451687987,0.9946397363533624,0.47560975609756095,0.8051657514487056,1.0,4/32,2.59%,APP;MEF2C;DAPK1;PTK2B
prerank,phosphate ion homeostasis (GO:0055062),-0.45535714852834375,-0.9945747030173047,0.4669603524229075,0.8542536410907844,1.0,3/10,10.72%,ENPP1;SFRP4;FGFR4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3940846328538253,-0.9943828749800027,0.472636815920398,0.8535683196909406,1.0,4/17,12.60%,AKAP13;ADRA1B;ADRA2A;ADRA1A
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4313148440164275,-0.9939407280078559,0.47268408551068886,0.853643230210485,1.0,5/12,16.96%,PPARA;WNK1;MIA3;FUT9;MDK
prerank,positive regulation of lyase activity (GO:0051349),0.4685219106026155,0.9939296820399549,0.48109965635738833,0.8061963457565737,1.0,2/14,3.49%,NOS3;ORAI1
prerank,T cell migration (GO:0072678),0.4701100191428017,0.993881672678768,0.48194945848375453,0.8057420836466942,1.0,3/13,7.41%,S1PR1;MSN;PIK3CG
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3772644363060811,-0.9937868828636703,0.46867167919799496,0.8528166668766146,1.0,4/21,4.18%,PRKN;SLC30A10;PPARA;SIRT2
prerank,DNA methylation (GO:0006306),0.4221709707753656,0.993779723946612,0.4652317880794702,0.8054194504320424,1.0,10/23,18.39%,ZFP57;KMT2E;ATF7IP;PPM1D;GATAD2A;PICK1;SPOCD1;ATRX;TEX15;EHMT1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4146135558300659,0.9935403991102332,0.4546979865771812,0.8053996640117779,1.0,6/24,12.17%,NOTCH1;HIF1A;KLF2;MBTPS2;ATF6;MUC1
prerank,positive regulation of transporter activity (GO:0032411),-0.41429507562308,-0.9934752988357113,0.4562647754137116,0.8524647001550576,1.0,9/13,37.67%,TRPC6;WNK3;NR1H3;SGK2;SGK1;KCTD7;PDZK1;STK39;RXRA
prerank,phospholipid homeostasis (GO:0055091),-0.43921301207755437,-0.9934076429141154,0.4725274725274725,0.8514031700149027,1.0,4/11,18.11%,TLCD2;RCN3;TLCD1;ANGPTL3
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4521968492532259,-0.9930351093685279,0.46813186813186813,0.8511442399607547,1.0,5/10,18.16%,PFKP;HK2;GFPT1;GFPT2;PFKM
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3487776351742649,-0.9928919712613489,0.4410112359550562,0.8503377157438083,1.0,7/30,7.58%,FSTL1;TGFBR3;DKK3;TWSG1;SMAD3;SFRP4;BCL9
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4749175847160298,0.9927701708487885,0.48314606741573035,0.806553888107033,1.0,2/13,4.00%,NOS3;TMSB4X
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.43162383340880894,-0.9926321397377268,0.475,0.8498365384386989,1.0,6/12,20.95%,ROCK2;APOE;FLOT2;ABCA7;CHRNA7;ABCA2
prerank,muscle tissue morphogenesis (GO:0060415),0.4562031988700862,0.992564226870027,0.47735191637630664,0.8064573292926971,1.0,2/16,2.77%,TBX1;NOTCH1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3860780361851046,-0.9925278220613759,0.4795180722891566,0.8489302875467342,1.0,14/19,46.13%,APOE;CHRNA7;CHRFAM7A;SLC5A7;CHRNB2;ACHE;COLQ;RAPSN;CHRNA5;CHRNA3;RIC3;CHRNE;CHRNB4;CHRNB3
prerank,vitamin transport (GO:0051180),0.4023450582610956,0.9924924318945135,0.4920886075949367,0.8060775646511842,1.0,6/29,13.94%,ABCG2;SLC52A3;AFM;CD320;SLC2A6;TCN2
prerank,regulation of neuron death (GO:1901214),0.346000796624995,0.992155587212745,0.45816186556927296,0.806248280414974,1.0,12/82,9.87%,MEF2C;CD200;DDIT4;TNFRSF1B;FYN;CD34;WNT5A;CHMP4A;CHMP4B;IKBKG;CSF1;BTBD10
prerank,cellular glucan metabolic process (GO:0006073),-0.4448693112580039,-0.9919779085279092,0.49036402569593146,0.8491315699658617,1.0,5/11,12.04%,PHKB;PYGM;PRKAG2;PPP1R3C;UGP2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.37410063968531526,0.9919238756061818,0.4629898403483309,0.806218074254643,1.0,13/49,17.66%,MEF2C;KMT2E;H3-3A;TNRC6C;ZFPM1;EIF6;RBM15;CBFB;RAB7B;ASH2L;KAT2B;ITGA2B;CIB1
prerank,receptor signaling pathway via STAT (GO:0097696),0.4175537684392744,0.9919106739471384,0.455,0.805698209626503,1.0,10/25,17.70%,SOCS2;STAT3;GHR;IFNAR1;IFNAR2;PKD2;NMI;SOCS6;STAT6;STAT1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3808276968113576,0.991730925046582,0.4670750382848392,0.8055366878434312,1.0,10/41,10.82%,PDGFB;NEDD9;EFNA1;FBXW7;FYN;TGFA;PTPN1;FCGR1A;GAS6;EPHA4
prerank,negative regulation of lipid storage (GO:0010888),0.43692424177194533,0.9914696005687574,0.4895833333333333,0.8055947792326986,1.0,6/19,15.52%,PPARD;NFKBIA;ITGB3;PNPLA2;ABCG1;TTC39B
prerank,negative regulation of nervous system development (GO:0051961),0.45717859771945646,0.9910434060129898,0.4665523156089194,0.8060042978142907,1.0,2/17,2.77%,B2M;NOTCH1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.38475514342556155,0.9906849857417583,0.4584615384615385,0.8062252634137459,1.0,6/42,9.61%,IL6R;SELP;RPS19;DROSHA;DEFA6;IL23A
prerank,actin cytoskeleton reorganization (GO:0031532),0.35726178470135844,0.9902434570770579,0.4767932489451477,0.8066387539515516,1.0,13/63,9.49%,PARVB;THSD7A;NEDD9;MYH9;S1PR1;CDC42BPB;TNIK;ATP2C1;PLEK2;TRPV4;GAB1;PTPN1;RICTOR
prerank,cellular response to calcium ion (GO:0071277),0.3559550077151592,0.9902235586683158,0.47802197802197804,0.8061468137541534,1.0,14/67,13.74%,MEF2C;CPNE8;IQGAP1;PLCG2;ALOX5AP;CHP2;WNT5A;ITPKB;RASA4;PKD2;SYT15;LGMN;CLIC4;MEF2A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4004455082702863,0.9901549721193823,0.48119122257053293,0.8057683900099286,1.0,4/33,5.18%,TAL1;STAT3;HIF1A;ACVR2A
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3306622540215824,0.9899581928903419,0.47753530166880614,0.8056512810404264,1.0,28/110,17.02%,DAB2IP;TAL1;FNIP2;BIK;SELP;TIRAP;RALB;ULK1;ATF7IP;SOST;SH3GLB1;BCL2L11;TGFB1;CDT1;AIDA;RB1;BID;NOP53;RACK1;PREB;WARS1;CDH5;SVIP;BMF;IRGM;PIH1D1;SPIDR;TMC8
prerank,regulation of amyloid fibril formation (GO:1905906),0.45960028386467877,0.9898647074668449,0.48633879781420764,0.8053124378604283,1.0,7/15,23.47%,APP;PSEN1;PFDN1;PFDN5;PFDN2;IAPP;CLU
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3819312079373701,0.9891338989772376,0.4691729323308271,0.8063910881989739,1.0,6/40,7.33%,LEF1;NOTCH1;WWTR1;SDCBP;TCF7L2;TGFB1
prerank,catecholamine metabolic process (GO:0006584),-0.40874703626511355,-0.9889730935233478,0.4527027027027027,0.8561610226038343,1.0,1/14,1.21%,PRKN
prerank,RNA destabilization (GO:0050779),-0.394064554539137,-0.9889558944974597,0.4587628865979381,0.8550078147324817,1.0,3/18,14.57%,ROCK2;CELF1;FTO
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4717716460628333,0.9888448152818725,0.47833935018050544,0.8065242348330453,1.0,2/12,3.59%,CELSR1;LAMA3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.41490613099247386,0.9886754842744413,0.47596153846153844,0.8058254135178569,1.0,6/23,14.12%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.41490613099247386,0.9886754842744413,0.47596153846153844,0.8058254135178569,1.0,6/23,14.12%,PPP1R13B;CASP8;MAPK8;SFN;BID;YWHAQ
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4215792919406487,0.9886149140596058,0.4842454394693201,0.805416674915959,1.0,10/25,24.31%,CCNK;ZNF326;EAF1;ZMYND11;ALYREF;THOC1;THOC5;SETD5;ERCC6;TCEA2
prerank,urogenital system development (GO:0001655),-0.4359250506237712,-0.9884726236667667,0.4786516853932584,0.8551079199685351,1.0,6/11,24.91%,OSR1;ANXA1;PAX8;EPHB3;EPHB2;LHX1
prerank,regulation of response to interferon-gamma (GO:0060330),0.4512947612393163,0.9881720369166477,0.48324514991181655,0.8058511021766892,1.0,8/14,25.48%,JAK1;HSP90AB1;STAT1;IFNGR1;PARP9;CDC37;JAK2;SUMO1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.44155384350363247,0.988019059336661,0.47923875432525953,0.8056525293755611,1.0,5/17,11.69%,WASF2;NCKAP1;GMFG;PICK1;CYFIP1
prerank,macrophage differentiation (GO:0030225),0.46873710691705395,0.9878656796450387,0.4845360824742268,0.8054591254724109,1.0,3/13,9.46%,IL15;CASP8;CSF1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3537820187375445,-0.9878122896027096,0.4767123287671233,0.8544432314854402,1.0,10/24,27.31%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.3537820187375445,-0.9878122896027096,0.4767123287671233,0.8544432314854402,1.0,10/24,27.31%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3994747944519292,0.9877902202233435,0.4794952681388013,0.8050860272952883,1.0,9/31,18.00%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.36932139202825565,-0.9873592864623093,0.4856396866840731,0.8543971200885672,1.0,7/23,16.51%,MAP6;KIF1A;KIF5C;DYNC1I1;KIF1B;HOOK2;KIF5A
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4342790475054796,-0.9872629328902711,0.4851063829787234,0.85345999807429,1.0,4/11,7.82%,PRKN;PTPN23;DAB2;EZR
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.43433741348231925,-0.9867041690812207,0.4576659038901602,0.8538552165152722,1.0,7/12,31.36%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1;CACNA1H;FDX2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.39201068489337376,-0.9866052177379139,0.4755244755244755,0.8528946081266342,1.0,3/18,2.95%,EGFR;DDX5;BMP4
prerank,cellular protein localization (GO:0034613),0.3049801692963331,0.9864684205721623,0.4944933920704846,0.8074304958733123,1.0,55/285,14.72%,TBC1D8;ESAM;STX3;OCLN;TBC1D30;SMURF1;TBC1D4;CELSR1;HHEX;ARHGEF2;REEP1;SGSM1;TBC1D22A;CPE;TBC1D15;STX6;ID1;MESD;PTPRK;HERC2;STX7;WNT5A;TBC1D12;ARL4A;AP2A1;TBC1D2;STX1A;TMED7;PIGU;TMED5;RAB38;ARL5A;AP3B1;TM9SF1;ACD;PIGK;TBC1D5;PICK1;STX8;RAB43;CEP68;WDR11;STXBP3;EVI5;TBC1D8B;RAB31;RAB5A;RABGAP1L;AMOT;RAB5B;NPM1;SNX13;RAB18;STX11;RAB32
prerank,negative regulation of viral process (GO:0048525),0.3621015787633778,0.9864569833058168,0.4697406340057637,0.8069188279081189,1.0,16/57,19.39%,TRIM14;ISG20;N4BP1;PTX3;MID2;TNIP1;OASL;ZFP36;IFIH1;IFITM3;STAT1;PLSCR1;BST2;IFITM1;EIF2AK2;TRIM62
prerank,regulation of DNA binding (GO:0051101),0.3789280701367953,0.9855682031757416,0.49640287769784175,0.8083819669025097,1.0,7/44,10.60%,LEF1;NFKBIA;MAPK8;TGFB1;BCL3;CDT1;TFAP4
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.36745059852063366,-0.985406992796059,0.4625,0.8547177583739243,1.0,6/21,9.32%,ROCK2;ERRFI1;BMP4;SFRP4;RUNX1;MAFG
prerank,protein kinase A signaling (GO:0010737),0.4761736730574527,0.9846635968729393,0.49466192170818507,0.8098536405383325,1.0,1/12,1.24%,LCP1
prerank,regulation of exocytosis (GO:0017157),0.38116627368849754,0.9845318443851931,0.46597633136094674,0.8095961102665927,1.0,10/46,17.28%,RAB27A;CADPS2;EXPH5;RAB12;RAB26;RAB5A;STXBP6;RAB8B;SYTL4;CPLX2
prerank,cellular response to lipid (GO:0071396),0.31252795327192096,0.984453101285038,0.49537037037037035,0.8092482567570296,1.0,33/191,10.19%,TBX1;ESR1;MEF2C;AHR;DAB2IP;FZD4;LYN;NR3C1;PTK2B;MSN;TNFRSF1B;SOX9;XBP1;CX3CR1;SBNO2;MAPK8;RET;ATP1A3;ATP1A1;WNT5A;ADAM15;WNT9B;IL36G;NCOA4;PPBP;BRINP2;NFKB1;LPL;CASP1;CREB1;DEFA6;NRIP1;TWF2
prerank,organophosphate catabolic process (GO:0046434),0.4889012521355703,0.9842954908207356,0.5219683655536028,0.8090597697395211,1.0,3/11,14.45%,ENPP2;PDXP;NUDT15
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3992210636214917,0.9842336631279559,0.5128205128205128,0.8086535289612367,1.0,6/33,8.10%,ESR1;PKN1;TRIM68;H3-3A;KCTD6;KDM4C
prerank,endocytic recycling (GO:0032456),0.3709379095856482,0.9841422570813866,0.4848920863309353,0.8083243890475852,1.0,9/50,13.71%,EHD4;DENND1B;LMTK2;STX6;SNX3;EHD2;EHD3;RAB11B;RAB7A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4566029167900167,0.983926401727137,0.48353552859618715,0.8083052149807729,1.0,3/14,6.10%,SEMA7A;PLCG2;WNT5A
prerank,response to fatty acid (GO:0070542),0.4382340419912915,0.9838511297547751,0.48976109215017066,0.8079350325091909,1.0,3/17,8.24%,FOXO1;SOX9;LPL
prerank,regulation of endocytosis (GO:0030100),0.3554342340319832,0.9835342605133642,0.4815340909090909,0.8081231485794049,1.0,8/61,6.19%,MCTP1;PRKD1;HIP1;HIP1R;NEDD4L;DLL1;OPHN1;CBLL1
prerank,embryonic organ development (GO:0048568),0.3523169723965309,0.9834927502402118,0.4935064935064935,0.807685542586746,1.0,11/61,9.03%,TEAD4;PBX1;KDR;KITLG;TAL1;SOX17;SOX18;TEAD2;TGFB1;NEUROD1;ZFPM1
prerank,negative regulation of cell aging (GO:0090344),0.4504004593456995,0.9834199042374164,0.4957983193277311,0.8072984626117893,1.0,5/16,18.00%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3521334296222736,0.9832617999355348,0.49247606019151846,0.8070914533136678,1.0,16/71,14.79%,CTSC;CASP8;ATXN3;CTSK;CTSO;MALT1;ZRANB1;RHBDD1;CHMP4B;PSMA8;PSMA6;LONP1;LGMN;OMA1;DDI1;SOCS6
prerank,regulation of tissue remodeling (GO:0034103),0.4538333815237743,0.983260908902463,0.49907235621521334,0.8065625505834967,1.0,5/18,9.61%,IL15;FLT4;CEACAM1;TGFB1;IL23A
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31176602260174896,0.9831399810093345,0.4964622641509434,0.8062988302630704,1.0,30/172,13.57%,INPP5D;PLA2G4A;PIP5K1B;DGKZ;PITPNM2;MTM1;LPCAT3;PIK3C2A;PLCG2;PIK3R6;DGKH;CEPT1;LPIN3;MTMR6;PLA2G2D;INPP5K;CDS2;BMX;PIK3CG;AGPAT1;SYNJ1;PLEKHA8;OCRL;INPP5F;DGKE;MTMR12;PEMT;PLD2;RAB5A;CHKA
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.37119992831158416,-0.9830210509366475,0.4803921568627451,0.860035635498797,1.0,13/23,33.68%,GJA1;GPSM2;HTT;UBXN2B;NDC80;MISP;SPDL1;CENPA;FBXW11;DCTN1;INSC;ZW10;PKHD1
prerank,renal water homeostasis (GO:0003091),-0.3730533128209937,-0.9828066745641986,0.4793187347931874,0.8594261424917045,1.0,9/23,14.56%,ADCY5;ADCY1;ADCY2;ADCY7;ADCY6;PRKACA;PRKAR1B;PRKAR1A;ADCY3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3956154155810308,0.9827687287113666,0.4869281045751634,0.8065537040312747,1.0,7/32,8.29%,ACER2;NEXMIF;ACVRL1;DUSP22;ADAM15;RASA1;NF2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.40338032370083154,0.9821508427701785,0.5100775193798449,0.807380776096041,1.0,14/31,26.28%,CNOT6;EDC3;EXOSC1;DCP2;LSM3;HBS1L;CNOT7;LSM7;LSM1;DCP1B;LSM2;DDX6;DIS3;EXOSC4
prerank,negative regulation of catabolic process (GO:0009895),-0.31552778030137213,-0.9820995275712917,0.47202797202797203,0.8600559792731397,1.0,9/47,11.32%,EGFR;NUPR1;HDAC4;PPARA;SIRT2;MDM4;ADRA2A;ALK;CST3
prerank,negative regulation of cellular protein localization (GO:1903828),0.3946571475785452,0.982086905573196,0.5030487804878049,0.8069712346421132,1.0,6/34,8.41%,ANKRD13A;NEDD4L;MFHAS1;CTNNA1;DNAJA1;CDT1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4043110795111747,0.9815873803882457,0.4802527646129542,0.8075372983740304,1.0,7/29,12.74%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,negative regulation of bone mineralization (GO:0030502),0.46549515196060354,0.9814634920154179,0.49727767695099817,0.8072662122221155,1.0,5/13,11.76%,PTK2B;FGF23;GREM1;SRGN;RFLNB
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29773857709439583,-0.981297873356072,0.4634920634920635,0.8609281810061301,1.0,25/56,27.27%,SON;ROCK2;SPIRE1;SNX18;ANK3;CIT;ARL3;JTB;RTKN;DCTN3;VPS4A;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;ALKBH4;RHOC;SEPTIN9;SNX33;IST1;CENPA;CEP55;SPAST
prerank,activation of protein kinase B activity (GO:0032148),-0.3483092207753373,-0.9811288882942231,0.5071633237822349,0.8601447741439475,1.0,6/29,8.32%,IGF1;NTRK3;FGF1;IL18;OSBPL8;ADRA2A
prerank,regulation of catecholamine secretion (GO:0050433),-0.3490053134961972,-0.9808001117896571,0.48787061994609165,0.8598352286879068,1.0,8/29,17.04%,PRKN;SYT1;SYT9;SYT12;SYT11;DTNBP1;SNCA;SYT3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.49095012804605176,0.9807878321543043,0.4898336414048059,0.8082065129685798,1.0,3/10,20.72%,WRAP53;CCT7;CCT2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3165892354076611,0.9806150238068364,0.5223325062034739,0.8080469944503069,1.0,24/150,8.07%,GNAQ;ENG;CAV1;OCLN;CNKSR3;PARD3;DAB2IP;LYN;DDIT4;PDE4D;PPM1F;NCK1;WWTR1;PAK2;CEACAM1;SMAD7;GREM1;PRR5L;INPP5K;TRIB3;SNX25;TGFB1;NIBAN1;SAMSN1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4064540390080214,0.9803708738262004,0.4884488448844885,0.8080688262523767,1.0,4/29,11.80%,JAM2;ANO6;GAS6;LGMN
prerank,protein insertion into membrane (GO:0051205),0.38939491685233174,0.9796114585933411,0.4807073954983923,0.8092600536049687,1.0,5/32,10.01%,APP;REEP1;STX1A;TRAM1;TRAM1L1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.31539454047850535,-0.9795162796356998,0.4642857142857143,0.8620513098975265,1.0,8/40,14.27%,SLC7A11;SLC13A3;SLC38A11;SLC27A1;SLC7A6;SLC5A6;ABCC5;SLC19A1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.48008496485274904,0.9794599724683698,0.4829443447037702,0.8090650790816053,1.0,3/11,10.79%,JAK3;SMAD7;RC3H1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3811903884073574,0.979439106388908,0.5190615835777126,0.8085823373041237,1.0,10/42,17.58%,GARS1;FARS2;IARS1;TARS3;LARS1;WARS1;RARS1;AIMP1;KARS1;WARS2
prerank,cellular protein-containing complex assembly (GO:0034622),0.31378182148580036,0.9794383058571606,0.5060096153846154,0.808056260242805,1.0,30/159,15.22%,SMAD1;HIP1;HIP1R;IMMP2L;PIK3C2A;NCK1;PXN;FKBP1A;FCHO2;TESPA1;RPL38;TCF4;VAMP4;TGFB1;CHMP4A;CHMP4B;TBCA;HIGD2A;VAMP8;POMP;PICALM;LONP1;NUP98;HSP90AB1;OMA1;NUP205;RAB5IF;HIGD1A;NUP153;STXBP6
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.4200663336592952,-0.9793151578303164,0.49665924276169265,0.861387200733974,1.0,3/12,4.15%,IRS1;PPARA;PPARGC1A
prerank,regulation of myoblast differentiation (GO:0045661),0.3953830141973379,0.979170182498199,0.4977238239757208,0.8081123401757467,1.0,6/32,7.33%,MEF2C;NOTCH1;PLCB1;SOX9;DLL1;TGFB1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3867796118288627,0.9791345802651455,0.48381877022653724,0.807662721275916,1.0,6/33,8.98%,DNM3;ITSN2;FCHO2;OPHN1;STX1A;SYNJ1
prerank,mitotic spindle assembly (GO:0090307),0.3710646583003302,0.9789402627343052,0.4789391575663027,0.8075564941816864,1.0,17/42,21.62%,RAB11A;AURKC;STAG2;KIF23;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;BCCIP;PIBF1;KIF4A;RACGAP1;KPNB1;KIF2A
prerank,positive regulation of protein polymerization (GO:0032273),0.3542454722690695,0.9788387531006816,0.475177304964539,0.8072640399833968,1.0,7/65,6.68%,OCLN;PTK2B;NCK1;EVL;NCKAP1;RAC1;CDC42EP3
prerank,early endosome to late endosome transport (GO:0045022),0.43587987533564887,0.9787387277362938,0.5035714285714286,0.8069589563875285,1.0,7/20,13.71%,LMTK2;EEA1;STX8;RILP;KIF16B;RAB5A;RAB7A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4272170787691604,0.9784335473526532,0.48327759197324416,0.8070915217863407,1.0,9/22,23.49%,CCNK;BTBD18;BRD4;CDC73;ALYREF;THOC1;THOC5;ERCC6;EAPP
prerank,male gonad development (GO:0008584),0.3926515941906175,0.9783664969295971,0.4923547400611621,0.8067035189339408,1.0,8/34,13.32%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.33670487443689867,-0.9782129618685139,0.46685082872928174,0.8631050571749291,1.0,14/33,20.67%,APPL2;PKD1;MN1;STXBP4;TAF1;GLI1;PAF1;PLK5;CDKN1A;TCIM;E2F1;DDRGK1;PTEN;ID2
prerank,synapse organization (GO:0050808),0.3229295599577591,0.9780164915151502,0.5076530612244898,0.8069290188319228,1.0,11/125,4.30%,SHANK3;DNM3;UNC13B;APBB2;APP;PPFIBP1;PLXND1;PPFIA2;PCDHB4;CDH2;GPHN
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.44612018621743704,0.9778439433234708,0.4964912280701754,0.806756752277376,1.0,7/16,18.10%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;KMT5B;PARP9
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.47898323063803905,0.9775768725437803,0.5027726432532348,0.8068078872844329,1.0,7/10,29.85%,NF2;INPP5F;PPP2R1A;PIBF1;PPP2CA;PARP14;SOCS3
prerank,nucleotide metabolic process (GO:0009117),-0.3565291352847495,-0.9774654776090957,0.5169712793733682,0.8638762469096662,1.0,8/23,21.95%,NMNAT2;FHIT;ME1;ENPP3;NMNAT1;NMNAT3;GUK1;CTPS2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3244846220133773,-0.9772120352883329,0.5058823529411764,0.8633987261422986,1.0,11/35,18.34%,MAGI2;PDGFRB;ITGA1;PPP4R4;PPP6R2;CRY2;HTT;PTPA;BOD1L1;TSC1;CSNK2B
prerank,cellular component disassembly (GO:0022411),0.3584868839760425,0.9768011200803254,0.476878612716763,0.8079645758511359,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,development of primary male sexual characteristics (GO:0046546),0.39080187325586013,0.9767840993592078,0.4969418960244648,0.8074777472331185,1.0,8/34,13.32%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2
prerank,extracellular matrix disassembly (GO:0022617),0.3589283942774002,0.9767405846809625,0.4878048780487805,0.8070344626188282,1.0,4/53,3.25%,TLL1;LCP1;ADAM10;BSG
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.39756773936702683,0.9765507419145444,0.4806800618238022,0.8069287162327707,1.0,7/30,12.74%,CASP8;IKBKB;CD40;IKBKG;UBE2D3;RIPK1;BIRC3
prerank,response to UV (GO:0009411),0.3344546352025224,0.9762821697889649,0.4960212201591512,0.8069972627326834,1.0,18/95,14.62%,DCUN1D3;POLK;MAP4K3;CAT;PTPRK;N4BP1;MAPK8;BCL3;NEDD4;PRIMPOL;RHBDD1;MC1R;RELA;EIF2AK4;ERCC4;FMR1;NPM1;YY1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4258819811211111,-0.9762566729042621,0.5307017543859649,0.8648149499139726,1.0,3/12,6.04%,EML2;MAP2;CLIP3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.31963493365437956,-0.9760124053344843,0.45454545454545453,0.8642595990859934,1.0,13/39,15.47%,DMD;OSR1;HECW2;FGF14;WNK4;ANK3;SLMAP;WNK1;GPD1L;SCN2B;FXYD1;WNK3;NETO1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.35478828977867877,0.9759795601936351,0.48450704225352115,0.8071418649046006,1.0,16/54,16.65%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C;E2F7;CHEK2
prerank,negative regulation of coagulation (GO:0050819),-0.4187844941615361,-0.9758984287047218,0.4613583138173302,0.8633810057703089,1.0,6/14,10.34%,VTN;TFPI;SERPINE2;APOE;SERPINE1;HS3ST5
prerank,sister chromatid segregation (GO:0000819),-0.3310252180976244,-0.9758735452830963,0.48614609571788414,0.8622681616640582,1.0,16/31,33.42%,TOP2B;ZWINT;KLHL22;NUSAP1;CENPK;KNSTRN;KIF18B;KIFC1;NDC80;TOP2A;CDCA8;SGO1;INO80;DSN1;ZW10;ESPL1
prerank,androgen receptor signaling pathway (GO:0030521),0.47287703132685116,0.9757063711422328,0.5112781954887218,0.8072013529808761,1.0,5/11,14.08%,PLPP1;KDM3A;ARID1A;ZMIZ1;PMEPA1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3708462278542302,-0.975566386510598,0.47572815533980584,0.8618849229483047,1.0,8/20,22.61%,SLC8A3;MCU;MICU1;YME1L1;SLC25A23;SLC8B1;MAIP1;SMDT1
prerank,regulation of cell size (GO:0008361),0.41270361782568293,0.9754533357824031,0.5101351351351351,0.8072573694376104,1.0,8/23,16.72%,EDN1;MSN;RAC1;RPTOR;LARS1;MTPN;RDX;RHOA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.31221231339970607,-0.9754415904082921,0.45980707395498394,0.8610431830430945,1.0,11/48,10.41%,ADCY5;AMPD3;ADCY1;ADCY2;SLC26A2;ADCY7;ADCY6;PAPSS2;GUCY1A1;DCAKD;ACAT1
prerank,pharyngeal system development (GO:0060037),0.4451002719158332,0.9752275294639808,0.5052816901408451,0.8071911756880746,1.0,2/15,0.88%,BMPR2;TBX1
prerank,cellular lipid catabolic process (GO:0044242),0.4062632778416031,0.9750686224496405,0.48538961038961037,0.8070342007622591,1.0,3/27,5.65%,PPARD;ENPP2;LPIN3
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3922927147710434,0.9749591960910653,0.4889937106918239,0.8067249518279682,1.0,10/30,20.99%,CAVIN1;TAF1B;POLR1A;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH
prerank,cGMP-mediated signaling (GO:0019934),-0.4142347021859325,-0.9742159769036088,0.5,0.8630894843240534,1.0,4/13,13.73%,IRAG1;KCNC2;APOE;GUCY1B1
prerank,macrophage chemotaxis (GO:0048246),-0.4476887997318337,-0.9741327623927495,0.5107296137339056,0.8621151462214222,1.0,4/10,34.16%,TAFA4;CCL2;CXCL17;CCL5
prerank,regulation of leukocyte migration (GO:0002685),-0.3844514200722804,-0.9740211003425332,0.5070754716981132,0.8612044133820844,1.0,5/16,11.17%,HOXA7;ANXA1;VEGFA;MIA3;CD81
prerank,regulation of hormone secretion (GO:0046883),0.461603488079138,0.9738743009005408,0.5121527777777778,0.8085636143074071,1.0,2/15,4.06%,EDN1;FGF23
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.41056994877744285,-0.9736636918173468,0.47277227722772275,0.8610276857867416,1.0,2/14,8.65%,ENPP1;ENPP3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.33858004811356546,-0.9736004402390448,0.5051020408163265,0.8600229401526227,1.0,9/30,12.19%,NOTCH2;IGF1;RASGRF1;ITGAV;NGF;SHC1;SRC;IRS2;MMD2
prerank,somite development (GO:0061053),-0.43212210204680346,-0.9733215312694938,0.515625,0.859585724762836,1.0,4/11,11.33%,MEOX2;LOXL3;SMO;MTHFD1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.48702795723584746,0.9732450287852933,0.5177570093457944,0.809418553140181,1.0,4/10,19.31%,FBXW7;TGFA;ADAM17;BTC
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.47917414511135714,0.9727377615543055,0.5148698884758365,0.8099463855936689,1.0,1/10,0.47%,CSGALNACT1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.4102384280787439,0.9724806819526945,0.4967105263157895,0.8100084996537439,1.0,6/25,13.75%,TMTC2;CAV1;TRPV6;CYP27B1;GRIN1;TRPM7
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.45941407731534045,0.9724478132376518,0.4876325088339223,0.8095699901210249,1.0,4/12,17.75%,SEC63;CHMP4A;CHMP4B;SEC62
prerank,positive regulation of lipid localization (GO:1905954),-0.42591126443171423,-0.9720948965298081,0.5056433408577878,0.8617051240207141,1.0,2/11,4.67%,LRP1;IKBKE
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4472341655454344,0.971780569215326,0.5223367697594502,0.8104571950619515,1.0,6/16,9.42%,PDGFB;PDGFD;PTPRJ;PIK3C2A;PDGFC;PTPN1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3677337125884518,-0.9716710241481986,0.5012658227848101,0.8616287289525347,1.0,5/20,9.53%,EGFR;PKD1;CCND2;SPDYA;RGCC
prerank,thymus development (GO:0048538),0.46395693037194885,0.970787008237681,0.5147826086956522,0.8120280151589281,1.0,1/13,0.88%,TBX1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.4118685867413441,-0.9705315449544347,0.5102564102564102,0.8635188013644436,1.0,4/14,15.61%,DPYD;UPB1;NT5E;NT5C1A
prerank,neuron differentiation (GO:0030182),0.3094471132172225,0.9704895641928126,0.5318396226415094,0.8121317863175124,1.0,17/165,9.33%,LHX6;PBX1;MEF2C;UGCG;ACSL4;FZD4;DDIT4;XBP1;PITX3;OPHN1;WNT5A;WNT9B;NEUROD1;THOC2;USH2A;IER2;SOX4
prerank,positive regulation of immune system process (GO:0002684),0.4403855734193591,0.9704182097767908,0.48211243611584326,0.811767155145702,1.0,1/16,1.27%,IL15
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3449429222853965,0.9698816073400913,0.49235048678720444,0.8124230978271036,1.0,15/63,13.39%,CNOT6;CNOT6L;PLK2;AURKA;CDKN1B;CRADD;CDK2;SOX4;BTG2;CNOT1;SFN;CNOT2;MUC1;CNOT7;CDC25C
prerank,mitotic cytokinesis (GO:0000281),-0.3032242964517547,-0.9696902779202181,0.47530864197530864,0.8645796326649458,1.0,21/47,27.27%,SON;ROCK2;SNX18;ANK3;CIT;ARL3;JTB;RTKN;KLHDC8B;CNTROB;STAMBP;RAB35;NUSAP1;EFHC1;CKAP2;CUL7;RHOC;SNX33;CENPA;CEP55;SPAST
prerank,stem cell development (GO:0048864),0.4475493184012702,0.9692172110338918,0.5160202360876898,0.8132794017601659,1.0,7/16,25.56%,CDH2;CYP26C1;KBTBD8;PDCD6;PEF1;TCOF1;NOLC1
prerank,anion transmembrane transport (GO:0098656),0.35102176771311344,0.9689979138690648,0.5073825503355704,0.8132032295104122,1.0,6/67,3.02%,LRRC8C;SLC6A5;SLC39A8;LRRC8B;SLC38A5;SLC3A2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4166208260769467,-0.9685632751158154,0.5168539325842697,0.8665110349557167,1.0,2/13,8.79%,GLI3;RUNX1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2765288927866426,-0.9682794421491149,0.5063291139240507,0.8660907105356476,1.0,24/69,20.16%,PRKN;BCL2;SLC30A10;NRBP2;PPARGC1A;NDNF;NTRK2;NGF;SIX1;SNX6;CPEB4;RETREG1;APOE;TGFB3;NFATC4;PRKCI;NONO;MT3;MDK;CLCF1;PPT1;TYRO3;NTF3;CRLF1
prerank,iron-sulfur cluster assembly (GO:0016226),0.41164137703181103,0.9682234590514128,0.5270049099836334,0.8142797189191279,1.0,11/24,24.30%,ABCB7;GLRX3;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3489708357385187,0.9682199295502396,0.5064377682403434,0.8137724970452775,1.0,15/62,14.81%,STAT3;H3-3A;TGFB1;PUM1;IPO8;NUP214;PUM2;NUP98;ZFP36;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,negative regulation of transmembrane transport (GO:0034763),0.47041863748723517,0.9680134440043753,0.49183303085299457,0.813697498551908,1.0,3/10,8.63%,CTTNBP2NL;INPP5K;AKT2
prerank,brain development (GO:0007420),0.3208204721266575,0.9679454228305329,0.5307881773399015,0.8133267882045921,1.0,18/136,11.63%,SHANK3;PBX1;ADGRL2;SHROOM4;DDIT4;SHROOM2;ADGRG1;AMIGO2;CDH2;CX3CR1;RAPGEF2;DNAJC30;SYNJ1;NFIB;SCYL2;CXCR4;UBE3A;GRIN1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.37594488362171896,-0.9678050519597758,0.4976303317535545,0.8661316004430578,1.0,1/19,0.34%,IGF1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4212580764681514,0.9673484590698007,0.5082781456953642,0.8141316524841139,1.0,3/22,4.39%,B2M;SOX9;DLL1
prerank,response to estradiol (GO:0032355),0.38508151165284077,0.9673142574757888,0.49050632911392406,0.8136840977566283,1.0,5/31,9.90%,ESR1;SOCS2;STAT3;TGFB1;NRIP1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.38298085819131733,-0.96717704122812,0.5141509433962265,0.8666110110859567,1.0,4/18,5.63%,IL34;PTN;DAAM2;NF1
prerank,negative regulation of cellular senescence (GO:2000773),0.46063384226206766,0.9670257382070176,0.5215889464594128,0.8137814040243031,1.0,5/13,18.00%,CDK6;MAP3K3;AKT3;YBX1;RBL1
prerank,neuromuscular process (GO:0050905),0.4430097617403608,0.9669902460781136,0.5155172413793103,0.8133480217116453,1.0,2/16,5.89%,GCH1;MYCBP2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3404528933800403,0.9667659176024437,0.5272988505747126,0.813275584341925,1.0,26/73,23.34%,ZFP57;EPC1;H3-3A;MTF2;TASOR;TAF1B;POLR1A;PPM1D;SMARCA5;MYBBP1A;AEBP2;MYO1C;PPHLN1;POLR1G;KAT2B;POLR1B;JARID2;PHF19;TAF1A;DEK;POLR2L;HDAC6;ERCC6;PHF1;PHF2;BMI1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.34165909668189365,-0.9662668419808325,0.4958904109589041,0.8678085945873468,1.0,10/25,27.31%,PFKP;ENO2;HK2;TPI1;ENO3;PFKM;ALDOA;PKM;ENO1;ALDOC
prerank,regulation of protein kinase B signaling (GO:0051896),0.30180697714721183,0.9658271156505295,0.5304449648711944,0.8147521529006564,1.0,27/193,8.63%,TEK;ENG;ESR1;INSR;KITLG;PDGFB;HIP1;MFHAS1;RASD2;PTPRJ;FYN;FGF23;F7;CX3CR1;RET;TCF7L2;INPP5K;RAC1;TRIB3;LCK;TGFB1;PIK3CG;PTK2;TGFA;GAB1;PPP2R5B;AKT2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.34149363727992266,-0.965281405787084,0.5133689839572193,0.8691874705859237,1.0,12/30,22.50%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,heterochromatin assembly (GO:0031507),0.4178615985620592,0.9650092737411377,0.5137931034482759,0.8160104856254569,1.0,4/20,8.56%,SMCHD1;H3-3A;ZNFX1;EZH1
prerank,extracellular matrix assembly (GO:0085029),-0.3625704413217225,-0.9647321530349169,0.5012531328320802,0.8694314339202683,1.0,6/23,7.87%,TNXB;GPM6B;FBLN5;NTN4;NTNG1;EFEMP2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.45671678227255047,0.9643117027693714,0.5230496453900709,0.8169795894138694,1.0,5/13,13.14%,TNRC6C;BTG2;CNOT1;ZFP36;CNOT7
prerank,protein catabolic process (GO:0030163),0.35302866112104647,0.9640268932459582,0.5355029585798816,0.8170844429823703,1.0,17/59,16.65%,STT3B;DAB2IP;CEACAM1;UBE2G1;CTRL;TRIM24;PSMA8;RAB12;SIAH1;RIPK1;CLN6;OGA;DDI1;SOCS6;RNF5;DDI2;CHEK2
prerank,positive regulation of behavior (GO:0048520),0.4909989861274192,0.9639881885933406,0.5295169946332737,0.8166426176577528,1.0,1/10,1.15%,MEF2C
prerank,cilium organization (GO:0044782),0.3039901739325582,0.9638450074733204,0.5310033821871477,0.8164231619308592,1.0,28/209,12.97%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;SSX2IP;DISC1;CEP41;PCNT;BBIP1;EHD2;DYNLL1;PKD2;EXOC5;TEKT5;EXOC4;OCRL;CEP83;ARL13B;EHD3;RTTN;ACTR2;RILP;WDR11;EXOC8
prerank,transcription by RNA polymerase I (GO:0006360),0.37798705040684993,0.9637615549151773,0.49544072948328266,0.8160768393212681,1.0,12/34,22.00%,CAVIN1;TAF1B;POLR1A;RRN3;POLR1G;POLR1B;GTF2H4;TAF1A;GTF2H1;POLR2L;CCNH;TCOF1
prerank,ion homeostasis (GO:0050801),-0.32825950724342084,-0.9636527964030337,0.5157593123209169,0.8712017198454268,1.0,8/30,10.51%,SLC4A10;FHL1;WNK4;WNK1;UNC80;SLC4A3;AP3D1;SLC4A2
prerank,negative regulation of type I interferon production (GO:0032480),0.3751319677934677,0.9636466066241306,0.5099540581929556,0.815801471460412,1.0,9/40,14.76%,RNF125;NLRC5;UBA7;TRIM25;RELB;IFIH1;ILRUN;YY1;GPATCH3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.43998972219808735,0.9634135342787105,0.5412371134020618,0.8157624682740513,1.0,4/17,6.61%,PARD3;DDIT4;SMAD7;INPP5K
prerank,presynaptic endocytosis (GO:0140238),-0.3575979558186427,-0.9630655531785178,0.5,0.8715932446642403,1.0,8/24,14.84%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4147634979038669,-0.9630359037816839,0.5153508771929824,0.8705009369398915,1.0,7/12,23.90%,ANO1;STX4;GPLD1;CFTR;PLA2G6;ADCY8;BAIAP3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4909183477042528,0.9627379391584981,0.5289719626168224,0.816651705033817,1.0,2/10,6.60%,LYN;CD40
prerank,cell projection organization (GO:0030030),0.39717407565288804,0.9626269869597968,0.5078125,0.8163718475952886,1.0,7/30,13.00%,PARVB;RHOJ;NCKAP1;RAC1;P2RY12;CYFIP1;CSPG5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.41096334242365823,0.9617212396970096,0.5091514143094842,0.8177340392827624,1.0,4/23,12.09%,SLC12A7;CLCN3;SLC12A9;SLC9A7
prerank,negative regulation of axonogenesis (GO:0050771),-0.33579757091134826,-0.9616496505547383,0.4896907216494845,0.8730528721501553,1.0,12/27,22.86%,PTPRS;MAP2;DCC;CDKL3;RTN4;SEMA3G;ULK2;MT3;PTEN;THY1;GDI1;RNF6
prerank,tryptophan catabolic process (GO:0006569),-0.4234708434709261,-0.9615591730828469,0.5173160173160173,0.8721324452192253,1.0,9/11,51.94%,KYAT1;HAAO;KYNU;AADAT;AFMID;TDO2;KMO;IDO1;ACMSD
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4406018529054917,0.9613871119624111,0.5180265654648957,0.8179512241893436,1.0,4/14,20.56%,CSF1;IL23A;TRAF6;CCR1
prerank,negative regulation of macrophage activation (GO:0043031),-0.3857986180980131,-0.9612834028088951,0.5035799522673031,0.8716853707125506,1.0,4/16,6.74%,IL31RA;LRFN5;LDLR;SYT11
prerank,mesenchymal cell development (GO:0014031),0.4329273557021515,0.9608099449391035,0.5207296849087893,0.818658566730966,1.0,3/18,6.57%,NOTCH1;CDH2;CYP26C1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4451173639690669,0.9607605357280352,0.5224137931034483,0.8182536335387458,1.0,4/15,4.00%,PRKD1;PRKD2;NOTCH1;TMSB4X
prerank,regulation of mitochondrion organization (GO:0010821),-0.2998909696998654,-0.9605314903426266,0.5171339563862928,0.872409732590031,1.0,6/47,8.43%,PID1;PRKN;PPARGC1A;SREBF1;LRRK2;SQSTM1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4605936189800408,0.9602533324667717,0.514018691588785,0.8187930951347134,1.0,1/12,1.29%,LMO2
prerank,response to thyroid hormone (GO:0097066),0.4508349721038196,0.9600511089749055,0.5145985401459854,0.8186935356665429,1.0,1/13,1.29%,LMO2
prerank,regulation of autophagosome maturation (GO:1901096),-0.406401722057371,-0.9599881685026392,0.5191011235955056,0.8726939105655105,1.0,6/13,25.44%,TMEM39A;RUBCN;SMCR8;ADRB2;CLN3;PHF23
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.42745463539635564,0.9598789747931765,0.5329861111111112,0.8185458423219748,1.0,7/20,19.92%,ACSL4;FASN;FAR2;SLC25A1;DGAT1;CBR4;PPT2
prerank,protein polyubiquitination (GO:0000209),0.2933808357700961,0.9594490893481314,0.5656565656565656,0.8189427228389401,1.0,89/297,24.92%,RNF125;KLHL3;SMURF1;RNF144B;NEDD4L;TRIM14;FBXW7;ZNRF1;TRAF1;DTX3L;TRIM68;PELI1;FBXL4;RNF144A;UBE3B;SASH1;UBE2G1;PSMA2;RNF167;FBXL7;NEDD4;UBE2H;ANAPC7;RNF146;FBXW2;RNF4;ANAPC1;PSMA8;SIAH1;UBE2D3;PSMA6;RC3H1;FBXO30;CDC26;UBE3A;CUL1;CBFB;HECTD1;MYLIP;FBXL3;UBE2K;TRAF6;TOPORS;PSME1;ARIH2;RNF5;DCAF15;TPP2;UBE3D;AREL1;BIRC2;NHLRC1;CTNNB1;CUL3;HERC6;CDC34;PSMA4;FBXW10;UBE2Q1;PSMF1;PELI2;TRIM62;FBXO17;PSMB7;TRIM71;PSMB1;UBE2L3;HACE1;ARIH1;THOP1;PSMD2;UBE2V2;KLHL42;LNPEP;PSMA5;PSMC3;FBXO7;FBXO11;TRAF2;UBE2J2;UBE2D1;RFFL;TNKS;UBE2R2;PSMD3;LONRF1;UBE2E1;FZR1;PSMA3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4228072324978924,0.9590815145185417,0.5285234899328859,0.8192169591715748,1.0,8/20,21.33%,DROSHA;DICER1;PUM1;PUM2;HENMT1;TRIM71;MRPL44;PRKRA
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4163799888306837,0.9588865296435689,0.5155993431855501,0.8191114451065841,1.0,4/22,5.28%,GATA2;SLC16A2;TOX;DLL4
prerank,acute inflammatory response (GO:0002526),0.4159246987697457,0.9588390652252272,0.4991568296795953,0.8186869016558359,1.0,7/23,17.97%,IL6R;SIGIRR;CTNNBIP1;ANO6;ITIH4;IL22;PLSCR1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.41245295830539896,0.9587582899880739,0.5357737104825291,0.8183452660466415,1.0,4/21,8.74%,TGM2;RAP1GDS1;MICU2;MCUB
prerank,negative regulation of hemostasis (GO:1900047),-0.4307873853760191,-0.9587028205513153,0.5393518518518519,0.8748184791184702,1.0,5/12,10.33%,VTN;TFPI;SERPINE2;APOE;SERPINE1
prerank,zinc ion homeostasis (GO:0055069),-0.3337465340173411,-0.958639233504958,0.5196629213483146,0.8738283572776779,1.0,5/28,8.73%,PRKN;SLC30A10;SLC39A14;SLC39A13;SLC39A10
prerank,regulation of cellular catabolic process (GO:0031329),0.3483655979387791,0.9579540908521468,0.5322128851540616,0.8194997379956783,1.0,11/62,11.84%,ACER2;DAPK1;BOK;DRAM2;TRIB3;RPTOR;FBXL2;DEPP1;SCARB2;ABL2;ABCD1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.44145144835300454,0.9576644453260998,0.5244122965641953,0.8195845273745219,1.0,4/15,5.08%,KDR;VEGFC;F7;VEGFD
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3708063275889417,0.957519439947841,0.5383458646616541,0.8193797889049653,1.0,10/41,11.63%,HTR2A;PLCG2;ATP2B4;TRPV6;LCK;ITPR3;TRPV4;PKD2;ERO1A;GRIN1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.33345126961752497,-0.9574745573505237,0.525065963060686,0.8745280710511198,1.0,13/29,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.33345126961752497,-0.9574745573505237,0.525065963060686,0.8745280710511198,1.0,13/29,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,integrin-mediated signaling pathway (GO:0007229),0.3414040544859671,0.9571670828465457,0.5246132208157525,0.8196262594657879,1.0,13/73,7.99%,PRKD1;SEMA7A;NEDD9;DOCK1;MYH9;ADAM10;PTK2B;DST;LAMA3;CEACAM1;ADAM15;PTK2;ITGA5
prerank,regulation of transport (GO:0051049),0.3767581733933003,0.9564121691047471,0.5139751552795031,0.8207054432634229,1.0,3/36,2.16%,EPB41;ICA1;RAB11A
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.38669996034561854,-0.9560861854707847,0.5226244343891403,0.87700961184628,1.0,3/16,8.47%,AUTS2;BCOR;CTR9
prerank,mesenchyme development (GO:0060485),-0.39830518976603757,-0.9559494053955887,0.547945205479452,0.8762374222257641,1.0,4/15,2.95%,FGFR2;BMP7;TGFBR1;BMP4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3843361591113243,0.9559432803369715,0.5104333868378812,0.8211575922950376,1.0,8/29,22.19%,RAD21L1;TRIP13;MEIOB;TERB1;TERB2;RAD21;PRDM9;SIRT7
prerank,negative regulation of autophagy (GO:0010507),-0.2988643366532543,-0.9559384275670538,0.5407166123778502,0.8751143834393111,1.0,15/54,16.21%,LEPR;SNRNP70;BCL2;NUPR1;NRBP2;SIRT2;KLHL22;LRRK2;DAPL1;EIF4G3;PTPN22;RUBCN;SMCR8;SNCA;MT3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30966172707348555,0.9553220238759705,0.5582232893157263,0.821944464311203,1.0,26/161,10.43%,CAV1;DAB2IP;SOX13;MLLT3;FZD6;FZD4;TLE4;SOX17;WWTR1;STK3;NKD2;ZNRF3;SOX9;STK4;GREM1;TCF7L2;WNT5A;JADE1;TMEM88;SOST;PSMA2;PSMA8;MAD2L2;SFRP2;SCYL2;PSMA6
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.37348035371910215,-0.9550603019921824,0.5300925925925926,0.8761159691684662,1.0,4/18,4.03%,DCN;PRKN;SPIRE1;MCU
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.40719855555811124,0.9550425582861805,0.5237315875613748,0.8220359391522991,1.0,6/21,9.65%,NCK1;TMBIM6;XBP1;BOK;BCL2L11;BCL2L1
prerank,translational elongation (GO:0006414),0.32194730571877933,0.9544756076902731,0.5258511979823455,0.8226862891223923,1.0,42/101,26.45%,MRPS18A;MRPL13;MRPS12;EEF2K;MRPL35;RACK1;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;EEFSEC;EEF2;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;EEF1G;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,protein K48-linked deubiquitination (GO:0071108),0.40966328393482876,0.954193210751638,0.5194805194805194,0.822741823517805,1.0,7/23,19.17%,MINDY1;MINDY2;ATXN3;OTUD4;YOD1;USP8;USP25
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.39059880668820124,-0.9537747766981345,0.5102974828375286,0.8783413999202782,1.0,4/15,5.77%,FGFR2;PDGFRA;TGFBR1;SIX1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.35753771740596846,0.9535107355645323,0.5198237885462555,0.823671055220907,1.0,10/47,12.94%,RAB27A;PDGFB;PLCG2;CBR1;TGFB1;GRIN1;RIPK1;XDH;GSTP1;TGFBR2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3857231113548177,0.9534713535878101,0.5371517027863777,0.8232457995045955,1.0,8/32,15.83%,ADIPOR2;SORBS1;CEACAM1;CREB1;EIF6;ADIPOR1;ASAH1;STAR
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3329501477065274,0.9530744240053706,0.5234806629834254,0.823569551441646,1.0,18/80,14.30%,FNBP1L;OCLN;EPS8;WASF2;NCKAP1;CCDC88A;RAC1;CDC42EP3;AGRN;TWF2;FSCN1;P2RY12;CYFIP1;ACTR2;FMR1;NDEL1;ACTR3;APC
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.33020240032813475,0.9530359306229973,0.5404663923182441,0.8231553389223761,1.0,20/90,14.30%,EPAS1;ADIPOR2;CAV1;KDM3A;ADRB1;LCN2;GATM;ESRRG;PDGFC;CXCR4;PRKAB1;IL4R;UCP2;PEMT;SIRT6;ADIPOR1;HADH;OMA1;IGF1R;APC
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4107587788928744,-0.9529043075524332,0.5379609544468547,0.8794302597211876,1.0,5/13,14.48%,ACSL1;C2CD5;CLIP3;AZIN1;SLC26A6
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4227165427025765,-0.9524108652041088,0.5412262156448203,0.8796047714334329,1.0,5/11,17.97%,EGLN3;P4HB;P4HA1;P4HTM;P4HA2
prerank,response to reactive oxygen species (GO:0000302),0.34916085819761206,0.9523382127136563,0.5386861313868613,0.824123794451554,1.0,14/54,13.80%,HIF1A;FYN;STK24;PXN;CAT;PTPRK;MAPK8;STK26;PKD2;PJVK;COA8;GLRX2;GSTP1;SOD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.427589766125934,-0.9521829282750313,0.5085836909871244,0.8779632877156354,1.0,6/10,23.37%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.427589766125934,-0.9521829282750313,0.5085836909871244,0.8779632877156354,1.0,6/10,23.37%,PRKCD;SMPD3;NSMAF;PLA2G6;SMPD2;SPHK2
prerank,autophagosome assembly (GO:0000045),0.3520510623971003,0.9518278864919867,0.5302593659942363,0.8246832505194163,1.0,17/52,24.23%,SMURF1;ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4261572426835729,0.9511210776994713,0.5202108963093146,0.8256299983970823,1.0,3/18,13.39%,RAB11A;BRD4;CDC25C
prerank,anterograde trans-synaptic signaling (GO:0098916),0.29688663518852354,0.9510795242895818,0.5878995433789954,0.8252096710837288,1.0,18/224,6.79%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,peptide hormone secretion (GO:0030072),0.40373019623716044,0.9510206841227207,0.5453074433656958,0.824837406255635,1.0,3/26,8.26%,EDN1;SNX19;NEUROD1
prerank,negative regulation of catalytic activity (GO:0043086),0.3943134902879125,0.9506674499833793,0.5393442622950819,0.8250689543427613,1.0,3/24,7.32%,NOTCH1;PPP1R12A;NOSIP
prerank,nuclear body organization (GO:0030575),-0.40703113310809225,-0.9506224884528669,0.5412262156448203,0.8808545299009132,1.0,8/12,31.23%,AFF2;SRPK2;HIPK2;USP50;HABP4;USPL1;ETS1;ZPR1
prerank,female gamete generation (GO:0007292),0.39387190898704566,0.9505190070688,0.5170731707317073,0.8248845699210574,1.0,4/29,8.15%,NANOS3;NANOS2;TRIP13;MARF1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3814973125559984,-0.9505049438535094,0.5282555282555282,0.8800189093884976,1.0,8/14,18.26%,ADGRV1;DGKD;ULK4;VEGFA;ADRA1A;GPD1L;WNT11;MYADM
prerank,regulation of protein modification process (GO:0031399),0.3594172024290241,0.9501061030774443,0.5242290748898678,0.82523086408468,1.0,12/50,14.68%,PPP1R16B;LYN;FNIP2;CCDC88A;PTK2;PARG;CORO1C;NOP53;PHIP;WARS1;CDH5;KAT2B
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3398240593648287,-0.9499255328292879,0.5378590078328982,0.8803629410877335,1.0,5/26,11.28%,IGF1;FHL2;AKAP6;EFHB;SLC9A1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.41850453035765545,0.9497214486814265,0.5137457044673539,0.8255539928389138,1.0,4/20,6.76%,FBXW7;SIK1;CEACAM1;TRIB3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.41206460873318507,0.9494296547407044,0.5255972696245734,0.8256838926785868,1.0,1/21,0.86%,CAV1
prerank,negative regulation of cell cycle (GO:0045786),0.3369155280335054,0.9494023566277163,0.5603799185888738,0.8252341997100603,1.0,18/73,14.95%,PPP1R13B;CDK6;HHEX;BTG3;PTPRK;CDKN1B;TGFB1;BRINP2;RNF167;BTG2;ANGEL2;TFAP4;BTG1;RB1;RHOB;INCA1;APC;GMNC
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.35720877408520113,-0.9489970356142164,0.5406824146981627,0.8815974868923588,1.0,7/22,23.33%,NFATC2;BCL6;RUNX1;DUSP10;MDK;LAG3;FANCA
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.28837708425559383,-0.9489388694974644,0.5585284280936454,0.8806061492877394,1.0,13/63,12.39%,TIMP3;LEPR;BCL2;TIMP2;NUPR1;SIRT2;KLHL22;DAPL1;EIF4G3;PTPN22;CST3;RGP1;RUBCN
prerank,regulation of actin nucleation (GO:0051125),-0.4129218123968355,-0.9489103320502453,0.5337837837837838,0.8795479007066157,1.0,4/12,24.31%,GSN;ARFIP2;ARPIN;CORO1B
prerank,regulation of macroautophagy (GO:0016241),0.320852290918371,0.9488779423323791,0.5541237113402062,0.8258323255501162,1.0,16/105,10.77%,KDR;ERN1;LZTS1;QSOX1;MAPK8;ULK1;SH3GLB1;ATP6V0A1;NEDD4;RPTOR;ATG101;ATP6V1G2;IKBKG;EXOC4;PRKAB1;BNIP3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33255665954301006,0.9486952376413206,0.5350140056022409,0.8256902762115822,1.0,7/75,4.52%,RGS3;EDN1;NMT2;GIT2;CNGB1;PLCB1;PPP1R9B
prerank,placenta development (GO:0001890),0.46258142681739167,0.9485925491472421,0.531951640759931,0.8253949053022248,1.0,5/12,15.97%,PTK2;CITED1;ANG;PLAC1;E2F7
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3149086479317872,0.9479715164685071,0.5340050377833753,0.8261750056614446,1.0,14/107,7.10%,MCTP1;APP;MEF2C;DGKZ;BCR;BTBD9;CDH2;SYN3;CX3CR1;KCNMB4;CACNA1A;OPHN1;SNCAIP;CLSTN1
prerank,positive regulation of wound healing (GO:0090303),-0.32087254131068843,-0.9475773527839848,0.5449275362318841,0.8818830584118794,1.0,9/36,11.47%,PLPP3;VTN;THBS1;FOXC2;SMOC2;ANXA1;ADRA2A;SERPINE1;CLDN1
prerank,histone H3-K36 demethylation (GO:0070544),-0.4384544021280358,-0.947195799106778,0.5180180180180181,0.881690378661182,1.0,3/10,12.49%,KDM7A;KDM2A;KDM8
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4416944618043086,0.9471590034862004,0.5227272727272727,0.8273610276566542,1.0,6/13,23.45%,DPAGT1;ALG6;ALG8;MPDU1;ALG12;ALG14
prerank,protein modification by small protein conjugation (GO:0032446),0.28547339689190104,0.9471510020458404,0.6080347448425625,0.8268712337981994,1.0,78/361,18.82%,EPAS1;DCUN1D3;KLHL3;SMURF1;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;MYCBP2;RNF144A;CBLL1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;STX1A;FBXL7;NEDD4;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;FBXL2;RAD18;UBE2D3;SUMO2;CBL;NUP214;CUL1;NUP98;SAE1;MYLIP;RACK1;RNF25;ASB11;ANAPC16;NUP133;IFIH1;NUP205;PEX14;FBXL3;KLHL8;UBE2K;NUP54;TOPORS;ELOC;NUP43;NUP153;MSL2;ARIH2;DCAF15;OTULIN;AREL1;CRBN;CDC73;NEDD8;UBE2I;CUL3;CDC34;KLHL18;USP7;RNF40;ABCB11;ATG7;CUL2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.28942814714119114,0.9468160450834314,0.6093073593073594,0.827037806354587,1.0,50/348,10.84%,LEF1;NOS3;RAB27A;APP;MEF2C;CLDN5;OCLN;INSR;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;SELE;CD34;PLCG2;FGF23;SOX9;KLF2;DTX3L;GREM1;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;ATF7IP;IL36G;KRAS;TASOR;ARRB1;TGFB1;NOS1AP;CITED1;PSEN1;RPL23;PTPN1;CSF1;MAPK11;INPP5F;SCYL2;PRKAB1;GAS6;PPHLN1
prerank,epidermis development (GO:0008544),-0.2946075204078688,-0.9461640888246432,0.546583850931677,0.8832718556126261,1.0,11/56,14.15%,FGFR2;SVEP1;CCN2;ATP2A2;CRABP2;GLI1;FLOT2;SCEL;FGF7;EDA2R;LAMC2
prerank,nuclear membrane organization (GO:0071763),-0.36150793347608523,-0.9460027479816879,0.5203836930455635,0.882535458116778,1.0,12/19,30.58%,AKAP8L;GPER1;UBXN2B;VPS4A;TMEM43;TARDBP;TOR1B;TOR1A;SPAST;TOR1AIP1;DCTN1;CHMP2A
prerank,regulation of hippo signaling (GO:0035330),0.43697508900731785,0.9458814777188952,0.5423728813559322,0.8284554990127089,1.0,5/17,9.51%,MARK3;VGLL4;NF2;WWC2;MAP2K3
prerank,positive regulation of phospholipase activity (GO:0010518),0.4081683385555582,0.9448260098280717,0.552,0.8301669937185862,1.0,3/22,1.87%,FLT1;ESR1;PLCG1
prerank,protein ubiquitination (GO:0016567),0.2805768613777332,0.9447035749901301,0.6268343815513627,0.8299223834167647,1.0,147/471,24.92%,EPAS1;RNF125;KLHL3;SMURF1;RNF144B;RNF141;NEDD4L;KLHL2;TRIM14;FBXW7;HIF1A;KLHL7;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;FBXL4;MYCBP2;RNF144A;UBE3B;CBLL1;SASH1;ARRB1;RNF7;TRIM47;UBE2G1;ARRDC1;PSMA2;RNF167;FBXL7;NEDD4;TRIM25;RNF139;KLHL24;UBR1;TRIM24;UBE2H;ANAPC7;RNF146;FBXL2;FBXW2;RNF4;PSMA8;RAD18;SIAH1;UBE2D3;PSMA6;RC3H1;CBL;FBXO30;UBE3A;CUL1;CBFB;RNF112;MYLIP;RACK1;RNF25;ASB11;ANAPC16;ASB4;PEX14;FBXL3;KLHL8;UBE2K;TRAF6;TOPORS;PSME1;ELOC;MSL2;ARIH2;DCAF15;OTULIN;TPP2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;CDC73;NEDD8;CUL3;HERC6;CDC34;PSMA4;KLHL18;FBXW10;USP7;RNF40;UBE2Q1;PSMF1;ABCB11;CUL2;KBTBD8;PELI2;OBI1;TRIM62;BCL10;FBXO17;PHC1;PSMB7;TRAF7;TRIM71;PSMB1;UBE2L3;HACE1;PLK1;ARIH1;THOP1;PSMD2;UBE2V2;VPS18;FBXO25;RNF111;RTF1;KLHL42;RNF103;LNPEP;PSMA5;PSMC3;FBXO7;UCHL3;FBXO11;TRAF2;PCNP;UBE2J2;CUL4B;DET1;UBE2D1;PEX10;TNKS;RNF11;MKRN2;UBE2R2;PSMD3;TSPAN17;SDE2;LONRF1;UBE2E1;TRIM33;VHL;PSMA3
prerank,response to steroid hormone (GO:0048545),0.38124805254886956,0.9442277035509797,0.5388198757763976,0.830410216277964,1.0,8/31,11.54%,CAV1;NR3C1;ABHD2;ATP1A3;ATP1A1;TGFB1;CATSPERD;UBE3A
prerank,positive regulation of cellular metabolic process (GO:0031325),0.32377724556275816,0.9441371645535658,0.5676392572944297,0.8300723621419646,1.0,22/98,13.55%,PPARD;INSR;PDGFB;FASN;ACACB;NFKBIA;SELE;GREM1;IFNAR1;ARRB1;CBR1;TGFB1;AGPAT1;CSF1;INPP5F;SCYL2;TBC1D5;PICK1;RIPK1;XDH;TGFBR2;FMR1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4515676118266565,0.9434071021667657,0.5311355311355311,0.830544916837235,1.0,4/11,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4515676118266565,0.9434071021667657,0.5311355311355311,0.830544916837235,1.0,4/11,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,regulation of cellular component movement (GO:0051270),0.358882917582879,0.9432499341780783,0.53,0.8303464697284088,1.0,10/49,5.89%,CDK6;LYN;PRAG1;ACTN4;ZSWIM6;PKN2;ACTN1;PKN1;RPS19;MYCBP2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4087635440010344,-0.9432379230014365,0.5491990846681922,0.8885146212664363,1.0,4/13,17.11%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,positive regulation of receptor internalization (GO:0002092),-0.35397508421858503,-0.9429385751319111,0.5182291666666666,0.888132117328508,1.0,7/22,10.00%,MAGI2;ANGPT1;SFRP4;ATAD1;AHI1;VEGFA;CD63
prerank,positive regulation of neuron death (GO:1901216),-0.30043999061256627,-0.9421533898452491,0.5541795665634675,0.8890144908803688,1.0,9/46,14.84%,EPHA7;NUPR1;MAP3K5;EFNB2;NF1;SRPK2;TGFB2;C1QA;SNCA
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4272333132925696,0.9421180102692693,0.5367132867132867,0.8322287660130112,1.0,4/18,15.41%,EDN1;ABL2;PDP1;RFK
prerank,negative regulation of gluconeogenesis (GO:0045721),0.45193091509509487,0.9420430187884474,0.518918918918919,0.8318683583286293,1.0,1/11,3.05%,SIK1
prerank,transport along microtubule (GO:0010970),-0.39448254791759996,-0.9419945321754052,0.5547945205479452,0.8882826661783433,1.0,6/13,11.02%,ARHGAP21;APBA1;CLIP3;COPG1;DYNC1I1;SPG11
prerank,xenobiotic transport (GO:0042908),0.4263723499960503,0.9419926037285987,0.5367521367521367,0.8314653930807115,1.0,3/17,8.48%,ABCG2;ABCA3;SLC15A2
prerank,cholesterol biosynthetic process (GO:0006695),-0.33237423575220265,-0.9415694882292833,0.5390835579514824,0.8882336808504617,1.0,12/31,22.50%,INSIG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,cell-matrix adhesion (GO:0007160),0.31975805057055345,0.9414728077171284,0.5577689243027888,0.8320358507176163,1.0,15/95,7.33%,THSD1;VCAM1;PEAK1;BCR;TAOK2;PPFIA2;CD34;SORBS1;ACTN1;PTPRK;BCAM;ADAM15;RAC1;VWA2;ITGA3
prerank,mRNA modification (GO:0016556),0.4134994377220209,0.941258768784631,0.5393634840871022,0.8319806756474597,1.0,12/22,27.21%,CBLL1;WTAP;VIRMA;TRMT6;METTL14;TRUB1;RPUSD2;PUS7;TRMT10C;TRMT61B;METTL16;NSUN2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4074326976769778,0.9410366190616524,0.5181347150259067,0.8319351762874058,1.0,3/22,2.77%,IL6ST;EDN1;NOTCH1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.30142430421947164,-0.9408883140188404,0.5615615615615616,0.8889021170589555,1.0,10/44,15.19%,CYP7B1;CYP27A1;INSIG2;PER2;PRKAG2;OSBPL3;OSBPL6;INSIG1;SCP2;ALOX12
prerank,embryonic axis specification (GO:0000578),-0.37409871479914103,-0.9408393453955226,0.5302325581395348,0.887899227288788,1.0,8/15,28.82%,COBL;SMAD6;CXXC4;TBX3;PTCH1;FZD5;STIL;RIPPLY2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.37496765025273354,0.9408060307270373,0.5344827586206896,0.8318974144425703,1.0,9/33,18.00%,DCUN1D3;CDK6;JADE1;PKD2;RB1;APC;E2F7;CDC73;RBL1
prerank,response to histamine (GO:0034776),-0.4395125216187886,-0.9406870125601445,0.5501066098081023,0.887172558916354,1.0,3/10,12.88%,GABRG2;GABRB1;GABRB3
prerank,protein polyglutamylation (GO:0018095),0.4512100851836685,0.940530583717144,0.5208711433756806,0.8319351941891883,1.0,5/11,20.81%,CEP41;TTLL7;TTLL5;TPGS1;TTLL9
prerank,lytic vacuole organization (GO:0080171),-0.31442418894372837,-0.9401080926939983,0.561046511627907,0.8875120466934155,1.0,13/32,25.88%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;MTOR
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4710210519498522,0.9391558910868193,0.5343228200371057,0.8342971676972801,1.0,4/10,22.00%,ATRX;JARID2;KDM1A;RIF1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2809182854350885,-0.9389118227815557,0.5559701492537313,0.8893901563416841,1.0,20/66,17.65%,EGFR;APPL2;FHL1;PKD1;DACT1;DLG1;KANK2;ANXA1;CCND2;ADAMTS1;UBE2E2;TFDP1;RGCC;PLK5;CDKN1A;RBL2;E2F1;HYAL1;FGF10;CDK2AP2
prerank,regulation of cellular pH (GO:0030641),-0.3280840565488347,-0.9389114766065949,0.587431693989071,0.8882612096599042,1.0,9/29,19.96%,SLC4A10;SLC9A9;SLC4A3;SLC4A2;SLC9A1;LACC1;SLC26A6;SLC4A8;SLC9A8
prerank,connective tissue development (GO:0061448),0.3689065674674946,0.9382253533609974,0.548489666136725,0.8356632412442113,1.0,6/35,6.00%,SPTLC2;ZBTB16;LRP5;SOX9;XBP1;SNORC
prerank,mitochondrion organization (GO:0007005),0.30129775223137606,0.9373474737582399,0.5890083632019116,0.8369989195825928,1.0,24/165,13.96%,DNM3;NOS3;IMMP2L;ALAS1;BIK;VPS13D;MTM1;CAV2;CYCS;SIRT5;RAB38;BCL2L1;HIGD2A;BNIP3;GABPB1;AKT3;TFB2M;PITRM1;LONP1;BID;OMA1;RAB5IF;MEF2A;HIGD1A
prerank,neurotrophin signaling pathway (GO:0038179),-0.35484138311455804,-0.9369792636689254,0.5516372795969773,0.8920798983869106,1.0,4/21,6.71%,MAGI2;NTRK2;NGF;KIDINS220
prerank,response to organophosphorus (GO:0046683),-0.3641000489996522,-0.936737559911669,0.5491606714628298,0.8915645485727047,1.0,3/16,5.70%,P2RX4;ABCC9;TRPC3
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.40315970907192306,-0.9365043195617813,0.518348623853211,0.8910090752895337,1.0,3/13,5.19%,IGF1;IRS1;IGF2
prerank,retinoic acid metabolic process (GO:0042573),-0.3987828935010351,-0.9363952902985578,0.5944700460829493,0.8901584800836128,1.0,2/14,3.70%,ALDH1A2;CYP26B1
prerank,regulation of complement activation (GO:0030449),0.3621896478325817,0.9363672399381153,0.5597579425113465,0.8385065810460965,1.0,4/40,7.48%,CFH;PROS1;CFB;CR1L
prerank,positive regulation of protein deacetylation (GO:0090312),0.4326427508384417,0.9360217881344761,0.5584192439862543,0.8387322380678066,1.0,6/14,22.93%,DYRK1A;CTBP1;APLNR;FNTA;SAP30BP;NIPBL
prerank,regulation of establishment of cell polarity (GO:2000114),-0.37518677987360755,-0.9359419513637721,0.5339805825242718,0.8901950452305377,1.0,4/16,8.33%,GSN;ROCK2;SHTN1;RIPOR2
prerank,programmed necrotic cell death (GO:0097300),0.41275297922515264,0.9354303158359596,0.5473684210526316,0.8394325373677287,1.0,5/18,17.87%,PGAM5;MLKL;RIPK1;TRPM7;IPMK
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.35094450102218083,-0.935410103685087,0.531322505800464,0.8904413145686394,1.0,1/20,0.34%,IGF1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40581025586595754,0.9353924271538028,0.552013422818792,0.839012631391624,1.0,4/23,7.13%,CBFA2T3;SIK1;FBP1;TIGAR
prerank,positive regulation of phosphatase activity (GO:0010922),-0.35546841094231063,-0.9353477234721328,0.5404699738903395,0.889489309678209,1.0,3/21,4.64%,MAGI2;PDGFRB;ITGA1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.39281795745966885,0.9352853149424398,0.5643086816720257,0.8387466777670269,1.0,8/27,20.49%,TIRAP;TNIP1;IRAK4;TRAF6;IRAK3;TAB3;IRAK2;MAP3K1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4457785360952027,0.9352460015792121,0.5340314136125655,0.8383213304978954,1.0,2/12,9.45%,UCK2;UPP1
prerank,positive regulation of cation channel activity (GO:2001259),0.35924323275029957,0.9349827254454344,0.5538922155688623,0.8383709011957565,1.0,2/40,4.00%,SHANK3;TMSB4X
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3576782873216875,-0.9345479330658637,0.5755968169761273,0.8905500507859304,1.0,4/20,8.32%,OSR1;ACTN2;HECW2;ADRA2A
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.355545659442375,0.9341506747738443,0.5440956651718983,0.8396069780540943,1.0,9/47,8.99%,LIMS2;NEDD9;DOCK1;RREB1;ACTN4;RAC1;PTK2;ARHGEF7;CRK
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3964282756933087,0.9341122642603724,0.535472972972973,0.8391761650618986,1.0,8/24,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,regulation of protein localization (GO:0032880),0.3393321365662577,0.9338092058990529,0.5534407027818448,0.8392803567684984,1.0,16/58,17.30%,TRIM14;FBXW7;PPM1F;FKBP1A;STX6;TRIM68;MAPK8;TRIM25;PICALM;ITGB3;RACK1;HSP90AB1;RABGAP1L;CEP290;MMD;USP8
prerank,protein complex oligomerization (GO:0051259),0.32169950969679706,0.9337784883229318,0.5497311827956989,0.8388413780119371,1.0,25/85,23.71%,LRRC8C;EHD4;AQP11;MAT2A;BOK;PKD2;RNF112;EHD3;ATL1;G3BP2;LRRC8A;PNPT1;TIFA;CARD9;GLRA3;FUS;BCL10;HOMER1;ELAVL1;CPSF6;JMJD6;OPA1;PDCD6IP;ZBTB1;STOML2
prerank,activation of phospholipase C activity (GO:0007202),0.38868462491636424,0.9337678813973759,0.5438871473354232,0.8383572786500937,1.0,4/29,3.22%,GNAQ;PLCG1;HTR2A;SELE
prerank,translational termination (GO:0006415),0.32332478013519333,0.9335248673368455,0.5785234899328859,0.8383439189109458,1.0,41/95,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;APEH;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;N6AMT1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GSPT2;MRPL24
prerank,selective autophagy (GO:0061912),0.34524021227946394,0.933476189890406,0.568870523415978,0.8379347915830867,1.0,11/56,15.31%,KLHL3;WDFY3;ULK1;PCNT;DYNLL1;DYNC1LI1;PJVK;ARL13B;RAB7A;ATG2A;ATG2B
prerank,primary miRNA processing (GO:0031053),0.46616645113160726,0.9330274860891924,0.5308411214953271,0.8383261078308182,1.0,2/10,5.95%,SMAD1;DROSHA
prerank,regulation of telomerase activity (GO:0051972),0.3610948755756543,0.932967098457243,0.5610859728506787,0.8379434148650822,1.0,10/45,16.74%,NEK7;HMBOX1;GREM1;WRAP53;PINX1;ACD;ERCC4;HSP90AB1;TERF1;CTNNB1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.35095994777236694,-0.9329615635593697,0.5467980295566502,0.8934023780136433,1.0,7/22,17.21%,NOTCH2;FGFR2;STXBP4;CASK;FGF7;MDK;FGF10
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3867704622871551,0.9326939136507781,0.5618892508143323,0.8379764799079149,1.0,6/29,14.82%,ESR1;KCTD6;CNOT1;CNOT2;CBFB;STRN3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.37803076697145416,0.9322387007850368,0.5658914728682171,0.8384270816819194,1.0,8/34,15.63%,DAB2IP;LYN;MFHAS1;GRAMD4;OTUD4;LRRC14;RAB7B;IRAK3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.44329829325774317,0.9321893422141149,0.5384615384615384,0.8380235503863903,1.0,3/12,9.25%,STAT3;PROM1;DSCAM
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.42686551481158735,-0.9321382174554914,0.5614849187935035,0.8943506054621552,1.0,5/11,21.00%,NECAB1;SOAT1;ABCA7;ABCA2;NECAB3
prerank,positive regulation of neuron differentiation (GO:0045666),0.36393654424417143,0.9319670611798144,0.5451807228915663,0.8379416701085702,1.0,6/40,8.26%,MEF2C;ARHGEF2;TCF4;BRINP2;TCF3;NEUROD1
prerank,zymogen activation (GO:0031638),-0.3084947459400257,-0.9318956014169109,0.564327485380117,0.8938199944408803,1.0,6/39,10.70%,CYFIP2;ASPH;MMP14;KLK2;PLAT;GRIN2A
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4073466632047551,-0.9312684119475697,0.5251141552511416,0.8941895890127479,1.0,3/12,5.19%,IGF1;IRS1;IGF2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.403076221066851,0.9309485423477404,0.5664,0.8395492639293379,1.0,7/21,12.53%,PDE2A;PDE4D;NT5C2;NUDT16;HINT1;HPRT1;XDH
prerank,lysine catabolic process (GO:0006554),-0.40209873864207313,-0.9309434712423204,0.5555555555555556,0.8927582007171931,1.0,7/12,36.36%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,lysine metabolic process (GO:0006553),-0.40209873864207313,-0.9309434712423204,0.5555555555555556,0.8927582007171931,1.0,7/12,36.36%,ALDH7A1;PHYKPL;AASS;GCDH;SLC25A21;HYKK;CRYM
prerank,excitatory postsynaptic potential (GO:0060079),0.40803717048724886,0.9307379644080537,0.5726643598615917,0.839514465479468,1.0,1/19,1.15%,MEF2C
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4170638466819755,-0.930706133984406,0.550321199143469,0.8922628278865832,1.0,4/10,30.37%,KMT5A;SETD4;SETD7;METTL18
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.4140296204287778,-0.9305370175931067,0.5645514223194749,0.8915909410510746,1.0,6/11,21.31%,FAP;SIRT2;FZD3;PTGIS;DFFA;TP53
prerank,tRNA metabolic process (GO:0006399),0.42459799286923694,0.9304128753728631,0.55,0.8396925963274496,1.0,5/17,15.50%,FARS2;DTD1;RPP30;ADAT1;KARS1
prerank,positive regulation of ATPase activity (GO:0032781),-0.30447254123141915,-0.9303143643963795,0.5859154929577465,0.8910394536442491,1.0,11/41,20.45%,ATP1B1;TPM1;RYR2;ATP1B2;DNAJB11;PFN2;HNRNPU;FGF10;MSH6;SETMAR;DNAJB2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.44690645882020785,0.9302291582330282,0.5701598579040853,0.8395790702150573,1.0,1/12,1.02%,MAOA
prerank,indolalkylamine catabolic process (GO:0046218),-0.4171996410170305,-0.9298681602035769,0.55,0.8911556463188152,1.0,8/10,51.94%,KYAT1;HAAO;KYNU;AADAT;TDO2;KMO;IDO1;ACMSD
prerank,positive regulation of gene expression (GO:0010628),0.27858562462162745,0.9297828825762935,0.6555323590814196,0.8399664375128124,1.0,58/442,10.83%,LEF1;NOS3;RAB27A;CADM1;APP;TENT4A;MEF2C;IL15;ERN1;CLDN5;OCLN;SMAD1;PDGFB;GATA2;PDE2A;STAT3;NOTCH1;HIF1A;MSN;PPM1F;CD34;PLCG2;FGF23;SOX9;RBM20;DLL4;MAPK8;SERPINB9;RAMP2;TNRC6C;WNT5A;RPS7;IL36G;KRAS;DYRK1A;TAF1B;POLR1A;TGFB1;PIK3CG;BCL3;AGPAT1;NIBAN1;HNRNPD;NOS1AP;CITED1;SMARCA5;PSEN1;MYBBP1A;RPL23;SOX4;CSF1;HNRNPLL;MAPK11;RBM3;PRKAB1;MYO1C;GAS6;EIF6
prerank,wound healing (GO:0042060),0.34040017735038286,0.9293811568252129,0.561141304347826,0.840331965900874,1.0,6/62,2.90%,MYOF;PRCP;MYH9;SCARB1;PPP3CA;DST
prerank,protein K63-linked deubiquitination (GO:0070536),0.3814710046043863,0.9293237608242417,0.5603174603174603,0.8399531011983589,1.0,10/31,19.17%,BABAM2;ATXN3;BRCC3;ZRANB1;OTUD4;ABRAXAS2;YOD1;USP8;USP7;USP25
prerank,membrane repolarization during action potential (GO:0086011),0.4449053437993682,0.9288227272785905,0.549645390070922,0.8404613781505312,1.0,3/13,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,mitochondrial translational termination (GO:0070126),0.3242105681914503,0.9287583532202813,0.5767690253671562,0.8400860258573791,1.0,38/88,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;MRRF;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MTRF1L;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;MRPL24
prerank,RNA processing (GO:0006396),-0.2395298153636779,-0.9285273008101025,0.6518987341772152,0.8935544965654763,1.0,34/176,16.06%,CELF2;SON;HNRNPH1;ATXN1;BICD1;SRSF5;PPARGC1A;HNRNPA2B1;DDX39B;LUC7L3;DUSP11;DDX17;RBMS1;NOVA1;APOBEC1;PRKACA;SRSF2;ADARB2;SRPK2;AKAP8L;WBP4;SRSF11;U2AF2;ZCRB1;RBM4;RNASEL;CELF1;LSM6;HNRNPR;HNRNPU;ELAVL4;RNPC3;SNRNP48;NONO
prerank,cellular defense response (GO:0006968),-0.30260396406976137,-0.9285176272504891,0.5727848101265823,0.8924686461829122,1.0,7/40,13.07%,DCDC2;CCR9;LBP;LSP1;ADORA2A;RAB23;IL1RL2
prerank,regulation of neuron projection development (GO:0010975),0.2981418789892465,0.928462964998673,0.5966785290628707,0.8401997244882162,1.0,24/163,8.58%,SHANK3;ABI3;ITGA6;PRKD1;DAB2IP;LYN;PRAG1;PTK2B;PPFIA2;PAK2;TOX;CDH2;DISC1;SCARF1;RET;CCDC88A;WNT5A;RAPGEF2;RAP1A;SNX3;TRPV4;MBOAT1;CAMSAP2;PSEN1
prerank,histone monoubiquitination (GO:0010390),-0.34003052707697495,-0.9279632349080859,0.604221635883905,0.8927761637185492,1.0,8/24,16.22%,BCOR;CTR9;PAF1;LEO1;DDB2;RING1;ATXN7L3;DDB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.41277176196620036,-0.9278799858409204,0.5622317596566524,0.8918906169766061,1.0,2/11,3.65%,CDH13;P2RX4
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2953170187287062,-0.9273074552502667,0.6187683284457478,0.8922429835312176,1.0,11/44,14.48%,GSN;SPIRE1;CARMIL1;NCK2;BIN1;BAIAP2;PFN2;CDC42EP4;CDC42EP5;LMOD1;CTTN
prerank,inositol phosphate catabolic process (GO:0071545),0.43619477200147383,0.9272926144278056,0.5402504472271914,0.8420703368866571,1.0,4/12,10.62%,INPP5K;SYNJ1;OCRL;INPP1
prerank,regulation of synapse organization (GO:0050807),0.39146050027752816,0.9270416127997272,0.5619834710743802,0.8420699546635331,1.0,9/26,20.64%,MEF2C;WNT5A;NEDD4;EPHA4;ABHD17B;KLK8;PDLIM5;ABHD17A;SETD5
prerank,lymphocyte chemotaxis (GO:0048247),-0.3128714796358658,-0.926877442779372,0.5730027548209367,0.8921954109204839,1.0,3/34,3.99%,CYP7B1;SLC12A2;CXCL16
prerank,generation of neurons (GO:0048699),0.29196132985559065,0.9267098735758987,0.6160092807424594,0.842234237343628,1.0,17/190,6.61%,LHX6;MEF2C;CDK6;ACSL4;CELSR1;FZD4;NAV1;DDIT4;CEP85L;DLL1;DISC1;CX3CR1;OPHN1;WNT5A;RAPGEF2;WNT9B;RAC1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.41048576657411756,-0.9263385561639536,0.5708245243128964,0.8923562016748502,1.0,2/11,8.79%,TWSG1;RUNX1
prerank,positive regulation of viral genome replication (GO:0045070),0.3762727493899109,0.9259296934933523,0.5598755832037325,0.8433219001388879,1.0,6/29,13.14%,NR5A2;ADARB1;PKN2;RAD23A;ADAR;CNOT7
prerank,anterior/posterior axis specification (GO:0009948),-0.37068481953699994,-0.9244470480966537,0.5539568345323741,0.8958858119768407,1.0,1/15,0.48%,WLS
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.369895699600011,0.9243729946586839,0.5466237942122186,0.8459779171882699,1.0,6/31,16.20%,GCH1;GPHN;MOCOS;SRD5A2;STAR;SRD5A1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.35962880317514795,0.9241900370363256,0.5804511278195489,0.8458220953013742,1.0,7/37,8.46%,APP;PARD3;DDIT4;SMAD7;INPP5K;TGFB1;RPTOR
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4132018961427547,-0.9237639481360866,0.5522727272727272,0.8965118688284753,1.0,1/10,1.35%,APPL2
prerank,negative regulation of defense response (GO:0031348),0.3238589255833604,0.9226890544014957,0.5783783783783784,0.8484116418624819,1.0,4/77,3.34%,TEK;PPARD;MFHAS1;LPCAT3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3735762681329028,-0.9225744206514501,0.562358276643991,0.8984024613458416,1.0,5/15,7.53%,AAK1;SNAP91;DGKD;BMP2K;DAB2
prerank,mitotic chromosome condensation (GO:0007076),0.3933636510515424,0.9223422026664211,0.5796610169491525,0.8485966482802465,1.0,7/26,18.26%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,vesicle transport along microtubule (GO:0047496),-0.34593589219912635,-0.9221738070125481,0.5512820512820513,0.898248475625724,1.0,8/23,17.26%,KIF3A;KIF1A;DYNC1I1;HTT;TRAK1;KIFAP3;KIF5A;DYNC1H1
prerank,regulation of humoral immune response (GO:0002920),0.35354192557430436,0.9214855393861618,0.5585185185185185,0.8497927370163004,1.0,4/44,7.48%,CFH;PROS1;CFB;CR1L
prerank,heterotypic cell-cell adhesion (GO:0034113),0.38663261482751676,0.921240759850665,0.5357142857142857,0.8497859139134855,1.0,5/25,11.77%,VCAM1;CD200;ITGA5;IZUMO1;ITGB3
prerank,cellular response to radiation (GO:0071478),0.35893209456581915,0.9208480162855742,0.56957928802589,0.8500626261183656,1.0,5/40,12.26%,NET1;OPN4;HUS1;OPN5;RHOB
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.34636218350225223,-0.920695688666953,0.5894736842105263,0.9008044161820212,1.0,10/22,23.99%,DDX5;PLA2R1;SPRED1;SPRED2;SPRED3;CHD5;CDK5RAP3;ATR;MSX1;ATM
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4033038355097502,-0.9204309091748766,0.5870535714285714,0.9003778025839763,1.0,4/12,8.00%,CBLB;F3;APOD;IFT20
prerank,glycerol metabolic process (GO:0006071),-0.41793285365625754,-0.920425933166512,0.5864332603938731,0.8992895405268635,1.0,4/10,18.11%,GK;GOT1;TPI1;ANGPTL3
prerank,metallo-sulfur cluster assembly (GO:0031163),0.39557655521159585,0.9203379444923759,0.5695581014729951,0.850588118356406,1.0,10/22,24.30%,ABCB7;MMS19;NUBP2;NUBP1;HSCB;LYRM4;NUBPL;FXN;CIAPIN1;CIAO2B
prerank,peptidyl-lysine methylation (GO:0018022),-0.3314945598842458,-0.9202503707885765,0.5756756756756757,0.8985919708446467,1.0,11/26,30.37%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;SETD7;EEF1AKMT3;METTL18
prerank,genitalia development (GO:0048806),0.44720093955976076,0.920234580372857,0.5581395348837209,0.8503020019747654,1.0,3/12,6.10%,CHD7;FOXF2;WNT5A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.42214251035260364,0.9200919674661485,0.5837651122625216,0.8500908675015169,1.0,2/15,3.86%,PPARD;ELOVL5
prerank,intermediate filament organization (GO:0045109),0.41712441819244733,0.9192466452442853,0.5495798319327732,0.8513160293259294,1.0,5/17,24.26%,MTM1;KLHL24;BFSP2;DNAJB6;NEFL
prerank,negative regulation of stress fiber assembly (GO:0051497),0.38828985291814766,0.9174282174445656,0.5681444991789819,0.8545011852569582,1.0,5/24,6.61%,TJP1;F11R;WASF2;PAK2;INPP5K
prerank,midbody abscission (GO:0061952),0.40400431137333376,0.9171293154591902,0.5478260869565217,0.8546002772572919,1.0,3/17,9.20%,CHMP2B;CHMP4A;CHMP4B
prerank,cellular response to hypoxia (GO:0071456),-0.24103531080711144,-0.9171256597700338,0.7172774869109948,0.9052465558137139,1.0,20/126,9.80%,CPEB1;BMP7;SLC8A3;CPEB2;SIRT2;NDNF;KCND2;RORA;PSME4;EGLN3;LMNA;P4HB;NPEPPS;MDM4;SFRP1;MDM2;VEGFA;HIPK2;RGCC;ARNT
prerank,histone H3-K9 demethylation (GO:0033169),0.4573716013345791,0.9170480085226821,0.583804143126177,0.8542592709074741,1.0,5/11,18.64%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A
prerank,regulation of immune effector process (GO:0002697),0.3552781886915634,0.9166761740103937,0.5867269984917044,0.8545301843148947,1.0,4/41,7.48%,CFH;PROS1;CFB;CR1L
prerank,acyl-CoA metabolic process (GO:0006637),0.36161364353762415,0.9157025655335573,0.572107765451664,0.8559697892728529,1.0,3/35,4.12%,HMGCS2;ACACB;GLYAT
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.32603028187465205,0.915190544063779,0.6032831737346102,0.856517520369516,1.0,25/67,25.41%,B2M;IKBKB;TAP2;PSMA2;IKBKG;SNAP23;PSMA8;FCGR1A;PSMA6;VAMP8;PSME1;PSMA4;PSMF1;SEC22B;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;TAP1;CYBA;PSMD3;PSMA3;VAMP3;TAPBP
prerank,chloride transmembrane transport (GO:1902476),-0.2848803603662341,-0.9151683761999387,0.6358024691358025,0.9090226663462843,1.0,20/48,22.93%,SLC1A3;SLC12A2;SLC6A1;GLRB;ANO1;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRB3;GABRG3;SLC1A1;CFTR;SLC4A8;CLCN1;GABRA1;SLC12A8;GABRA5;GABRA3
prerank,TOR signaling (GO:0031929),0.38275779114443104,0.9151486758215671,0.5427215189873418,0.856090752011127,1.0,8/26,18.72%,CCDC88A;PRR5L;RPTOR;RICTOR;EIF4EBP1;RPS6;TIPRL;SYAP1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4425356331760847,0.9151333678573287,0.5708955223880597,0.8551162796409205,1.0,3/11,16.26%,FKBP1A;PKD2;CALM1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4425356331760847,0.9151333678573287,0.5708955223880597,0.8551162796409205,1.0,3/11,16.26%,FKBP1A;PKD2;CALM1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3592141202603899,-0.9148463681083658,0.5857461024498887,0.9087201108694399,1.0,5/18,11.92%,HDAC4;SOX6;CCN3;BHLHE41;FZD7
prerank,nucleic acid metabolic process (GO:0090304),-0.27113251364611823,-0.914566098277695,0.6340579710144928,0.908379674310828,1.0,24/69,23.58%,ENPP1;HNRNPH1;HNRNPA2B1;DUSP11;RECQL5;RBFOX2;PCBP2;ATXN2;NT5E;RAD50;POLR2B;HNRNPR;HNRNPU;POLR2K;HNRNPA1;KPNA2;GTF2F1;SETMAR;DNA2;PDE12;POLR2I;POLG;DNASE2;DNASE1L2
prerank,regulation of RNA metabolic process (GO:0051252),0.3342937081232937,0.9142706910342312,0.6028571428571429,0.8563424266709303,1.0,14/59,12.18%,NOVA2;TNFRSF1B;IGF2BP3;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;MBNL3;RASA1;ZNF326;HNRNPLL;RC3H1;OASL
prerank,mRNA metabolic process (GO:0016071),-0.2590970468212376,-0.9142151648525922,0.68,0.9080720199204128,1.0,16/90,13.74%,SON;DDX5;SRSF5;PPARGC1A;HNRNPA2B1;PRKACA;PCBP2;SRSF2;AKAP8L;AGO3;SRSF11;U2AF2;CNOT10;CELF1;LSM6;HNRNPR
prerank,positive regulation of growth (GO:0045927),0.3274707406790823,0.9141726757008614,0.5922865013774105,0.8560297930209303,1.0,15/64,14.35%,INSR;ADAM10;PPM1F;PLCB1;RPS6KA3;SDCBP;RPS6KA1;H3-3A;RPTOR;RFTN1;SFRP2;MTPN;ADAM17;ERBB2;S100A9
prerank,cognition (GO:0050890),0.35397628001744197,0.9140477143682252,0.5701492537313433,0.8557743167995416,1.0,5/42,5.98%,APP;SHROOM4;CHD7;DOP1B;CHMP2B
prerank,regulation of organelle assembly (GO:1902115),0.3216352410374532,0.9136983011318458,0.6072423398328691,0.8559861566437111,1.0,13/72,14.04%,TBC1D8;MSN;TBC1D22A;TBC1D15;PLK2;TBC1D12;TBC1D2;RNF4;NPRL2;TBC1D5;EVI5;RAB5A;NPM1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3698887796897674,0.9136774698116781,0.5918057663125948,0.8555238376834549,1.0,2/32,1.87%,CAV1;PLCG1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.38778279332049825,0.9136592320056489,0.5844370860927153,0.8550602111365789,1.0,7/24,14.50%,AQP11;LPCAT3;TMBIM6;XBP1;BCL2L1;RACK1;UBXN1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3711723657115342,0.9132873418665307,0.5905383360522023,0.8552936516394748,1.0,2/26,3.34%,PDE8A;FYN
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3594149594085387,0.9131542347681547,0.5790273556231003,0.8550645872647771,1.0,10/39,18.35%,SOCS2;PIK3C2A;CISH;ITPKB;PIK3CG;SLA2;SOCS6;SOCS4;EFR3B;PIK3C2B
prerank,Rho protein signal transduction (GO:0007266),0.3362357362165226,0.9130689002765632,0.5903271692745377,0.8547459816287902,1.0,7/53,4.40%,NTN1;EPS8;ARHGEF3;CELSR1;ADGRG1;PLEKHG5;RHOJ
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.37247791784637213,0.9130102259035657,0.5797788309636651,0.8543564346488054,1.0,6/29,11.72%,SMAD1;DROSHA;DICER1;PUM1;ADAR;PUM2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3406449213244595,0.9129338566887361,0.5803183791606368,0.8540152663057837,1.0,11/52,15.35%,PPP1R13B;FBXW7;CASP8;MAPK8;SH3GLB1;UBE2D3;SFN;BID;SAE1;YWHAQ;ARIH2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3420645360466516,0.9128920005863129,0.6135338345864662,0.853611248352331,1.0,14/49,20.51%,ACER2;BCL3;BRIP1;MAD2L2;HUS1;BID;MAP3K20;ATRX;E2F7;CHEK2;TIPRL;GRB2;MYO6;RAD17
prerank,diacylglycerol metabolic process (GO:0046339),0.38719775071707274,0.9125456003265496,0.5735537190082645,0.8537900981310484,1.0,9/23,15.79%,DGKZ;LIPE;DGKH;ANG;DGKE;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3515425112081806,0.9124543456417269,0.6032934131736527,0.853467029190345,1.0,10/44,13.24%,DAB2IP;LYN;PTPRJ;INPP5K;DNAJA1;PTPN1;AIDA;STK38;GSTP1;DUSP7
prerank,cardiocyte differentiation (GO:0035051),-0.42148457913129644,-0.9122983953969137,0.5837004405286343,0.9116305119648115,1.0,6/10,22.54%,AKAP13;TGFB2;MYOCD;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.43620981967217565,0.91216625571515,0.5861456483126111,0.8535642282510726,1.0,6/13,19.86%,JAK3;PIGU;IL7R;MGAT5;CRLF2;HES1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3991774683074375,0.912099771440397,0.5603864734299517,0.8532128732450142,1.0,9/20,18.52%,CASP8;SDCBP;PELI1;MLKL;RIPK1;BIRC3;ASAH1;BIRC2;CDC37
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3965397902965231,0.9120958788422696,0.5950819672131148,0.8527247787343866,1.0,4/21,5.39%,TOX;DISC1;DLL4;CX3CR1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.32561134851974927,-0.9111675879230289,0.5910364145658263,0.913365460550581,1.0,10/27,15.95%,SLC7A2;SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,protein deubiquitination (GO:0016579),0.28264401913225706,0.9110157407872882,0.6457399103139013,0.8542981722343866,1.0,73/242,23.27%,ESR1;SMAD1;HIF1A;NFKBIA;MINDY1;USP3;BABAM2;MINDY2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;ENY2;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;OTULIN;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3411778263626534,0.9104903183221308,0.5827338129496403,0.854831926105699,1.0,11/51,10.32%,BMPR2;SMAD1;SMURF1;NOTCH1;SMAD7;ACVR2A;GREM1;SOST;SKIL;SMAD5;UBE2D3
prerank,regulation of endocytic recycling (GO:2001135),-0.3996006406762552,-0.9104212195115183,0.5930735930735931,0.9141058510016813,1.0,4/11,13.77%,ACTN2;ATP9A;EHD1;ARHGAP1
prerank,megakaryocyte differentiation (GO:0030219),0.4438579088006046,0.9101854599733997,0.5905797101449275,0.8549653342656749,1.0,2/11,9.03%,TAL1;ZFPM1
prerank,autonomic nervous system development (GO:0048483),-0.35661565672628726,-0.9091067329808701,0.5683962264150944,0.9160737930226734,1.0,3/17,8.07%,NRP1;NF1;SEMA3A
prerank,DNA conformation change (GO:0071103),0.4163176268674963,0.908716096308857,0.5689948892674617,0.8574185865996464,1.0,4/17,15.11%,HHEX;HAT1;TOP1;KAT6A
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3929420047530554,0.908416777039018,0.5564516129032258,0.8575259208333255,1.0,3/22,8.59%,PPARD;SORBS1;CREB1
prerank,regulation of establishment of planar polarity (GO:0090175),0.31389660927048635,0.9083892683936924,0.6154873164218959,0.8570907164853756,1.0,13/88,12.60%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.39522438305956487,0.9081419461480842,0.5945485519591142,0.8571066483038641,1.0,5/20,14.30%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,regulation of defense response to virus (GO:0050688),-0.37421025681934905,-0.907951457351333,0.5866983372921615,0.9178387396191147,1.0,8/14,28.90%,PCBP2;ITCH;TRAF3IP1;PPM1B;C1QBP;RNF26;IFNLR1;DHX9
prerank,glycine metabolic process (GO:0006544),0.432180419555462,0.9078172087426432,0.589605734767025,0.8572596842284779,1.0,1/12,4.12%,GLYAT
prerank,dendrite morphogenesis (GO:0048813),0.3559686927891251,0.9077464014763459,0.5809968847352025,0.8569021332030851,1.0,3/35,3.42%,SHANK3;KLF7;TAOK2
prerank,mucosal immune response (GO:0002385),0.41750093566549146,0.907272959860673,0.5807017543859649,0.8573126027867813,1.0,2/15,9.16%,RPL39;DEFA6
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.38125194689186226,0.9071676997258763,0.5562805872756933,0.8570326982256841,1.0,10/25,23.49%,BTBD18;NELFE;BRD4;EAF1;ZMYND11;NELFCD;CDC73;NELFB;NELFA;EAPP
prerank,protein destabilization (GO:0031648),-0.3164500232288623,-0.9070921461219551,0.5765027322404371,0.918880677460782,1.0,7/32,14.84%,GSN;PRKN;BTRC;MDM2;KDM8;HTT;SNCA
prerank,positive regulation of double-strand break repair (GO:2000781),0.3540194499412048,0.9070524235358951,0.6036308623298033,0.8567622372710479,1.0,17/39,25.04%,SMCHD1;DTX3L;SHLD1;WRAP53;MAD2L2;MMS19;ACTR2;SPIDR;WDR48;KMT5B;PARP9;MGMT;FUS;RIF1;ERCC6;ARID2;FMN2
prerank,hexose metabolic process (GO:0019318),0.3530364158573988,0.9067521717584454,0.5883256528417818,0.8568712777822299,1.0,7/39,14.02%,PPARD;FUCA2;FBP1;SORD;PMM2;OMA1;GALM
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2937716959543517,-0.9059482214721509,0.6120689655172413,0.9205669829113254,1.0,9/41,18.45%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.34924276014355404,-0.9059341536613684,0.616751269035533,0.919489144930065,1.0,5/20,22.75%,AKR1B1;FDX1;FDXR;TSPO;TSPOAP1
prerank,cytoplasmic translational initiation (GO:0002183),-0.36177227974560955,-0.9058353205132244,0.6207729468599034,0.9186537069341182,1.0,9/17,31.25%,EIF4A1;EIF2S2;RBM4;EIF3A;EIF2D;EIF4G1;EIF2B3;EIF4A2;EIF4B
prerank,negative regulation of ion transport (GO:0043271),-0.33185701700066367,-0.9057478927449752,0.6062992125984252,0.9177516778672704,1.0,8/24,14.96%,ACTN2;GPM6B;WNK4;SYT11;ADRA2A;WNK1;SNCA;WNK3
prerank,positive regulation of protein maturation (GO:1903319),0.4431773398824683,0.9055444747804057,0.5581818181818182,0.8588033814853984,1.0,3/11,9.33%,NKD2;RHBDD1;SOX4
prerank,regulation of protein catabolic process (GO:0042176),0.3122633847865114,0.905249087690257,0.6258148631029987,0.8588910896834816,1.0,20/99,16.65%,FOXO1;SMURF1;DAB2IP;NEDD4L;PLK2;WNT5A;CDKN1B;SNX3;NEDD4;VPS28;MAD2L2;RAB26;RILP;ASB11;RAB7A;APC;PRKCG;IRAK3;AREL1;CHEK2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4071234998917845,0.9050671374772734,0.579734219269103,0.8587791171815973,1.0,4/18,11.53%,SPTBN1;STX7;VAMP8;STX8
prerank,protein homooligomerization (GO:0051260),0.30153542712530945,0.9048830013844856,0.6104060913705583,0.8586466602271295,1.0,27/114,19.75%,EHD4;B2M;GBP5;SAMHD1;ACACB;AQP11;GLS;ALOX5AP;MLKL;PKD2;HPRT1;RNF112;EHD3;SIGMAR1;SOD2;ATL1;G3BP2;PNPT1;APIP;TIFA;CBR4;CARD9;GLRA3;FUS;OSBPL2;BCL10;ALDH1A3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.28908401357054636,-0.9047425105140265,0.6017699115044248,0.9191931112888465,1.0,13/46,21.72%,ZIC1;PRKCD;CDH1;SMAD3;CAMK1;MAVS;PIK3R2;TRIM28;UBR5;HDAC3;JUP;TP53;BAG3
prerank,endoplasmic reticulum organization (GO:0007029),0.3196491629577195,0.9042536631465579,0.6204081632653061,0.8593638653715702,1.0,12/72,14.33%,APP;REEP1;LPCAT3;CAV2;DOP1B;STX1A;TRAM1;TRAM1L1;RNF112;ATL1;ALDH3A2;RAB18
prerank,membrane depolarization (GO:0051899),0.36184117762966106,0.9040910234358052,0.5880398671096345,0.859193678626616,1.0,3/32,5.87%,CAV1;CACNA1E;CACNA1A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.29061930476440534,-0.9038771837084137,0.640117994100295,0.9201803431024186,1.0,9/43,18.45%,IGF1;LBP;SELENOS;SYT11;PTPN22;SIRPA;NR1H4;CACTIN;CHRNA7
prerank,photoperiodism (GO:0009648),0.3681266379721949,0.9034542611451234,0.5769854132901134,0.8599454536211906,1.0,5/28,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.41390245701081285,0.9034116517041824,0.5960854092526691,0.8595355946932162,1.0,3/18,5.95%,CAV1;NEDD4L;SLC43A2
prerank,nucleus organization (GO:0006997),0.3403605651831183,0.9031188903285836,0.6101449275362318,0.8596110439403997,1.0,11/47,14.27%,RPS19;CHMP2B;SYNE1;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;SPAG4;PITPNB;NUP54
prerank,protein localization to vacuole (GO:0072665),0.4327394628949849,0.9030115731422229,0.5974499089253188,0.8593154346647282,1.0,3/13,11.29%,SH3BP4;SH3GLB1;GLMP
prerank,negative regulation of viral genome replication (GO:0045071),0.3503890013248705,0.9028854097334297,0.5856697819314641,0.8590823601580507,1.0,12/40,19.35%,ISG20;N4BP1;INPP5K;TASOR;TNIP1;OASL;IFIH1;IFITM3;PLSCR1;BST2;IFITM1;EIF2AK2
prerank,"wound healing, spreading of cells (GO:0044319)",0.377102972813583,0.9026808262032477,0.5799011532125206,0.859001633868633,1.0,5/24,7.99%,LCP1;ACVRL1;MRTFA;CEACAM1;ITGA5
prerank,lysosome organization (GO:0007040),-0.29314056613180284,-0.9016527933926237,0.6402439024390244,0.9243644888445406,1.0,14/36,25.88%,ARSB;LRRK2;GAA;CLVS2;HPS4;HPS1;HOOK2;TPP1;CLN3;ACP3;SNAPIN;LAMTOR1;TMEM165;MTOR
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.36874493778593215,0.9014768261636485,0.5844155844155844,0.860892096591086,1.0,5/27,13.99%,CRTC1;SIK1;OPN5;PDE6B;FBXL3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.40842888056035714,0.9014765554589697,0.5711947626841244,0.8604005190900623,1.0,3/18,4.89%,DAB2IP;MSN;VGLL4
prerank,positive regulation of sodium ion transport (GO:0010765),0.4306405302062733,0.90139677590032,0.5670289855072463,0.8600878323760862,1.0,1/12,1.76%,CNKSR3
prerank,response to nutrient levels (GO:0031667),0.41027001599539026,0.9011874240306399,0.5922671353251318,0.8600109306384113,1.0,3/17,8.46%,KCNB1;ULK1;RPTOR
prerank,proteoglycan metabolic process (GO:0006029),0.375111240678902,0.9006297335759831,0.5875796178343949,0.8605852341859261,1.0,2/26,0.68%,CSGALNACT1;BMPR2
prerank,positive regulation of mRNA processing (GO:0050685),-0.33745001531592966,-0.9006155217854167,0.5916230366492147,0.9257809670732305,1.0,5/21,10.10%,CELF4;DAZAP1;PAF1;LEO1;CIRBP
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.329531183524242,-0.9004105398381989,0.6189320388349514,0.9251539691431399,1.0,6/22,15.93%,BMP7;BMP4;INHBA;CDKN1A;CDKN1C;PLEK
prerank,histone H2A monoubiquitination (GO:0035518),-0.36215733117560706,-0.9002827101275923,0.5908045977011495,0.9243382069638564,1.0,7/17,21.34%,BCOR;PCGF2;DDB2;RING1;DDB1;PCGF6;PCGF1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.30852183043877074,0.8999066622213934,0.6428571428571429,0.8615522159434895,1.0,22/104,14.33%,BMPR2;CAV1;SMAD1;SMURF1;NOTCH1;FKBP1A;SMAD7;ACVR2A;GREM1;ACVR1;SOST;SNX25;TGFB1;SKIL;SMAD5;UBE2D3;TGFBR2;ADAM17;PMEPA1;FAM89B;BCL9L;ACVR2B
prerank,positive regulation of proteolysis (GO:0045862),0.3282020608828753,0.8992929836226047,0.5927536231884057,0.8623053097038824,1.0,4/55,3.89%,CTSC;TNFRSF1B;CASP8;NKD2
prerank,membrane raft organization (GO:0031579),-0.3651344329023274,-0.8990767719782065,0.6024096385542169,0.9261351268730228,1.0,7/15,22.68%,ANXA2;S100A10;FLOT2;ABCA7;MYADM;PPT1;CLN3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3581445259257228,-0.898707814704254,0.6218097447795824,0.9258917048959742,1.0,4/16,8.33%,RANBP3L;IGFBP3;BOC;RIPOR2
prerank,iron ion homeostasis (GO:0055072),0.3270368056562789,0.8986954986230614,0.6070422535211267,0.8629596232730786,1.0,12/58,17.46%,ABCG2;B2M;ABCB7;LCN2;GLRX3;CUL1;PICALM;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,copper ion transport (GO:0006825),0.428134928674764,0.8984479609809649,0.5645472061657033,0.8629491486436578,1.0,2/11,10.25%,SLC31A1;ATP7B
prerank,pulmonary valve morphogenesis (GO:0003184),0.4026959872308033,0.8981489488263762,0.5731922398589065,0.863026894423631,1.0,3/17,2.77%,NOS3;NFATC1;NOTCH1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4416794080912766,0.8980728970653948,0.589648798521257,0.862676354489753,1.0,3/11,15.34%,H3-3A;HAT1;ATRX
prerank,positive regulation of nervous system development (GO:0051962),-0.29430342531263837,-0.8978401591285342,0.6160714285714286,0.9268908180436696,1.0,12/42,13.08%,NLGN2;CLSTN2;CUX2;PTPRD;IL1RAPL1;NRXN1;NLGN1;SERPINF1;NLGN3;SRPX2;GRID2;GPER1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4552311518010119,0.8976847188078719,0.60075329566855,0.8629417712787881,1.0,2/10,5.94%,MSN;OPHN1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.40392400735537703,0.8975852407696456,0.5803108808290155,0.8626348089819406,1.0,6/15,14.30%,PTPN12;MVB12B;CEACAM1;LGMN;RHBDF2;ERBB2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.35627484147298993,-0.8975157552925742,0.6046511627906976,0.926558855823725,1.0,3/18,4.59%,ROCK2;SLC2A13;LRRTM3
prerank,action potential (GO:0001508),0.34232312197811954,0.8972960889514252,0.6171171171171171,0.8627119579770306,1.0,5/44,7.06%,GNAQ;KCNQ1;KCNB1;KCNMB4;KCNE2
prerank,inner ear morphogenesis (GO:0042472),0.3864609247697867,0.8971047666229109,0.6048526863084922,0.862576604013786,1.0,4/22,6.26%,TBX1;CHD7;SOX9;TMIE
prerank,regulation of lipid kinase activity (GO:0043550),0.4376939866096147,0.8969521169522785,0.5820610687022901,0.8623720342495113,1.0,3/11,18.00%,PPP2R5A;RB1;RBL1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.39744280662441556,0.8969450001438134,0.6061643835616438,0.8619011341935737,1.0,4/21,10.91%,JAK3;TIGIT;SAMSN1;LST1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.43098596497769526,0.8968009346687252,0.581981981981982,0.8616744809157443,1.0,4/12,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.43926713137505896,0.8967784424403723,0.5670840787119857,0.8612313750237807,1.0,4/11,12.73%,DCTD;TPK1;NT5C3A;SLC19A3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42198035036131615,0.8965910477824957,0.604735883424408,0.8610972433567226,1.0,3/13,12.71%,NCK1;PTPN1;RACK1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.41737712155656825,0.8965145353637372,0.5597147950089126,0.8607575331880606,1.0,5/14,22.83%,TSEN34;RTCB;CPSF1;TSEN2;RTRAF
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3602082635565049,0.8964313632799958,0.5718701700154559,0.860445026738777,1.0,6/30,10.43%,CAV1;SAMSN1;NF2;INPP5F;SFRP2;SEMA4D
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.315505865829623,-0.8955982314058709,0.6016713091922006,0.9300328628549156,1.0,7/29,12.80%,GOLGA5;COPZ2;COPB1;COPA;COPG1;TRAPPC10;COG8
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3789289153988226,0.895564340044812,0.5724137931034483,0.8616249656496036,1.0,7/21,13.14%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;ZFP36;CNOT7
prerank,potassium ion export across plasma membrane (GO:0097623),0.43071807465072237,0.8954770764542819,0.6069469835466179,0.8612724364774856,1.0,2/13,7.06%,KCNQ1;KCNE2
prerank,positive regulation of bone resorption (GO:0045780),0.42685435633338087,0.8954712788505005,0.5760869565217391,0.8607983363010437,1.0,3/11,10.76%,TNFRSF11A;DCSTAMP;MC4R
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.33539563907405684,0.8954694557588552,0.6082621082621082,0.8603146627088945,1.0,15/51,24.36%,NEK7;HMBOX1;PINX1;ACD;DCP2;HNRNPC;TERF1;CTNNB1;CCT7;CCT2;TEN1;MAP2K7;SMG6;TENT4B;TNKS
prerank,spindle assembly (GO:0051225),0.3194126713534309,0.8953934580138553,0.624103299856528,0.8599706014285777,1.0,19/67,21.97%,NEK7;RAB11A;STARD9;NEK6;STAG2;STAG1;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;NUMA1;BCCIP;RPS3;PIBF1;KPNB1;KIF2A;SAC3D1
prerank,protein autoprocessing (GO:0016540),0.4140234480686221,0.895324693544035,0.6050269299820467,0.8596120791182442,1.0,3/17,13.22%,CASP4;CASP1;OMA1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3938846514274519,0.8952956612493734,0.5783132530120482,0.8591845061934402,1.0,4/20,14.50%,SYNE1;BCL3;TAF3;TOPORS
prerank,proteasomal protein catabolic process (GO:0010498),0.28109991754700697,0.8949507567014535,0.6737089201877934,0.8593904623245173,1.0,59/201,22.49%,SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;ATXN3;ARRB1;UBE2G1;PSMA2;NEDD4;ARMC8;RNF139;RHBDD1;SPOPL;RNF4;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;COP1;DDI1;UBE2K;TOPORS;UBXN1;PSME1;SOCS6;RNF5;DDIT3;DDI2;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;CDC34;PSMA4;DNAJB12;PSMF1;ZFAND2A;APPBP2;CCDC47;PSMB7;TRIM71;PSMB1;HACE1;KCTD2;SEL1L;PSMD2;KCTD5;KLHL42;UBXN2A;PSMA5;PSMC3
prerank,regulation of peptide hormone secretion (GO:0090276),0.31849438519138545,0.8947848584563092,0.6435643564356436,0.8592338865211063,1.0,10/67,8.26%,SLC2A1;CACNA1E;CHD7;KCNB1;CACNA1A;PPP3CB;RAP1A;STX1A;ITPR3;NEUROD1
prerank,hepaticobiliary system development (GO:0061008),-0.34089134988647296,-0.8947748969799278,0.5919395465994962,0.9308593272211783,1.0,4/20,5.63%,TGFBR3;WNT4;COBL;NF1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.35558065411801587,-0.8946826917425654,0.5980629539951574,0.9299663816656627,1.0,6/16,21.38%,AMPD3;LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,macrophage migration (GO:1905517),-0.3882166767945597,-0.8942853014292936,0.5875576036866359,0.9298229650879448,1.0,6/13,34.16%,P2RX4;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.36224746454948503,0.8941118036456718,0.6150234741784038,0.8600440643075814,1.0,7/32,20.90%,NEK7;HMBOX1;ACD;CTNNB1;CCT7;CCT2;MAP2K7
prerank,nuclear export (GO:0051168),-0.25292461205775274,-0.8941027840111079,0.6788617886178862,0.9291868232586739,1.0,11/80,11.22%,RANBP3L;ATXN1;SRSF5;PKD1;DDX39B;SRSF2;STRADA;SRSF11;U2AF2;RAE1;POM121
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3731572858104402,-0.894099954086601,0.5931372549019608,0.928102424905216,1.0,3/13,10.70%,CYFIP2;ASPH;GRIN2A
prerank,regulation of cholesterol esterification (GO:0010872),-0.4123807378508388,-0.8940072981040659,0.6063829787234043,0.9272318459382802,1.0,4/10,25.16%,AGTR1;APOE;ABCA2;LAMTOR1
prerank,SNARE complex assembly (GO:0035493),0.44821621841415815,0.8934991734842379,0.5796296296296296,0.8607236180739847,1.0,3/10,15.22%,VAMP4;VAMP8;STXBP6
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3893515894455675,0.8931862444464204,0.6038961038961039,0.8608518828138807,1.0,4/24,7.96%,B2M;MFSD6;TAP2;ERAP1
prerank,regulation of protein kinase activity (GO:0045859),0.29891744465626624,0.8928140814454442,0.6353887399463807,0.8611030624470193,1.0,21/106,13.61%,GNAQ;IQGAP1;PTK2B;PPM1F;WWTR1;PAK2;CEACAM1;RAPGEF2;INPP5K;TRIB3;PTK2;RAP1A;CSF1;MAP2K3;GAS6;SFN;RB1;GSTP1;WARS1;TRIB1;GSKIP
prerank,response to peptide hormone (GO:0043434),-0.290780938409606,-0.8924387313735643,0.625748502994012,0.929854832045233,1.0,9/43,10.15%,ROCK2;TGFBR3;IRS1;IGFBP5;OGT;ANXA1;GNAI1;SRC;SLC27A1
prerank,regulation of mononuclear cell migration (GO:0071675),0.38548595541643405,0.8921531598961361,0.5829228243021346,0.8618961799781878,1.0,5/23,9.46%,LYN;STK10;MSN;PTK2;CSF1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.44801371527654693,0.8917951991694889,0.6029684601113172,0.8611108942467832,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.44801371527654693,0.8917951991694889,0.6029684601113172,0.8611108942467832,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.44801371527654693,0.8917951991694889,0.6029684601113172,0.8611108942467832,1.0,4/11,19.84%,SLC25A16;PANK2;PANK3;PPCDC
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3753757057880852,0.8917736412890653,0.6048387096774194,0.8606632875653686,1.0,4/23,7.33%,ENG;SMAD7;TGFB1;ITGA3
prerank,regulation of microtubule polymerization (GO:0031113),0.3465293336294016,0.8911952347398755,0.6128550074738416,0.8613140960893916,1.0,12/40,20.57%,OCLN;RAC1;DYRK1A;CAMSAP2;PRUNE1;MET;CDH5;PAK1;CDK5RAP2;CLIP1;NUMA1;RPS3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4364358390504583,0.8905728782692357,0.5912408759124088,0.8620083746577867,1.0,5/10,23.71%,CDT1;ATRX;E2F7;DBF4;STOML2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4007364177677718,0.8904596369423052,0.6126279863481229,0.8617465466129847,1.0,6/17,13.80%,BOK;BCL2L1;GGCT;SFN;BID;SOD2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4117569246220403,0.8903480156718165,0.5727272727272728,0.8614579332149875,1.0,2/15,2.21%,IL6ST;EDN1
prerank,double-strand break repair (GO:0006302),0.2814263011928421,0.8900514557871451,0.6722488038277512,0.8615320502839962,1.0,37/158,18.10%,TENT4A;SAMHD1;BABAM2;DTX3L;HERC2;MAPK8;MMS22L;RPA1;TRIP13;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;SEM1;PARP2;RECQL;MEIOB;MAD2L2;FAN1;HUS1;XRCC2;MCM9;RMI1;CYREN;ERCC4;UBXN1;YY1;ACTR5;CHEK2;SPIDR;KDM4A;RAD21;NSMCE1;CIB1;DCLRE1C;PARP9
prerank,positive regulation of axonogenesis (GO:0050772),0.3429542227143061,0.8897744051844978,0.6137026239067055,0.8616149045295152,1.0,4/43,2.82%,PLXNA4;NTN1;SEMA7A;PLXND1
prerank,photoreceptor cell development (GO:0042461),-0.3626122846979455,-0.889366890014401,0.600451467268623,0.9360059505412217,1.0,5/14,18.06%,AHI1;ARL3;VEGFA;MFSD2A;TULP1
prerank,lipid biosynthetic process (GO:0008610),-0.26189006534528164,-0.889293438248782,0.6725978647686833,0.9350855872260398,1.0,20/77,21.41%,ACSL1;ABCD3;AGPAT4;PRKAA2;SREBF1;ACACA;PCYT2;GPAM;SCD;PRLR;FDFT1;ACSS2;SCP2;MVK;LPCAT1;AGPAT3;FDXR;LSS;SCD5;CYP51A1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.33269254815159227,0.8892898584261197,0.6207865168539326,0.8620731861897277,1.0,8/54,7.94%,CAV1;NEDD4L;KCNQ1;GNB1;KCNMB4;KCNE2;NEDD4;NOS1AP
prerank,transepithelial transport (GO:0070633),0.41290382054718233,0.8890194670855127,0.5942275042444821,0.8621157070706742,1.0,2/15,4.74%,ABCG2;BEST1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.39496614140039676,-0.8886485429720417,0.5912087912087912,0.9354694518617495,1.0,1/11,1.79%,GRK3
prerank,ERBB2 signaling pathway (GO:0038128),-0.3103191940363028,-0.8884823867118892,0.6348773841961853,0.9347523563247383,1.0,6/31,9.04%,EGFR;ERBB4;HSP90AA1;SHC1;PRKCA;SRC
prerank,RNA modification (GO:0009451),0.33337916391901634,0.8881159625192272,0.6091445427728613,0.8633369024610206,1.0,16/54,25.64%,ADARB1;CDKAL1;RBM15;ADAR;NSUN4;HENMT1;DTWD2;TRMT6;PUS7L;JMJD6;THUMPD1;TRUB1;NSUN6;PUS7;AARS2;LCMT2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.34164002514762315,0.8879889545057172,0.6122137404580152,0.8630999961526314,1.0,11/41,14.81%,HIF1A;SCARB2;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,regulation of calcium ion import (GO:0090279),0.37879304499549205,0.887928457499291,0.5961538461538461,0.8627349409915152,1.0,3/21,8.09%,PDGFB;FYN;PKD2
prerank,melanocyte differentiation (GO:0030318),-0.3879289160606378,-0.8878734896925704,0.6236559139784946,0.9351198208845937,1.0,4/11,8.53%,ENPP1;MITF;KIT;USP13
prerank,organelle transport along microtubule (GO:0072384),-0.3071112814264642,-0.8878187766135253,0.6091954022988506,0.9341656161550063,1.0,8/31,16.42%,BICD1;ARHGAP21;COPG1;DYNC1I1;HTT;BICD2;TRAK1;MAP1S
prerank,regulation of ion transport (GO:0043269),-0.25392390101152845,-0.8867922189564562,0.7120622568093385,0.9355001674364147,1.0,26/76,23.00%,PRKN;SYT1;P2RX4;NKAIN4;ANK3;NKAIN2;SYT9;SYT12;SYT11;SNX6;KCNJ2;KCNJ13;WNK1;DTNBP1;KCNJ10;SNCA;KCNJ8;KCNJ15;SYT3;KCNJ6;NKAIN3;CLDN10;SYT2;SPTBN4;VAMP2;SYT6
prerank,phosphate ion transmembrane transport (GO:0035435),0.4351506356568538,0.8867480555698938,0.6018181818181818,0.8645427161463981,1.0,4/12,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41274947433261683,-0.8865634881016204,0.5958762886597938,0.9349246887354846,1.0,2/10,5.19%,DNMT3A;IGF2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.40408342674118236,-0.8861182620890541,0.6365591397849463,0.934838853294345,1.0,3/10,2.54%,VTN;PRKCB;GRB10
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.31599087174121454,0.8860100528304613,0.6089385474860335,0.8655337620178328,1.0,6/60,7.80%,NEK7;PDGFB;PRKD2;HMBOX1;GREM1;WRAP53
prerank,glucose metabolic process (GO:0006006),-0.26637597088365694,-0.8856985913294838,0.6865671641791045,0.9347563770933268,1.0,18/58,18.72%,RBP4;PPARGC1A;APOD;SLC39A14;PER2;ENO2;GAA;SLC25A12;GOT1;TPI1;IRS2;SLC25A13;G6PC3;ENO3;PFKFB1;MDH1;CRY1;PCK2
prerank,regulation of receptor binding (GO:1900120),0.4366474021110671,0.8856745120690522,0.5939278937381404,0.8657147090106057,1.0,2/10,6.17%,B2M;ADAM15
prerank,phagolysosome assembly (GO:0001845),0.43671763722408596,0.8853540068734455,0.6300884955752213,0.8658486504555553,1.0,4/12,15.28%,ARL8B;RAB7A;RAB7B;SYT7
prerank,regulation of lipid metabolic process (GO:0019216),0.3018478383155854,0.8853502044802166,0.677376171352075,0.8653749072925118,1.0,7/88,5.80%,CAV1;PPARD;PLPP1;FASN;ACACB;NCOA1;TGS1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3253194577039549,-0.8852126262683045,0.6293532338308457,0.934797201508932,1.0,5/24,7.59%,DCN;PRKN;SPIRE1;MCU;LRRK2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3906303974781469,0.885054486695547,0.6051282051282051,0.865467395761375,1.0,2/19,5.12%,CSGALNACT1;EXTL3
prerank,smooth muscle tissue development (GO:0048745),0.44239272848376515,0.8847627118876219,0.5955631399317406,0.8655679587943975,1.0,1/10,0.85%,ENG
prerank,"transcription, DNA-templated (GO:0006351)",0.27689205885913154,0.8836101423717454,0.7115165336374002,0.8672708286644487,1.0,62/207,22.56%,PIR;MLLT3;RREB1;CCNK;XBP1;EPC1;PWP1;GTF2F2;KLF13;TAF1B;GTF2E2;BCL3;GMEB2;NFKB1;TRIP13;NELFE;SMARCA5;TAF3;TRIM24;TAF4B;COPS2;RNGTT;EAF1;TFB2M;RO60;MMS19;RNPS1;CBFB;CEBPD;SNAPC3;RNMT;GTF2A2;PTMA;BTF3;MEF2A;TOPORS;ELOC;NELFCD;CTDP1;MNT;GTF2H4;GTF3C1;CDC73;TAF1A;HIPK3;NR4A2;GTF2H1;TAF9;NELFB;POLR3A;MRPL12;DEK;POLR2L;CCNH;SETX;TAF15;TAF7;NELFA;RTF1;NOCT;POLR2J;ERCC6
prerank,cellular zinc ion homeostasis (GO:0006882),0.3685638198241118,0.8835538786550802,0.6140350877192983,0.8669011989636538,1.0,2/26,7.19%,SLC39A8;LCK
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.28406649007035234,-0.8835482529427716,0.6537313432835821,0.9376115290168547,1.0,11/44,16.21%,SH3RF1;THBS1;NGF;FNIP1;SIAH2;CD44;SRC;VEGFA;SNCA;USP47;MT3
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2938183546277948,-0.8832513355635608,0.6732394366197183,0.9372007020546522,1.0,13/36,16.52%,VAMP5;ANK3;AFDN;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3265818135291618,0.8830202417966835,0.6555090655509066,0.8674772039392207,1.0,9/59,6.69%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4410095716161364,0.8830136464499295,0.6193895870736086,0.8670122916127084,1.0,6/11,30.16%,CYCS;UQCRQ;UQCRC1;UQCC3;UQCRC2;UQCR11
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.40156960335080694,-0.8817846134840519,0.6194895591647331,0.9395863337518426,1.0,4/11,8.61%,RSPO3;PLEKHA4;DAB2;SFRP1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.42937927379252994,0.8817757684803003,0.6037735849056604,0.8688562120776179,1.0,6/10,23.82%,DNAJA1;AIDA;GSTP1;HIPK3;DUSP19;PDCD4
prerank,T cell differentiation (GO:0030217),0.3398831075891184,0.8817095233049417,0.6259780907668232,0.86850864483074,1.0,7/40,10.70%,LFNG;SOX13;CHD7;DLL4;LCK;SOX4;JAG2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.34262236397532075,0.8816123974217944,0.64576802507837,0.8682277895538795,1.0,14/39,20.49%,PTPN12;DAB2IP;PTPRJ;TGFA;ARHGEF7;CBL;LGMN;ERBB2;SH3GL2;GRB2;STAM;BTC;TSG101;EPS15
prerank,carbohydrate transport (GO:0008643),0.44440984101690456,0.880943280255877,0.6071428571428571,0.8690125571481213,1.0,1/11,3.29%,AQP11
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.43105864024024876,0.8800360145645656,0.591304347826087,0.8702218835213347,1.0,2/11,7.94%,ALG10B;NOS1AP
prerank,positive regulation of cell division (GO:0051781),0.3479823562742524,0.8799339203700638,0.6349693251533742,0.8699393862835463,1.0,3/38,4.00%,PKP4;TAL1;PKN2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.31739002866317056,0.8799251866802782,0.6563380281690141,0.8694743301327725,1.0,22/64,25.61%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;TCEA2;GTF2H5;PCID2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.37562423431271347,0.8798878212673316,0.637123745819398,0.8690770920788814,1.0,3/23,5.16%,PTK2B;NOTCH1;GHR
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3298941092443065,0.8798860102562465,0.6345029239766082,0.8686002651027662,1.0,13/52,13.14%,CNOT6;PAN3;CNOT6L;EDC3;CNOT1;RC3H1;EXOSC1;CNOT2;DCP2;LSM3;HBS1L;ZFP36;CNOT7
prerank,pre-miRNA processing (GO:0031054),0.4150445949821818,0.8798136912230412,0.5882352941176471,0.8682468344381581,1.0,5/14,21.33%,DROSHA;DICER1;ADAR;MRPL44;PRKRA
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.41288425966984216,0.8796312781900393,0.6097560975609756,0.8681231809557324,1.0,3/15,7.06%,KCNQ1;ATP1A1;KCNE2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.32745303038513707,-0.8791450999704744,0.6584766584766585,0.9446613534522067,1.0,6/24,13.37%,DMD;JPH1;AKAP6;PRKACA;GSTM2;JPH2
prerank,response to gamma radiation (GO:0010332),0.36957166820202725,0.8784879421599595,0.6187290969899666,0.8697515513273584,1.0,1/24,0.84%,DCUN1D3
prerank,regulation of establishment of protein localization (GO:0070201),0.41561853975318513,0.8784533878207852,0.6083032490974729,0.8693332644412305,1.0,5/13,16.92%,DNAJA1;GAPVD1;CEP290;CEP295;SPIDR
prerank,lymphocyte mediated immunity (GO:0002449),-0.3842227843435354,-0.8783587280434089,0.6410835214446953,0.9454375069783945,1.0,3/12,14.90%,CD55;JAG1;GNL1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4292938255054286,0.8774059138586946,0.5904255319148937,0.870827327351734,1.0,2/10,15.66%,VSIR;DDIT3
prerank,regulation of multicellular organism growth (GO:0040014),0.390843291482282,0.87686543504672,0.620253164556962,0.8713805134803858,1.0,2/15,5.16%,APP;GHR
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2756345218384929,-0.8767593668488831,0.6855123674911661,0.94798517839776,1.0,15/46,27.51%,HK2;TOMM40;AIFM1;TIMM22;RALA;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16
prerank,acetyl-CoA metabolic process (GO:0006084),0.4084759138120089,0.8766081832980926,0.6414048059149723,0.8713871900313366,1.0,2/15,3.00%,HMGCS2;ACACB
prerank,myoblast differentiation (GO:0045445),0.4061710374078606,0.8759275916810967,0.6151079136690647,0.8721709832469935,1.0,3/14,5.65%,EPAS1;MBNL1;TCF7L2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28003791212342066,0.8754067352849507,0.7282352941176471,0.8726775145240969,1.0,30/186,10.43%,CAV1;NFATC1;DAB2IP;SOX13;MLLT3;FZD6;FZD4;TLE4;SOX17;WWTR1;STK3;NKD2;ZNRF3;SOX9;STK4;VGLL4;GREM1;TCF7L2;WNT5A;JADE1;TMEM88;SOST;PSMA2;CTNNBIP1;CITED1;PSMA8;MAD2L2;SFRP2;SCYL2;PSMA6
prerank,aminoglycan metabolic process (GO:0006022),-0.3941637062439368,-0.8751270275129288,0.6666666666666666,0.9505489188533588,1.0,6/10,29.58%,XYLT1;B4GALT7;B3GAT2;CHST9;B3GALT6;GAL3ST3
prerank,regulation of protein localization to cell surface (GO:2000008),0.34924661098557114,0.874584354374049,0.6251968503937008,0.8737152321094478,1.0,6/33,12.95%,STX3;NEDD4L;RAB11FIP5;PICALM;RAB11B;HSP90AB1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.28842894959091314,-0.8739518623333545,0.6967930029154519,0.9520881919318818,1.0,6/39,8.63%,PLPP3;PDGFRA;MEGF11;GNAS;UBASH3B;MYL9
prerank,fibrinolysis (GO:0042730),-0.37400214325706244,-0.8735259493467302,0.6291079812206573,0.951962950226182,1.0,4/13,27.28%,PLAT;SERPINE1;PLAU;HRG
prerank,protein tetramerization (GO:0051262),0.31167695841934745,0.8734693549927753,0.6648199445983379,0.8753230360690059,1.0,5/67,3.41%,B2M;GBP5;SAMHD1;ACACB;GLS
prerank,regulation of primary metabolic process (GO:0080090),-0.23352505219628164,-0.8722865364688841,0.7836538461538461,0.9536583110375464,1.0,35/126,20.67%,CHD9;ROCK2;PPARA;PSAP;LDLR;PSME4;SREBF1;HMGCS1;ACACA;C1QTNF2;OAZ2;SMARCD3;APOE;TNFAIP8L3;FGFR4;ODC1;IRS2;PSMD12;GPAM;SCD;AZIN1;CERS2;FDFT1;MVK;FDPS;ABCA7;CARM1;PRKAB2;PSMC4;PSMB6;LSS;NCOR1;ZFP69;HDAC3;ID2
prerank,oligodendrocyte differentiation (GO:0048709),0.39140452166330975,0.8722201681045346,0.632890365448505,0.877181986526081,1.0,4/19,8.84%,SOX13;SOX9;EIF2B5;PRDM8
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3329922635803439,-0.8721898420620156,0.6650366748166259,0.9527907600593362,1.0,8/19,23.69%,PRKN;SREBF1;VDAC1;HTT;HAX1;HTRA2;FZD5;DNM1L
prerank,regulation of protein targeting to membrane (GO:0090313),0.35529019609385687,0.8719439648375791,0.6150081566068516,0.8772338347360531,1.0,9/28,17.66%,FYN;KCNB1;INPP5K;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,positive regulation of glucose import (GO:0046326),0.3800928521306572,0.8709900206564004,0.6024096385542169,0.8785297818490261,1.0,3/21,4.22%,OCLN;INSR;SORBS1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3212902061972949,-0.8706771087283662,0.6495098039215687,0.9551320093605892,1.0,5/23,10.86%,ATAD1;SYT11;LRRK2;SLC24A2;PRRT1
prerank,vacuolar acidification (GO:0007035),-0.3319341729828536,-0.8703305428271277,0.615,0.9547944704572392,1.0,13/21,35.60%,ATP6V0A4;ATP6V0D1;ATP6AP2;PPT1;SLC11A1;CLN3;TMEM199;TMEM9;CCDC115;ATP6V0D2;GRN;DMXL2;TCIRG1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3008960416294887,-0.8700231849491614,0.6862244897959183,0.9544514877852347,1.0,13/30,18.29%,VAMP5;ANK3;OPTN;GGA2;RAB10;GGA1;SYS1;BBS2;ARFRP1;MACF1;GOLPH3L;GOLGA4;SEC16A
prerank,primary neural tube formation (GO:0014020),-0.29878148455196607,-0.8700229010440569,0.6657381615598886,0.9533656499151719,1.0,7/30,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42791503859231417,0.8688077992582396,0.6078098471986417,0.882069127049896,1.0,5/11,15.16%,FYN;ABCB7;COA8;ABCD1;SLC18A2
prerank,negative regulation of neuron death (GO:1901215),0.29741238534350617,0.868615683070536,0.7001254705144291,0.8819463464774636,1.0,14/93,9.87%,MEF2C;CD200;PTK2B;TNFRSF1B;CD34;FOXQ1;TOX3;RASA1;CITED1;CHMP4A;CHMP4B;IKBKG;CSF1;BTBD10
prerank,ribosomal large subunit biogenesis (GO:0042273),0.31461484905439135,0.8678504378200798,0.6425470332850941,0.882903229093392,1.0,18/54,22.89%,RPF1;RSL24D1;RRS1;RPL14;EIF6;NOP53;RPL6;RPL10;NOP16;NPM1;RPL35A;MAK16;RPL11;RPL3;TRAF7;RPL7;RPL26;MRPL1
prerank,mitochondrial transport (GO:0006839),-0.26625915924330856,-0.867735264001411,0.7156862745098039,0.9574311923809494,1.0,18/53,25.20%,BCL2;HSP90AA1;TOMM40;TIMM22;SLC25A13;FLVCR1;MTX2;COX18;SLC25A4;TIMM17B;MAIP1;TSPO;TIMM8B;TMEM14A;TIMM9;PPIF;GDAP1;TIMM10
prerank,cellular amide metabolic process (GO:0043603),0.29012099643752026,0.8677074851672846,0.6675531914893617,0.882691125064397,1.0,8/102,5.81%,ST6GAL1;ST3GAL1;PLPP1;CPD;CPE;GLYAT;ASAH2;MTHFD1L
prerank,neuromuscular synaptic transmission (GO:0007274),-0.34636457347686933,-0.8676784900216622,0.6397379912663755,0.9564847778813079,1.0,8/18,30.71%,DTNA;KIF1B;FCHSD2;STAC3;TBC1D24;TSPOAP1;SLC5A7;CHRNB2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3462600380794657,0.8675261253863775,0.6507936507936508,0.8825429547879045,1.0,7/35,10.48%,FASN;HMGCS2;ALOX5AP;PAM;LTC4S;FAR2;SLC25A1
prerank,DNA repair (GO:0006281),0.2630761029432159,0.867322414756649,0.7441340782122905,0.882443127015363,1.0,73/284,22.56%,TENT4A;POLK;USP3;BABAM2;DTX3L;HERC2;MAPK8;ASCC1;RNASEH2A;ATXN3;RPA1;ASCC3;WDR33;TRIP13;PRIMPOL;POLA1;SMARCA5;BRCC3;RAD51D;BRIP1;BACH1;BTG2;PARP2;RECQL;RAD18;RAD23A;MAD2L2;FAN1;HUS1;XRCC2;MC1R;MMS19;UNG;NOP53;ERCC4;NSMCE4A;NPM1;MPG;UBXN1;ENDOV;GTF2H4;ACTR5;CHEK2;PDS5A;WDR48;KDM4A;RAD21;PDS5B;RFC3;NSMCE1;CIB1;KMT5B;DCLRE1C;PARP9;CETN2;MGMT;NUDT1;CHD1L;PMS1;GTF2H1;XRCC4;FAAP100;MSH2;RAD17;RMI2;TRRAP;SETX;UBE2V2;BABAM1;MBD4;RFC5;NSD2;ERCC6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.38302801854658264,0.8672732223887056,0.6233108108108109,0.8820556252513351,1.0,6/18,22.29%,WRAP53;CHP1;CEP295;CCT7;CCT2;CEP120
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.421404140609759,0.8672225786473162,0.6195462478184991,0.8816622425791811,1.0,6/12,29.26%,CDT1;WDR18;TIPIN;GMNN;TICRR;KAT7
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4151783182622317,0.8669379672628895,0.6245487364620939,0.8817039281719055,1.0,4/13,8.79%,B3GNT3;B3GNT4;B4GAT1;B3GNT6
prerank,positive regulation of embryonic development (GO:0040019),-0.33330918168950885,-0.8669043753116906,0.6570048309178744,0.9571484728682184,1.0,2/19,2.02%,WNT4;OSR1
prerank,negative regulation of biosynthetic process (GO:0009890),0.39808447784616063,0.8666397987211508,0.6386554621848739,0.8817604492313397,1.0,6/16,15.16%,ABCB7;CEACAM1;COA8;ABCD1;GSTP1;SLC18A2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3134372362671773,-0.8665754471167486,0.6326530612244898,0.9567419621399474,1.0,10/24,32.02%,KIF24;MAP7D3;NCKAP5L;TPPP3;CKAP5;KIF18B;STMN4;FGF13;TPPP;STMN2
prerank,polyamine metabolic process (GO:0006595),-0.3706648645790869,-0.8658731256274611,0.6359649122807017,0.9571920113835439,1.0,4/13,12.97%,OAZ2;SMS;ODC1;SAT1
prerank,tube closure (GO:0060606),-0.29526766442971236,-0.8653447068136354,0.6611111111111111,0.9573071867545234,1.0,7/31,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.35694139607579156,-0.8653317658520263,0.6311300639658849,0.95625338300232,1.0,3/13,13.02%,APOD;SUFU;RAB23
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3368843852709765,0.8652885075389335,0.6492537313432836,0.883764087768554,1.0,9/41,15.26%,PLA2G4A;ELOVL5;PTGS1;EPHX1;DEGS1;ABCD1;GSTP1;PNPLA8;FAAH
prerank,histone deacetylation (GO:0016575),0.32930163782778166,0.8650041546131949,0.6328125,0.8837988472410397,1.0,7/43,12.75%,HDAC9;ELK4;RCOR1;RBM14;MIER1;SIRT6;MIDEAS
prerank,cellular response to oxidative stress (GO:0034599),0.2862588828848652,0.8648572208738038,0.7192546583850932,0.8835867216260231,1.0,11/118,6.03%,FOXO1;PRKD1;DAPK1;HIF1A;PXN;CAT;PTPRK;MAPK8;GSR;CYCS;PRR5L
prerank,positive regulation of cellular protein localization (GO:1903829),0.3111167572834774,0.8647612544566257,0.6837016574585635,0.8833040101696181,1.0,10/69,9.89%,STX3;FYN;WWTR1;CARD10;DTX3L;LIMK2;CCDC88A;TGFB1;CDT1;VPS28
prerank,nucleotide-excision repair (GO:0006289),0.29026905527427227,0.864593501981427,0.6917989417989417,0.8831414703471792,1.0,29/101,24.50%,POLK;ATXN3;RPA1;POLA1;BRIP1;COPS2;RAD23A;FAN1;HUS1;COPS4;MMS19;ERCC4;AQR;GTF2H4;RFC3;USP7;CETN2;CHD1L;GTF2H1;POLR2L;CCNH;RNF111;POLR2J;RFC5;ERCC6;CUL4B;COPS8;LIG4;POLL
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3595350972661028,-0.8645848242255415,0.6436781609195402,0.9567608822401846,1.0,5/14,16.59%,PRKN;SELENOS;LRRK2;CREB3;CREB3L1
prerank,mitochondrial translational elongation (GO:0070125),0.30091297639035436,0.8644508635430665,0.6666666666666666,0.8829448779844216,1.0,37/88,26.45%,MRPS18A;MRPL13;MRPS12;MRPL35;MRPL41;MRPL52;MRPL4;MRPS16;MRPL23;MRPS5;MRPL37;PTCD3;MRPL11;MRPL54;MRPS9;GADD45GIP1;MRPL43;MRPS26;MRPL12;MRPL44;MRPS30;AURKAIP1;MRPL1;MRPL50;MRPL17;MRPL39;MRPL32;MRPL14;MRPS11;MRPL9;MRPL46;DAP3;MRPL19;MRPL15;MRPL42;GFM1;MRPL24
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.314599731510283,0.8641473983713771,0.6733238231098431,0.883042135257613,1.0,21/62,25.61%,MLLT3;CCNK;GTF2F2;NELFE;EAF1;ELOC;NELFCD;CTDP1;GTF2H4;CDC73;GTF2H1;NELFB;POLR2L;CCNH;NELFA;RTF1;POLR2J;ADRM1;IWS1;GTF2H5;PCID2
prerank,cortical cytoskeleton organization (GO:0030865),0.3283461843277192,0.8624932573945906,0.6461086637298091,0.8856489504070889,1.0,9/41,8.82%,LCP1;FMNL3;IKBKB;NCKAP1;RAC1;FMNL2;TRPV4;RHOBTB1;LLGL1
prerank,sulfur compound biosynthetic process (GO:0044272),0.29337681539946214,0.8622358314464742,0.7029449423815621,0.8856506639934666,1.0,23/104,13.98%,ST3GAL6;CSGALNACT1;ST3GAL1;B3GNT3;MAT2A;B4GALT4;SLC35B3;SLC10A7;B3GNT4;SLC26A1;B4GALT5;GSTO2;GSTA4;B4GAT1;TPK1;SLC35D2;GGCT;GCLM;MPST;GSTP1;CSPG5;NCAN;OPLAH
prerank,establishment of spindle orientation (GO:0051294),-0.3131895480342632,-0.8618229276594094,0.6753246753246753,0.9616592601733284,1.0,15/28,33.68%,GJA1;GPSM2;HTT;UBXN2B;LLGL2;NDC80;MISP;SPDL1;CENPA;FBXW11;CLASP1;DCTN1;INSC;ZW10;PKHD1
prerank,sarcomere organization (GO:0045214),-0.30682753814862107,-0.8617150302681104,0.6356164383561644,0.9608434124375016,1.0,10/27,34.54%,ACTN2;TPM1;FHOD3;MYOM2;KRT19;TNNT3;MYPN;MYLK3;TCAP;OBSCN
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4264958334964585,0.8608153880136074,0.6177536231884058,0.887831441244521,1.0,2/10,2.90%,PTPN12;PTPRJ
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3978551174870746,0.8607346768379213,0.6493738819320215,0.8875036976281666,1.0,7/15,22.86%,KHNYN;NUDT16;DICER1;RPP30;ZC3H12C;RNASEH1;LACTB2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4007406113507767,0.8603582974131699,0.6163636363636363,0.8877142311048335,1.0,6/15,19.25%,DDIT4;ZFYVE27;SOS1;GRB2;BCAR1;FRS2
prerank,negative regulation of RNA splicing (GO:0033119),0.38579212608109037,0.8603039607886308,0.637123745819398,0.887339733738788,1.0,8/19,27.18%,TMBIM6;PTBP3;RNPS1;RPS13;SRSF10;SRSF4;RBMX;RPS26
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3540134623882157,0.8599617708970971,0.6398104265402843,0.8875103674400242,1.0,5/28,11.99%,DAB2IP;CASP8;TNFRSF1A;CRADD;BID
prerank,regulation of mitotic nuclear division (GO:0007088),0.3188058522969797,0.8597072254531721,0.6748911465892597,0.8874940407390234,1.0,7/55,7.47%,INSR;PDGFB;EDN1;LRP5;CAV2;AURKA;TGFA
prerank,regulation of ERAD pathway (GO:1904292),0.4264398510275046,0.8590914010945014,0.6387832699619772,0.8881937950219807,1.0,4/11,19.17%,AQP11;ATXN3;UBXN1;USP25
prerank,proteolysis (GO:0006508),-0.20957081266348834,-0.8588970991234182,0.9636363636363636,0.9660203820951663,1.0,28/252,9.22%,TRABD2B;ADAMTS12;AEBP1;CPQ;ADGRV1;F3;DPP4;HTRA3;OGT;PCSK5;FAP;GGT5;MMP14;HTRA1;MMP16;NAALAD2;ADAM19;TASP1;CLPX;NPEPPS;ENPEP;CPXM2;ADAM33;PLAT;APH1B;MDM2;CPXM1;MMP2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.32869776905272585,0.8587098246235608,0.6697388632872504,0.8884198358592335,1.0,8/39,20.05%,POLK;RPA1;FAN1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1
prerank,apoptotic cell clearance (GO:0043277),0.3471296231674817,0.8586782837969028,0.6451104100946372,0.8879977891305524,1.0,6/30,11.77%,TGM2;SCARB1;RAC1;RHOBTB1;GAS6;ITGB3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4207519929696817,0.858646979332485,0.6360424028268551,0.887576762947653,1.0,11/11,57.95%,PKD1L3;RTP3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;PKD2L1
prerank,activin receptor signaling pathway (GO:0032924),-0.34340404724642937,-0.8584203363557732,0.6636363636363637,0.9659942707109409,1.0,4/15,12.07%,TGFBR1;SMAD3;INHBA;ACVR1B
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.37351781254850674,-0.8582598865753922,0.6380510440835266,0.9652486694942967,1.0,4/12,15.88%,SIX1;VEGFA;SMO;PAX8
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4195509328485727,0.8581364618015739,0.6446428571428572,0.8880615167610696,1.0,3/12,9.46%,LYN;PTK2;CSF1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.32381091193326805,-0.8578779938181627,0.655940594059406,0.9649862753468341,1.0,4/20,19.08%,WNT4;C1QTNF3;CRY1;NCOR1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.42321588366432467,0.8575699647373318,0.6229508196721312,0.8886102598402632,1.0,2/11,5.72%,KCNQ1;ATP1A1
prerank,regulation of defense response to virus by host (GO:0050691),0.3519097071389887,0.8574738682056746,0.6392092257001647,0.8883270178612214,1.0,8/30,18.36%,AIM2;DTX3L;CGAS;IL23A;EIF2AK4;STAT1;PARP9;ZDHHC1
prerank,membrane lipid catabolic process (GO:0046466),-0.39084501243457304,-0.8571577732404321,0.6289592760180995,0.9654586774254064,1.0,6/10,27.32%,CYP1B1;PDXDC1;PPT1;SMPD2;NAGA;SGPL1
prerank,ubiquinone metabolic process (GO:0006743),-0.3518947098409263,-0.857044711637507,0.6503496503496503,0.9646176437754571,1.0,7/15,31.38%,COQ8B;COQ5;FDXR;AIFM2;COQ10A;COQ10B;COQ6
prerank,activation of protein kinase activity (GO:0032147),0.2887787056191403,0.856929282771725,0.7216358839050132,0.8888705071580916,1.0,18/106,9.49%,ADCY4;INSR;PDGFB;PTK2B;TAOK2;STK3;PRKAR2B;PAK2;CARD10;TIRAP;STK4;GHR;CCDC88A;WNT5A;TNIK;MALT1;ANG;RICTOR
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.388489912062213,-0.8567361412449425,0.6481069042316259,0.9642198559982462,1.0,2/10,2.47%,OSR1;HECW2
prerank,negative regulation of macroautophagy (GO:0016242),0.35299578850444807,0.8565014686115994,0.664983164983165,0.8891970304037244,1.0,6/26,9.20%,LZTS1;MTM1;QSOX1;FEZ2;CHMP4A;CHMP4B
prerank,positive regulation of catalytic activity (GO:0043085),0.3416109430425623,0.8564582263850793,0.6646341463414634,0.8888015609856925,1.0,20/37,29.64%,CAV1;MAPK8;PSEN1;APH1A;ABL2;CIB1;XRCC4;MSH2;ATP7A;PHACTR4;MAPK14;FXN;B3GAT3;SOD1;NOD2;MSH3;MID1IP1;PSEN2;BCAS3;MAPK3
prerank,transition metal ion transport (GO:0000041),0.3333425442230358,0.8564150701838935,0.6334405144694534,0.8884053867104973,1.0,4/35,10.25%,SLC39A8;SLC31A1;ATP2C1;ATP7B
prerank,GTP metabolic process (GO:0046039),-0.3527385630855373,-0.8564130750168661,0.6521739130434783,0.9638411983164755,1.0,4/15,17.11%,RHOQ;LRRK2;RAB23;ENTPD7
prerank,regulation of urine volume (GO:0035809),0.4214339018811987,0.8562272080211263,0.6579439252336449,0.888273617195514,1.0,3/10,13.32%,NPR1;INPP5K;HAS2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.37071228483407875,-0.8560559651214702,0.6589473684210526,0.9635372877542662,1.0,7/12,35.74%,CDC14B;BTRC;PTEN;GORASP1;GOLGA2;UBE2C;UBE2S
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.36588169997238507,0.8556981193502459,0.642504118616145,0.8887615595136186,1.0,2/22,6.10%,TNFRSF1B;WNT5A
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.36371421543323024,-0.855540637851915,0.672686230248307,0.963569789788686,1.0,2/13,2.95%,GLI2;BMP4
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3873043545742684,-0.8551205999256826,0.6330472103004292,0.9634537303588223,1.0,5/10,20.99%,PTPRS;SIRPA;PPM1B;CACTIN;PYCARD
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.39281073559198576,0.8550255339365853,0.6536502546689303,0.889527327451873,1.0,5/18,16.45%,MFHAS1;CTNNA1;POLR1A;ILRUN;CHP1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.34993797024988826,0.8546177812711389,0.6645056726094003,0.8897972625303476,1.0,4/31,10.91%,LYN;PLA2G2D;RC3H1;LST1
prerank,cellular response to amino acid stimulus (GO:0071230),0.34006371114168,0.8545359144633025,0.6613418530351438,0.8894792887515172,1.0,6/33,10.32%,SH3BP4;FYN;XBP1;RPTOR;UBR1;LARS1
prerank,mRNA catabolic process (GO:0006402),0.3306995608218479,0.854426037278624,0.6581709145427287,0.889199908362558,1.0,18/44,27.43%,ERN1;NANOS2;NUDT16;NBDY;RC3H1;DCP2;ZFP36;XRN2;PNPT1;DHX34;RNH1;RIDA;NBAS;LSM2;EXOSC4;HSPA1B;METTL16;TUT7
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.29535967788339756,-0.8543075270542171,0.7150537634408602,0.9641239471444399,1.0,13/31,23.00%,SYT1;CACNA1G;SYT9;SYT12;SYT11;ADRA2A;SCAMP5;SYT3;CBARP;REST;SYT2;RAB3GAP1;SYT6
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33413528484355015,0.8540718156662864,0.6504559270516718,0.8893554483957358,1.0,11/40,11.52%,B2M;INSR;HIP1;SELE;GREM1;ARRB1;HNRNPK;SCYL2;CBL;TBC1D5;PICK1
prerank,positive regulation of protein processing (GO:0010954),0.3820948000852529,0.8536089619023377,0.637478108581436,0.8897350419397274,1.0,4/19,9.09%,MYH9;LPCAT3;NKD2;RHBDD1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.39793683184522954,0.852616749819096,0.6550522648083623,0.89110611145489,1.0,1/15,2.43%,GBP5
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.32612393060187156,0.8519286847903512,0.6708860759493671,0.8918784380255348,1.0,6/40,11.99%,TNFSF10;BIK;BCL2L11;BCL2L1;BNIP3;BID
prerank,manganese ion transport (GO:0006828),-0.3567437226787409,-0.8517134158307161,0.6283185840707964,0.9686216561871648,1.0,7/14,13.03%,SLC30A10;SLC39A14;TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,synaptic vesicle membrane organization (GO:0048499),0.3902127848625344,0.851697666451103,0.6589698046181173,0.8918487544219299,1.0,3/17,9.47%,STX3;STX1A;SNAP23
prerank,catecholamine biosynthetic process (GO:0042423),0.4158975925739353,0.8509528701237866,0.6357012750455373,0.8927241638030199,1.0,1/11,1.55%,GCH1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4038557364035526,0.8507895832197511,0.6225749559082893,0.8925388147510623,1.0,6/13,24.87%,DDX20;AAR2;SRSF10;SART3;PRPF3;LSM2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.29367608203166923,0.8506348051742226,0.7097203728362184,0.8923441401557713,1.0,13/85,12.60%,SMURF1;CELSR1;FZD6;FZD4;AP2B1;WNT5A;RAC1;AP2A1;PSMA2;PSMA8;PSMA6;PRICKLE1;VANGL2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.26817559676903047,-0.850554751520385,0.7791798107255521,0.9700790109237214,1.0,12/49,15.84%,SMAD6;IMPACT;DACT1;PRKCZ;SRC;THRA;JAM3;TRAF3IP1;ANKRD27;PYDC1;PPM1A;LCMT1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.42794956602841583,0.8505243908594542,0.6500920810313076,0.8920623340185357,1.0,3/10,10.66%,LYN;RAPGEF2;GAS6
prerank,positive regulation of cell cycle (GO:0045787),0.31049386236300447,0.8505042776474876,0.6926345609065155,0.8916280661374077,1.0,13/62,11.80%,APP;PDGFB;TAL1;PKN2;EIF4E;CDKN1B;CCNYL1;PKD2;CCNY;NUDT16;RAD23A;EIF4EBP1;LGMN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3885186607853266,0.8503999314965281,0.6696113074204947,0.8913430247257348,1.0,4/16,8.04%,ESR1;DDX54;NCOA4;ARID1A
prerank,gonad development (GO:0008406),0.32866965941062837,0.8501836201057623,0.658284023668639,0.8912762845517446,1.0,9/41,15.33%,KITLG;BIK;SOX9;WNT5A;NCOA4;MAMLD1;ADAM21;SRD5A2;IRX5
prerank,bile acid biosynthetic process (GO:0006699),-0.30935063126347395,-0.8498871649043862,0.6852791878172588,0.9703836706016556,1.0,5/24,15.09%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4013134057552801,0.8498347408918259,0.6236749116607774,0.8914219114429041,1.0,4/12,15.00%,LPCAT3;SOAT2;APOC4;DGAT1
prerank,skin development (GO:0043588),0.3049108263480177,0.8489135384454309,0.7105643994211288,0.8926422618029358,1.0,8/65,7.33%,ITGA6;UGCG;LSR;BCR;DLL1;WNT5A;ASCL4;ITGA3
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.36957111045638813,0.8487763859502674,0.6559485530546624,0.8924069564656871,1.0,4/21,8.96%,LIMCH1;PEAK1;PTK2;SLK
prerank,negative regulation of stem cell differentiation (GO:2000737),0.40936219235372734,0.8480202884072962,0.6167247386759582,0.8933131318307933,1.0,5/12,20.19%,NOTCH1;TCF15;ESRRB;HES1;NELFB
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.36180346945796926,-0.8475621300878556,0.6599552572706935,0.9742718915201952,1.0,3/13,16.49%,CBLB;RGPD1;KPNA2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.33129399368361434,-0.8472954396785654,0.6804597701149425,0.9737393979527827,1.0,6/18,29.33%,EHMT2;KMT2D;SETMAR;SETD4;SETD7;SETD1A
prerank,cellular response to gamma radiation (GO:0071480),-0.3428872544531425,-0.8470205331145947,0.6643518518518519,0.9732712256723922,1.0,8/17,23.99%,MDM2;XRCC5;XRCC6;ATR;TSPYL5;TP53;CRYAB;ATM
prerank,negative regulation of lyase activity (GO:0051350),-0.3453723590876262,-0.8469737582701862,0.7097560975609756,0.9722854469317331,1.0,6/16,24.84%,ADGRV1;GRM3;PALM;GABBR2;CCR2;MTRR
prerank,regulation of DNA replication (GO:0006275),-0.2646043063215062,-0.8469201791305179,0.7133956386292835,0.9713148388056311,1.0,6/49,8.84%,EGFR;GLI2;EHMT2;NUCKS1;GLI1;ZBTB38
prerank,RNA stabilization (GO:0043489),-0.2810606850792991,-0.8468113854759146,0.7295774647887324,0.9704672465781402,1.0,9/33,23.09%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;PHAX;SLC11A1;RBM24
prerank,insulin secretion (GO:0030073),0.3761458322551608,0.8462485700826924,0.6554621848739496,0.8960123549216049,1.0,4/19,12.23%,RAB11FIP5;SNX19;NEUROD1;RAB11B
prerank,sterol biosynthetic process (GO:0016126),-0.2943145762564577,-0.8460396350548788,0.7108753315649867,0.9710066473959695,1.0,13/33,22.50%,INSIG2;PRKAG2;HMGCS1;NSDHL;ACAT2;INSIG1;FDFT1;MVK;FDPS;LSS;DHCR24;CYP51A1;DHCR7
prerank,cholesterol efflux (GO:0033344),0.3736906091987817,0.8460194884359191,0.6706896551724137,0.8959533856108792,1.0,5/20,19.36%,SCARB1;SOAT2;ABCG1;STX12;ABCA1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.383140295663107,0.8460186179829476,0.6360485268630849,0.8954795868876583,1.0,5/18,13.77%,ADAM10;PSEN1;APH1A;ADAM17;ABCG1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3986212951042396,0.8459118755961406,0.6605166051660517,0.8952150167739242,1.0,2/14,3.04%,CD200;TNFRSF1B
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3172656484819163,0.845525625828739,0.6793002915451894,0.8954480703101679,1.0,12/48,16.25%,HIF1A;TIGAR;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153;PNPT1
prerank,regulation of ion transmembrane transport (GO:0034765),0.34139847635130893,0.8454327476726692,0.6578947368421053,0.8951243021149269,1.0,5/33,10.58%,NEDD4L;KCNQ1;KCNE2;NEDD4;ANO6
prerank,negative regulation of response to external stimulus (GO:0032102),0.28537785127812054,0.8451856858621388,0.7496790757381258,0.8951087479429892,1.0,17/105,14.29%,TEK;PPARD;MFHAS1;LPCAT3;SIGIRR;TNFRSF1A;CRK;INPP5F;NMI;EPHA4;RB1;CARD16;TRIB1;CDH5;KLK8;ILRUN;PROC
prerank,positive regulation of biosynthetic process (GO:0009891),0.3261418481987603,0.8450183337730108,0.6805555555555556,0.8949460204077992,1.0,7/40,13.03%,RAB27A;PLCG2;SORBS1;TGFB1;CREB1;GRIN1;MTPN
prerank,epithelial cell development (GO:0002064),0.3755881663618608,0.8443198453610018,0.67779632721202,0.8957405263147564,1.0,3/20,9.67%,EXPH5;SIPA1L3;SLC4A7
prerank,non-motile cilium assembly (GO:1905515),-0.2912205594916756,-0.8442807658765593,0.702247191011236,0.9737159821228718,1.0,9/30,19.63%,IFT88;RPGRIP1L;TTC8;CEP89;FUZ;PCM1;C2CD3;TMEM17;IFT57
prerank,zinc ion transport (GO:0006829),0.36217053068776917,0.8441925519985974,0.6416938110749185,0.8954827584106739,1.0,1/21,0.92%,SLC39A8
prerank,protein stabilization (GO:0050821),0.2721645603344562,0.8438143380303754,0.7735849056603774,0.8957027343860008,1.0,50/168,22.13%,GNAQ;TSPAN1;HIP1;HIP1R;EFNA1;FBXW7;SOX17;STK3;STK4;SMAD7;RPS7;ATF7IP;TMEM88;ATP1B3;CREB1;RPL23;SOX4;AFM;EPHA4;GLMP;FKBPL;COA8;NOP53;HSP90AB1;NAA16;STX12;BAG4;IRGM;CHP1;CHEK2;RPL11;BAG1;USP7;CDC37;COG7;MTMR9;ZBED3;SWSAP1;NLK;CCT7;TAF9;PPIB;CCT2;BAG2;CCNH;SEL1L;PRKRA;CDC37L1;MFSD1;TNIP2
prerank,cellular response to acid chemical (GO:0071229),0.3507801112771618,0.8432959540394408,0.6516666666666666,0.8961752230839596,1.0,5/27,10.32%,SH3BP4;KLF2;XBP1;RPTOR;LARS1
prerank,positive regulation of immune effector process (GO:0002699),0.3511863622846688,0.8432871299779398,0.6849757673667205,0.8957226350860937,1.0,4/27,9.61%,PTPRJ;RPS19;XBP1;IL23A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3635620105491337,-0.8431417549381675,0.6879271070615034,0.9749874964353944,1.0,6/13,23.45%,CDH13;LDLR;CD81;SYK;ITGB2;PPARG
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3845482077410466,-0.8429291216740238,0.6777777777777778,0.9743902492757992,1.0,4/10,19.65%,OGT;SELENOS;DGKQ;PDK2
prerank,regulation of axon guidance (GO:1902667),-0.38882602182436876,-0.8427978706464311,0.6645021645021645,0.9735896318773649,1.0,3/10,9.30%,NRP1;ZSWIM8;VEGFA
prerank,body fluid secretion (GO:0007589),-0.3455350721542645,-0.8427577325340155,0.6873508353221957,0.9726349421461816,1.0,5/15,15.14%,ERBB4;SLC22A4;VEGFA;PRLR;SLC22A2
prerank,modulation by host of viral genome replication (GO:0044827),-0.3568607172350821,-0.8423873279471724,0.6688741721854304,0.9723436013128123,1.0,4/13,13.23%,PRKN;IFI27;NUCKS1;TBC1D20
prerank,signal peptide processing (GO:0006465),-0.36884338769178954,-0.8422819419308022,0.6590909090909091,0.971510197448676,1.0,3/11,14.14%,PCSK5;SPCS3;SPCS2
prerank,regulation of phosphate metabolic process (GO:0019220),0.3853030572596123,0.8422775298396303,0.6666666666666666,0.8971275688743202,1.0,4/16,9.83%,IKBKB;TIGAR;PSEN1;SMG7
prerank,mitotic cell cycle phase transition (GO:0044772),0.2632382692627146,0.8421647567523909,0.7758816837315131,0.8968763900457898,1.0,47/203,20.99%,EPS8;CDK6;TPD52L1;PLCB1;PRKAR2B;PPP1R12A;EIF4E;CEP41;PLK2;AURKA;PCNT;ACVR1;CDKN1B;FBXL7;DYNLL1;ANAPC7;CCNY;CHMP4B;CDK2;CNTRL;CEP57;ANAPC1;RB1;PPP2R2D;EIF4EBP1;CUL1;MAX;CDC25C;FBXL3;CEP290;CCNJ;CTDP1;CHEK2;CUL3;CEP131;CDC34;CEP72;PPP2R2A;CETN2;CDK5RAP2;CUL2;PPP2R1A;E2F3;TRIM71;DBF4;PLK1;CCNH
prerank,regulation of axon regeneration (GO:0048679),-0.3603808498447376,-0.8421158688659213,0.6904231625835189,0.9707626932788829,1.0,2/12,2.38%,PTN;PTPRS
prerank,regulation of axon extension (GO:0030516),0.332727515695348,0.841938216867744,0.6965098634294385,0.8967969358572443,1.0,3/37,4.06%,NTN1;SEMA7A;DIP2B
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.30831813875844644,-0.8418966233156729,0.6876456876456877,0.9701452764132757,1.0,5/22,13.57%,APOD;LRRK2;SUFU;RAB23;INSIG1
prerank,protein maturation (GO:0051604),-0.23062300289046223,-0.8414000723086985,0.8312236286919831,0.9701056658644467,1.0,28/95,22.68%,AEBP1;F3;OGT;PCSK5;MMP14;NNAT;MMP16;ADAM19;NAA40;TASP1;CPXM2;APH1B;CPXM1;DNAJB11;CCS;TSPAN15;PCSK6;NCSTN;LMF1;CPM;CIAO1;NFU1;BACE1;PTCH1;CTSS;NAA60;EEF1AKMT4-ECE2;CLN3
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.28733378980865687,-0.8413413269023966,0.7107438016528925,0.9691994226602197,1.0,4/32,4.64%,MAGI2;PDGFRB;PRKCD;ITGA1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.39912513188945836,0.8413341531641788,0.6441605839416058,0.8973864639791129,1.0,4/13,13.43%,PLCG1;AKT3;SIRT6;ADAM17
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.38878375863940545,-0.8412196414210488,0.690744920993228,0.9683926541544905,1.0,3/10,16.71%,PRKACA;APOE;ABCA7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2705090705519008,-0.8404455309271714,0.75,0.9689454052100126,1.0,6/43,9.47%,EGFR;ERRFI1;CBLB;ITGA1;SNX6;MVP
prerank,protein targeting (GO:0006605),0.28259288072798444,0.8398570208891509,0.7638376383763837,0.8996218800203711,1.0,25/118,18.98%,RASSF9;PARD3;AQP11;TAOK2;SDCBP;SEC63;ZDHHC18;ZDHHC9;ZFAND2B;MYO1C;ICMT;HOMER3;PITRM1;SPCS1;GIPC1;AP1S3;VPS37C;RPL11;ZDHHC24;TRAK2;ZDHHC1;CDC37;TOMM22;NACA;ZFAND2A
prerank,positive regulation of blood coagulation (GO:0030194),-0.3421735485860767,-0.8393770976567942,0.7046511627906977,0.9700974702785009,1.0,3/17,10.33%,F3;THBS1;SERPINE1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.316411440391041,0.8392056756226447,0.7038081805359662,0.9002827549973543,1.0,11/51,14.62%,VEGFC;IL6R;F7;VEGFD;PTK2;CSF1;ANO6;GAS6;LGMN;ADAM17;PGF
prerank,histone modification (GO:0016570),0.2798187533211399,0.8390735329569714,0.7416452442159382,0.9000305807327755,1.0,16/109,12.99%,RPS6KA5;HDAC9;USP3;PADI4;PHF20;RCOR1;RBM14;KAT6B;AURKC;CDK2;PARP2;PHF20L1;ENY2;MIER1;MIDEAS;PADI1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3683056626914478,0.8388364599788971,0.6787564766839378,0.8999960210318976,1.0,5/19,16.38%,DDIT4;HIPK1;BCL3;SNW1;TMEM109
prerank,positive regulation of cellular respiration (GO:1901857),-0.3719429238256733,-0.8384740911770463,0.6897321428571429,0.9708219412549278,1.0,1/11,1.98%,NUPR1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.33017669852589543,-0.8381500168855626,0.6748768472906403,0.9704140910411896,1.0,4/17,9.36%,IL34;PTN;SERPINE2;BIN1
prerank,regulation of multicellular organismal development (GO:2000026),0.35619630491648413,0.8370132023501825,0.684640522875817,0.9028147951409168,1.0,2/25,3.28%,INSR;SOX17
prerank,positive regulation of macrophage activation (GO:0043032),-0.3303063306075299,-0.8365712482464776,0.7062937062937062,0.9725365832957755,1.0,2/17,3.57%,LBP;THBS1
prerank,mitochondrial membrane organization (GO:0007006),-0.28285159117823255,-0.8358836362738724,0.7506925207756233,0.9727981052437973,1.0,14/32,32.04%,BCL2;MICOS10;CHCHD3;CHCHD6;MTX2;SLC25A4;MAIP1;PPIF;SAMM50;APOO;PMAIP1;DNAJC11;TMEM11;IMMT
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.38974690450917704,0.8357620980983282,0.6420863309352518,0.9045036742198792,1.0,3/11,12.17%,MAD2L2;TFAP4;MUC1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.28496864086195084,0.8357506334173693,0.7393048128342246,0.9040575959155848,1.0,18/88,16.92%,DAB2IP;TAL1;FNIP2;BIK;TIRAP;SDCBP;SH3GLB1;BCL2L11;TGFB1;CDT1;BID;RACK1;WARS1;RAB7A;CDH5;BMF;PIH1D1;SPIDR
prerank,response to leucine (GO:0043201),0.4061574937189601,0.8357325673764366,0.6622641509433962,0.9031431786593076,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,cellular response to leucine (GO:0071233),0.4061574937189601,0.8357325673764366,0.6622641509433962,0.9031431786593076,1.0,3/10,10.32%,RPTOR;UBR1;LARS1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.429620100976831,0.8356647148563674,0.6612903225806451,0.9023125660692908,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,negative regulation of glycolytic process (GO:0045820),0.429620100976831,0.8356647148563674,0.6612903225806451,0.9023125660692908,1.0,3/10,7.13%,CBFA2T3;FBP1;TIGAR
prerank,ether lipid metabolic process (GO:0046485),-0.35298723765028883,-0.8356460640741212,0.6598173515981736,0.9721998018442161,1.0,1/14,0.33%,AGMO
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.33915146934187734,-0.8355393987461763,0.6958424507658644,0.9713654952073099,1.0,4/14,14.19%,IRS1;PPARA;IRS2;MFSD2A
prerank,negative regulation of cyclase activity (GO:0031280),-0.35083687350912957,-0.8350049265437097,0.7283372365339579,0.971440145812327,1.0,3/14,13.84%,ADGRV1;GRM3;PALM
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3768654223655444,0.8349335144675586,0.684297520661157,0.9031279010869792,1.0,3/17,5.23%,KDR;EPHB4;GREM1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3239106742189696,-0.8344887246967889,0.6950354609929078,0.9713908872433041,1.0,10/20,22.58%,PLCE1;KCNB2;SPHK1;CTTN;MYOCD;ZDHHC21;CHRM3;ADRB2;CHRM2;DAPK3
prerank,polyol biosynthetic process (GO:0046173),-0.3294841690589059,-0.8344080076421979,0.6892523364485982,0.9705192453684061,1.0,3/16,8.41%,CYP27A1;FGF2;ISYNA1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2561102629633453,-0.8343869224159384,0.7738853503184714,0.9695308451132781,1.0,19/47,32.04%,MICOS10;CHCHD3;CHCHD6;TIMM22;MTX2;ATP5PO;MAIP1;TIMM8B;TIMM9;TIMM10;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;TMEM11;IMMT
prerank,intracellular sterol transport (GO:0032366),0.39638774871965987,0.8342545003146015,0.6497277676950998,0.9039292084207968,1.0,9/13,30.70%,ABCG1;STAR;OSBPL2;ABCA1;STARD4;NPC1;RELCH;NPC2;OSBP
prerank,mRNA destabilization (GO:0061157),-0.27614055907359275,-0.8341286234151204,0.7312138728323699,0.9690292253850292,1.0,12/38,26.50%,ROCK2;CPEB3;MOV10;CELF1;FTO;RC3H2;TUT4;PDE12;RBM24;TARDBP;ZFP36L2;POLR2D
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3573891770543321,-0.8339248923142156,0.6931818181818182,0.9684015745043407,1.0,3/13,13.84%,ADGRV1;GRM3;PALM
prerank,receptor recycling (GO:0001881),0.4223018903536911,0.8337828810301359,0.6684782608695652,0.904287367165484,1.0,3/10,12.23%,LMTK2;EHD3;RAB11B
prerank,phosphate ion transport (GO:0006817),0.39353089690016685,0.8328396001694006,0.6868131868131868,0.9054558213185022,1.0,4/16,12.60%,SLC37A3;SLC25A30;SLC37A1;XPR1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.40063893987931143,0.8323233843136328,0.6545801526717557,0.9058780488328961,1.0,5/11,12.94%,SMAD7;USP15;ACVR1;TGFB1;TGFBR2
prerank,synaptic vesicle cycle (GO:0099504),-0.2949016070960241,-0.8321006867625292,0.7362637362637363,0.9709746198884448,1.0,4/30,6.02%,BRSK1;SNAP25;PCLO;NLGN1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.41622427740619516,0.8319139871149546,0.6763565891472868,0.9061409403489138,1.0,2/11,4.20%,SCARB1;PLIN5
prerank,synaptonemal complex organization (GO:0070193),0.38520235734016034,0.8316553532779299,0.6607460035523979,0.9056587797908665,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.38520235734016034,0.8316553532779299,0.6607460035523979,0.9056587797908665,1.0,3/15,16.98%,RAD21L1;TRIP13;RAD21
prerank,regulation of Ras protein signal transduction (GO:0046578),0.28670018039679135,0.8314728166174187,0.7562326869806094,0.9054973997236673,1.0,12/86,8.49%,EPS8;DAB2IP;ARHGEF2;LYN;BCR;NOTCH1;DENND4C;ARHGAP17;OPHN1;FBP1;SYNGAP1;SHOC2
prerank,regulation of macrophage differentiation (GO:0045649),-0.3439270846404112,-0.8313938141538048,0.6791569086651054,0.9713211878709965,1.0,4/15,14.36%,IL34;PRKCA;INHBA;PTPN2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2553779558345536,-0.8313660613313444,0.7678018575851393,0.9703565348652199,1.0,9/56,9.53%,EGFR;ANXA1;CCND2;ANAPC5;RAD51B;ADAMTS1;UBE2E2;TFDP1;RGCC
prerank,alcohol catabolic process (GO:0046164),-0.38197136471966914,-0.8312405338426809,0.6790123456790124,0.9695832914142358,1.0,3/10,16.21%,CYP27A1;APOE;MT3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.34063992627739825,0.8312308935811684,0.6816,0.90548272467654,1.0,5/27,17.38%,CD200;ARRB1;GAS6;IRAK3;CD200R1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.39571777207601305,0.8308834730285014,0.6678571428571428,0.9056057822916848,1.0,3/13,10.67%,AQP11;LPCAT3;MBTPS2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.29415185892501555,0.8306149231079839,0.7256515775034293,0.905595982181221,1.0,13/72,17.53%,POLK;ISG20;EDC3;RNASE1;RPA1;RNASE4;DICER1;FAN1;PNRC2;ERCC4;XRN2;GTF2H4;RFC3
prerank,chemical synaptic transmission (GO:0007268),0.25453536107462066,0.8304741799241934,0.8232044198895028,0.9053896570245081,1.0,19/284,6.79%,MPZ;UNC13B;SLC6A5;SLC6A2;SLC12A7;HTR2A;PDE7B;CACNA1E;PRKAR2B;PCDHB4;SYPL1;RPS6KA3;SDCBP;RPS6KA1;SYN3;KCNMB4;CACNA1A;HCRTR1;ATXN3
prerank,regulation of cholesterol transport (GO:0032374),-0.3176668412666168,-0.8303399534638279,0.7162790697674418,0.9703712802570623,1.0,1/20,0.50%,LRP1
prerank,telomere maintenance (GO:0000723),-0.25678351371098895,-0.8293846309056353,0.7857142857142857,0.9711932684426313,1.0,22/50,31.09%,PARP3;RTEL1;TEP1;RAD50;XRCC5;TERF2;XRCC6;SMC6;ATR;DNA2;TPRKB;TERT;PRKDC;ATM;POLD1;LTO1;XRCC3;POLD2;SMC5;DCLRE1B;RPA2;BLM
prerank,peptidyl-proline modification (GO:0018208),-0.3005813294100168,-0.8293401186161246,0.7274939172749392,0.9702646190578502,1.0,5/25,14.46%,FKBP5;NKTR;FKBP10;PPIC;PPIH
prerank,female gonad development (GO:0008585),-0.31435918473110847,-0.8292658087737064,0.7132352941176471,0.9693706440681155,1.0,7/19,19.48%,KIT;VEGFA;INHBA;NR2F2;CEBPB;INHBB;NUP107
prerank,positive regulation of tissue remodeling (GO:0034105),0.41345038065348405,0.8292533068764392,0.6574585635359116,0.907063303948741,1.0,2/10,9.61%,IL15;IL23A
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3731602443552502,-0.8292080457480994,0.7010526315789474,0.9684449236530629,1.0,1/10,2.25%,BICD1
prerank,regulation of Golgi organization (GO:1903358),-0.3340467218699054,-0.8290425416791914,0.6897374701670644,0.9677630777064439,1.0,7/17,24.73%,MYO5A;MAP2K2;RBSN;MAP2K1;PDE4DIP;RAB33B;CAMSAP3
prerank,organic cation transport (GO:0015695),-0.3186999193143515,-0.8280585430820607,0.7108433734939759,0.968691847084903,1.0,5/20,15.26%,SLC47A1;SLC22A4;SLC25A42;SLC22A2;SLC22A18
prerank,response to X-ray (GO:0010165),-0.3438371725493004,-0.8279997417187123,0.691747572815534,0.9677831799966792,1.0,6/14,23.99%,ANXA1;NUCKS1;IKBIP;XRCC5;XRCC6;ATM
prerank,regulation of proteolysis (GO:0030162),-0.269192977608936,-0.8279527650055623,0.7633333333333333,0.9668639853326924,1.0,11/48,14.41%,CYFIP2;OGT;ASPH;SERPINE2;CAMK2N1;PLAT;BTRC;FGFR4;CST3;ITCH;LTBP4
prerank,regulation of autophagosome assembly (GO:2000785),0.3315540636694324,0.8270363969279034,0.7041800643086816,0.910433486186808,1.0,8/33,9.76%,MTM1;RALB;TBC1D12;SH3GLB1;FEZ2;CHMP4A;CHMP4B;NPRL2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3442458654471866,0.8268237098850688,0.7128547579298832,0.9103290884583276,1.0,1/25,1.15%,MEF2C
prerank,negative regulation of insulin secretion (GO:0046676),0.3746184780602,0.8264770867268817,0.674457429048414,0.9104694145851757,1.0,3/17,4.04%,PIM3;KLF7;KCNB1
prerank,cGMP biosynthetic process (GO:0006182),0.4196240019074,0.8258597825616388,0.6672932330827067,0.9110789716014176,1.0,1/10,2.54%,NPR1
prerank,glutamate metabolic process (GO:0006536),0.3700002875326303,0.8257467858455878,0.7014134275618374,0.9108045997895233,1.0,3/19,3.41%,DGLUCY;GLS2;GLS
prerank,purine-containing compound catabolic process (GO:0072523),0.4021045713296066,0.8253983915205834,0.6696750902527075,0.910948270553947,1.0,4/13,14.45%,GDA;NT5C2;XDH;NUDT15
prerank,liver development (GO:0001889),0.3322083722219784,0.8251038979814054,0.6926605504587156,0.9109754462291154,1.0,5/32,8.09%,LSR;ZIC3;XBP1;AURKA;PKD2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.40139866830400245,0.8250976607125957,0.6624087591240876,0.9105157111804281,1.0,1/12,0.70%,UNC13B
prerank,monoacylglycerol metabolic process (GO:0046462),0.3917233736597895,0.8249233652609247,0.6781193490054249,0.9103269218993524,1.0,4/13,15.79%,PLA2G4A;DGAT1;FAAH;MOGAT2
prerank,synaptic vesicle recycling (GO:0036465),-0.28950608501457376,-0.8242899179478582,0.7593582887700535,0.9729663366772998,1.0,12/31,23.17%,NLGN2;SYT1;SYNJ2;NLGN1;STON2;NLGN3;AMPH;SNCA;TBC1D24;SYT2;VAMP2;CANX
prerank,epiboly involved in wound healing (GO:0090505),0.37850256603705495,0.8236699684501299,0.6591304347826087,0.9120512800592144,1.0,3/16,5.12%,LCP1;MRTFA;CEACAM1
prerank,regulation of cell death (GO:0010941),0.2815432466071073,0.823512186348024,0.7525906735751295,0.9118564686236675,1.0,6/94,3.44%,ACER2;PDE8A;PRKD1;SRGAP2;TNFRSF1B;NCK1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.28009739116402266,-0.8234137162524329,0.7398843930635838,0.9736202603839486,1.0,8/32,14.84%,CEMIP;AKAP6;TRPC1;GSTM2;GPER1;HTT;JPH2;SNCA
prerank,cell differentiation in spinal cord (GO:0021515),0.419945553054748,0.8233864762562548,0.6715867158671587,0.9116081724347226,1.0,2/10,9.33%,SOX13;SOX4
prerank,DNA alkylation (GO:0006305),0.365866540099295,0.8231033165154404,0.6828046744574291,0.9111524335868347,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.365866540099295,0.8231033165154404,0.6828046744574291,0.9111524335868347,1.0,8/19,18.39%,KMT2E;ATF7IP;PPM1D;GATAD2A;SPOCD1;ATRX;TEX15;EHMT1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.38749926151606723,0.8225329455738387,0.666077738515901,0.9116758931628892,1.0,3/14,10.68%,MSN;OPHN1;FSCN1
prerank,regulation of RNA splicing (GO:0043484),0.2951547245411186,0.822404917274159,0.7452574525745257,0.9114184592244557,1.0,13/69,10.71%,ERN1;TMBIM6;RBM20;MBNL1;PTBP3;MBNL2;HNRNPF;DYRK1A;MBNL3;HNRNPK;ZNF326;HNRNPLL;YTHDC1
prerank,positive regulation of synaptic transmission (GO:0050806),0.29321548267132996,0.8222914370313479,0.7335203366058906,0.9111299184555683,1.0,3/72,2.59%,SHANK3;APP;PTK2B
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.33675229772636583,0.8222803019504351,0.6928327645051194,0.9106778702086125,1.0,5/30,8.10%,FOXP1;PKN1;TRIM68;H3-3A;KDM4C
prerank,motile cilium assembly (GO:0044458),-0.3622339059697701,-0.8222240989074692,0.7266355140186916,0.9748986053044797,1.0,4/12,15.43%,BBOF1;BBS5;CCDC39;RSPH9
prerank,P-body assembly (GO:0033962),0.40530379637229363,0.8221860111400362,0.6702702702702703,0.9103678520273876,1.0,7/12,27.52%,EDC3;RC3H1;LSM3;LSM14A;EIF4ENIF1;DDX6;PATL2
prerank,cellular response to glucose starvation (GO:0042149),-0.2645417176986868,-0.8221603700931781,0.7597765363128491,0.973997724122996,1.0,12/41,16.48%,BRSK1;IMPACT;PRKAA2;PRKAG2;CPEB4;EIF2AK3;PRKAG3;SZT2;NUAK2;HNRNPA1;SESN2;PRKAG1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.33790565231175157,-0.822032237822717,0.7037037037037037,0.9732053486523177,1.0,7/15,25.90%,RYR2;SPCS3;RAB10;SPCS2;RAB3GAP1;SEC61A1;SRPRB
prerank,secretion (GO:0046903),0.38382281206234237,0.8212173984324591,0.6996402877697842,0.911578937886247,1.0,3/14,8.40%,NPR1;TPD52;GUCA1B
prerank,water transport (GO:0006833),-0.3592011322229881,-0.8211718048004147,0.7217391304347827,0.9738268065033092,1.0,1/12,1.60%,PDPN
prerank,neutral amino acid transport (GO:0015804),0.342500774268008,0.820961408391443,0.718944099378882,0.9115284074663837,1.0,7/28,15.20%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC36A4;SLC7A5
prerank,regulation of TOR signaling (GO:0032006),0.29432223963725085,0.8209226541649528,0.746077032810271,0.9111283337651968,1.0,10/67,10.66%,SH3BP4;DDIT4;TNFAIP8L1;GNA12;RPTOR;UBR1;RICTOR;NPRL2;LARS1;GAS6
prerank,negative regulation of translation (GO:0017148),0.2852595959046481,0.8207875487345578,0.7550744248985115,0.9108710244528074,1.0,19/87,15.91%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;PUM1;BTG2;RPL13A;CNOT1;MRPL13;EIF4EBP1;RACK1;EIF2AK4;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,DNA geometric change (GO:0032392),-0.30189234517445546,-0.8204362582310899,0.7101063829787234,0.9742313232341788,1.0,5/24,11.11%,HNRNPA2B1;ANXA1;RECQL5;RTEL1;RAD50
prerank,response to organonitrogen compound (GO:0010243),-0.2723305032144987,-0.8195613481626665,0.7758620689655172,0.9750364117686405,1.0,3/38,5.80%,PRKN;GLRB;RCN3
prerank,ERAD pathway (GO:0036503),-0.23590266755170738,-0.8188858130638458,0.83203125,0.9751999312946055,1.0,19/83,20.60%,PRKN;UGGT2;SELENOS;RCN3;AMFR;USP13;UBXN4;JKAMP;UBE4B;NPLOC4;GET4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,response to amino acid (GO:0043200),0.3289657211626213,0.8187309890275123,0.705511811023622,0.9139969446924948,1.0,6/31,11.63%,SH3BP4;TMBIM6;XBP1;RPTOR;LARS1;GRIN1
prerank,pore complex assembly (GO:0046931),0.367373115790625,0.8183857417927342,0.6813380281690141,0.9140869512126011,1.0,6/19,15.34%,ADAM10;ANO6;NUP98;NUP205;NUP153;TSPAN33
prerank,phospholipid metabolic process (GO:0006644),0.29878302772532683,0.8183545051163101,0.7417127071823204,0.9136788500752904,1.0,8/71,8.50%,PLA2G4A;PLPP1;ENPP2;PLA2G2D;AGPAT1;MBOAT1;LPL;PLAAT3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3774261207958642,0.8181817738535412,0.6742556917688266,0.9135063245155741,1.0,7/15,27.12%,TCF7L2;GAS6;ANP32B;RAPGEF3;YWHAE;GSK3B;EMD
prerank,zinc ion transmembrane transport (GO:0071577),0.35075705197425955,0.818148905391594,0.675,0.9130994746193886,1.0,1/22,0.92%,SLC39A8
prerank,spliceosomal snRNP assembly (GO:0000387),0.31902084738270425,0.8181244950449117,0.7174887892376681,0.9126742251109009,1.0,19/38,31.39%,TGS1;WDR77;DDX20;AAR2;STRAP;SRSF10;SART1;SART3;PRPF3;SNRPD3;LSM2;SNUPN;PRMT5;SNRPD2;SNRPD1;COIL;SNRPB;CLNS1A;GEMIN8
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3535460678081944,0.8179611359146723,0.6895973154362416,0.9125046253706991,1.0,7/22,22.27%,MVB12B;NEDD4;VPS28;VPS37C;STAM;TSG101;VPS36
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3177342228321073,-0.8179452256168774,0.7296037296037297,0.975962559691645,1.0,4/18,14.40%,PTN;CNOT3;TAF6L;WDR43
prerank,positive regulation of reproductive process (GO:2000243),-0.28196432228194246,-0.8179237618800467,0.7771739130434783,0.9749942905234361,1.0,11/31,28.20%,SIRT2;VEGFA;INHBA;SYDE1;ACVR1B;INHBB;CFAP69;SMURF2;CACNA1H;C1QBP;HYAL3
prerank,positive regulation of cell death (GO:0010942),0.2970027018565703,0.8176661920178501,0.7443820224719101,0.9125435633388855,1.0,10/59,12.40%,ACER2;DDIT4;FYN;SLC6A6;WNT5A;CDKN1B;BNIP3;PICALM;RIPK1;RIPK2
prerank,cardiac muscle cell differentiation (GO:0055007),0.3498961311325753,0.8176081974499069,0.6881188118811881,0.9121858042496414,1.0,3/21,6.28%,MEF2C;SIK1;ACVR1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34178196094932195,0.8176039371788919,0.6750841750841751,0.9117318440961897,1.0,8/24,17.66%,FYN;KCNB1;AKT2;MYO1C;TCAF2;ERBB2;CHP1;CIB1
prerank,protein modification by small protein removal (GO:0070646),0.25300359050058724,0.8174951324524534,0.8344444444444444,0.911465480797157,1.0,76/252,24.09%,ESR1;SMAD1;HIF1A;NFKBIA;USP3;BABAM2;SMAD7;USP15;UCHL5;ATXN3;SNX3;PSMA2;BRCC3;FOXK1;ZRANB1;IKBKG;COPS2;PSMA8;RAD23A;TNIP1;PSMA6;OTUD4;COPS4;RIPK1;ASXL1;BIRC3;IFIH1;TRAF6;APC;PSME1;MBD5;YY1;KAT2B;USP12;ACTR5;BIRC2;RHOA;ABRAXAS2;WDR48;RHOT1;NEDD8;YOD1;USP8;WDR20;DESI2;DESI1;NFRKB;PSMA4;USP7;PSMF1;STAM;NLRP3;USP25;USP21;SMAD2;PSMB7;PSMB1;TRRAP;ATXN7;PSMD2;TADA2B;TNIP2;BABAM1;PSMA5;CCNA2;PSMC3;EIF3F;JOSD1;STAM2;UCHL3;ADRM1;TRAF2;SENP6;COPS8;UBE2D1;SUDS3
prerank,negative regulation by host of viral process (GO:0044793),0.39976183722751824,0.8174852093564067,0.6685823754789272,0.9110171726305349,1.0,3/10,12.83%,CCNK;PTX3;EIF2AK4
prerank,RNA 3'-end processing (GO:0031123),0.293445674241113,0.8164182935620151,0.7406896551724138,0.9123937673821978,1.0,26/69,27.56%,TENT4A;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;PNPT1;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;TUT1;TUT7;PAPOLA
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.40406827870793693,0.8161345225723755,0.6774809160305344,0.9124272890914453,1.0,2/11,7.27%,LYN;JAK1
prerank,kinetochore organization (GO:0051383),-0.3487671062896597,-0.8156812229942857,0.7323008849557522,0.9781266246337308,1.0,9/13,37.47%,CENPT;CENPH;NDC80;CENPF;CENPA;DLGAP5;CENPC;CENPW;MIS12
prerank,myoblast fusion (GO:0007520),0.3979450060513552,0.8152878989171451,0.6771217712177122,0.9133790295669809,1.0,2/12,7.97%,JAM2;PTGFRN
prerank,positive regulation of translation (GO:0045727),-0.22758138635190486,-0.814981004833241,0.848,0.978466569087188,1.0,9/94,10.10%,SAMD4A;PLD1;THBS1;CPEB3;FXR2;PRR16;RMND1;LARP6;CIRBP
prerank,GPI anchor metabolic process (GO:0006505),0.34239181755688236,0.8144754532816576,0.704225352112676,0.9142870160694094,1.0,8/26,18.19%,PGAP1;PIGU;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3729176373599945,-0.8143579914908013,0.7133757961783439,0.9786369990472005,1.0,4/10,23.37%,CAMK1;SMARCB1;CHEK1;SPHK2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.3262583100180238,-0.8138259443789407,0.7302325581395349,0.9785988736813168,1.0,5/15,32.65%,SELENOS;NPLOC4;DERL2;HSP90B1;VCP
prerank,V(D)J recombination (GO:0033151),0.402231861602493,0.8137464714751128,0.7102272727272727,0.915101600301704,1.0,5/11,24.16%,TCF3;DCAF1;XRCC4;HMGB1;LIG4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.37783415784904456,0.8135975734813692,0.6804308797127468,0.9148900403038449,1.0,4/15,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,regulation of stem cell differentiation (GO:2000736),0.2798904091018794,0.8128855287467104,0.7841352405721717,0.9156330010347914,1.0,11/89,11.57%,LMO2;GATA2;TAL1;NOTCH1;TCF12;PSMA2;TCF3;TCF15;PSMA8;PSMA6;CBFB
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4114539245791805,0.8127114836156213,0.6631205673758865,0.9154614178770757,1.0,2/10,10.79%,BTN2A2;RC3H1
prerank,nuclear pore organization (GO:0006999),0.384198898401091,0.8127074473754679,0.6738351254480287,0.9150029931524735,1.0,5/14,14.81%,NUP98;NUP133;NUP205;NUP54;NUP153
prerank,mRNA transport (GO:0051028),0.27624240797236316,0.8125835286318989,0.7635658914728682,0.9147652507695916,1.0,28/101,19.97%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;ZFP36;UPF2;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153;AGFG1;ZFP36L1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.24254046019627692,-0.8123070145698146,0.8105263157894737,0.9803960028945286,1.0,7/68,8.00%,AMPD3;RHOQ;ENPP1;ACOT11;TPST1;LRRK2;ABHD14B
prerank,monosaccharide transmembrane transport (GO:0015749),-0.33800262898080424,-0.8110990055629785,0.7336561743341404,0.9815416570204208,1.0,4/16,14.20%,SLC5A3;SLC2A12;SLC2A10;SLC45A3
prerank,negative regulation of bone remodeling (GO:0046851),-0.36263110008387023,-0.8108374564077953,0.6737089201877934,0.9810639344954722,1.0,4/11,18.70%,UBASH3B;SFRP1;GPR137B;TMEM119
prerank,steroid catabolic process (GO:0006706),0.40008552868989256,0.8107479892576339,0.6833333333333333,0.9173587577794138,1.0,2/10,10.26%,FGF23;CYP27B1
prerank,regulation of intracellular transport (GO:0032386),0.31333643984905635,0.8099185166410429,0.7258566978193146,0.9182940830027038,1.0,8/38,13.90%,LCP1;DNAJC30;RNF139;PTPN1;INPP5F;NUP214;RAB11B;NDEL1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3410240890491333,-0.8097712213223631,0.7091346153846154,0.9820395347463949,1.0,7/15,31.38%,COQ8B;COQ5;FDXR;COQ10A;NDUFA9;COQ10B;COQ6
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.26470753916447515,-0.8092556122312592,0.782051282051282,0.9819915374904744,1.0,4/40,5.86%,PRKCD;KMT5A;FXR2;NEK4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2983878663427533,-0.8092538622588515,0.7237851662404092,0.9809820902176333,1.0,5/25,18.37%,IGF1;PER2;DOT1L;HEY2;HEY1
prerank,apoptotic mitochondrial changes (GO:0008637),0.32862714224676576,0.8092426669376318,0.7149460708782742,0.9189537404583141,1.0,9/32,14.20%,BIK;BOK;BCL2L1;GGCT;BNIP3;SFN;BID;SOD2;THEM4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.38358033442589706,0.8088316008922983,0.6710280373831776,0.9191620103495061,1.0,1/12,1.99%,FOXP1
prerank,microtubule bundle formation (GO:0001578),0.31054567357796387,0.8087477451903431,0.7265861027190332,0.9188302225597591,1.0,12/42,23.58%,NAV1;RP1L1;CFAP46;SPAG16;CHP1;CDK5RAP2;CLIP1;NUMA1;PLK1;GAS2L1;CFAP206;RSPH4A
prerank,response to endoplasmic reticulum stress (GO:0034976),0.27094488884232765,0.8082579872020427,0.7787723785166241,0.9191813451454443,1.0,14/107,11.40%,ERN1;RASGRF2;DAB2IP;CASP4;NCK1;TRIB3;BCL2L11;NIBAN1;RNF139;EIF2B5;RHBDD1;ERO1A;MBTPS2;ATF6
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3483683169044723,0.80770749756595,0.6792452830188679,0.9196346606055047,1.0,2/22,5.12%,PPP2R5A;CEACAM1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3476737522076604,-0.8073334816336306,0.7075892857142857,0.983483054149058,1.0,2/11,6.81%,PRKN;P4HB
prerank,positive regulation of hormone secretion (GO:0046887),0.37067306607448264,0.8062019823537929,0.6996336996336996,0.9217253221671312,1.0,2/17,10.49%,EDN1;VAMP8
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3300600802300218,0.8057720298040637,0.7163695299837926,0.9219401629692376,1.0,4/28,12.84%,ESAM;RASA1;ARHGAP28;DBNL
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.375598810910786,0.8055799638152334,0.6947368421052632,0.9217919050967693,1.0,4/13,15.66%,TMSB4X;PSEN1;MAD2L2;DDIT3
prerank,mitochondrion distribution (GO:0048311),0.3859762778970985,0.8054026367152566,0.7096774193548387,0.92162364655562,1.0,4/12,18.22%,MTM1;MEF2A;MSTO1;TRAK2
prerank,peptidyl-threonine modification (GO:0018210),0.29147808906474404,0.8053448529975477,0.7753424657534247,0.9212520390839315,1.0,9/66,6.69%,PRKD1;PRKD2;LMTK2;HIPK1;CDC42BPB;MAPK8;ULK1;ACVR1;DYRK1A
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.262714157981849,-0.8049418391094048,0.7678100263852242,0.9868207222867426,1.0,10/38,19.81%,MAGI2;PPARA;DAG1;TSC2;PHLPP2;GPER1;PHLDA3;OTUD3;FLCN;PTEN
prerank,dendritic cell differentiation (GO:0097028),0.34257760045600605,0.8048884395310495,0.7197986577181208,0.9215207180335719,1.0,4/22,12.94%,LYN;DCSTAMP;GAS6;TGFBR2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.311011656789744,0.8047622514985949,0.7231726283048211,0.9212824310910028,1.0,11/37,26.60%,POLK;RPA1;ERCC4;GTF2H4;RFC3;CHD1L;GTF2H1;RFC5;CUL4B;GTF2H5;RPA3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3677226473186778,0.8044622948681739,0.7005347593582888,0.921349200850434,1.0,2/16,2.21%,IL6ST;EDN1
prerank,regulation of wound healing (GO:0061041),0.30862385583798135,0.8040606997838673,0.753731343283582,0.9215502519523506,1.0,5/42,10.39%,CAV1;OCLN;PTK2;CRK;INSL3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3129102969753482,-0.8035481481567165,0.73989898989899,0.9883603695232533,1.0,1/18,0.53%,FBN1
prerank,fatty acid transport (GO:0015908),0.36554018139867384,0.8034415456543115,0.7043918918918919,0.9221639887454767,1.0,1/17,1.07%,PPARD
prerank,positive regulation of response to wounding (GO:1903036),-0.29439331460052887,-0.8031393790667183,0.7437185929648241,0.9880739608048396,1.0,6/24,13.72%,PTN;VTN;ANXA1;ADRA2A;CLDN1;HBEGF
prerank,visual system development (GO:0150063),0.31191875508007827,0.8027440591007289,0.7329192546583851,0.9228880736410451,1.0,4/37,5.03%,PBX1;FREM2;HIPK1;SIPA1L3
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3968319756445905,0.8026502624384958,0.6951219512195121,0.9225741751711352,1.0,2/11,5.23%,RIN3;GREM1
prerank,regulation of centrosome cycle (GO:0046605),0.34746179962165324,0.8024205053693002,0.7234401349072512,0.9224844083729304,1.0,5/21,17.56%,CHMP2B;AURKA;CHMP4B;NPM1;CEP131
prerank,negative regulation of myotube differentiation (GO:0010832),0.38517304710140265,0.8023825462498133,0.696969696969697,0.9220876649532797,1.0,2/12,4.97%,NOTCH1;XBP1
prerank,regulation of fibroblast migration (GO:0010762),0.35260511728337846,0.8023078392958861,0.721830985915493,0.9217451077150322,1.0,7/20,12.01%,PRR5L;RAC1;TGFB1;PTK2;GNA12;ARHGEF7;CORO1C
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3291638331779407,0.8022991640084988,0.7365930599369085,0.9212974778462716,1.0,4/30,11.84%,ELOVL7;ELOVL5;ABCD4;ABCD1
prerank,neural tube closure (GO:0001843),-0.27046771280185533,-0.8019440634023846,0.8005698005698005,0.9892431000281655,1.0,7/34,11.48%,LMO4;COBL;LRP6;TSC2;FUZ;MTHFD1;TGFB2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.34542646157978496,0.801872977812711,0.7140468227424749,0.9215583338239148,1.0,8/22,24.92%,PSMA2;PSMA8;PSMA6;PSMA4;PSMB7;PSMB1;PSMA5;PSMA3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.34811876099752015,0.8011329059951924,0.697986577181208,0.9223123068349213,1.0,7/21,23.45%,ARHGEF2;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2850672654742858,-0.7998915089554073,0.7651515151515151,0.9918679703509375,1.0,11/23,39.56%,SELENOS;TMED9;NPLOC4;SEC16A;SEC13;DERL2;HSP90B1;VCP;TECPR2;DERL1;LMAN1
prerank,cilium assembly (GO:0060271),0.24714219892147515,0.7998803331319458,0.8801295896328294,0.9239102175778953,1.0,33/296,12.97%,ABCC4;ABLIM1;FNBP1L;EXOC6;EHD4;RAB11A;NOTCH1;CNGB1;PRKAR2B;SSX2IP;DISC1;CEP41;SPATA6;PCNT;RP1L1;BBIP1;EHD2;DYNLL1;EXOC5;CNTRL;TEKT5;CEP57;EXOC4;OCRL;CEP83;DYNLRB1;ARL13B;EHD3;ACTR2;RILP;VANGL2;WDR11;EXOC8
prerank,NAD biosynthetic process (GO:0009435),0.34784339724564034,0.7997656915515716,0.6877076411960132,0.9236386188256517,1.0,3/20,12.73%,PTGS2;NAXE;SLC5A8
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.31599376582814787,0.7996402826549176,0.7302839116719243,0.9233783322659591,1.0,7/35,13.92%,PCDHB4;SELP;ATP2C1;CDH23;PCDHB5;PCDHB11;CDH5
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.35208794575682045,-0.799629807291141,0.7260869565217392,0.9913018423346011,1.0,2/11,3.04%,ACTN2;GPM6B
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2684766920779163,0.7992650537061257,0.7714663143989432,0.9235213636484303,1.0,20/95,19.10%,SAMHD1;RAD21L1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1;SPIDR;RAD21;NSMCE1;SWSAP1;GINS2
prerank,regulation of microtubule depolymerization (GO:0031114),0.3361033812838033,0.7988393656759458,0.7085987261146497,0.9237456641658999,1.0,8/25,23.45%,ARHGEF2;TRPV4;CAMSAP2;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,bile acid metabolic process (GO:0008206),-0.2854751560053095,-0.7987578795306085,0.7903225806451613,0.9918094255469921,1.0,5/27,15.09%,CYP7B1;CYP27A1;OSBPL3;OSBPL6;SCP2
prerank,polarized epithelial cell differentiation (GO:0030859),0.3824932303277627,0.7985508439267783,0.6898395721925134,0.9237587008429806,1.0,2/13,5.94%,MSN;OPHN1
prerank,negative regulation of T cell activation (GO:0050868),0.31374864765479266,0.7981484486613541,0.7515723270440252,0.9239443554599683,1.0,4/35,6.40%,JAK3;CEACAM1;PLA2G2D;TIGIT
prerank,cellular response to UV (GO:0034644),0.2776835305685255,0.7974131527154995,0.7724795640326976,0.92469990531706,1.0,18/76,19.01%,POLK;PTPRK;N4BP1;NEDD4;RHBDD1;MC1R;CARD16;OPN5;EIF2AK4;ERCC4;FMR1;NPM1;YY1;BMF;ACTR5;KDM1A;BAK1;DHX36
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.24263103251586418,0.7970533639784675,0.8913043478260869,0.9248178100778692,1.0,76/314,22.49%,STT3B;SMURF1;NEDD4L;FBXW7;ZNRF1;KCTD10;PELI1;FBXL4;AURKA;ATXN3;ARRB1;UBE2G1;PSMA2;FBXL7;NEDD4;TRIM25;ARMC8;UBR1;ANAPC7;FBXL2;CDK2;SPOPL;RNF4;ANAPC1;ZFAND2B;PSMA8;RAD23A;SIAH1;UBE2D3;PSMA6;CDC26;RB1;CUL1;COP1;ANAPC16;FBXL3;UBE2K;BUB3;TOPORS;UBXN1;PSME1;RNF5;DDIT3;UBE3D;AREL1;CRBN;BIRC2;NHLRC1;CTNNB1;MAEA;CUL3;YOD1;CDC34;PSMA4;DNAJB12;PSMF1;CUL2;ZFAND2A;DNAJC10;APPBP2;FBXO17;PSMB7;TRIM71;PSMB1;HACE1;PLK1;KCTD2;SEL1L;DNAJB9;PSMD2;KCTD5;KLHL42;RNF103;UBXN2A;PSMA5;PSMC3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3533558822735351,0.7969340684220896,0.7422680412371134,0.9245557476027839,1.0,2/21,4.17%,KDR;SOX9
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3674753260792444,0.7958834549656223,0.7259528130671506,0.92582620531337,1.0,2/16,4.20%,SCARB1;PLIN5
prerank,negative regulation of leukocyte migration (GO:0002686),0.397601596955133,0.7953312755261388,0.6717267552182163,0.9262731228529973,1.0,1/10,1.49%,CD200
prerank,steroid biosynthetic process (GO:0006694),-0.24605975756740622,-0.7952167295626996,0.8392282958199357,0.9969580395848853,1.0,15/56,22.72%,CYP7B1;CYP27A1;INSIG2;PRKAG2;OSBPL3;OSBPL6;INSIG1;PRLR;FDFT1;SCP2;FDXR;LSS;CYP51A1;DHCR7;DHRS11
prerank,regulation of B cell differentiation (GO:0045577),-0.31425883493900225,-0.7950114688849197,0.7721822541966427,0.9963133894223364,1.0,5/17,20.67%,MMP14;SFRP1;INHBA;SYK;ID2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.36005391927637365,-0.7936866750138906,0.7300613496932515,0.9975808659400494,1.0,4/10,9.04%,DCN;BCL2;LRRK2;SRC
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2994173896747433,0.7936800209242244,0.7636632200886263,0.9285087697031325,1.0,5/46,7.55%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.2961544785757947,-0.7936460363869988,0.7881136950904393,0.9966427946377819,1.0,1/23,0.34%,IGF1
prerank,regulation of protein polymerization (GO:0032271),0.31660167785067284,0.7935124905801739,0.7503875968992249,0.9283321948553441,1.0,6/35,12.84%,ESAM;RASA1;CAMSAP2;ARHGAP28;PRUNE1;DBNL
prerank,positive regulation of telomere maintenance (GO:0032206),0.3183417361574757,0.7929796355766235,0.7534456355283308,0.9287322570891823,1.0,5/31,15.34%,NEK7;PPP1R10;HNRNPD;SIRT6;ATRX
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3731228642163066,0.7928559653696589,0.6996402877697842,0.928488360621257,1.0,4/12,14.03%,ATF7IP;TASOR;PPHLN1;SETDB2
prerank,alanine transport (GO:0032328),0.39930127256970827,0.7926332935806765,0.708029197080292,0.9283893311894348,1.0,2/10,13.57%,SLC6A6;SLC36A4
prerank,regulation of lymphocyte activation (GO:0051249),0.37615936285510776,0.7923934618978812,0.7078039927404719,0.9283232766988364,1.0,3/12,16.15%,LCK;DCAF15;LAT
prerank,UV protection (GO:0009650),-0.3616316354255944,-0.7923765259679046,0.7308533916849015,0.9978057312020954,1.0,3/10,12.97%,SCARA3;MFAP4;ERCC5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.38554943751320336,0.7923675389912536,0.7094339622641509,0.9279052107332088,1.0,4/11,12.01%,RREB1;ENPP2;ARHGEF7;CORO1C
prerank,response to ionizing radiation (GO:0010212),0.28012776687121105,0.7919614106907911,0.809052333804809,0.9281168126989868,1.0,7/70,12.26%,NET1;DCUN1D3;BABAM2;BRCC3;HUS1;COP1;RHOB
prerank,mitochondrial fusion (GO:0008053),-0.30812637440067914,-0.7917114875196716,0.7380952380952381,0.9979621235849845,1.0,5/18,25.13%,MIGA2;CHCHD3;MIEF2;BAX;GDAP1
prerank,coenzyme A metabolic process (GO:0015936),0.3778586373310526,0.7916099461918636,0.7190812720848057,0.9282099202732479,1.0,5/14,21.05%,SLC25A16;PANK2;PANK3;PPCDC;CROT
prerank,histone H4-K5 acetylation (GO:0043981),0.3714222779804105,0.7913327917107393,0.7142857142857143,0.9277284961131715,1.0,4/15,9.15%,PHF20;JADE2;JADE1;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),0.3714222779804105,0.7913327917107393,0.7142857142857143,0.9277284961131715,1.0,4/15,9.15%,PHF20;JADE2;JADE1;JADE3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.294568960711309,-0.7910870401840029,0.769041769041769,0.9980352163887224,1.0,6/22,22.32%,ERI3;FTSJ3;EXOSC7;EXOSC3;EXOSC9;KRI1
prerank,protein targeting to peroxisome (GO:0006625),-0.2765454040060449,-0.7902148775094923,0.8184210526315789,0.9985659437937565,1.0,11/29,27.01%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;ZFAND6;PEX5;GDAP1;ABCD2;PEX16
prerank,regulation of macrophage activation (GO:0043030),0.326423863602194,0.7898075886439513,0.7786499215070644,0.9297389884384528,1.0,3/30,6.10%,CD200;MFHAS1;WNT5A
prerank,DNA recombination (GO:0006310),-0.2608422795962707,-0.7896155651919918,0.7964601769911505,0.99855730342894,1.0,19/37,32.55%,RECQL5;RAD51B;RTEL1;RAD50;RHNO1;DMC1;IGHMBP2;RAD51C;FBH1;RAD52;GEN1;XRCC3;RAD54L;RPAIN;EXO1;SUPV3L1;ERCC1;BLM;WRN
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.2769394329971066,0.7893318169958747,0.8144611186903138,0.9300490119516371,1.0,27/84,24.92%,AURKA;PSMA2;ANAPC7;CDK2;ANAPC1;PSMA8;PSMA6;CDC26;RB1;ANAPC16;BUB3;PSME1;CUL3;PSMA4;PSMF1;PSMB7;PSMB1;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3018705017365717,0.7892604784766415,0.7515151515151515,0.9297157451533354,1.0,10/41,14.81%,HIF1A;EIF6;NUP214;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,synaptic vesicle exocytosis (GO:0016079),0.31066498790434394,0.7892512262848611,0.76103500761035,0.9292705872277204,1.0,2/40,1.30%,UNC13B;STX3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.27195358551803256,-0.7892264303228362,0.7728531855955678,0.9981901811088097,1.0,6/33,18.17%,FBN1;UBASH3B;PRXL2A;GPR137B;CEBPB;FSTL3
prerank,histone lysine demethylation (GO:0070076),0.3371225819152954,0.7889291752382919,0.7278688524590164,0.9293243777345563,1.0,4/25,8.10%,KDM3A;KDM6A;JMJD1C;KDM4C
prerank,GPI anchor biosynthetic process (GO:0006506),0.32419196181637405,0.7888200589240671,0.7333333333333333,0.9290334828074762,1.0,9/30,18.19%,PGAP1;PIGU;PIGK;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.25474584702976455,0.7885029948737331,0.840937114673243,0.9290743678929458,1.0,45/148,24.73%,PPP1R13B;JMY;RPS15;HIPK1;PHF20;RPS20;AURKA;RPA1;TAF3;RRS1;TAF4B;RPL23;CDK2;RICTOR;BRIP1;MAPK11;NUAK1;PRKAB1;HUS1;RMI1;NOP53;KAT6A;CHEK2;RPL11;RFC3;PRKAA1;USP7;CSNK2A2;CSNK2A1;EHMT1;TTC5;TAF9;RAD17;RMI2;TAF15;TAF7;MAP2K6;RFC5;MAPK14;MAPKAP1;PDPK1;RFFL;PLK3;PIP4K2B;MBD3
prerank,regulation of telomere capping (GO:1904353),0.3384482830464038,0.7884438268361628,0.7296416938110749,0.9287185498022239,1.0,2/23,7.80%,NEK7;HNRNPD
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.37958170340824476,0.7879010649619245,0.7064056939501779,0.9291026367208306,1.0,1/11,4.97%,XBP1
prerank,positive regulation of coagulation (GO:0050820),-0.3641403872417551,-0.787368375237376,0.7152173913043478,0.9993635453129129,1.0,4/10,22.92%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.3641403872417551,-0.787368375237376,0.7152173913043478,0.9993635453129129,1.0,4/10,22.92%,THBS1;SERPINE1;ST3GAL4;HPSE
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35052604652166525,0.7870210738877972,0.7302405498281787,0.930040609550876,1.0,4/18,16.39%,NR3C1;BCL2L11;ZFP36;ZFP36L1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.34170845701944685,0.7864341574669573,0.7383820998278829,0.9305613900155176,1.0,6/22,13.77%,LYN;EFNA1;EPHA4;PICALM;RELA;ABCG1
prerank,histone mRNA catabolic process (GO:0071044),0.36419334351928984,0.7863472324634468,0.746031746031746,0.9302552200627596,1.0,7/15,27.43%,DCP2;MTPAP;LSM1;TENT4B;EXOSC4;TUT1;TUT7
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.22563501270495034,-0.7863318325925509,0.8888888888888888,1.0,1.0,15/80,15.17%,DENND2A;SGSM2;SNX32;SNX6;STX16;RHOBTB3;RAB29;TMED9;GBF1;SNX5;RGP1;TRAPPC10;GGA1;ARFRP1;RBSN
prerank,protein lipidation (GO:0006497),0.2871327378583769,0.7858552775764491,0.7723463687150838,0.9306010735827066,1.0,16/59,20.92%,UGCG;PIGU;ZDHHC18;ZDHHC9;HHAT;PIGQ;PGAP4;PIGG;PIGF;PIGL;PIGC;ZDHHC1;ATG7;ZDHHC6;SELENOK;ZDHHC8
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3780013577946865,0.7854053390329482,0.713472485768501,0.9308421562928432,1.0,4/12,12.62%,EDN1;TGFB1;AP2A1;GSTP1
prerank,cellular response to estradiol stimulus (GO:0071392),0.33836267153476357,0.7853061266844811,0.7219343696027634,0.9305393996622087,1.0,1/18,0.95%,ESR1
prerank,response to sterol (GO:0036314),-0.3474767912617416,-0.7850954089141775,0.7605321507760532,1.0,1.0,3/11,13.57%,TGFBR1;RORA;INSIG1
prerank,cellular response to UV-A (GO:0071492),-0.34795050586909093,-0.7847224188357356,0.7384615384615385,1.0,1.0,6/11,35.50%,MMP2;CERS1;PPID;TIMP1;MMP3;MME
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.33600746942081006,0.7845550006024962,0.7609427609427609,0.9312802280431985,1.0,7/23,16.26%,APP;TGFB1;RPTOR;RIPK2;UBE2K;IRGM;CALM1
prerank,triglyceride metabolic process (GO:0006641),0.29882563797099265,0.783800811116734,0.7694610778443114,0.9320688553709782,1.0,10/48,15.79%,CAV1;LPIN3;LPL;PLAAT3;FABP12;GK5;MOGAT1;PNPLA2;DGAT1;MOGAT2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.32848921685046684,0.7837065705332621,0.7319422150882825,0.9317643948047044,1.0,4/26,5.98%,LRP5;PIM3;KLF7;PPP3CB
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3661388584758295,0.7836100838136971,0.7247386759581882,0.9314581695550458,1.0,2/14,11.84%,CRAT;ABCD1
prerank,mitotic nuclear division (GO:0140014),0.27154451698190524,0.7833494218482216,0.8086330935251799,0.9314357514926918,1.0,20/71,21.62%,EPS8;RAB11A;CHMP4B;STAG2;PPP2R2D;NDEL1;STAG1;LSM14A;CTDP1;CHEK2;RHOA;ABRAXAS2;WRAP73;SMC4;MZT1;BCCIP;PIBF1;PLK1;KPNB1;KIF2A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2930269780461001,0.7827408671095093,0.7796101949025487,0.9319234190349469,1.0,8/48,13.14%,NLRC5;SAMHD1;SIGIRR;OTUD4;GAS6;CARD16;GSTP1;CNOT7
prerank,entry into host (GO:0044409),0.366354589490912,0.7821292880275336,0.7109090909090909,0.9324131844601709,1.0,6/13,17.90%,CBLL1;CXCR4;CBL;MET;CTNNB1;GRB2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3408770509290108,0.7814877777083927,0.735593220338983,0.932988942780093,1.0,6/22,14.91%,PPM1F;PPM1D;DUSP16;DUSP7;DUSP2;PDP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.38229315344884707,0.7814199915557182,0.7050359712230215,0.9321940321231657,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.38229315344884707,0.7814199915557182,0.7050359712230215,0.9321940321231657,1.0,5/12,16.45%,HOMER2;ATP2B4;HOMER3;RCAN1;CHP1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.34307338412340954,-0.7810591296577846,0.7345132743362832,1.0,1.0,4/12,21.30%,PARP3;PARP11;PARP8;TIPARP
prerank,regulation of translational initiation (GO:0006446),0.28191435599633385,0.7810331684363677,0.7808022922636103,0.9323357873229848,1.0,16/63,17.27%,NCK1;EIF3H;EIF1;EIF2B5;EIF4EBP1;EIF5B;EIF2AK4;UHMK1;FMR1;EIF2B2;PAIP1;NPM1;PAIP2B;EIF5;CTIF;CSDE1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.28394139244536687,-0.7809820836883135,0.7835051546391752,1.0,1.0,7/26,19.13%,OGT;KMT5C;CTR9;KMT2D;SETD4;VCPKMT;BEND3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3420919922185299,0.7808575473978816,0.7359098228663447,0.932156850508778,1.0,4/20,10.58%,PLCG1;ECSCR;CD40;ANO6
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3636489183661171,0.7805670624163269,0.7079646017699115,0.9321901460929508,1.0,4/14,20.67%,JAK3;TIGIT;IRAK3;PIBF1
prerank,cobalamin metabolic process (GO:0009235),0.3490972140673876,0.7803356107149709,0.7342419080068143,0.9321089640222079,1.0,6/17,22.90%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3087220248938316,0.7797248033972933,0.7626582278481012,0.9326300728017618,1.0,4/37,6.05%,STAT3;GBP5;HIF1A;CUEDC2
prerank,histone exchange (GO:0043486),-0.2601945357450609,-0.7796427639511111,0.797752808988764,1.0,1.0,14/37,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;ZNHIT1;CENPK;RBBP4;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,macroautophagy (GO:0016236),0.2604513704890938,0.7791129065257641,0.8551637279596978,0.9331327294109888,1.0,37/118,24.44%,KLHL3;ULK1;CHMP2B;PGAM5;TECPR1;DYNLL1;ATG101;CHMP4A;CHMP4B;VPS28;ARL8B;VAMP8;PRKAB1;TBC1D5;GABARAPL1;ILRUN;VPS37C;MFN1;YOD1;PRKAA1;MTERF3;CSNK2A2;CSNK2A1;STAM;TOMM22;ATG7;VTA1;TSG101;PLEKHM1;VTI1B;PIK3R4;VPS36;STAM2;MTMR14;RB1CC1;ZFYVE1;PIP4K2B
prerank,glycogen biosynthetic process (GO:0005978),0.3760521105866973,0.7789659579595675,0.7135036496350365,0.932454482259685,1.0,5/12,23.26%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.3760521105866973,0.7789659579595675,0.7135036496350365,0.932454482259685,1.0,5/12,23.26%,GBE1;PGM2;NHLRC1;PGM1;PGM2L1
prerank,transition metal ion homeostasis (GO:0055076),0.3147501851413418,0.7789033628819235,0.758887171561051,0.9321035662402304,1.0,7/28,17.02%,B2M;ABCB7;XIAP;PICALM;HMOX2;CP;TMC8
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3201355271696604,0.7788258915299223,0.7508250825082509,0.9317678308648109,1.0,6/29,12.61%,DAB2IP;EFNA1;SMAD7;MAD2L2;SFRP2;ADIPOR1
prerank,regulation of ATP metabolic process (GO:1903578),0.2845357635669281,0.7786869993666925,0.7819767441860465,0.931532156778967,1.0,12/54,14.81%,HIF1A;AK4;EIF6;NUP214;ABCD1;NUP98;SLC2A6;NUP133;NUP205;NUP54;NUP43;NUP153
prerank,positive regulation of organelle organization (GO:0010638),-0.2599809953952622,-0.7786850594299614,0.8161559888579387,1.0,1.0,14/32,32.06%,C2CD5;PPARGC1A;ANXA1;ANXA2;TMED9;SMCR8;HTRA2;ADRB2;RAB3GAP1;TREM2;ATL3;PLA2G5;P2RX7;KATNBL1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3191036097507681,0.7779461370776867,0.7363344051446945,0.9322036054069166,1.0,4/27,7.04%,CDK6;PDGFB;WNT5A;PDGFC
prerank,central nervous system neuron differentiation (GO:0021953),-0.26623943653745835,-0.776837543689519,0.7804878048780488,1.0,1.0,16/33,28.80%,MAP2;NTRK2;RYK;LRP6;MDGA1;GRID2;CHD5;FAIM2;MDGA2;SPOCK1;NPY;LHX1;KNDC1;CEND1;LMX1A;WNT2
prerank,regulation of mRNA stability (GO:0043488),-0.20843808266265884,-0.7766477814803582,0.9709302325581395,1.0,1.0,30/145,20.98%,SAMD4A;ROCK2;PRKCD;FXR2;TENT5A;PSME4;AXIN2;PRKCA;CIRBP;EXOSC7;CELF1;IGF2BP2;PSMD12;CSDC2;EXOSC3;HNRNPU;FTO;RC3H2;TENT5C;PCBP4;E2F1;HSPB1;SAMD4B;TBRG4;PSMC4;PSMB6;EXOSC9;FASTKD3;PDE12;EIF4G1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3544647104572748,-0.7762126662409145,0.7440860215053764,1.0,1.0,5/10,18.50%,PRKAA2;KLF15;MYOCD;DIP2A;FLCN
prerank,organophosphate biosynthetic process (GO:0090407),-0.258417623032047,-0.775449763293777,0.8221024258760108,1.0,1.0,15/37,25.93%,FGF2;AGPAT4;GK;PCYT2;TKT;TPI1;GPAM;LPCAT1;AGPAT3;PPIP5K2;IP6K1;PNPO;NFS1;FADS1;MOCS1
prerank,regulation of regulated secretory pathway (GO:1903305),0.31040410088161163,0.7752818416616772,0.8081761006289309,0.9359626816237288,1.0,6/34,15.85%,RAB27A;TRPV6;SYT15;RAB5A;SYT7;RIMS4
prerank,acylglycerol homeostasis (GO:0055090),0.3427652667037731,0.7749451277971696,0.7408056042031523,0.936042982847075,1.0,6/20,17.93%,SCARB1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,regulation of cell aging (GO:0090342),-0.3461507319128909,-0.774376309086154,0.7698744769874477,1.0,1.0,2/11,6.51%,NEK4;LMNA
prerank,cellular response to estrogen stimulus (GO:0071391),0.36138403036267686,0.7743366241887689,0.7334525939177102,0.936534135172833,1.0,4/14,14.57%,SERPINB9;NCOA4;TRIM24;PELP1
prerank,mRNA export from nucleus (GO:0006406),0.26332815590499453,0.7740050922127838,0.8333333333333334,0.9366069385899232,1.0,36/102,25.71%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;ENY2;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5;THOC7;SRSF4;IWS1;SMG6;NUP42;SLU7;CPSF2;NUP85;PCID2;CPSF3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3296811191563892,0.7737186990073821,0.7288135593220338,0.9365843059188245,1.0,6/23,12.61%,HDAC7;ADGRG3;TMSB4X;NMI;RELA;ADIPOR1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2873322753602959,0.7736864964204866,0.8031837916063675,0.93572342415328,1.0,12/50,14.81%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,regulation of gene silencing by RNA (GO:0060966),0.2873322753602959,0.7736864964204866,0.8031837916063675,0.93572342415328,1.0,12/50,14.81%,H3-3A;PUM1;IPO8;NUP214;PUM2;NUP98;NUP133;NUP205;FMR1;NUP54;NUP43;NUP153
prerank,dendritic cell chemotaxis (GO:0002407),0.3567947563852393,0.7734680189886287,0.7259528130671506,0.9356146813355392,1.0,5/14,23.48%,PIK3CG;CXCR4;CCR1;HMGB1;TRPM2
prerank,fatty acid beta-oxidation (GO:0006635),0.28939356281144224,0.7730147562257491,0.8141843971631205,0.9358679358131801,1.0,12/51,19.60%,PPARD;CRAT;HADHA;ECI1;ABCD4;ABCD1;HADH;AUH;ETFDH;ETFA;ETFB;ACAD10
prerank,phosphatidic acid metabolic process (GO:0046473),0.2904571957889369,0.7728809949563443,0.7927007299270074,0.9356279721630548,1.0,5/48,7.55%,PLA2G4A;DGKZ;DGKH;PLA2G2D;AGPAT1
prerank,regulation of cilium movement (GO:0003352),-0.3500994171446694,-0.7726286073565044,0.745575221238938,1.0,1.0,4/10,25.30%,CCDC39;DNAH11;CFAP43;DRC1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.38258259033179903,0.7723311199459478,0.7140221402214022,0.9360009813832848,1.0,5/10,22.43%,DISC1;CX3CR1;CTNNB1;KDM1A;CX3CL1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.2851522627585885,-0.7721880444205408,0.8239795918367347,1.0,1.0,6/24,13.21%,NBL1;CCN3;CXCL12;SERPINE1;SLIT2;CREB3
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2553102241132395,-0.77128564270102,0.8213333333333334,1.0,1.0,14/36,23.99%,CEP63;CLSPN;DOT1L;RAD9B;RHNO1;E2F1;SETMAR;DONSON;USP28;ATR;INTS7;DNA2;CHEK1;ATM
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2835243872251343,-0.7710891532253807,0.7684210526315789,1.0,1.0,6/26,10.25%,KANK2;HEYL;DAB2;SFRP1;CRY2;SMARCA4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2927022201290462,-0.7709512779709893,0.7699530516431925,1.0,1.0,4/20,14.46%,FKBP5;NKTR;PPIC;PPIH
prerank,fluid transport (GO:0042044),-0.3436877211428959,-0.770744165319044,0.7682403433476395,1.0,1.0,1/12,1.60%,PDPN
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.2988194684422399,-0.7706542483534707,0.7976744186046512,1.0,1.0,3/17,8.01%,ANK3;AKAP6;KCNAB1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.3319059682032465,-0.7705454901602259,0.7599118942731278,1.0,1.0,5/12,23.19%,GLI2;SZT2;TSKU;SPTBN4;EPHB2
prerank,positive regulation of protein transport (GO:0051222),0.27127286789074084,0.7705092589053677,0.8083670715249662,0.938385297716469,1.0,9/67,9.89%,UNC13B;CD2AP;EXPH5;PRR5L;PCNT;TGFB1;ATP2C1;ANG;VPS28
prerank,bicarbonate transport (GO:0015701),-0.2748758700731718,-0.7703056340545127,0.8165374677002584,1.0,1.0,8/25,18.10%,SLC4A10;SLC26A7;CA4;SLC4A3;SLC4A2;SLC26A6;CFTR;SLC4A8
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2597875353381127,-0.7698526424040381,0.829971181556196,1.0,1.0,17/33,39.51%,HSP90AA1;OAS2;MAVS;RNF135;POLR3D;IRF3;PTPN11;DHX9;IRF7;TLR2;TLR8;TRIM56;TOMM70;POLR3C;IRF1;OAS3;IRF5
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.26472914294187844,0.7695816007303836,0.8386243386243386,0.9393702909437734,1.0,25/96,19.97%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,positive regulation of type 2 immune response (GO:0002830),-0.32059111304085497,-0.7695196606011756,0.7811764705882352,1.0,1.0,3/14,11.17%,IL18;PRKCZ;CD81
prerank,regulation of feeding behavior (GO:0060259),0.3821206464152463,0.7691689281025275,0.7285974499089253,0.9395444518072248,1.0,4/11,16.42%,STAT3;UCN;EIF2AK4;AGRP
prerank,aggrephagy (GO:0035973),-0.27615723047347884,-0.7690900663671569,0.7984084880636605,1.0,1.0,4/27,8.90%,PRKN;IFT88;SQSTM1;DYNC1I1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.36274035901610124,0.7687215243185787,0.7392739273927392,0.9397539711086801,1.0,4/15,6.28%,FKBP1A;SMAD7;ACVR2A;ACVR1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3299881659210181,0.7684059335568681,0.7611940298507462,0.9397532770598445,1.0,5/22,14.30%,HHEX;CDKN1B;TFAP4;INCA1;APC
prerank,autophagy of peroxisome (GO:0030242),-0.3285689058176327,-0.7682003336128763,0.7583892617449665,1.0,1.0,4/12,25.01%,SQSTM1;NBR1;ATM;PEX5
prerank,sulfur compound transport (GO:0072348),0.319656527267152,0.768173340122521,0.7692307692307693,0.9396613182930892,1.0,4/27,9.78%,ABCG2;SLC6A6;SLC26A1;SLC25A30
prerank,regulation of transposition (GO:0010528),0.3535548108445868,0.7679777596464082,0.7192982456140351,0.9395192762267977,1.0,5/13,25.08%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5
prerank,purine nucleotide metabolic process (GO:0006163),0.3263983869121394,0.76789480911224,0.7400318979266348,0.9391909632901301,1.0,8/24,19.80%,GDA;NT5C2;ADSL;HPRT1;XDH;NUDT15;GART;PNP
prerank,regulation of centriole replication (GO:0046599),0.3502270044556043,0.7676853537955406,0.7422680412371134,0.9390452335459184,1.0,6/17,18.62%,PLK2;RBM14;NPM1;KAT2B;CEP295;CDK5RAP2
prerank,recombinational repair (GO:0000725),0.2685678813192262,0.7673471044069468,0.8517482517482518,0.939120283984991,1.0,14/77,14.62%,SAMHD1;MMS22L;RPA1;RAD51D;SEM1;RECQL;MEIOB;FAN1;HUS1;XRCC2;MCM9;RMI1;ERCC4;YY1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3121732530273079,0.7660662762807778,0.7840735068912711,0.9405923158259651,1.0,6/33,12.98%,NET1;RNF112;RIPK1;RHOB;RELA;SIGMAR1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.2949872992667007,0.7659848635632915,0.7809076682316118,0.9402722073206785,1.0,14/38,23.16%,GBP5;USP15;SASH1;PUM1;NMI;PUM2;OASL;POLR3B;PLSCR1;CD180;SLC15A4;ZCCHC3;CYBA;RIOK3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.26939661647760116,0.7659135781256784,0.8335535006605019,0.9399205704298279,1.0,3/76,1.96%,TGM2;ESR1;HTR2A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.31610824771455925,-0.7653842533671905,0.7793764988009593,1.0,1.0,4/14,10.15%,LPIN1;ETNK2;PCYT2;SLC27A1
prerank,lipid catabolic process (GO:0016042),0.3434511147375567,0.76515095325366,0.7457044673539519,0.940645100793584,1.0,3/18,8.50%,LIPE;LPL;PLAAT3
prerank,regulation of fibroblast proliferation (GO:0048145),0.2936680010154994,0.7648941242333386,0.8149847094801224,0.9405834017939616,1.0,5/45,7.04%,CDK6;PDGFB;DAB2IP;WNT5A;PDGFC
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3188104391981918,0.7643362000786196,0.7579831932773109,0.9409380572973322,1.0,6/26,14.80%,APP;FBXW7;TGFA;CBL;ADAM17;SOCS4
prerank,DNA metabolic process (GO:0006259),0.23322238807736614,0.7637182478650547,0.9311512415349887,0.9414088799726001,1.0,66/270,22.46%,POLK;SAMHD1;USP3;UHRF2;TCF7L2;CNBP;RNASEH2A;MCM10;RPA1;PRIMPOL;POLA1;CDT1;RAD51D;CDK2;BACH1;BTG2;PARP2;RECQL;RAD18;HELB;FAN1;HUS1;XRCC2;ACD;MMS19;UNG;PARG;LONP1;NOP53;GLRX2;ERCC4;TOP1;NSMCE4A;NPM1;MPG;NUDT15;PRIM2;ENDOV;ORC5;ORC3;GTF2H4;TERF1;PDS5A;RAD21;PDS5B;RFC3;CDC34;KMT5B;USP7;MGMT;NUDT1;CHD1L;GTF2H1;MSH2;ENDOG;RAD17;RMI2;PURA;TRRAP;DBF4;UBE2V2;RNASEH1;RIF1;SIRT7;MBD4;RFC5
prerank,estrogen metabolic process (GO:0008210),-0.3106455767532567,-0.7636310867569533,0.7707317073170732,1.0,1.0,9/15,49.14%,CYP1B1;HSD17B14;HSD17B1;HSD17B2;HSD17B8;CYP1A1;SULT1A1;CYP19A1;HSD17B10
prerank,protein monoubiquitination (GO:0006513),-0.2517913671435389,-0.7635954111968132,0.8352941176470589,1.0,1.0,7/36,14.33%,PRKN;KLHL22;CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,neutrophil chemotaxis (GO:0030593),0.28479587337307866,0.7631207603764848,0.8048433048433048,0.9418787477668239,1.0,5/53,10.41%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,RNA biosynthetic process (GO:0032774),0.3042219329640919,0.7630890922694901,0.7745398773006135,0.9414739408084475,1.0,13/31,30.06%,POLA1;SMARCA5;HELB;PRIM2;SETX;TAF7;TCEA2;BRF1;TTF2;PRIM1;PRMT5;POLA2;RSF1
prerank,stress granule assembly (GO:0034063),-0.2911988506904008,-0.7630786136470044,0.8390243902439024,1.0,1.0,6/20,19.50%,BICD1;ATXN2;CIRBP;UBAP2L;DYNC1H1;ATXN2L
prerank,negative regulation of centrosome duplication (GO:0010826),0.38037089890711556,0.7625446499599645,0.7435424354243543,0.9418174192749684,1.0,4/11,18.62%,RBM14;NPM1;KAT2B;CDK5RAP2
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.33160125364998727,-0.7614956101282894,0.7635135135135135,1.0,1.0,2/12,6.97%,HDAC8;AXIN2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32766229872571917,0.7614103264910067,0.7553719008264462,0.9430133195355684,1.0,3/23,9.47%,FOXL2;CECR2;DICER1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.28952047332651765,-0.7612857398223611,0.7937649880095923,1.0,1.0,4/20,11.96%,IL18;LBP;PTPN22;TICAM1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3003074566730065,0.7607452997869978,0.7812971342383107,0.9435730967893143,1.0,8/35,20.90%,NEK7;HMBOX1;ACD;CTNNB1;DHX36;CCT7;CCT2;MAP2K7
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3050727007923122,-0.7603042681662487,0.8222748815165877,1.0,1.0,5/17,24.56%,GJA1;HNRNPU;LTBP3;TERT;PTPRC
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2675009607844754,-0.7600567678001503,0.8442211055276382,1.0,1.0,11/28,23.99%,CEP63;CLSPN;DOT1L;RHNO1;E2F1;DONSON;USP28;ATR;INTS7;CHEK1;ATM
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3665090530497587,0.7598573719499713,0.7182320441988951,0.9444305671797169,1.0,3/11,11.87%,CASP8;RFTN1;RIPK1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.34887228987075475,0.7596863535107838,0.7491749174917491,0.9442532194274866,1.0,3/17,7.51%,TMSB4X;ARRB1;BCL3
prerank,negative regulation of autophagosome assembly (GO:1902902),0.35057219213816004,0.7596026590572247,0.7509293680297398,0.9439197840022976,1.0,4/13,9.20%,MTM1;FEZ2;CHMP4A;CHMP4B
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2851496684112822,-0.7594646235391994,0.8135198135198135,1.0,1.0,5/22,17.30%,ROCK2;PPP4R4;CRY2;PTPA;BOD1L1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3640754005337097,0.7593618690445668,0.7705223880597015,0.9438282219793889,1.0,5/13,13.34%,WNT5A;AGPAT1;GAS6;IL7;IFIH1
prerank,endomembrane system organization (GO:0010256),0.2439822462187532,0.7593216739362972,0.8970760233918129,0.9434486251915861,1.0,14/178,8.75%,MYOF;ATP8B1;SPTBN1;PRKD1;CAV2;ALS2CL;DOP1B;CHMP2B;SYNE1;SRGN;TMED7;RAB2A;TMED5;ARHGEF7
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.21453571050734668,-0.7577875496050223,0.8893280632411067,1.0,1.0,23/82,24.86%,NINL;HSP90AA1;YWHAG;ALMS1;ATF5;PRKACA;SDCCAG8;CEP63;CEP192;ODF2;CEP152;PCM1;CEP43;DCTN3;DYNC1H1;CKAP5;TP53;HAUS6;TPX2;HAUS2;SFI1;CENPF;CSNK1E
prerank,cellular iron ion homeostasis (GO:0006879),0.28007344357359243,0.7576131385369644,0.8202898550724638,0.9455408413930287,1.0,10/55,17.46%,ABCG2;ABCB7;LCN2;GLRX3;CUL1;HMOX2;CP;FRRS1;NEDD8;NUBP1
prerank,gastrulation (GO:0007369),0.34959317900397063,0.7575833322949761,0.7467889908256881,0.94513521527925,1.0,2/15,6.89%,LRP5;TASOR
prerank,lipid droplet organization (GO:0034389),0.3291118394527189,0.757350064129538,0.7593220338983051,0.9450267082200845,1.0,8/22,28.40%,PLIN5;CDS2;RAB18;HILPDA;PPIA;ZFYVE1;AUP1;FAF2
prerank,histone H4-K16 acetylation (GO:0043984),0.34216134628831324,0.7571827529940539,0.7731958762886598,0.9448356394692774,1.0,6/19,18.43%,PHF20;JADE2;JADE1;JADE3;MSL2;KANSL1
prerank,chemical homeostasis (GO:0048878),0.2714127633800022,0.7570703204109606,0.8262068965517242,0.9445516108151782,1.0,7/61,10.33%,KLHL3;NEDD4L;FBXW7;AQP11;TLCD3A;SLC4A7;USF2
prerank,regulation of microtubule nucleation (GO:0010968),-0.34437385129315434,-0.7567497454892604,0.7618025751072961,1.0,1.0,1/10,2.14%,EML2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3204479287081885,0.7567090801028153,0.7896494156928213,0.9446417431008417,1.0,4/26,9.63%,CDK6;CEACAM1;ZFPM1;MAFB
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2725112289770188,-0.7561123741765071,0.8359788359788359,1.0,1.0,5/27,8.04%,BRSK1;IL1RAPL1;NTNG1;CTNNA2;ULK4
prerank,regulation of viral release from host cell (GO:1902186),0.3322113467593541,0.7556059609889928,0.7628865979381443,0.9457683814771141,1.0,3/21,7.85%,CHMP2B;MID2;TRIM25
prerank,neuron fate commitment (GO:0048663),0.3534905263366177,0.7554153810218747,0.7637931034482759,0.9456008257157906,1.0,2/14,5.28%,DLL1;DLL4
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26682787350955073,0.7552830714736682,0.8453038674033149,0.9453319674285192,1.0,12/68,16.10%,SLC2A1;MTHFD1L;SLC52A3;GSTO2;ABCD4;PANK2;TPK1;CD320;SLC19A3;TCN2;RFK;MTR
prerank,regulation of mast cell degranulation (GO:0043304),0.3564537129262554,0.7551459588745822,0.7491289198606271,0.9451223139099467,1.0,1/14,2.31%,LYN
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3282502865054252,-0.7548092715079433,0.7868480725623582,1.0,1.0,1/11,6.12%,AGTR1
prerank,positive regulation of viral process (GO:0048524),0.272006520630874,0.7547265607832917,0.8271954674220963,0.9452733803241428,1.0,11/60,16.05%,NR5A2;ADARB1;PKN2;GTF2F2;NELFE;RAD23A;ADAR;CNOT7;RAB7A;NELFCD;CTDP1
prerank,protein localization to nucleus (GO:0034504),-0.21328252328535066,-0.754469946092571,0.9395161290322581,1.0,1.0,25/102,19.92%,COL1A1;APPL2;BMP7;BMP4;SIX1;LMNA;PAF1;MDM2;TSC2;FAM53C;IPO13;POM121;NUP93;INTS13;CNEP1R1;HNRNPU;TNPO2;DVL1;ABCA7;SYK;CHCHD10;RANBP17;NUP107;NOL8;SEC13
prerank,regulation of mitotic spindle organization (GO:0060236),-0.25711324782570993,-0.7543429495693272,0.8531073446327684,1.0,1.0,13/35,30.58%,PARP3;GNAI1;GPSM2;RAE1;HNRNPU;DYNC1H1;TPX2;FSD1;CHMP1A;EML3;DCTN1;MAP9;CHMP2A
prerank,cytosolic transport (GO:0016482),0.2528849963418997,0.7540557598427475,0.8652849740932642,0.9458086106026053,1.0,21/108,16.11%,MYO1D;LMTK2;STX6;DOP1B;EEA1;VTI1A;AP2A1;GCC2;SPAG9;ANKFY1;TBC1D5;STX8;EHD3;RILP;KIF16B;EVI5;RAB5A;RAB7A;ERC1;RAB6A;RIC1
prerank,mRNA 3'-end processing (GO:0031124),0.26616707225336544,0.7539918219862506,0.8455284552845529,0.9454573519634444,1.0,25/78,26.03%,APP;WDR33;THOC2;RNPS1;THOC6;RPRD1B;MTPAP;RPRD2;CDC73;ALYREF;CDC40;THOC3;THOC1;CPSF1;RPRD1A;THOC5;CPSF6;THOC7;SRSF4;TENT4B;SLU7;CPSF2;PCF11;CPSF3;LSM11
prerank,triglyceride homeostasis (GO:0070328),0.3173958720333,0.7539470606266793,0.7712854757929883,0.9450660371330104,1.0,7/26,17.93%,SCARB1;XBP1;LPL;APOC4;PNPLA8;ANGPTL4;MLXIPL
prerank,cellular response to ATP (GO:0071318),-0.3152423929575604,-0.7538118647707971,0.7751196172248804,1.0,1.0,2/14,8.19%,P2RX4;TAF1
prerank,regulation of myoblast fusion (GO:1901739),-0.3306428164007187,-0.7536270613014134,0.7636761487964989,1.0,1.0,3/11,14.16%,RIPOR2;EHD1;CD53
prerank,negative regulation of protein secretion (GO:0050709),0.29806780513111014,0.7535058368927222,0.8055130168453293,0.9452417637784799,1.0,4/38,5.36%,CD200;RAB11FIP1;KCNB1;RAB11FIP5
prerank,meiosis I (GO:0007127),0.3159215736820118,0.7532857707665103,0.7774193548387097,0.9451129510404682,1.0,4/23,13.64%,BTBD18;BCL2L11;MEIOB;ZSCAN21
prerank,telomere maintenance via telomerase (GO:0007004),0.30630780523765644,0.7525096916761604,0.7660910518053375,0.9458197701498341,1.0,7/28,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.2754278771952112,0.7523252355527623,0.838150289017341,0.9456470097359237,1.0,16/55,22.49%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.29981614321831096,-0.7517412270389632,0.8144578313253013,1.0,1.0,3/16,17.76%,WBP4;PSIP1;CACTIN
prerank,negative regulation of leukocyte activation (GO:0002695),0.34720500678982064,0.7509912915420219,0.7816901408450704,0.9471393768959016,1.0,1/15,1.49%,CD200
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.257340172457973,0.7508437369894586,0.8543563068920677,0.9469084796456086,1.0,13/78,15.62%,PDGFB;HHEX;CCNK;CDKN1B;CCNYL1;PKD2;CCNY;TFAP4;INCA1;CDC25C;ADAM17;APC;CCNJ
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3734220012275775,0.7508115902654403,0.7495361781076066,0.9465207545664902,1.0,1/10,2.17%,MLLT3
prerank,chromosome condensation (GO:0030261),0.3021452110374697,0.7506907389141665,0.7965571205007824,0.946259568705563,1.0,7/36,18.26%,TENT4A;MCPH1;NCAPH;RB1;SMC4;CSNK2A2;CSNK2A1
prerank,mRNA stabilization (GO:0048255),0.2965378426056206,0.7506572227659511,0.8129829984544049,0.9458675500618929,1.0,15/40,22.93%,TIRAP;HNRNPA0;YBX3;ANGEL2;HNRNPC;ZFP36;PAIP1;YBX1;FUS;DAZL;ELAVL1;TAF15;NOCT;EIF4ENIF1;MAPK14
prerank,phagosome maturation (GO:0090382),0.301506649673255,0.7501994857263963,0.7921092564491654,0.9460520792381288,1.0,8/35,14.72%,ATP6V0A1;RAB38;ATP6V1G2;MREG;RAB43;RAB31;RAB7A;RAB32
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3206569807572248,-0.7493092266876231,0.7823275862068966,1.0,1.0,8/12,42.06%,ABCC9;KCNJ8;CACNA1H;P2RX3;TRPM4;KCNJ11;RHAG;PKD2L1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29605697184642893,-0.7491899630023432,0.8140043763676149,1.0,1.0,6/17,30.50%,P4HB;HSPB1;HTRA2;NME5;TREM2;VNN1
prerank,arachidonic acid secretion (GO:0050482),-0.3458804513472311,-0.7487897920896281,0.7952069716775599,1.0,1.0,2/10,8.13%,ANXA1;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.3458804513472311,-0.7487897920896281,0.7952069716775599,1.0,1.0,2/10,8.13%,ANXA1;BDKRB2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3327386459571464,-0.7486866492230466,0.7886363636363637,1.0,1.0,3/11,15.93%,SEMA5A;NES;PLEK
prerank,protein O-linked mannosylation (GO:0035269),0.33789914809483,0.7481814660194978,0.7655172413793103,0.9485301414642157,1.0,3/18,8.88%,TMTC2;B4GAT1;RXYLT1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3182160267290542,-0.7478379470372574,0.7986725663716814,1.0,1.0,8/13,35.42%,SEC16B;CD81;INSIG1;SEC16A;TMEM30B;TM9SF4;SAR1A;SORL1
prerank,regulation of cell cycle phase transition (GO:1901987),0.2559668500966757,0.7477820061037065,0.8651535380507344,0.9486314346048091,1.0,29/91,24.92%,FBXW7;ATP2B4;CDKN1B;PSMA2;ANAPC7;ANAPC1;PSMA8;PSMA6;TFAP4;CDC26;CUL1;ANAPC16;BUB3;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;DBF4;PLK1;PSMD2;PSMA5;PSMC3;UBE2D1;PSMD3;UBE2E1;FBXO5;FZR1;PSMA3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.36463146737081026,0.7477080584016955,0.7523105360443623,0.9482861175225699,1.0,2/12,9.61%,PAEP;IL23A
prerank,negative regulation by host of viral transcription (GO:0043922),0.35448167809716175,0.7476329718116514,0.7569060773480663,0.9479406299478628,1.0,4/12,22.95%,INPP5K;TFAP4;PSMC3;JUN
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2577195490148021,-0.7444598114823713,0.8544973544973545,1.0,1.0,8/29,23.09%,TENT5A;AXIN2;CIRBP;HNRNPU;TENT5C;E2F1;SLC11A1;RBM24
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.26717568703212474,-0.7444255229419047,0.8329113924050633,1.0,1.0,8/26,21.02%,LARGE1;GK;GBGT1;TKT;TPI1;GAL3ST2;SCCPDH;ST3GAL4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.30834905388181255,0.7443544971834364,0.7844036697247706,0.9521445473343447,1.0,7/27,16.72%,SKAP1;LCK;CYRIB;RELA;HAS2;TRAF6;RHOA
prerank,fat cell differentiation (GO:0045444),0.27283136334992614,0.7442754075748421,0.8408450704225352,0.9518158817934403,1.0,6/57,9.63%,FOXO1;TCF7L2;ERAP1;CTBP1;AKT2;MAFB
prerank,response to acidic pH (GO:0010447),0.35421325753198146,0.7439931918137485,0.7629233511586453,0.9517887643653437,1.0,4/13,16.45%,RAB11FIP5;LGMN;RAB11B;CHP1
prerank,response to organic cyclic compound (GO:0014070),0.2798843812622856,0.7439254840694484,0.8425787106446777,0.9514348649531661,1.0,3/52,2.42%,ESR1;SOCS2;STAT3
prerank,positive regulation of calcium ion import (GO:0090280),0.35349122080824424,0.7438580378758428,0.7703180212014135,0.9510763558682114,1.0,1/12,1.89%,PDGFB
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.33018683046106634,-0.7438302008152858,0.7905982905982906,1.0,1.0,7/10,47.18%,ASRGL1;KYAT1;PCBD1;KYNU;THAP4;IYD;QDPR
prerank,RNA export from nucleus (GO:0006405),0.25403074955194704,0.7432965116086591,0.8646517739816032,0.9514210737796636,1.0,25/100,19.97%,HHEX;EIF4E;NXF2;WDR33;THOC2;SMG7;YTHDC1;NUP214;RNPS1;THOC6;NUP98;UPF2;NUP133;NUP205;NUP54;NUP43;NUP153;AGFG1;ALYREF;CDC40;THOC3;THOC1;CPSF1;GLE1;THOC5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26532933933808706,0.7432470822467725,0.8593530239099859,0.9510505643574204,1.0,17/69,22.30%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,cytoplasmic microtubule organization (GO:0031122),0.2790594972542577,0.7428647969952135,0.8468335787923417,0.9511344101732071,1.0,7/54,8.96%,RAB11A;DST;LIMK2;CCDC88A;TRPV4;CAMSAP2;SLK
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2672717219460992,0.742708531973066,0.859375,0.9508921353554669,1.0,9/62,10.31%,ARHGEF2;ARMC10;TMBIM6;XBP1;DNAJA1;YBX3;BCL2L1;DDIAS;SFRP2
prerank,snRNA processing (GO:0016180),0.3352342370363027,0.7425655728598554,0.7797513321492007,0.9506441710882044,1.0,6/16,26.79%,INTS11;INTS12;INTS8;TOE1;INTS6L;TUT1
prerank,positive regulation of chromosome organization (GO:2001252),0.3414988600973683,0.7425404244327753,0.7905282331511839,0.9502343096051196,1.0,5/15,19.01%,PPP1R10;SIRT6;ATRX;RAD21;DHX36
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.30350557207080553,0.7423501055502174,0.8145800316957211,0.950036633911551,1.0,4/29,4.22%,SCARB1;ELOVL5;PLIN5;SORBS1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2464007315909134,-0.7423294547136539,0.8934169278996865,1.0,1.0,13/39,24.92%,TANGO2;RCN3;COPG1;STEAP3;MIA3;RAB10;SCG2;LTBP2;NECAB3;RAB8A;OLFM2;CANX;RAB3C
prerank,substantia nigra development (GO:0021762),-0.24331533904975955,-0.7421892945739235,0.8895348837209303,1.0,1.0,10/37,18.92%,NDRG2;SIRT2;PLP1;CKB;MBP;COX6B1;S100A1;TTBK1;SEC16A;PADI2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2525471585798782,-0.7406166694941291,0.8495575221238938,1.0,1.0,11/31,27.51%,PEX1;TOMM40;AIFM1;PEX7;TIMM17B;GRPEL2;TIMM21;PEX5;DNAJC15;PEX16;PAM16
prerank,histone ubiquitination (GO:0016574),-0.28033351418023505,-0.7397671641380552,0.8578811369509044,1.0,1.0,5/21,14.33%,CTR9;PAF1;LEO1;UBE2B;ATXN7L3
prerank,negative regulation of secretion by cell (GO:1903531),0.2881152681753092,0.7369962601616242,0.8405797101449275,0.9570336110809978,1.0,8/38,15.22%,NOTCH1;TNFRSF1B;FGF23;TNFRSF1A;VAMP8;PNKD;RHBDF2;STXBP6
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.31108119992845945,-0.7368542988475814,0.8116591928251121,1.0,1.0,3/14,7.15%,IL18;ANXA1;PRKCZ
prerank,eosinophil chemotaxis (GO:0048245),-0.3111288698469672,-0.7364821046634915,0.821917808219178,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,eosinophil migration (GO:0072677),-0.3111288698469672,-0.7364821046634915,0.821917808219178,1.0,1.0,9/14,45.93%,SCG2;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3
prerank,regulation of telomere maintenance (GO:0032204),0.3075043314450072,0.7360666763800592,0.8012718600953895,0.9578752177650788,1.0,8/26,19.01%,PPP1R10;HNRNPD;SIRT6;ERCC4;YLPM1;ATRX;USP7;DHX36
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3114965106719257,0.7354969954924997,0.7922705314009661,0.958184323020937,1.0,9/24,24.36%,PINX1;ACD;DCP2;HNRNPC;ERCC4;TERF1;TEN1;TENT4B;TNKS
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2828225196066699,-0.7350600007043858,0.8138424821002387,1.0,1.0,4/20,10.15%,PLOD2;GCLC;FPGS;SLC27A1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.33427882952344945,0.7349532038979137,0.7771929824561403,0.9584803569227138,1.0,1/15,1.07%,PPARD
prerank,platelet aggregation (GO:0070527),0.28951537218418005,0.7341349826386824,0.813953488372093,0.959118138996883,1.0,6/33,12.82%,MYH9;ACTN1;PIK3CG;P2RY12;ITGB3;STXBP3
prerank,mitotic nuclear membrane organization (GO:0101024),0.2712936320622562,0.7334580530895981,0.8552821997105644,0.9591512727016095,1.0,21/51,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2712936320622562,0.7334580530895981,0.8552821997105644,0.9591512727016095,1.0,21/51,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,carnitine shuttle (GO:0006853),-0.3278853285784081,-0.7332570494361204,0.81875,1.0,1.0,3/11,6.99%,PRKAA2;PRKAG2;ACACA
prerank,quinone biosynthetic process (GO:1901663),-0.3119524912795946,-0.7331542071190584,0.8368298368298368,1.0,1.0,6/14,31.38%,COQ8B;COQ5;FDXR;COQ10A;COQ10B;COQ6
prerank,fatty acid catabolic process (GO:0009062),0.2626520105367273,0.7329785796796134,0.8656509695290858,0.9593515938319643,1.0,11/67,16.76%,PPARD;ABHD2;LPIN3;HADHA;ECI1;ABCD4;ABCD1;HADH;ALDH3A2;FAAH;AUH
prerank,response to peptide (GO:1901652),0.29403845932849315,0.7327958542129355,0.8201892744479495,0.959146576260336,1.0,8/33,17.70%,STAT3;FYN;CACNA1A;EIF2B5;EIF2B2;STAT6;ERBIN;STAT1
prerank,iron ion transport (GO:0006826),-0.23248786815573003,-0.7323965633644356,0.9153605015673981,1.0,1.0,8/47,13.77%,SCARA5;ATP6V0A4;SLC39A14;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3202312873489819,0.7323081990828141,0.8009630818619583,0.9593731876683195,1.0,8/21,22.95%,FOSL1;HNF1B;SUB1;DHX36;SETX;MED12;MED17;JUN
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3012192675501993,-0.7322562729593615,0.817966903073286,1.0,1.0,8/15,44.35%,GNAS;ADCY3;GNAL;CD36;UBR3;C5AR1;BBS4;SYT10
prerank,homologous chromosome segregation (GO:0045143),0.31696416492394464,0.7322379783650882,0.8077601410934744,0.9590277086778496,1.0,6/20,25.04%,MEIOB;TERB1;TERB2;PRDM9;SIRT7;FMN2
prerank,tRNA processing (GO:0008033),0.2665466290643284,0.7309685581997928,0.8695035460992908,0.960232813920661,1.0,20/61,27.84%,CDKAL1;FARS2;RPP30;TSEN34;RTCB;ADAT1;DTWD2;KARS1;TRMT6;CPSF1;TSEN2;THUMPD1;TRUB1;RTRAF;NSUN6;AARS2;LCMT2;TRMT10C;NSUN2;TSEN15
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.20981285738727717,-0.7309186450741934,0.9625,1.0,1.0,26/78,23.25%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.20981285738727717,-0.7309186450741934,0.9625,1.0,1.0,26/78,23.25%,SEC24D;KIF3C;KIF3A;SEC31A;DYNC1I1;SEC23A;ACTR1B;AP2S1;CTSD;KIFAP3;DCTN5;CAPZB;KLC1;DCTN4;KIF5A;DCTN3;DYNC1H1;CTSL;SEC13;CTSS;KLC2;CD74;LAG3;AP1S1;CANX;DYNC1LI2
prerank,cellular response to nitrogen compound (GO:1901699),0.31040262050977,0.7297600462560567,0.8022875816993464,0.9613638502271563,1.0,7/20,16.92%,ATP2B4;AOC1;FMR1;DDI1;ATRX;DDI2;SPIDR
prerank,intracellular cholesterol transport (GO:0032367),-0.30544660166043935,-0.7296093533770994,0.8306264501160093,1.0,1.0,4/15,17.70%,LDLR;LRP6;SERAC1;VPS4A
prerank,regulation of phosphatase activity (GO:0010921),0.31129513867552383,0.7294603537987926,0.7974068071312804,0.9613110540266432,1.0,6/24,18.88%,PPP1R2;CHP2;GPATCH2;CHP1;TIPRL;MTMR9
prerank,Golgi organization (GO:0007030),0.24375863830070868,0.729411891154395,0.907035175879397,0.9609247188606292,1.0,11/112,8.75%,ATP8B1;PRKD1;STX6;VAMP4;SYNE1;VTI1A;GCC2;TMED7;RAB2A;TMED5;ARHGEF7
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3205813670988858,0.7290856360910607,0.7737478411053541,0.9609181326099677,1.0,7/19,26.73%,CHMP2B;CHMP4B;PLK1;PDCD6IP;CHMP3;HSPA1B;CHMP4C
prerank,histone H2B ubiquitination (GO:0033523),-0.3316656462473187,-0.7287138259066892,0.8115631691648822,1.0,1.0,3/10,9.56%,CTR9;PAF1;LEO1
prerank,glycoprotein catabolic process (GO:0006516),0.3260166263908177,0.7286133949043774,0.7790055248618785,0.9611021369029132,1.0,1/17,1.62%,STT3B
prerank,nuclear pore complex assembly (GO:0051292),-0.32502325949498945,-0.7286094316199547,0.8034557235421166,1.0,1.0,4/10,19.48%,NDC1;NUP93;RTN4;NUP107
prerank,positive regulation of RNA metabolic process (GO:0051254),0.27854722701823653,0.7284234191709201,0.8357558139534884,0.9609005823754089,1.0,11/45,17.33%,ERN1;RBM20;DYRK1A;TGFB1;NFKB1;HNRNPLL;RIPK1;RELA;RIOK1;PNPT1;HEATR1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.29538043338652764,0.7273705920231881,0.8120063191153238,0.9618094381988099,1.0,7/29,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.30182657110687894,-0.7273465902706919,0.8260869565217391,1.0,1.0,5/15,14.16%,RIPOR2;CAMK1;ADAM9;EHD1;CD53
prerank,protein localization to Golgi apparatus (GO:0034067),0.3055044248055374,0.7272888780267445,0.8263665594855305,0.9614652470965174,1.0,4/27,8.81%,GBP5;VPS13D;GCC2;ARL5A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.310793353660505,0.7269778820315487,0.8096026490066225,0.9614306226973606,1.0,7/24,20.81%,CEP41;TTLL7;TTLL10;NAA11;TTLL5;TPGS1;TTLL9
prerank,stem cell differentiation (GO:0048863),0.28487680751642447,0.7267596569577747,0.8366412213740458,0.9612712183695413,1.0,3/39,5.60%,MEF2C;MLLT3;MTF2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2392079223929384,-0.7264843052245087,0.9098360655737705,1.0,1.0,12/38,23.53%,PRKN;SREBF1;NPEPPS;LRRK2;ABLIM3;HPS4;RHOU;HAX1;HTRA2;ATP5IF1;VPS11;FZD5
prerank,protein import into mitochondrial matrix (GO:0030150),-0.27981306524638705,-0.7261490711050236,0.8072916666666666,1.0,1.0,9/18,37.16%,TOMM40;TIMM17B;GRPEL2;TIMM21;DNAJC15;PAM16;TIMM23;TOMM70;DNAJC19
prerank,autophagosome organization (GO:1905037),0.2711991620250957,0.7261260491918989,0.843108504398827,0.9616636091883317,1.0,16/50,24.23%,ULK1;ATG101;EMC6;GABARAPL1;RAB43;RAB7A;ATG2A;ATG2B;STX12;IRGM;RAB1A;ATG7;UBXN2A;RAB1B;VMP1;RB1CC1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3145385840127665,0.7260756818331503,0.805921052631579,0.9612879740145496,1.0,3/20,6.12%,PDE4D;ADRB1;RAPGEF2
prerank,regulation of vacuole organization (GO:0044088),0.3158254212940724,0.7259003006344459,0.7925801011804384,0.9610660504140354,1.0,5/20,13.44%,MTM1;TBC1D12;NPRL2;SCARB2;RAB5A
prerank,RNA metabolic process (GO:0016070),0.2394362638981007,0.7251732166319971,0.9225888324873096,0.9615285556794173,1.0,32/127,18.44%,RBPMS;ADARB1;DDX54;ISG20;DROSHA;HNRNPF;RNASE1;GTF2F2;RNASEH2A;HNRNPA0;MTREX;HNRNPK;HNRNPD;RNASE4;LSM8;DICER1;RNGTT;RBM3;ADAR;RNASEH2C;RNASEH2B;HNRNPC;FASTKD2;WTAP;XRN2;DDX20;HNRNPUL1;PNPT1;METTL14;THOC1;PRPF4;HNRNPM
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3155201323190534,0.7251230956553185,0.7918088737201365,0.9611530169757873,1.0,4/18,17.57%,CFAP53;SPA17;CABYR;RFX3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.2382346894983508,0.7249894741886409,0.9368932038834952,0.9608896501752898,1.0,30/144,17.66%,PPP1R13B;FBXW7;FYN;CASP8;KCNB1;MAPK8;TCF7L2;PRR5L;CHP2;PCNT;SH3GLB1;TGFB1;PSEN1;AKT2;UBE2D3;MYO1C;GAS6;SFN;BID;TCAF2;SAE1;YWHAQ;ERBB2;ARIH2;CEP290;CHP1;ANP32B;RAPGEF3;CEP131;CIB1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.29228857300872424,0.7249839677515882,0.8380952380952381,0.9604520625258385,1.0,5/31,12.24%,PARD3;MSN;OPHN1;ANK1;PARD3B
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2828315022615308,-0.7247371594756538,0.8372641509433962,1.0,1.0,7/19,23.47%,AXL;MMP14;MDK;SYK;XRCC6;RHOH;PRKDC
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.31175249939613003,-0.7245229415153402,0.8048780487804879,1.0,1.0,1/11,0.87%,GSN
prerank,positive regulation of vacuole organization (GO:0044090),0.3617457819005343,0.7243722287296739,0.7654545454545455,0.9608187911035775,1.0,2/10,6.64%,RALB;SH3GLB1
prerank,negative regulation of DNA recombination (GO:0045910),0.27662357198388293,0.7239033765398758,0.8607407407407407,0.9609778628584849,1.0,13/43,22.30%,SMCHD1;SHLD1;CGAS;MAD2L2;HELB;ACD;ATRX;TERF1;MSH2;RMI2;POLR2L;RIF1;POLR2J
prerank,regulation of mRNA catabolic process (GO:0061013),0.24046896103844045,0.7237939251194648,0.9188514357053683,0.9606825471382586,1.0,32/121,22.49%,ANP32A;IGF2BP3;PRR5L;PSMA2;HNRNPD;XPO1;PUM1;SERBP1;PSMA8;CNOT1;PSMA6;RC3H1;EXOSC1;NUP214;DCP2;PUM2;ZFP36;CNOT7;FMR1;PSME1;PNPT1;ZFP36L1;PSMA4;PSMF1;DHX36;PSMB7;PSMB1;ELAVL1;PSMD2;ZC3H14;PSMA5;PSMC3
prerank,snRNA transcription (GO:0009301),0.25828672706077027,0.7237267050372608,0.8808510638297873,0.9603346301310487,1.0,17/70,22.30%,CCNK;GTF2F2;GTF2E2;POU2F1;INTS11;SNAPC3;RPRD1B;GTF2A2;INTS12;RPRD2;POU2F2;RPRD1A;SP1;TAF9;POLR2L;INTS8;POLR2J
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25129624416285756,0.7217798364549053,0.9027777777777778,0.9624156631700707,1.0,20/72,26.60%,POLK;RPA1;COPS2;COPS4;ERCC4;AQR;GTF2H4;RFC3;USP7;GTF2H1;POLR2L;CCNH;POLR2J;RFC5;ERCC6;CUL4B;COPS8;GTF2H5;ISY1;RPA3
prerank,snRNA metabolic process (GO:0016073),0.3217101122752497,0.721675756429388,0.8006872852233677,0.9621133086696935,1.0,5/17,22.96%,MTREX;INTS11;INTS12;INTS8;RBM7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2814769441342503,0.7213219978552109,0.8774002954209749,0.9621512861459255,1.0,3/39,2.87%,UTRN;NEDD4L;FXYD6
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.28547975046534513,0.7209177541826887,0.8462809917355372,0.9622424889884476,1.0,4/33,7.41%,HTR2A;EDN1;PIK3C2A;PIK3CG
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2889679705583951,-0.7204563375390105,0.8365384615384616,1.0,1.0,4/17,13.42%,PRKN;CD44;MDM2;SNAI1
prerank,integrated stress response signaling (GO:0140467),-0.29813412133995854,-0.7199646057103811,0.8286384976525821,1.0,1.0,5/14,26.53%,IMPACT;EIF2AK3;EIF2AK1;HSPA5;CCL2
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.28428896017923877,-0.7196534591417908,0.8419753086419753,1.0,1.0,8/18,22.09%,PTPN23;DAB2;EZR;SRC;MAP2K2;MAP2K1;RAB21;VPS11
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3112495938862663,-0.7194843187469104,0.8147268408551069,1.0,1.0,6/13,26.39%,CD44;MDM2;SNAI1;CD74;TWIST1;SNAI2
prerank,purine-containing compound salvage (GO:0043101),0.35320123432403583,0.7194339517705356,0.7855787476280834,0.9636799900832562,1.0,4/12,19.80%,GMPR;HPRT1;ADA;PNP
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3343253463955973,-0.7194121764126031,0.8081264108352144,1.0,1.0,3/10,14.84%,KLF15;THAP7;SNCA
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18267268739638623,-0.7193183534471767,1.0,1.0,1.0,46/184,25.62%,APPL2;NINL;HECW2;PKD1;SIRT2;HSP90AA1;CDC14B;YWHAG;ALMS1;PSME4;ANAPC5;PRKACA;BTRC;SDCCAG8;RGCC;CEP63;ANAPC15;CEP192;ODF2;PLK5;PSMD12;CEP152;PCM1;CEP43;DDB1;E2F1;XPC;DCTN3;DYNC1H1;PSMC4;NEK11;PSMB6;CDC16;ID2;CKAP5;HAUS6;TPX2;HAUS2;SFI1;PSMD4;UBC;CENPF;PSMC5;CSNK1E;BUB1B;ZFP36L2
prerank,sterol metabolic process (GO:0016125),0.25904019138529977,0.7190722967905039,0.8870056497175142,0.9636804313622748,1.0,10/60,14.73%,PPARD;LBR;CH25H;CYP26A1;CYP26C1;SOAT2;CYP39A1;CLN6;ABCG1;PMVK
prerank,Golgi inheritance (GO:0048313),-0.3197806308007098,-0.7190695932774472,0.8218884120171673,1.0,1.0,2/11,12.24%,GBF1;PLK5
prerank,protein kinase B signaling (GO:0043491),0.30674320583771014,0.7188192265096485,0.825503355704698,0.9635754654174542,1.0,5/23,16.39%,KDR;TGFB1;GAS6;THEM4;ZFP36L1
prerank,B cell mediated immunity (GO:0019724),0.35655752273404584,0.7181179953035689,0.7785977859778598,0.9640471674879071,1.0,4/10,23.11%,SLA2;CARD9;MSH2;FCER1G
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3157600151897697,-0.717573043852967,0.8212669683257918,1.0,1.0,4/11,19.13%,OGT;CTR9;KMT2D;BEND3
prerank,histone H2A ubiquitination (GO:0033522),-0.2907122094455499,-0.7175513213658937,0.8489208633093526,1.0,1.0,6/17,21.34%,BCOR;DDB2;UBE2B;RING1;DDB1;PCGF1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.28531172101755653,0.7170395834322235,0.8450704225352113,0.9649493387431017,1.0,7/33,16.50%,RPA1;WRAP53;PINX1;CDK2;ACD;HSP90AB1;TERF1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3235678745977027,0.7165628090415402,0.8324786324786325,0.9651360611004063,1.0,6/19,20.76%,PINX1;ACD;DCP2;HNRNPC;TERF1;TEN1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2882686619666569,-0.7163524722583123,0.8426150121065376,1.0,1.0,3/16,10.10%,CELF4;DAZAP1;CIRBP
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23462146475068626,-0.7161541842224511,0.9224137931034483,1.0,1.0,18/40,32.55%,NUCKS1;RTEL1;CDK9;SMARCAL1;BOD1L1;SETMAR;DONSON;ATR;FBH1;POLE;GEN1;POLD1;CENPX;BLM;ZRANB3;EXD2;EME2;WRN
prerank,apoptotic nuclear changes (GO:0030262),0.31131345030954954,0.7160811248458938,0.81,0.9653134423181197,1.0,3/24,9.47%,FOXL2;CECR2;DICER1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.31216315946255396,-0.7158528089797411,0.8302752293577982,1.0,1.0,7/12,31.18%,ACSL1;FADS2;SCP2;ELOVL1;FADS1;ACOT8;ELOVL2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2515618016936374,0.7157825725994785,0.8858321870701513,0.9652388429754272,1.0,16/84,15.91%,NANOS3;DAPK1;IGF2BP3;NANOS2;GRB7;RNF139;BTG2;RPL13A;CNOT1;MRPL13;RACK1;CNOT7;FMR1;LSM14A;YBX1;PAIP2B
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2678156431423999,-0.7156013219254902,0.8492462311557789,1.0,1.0,8/19,29.69%,AR;ICE2;CEBPA;BRF2;MAF1;MTOR;NAB2;ZC3H8
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.29821468950062935,-0.7152715751741533,0.7853881278538812,1.0,1.0,7/14,27.69%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;C1QBP
prerank,tetrapyrrole metabolic process (GO:0033013),0.3212340060694362,0.7152529317376176,0.8153310104529616,0.9654623048553226,1.0,6/18,22.90%,ABCD4;CD320;TCN2;MTR;MMAA;LMBRD1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3407306447785037,0.7152447006533719,0.7974683544303798,0.9650291211097237,1.0,2/14,9.61%,PAEP;IL23A
prerank,response to hexose (GO:0009746),0.30753194795453787,0.7152140761715192,0.8064516129032258,0.9646194575941107,1.0,6/25,13.79%,TCF7L2;LPL;NEUROD1;EIF2B5;PFKL;EIF2B2
prerank,regulation of pH (GO:0006885),0.3507723096306797,0.7139596506211925,0.8123861566484517,0.9657370931537204,1.0,3/11,12.09%,CLCN3;ATP1A4;SLC9A7
prerank,negative regulation of TOR signaling (GO:0032007),0.2805251898923071,0.7137373665542899,0.8569206842923794,0.9655753539744234,1.0,5/36,9.76%,SH3BP4;DDIT4;TNFAIP8L1;UBR1;NPRL2
prerank,nuclear membrane reassembly (GO:0031468),0.26101010969918637,0.7136810642827016,0.8804500703234881,0.9652078569996223,1.0,22/54,27.12%,LBR;CHMP2B;CHMP4A;CHMP4B;NUP98;NUP133;NUP205;NUP43;UBE2I;PPP2R2A;VRK1;PPP2R1A;KPNB1;REEP3;UBXN2A;NUP85;PPP2CA;SUMO1;CHMP3;ANKLE2;CHMP4C;EMD
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.30520997136313777,-0.7136655495385871,0.8197802197802198,1.0,1.0,3/13,10.34%,SYT1;CACNA1G;SCAMP5
prerank,cranial nerve development (GO:0021545),0.3440123274935418,0.713431255211236,0.8132635253054101,0.9650719931972782,1.0,1/11,3.59%,CHD7
prerank,regulation of cellular response to stress (GO:0080135),-0.1914680991099578,-0.7130922594398071,0.9855072463768116,1.0,1.0,28/115,23.99%,ROCK2;PRKN;NUPR1;HSP90AA1;NEK4;DNAJC7;AMFR;RAE1;POM121;NDC1;NUP93;HSPH1;CAMK2B;CEBPB;NPAS2;USP19;AIFM2;NUP107;SEC13;ATR;EIF4G1;MLST8;BAG3;ADCY8;CLN3;CRYAB;AKT1S1;ATM
prerank,regulation of lipase activity (GO:0060191),-0.2990263572846179,-0.7128174149235834,0.8631090487238979,1.0,1.0,5/13,18.11%,PCSK5;PCSK6;SNCA;LMF1;ANGPTL3
prerank,endodermal cell fate commitment (GO:0001711),-0.3217440286318519,-0.7119628529095509,0.7929515418502202,1.0,1.0,3/10,9.56%,CTR9;PAF1;LEO1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.34700441640698,0.7114004117708325,0.7900552486187845,0.9671020561475347,1.0,4/11,11.87%,CASP8;TGFB1;CSF1;RIPK1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.2856090037424316,-0.7102930272486337,0.8689320388349514,1.0,1.0,3/17,9.84%,FGF1;SREBF1;APOE
prerank,nucleic acid-templated transcription (GO:0097659),0.2704609530967689,0.7100095971160071,0.8736681887366818,0.9684163488256217,1.0,9/42,14.50%,EPC1;PWP1;TAF1B;BCL3;MMS19;RNPS1;PTMA;MEF2A;TOPORS
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24244846780999507,0.7098398823807544,0.9153439153439153,0.9681735615605851,1.0,25/88,27.08%,FBXW7;FBXL4;PSMA2;FBXL7;FBXL2;PSMA8;PSMA6;CUL1;FBXL3;PSME1;PSMA4;PSMF1;CUL2;FBXO17;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;CUL4B;PSMD3;PSMA3;FBXW4;FBXL8;FBXL15
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.29267318179067625,-0.7096623276406842,0.8637362637362638,1.0,1.0,7/15,25.81%,ADRA2A;APOE;ADAM9;GPLD1;PACSIN3;SNX33;NRDC
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3125902803711909,-0.7096491051035154,0.8270509977827051,1.0,1.0,4/11,23.88%,PAF1;LEO1;BARD1;ZC3H3
prerank,dendrite self-avoidance (GO:0070593),0.32585921264935086,0.708751004487096,0.8033333333333333,0.9690388157866687,1.0,3/16,9.25%,BSG;ROBO4;DSCAM
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.32010194207449405,-0.708732285585907,0.8219780219780219,1.0,1.0,3/10,24.48%,CHFR;TUT4;UBC
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.27228286865919904,-0.7086278157915402,0.8491879350348028,1.0,1.0,5/19,17.41%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,DNA catabolic process (GO:0006308),0.3506484031834324,0.7085035655317847,0.8033395176252319,0.968917828430505,1.0,2/11,15.02%,ISG20;XRN2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23280998011432955,0.7083743846970241,0.950186799501868,0.9686363005866624,1.0,37/132,21.85%,RPS15;RPS19;RPS14;RPSA;RPL38;SRPK3;TGS1;RSL24D1;RRS1;DICER1;YTHDC1;EIF6;RPS27;MCTS1;NOP53;RPL6;RPL10;HSP90AB1;SCAF11;WDR77;DDX20;EIF5;LUC7L2;RPL11;CDC73;STRAP;SRSF10;SART1;RPL3;TRAF7;SART3;RPS28;SETX;DENR;SF3A2;CPSF6;LUC7L
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23792133529543102,0.7083531128459898,0.9260700389105059,0.9682193769439559,1.0,22/104,20.05%,DAB2IP;LRP5;CCNK;RALB;CDKN1B;TRIB3;RPTOR;RB1;TRIB1;CDC25C;CCNJ;IRGM;CALM1;PIH1D1;RHOA;CIB1;CDC37;SYAP1;TSG101;BCCIP;DUSP19;GTF2H1
prerank,regulation of rRNA processing (GO:2000232),0.3255718469882988,0.7082470503532131,0.8347529812606473,0.9679044056630971,1.0,6/16,22.19%,NUDT16;RIOK1;KAT2B;HEATR1;RIOK2;SIRT7
prerank,negative regulation of cell cycle process (GO:0010948),-0.21311668289280172,-0.7079639569162501,0.9681978798586572,1.0,1.0,18/61,22.62%,BMP7;BMP4;TOM1L2;EHMT2;RBBP7;TFDP1;PCGF2;CBX5;GPER1;RING1;ZFYVE19;E2F1;PCGF6;VPS4A;TERF2;TFDP2;CHEK1;RBBP4
prerank,early endosome to Golgi transport (GO:0034498),-0.316048321190813,-0.7073521410823993,0.8266384778012685,1.0,1.0,4/11,18.22%,TMED9;TRAPPC10;RBSN;SNX2
prerank,regulation of mRNA processing (GO:0050684),-0.24100660932609733,-0.7073336809685248,0.9315068493150684,1.0,1.0,8/32,18.84%,SON;SRPK2;TIA1;SF1;KHDRBS3;PABPN1;SRSF3;SAFB2
prerank,regulation of mitochondrial translation (GO:0070129),-0.2672050189139472,-0.7071740682301139,0.8591549295774648,1.0,1.0,9/21,28.62%,RMND1;UQCC2;FASTKD3;MPV17L2;TRUB2;MRPS27;MTG1;C1QBP;TSFM
prerank,regulation of chromatin organization (GO:1902275),0.3337650967380994,0.7070432674428946,0.8164665523156089,0.9689335143153223,1.0,4/14,20.64%,MLLT3;PARG;TLK1;SETD5
prerank,response to amino acid starvation (GO:1990928),0.24971648524553225,0.7066950725877432,0.8950953678474114,0.9688889602870194,1.0,18/72,22.15%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,retrograde axonal transport (GO:0008090),-0.28301935005004175,-0.7065719467843392,0.8549618320610687,1.0,1.0,7/16,27.30%,DLG2;KIF1A;KIF5A;DYNC1H1;TMEM108;MAP1A;FBXW11
prerank,protein deneddylation (GO:0000338),0.35711046784810674,0.7065100763609373,0.7938342967244701,0.9686851179464515,1.0,2/10,10.85%,COPS2;COPS4
prerank,cellular response to amino acid starvation (GO:0034198),0.25007081392406133,0.7063085686222946,0.8930041152263375,0.968468069816804,1.0,18/71,22.15%,PRKD1;FAS;MAPK8;SH3GLB1;RPTOR;ATP6V1G2;NPRL2;LARS1;EIF2AK4;CASTOR1;RHEB;EIF2AK2;ATP6V1F;KPTN;WDR59;ATP6V1D;TFEB;GCN1
prerank,mitochondrial gene expression (GO:0140053),0.27027561094295216,0.7062844945328373,0.8880706921944035,0.9680623966946611,1.0,13/42,24.80%,MRPS18A;NDUFA7;TFB2M;MRPS12;FASTKD2;QRSL1;MRPS16;MRPL23;PTCD3;MRPL12;NOA1;RARS2;MRPS11
prerank,positive regulation of leukocyte activation (GO:0002696),0.31617874887515873,0.706154092068291,0.8240418118466899,0.9677698557040649,1.0,4/18,15.50%,NECTIN2;WNT5A;CRLF2;KARS1
prerank,protein export from nucleus (GO:0006611),0.2944950074288575,0.7057957382881334,0.8195121951219512,0.9677646157900481,1.0,8/27,17.36%,SMURF1;TGFB1;DUSP16;XPO1;NUP214;STYX;CHP1;DESI1
prerank,protein-DNA complex disassembly (GO:0032986),0.3201486520615672,0.7050357103461026,0.7993197278911565,0.9682267360332665,1.0,8/16,24.69%,ARID1A;RPL23;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3150735306382085,0.7048120689785784,0.8110516934046346,0.9680533320930935,1.0,4/18,15.50%,PLCG2;SBNO2;NMI;KARS1
prerank,negative regulation of neurogenesis (GO:0050768),0.2803349628766887,0.7043930984945911,0.8584474885844748,0.9681261903820437,1.0,3/34,6.12%,B2M;NOTCH1;RAPGEF2
prerank,RNA interference (GO:0016246),0.3191059497684363,0.704118887201611,0.7912457912457912,0.9680125804651539,1.0,5/17,21.33%,DROSHA;DICER1;HENMT1;MRPL44;PRKRA
prerank,calcium import into the mitochondrion (GO:0036444),-0.32000631936783197,-0.7033759429172881,0.8336933045356372,1.0,1.0,5/10,22.61%,MCU;MICU1;SLC25A23;MAIP1;SMDT1
prerank,negative regulation of B cell activation (GO:0050869),0.3115191646311901,0.7032900706480031,0.8103161397670549,0.9685519007731461,1.0,3/21,10.79%,LYN;SAMSN1;RC3H1
prerank,protein alkylation (GO:0008213),-0.2557546424016342,-0.7024223189075471,0.8771498771498771,1.0,1.0,7/22,26.16%,LCMT1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29201606174713507,0.7021122692789995,0.848,0.9694936837375407,1.0,8/30,20.91%,FBXW7;SH3GLB1;UBE2D3;SAE1;ARIH2;CSNK2A2;UBE2L3;LEPROT
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2728222260255987,-0.7017317391120466,0.8606356968215159,1.0,1.0,5/18,25.62%,XRCC6;PRDM1;PRKDC;CCR2;ZFP36L2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.25206503016428,0.7012392027876527,0.9025069637883009,0.9700980227237107,1.0,8/66,8.83%,WWTR1;CARD10;DTX3L;LIMK2;CHP2;TGFB1;PSEN1;PINX1
prerank,phospholipid biosynthetic process (GO:0008654),0.28181503928468654,0.7010419195551273,0.8512,0.9698852219658929,1.0,7/36,19.34%,SGMS1;MBOAT1;NUS1;DPAGT1;DOLK;CPNE3;GNPAT
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3153238344313505,0.7003299905575863,0.7958833619210978,0.9702881115834944,1.0,4/17,13.84%,STAT3;BACH2;BTN3A3;SLA2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.32597903298471653,-0.7001428138042088,0.824847250509165,1.0,1.0,4/10,22.66%,LBP;PTPN22;NR1H3;IFI35
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3139502670035955,-0.6978526695513582,0.831140350877193,1.0,1.0,3/10,26.53%,EIF2AK3;HSPA5;CCL2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24777458060508137,0.6978040990260906,0.9076704545454546,0.9727759203297477,1.0,28/68,31.05%,CAVIN1;TAF1B;POLR1A;WDR33;POLR1G;POLR1B;GTF2H4;TAF1A;CPSF1;GTF2H1;POLR2L;CCNH;SETX;SNRPD3;CPSF2;PCF11;TTF2;GTF2H5;CPSF3;LSM11;PAPOLA;PRMT5;POLR1F;CSTF3;GTF2H2;CSTF2T;POLR1H;SNRPB
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2510385143756697,-0.6969900063292898,0.8948717948717949,1.0,1.0,4/24,13.42%,BCL2;CD44;CXCL12;SNAI1
prerank,establishment of protein localization to organelle (GO:0072594),0.2486610445999508,0.6964721606741414,0.920863309352518,0.9738857040533295,1.0,19/72,22.69%,RAB11A;STAT3;IPO11;PPP1R10;NEURL1B;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;CD68;HIKESHI;EIF4ENIF1;APPL1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2996159736782964,0.6962217405192936,0.8391376451077943,0.9737105297348893,1.0,5/22,15.27%,NOTCH1;GHR;IL7R;MGAT5;CRLF2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.33784612739189457,0.6959860683617982,0.7890909090909091,0.9735369377663549,1.0,3/12,20.72%,WRAP53;CCT7;CCT2
prerank,regulation of spindle assembly (GO:0090169),0.2926293717762108,0.6950581523783976,0.8369747899159664,0.9741736165725158,1.0,10/25,26.73%,CHMP2B;CHMP4B;RNF4;NUMA1;PLK1;PDCD6IP;SENP6;CHMP3;HSPA1B;CHMP4C
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.31796676580847993,-0.6947778766645104,0.8301486199575372,1.0,1.0,3/10,10.76%,RYK;LRP6;FZD1
prerank,DNA-dependent DNA replication (GO:0006261),0.22669572816959782,0.693179235967143,0.9615877080665813,0.9758732590829092,1.0,31/128,22.49%,MCM10;RPA1;PSMA2;PRIMPOL;POLA1;CDT1;CDK2;RECQL;PSMA8;HELB;PSMA6;PSME1;PRIM2;ORC5;ORC3;BAZ1A;RFC3;CDC34;PSMA4;PSMF1;GINS2;MCMBP;PSMB7;PSMB1;PURA;DBF4;PSMD2;SIRT7;PSMA5;RFC5;PSMC3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.31691037763042573,-0.6931721739704594,0.8322295805739515,1.0,1.0,2/10,4.40%,SIRT2;IMPACT
prerank,cholesterol metabolic process (GO:0008203),0.24826561354989124,0.6928830296069234,0.9024390243902439,0.9757653097112801,1.0,10/68,14.90%,PPARD;LBR;CH25H;SCARF1;SOAT2;CLN6;ABCG1;PMVK;GGPS1;PLPP6
prerank,mitotic cytokinetic process (GO:1902410),0.29687326473945236,0.6928167891550436,0.8285229202037352,0.9753887318725077,1.0,3/20,9.20%,CHMP2B;CHMP4A;CHMP4B
prerank,protein heterooligomerization (GO:0051291),0.31116396525642165,0.6925195969556214,0.831081081081081,0.9752957832033712,1.0,6/17,21.61%,MAT2A;PKD2;GRIN1;CBR4;KRT10;CPSF6
prerank,outer dynein arm assembly (GO:0036158),-0.2826897989639604,-0.6913522651736153,0.8773584905660378,1.0,1.0,7/14,35.21%,DNAL1;DNAH8;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2961911145780448,-0.6912631643550089,0.860730593607306,1.0,1.0,3/12,8.37%,CLCN2;SREBF1;H6PD
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.25381946499115005,0.6907164796575658,0.921015514809591,0.9759991026374648,1.0,1/61,0.35%,CTSC
prerank,vesicle coating (GO:0006901),0.25381946499115005,0.6907164796575658,0.921015514809591,0.9759991026374648,1.0,1/61,0.35%,CTSC
prerank,COPII vesicle coating (GO:0048208),0.25381946499115005,0.6907164796575658,0.921015514809591,0.9759991026374648,1.0,1/61,0.35%,CTSC
prerank,negative regulation of cholesterol transport (GO:0032375),0.35064069993702185,0.6905076959034432,0.7767175572519084,0.9758237659232456,1.0,1/10,7.86%,NFKB1
prerank,granulocyte chemotaxis (GO:0071621),0.2565635226539157,0.6902257093768026,0.8904694167852063,0.9756996345940172,1.0,5/55,10.41%,EDN1;BSG;PPBP;PIK3CG;CCL14
prerank,positive regulation of intracellular transport (GO:0032388),0.27235238325072364,0.6895337710711616,0.8834080717488789,0.9760395649934315,1.0,15/38,25.81%,PGAP1;PRR5L;PCNT;EHD2;NEDD4;CEP290;CEP131;NUMA1;MLC1;TENM1;RIPOR1;STX18;PLK3;RUFY3;B3GAT3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.30694732340980185,-0.6891449375826868,0.8337078651685393,1.0,1.0,3/10,11.82%,HDAC4;PIAS1;PIAS3
prerank,regulation of isotype switching (GO:0045191),-0.2874166833300293,-0.689059672228667,0.8489208633093526,1.0,1.0,2/14,5.28%,PARP3;KMT5C
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2986249457540804,-0.6889228265537269,0.826271186440678,1.0,1.0,2/12,12.53%,ZWINT;CHFR
prerank,AMP metabolic process (GO:0046033),-0.29769281615121523,-0.6888131053355757,0.8822170900692841,1.0,1.0,2/13,8.27%,AMPD3;NT5E
prerank,regulation of astrocyte differentiation (GO:0048710),0.33303433446200403,0.6884021389679637,0.8202443280977313,0.9768844901780447,1.0,2/12,10.82%,NOTCH1;EPHA4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.2943812787649852,0.6881664651479633,0.8418367346938775,0.9767104870643502,1.0,4/21,12.74%,AIM2;FYN;GRIN1;BIRC3
prerank,DNA strand elongation (GO:0022616),-0.2694703956552978,-0.6865240987624166,0.8692660550458715,1.0,1.0,9/18,32.58%,RAD50;GINS3;GINS1;TERT;POLD2;GINS4;DCLRE1B;MCMDC2;MCM3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3349300037676602,0.686173569071047,0.8178506375227687,0.9784442061552081,1.0,5/12,26.75%,SOX9;STRAP;MUC6;MUC13;NOD2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.28695851664511846,0.6847100761011741,0.8442211055276382,0.9795670546121467,1.0,2/23,6.08%,CAV1;DUSP22
prerank,regulation of embryonic development (GO:0045995),0.2759975312297113,0.6845480143193985,0.8661417322834646,0.9793086470853558,1.0,14/34,23.45%,INSR;SOX17;PLCB1;B4GALT5;NR2C2;NIBAN2;CFL1;EHMT1;ZBED3;DHX36;RACGAP1;CRB2;NIPBL;CLASP2
prerank,pre-replicative complex assembly (GO:0036388),0.24653116945345768,0.6833118266830922,0.9198855507868383,0.9801464498908976,1.0,19/64,26.30%,PSMA2;CDT1;PSMA8;PSMA6;PSME1;ORC5;ORC3;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3;ORC6;GMNN;MCM6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2996309798205274,0.6831851715237853,0.8519793459552496,0.9798470395106273,1.0,9/21,24.91%,RPS7;RPL23;MAD2L2;RPL11;RAB1A;BAG2;PLK1;FBXO5;FZR1
prerank,ruffle organization (GO:0031529),-0.283674157248455,-0.6825749944991462,0.8784403669724771,1.0,1.0,5/16,15.93%,TPM1;CARMIL1;AIF1L;ARFIP2;PLEK
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.24832144553306662,0.682152224089362,0.9332365747460087,0.9805322662908114,1.0,6/61,10.43%,CAV1;SIRT5;PSMA2;PANK2;PSMA8;PSMA6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22271981834191834,0.6820594338588836,0.9753694581280788,0.9801929539474078,1.0,31/145,21.23%,RAB11A;PRKAR2B;CEP41;AURKA;PCNT;AVEN;PSMA2;FBXL7;DYNLL1;PINX1;BRD4;CDK2;CNTRL;CEP57;PSMA8;PSMA6;CUL1;CDC25C;PSME1;CEP290;CEP131;CEP72;PSMA4;PSMF1;CETN2;CDK5RAP2;PPP2R1A;PSMB7;PSMB1;PLK1;PSMD2
prerank,telomere maintenance via recombination (GO:0000722),-0.3095310111221933,-0.6817463785535954,0.862144420131291,1.0,1.0,7/11,30.90%,TEP1;RAD50;SMC6;TPRKB;XRCC3;SMC5;ERCC1
prerank,regulation of cellular response to heat (GO:1900034),0.2399749041356226,0.6814208646689403,0.9297520661157025,0.9804305869528511,1.0,29/77,26.72%,CD34;RPA1;RPTOR;NUP214;NUP98;HSP90AB1;NUP133;NUP205;NUP54;NUP43;NUP153;BAG4;CHORDC1;HSPB8;BAG1;DNAJB1;IER5;DNAJB6;BAG2;HIKESHI;YWHAE;FKBP4;DNAJC2;NUP42;NUP85;GSK3B;CREBBP;RPA3;HSPA1B
prerank,organonitrogen compound catabolic process (GO:1901565),0.25373595148471006,0.6806009080885811,0.8903318903318903,0.9809007243350072,1.0,13/57,17.26%,PLA2G4A;ENPP2;CTRL;ERAP1;TRIM24;SIAH1;GNPDA2;MPST;CLN6;PNPLA8;ACE;ADO;GGACT
prerank,mRNA processing (GO:0006397),0.20765718917408363,0.6802616617242812,0.9910813823857302,0.9808098220258848,1.0,87/287,25.96%,NOVA2;ERN1;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;THOC2;LSM8;RNGTT;YTHDC1;SPEN;RBM15;RNPS1;LSM3;THOC6;RPRD1B;HNRNPC;RNMT;ZMAT2;SMU1;SF3B6;DHX15;RPRD2;SNRNP25;SCAF11;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;GTF2H4;ALYREF;CDC40;LSM7;PRPF40A;THOC3;PHF5A;METTL14;RALY;CWF19L2;THOC1;PRPF4;HNRNPM;CPSF1;RPRD1A;SRSF10;FUS;THOC5;GTF2H1;SART1;SART3;POLR2L;ELAVL1;CCNH;SF3A2;CPSF6;POLR2J;PRPF3;AURKAIP1;THOC7;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;GTF2H5;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,respiratory electron transport chain (GO:0022904),0.32049625300066137,0.6797485676176238,0.8354430379746836,0.9808965530975717,1.0,1/14,2.31%,GPD2
prerank,regulation of pseudopodium assembly (GO:0031272),0.3312338493712116,0.6788720325745997,0.8174904942965779,0.9809529285327994,1.0,2/10,14.30%,CDC42EP3;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3312338493712116,0.6788720325745997,0.8174904942965779,0.9809529285327994,1.0,2/10,14.30%,CDC42EP3;APC
prerank,steroid metabolic process (GO:0008202),-0.20080169278027726,-0.6783348299529802,0.9671532846715328,1.0,1.0,15/72,22.72%,CYP7B1;CYP27A1;CYP26B1;CYP1B1;FDX1;PRLR;FDFT1;SCP2;FDXR;CUBN;LSS;DHCR24;CYP51A1;TSPO;DHRS11
prerank,lipid homeostasis (GO:0055088),-0.2066582384804642,-0.6782160630762217,0.9685534591194969,1.0,1.0,16/57,24.30%,RBP1;ZBTB20;TLCD2;PRKAA2;RCN3;APOE;IRS2;TLCD1;ORMDL2;ANGPTL3;ABCA2;DGAT2;NR1H3;PPARG;CEBPA;POLD1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.29486701395421605,0.6781554782399082,0.8609271523178808,0.9812683945987257,1.0,3/20,9.65%,FAS;BOK;BCL2L1
prerank,negative regulation of histone methylation (GO:0031061),0.3427223468589505,0.6781467083713668,0.8183520599250936,0.9808422828141662,1.0,4/10,22.76%,MTF2;JARID2;KDM1A;PHF1
prerank,peroxisomal membrane transport (GO:0015919),-0.23781938384625012,-0.6767680146502637,0.9365482233502538,1.0,1.0,10/27,27.01%,ABCD3;ATAD1;PEX1;PXMP2;PEX7;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,myelin maintenance (GO:0043217),-0.311141447474124,-0.6767328645396221,0.8454545454545455,1.0,1.0,1/10,1.47%,EPB41L3
prerank,regulation of p38MAPK cascade (GO:1900744),0.2697944278347666,0.676410327240985,0.8944881889763779,0.9822073377952205,1.0,3/35,6.63%,DAB2IP;MFHAS1;SASH1
prerank,microtubule polymerization (GO:0046785),-0.23958968930098648,-0.6762067724067292,0.9276139410187667,1.0,1.0,10/28,31.48%,TUBGCP5;MAP7D3;TPPP3;CKAP5;CCDC57;TPX2;CLASP1;FGF13;GOLGA2;TPPP
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3000273609325346,-0.6760500468506534,0.8502109704641351,1.0,1.0,1/10,4.18%,SIRT2
prerank,cellular response to ionizing radiation (GO:0071479),0.25465072379636444,0.6757571737544124,0.9150227617602428,0.9824328171946926,1.0,13/47,24.16%,NET1;HUS1;RHOB;MAP3K20;TMEM109;SPIDR;GRB2;KDM1A;RPL26;NIPBL;MAPK14;TANK;LIG4
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27657784703133714,-0.6750835960449363,0.8691796008869179,1.0,1.0,5/15,17.70%,SDC4;SMPD3;SDC1;SNF8;VPS4A
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.24460026358728054,-0.6749538196576199,0.9090909090909091,1.0,1.0,8/26,18.99%,SIRT2;PCBP2;TRAFD1;ITCH;TRAF3IP1;PPM1B;CACTIN;TYRO3
prerank,regulation of microtubule-based movement (GO:0060632),-0.3060813543560632,-0.6747785585326931,0.865934065934066,1.0,1.0,5/11,33.05%,MAP2;TTC21B;DRC1;NEFH;LAMP1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.25944905234669013,-0.6742835128206915,0.8850574712643678,1.0,1.0,5/18,21.77%,PRKN;NONO;HSPB1;HTRA2;NME5
prerank,positive regulation of actin nucleation (GO:0051127),0.33478533461861715,0.6739441481311733,0.828996282527881,0.9838858556246977,1.0,2/11,5.07%,WASF2;NCKAP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3218092957777642,0.673772863431535,0.8359511343804538,0.9836044319925764,1.0,4/11,22.19%,PWP1;NOP53;PIH1D1;SIRT7
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2732427778623586,0.6735790244868617,0.8660436137071651,0.9833709777805741,1.0,7/32,18.26%,LPCAT3;CEPT1;LPIN3;PEMT;CHKA;CSNK2A2;CSNK2A1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.29224320346246824,-0.6718187900437418,0.8701298701298701,1.0,1.0,4/11,20.05%,PRKN;NONO;REST;NR4A3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2340611374640283,0.671518173049148,0.9443708609271523,0.9850316295058795,1.0,21/91,18.66%,HIP1;HIP1R;RAB11A;SCARB1;OPHN1;RNF139;PTPN1;INPP5F;RAB12;ABL2;PICALM;RAB26;RAB11B;RAB5A;RAB5B;SYT7;PACSIN2;RAB8B;CPLX2;USP7;STXBP5
prerank,serine family amino acid metabolic process (GO:0009069),-0.27333854785203787,-0.6709192252881954,0.8847926267281107,1.0,1.0,9/16,34.63%,GCLC;MTHFD1;SARS1;CBS;CTH;SEPSECS;CDO1;THNSL2;PSPH
prerank,response to UV-B (GO:0010224),-0.2907215953970459,-0.6708680428051251,0.8678414096916299,1.0,1.0,7/12,37.49%,MFAP4;CDKN1A;HYAL1;CRIP1;HYAL3;MME;IL12A
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30522706150592527,-0.6708250128980271,0.8607594936708861,1.0,1.0,4/11,18.91%,AGBL4;LCMT1;GPLD1;AGBL1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.26249694453320344,0.6707008828778595,0.9181286549707602,0.985421289651011,1.0,4/42,10.95%,PTK2B;PPBP;CCL14;RBM15
prerank,toxin transport (GO:1901998),0.32668241464098946,0.6704552438391679,0.8235294117647058,0.9852298566057068,1.0,1/10,2.40%,ADAM10
prerank,protein mannosylation (GO:0035268),0.293766958449082,0.6703030918366873,0.8554817275747508,0.984949861984953,1.0,3/22,8.88%,TMTC2;B4GAT1;RXYLT1
prerank,negative regulation of DNA replication (GO:0008156),0.32550652475693137,0.6693463468648392,0.8451730418943534,0.9854543398479186,1.0,6/13,26.41%,GMNC;TERF1;PDS5A;RAD17;GMNN;GTPBP4
prerank,tRNA transport (GO:0051031),0.2654612590770072,0.6690550845871515,0.884437596302003,0.9853009406715497,1.0,9/35,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;YBX1;XPOT
prerank,nuclear envelope organization (GO:0006998),-0.2560737130942425,-0.668976306870491,0.905,1.0,1.0,7/20,28.35%,DMPK;NUP93;VPS4A;TMEM43;TOR1B;TOR1A;TOR1AIP1
prerank,glutathione metabolic process (GO:0006749),0.26693209642212967,0.668715381015097,0.9032258064516129,0.9851980471296728,1.0,8/38,13.98%,GSR;GSTA4;GGCT;GCLM;ETHE1;GLRX2;GSTP1;OPLAH
prerank,regulation of membrane depolarization (GO:0003254),0.3013371102539789,0.6679079840832602,0.8587155963302753,0.9855283261227923,1.0,2/18,5.18%,NEDD4L;SMAD7
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3143441003271175,0.6673968630746064,0.8418181818181818,0.9855763985873861,1.0,3/13,11.62%,NFKBIA;PKD2;NFKBIE
prerank,protein deacylation (GO:0035601),-0.24817141520958452,-0.6666771674639677,0.9051094890510949,1.0,1.0,7/23,20.24%,HDAC4;SIRT2;NOTUM;ABHD10;ABHD17C;PPT1;HDAC3
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.23311096797685754,-0.6658072569189983,0.937007874015748,1.0,1.0,4/27,6.74%,SYT1;SYT9;SYT12;SYT11
prerank,protein-containing complex disassembly (GO:0032984),0.24406234958548287,0.6656305386153425,0.927246790299572,0.986866165666837,1.0,6/54,14.30%,CAV1;TECPR1;RPL23;VAMP8;GABARAPL1;APC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.26540492763707846,0.6655605524903894,0.8984615384615384,0.9865076341578118,1.0,12/30,28.06%,DNAJB5;ERO1A;UGGT1;BAG1;HSPE1;DNAJB12;DNAJB1;CCT2;GAK;HSPA1B;HSPA13;HSPA14
prerank,protein K63-linked ubiquitination (GO:0070534),0.25699622502730646,0.6654271953322325,0.915929203539823,0.9861959551358122,1.0,9/41,15.54%,TRAF1;PELI1;UBE2G1;NEDD4;RNF4;HECTD1;TRAF6;ARIH2;RNF5
prerank,import into nucleus (GO:0051170),0.2359633422652563,0.6654268973650391,0.92524682651622,0.9857603562156992,1.0,21/73,25.16%,STAT3;IPO11;PPP1R10;BACH2;IPO8;NUP214;PRICKLE1;NUP133;TNPO3;NUP153;DDX20;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;SNRPD3;NUP85;SNUPN
prerank,protein heterotetramerization (GO:0051290),0.3149219297960366,0.6639844363257879,0.8457446808510638,0.9867343911971984,1.0,7/13,27.54%,PKD2;GRIN1;CBR4;KRT10;CPSF6;FARSB;GRIN2B
prerank,histone mRNA metabolic process (GO:0008334),0.27286508497177364,0.6621878719063523,0.8934169278996865,0.9880463620433348,1.0,13/27,31.05%,DCP2;MTPAP;LSM1;SNRPD3;TENT4B;CPSF2;CPSF3;LSM11;EXOSC4;TUT1;TUT7;ERI1;SNRPB
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.28374764691634485,-0.6619692324286335,0.9038031319910514,1.0,1.0,6/14,22.28%,BRCA2;XRCC5;TPP1;TERF2;ATR;TERT
prerank,chromosome organization (GO:0051276),0.2249203246788036,0.661652704187179,0.951935914552737,0.9881205829087882,1.0,25/99,24.16%,HHEX;PADI4;TCF7L1;H3-3A;MTF2;TCF7L2;CDT1;EZH1;COPS2;COPS4;PADI1;NUP133;HMG20A;PHF19;EHMT1;CETN2;BAHD1;MSH2;GATAD1;LATS1;SUV39H1;PHF1;CUL4B;COPS8;LIG4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.2590585240154656,-0.6612076531423304,0.9219512195121952,1.0,1.0,2/18,7.20%,UGGT2;AMFR
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.31697128130052443,0.660558504985193,0.8679927667269439,0.9887208245690337,1.0,7/12,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2961304389805032,-0.6604662708020883,0.8788546255506607,1.0,1.0,3/11,10.76%,RYK;LRP6;FZD1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2109698855741684,-0.6602862095110298,0.9489795918367347,1.0,1.0,15/42,27.51%,C2CD5;PEX1;TOMM40;AIFM1;SEC61A2;PEX7;TIMM17B;GRPEL2;TIMM21;SEC61A1;PEX5;DNAJC15;HSPA5;PEX16;PAM16
prerank,ncRNA metabolic process (GO:0034660),0.2555947277046694,0.6596769345788063,0.9223744292237442,0.9891116805962406,1.0,5/37,13.10%,DTD1;DROSHA;NIFK;DICER1;HENMT1
prerank,neurogenesis (GO:0022008),0.25395730170374614,0.6591774424464295,0.9061102831594635,0.9891296635236789,1.0,11/43,18.62%,CDK6;BTBD1;BTBD3;NEUROD1;THOC2;CXCR4;NDUFS2;METTL14;TRAK2;BTBD6;CDK5RAP2
prerank,RNA methylation (GO:0001510),0.23790356400310575,0.6587985657334953,0.9483240223463687,0.9890544235108939,1.0,19/60,27.21%,TGS1;CBLL1;RBM15;TFB2M;NSUN4;FBLL1;HENMT1;WTAP;VIRMA;TRMT6;METTL14;NSUN6;ALKBH8;LCMT2;TRMT10C;TRMT61B;TRMT12;METTL16;NSUN2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.25316727142286755,-0.6582089634424695,0.8897058823529411,1.0,1.0,3/19,9.30%,RYK;LRP6;VEGFA
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3115160046182002,0.658013190913299,0.8661844484629295,0.989368136995419,1.0,7/13,28.93%,NELFE;NELFCD;NELFB;NELFA;EAPP;RNF168;RNF8
prerank,regulation of protein sumoylation (GO:0033233),0.2968742274064311,0.6580001303657871,0.8707482993197279,0.9889416701167907,1.0,4/17,16.74%,RASD2;ZMIZ1;SAE1;CTNNB1
prerank,peptidyl-arginine modification (GO:0018195),0.30477984151543247,0.6570504120214331,0.8543859649122807,0.9893737121946028,1.0,4/15,21.16%,PADI4;PADI1;ART4;KRTCAP2
prerank,positive regulation of peptidase activity (GO:0010952),-0.2440464740983621,-0.6567422358833668,0.9023809523809524,1.0,1.0,4/20,17.53%,RCN3;APH1B;NCSTN;DDRGK1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.28196855802252424,0.6567380216797667,0.8716216216216216,0.989228599055465,1.0,3/22,12.53%,MFHAS1;SASH1;XDH
prerank,COPII-coated vesicle budding (GO:0090114),0.23696755652469564,0.6566861495407826,0.9368131868131868,0.9888448611501827,1.0,1/68,0.35%,CTSC
prerank,negative regulation of translational initiation (GO:0045947),0.3136691323821262,0.6565886455220437,0.8690909090909091,0.9884989223968803,1.0,4/13,15.91%,EIF4EBP1;EIF2AK4;FMR1;PAIP2B
prerank,regulation of lipid catabolic process (GO:0050994),-0.25260933489140563,-0.655820857533958,0.9146341463414634,1.0,1.0,4/19,18.11%,ADRA2A;ALK;RARRES2;ANGPTL3
prerank,negative regulation of cation channel activity (GO:2001258),-0.23751662267102502,-0.6558190666982354,0.9427860696517413,1.0,1.0,9/26,26.51%,SLC6A9;GNB5;KCNAB1;GSTM2;CASQ2;CBARP;EPHB2;GPR35;EPO
prerank,regulation of inclusion body assembly (GO:0090083),0.319343258686426,0.6550887233043979,0.8633093525179856,0.9894902357975728,1.0,3/11,20.04%,SNCAIP;DNAJB1;DNAJB6
prerank,rRNA pseudouridine synthesis (GO:0031118),0.32280944012051216,0.6546980351728483,0.8512544802867383,0.9894197225769512,1.0,10/10,67.74%,RPUSD2;RPUSD4;RPUSD1;TSR3;NOP10;DKC1;NAF1;GAR1;RPUSD3;NHP2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.24484018067430077,-0.6546327655455936,0.9314720812182741,1.0,1.0,2/23,9.38%,AXL;INHBA
prerank,cellular response to virus (GO:0098586),0.2688790979973162,0.6541091033357754,0.8916797488226059,0.9894896846968594,1.0,12/30,25.22%,HIF1A;MAPK11;IFIH1;FMR1;RRP1B;IRGM;POU2F2;POU2AF1;MAPK14;RIOK3;EIF5A;CXCL10
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2840381040099142,-0.6537016294573527,0.8943820224719101,1.0,1.0,4/11,25.20%,TIMM22;TIMM8B;TIMM9;TIMM10
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.28588591811348935,0.652449112322648,0.8845500848896435,0.9905877556898501,1.0,4/19,13.07%,PARD3;FSCN1;PARD3B;CLIC4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.25041792091711923,-0.651552068062421,0.9299065420560748,1.0,1.0,1/18,1.56%,BCL2
prerank,secondary alcohol metabolic process (GO:1902652),0.25047722080042173,0.6514587717656456,0.9170653907496013,0.9910669403623089,1.0,5/42,13.77%,PPARD;CH25H;SOAT2;CLN6;ABCG1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2396269415080713,-0.6503125646208502,0.9256410256410257,1.0,1.0,10/23,30.00%,HSP90AA1;TIMM22;COX18;MAIP1;TIMM8B;BAX;TIMM9;TIMM10;SAMM50;PMAIP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.3014893273466632,0.6500396982084488,0.8518518518518519,0.9918990453643692,1.0,3/15,9.74%,NEK6;ANAPC7;ANAPC1
prerank,regulation of superoxide anion generation (GO:0032928),-0.2678032331460146,-0.6500264950293746,0.8771551724137931,1.0,1.0,4/14,22.19%,PRKCD;SYK;ITGB2;AATF
prerank,protein import into nucleus (GO:0006606),0.23284422866323495,0.6499835046315806,0.9432624113475178,0.9915081051116763,1.0,19/66,22.69%,STAT3;IPO11;PPP1R10;RPL23;IPO8;NUP214;PRICKLE1;NUP133;NUP54;TNPO3;NUP153;PTTG1IP;E2F3;CSE1L;KPNB1;KPNA4;HIKESHI;EIF4ENIF1;APPL1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23131924694799136,0.6494866053813949,0.9446749654218534,0.9915106340767013,1.0,16/65,22.49%,AURKA;AVEN;PSMA2;FBXL7;PINX1;PSMA8;PSMA6;CUL1;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3
prerank,base-excision repair (GO:0006284),-0.20516399785662134,-0.6490894370640085,0.9762611275964391,1.0,1.0,21/48,32.71%,ERCC5;RFC1;USP47;APEX2;NEIL3;DNA2;POLE;MUTYH;POLG;TDG;NTHL1;POLD1;POLB;POLD2;NEIL1;LIG1;ADPRS;RPA2;FEN1;WRN;PRMT6
prerank,protein import into peroxisome membrane (GO:0045046),-0.2405764555601989,-0.6487737851810057,0.9251207729468599,1.0,1.0,8/22,27.01%,ABCD3;ATAD1;PXMP2;PEX11B;PEX5;GDAP1;ABCD2;PEX16
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.20632314804383853,0.6479819073165877,0.9871645274212368,0.9924008799535584,1.0,23/173,14.54%,CTSC;SPTBN1;PGAP1;F7;PROS1;VAMP4;COG5;VTI1A;TGFA;TMED7;DYNLL1;RAB2A;DYNC1LI1;TMED5;ANK1;SPTAN1;GAS6;TRAPPC3;PREB;ACTR10;CAPZA1;PROC;NRBP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.28722167581419367,0.64767454249063,0.8910034602076125,0.9922386275702,1.0,11/18,35.21%,DCP2;CCT7;CCT2;RUVBL1;RUVBL2;PARN;CCT8;NOP10;CCT6A;DKC1;EXOSC10
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.31057245522147237,0.6471079557909116,0.8541266794625719,0.9922923843409861,1.0,3/12,13.77%,NFKBIA;ITGB3;ABCG1
prerank,microtubule depolymerization (GO:0007019),-0.25518873557292354,-0.6468203784543881,0.912751677852349,1.0,1.0,6/17,32.02%,KIF24;NCKAP5L;CKAP5;KIF18B;STMN4;STMN2
prerank,negative regulation of mRNA processing (GO:0050686),-0.26697869784007683,-0.6465838653338702,0.8744292237442922,1.0,1.0,6/15,31.79%,U2AF2;PCBP4;BARD1;SRSF6;C1QBP;SRSF9
prerank,regulation of store-operated calcium entry (GO:2001256),0.3218342187764278,0.645694630407318,0.8514680483592401,0.9930302188305602,1.0,4/10,21.78%,HOMER2;HOMER3;HOMER1;CASQ1
prerank,positive regulation of viral transcription (GO:0050434),0.27511571989766404,0.6443924481354892,0.9087837837837838,0.9936814133270095,1.0,8/25,22.30%,GTF2F2;NELFE;NELFCD;CTDP1;NELFB;POLR2L;NELFA;POLR2J
prerank,cilium-dependent cell motility (GO:0060285),-0.23574437082667435,-0.6439133641242921,0.9069148936170213,1.0,1.0,8/22,25.30%,CFAP44;DNAH8;CCDC39;RSPH9;EFHC1;GAS8;DNAH2;DRC1
prerank,regulation of interferon-alpha production (GO:0032647),-0.23472818524250788,-0.6436360504495859,0.9232804232804233,1.0,1.0,3/23,13.79%,PTPRS;CHUK;MAVS
prerank,regulation of DNA metabolic process (GO:0051052),0.2492064115191455,0.6426049527347633,0.9317507418397626,0.9947999821503629,1.0,16/44,27.04%,HNRNPD;CDT1;IL7R;SUB1;HELB;PARG;YLPM1;ALYREF;WDR18;THOC1;UBE2V2;SIRT7;SMG6;UBE2N;SMARCAD1;TICRR
prerank,reticulophagy (GO:0061709),0.31318072139928876,0.6419440971413608,0.8731884057971014,0.9949301777138592,1.0,5/12,25.09%,ULK1;ATG2A;ATG2B;RB1CC1;UFM1
prerank,negative regulation of protein metabolic process (GO:0051248),0.24233544262316745,0.6411154399197344,0.9423631123919308,0.995180128623774,1.0,11/48,15.63%,EDN1;PTX3;SNX3;NFKB1;MAD2L2;ITGB3;RILP;HSP90AB1;PFDN1;PRKCG;IRAK3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2398134548076075,0.640961341837021,0.9381294964028777,0.9948711763066445,1.0,17/50,24.06%,PAK2;RPS6KA3;RPS6KA1;XIAP;GAS6;SFN;CARD16;PIH1D1;ARL6IP1;MAP2K5;CAAP1;CSNK2A1;DNAJB6;IGBP1;PLAUR;YWHAE;RFFL
prerank,gas transport (GO:0015669),0.31433592769269403,0.6407398550393358,0.8552123552123552,0.9946166396062803,1.0,10/10,68.59%,CA2;IPCEF1;AQP5;MB;AQP6;CYGB;RHAG;NGB;AQP1;MYC
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.25242557641081337,0.640547508279961,0.9310344827586207,0.9943458125888246,1.0,1/34,1.15%,MEF2C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.31569793622443126,0.6401946263263787,0.8768382352941176,0.993786076663097,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),0.31569793622443126,0.6401946263263787,0.8768382352941176,0.993786076663097,1.0,3/11,12.67%,TNRC6C;EIF6;ZFP36
prerank,axonemal dynein complex assembly (GO:0070286),-0.223009045734892,-0.6396519802839267,0.9428571428571428,1.0,1.0,12/27,35.21%,DNAI4;DNAL1;DNAH8;CCDC39;SPAG1;DRC1;TTC12;ODAD4;DNAAF5;ODAD1;DNAAF4;CCDC63
prerank,regulation of sequestering of triglyceride (GO:0010889),0.3022150701255505,0.6393655396378646,0.8729874776386404,0.994043660071995,1.0,4/15,14.43%,PLIN5;LPL;PNPLA2;APOC4
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.23481742436169914,-0.6389600252404957,0.9541984732824428,1.0,1.0,7/23,24.48%,DDB2;COPS7B;DDB1;XPC;COPS6;CUL4A;UBC
prerank,regulation of immunoglobulin production (GO:0002637),-0.23251238222259585,-0.6389246539793076,0.9496221662468514,1.0,1.0,6/23,26.99%,RBP4;STX4;CLCF1;EPHB2;PTPRC;FCGR2B
prerank,ovarian follicle development (GO:0001541),0.3005527484346784,0.6385544330720888,0.8835978835978836,0.9942845361729531,1.0,4/13,13.79%,FOXL2;EIF2B5;ANG;EIF2B2
prerank,glutathione biosynthetic process (GO:0006750),0.3124948658889807,0.6380561717837558,0.847985347985348,0.9942473965629225,1.0,3/11,13.98%,GGCT;GCLM;OPLAH
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3110915824493129,0.6375741593549271,0.8402154398563735,0.9937881897129625,1.0,11/11,68.91%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3110915824493129,0.6375741593549271,0.8402154398563735,0.9937881897129625,1.0,11/11,68.91%,CCT7;CCT2;CCT8;CCT6A;DKC1;LARP7;CCT4;CCT3;CCT5;TCP1;MEPCE
prerank,autophagosome maturation (GO:0097352),-0.21541727123456464,-0.6372319696599208,0.9647058823529412,1.0,1.0,11/32,29.10%,LAMP2;ATP2A2;LIX1;LIX1L;VPS16;VIPAS39;STX17;CLN3;GABARAP;WIPI2;EPG5
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.30840767184959345,0.6372119856925804,0.8717472118959108,0.993638416327299,1.0,5/10,27.73%,PIH1D1;TAF9;RUVBL1;NUFIP1;RUVBL2
prerank,regulation of secretion (GO:0051046),0.30565031810803484,0.6367735554012476,0.8908765652951699,0.9935531925334321,1.0,1/13,2.39%,KCNQ1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.22090256066755257,0.6367001675757051,0.9583333333333334,0.993174854909779,1.0,31/79,27.03%,KIF26A;AP2B1;MFSD6;AP2A1;DYNLL1;DYNC1LI1;KIF22;AP1S2;KIF23;LGMN;RILP;ACTR10;CAPZA1;RAB7A;AP1S3;SH3GL2;OSBPL1A;KIF4A;RACGAP1;AP1G1;KIF2A;DCTN6;FCER1G;KIF18A;SAR1B;AP2M1;CAPZA2;CLTA;DNM2;CTSE;SPTBN2
prerank,folic acid metabolic process (GO:0046655),-0.24644653790886223,-0.6362257935756875,0.923963133640553,1.0,1.0,5/18,17.41%,ALDH1L1;FPGS;MTHFD1;SLC19A1;MTHFD2L
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.21700576589674045,-0.6355243602155706,0.9468085106382979,1.0,1.0,7/32,15.89%,EML2;MAP2;CLIP3;NAV3;TTBK2;SNCA;APC2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.2894207212381361,0.6349761469780305,0.8982456140350877,0.9941553320677653,1.0,6/16,23.47%,BCL2L1;DDIAS;SFRP2;TPT1;RPS3;CLU
prerank,regulation of chromosome organization (GO:0033044),0.2750532174429898,0.6348851210536338,0.8961038961038961,0.9938007881163717,1.0,7/22,24.16%,HNRNPD;CDT1;RB1;YLPM1;RMI2;SMG6;LIG4
prerank,miRNA metabolic process (GO:0010586),0.27352926387622717,0.6345558298980704,0.9131205673758865,0.9936335462697415,1.0,10/20,31.94%,DROSHA;DICER1;TRIM71;PRKRA;SND1;TENT4B;TUT7;PARN;DIS3L2;XPO5
prerank,protein processing (GO:0016485),0.21288361296588412,0.6344756353002665,0.9801587301587301,0.9932772557243847,1.0,19/102,16.30%,ADAM10;CASP4;CPD;CPE;F7;SRGN;CASP1;PSEN1;APH1A;PITRM1;LGMN;OMA1;SPCS1;ADAM17;PCSK7;VSIR;SPPL3;ZMPSTE24;DDI2
prerank,cellular respiration (GO:0045333),-0.2053495016194287,-0.6342939767812735,0.9649122807017544,1.0,1.0,15/41,29.85%,PPARGC1A;SLC25A13;SDHAF4;NR4A3;SLC25A14;MTFR1L;COQ10A;SDHC;UQCRB;NDUFS7;MDH2;COQ10B;UQCR10;COX4I2;MTLN
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28813894717613636,0.6342375187035425,0.9020618556701031,0.9930506896740664,1.0,1/18,2.14%,DAB2IP
prerank,protein palmitoylation (GO:0018345),-0.215490147679085,-0.633396306605556,0.9572192513368984,1.0,1.0,3/30,8.44%,GLUL;CLIP3;ZDHHC20
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.26700759958452785,0.6331171411028416,0.8969404186795491,0.9935166698529597,1.0,6/27,15.03%,CEPT1;LPIN3;PLA2G2D;PLAAT3;CHKA;PNPLA8
prerank,establishment of spindle localization (GO:0051293),0.2958798003558851,0.6328533095373357,0.8815331010452961,0.9932974809476441,1.0,6/14,23.87%,LLGL1;CFL1;ZBED3;KPNB1;CLASP2;MAP4
prerank,oligodendrocyte development (GO:0014003),0.2921736791790698,0.6326345012093727,0.8754448398576512,0.9930457142959689,1.0,4/15,13.79%,B4GALT5;EIF2B5;PRDM8;EIF2B2
prerank,protein K11-linked ubiquitination (GO:0070979),0.26500949164998716,0.6325803423633316,0.9201331114808652,0.992659513774983,1.0,6/27,11.25%,UBE2H;ANAPC7;RNF4;ANAPC1;UBE2D3;CDC26
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25603117141604037,-0.6320197791320363,0.9044117647058824,1.0,1.0,3/17,14.87%,NSA2;FTSJ3;RRP15
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.27850788907940094,0.6311478015795262,0.8950819672131147,0.9933790392037504,1.0,7/20,19.37%,NT5C2;AK4;ADSL;HPRT1;IMPDH1;ADSS2;GART
prerank,telomere organization (GO:0032200),-0.2015775447796919,-0.6307623484940409,0.9602272727272727,1.0,1.0,19/43,32.55%,PARP3;RTEL1;RAD50;DOT1L;XRCC5;TERF2;XRCC6;ATR;DNA2;TERT;PRKDC;ATM;POLD1;LTO1;POLD2;DCLRE1B;RPA2;BLM;WRN
prerank,amyloid-beta metabolic process (GO:0050435),0.28300371070221225,0.6306493074457404,0.8908450704225352,0.9933425468663697,1.0,5/16,15.49%,DYRK1A;PSEN1;APH1A;APEH;ACE
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.29661001327695496,0.6287215692275389,0.8939929328621908,0.9944350576978528,1.0,4/13,24.97%,DUT;UNG;MBD4;NEIL2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.280253701848349,-0.6285791331625215,0.9232409381663113,1.0,1.0,1/11,3.76%,UGGT2
prerank,myeloid dendritic cell activation (GO:0001773),0.3055675661553464,0.6285175265671717,0.8728971962616823,0.9941529173848482,1.0,2/12,12.94%,DCSTAMP;TGFBR2
prerank,protein localization to centrosome (GO:0071539),-0.25172285140828904,-0.6274312803921173,0.906801007556675,1.0,1.0,4/17,18.89%,GOLGB1;CEP192;PCM1;C2CD3
prerank,Golgi to lysosome transport (GO:0090160),0.3085358647461773,0.6256532510591223,0.8763837638376384,0.9958746360210067,1.0,5/11,27.39%,ANKFY1;EHD3;AP1G1;GAK;SORT1
prerank,proteasome assembly (GO:0043248),0.3033553300807475,0.6239217170464728,0.9135338345864662,0.9967482158439699,1.0,5/11,30.92%,POMP;PSMG2;ADRM1;OTUD6B;PSMG1
prerank,cellular response to oxygen levels (GO:0071453),-0.29193878403697054,-0.6234121934793468,0.8961038961038961,1.0,1.0,6/10,35.28%,CPEB4;ATP6V0D1;TMEM199;CCDC115;ATP6V1G1;ATP6AP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2068572894513417,0.6233492821977151,0.98875,0.9967475407242661,1.0,24/128,18.62%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57;BACH1;CUL1;CDC25C;FBXL3;CEP290;CHEK2;CEP131;CEP72;PPP2R2A;CETN2;CDK5RAP2
prerank,positive regulation of protein acetylation (GO:1901985),0.29900516351151074,0.6231431903808335,0.8839458413926499,0.9964707841362683,1.0,4/12,17.53%,DIP2B;CEP295;RAPGEF3;PRKAA1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.2817552640944599,0.6228240908184342,0.8998272884283247,0.9962808157724777,1.0,5/18,15.85%,RAP1B;RAP1A;RAB5A;FMR1;RIMS4
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30310545734712024,0.6224243210223322,0.8731884057971014,0.9961399290693571,1.0,3/10,19.93%,ABCA3;MTMR9;MTMR2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.1814240562094492,-0.6224111176918672,0.993006993006993,1.0,1.0,14/69,20.60%,SELENOS;AMFR;UBXN4;JKAMP;UBE4B;NPLOC4;UBE2G2;UBE4A;RNF121;USP19;DNAJC18;FAM8A1;DNAJB2;TMEM67
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2768217342584747,-0.622283483494285,0.9022222222222223,1.0,1.0,2/12,9.84%,LDLR;APOE
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22516823361916352,-0.6213644405694763,0.9459459459459459,1.0,1.0,7/25,19.75%,PPP4R4;SH3RF2;CRY2;TGFB2;PTPA;BOD1L1;SH2D4A
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.2823682832271327,-0.6211713180763676,0.9239130434782609,1.0,1.0,1/10,4.29%,HSP90AA1
prerank,lysosome localization (GO:0032418),0.2463285686030087,0.6208152321895538,0.9548192771084337,0.9968897266903262,1.0,11/37,24.16%,MYH9;PIK3CG;SPAG9;ARL8B;NDEL1;SYTL4;PLEKHM1;TFEB;HDAC6;RAB3A;BORCS5
prerank,response to light stimulus (GO:0009416),0.22874551960550055,0.620334271616962,0.9677891654465594,0.9968355904313484,1.0,7/55,12.93%,MAP4K3;MAPK8;OPN4;GNAT1;PRIMPOL;OPN5;ERCC4
prerank,protein sumoylation (GO:0016925),0.23174860202665531,0.6200345145202021,0.9503012048192772,0.9966154834464361,1.0,12/49,14.81%,STX1A;SUMO2;NUP214;NUP98;SAE1;NUP133;IFIH1;NUP205;NUP54;TOPORS;NUP43;NUP153
prerank,tRNA export from nucleus (GO:0006409),0.2477091699965422,0.6196156975042779,0.924031007751938,0.9960736899837946,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2477091699965422,0.6196156975042779,0.924031007751938,0.9960736899837946,1.0,8/32,17.14%,NUP214;NUP98;NUP133;NUP205;NUP54;NUP43;NUP153;XPOT
prerank,cellular response to leucine starvation (GO:1990253),-0.27932935109928536,-0.6195903569523317,0.9368191721132898,1.0,1.0,4/10,26.17%,IMPACT;SESN2;MTOR;RRAGD
prerank,cristae formation (GO:0042407),-0.21484184117830668,-0.6195553083998373,0.94579945799458,1.0,1.0,11/27,32.04%,CHCHD3;CHCHD6;ATP5PO;ATP5PF;ATP5ME;SAMM50;ATP5MG;DMAC2L;APOO;DNAJC11;IMMT
prerank,protein localization to kinetochore (GO:0034501),-0.25846415546546975,-0.6195169625829662,0.918141592920354,1.0,1.0,9/14,43.58%,IK;CENPT;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.26151371240224597,0.6189793511462754,0.9306451612903226,0.9960967994465878,1.0,5/27,15.11%,PHF20;KAT6B;PHF20L1;KAT2B;KAT6A
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.24840201292546443,-0.6173838874612225,0.9301801801801802,1.0,1.0,4/17,16.79%,ADRA2A;ALK;MFSD2A;GPLD1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.25618217358974704,-0.616612582178845,0.9385342789598109,1.0,1.0,2/14,8.47%,AUTS2;CTR9
prerank,transferrin transport (GO:0033572),-0.20964659243983774,-0.6163342047396657,0.967741935483871,1.0,1.0,6/33,13.77%,ATP6V0A4;ATP6V1B2;STEAP3;ATP6V0D1;ATP6V0B;ARHGAP1
prerank,ESCRT III complex disassembly (GO:1904903),0.30723406116491114,0.6161189556996496,0.845437616387337,0.9973459227490247,1.0,1/10,5.98%,CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.30723406116491114,0.6161189556996496,0.845437616387337,0.9973459227490247,1.0,1/10,5.98%,CHMP2B
prerank,axonal transport (GO:0098930),0.24519406360095652,0.6160201947374156,0.9491525423728814,0.9969908028953162,1.0,2/36,2.90%,HIF1A;DST
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2522194442710617,-0.6156263510068736,0.9430523917995444,1.0,1.0,5/16,24.06%,NUPR1;UQCC2;SLC25A33;PDE12;PPIF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2333522630771405,-0.6154250332742437,0.9461358313817331,1.0,1.0,8/20,26.23%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2333522630771405,-0.6154250332742437,0.9461358313817331,1.0,1.0,8/20,26.23%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2333522630771405,-0.6154250332742437,0.9461358313817331,1.0,1.0,8/20,26.23%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27933363008248546,0.6146452052737094,0.8977072310405644,0.9975352950052976,1.0,7/16,26.55%,NAA11;KAT2B;NAA16;NAA30;NAA35;NAA50;CREBBP
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.282493129666374,0.6139937163609877,0.8892921960072595,0.9975906387282375,1.0,5/15,17.95%,PLCG2;NPM1;CDC73;CUL3;KLHL18
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.2764551125300176,-0.6132642858056531,0.9170305676855895,1.0,1.0,6/11,37.55%,SMARCAL1;DONSON;FBH1;BLM;ZRANB3;LIG3
prerank,histone H2A acetylation (GO:0043968),-0.24917218165254834,-0.6130083879148177,0.9284009546539379,1.0,1.0,6/16,23.37%,NAA40;MORF4L2;BRD8;ACTL6A;MEAF6;SPHK2
prerank,mitotic spindle organization (GO:0007052),0.1959049087653136,0.6128650117558992,0.9975369458128078,0.9979442461544951,1.0,42/153,24.75%,RAB11A;PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;STAG2;KIF23;RPS27;NUP98;MAD1L1;NUP133;NDEL1;STAG1;BUB3;NUP43;LSM14A;CHEK2;RHOA;ABRAXAS2;WRAP73;MZT1;PPP1CC;CLIP1;BCCIP;PIBF1;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85
prerank,protein import into peroxisome matrix (GO:0016558),-0.26434470303725743,-0.6121781063280443,0.940677966101695,1.0,1.0,5/12,27.01%,PEX1;PEX7;PEX5L;PEX5;PEX16
prerank,regulation of exit from mitosis (GO:0007096),-0.19797422579011273,-0.6118350461091248,0.9680232558139535,1.0,1.0,5/38,10.88%,SIRT2;CDC14B;ANAPC5;RGCC;ANAPC15
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2428230925951445,-0.6116985074085968,0.9247058823529412,1.0,1.0,9/18,32.58%,GINS3;GINS1;POLE;POLD2;GINS4;LIG1;POLE3;MCMDC2;MCM3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.23868877036373182,-0.6111629975516714,0.9569377990430622,1.0,1.0,2/17,11.90%,SELENOS;NPLOC4
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21941355704858745,-0.6108151333968302,0.9654255319148937,1.0,1.0,11/28,32.64%,MAP2;MAP1S;MAP1A;CAMSAP3;STMN4;CLASP1;SKA3;MAPRE1;GBA2;STMN2;ARL2
prerank,response to glucocorticoid (GO:0051384),0.2589107241922922,0.610568813034599,0.9081967213114754,0.9990767918941562,1.0,6/26,21.59%,NR3C1;BCL2L11;ZFP36;ZFP36L1;UBE2L3;SLIT3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23707065830717816,-0.6102549548124617,0.9407582938388626,1.0,1.0,9/17,37.31%,GET4;EMC8;GET1;EMC4;EMC1;BAG6;GET3;CAMLG;EMC10
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2645848931447019,-0.6101760030847654,0.9147465437788018,1.0,1.0,4/13,26.58%,TRIM35;TRIM28;TRIM8;TRIM5
prerank,positive regulation of type I interferon production (GO:0032481),0.2166576639144485,0.609950870512941,0.9752407152682255,0.9990701735458596,1.0,15/73,20.69%,LRRFIP1;NFKB1;G3BP1;CGAS;RELA;RIPK2;IFIH1;NFKB2;STAT6;CTNNB1;STAT1;POLR3B;DHX36;POLR3A;POLR2L
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.29761594094509014,0.6097936298263574,0.9073083778966132,0.9987570814166756,1.0,3/10,17.93%,ELOVL5;ABCD1;MLXIPL
prerank,regulation of interferon-beta production (GO:0032648),-0.19135199415823057,-0.60964979708714,0.9850746268656716,1.0,1.0,10/46,20.99%,PTPRS;HSP90AA1;OAS2;MAVS;RNF135;SIRPA;PPM1B;CACTIN;POLR3D;PYCARD
prerank,nucleosome disassembly (GO:0006337),0.2847268024281801,0.6095314627091535,0.8894645941278065,0.99808178713482,1.0,7/14,24.69%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,chromatin disassembly (GO:0031498),0.2847268024281801,0.6095314627091535,0.8894645941278065,0.99808178713482,1.0,7/14,24.69%,ARID1A;SMARCE1;GRWD1;SMARCC1;ARID2;SMARCD1;SET
prerank,linoleic acid metabolic process (GO:0043651),0.2724949734537405,0.6094311547632753,0.9045936395759717,0.9977227731716937,1.0,4/17,15.03%,ELOVL5;ABCD1;GSTP1;PNPLA8
prerank,histone lysine methylation (GO:0034968),0.24106083598248773,0.6086604253090887,0.9476190476190476,0.9977958190354604,1.0,13/33,29.23%,KDM6A;SMYD3;SETDB2;ASH2L;CXXC1;RBBP5;PRDM9;SUV39H1;N6AMT1;DYDC2;EZH2;SMYD2;SMYD1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18663914559640543,0.6080760147204268,0.9988751406074241,0.9977762913687895,1.0,75/264,25.96%,NOVA2;RSRC1;SRPK3;TGS1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;SCAF11;WDR77;CWC27;SNW1;YBX1;AQR;DDX20;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;STRAP;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;SNUPN;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,intracellular pH reduction (GO:0051452),0.24307750518438181,0.6076068127959287,0.9407407407407408,0.9976656552288186,1.0,5/33,13.71%,CLCN3;ATP6V0A1;RAB38;ATP6V1G2;RAB7A
prerank,central nervous system neuron axonogenesis (GO:0021955),0.28425092669113655,0.6071096329695042,0.912568306010929,0.9975811380232532,1.0,3/12,12.95%,MYCBP2;B4GALT5;HSP90AB1
prerank,transcription preinitiation complex assembly (GO:0070897),0.28664678494483037,0.6067752072332009,0.8821428571428571,0.9973796317350412,1.0,2/12,12.88%,TAF1B;GTF2A2
prerank,sensory perception of taste (GO:0050909),0.3015942756716044,0.606712604714293,0.8794326241134752,0.9969967278505488,1.0,10/10,69.86%,PKD1L3;ASIC1;ASIC2;TAS1R3;GNAT3;TAS1R2;PKD2L1;TAS1R1;ASIC3;CD36
prerank,ncRNA export from nucleus (GO:0097064),0.23841237158227674,0.6066164461674082,0.9282442748091603,0.9966504482218083,1.0,9/36,17.14%,NUP214;NUP98;NUP133;NUP205;NPM1;NUP54;NUP43;NUP153;XPOT
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.238359803162468,0.6063637822585977,0.9475357710651828,0.9963882274933371,1.0,10/36,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,regulation of response to stress (GO:0080134),-0.2778443564121671,-0.6062479028176504,0.9136363636363637,1.0,1.0,5/10,35.35%,EIF4G1;ADCY8;SLC38A2;CORO2B;DYRK3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.2595061334693252,-0.6041496684994723,0.9320843091334895,1.0,1.0,5/12,21.38%,LHPP;PAICS;ATIC;PFAS;ADSS1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2302840458430233,0.6013634450934847,0.9734513274336283,0.9992541908991331,1.0,6/43,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;HUS1;NOP53
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2539267815757516,-0.601232588182187,0.9225941422594143,1.0,1.0,1/13,2.78%,PRKCD
prerank,Golgi to endosome transport (GO:0006895),0.2741925472264195,0.6008622283947311,0.9214659685863874,0.9991311717682427,1.0,5/16,20.49%,DOP1B;AP2A1;KIF16B;AP1AR;EPS15
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2583964528847611,-0.5990391281743874,0.9315673289183223,1.0,1.0,5/12,24.46%,BDH2;GCLC;HAGH;GGT1;CNDP2
prerank,rRNA catabolic process (GO:0016075),-0.23565386099876937,-0.5990061957497915,0.9471264367816092,1.0,1.0,3/16,19.18%,EXOSC7;EXOSC3;EXOSC9
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.26624843815854343,0.5983305841310194,0.9065255731922398,1.0,1.0,7/19,25.59%,GMPR;HPRT1;ADA;PNP;TYMS;POLL;ADK
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2927486175988687,0.5966911074179828,0.9102333931777379,1.0,1.0,3/13,17.56%,RRS1;RPS21;NOP14
prerank,lipid droplet formation (GO:0140042),0.30238644473872,0.5964565120201534,0.8996212121212122,1.0,1.0,1/10,6.96%,CDS2
prerank,protein ADP-ribosylation (GO:0006471),-0.21204019384180378,-0.5958761408114008,0.972636815920398,1.0,1.0,3/28,7.77%,SIRT2;PARP3;PARP11
prerank,carnitine metabolic process (GO:0009437),0.29116215216107627,0.5958338404662545,0.8875,1.0,1.0,4/12,22.25%,CRAT;CPT1A;CROT;ALDH9A1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.26875156555432306,-0.5956478985609516,0.9013157894736842,1.0,1.0,3/10,23.40%,IVD;GCDH;ACADS
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2405852205481197,0.5952073802464994,0.9580745341614907,1.0,1.0,5/32,12.25%,TAOK2;BABAM2;BRCC3;FOXN3;NOP53
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.27954861064096603,0.5936753899272514,0.8791593695271454,1.0,1.0,3/12,20.74%,CDT1;MAD1L1;CHAMP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.26586975115607975,0.5936152540101665,0.9117647058823529,1.0,1.0,3/17,14.21%,HASPIN;RB1;BUB3
prerank,tRNA methylation (GO:0030488),-0.19600201156650743,-0.5932921992962059,0.9757412398921833,1.0,1.0,34/34,80.45%,TARBP1;GTPBP3;MTO1;THUMPD3;METTL1;BCDIN3D;DALRD3;TRMT61A;METTL2A;METTL2B;THUMPD2;TRMT13;TRMT44;FTSJ1;HSD17B10;TRMT5;TRDMT1;TRMT1;THADA;WDR6;TRMO;METTL6;TYW3;TRMT112;TRMT10A;TRMT1L;NSUN2;TRMT12;TRMT61B;TRMT10C;LCMT2;ALKBH8;NSUN6;PRORP
prerank,tRNA wobble uridine modification (GO:0002098),-0.2397664490205927,-0.5931448480560255,0.9449339207048458,1.0,1.0,14/14,76.05%,GTPBP3;ELP4;MTO1;URM1;ELP1;TRMT9B;CTU1;CTU2;TRMU;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,histone H3-K4 methylation (GO:0051568),0.244404723860905,0.5922933990342417,0.9270664505672609,1.0,1.0,7/26,22.14%,KDM6A;TET3;TET2;ASH2L;CXXC1;RBBP5;PRDM9
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.2811728167087405,0.5914735081786797,0.9074074074074074,1.0,1.0,2/10,12.17%,TFAP4;MUC1
prerank,negative regulation of chemokine production (GO:0032682),0.2754402533551627,0.5914498731753571,0.9054982817869416,1.0,1.0,3/14,16.94%,SIGIRR;GSTP1;MAP2K5
prerank,immunoglobulin mediated immune response (GO:0016064),-0.2674092635900558,-0.5913032443753173,0.9342105263157895,1.0,1.0,4/10,34.72%,CD81;CD74;FCGR2B;TLR8
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.294479946505116,0.5911844325306653,0.908411214953271,1.0,1.0,3/10,20.74%,ATP5PD;VPS9D1;ATP5MC2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.23605307303622378,0.5910342994445125,0.9481132075471698,0.9996266687873921,1.0,8/31,22.30%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,7-methylguanosine RNA capping (GO:0009452),0.23605307303622378,0.5910342994445125,0.9481132075471698,0.9996266687873921,1.0,8/31,22.30%,GTF2F2;RNGTT;RNMT;GTF2H4;GTF2H1;POLR2L;CCNH;POLR2J
prerank,skeletal muscle contraction (GO:0003009),-0.23189603034395,-0.5907511101568955,0.9557109557109557,1.0,1.0,7/19,39.24%,STAC3;TNNI1;TNNT3;TNNC1;TCAP;STAC2;TNNI2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1823725290111821,0.5903655872780736,0.9988649262202043,0.9995954263890503,1.0,68/241,25.96%,NOVA2;RSRC1;HNRNPF;SF3B4;GTF2F2;CTNNBL1;HNRNPA0;MTREX;HNRNPK;RBM14;HNRNPD;WDR33;LSM8;YTHDC1;SPEN;RBM15;RNPS1;LSM3;HNRNPC;ZMAT2;SMU1;SF3B6;DHX15;SNRNP25;CWC27;SNW1;YBX1;AQR;HNRNPUL1;CWC22;ALYREF;CDC40;LSM7;PRPF40A;PHF5A;METTL14;RALY;CWF19L2;PRPF4;HNRNPM;CPSF1;SRSF10;FUS;SART1;SART3;POLR2L;ELAVL1;SF3A2;POLR2J;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PSPC1;SLU7;CPSF2;SYF2;LSM2;HNRNPA3;PCF11;RBMX;SNRNP200;CPSF3;PUF60;PRPF40B;ISY1;GCFC2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19471975505342182,-0.590084937464175,0.9850299401197605,1.0,1.0,14/38,26.49%,RBBP7;CENPP;ITGB3BP;CENPT;MIS18BP1;CENPU;CENPK;RBBP4;HIRA;CENPH;KNL1;CENPX;CENPQ;CENPA
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.24398238098771968,0.5898430340531916,0.9629629629629629,0.9994930548946791,1.0,10/25,28.06%,DNAJB5;ERO1A;BAG1;HSPE1;DNAJB12;DNAJB1;GAK;HSPA1B;HSPA13;HSPA14
prerank,regulation of calcium-mediated signaling (GO:0050848),0.24984712923872038,0.5891893824777751,0.9254966887417219,0.999468118749949,1.0,4/25,13.84%,BST1;PLCG2;TMBIM4;SLA2
prerank,peroxisome organization (GO:0007031),0.24335483303837127,0.5873219357462721,0.9434571890145396,1.0,1.0,5/25,13.86%,TMEM135;PLAAT3;ABCD4;ABCD1;PEX14
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.22127169508010341,-0.5866360581872373,0.9596199524940617,1.0,1.0,8/21,26.23%,ZWINT;KLHL22;TEX14;IK;ATM;CENPF;BUB1B;KNTC1
prerank,secretory granule organization (GO:0033363),0.28918806321057344,0.5860677353010939,0.9206049149338374,1.0,1.0,2/10,19.36%,SRGN;ABCA1
prerank,cellular response to copper ion (GO:0071280),-0.2294967662606317,-0.5856512067650267,0.9375,1.0,1.0,2/16,16.21%,SNCA;MT3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.23627026694507375,-0.5843909904530066,0.9429223744292238,1.0,1.0,3/17,17.07%,PRKCZ;CEBPB;SYK
prerank,protein localization to condensed chromosome (GO:1903083),-0.2538637931522647,-0.5817963535598327,0.9381898454746137,1.0,1.0,8/12,43.58%,IK;KNL1;SPDL1;CDK1;ZW10;MIS12;TTK;ZWILCH
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.23417964446218895,0.5803921223531201,0.9637795275590552,1.0,1.0,10/30,20.57%,DYRK1A;BCL2L1;DDIAS;SFRP2;TPT1;THOC1;KDM1A;PTTG1IP;THOC5;RPS3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2665163059106793,0.5799564287471699,0.9288321167883211,1.0,1.0,3/14,12.62%,GAS6;CARD16;GSTP1
prerank,cell cycle G2/M phase transition (GO:0044839),0.19211923779800824,0.5799181418148561,0.9950062421972534,1.0,1.0,13/129,9.41%,TPD52L1;PLCB1;PRKAR2B;PPP1R12A;CEP41;AURKA;PCNT;FBXL7;DYNLL1;CCNY;CDK2;CNTRL;CEP57
prerank,transcription by RNA polymerase III (GO:0006383),-0.20672478506183786,-0.5792375043333352,0.983957219251337,1.0,1.0,10/27,32.94%,ICE2;POLR2K;POLR3H;GTF3A;GTF3C4;POLR3K;CRCP;ZC3H8;TBP;SNAPC4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.21730218955497288,-0.5785833478731618,0.9845758354755784,1.0,1.0,2/22,7.20%,UGGT2;AMFR
prerank,microtubule nucleation (GO:0007020),-0.22246377397160783,-0.5785114146923044,0.9491525423728814,1.0,1.0,6/19,31.48%,TUBGCP5;CCDC57;TPX2;CLASP1;GOLGA2;TPPP
prerank,DNA replication (GO:0006260),0.194048936934278,0.5779543463446736,0.9960369881109643,1.0,1.0,37/105,29.55%,RNASEH2A;MCM10;RPA1;POLA1;DUT;CDK2;BRIP1;HELB;HUS1;MCM9;RMI1;TOP1;GRWD1;ORC5;ORC3;BAZ1A;RFC3;MCMBP;RAD17;RMI2;DBF4;TIPIN;RFC5;TBRG1;POLL;SET;ORC6;MCM6;RPA3;TICRR;RBBP8;TIMELESS;RFC2;TOP1MT;KAT7;POLG2;POLA2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.27507846829880733,0.5778652333190196,0.9190207156308852,1.0,1.0,12/12,72.51%,GINS2;MCM6;MUS81;MCM7;MCM2;MCM4;MCM5;CDC7;CDC45;MCM3;MCMDC2;GINS4
prerank,regulation of mRNA metabolic process (GO:1903311),0.28499939635146193,0.5762430373476113,0.9109090909090909,1.0,1.0,4/11,23.97%,SRPK3;SLTM;CDK11B;IWS1
prerank,autophagy of nucleus (GO:0044804),0.26577692603918107,0.5762016103833331,0.927536231884058,1.0,1.0,4/16,18.72%,ULK1;ATG2A;ATG2B;ATG7
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.2905644552103088,0.5761444549004145,0.9095744680851063,1.0,1.0,3/10,19.82%,EMC6;EMC3;EMC7
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2817541895360327,0.5760390998655665,0.9092664092664092,1.0,1.0,1/10,5.81%,MTHFD1L
prerank,negative regulation of protein depolymerization (GO:1901880),0.24557683830945523,0.5740433604255714,0.9548494983277592,1.0,1.0,8/24,23.45%,ARHGEF2;CAMSAP2;LIMA1;APC;CIB1;ATXN7;TAOK1;CLASP2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.19614219046426723,-0.573407788653431,0.9831932773109243,1.0,1.0,8/34,24.56%,RBP4;STX4;PTPN22;LACC1;CLCF1;EPHB2;SPHK2;PTPRC
prerank,tRNA wobble base modification (GO:0002097),-0.2397664490205927,-0.5733562569314511,0.9584295612009238,1.0,1.0,14/14,76.05%,GTPBP3;ELP4;MTO1;ADAT2;URM1;TRMT9B;CTU1;CTU2;ALKBH1;ELP3;MOCS3;DPH3;KTI12;ALKBH8
prerank,regulation of double-strand break repair (GO:2000779),0.2216462113080132,0.5730370493415532,0.9654631083202512,1.0,1.0,9/39,22.19%,RNF169;WRAP53;ACTR2;SIRT6;SPIDR;MGMT;KDM1A;DEK;SIRT7
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.22726380412990266,0.5725221189421412,0.9711684370257967,1.0,1.0,10/38,24.70%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.27379627902843295,0.5722817415931944,0.9042357274401474,1.0,1.0,3/12,23.51%,IL23A;CARD9;ZBTB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.274917638346285,0.571820642068489,0.9210526315789473,1.0,1.0,3/11,15.66%,MBTPS2;ATF6;DDIT3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.24864019312273639,-0.5707096360971877,0.9414414414414415,1.0,1.0,5/13,24.99%,ANAPC15;LCMT1;GEN1;NDC80;XRCC3
prerank,regulation of steroid metabolic process (GO:0019218),0.24325235479555798,0.5695692206564202,0.9552238805970149,1.0,1.0,8/23,21.58%,PANK2;ABCG1;ASAH1;TTC39B;STAR;ABCB11;FMO5;RORC
prerank,sulfur amino acid catabolic process (GO:0000098),-0.25702321076860946,-0.5694027723565876,0.9329004329004329,1.0,1.0,4/10,24.84%,CBS;BLMH;CTH;MTRR
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.27342040092543396,0.5692135291031244,0.9330855018587361,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.27342040092543396,0.5692135291031244,0.9330855018587361,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.27342040092543396,0.5692135291031244,0.9330855018587361,1.0,1.0,4/12,20.64%,ANAPC7;RB1;CUL3;NSMCE2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2684741246523573,0.5687199370392347,0.9058219178082192,1.0,1.0,5/14,19.37%,ADSL;IMPDH1;RFK;ADSS2;GART
prerank,protein import (GO:0017038),0.19768226286248114,0.5681302337477707,0.9916201117318436,1.0,1.0,24/84,23.47%,STAT3;IPO11;PPP1R10;PEX26;IPO8;NUP214;ABCD1;PRICKLE1;NUP133;PEX14;ALDH3A2;TNPO3;NUP153;RAB8B;TOMM22;PTTG1IP;E2F3;CSE1L;KPNB1;HIKESHI;EIF4ENIF1;APPL1;HSPA4;CLU
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.23003956156990601,-0.5680154227424792,0.9644444444444444,1.0,1.0,6/16,26.17%,KLHL22;GPR137B;FLCN;GPR137C;PIP4P1;RRAGD
prerank,regulation of catabolic process (GO:0009894),0.24977478583291338,0.566701645339186,0.9429530201342282,1.0,1.0,1/18,2.36%,NEDD4L
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.22246474439368874,-0.5663187435337683,0.9610705596107056,1.0,1.0,6/18,23.03%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,organelle fusion (GO:0048284),-0.2160100672298316,-0.5655994294439484,0.9776119402985075,1.0,1.0,7/22,25.13%,MIGA2;CHCHD3;STX4;MIEF2;VPS11;BAX;GDAP1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2574835097590048,0.5642650082151314,0.9334500875656743,1.0,1.0,2/16,10.48%,FASN;SLC25A1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2687567998400888,0.5640072980577919,0.9391771019677997,1.0,1.0,4/12,19.61%,ADSL;HPRT1;GART;ADA
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2668006055282261,0.5635249175388677,0.9381818181818182,1.0,1.0,4/14,21.42%,NIFK;RPL7L1;URB1;RPL7
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24047549606703644,0.5633888838007916,0.9611486486486487,1.0,1.0,3/25,9.72%,GMPR;ADSL;HPRT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.22591650103325314,-0.5627999262634577,0.9585253456221198,1.0,1.0,6/16,26.80%,HNRNPA2B1;RTEL1;TERF2;SLX4;ATM;SMG5
prerank,replication fork processing (GO:0031297),0.217774955818063,0.5619842653405954,0.9626168224299065,1.0,1.0,3/38,8.20%,SAMHD1;MMS22L;PRIMPOL
prerank,melanosome organization (GO:0032438),0.23700985728293403,0.5613715800317489,0.9565217391304348,1.0,1.0,5/26,17.01%,SHROOM2;RAB38;AP3B1;RAB32;BLOC1S5
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.20529171014296865,0.5603128825914591,0.9869565217391304,1.0,1.0,14/57,22.46%,TAOK2;BABAM2;BRCC3;CDK2;FOXN3;HUS1;NOP53;CHEK2;RAD17;PLK1;RINT1;TIPIN;BABAM1;TAOK1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25510191561659445,0.5602228250755842,0.9455535390199638,1.0,1.0,2/16,9.99%,RPA1;RECQL
prerank,aerobic respiration (GO:0009060),-0.2146443539980714,-0.5601688629798404,0.9768041237113402,1.0,1.0,7/20,28.22%,SLC25A14;MTFR1L;SDHC;UQCRB;NDUFS7;MDH2;UQCR10
prerank,positive regulation of phospholipid transport (GO:2001140),0.27819863426748714,0.5599817958084669,0.9215328467153284,1.0,1.0,1/10,5.76%,ABCA3
prerank,protein targeting to mitochondrion (GO:0006626),-0.17153841691359684,-0.5579553320338241,0.9925650557620818,1.0,1.0,16/52,28.95%,HSP90AA1;TOMM40;AIFM1;TIMM22;TIMM17B;GRPEL2;TSPO;TIMM8B;TIMM21;TIMM9;GDAP1;DNAJC15;TIMM10;PAM16;SAMM50;PMPCB
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.26619627463376905,0.5571979579721974,0.9481216457960644,1.0,1.0,3/13,17.29%,SVIP;UBAC2;YOD1
prerank,maintenance of protein localization in organelle (GO:0072595),0.24586423152257653,0.5568306638526797,0.9434931506849316,1.0,1.0,3/19,14.50%,BCL3;TAF3;TOPORS
prerank,steroid hormone biosynthetic process (GO:0120178),-0.1929302583431648,-0.5561164232605859,0.978021978021978,1.0,1.0,6/29,22.75%,AKR1B1;FDX1;FDXR;TSPO;DHCR7;TSPOAP1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.23939626835579217,-0.5551531525079204,0.952808988764045,1.0,1.0,3/11,21.68%,FGF2;PPIP5K2;IP6K1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24010411634680326,0.5544839406392349,0.9524590163934427,1.0,1.0,7/20,23.47%,LONP1;HSP90AB1;CCT2;MKKS;PSMG2;HSPA4;CLU
prerank,mitochondrial transcription (GO:0006390),-0.2521162987741989,-0.5539609517243347,0.9453781512605042,1.0,1.0,3/10,19.83%,TFAM;SLC25A33;POLRMT
prerank,organelle disassembly (GO:1903008),0.22554862475853188,0.5530815688672234,0.9553719008264463,1.0,1.0,12/33,25.09%,ULK1;MCTS1;MRRF;MTIF3;ATG2A;ATG2B;VRK1;DENR;PLK3;RB1CC1;MTIF2;UFM1
prerank,regulation of G0 to G1 transition (GO:0070316),0.21549809859382926,0.5525360527714344,0.981042654028436,1.0,1.0,10/38,23.34%,DAB2IP;EPC1;MAX;RYBP;APAF1;PHC3;EHMT1;PHC1;UXT;BMI1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2553713819043128,0.5517517407022122,0.9453262786596119,1.0,1.0,5/16,18.19%,PIGQ;PIGG;PIGF;PIGL;PIGC
prerank,mitochondrion disassembly (GO:0061726),0.22129220293375795,0.5507573601167707,0.9694656488549618,1.0,1.0,8/34,18.72%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,negative regulation of T cell proliferation (GO:0042130),0.23082990634266878,0.5498158670592703,0.9575856443719413,1.0,1.0,3/28,10.79%,PLA2G2D;BTN2A2;RC3H1
prerank,regulation of histone deacetylation (GO:0031063),0.26273114244622847,0.5484613443668389,0.9391304347826087,1.0,1.0,4/13,22.93%,CTBP1;APLNR;SAP30BP;NIPBL
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.23327125173649738,0.548417702358073,0.9434931506849316,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.23327125173649738,0.548417702358073,0.9434931506849316,1.0,1.0,11/21,31.54%,RPA1;ERCC4;GTF2H4;CHD1L;GTF2H1;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1
prerank,response to copper ion (GO:0046688),0.2400998738266653,0.5475506217003139,0.9471890971039182,1.0,1.0,2/20,13.27%,ATP7B;AOC1
prerank,prostanoid metabolic process (GO:0006692),0.2561771219896664,0.5464139946929586,0.9529616724738676,1.0,1.0,2/13,12.62%,PTGS1;GSTP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2595370688492723,0.5457705664914595,0.9408502772643254,1.0,1.0,2/13,11.20%,GLRX3;MMS19
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2433456795488637,-0.54473943408685,0.9634408602150538,1.0,1.0,2/10,18.46%,DDX39B;CRY1
prerank,regulation of centrosome duplication (GO:0010824),0.22355228158037174,0.5444812008552635,0.972176759410802,1.0,1.0,6/29,17.56%,PLK2;CHMP2B;CHMP4B;NPM1;CEP295;CEP131
prerank,cell differentiation in hindbrain (GO:0021533),-0.24614218115755468,-0.5424840653276956,0.9557894736842105,1.0,1.0,6/11,32.17%,GRID2;FAIM2;LHX1;KNDC1;CEND1;NOG
prerank,positive regulation of rRNA processing (GO:2000234),0.2691639789196879,0.5417765819027489,0.9327272727272727,1.0,1.0,4/10,22.19%,RIOK1;HEATR1;RIOK2;SIRT7
prerank,mitochondrial genome maintenance (GO:0000002),0.2615966955304484,0.5404188973230541,0.9464285714285714,1.0,1.0,3/11,13.74%,AKT3;LONP1;MEF2A
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2268462835959828,-0.5399480359146048,0.9699074074074074,1.0,1.0,5/14,31.79%,U2AF2;PCBP4;SRSF6;C1QBP;SRSF9
prerank,negative regulation of histone modification (GO:0031057),-0.22174785509464565,-0.5399414075927955,0.9675925925925926,1.0,1.0,5/14,23.91%,THAP7;SNCA;AASS;SPHK2;TWIST1
prerank,cellular response to pH (GO:0071467),0.2433223357053943,0.538471500692004,0.9671848013816926,1.0,1.0,4/17,16.45%,RAB11FIP5;RAB11B;KCNK4;CHP1
prerank,protein methylation (GO:0006479),-0.17484414125477063,-0.5383639629174192,0.9971751412429378,1.0,1.0,17/40,38.14%,EHMT2;LCMT1;CARM1;VCPKMT;EEF1AKMT1;PRMT8;METTL21A;EEF2KMT;PRMT2;EEF1AKMT3;NTMT1;PRMT7;PRMT6;GSPT1;NSD1;PRMT1;EEF1AKMT2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2640262562659251,0.5373639539013788,0.9574074074074074,1.0,1.0,8/11,35.21%,FBLL1;TENT4B;EXOSC4;PARN;EXOSC5;EXOSC2;DKC1;EXOSC10
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20491575429557002,-0.5364493883310807,0.9923469387755102,1.0,1.0,6/21,23.03%,COX16;COX19;COX17;COX18;FASTKD3;TIMM21
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2004094851748774,-0.5360306357598773,0.9675,1.0,1.0,4/22,14.40%,EIF2AK3;SMARCA4;SMARCB1;WDR43
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.22734700079343134,0.5355402328058242,0.9748743718592965,1.0,1.0,6/25,17.22%,ATXN3;LONP1;OMA1;UGGT1;RNF5;CUL3
prerank,mitotic DNA replication (GO:1902969),-0.24549703939097972,-0.5351651021689408,0.9637526652452025,1.0,1.0,6/10,36.24%,GINS3;GINS1;LIG1;MCMDC2;MCM3;CDC45
prerank,peptidyl-amino acid modification (GO:0018193),-0.24199851321942845,-0.5347321134041687,0.9621848739495799,1.0,1.0,4/10,35.68%,FKBP10;TTLL4;FKBP7;METAP1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2443025246870737,0.5329362341922528,0.9619377162629758,1.0,1.0,4/15,21.65%,HUS1;CHEK2;RAD17;TIPIN
prerank,autophagy of mitochondrion (GO:0000422),0.20896894795289989,0.5315869280971781,0.982089552238806,1.0,1.0,8/38,18.72%,ULK1;CTSK;BNIP3;GABARAPL1;ATG2A;ATG2B;CISD2;ATG7
prerank,regulation of cholesterol metabolic process (GO:0090181),0.23174744221782104,0.5312978529995772,0.9564489112227805,1.0,1.0,7/20,24.45%,LPCAT3;MBTPS2;TTC39B;FMO5;KPNB1;SEC14L2;LDLRAP1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.18524145818716642,0.5305870460011035,0.9960732984293194,1.0,1.0,26/87,26.77%,IMMP2L;NDUFA8;NDUFA7;COA8;NDUFA10;OMA1;COA3;NDUFS2;SURF1;NDUFS4;SDHAF2;NDUFS6;SCO2;PET100;NDUFB9;COA5;UQCC3;NDUFC1;NUBPL;NDUFS8;NDUFB7;SCO1;ECSIT;SDHAF1;NDUFAF8;NDUFA6
prerank,telomere capping (GO:0016233),0.2368179006600885,0.5297193177234825,0.9659863945578231,1.0,1.0,4/16,20.76%,ACD;TERF1;DCLRE1C;TEN1
prerank,negative regulation of secretion (GO:0051048),-0.23551786634861602,-0.5287994768986451,0.9590909090909091,1.0,1.0,5/10,29.64%,CD74;NR1H3;ERBB3;NRG1;EGF
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.22260717718777537,-0.5283598678589913,0.9615384615384616,1.0,1.0,4/14,21.28%,TFAM;SLC25A33;POLRMT;FASTKD5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2629782131703366,0.5283473556804241,0.9360146252285192,1.0,1.0,3/10,17.29%,SVIP;UBAC2;YOD1
prerank,positive regulation of TOR signaling (GO:0032008),0.20410707653103843,0.5275107130965154,0.9808306709265175,1.0,1.0,7/40,16.43%,SIK3;RPTOR;RICTOR;LARS1;GAS6;PIH1D1;RHEB
prerank,aerobic electron transport chain (GO:0019646),0.19052262073439016,0.5262875310334947,0.9943661971830986,1.0,1.0,17/68,24.80%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,UV-damage excision repair (GO:0070914),0.25976876015237915,0.5247535806462201,0.9573283858998145,1.0,1.0,3/12,16.59%,POLA1;MC1R;ACTR5
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.18990682141474224,0.524555815470907,0.9943582510578279,1.0,1.0,17/69,24.80%,NDUFA8;CYCS;NDUFA7;NDUFA10;NDUFS2;COX6C;UQCRQ;NDUFS4;SDHAF2;NDUFS6;UQCRC1;NDUFB9;UQCC3;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.22389232938662124,-0.5241293634842296,0.9611872146118722,1.0,1.0,4/13,20.55%,FUT9;MDK;ZDHHC21;ITGB2
prerank,negative regulation of cell division (GO:0051782),-0.23450226586877468,-0.5241059105215831,0.9646017699115044,1.0,1.0,6/11,32.53%,ZFYVE19;VPS4A;SUSD2;BLM;MYC;E2F8
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2148005742032631,0.5209958251650361,0.9732283464566929,1.0,1.0,7/31,22.00%,XBP1;SHLD1;MAD2L2;KMT5B;GPI;DNAJB9;RIF1
prerank,negative regulation of protein transport (GO:0051224),0.2184627879914971,0.519808301316081,0.98,1.0,1.0,4/25,16.57%,PPM1F;SNX3;RHBDF2;NDFIP2
prerank,ncRNA catabolic process (GO:0034661),0.21271603832246783,0.5191448655093688,0.9884678747940692,1.0,1.0,9/28,26.28%,MTREX;NUDT16;TRIR;DIS3L;RBM7;SND1;TENT4B;DIS3;EXOSC4
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.20598714828108272,-0.5183950274346253,0.9780487804878049,1.0,1.0,6/19,26.61%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.20598714828108272,-0.5183950274346253,0.9780487804878049,1.0,1.0,6/19,26.61%,POLR2B;POLR2K;TERF2;POLR2I;POLR2D;POLR2H
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2106274258263831,-0.518284011766044,0.981941309255079,1.0,1.0,1/15,3.31%,CPEB2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.1892745171497211,0.5181952819427811,0.9971181556195965,1.0,1.0,21/58,27.37%,BABAM2;HERC2;POLA1;BRCC3;CYREN;ERCC4;DCLRE1C;XRCC4;NSMCE2;UBE2V2;RIF1;BABAM1;NSD2;ERCC6;HMGB1;LIG4;POLL;SUMO1;UBE2N;RNF168;UIMC1
prerank,male meiosis I (GO:0007141),-0.20936847663932975,-0.5181628378804749,0.9734299516908212,1.0,1.0,8/16,36.21%,FOXJ3;BRDT;HSF2BP;MYBL1;SYCP3;DDX4;TDRD9;SLC25A31
prerank,piRNA metabolic process (GO:0034587),0.2259715030973343,0.5169432001785553,0.9690048939641109,1.0,1.0,3/19,17.51%,BTBD18;HENMT1;TEX15
prerank,regulation of glycogen metabolic process (GO:0070873),-0.223863950183021,-0.5166762187951234,0.9742388758782201,1.0,1.0,3/12,20.02%,PPP1R3C;PPP1R3F;PPP1R3B
prerank,cellular response to misfolded protein (GO:0071218),0.22860299906957343,0.5151961691091799,0.9708904109589042,1.0,1.0,5/20,18.28%,ATXN3;UGGT1;RNF5;CUL3;DNAJB12
prerank,negative regulation of immune effector process (GO:0002698),0.2472465447456287,0.5147249539078862,0.9555160142348754,1.0,1.0,5/13,24.38%,RPS19;RC3H1;HAVCR2;APPL1;CD47
prerank,snRNA 3'-end processing (GO:0034472),-0.199229666939313,-0.5134030241775739,0.9880952380952381,1.0,1.0,4/19,20.43%,EXOSC7;EXOSC3;EXOSC9;INTS7
prerank,negative regulation of transposition (GO:0010529),0.22815842160711447,0.5095697055374582,0.9584055459272097,1.0,1.0,6/16,27.43%,BTBD18;SPOCD1;TEX15;SIRT7;SMYD5;TUT7
prerank,maturation of LSU-rRNA (GO:0000470),0.21019976637261742,0.5071749079505958,0.9882154882154882,1.0,1.0,9/26,24.48%,RPF1;NIFK;EIF6;RPL7L1;MAK16;URB1;RPL7;MRPL1;LAS1L
prerank,RNA splicing (GO:0008380),0.17088345770895494,0.5068280339407057,1.0,1.0,1.0,35/95,30.54%,RSRC1;PPP1R9B;MBNL1;SF3B4;RNPS1;HNRNPC;SMU1;DHX15;SNRNP25;SCAF11;PRPF4;SRSF10;FUS;PPP2R1A;LSM1;DDX47;PRPF3;TRA2B;DBR1;SNRPD3;SRSF4;PPIG;SLU7;PPP2CA;RP9;SYNCRIP;DHX8;SFPQ;PRPF18;SMNDC1;IVNS1ABP;SNRPD2;SNRPD1;SF3B2;SF3B1
prerank,regulation of biosynthetic process (GO:0009889),-0.22519851804940116,-0.5053601177523324,0.9797752808988764,1.0,1.0,4/11,31.29%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,cilium movement (GO:0003341),0.18831970567955672,0.5048227456138357,0.994413407821229,1.0,1.0,6/47,13.46%,CFAP53;TEKT5;SPA17;CFAP73;DNAH17;CABYR
prerank,DNA replication checkpoint signaling (GO:0000076),0.2275819649418651,0.500942832064574,0.968476357267951,1.0,1.0,6/16,27.96%,CDT1;HUS1;RAD17;TIPIN;TICRR;TIMELESS
prerank,tryptophan metabolic process (GO:0006568),0.24624945075638704,0.49897813869844904,0.9719101123595506,1.0,1.0,11/11,75.39%,ATP7A;IL4I1;IDO2;ACMSD;IDO1;KMO;TDO2;AADAT;KYNU;HAAO;KYAT1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.19529199899851907,-0.4986972082268362,0.9857482185273159,1.0,1.0,5/18,25.85%,EIF2AK3;WDR43;POLR2K;RASL11A;MAF1
prerank,peptidyl-methionine modification (GO:0018206),0.24255526944413686,0.4982313702786598,0.9712643678160919,1.0,1.0,3/12,22.79%,NAA16;NAA30;PDF
prerank,phagosome acidification (GO:0090383),0.2090761910169805,0.49803866672963615,0.98145285935085,1.0,1.0,6/26,20.73%,ATP6V0A1;RAB38;ATP6V1G2;RAB7A;ATP6V1F;ATP6V1D
prerank,rRNA methylation (GO:0031167),0.2102535512644421,0.49777774123793256,0.978369384359401,1.0,1.0,4/22,15.17%,TFB2M;NSUN4;FBLL1;EMG1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.22942141949350559,0.4961264567733981,0.9804964539007093,1.0,1.0,6/17,24.97%,ACD;UNG;MPG;TERF1;MBD4;NEIL2
prerank,response to zinc ion (GO:0010043),-0.18448290754795557,-0.4960376796289966,1.0,1.0,1.0,1/25,3.65%,P2RX4
prerank,isotype switching (GO:0045190),-0.22202107688882955,-0.4936065005136724,0.981941309255079,1.0,1.0,2/10,17.56%,EXOSC3;MSH6
prerank,negative regulation of phagocytosis (GO:0050765),0.22378730590729554,0.493601136654126,0.9661590524534687,1.0,1.0,6/17,24.38%,SNX3;RACK1;PLSCR1;APPL1;HMGB1;CD47
prerank,interstrand cross-link repair (GO:0036297),-0.1546876077103731,-0.4925150487242519,1.0,1.0,1.0,20/53,34.59%,NUCKS1;FANCI;FANCE;MSH6;NEIL3;ATR;SLX4;FANCA;UBC;XRCC3;CENPX;ERCC6L2;DCLRE1B;FANCB;RPA2;ERCC1;FAAP24;VCP;UBE2T;FANCF
prerank,positive regulation of lymphocyte activation (GO:0051251),0.20494651346726472,0.49135575307246643,0.9884868421052632,1.0,1.0,3/28,10.01%,LCK;IL23A;CYRIB
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2364431996587723,0.49081464641981404,0.9618874773139746,1.0,1.0,6/10,31.35%,ACD;DCLRE1C;RIF1;APEX1;TFIP11;DCLRE1A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.19733565717199397,-0.4904419472147745,0.9854368932038835,1.0,1.0,3/17,13.21%,CXCL12;SERPINE1;CREB3
prerank,eye photoreceptor cell development (GO:0042462),0.22321872407515395,0.4899278268510688,0.9810017271157168,1.0,1.0,3/15,15.49%,NRL;TOPORS;CEP290
prerank,pseudouridine synthesis (GO:0001522),-0.20384204909284953,-0.489305366391024,0.9839816933638444,1.0,1.0,13/13,79.64%,PUS3;TRUB2;NHP2;GAR1;PUS1;DKC1;NOP10;PUS10;PUSL1;PUS7;RPUSD2;TRUB1;PUS7L
prerank,regulation of nuclear division (GO:0051783),0.21571126497379173,0.48888041935323245,0.9865092748735245,1.0,1.0,3/20,14.41%,CAV2;CDC25C;PDXP
prerank,DNA modification (GO:0006304),0.21071829843087647,0.4879439463408021,0.9900826446280991,1.0,1.0,5/22,16.50%,PARP2;ACD;UNG;MPG;TERF1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2120072858591045,0.48654215532086803,0.9829059829059829,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2120072858591045,0.48654215532086803,0.9829059829059829,1.0,1.0,7/22,23.64%,ZDHHC18;ZDHHC9;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2143647410443556,0.4862744821527968,0.9858407079646018,1.0,1.0,2/19,10.61%,TIRAP;NMI
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.19237878457985014,-0.4831432830605138,0.9884259259259259,1.0,1.0,3/17,17.38%,AFG1L;COX6B1;COX7B
prerank,negative regulation of telomere maintenance (GO:0032205),-0.19639991438969792,-0.48164890449427866,0.9933035714285714,1.0,1.0,9/15,38.38%,RTEL1;RAD50;TERF2;SLX4;ATM;ERCC1;TNKS2;PARP1;NBN
prerank,inner dynein arm assembly (GO:0036159),-0.2105361502884076,-0.4792910988743733,0.9865470852017937,1.0,1.0,7/10,43.80%,CCDC39;DNAAF5;DNAAF4;CFAP100;DNAAF1;DNAI3;DNAH1
prerank,microtubule-based transport (GO:0099111),0.22891326606020818,0.4767919687187534,0.9764065335753176,1.0,1.0,2/12,13.46%,SPA17;CABYR
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.15579294187458076,0.4761744413139097,1.0,1.0,1.0,33/125,25.67%,PLK2;AURKA;PCNT;DYNLL1;XPO1;DYNC1LI1;NEK6;AURKC;RPS27;NUP98;MAD1L1;NUP133;NDEL1;BUB3;NUP43;PPP1CC;CLIP1;BCCIP;SBDS;PLK1;KIF4A;KPNB1;KIF2A;TAOK1;DCTN6;CLASP2;KIF18A;MAP4;CENPN;TNKS;NUP85;NSL1;RCC2
prerank,regulation of DNA recombination (GO:0000018),0.18788766056494813,0.47591580323965316,0.9984591679506933,1.0,1.0,7/32,20.19%,IL7R;SIRT6;SPIDR;ALYREF;THOC1;KDM1A;MSH2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2089429276443394,0.4721623910962484,0.9715242881072027,1.0,1.0,4/19,19.01%,RIPK2;IFIH1;STAT1;DHX36
prerank,sensory perception of smell (GO:0007608),-0.21128617161509006,-0.4719510379477956,0.9823008849557522,1.0,1.0,11/11,78.89%,ADCY3;UBR3;BBS4;SYT10;BEST2;OMP;OBP2B;GFY;DRD2;SLC24A4;MKKS
prerank,glutathione derivative metabolic process (GO:1901685),0.20886345639649667,0.4713058688591386,0.9752475247524752,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.20886345639649667,0.4713058688591386,0.9752475247524752,1.0,1.0,6/20,22.95%,GSTO2;GSTA4;GSTP1;ESD;MGST1;AKR1A1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2155192617461612,0.46873699339933306,0.978021978021978,1.0,1.0,5/16,20.46%,RC3H1;ZFP36;ZFP36L1;DHX36;TRIM71
prerank,regulation of T cell differentiation (GO:0045580),0.18820014849941788,0.4679071857838496,0.9938080495356038,1.0,1.0,4/33,11.57%,XBP1;IL7;ZMIZ1;CBFB
prerank,positive regulation of translational initiation (GO:0045948),0.21037427781964346,0.46776876703076353,0.9897959183673469,1.0,1.0,18/18,78.99%,EIF2B5;UHMK1;DAZL;YTHDF3;YTHDF1;DDX3X;LARP1;RPS6KB2;KHDRBS1;CDC123;YTHDF2;CCL5;POLR2G;BOLL;POLR2D;MTOR;RPS6KB1;HABP4
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.21642493878319818,0.46500370610198993,0.9816849816849816,1.0,1.0,15/15,78.38%,CCT7;CCT2;RUVBL1;RUVBL2;CCT8;NOP10;CCT6A;DKC1;CCT4;NAF1;CCT3;CCT5;TCP1;NHP2;SHQ1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21784167242136965,0.464930360657464,0.9761029411764706,1.0,1.0,13/13,78.23%,CPSF1;CPSF6;CPSF2;TUT1;CSTF2T;CPSF4L;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CPSF4;FIP1L1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.18642084823561295,-0.46167763264839995,0.995249406175772,1.0,1.0,8/16,43.70%,PLEKHM2;RAET1E;VAMP2;CORO1A;TUBB4B;KIF5B;SLAMF7;KLRK1
prerank,axoneme assembly (GO:0035082),-0.16461612949094828,-0.46125605267175396,0.9941520467836257,1.0,1.0,9/30,28.55%,DNAI4;CCDC39;RSPH9;SPAG1;GAS8;DRC1;JHY;FOXJ1;TTC12
prerank,DNA biosynthetic process (GO:0071897),0.21493155845786768,0.4593290598083006,0.977818853974122,1.0,1.0,16/16,78.53%,POLA1;RFC3;PPIA;TYMS;POLL;POLD4;POLH;WRNIP1;POLD3;SIRT1;WRN;POLD2;POLD1;CDKN2D;TERT;POLE
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.23134098828529145,0.4592049943229273,0.974609375,1.0,1.0,3/10,16.78%,FMR1;CALM1;CRHR1
prerank,mismatch repair (GO:0006298),0.19170758492246393,0.45648748510472986,0.9917763157894737,1.0,1.0,6/27,22.07%,RNASEH2A;RPA1;MCM9;PMS1;MSH2;MSH5
prerank,DNA duplex unwinding (GO:0032508),-0.14389503057029446,-0.4552634231044749,1.0,1.0,1.0,7/50,16.43%,ANXA1;RECQL5;RTEL1;RAD50;DDB2;DDB1;XPC
prerank,ncRNA 3'-end processing (GO:0043628),0.21367221944141856,0.454972856723549,0.981549815498155,1.0,1.0,4/14,24.10%,INTS12;INTS8;TOE1;INTS6L
prerank,natural killer cell mediated immunity (GO:0002228),-0.18474510358194746,-0.4534485508617998,0.9950980392156863,1.0,1.0,2/15,17.98%,PLEKHM2;RAET1E
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.1669972538092479,0.45311956283305554,0.9985632183908046,1.0,1.0,10/50,22.42%,CCNK;CDKN1B;HSP90AB1;CDC25C;CCNJ;CDC37;BCCIP;GTF2H1;CCNH;CCNA2
prerank,negative regulation of histone acetylation (GO:0035067),0.2264470059849994,0.45232531123007885,0.9783393501805054,1.0,1.0,4/11,26.56%,CTBP1;TAF7;SET;SIN3A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.18945709326356872,0.45124817241702,0.9948717948717949,1.0,1.0,8/26,21.00%,NEK6;ANAPC7;RB1;CUL3;CDK5RAP2;NSMCE2;PLK1;RIOK2
prerank,rRNA modification (GO:0000154),0.19262229173373752,0.4499248982603467,0.9965986394557823,1.0,1.0,3/21,13.09%,TFB2M;NSUN4;FBLL1
prerank,tRNA 5'-leader removal (GO:0001682),-0.1899089147472116,-0.44761031979410704,0.9911699779249448,1.0,1.0,7/13,34.05%,POP1;POP4;SSB;RPP25L;POP5;RPP40;RPP21
prerank,B cell activation involved in immune response (GO:0002312),-0.18701738966664574,-0.4461036979672214,0.9954233409610984,1.0,1.0,13/13,81.32%,EXOSC3;MSH6;FCGR2B;BATF;GPR183;CD19;GAPT;CD40LG;RNF8;RNF168;LIG4;MSH2;CD180
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.16488693467336685,-0.4449225546688429,0.9900249376558603,1.0,1.0,22/22,83.54%,DDB2;DDB1;XPC;CUL4A;UBC;GTF2H3;PARP1;ERCC2;RAD23B;UBB;ERCC3;UBA52;RPS27A;RBX1;XPA;GTF2H2;GTF2H5;CUL4B;GTF2H1;CHD1L;CETN2;GTF2H4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.17820101829153306,0.4433785879487477,0.9984177215189873,1.0,1.0,33/33,82.22%,WDR33;CPSF1;SETX;SNRPD3;CPSF2;PCF11;TTF2;CPSF3;LSM11;PAPOLA;CSTF3;CSTF2T;SNRPB;SCAF8;CLP1;LSM10;SLBP;SSU72;NUDT21;CPSF7;NCBP1;CSTF2;NCBP2;CSTF1;SNRPE;SYMPK;SNRPG;CPSF4;MAZ;MED18;FIP1L1;SNRPF;PABPN1
prerank,error-free translesion synthesis (GO:0070987),-0.1647548686907692,-0.4432106468654172,1.0,1.0,1.0,7/22,32.65%,NPLOC4;POLDIP2;RFC1;POLD1;UBC;RPA2;VCP
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.2172913996943187,0.4415071739776388,0.974910394265233,1.0,1.0,4/10,26.28%,HSP90AB1;FN1;CDH3;FURIN
prerank,regulation of oxidoreductase activity (GO:0051341),0.20951509493536524,0.4398760042127318,0.9856887298747764,1.0,1.0,5/13,26.75%,ABL2;ATP7A;HDAC6;ECSIT;NOD2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.1943684731348373,-0.43831058366160136,0.991304347826087,1.0,1.0,1/11,8.29%,AKAP8L
prerank,androgen metabolic process (GO:0008209),0.19606035531552662,0.43794811339521356,0.9949324324324325,1.0,1.0,3/18,19.16%,SRD5A2;SRD5A1;HSD17B11
prerank,histone methylation (GO:0016571),0.18121057742378427,0.4376773434912675,0.9931972789115646,1.0,1.0,11/26,29.23%,SMYD3;FBLL1;EHMT1;SIRT7;SUV39H1;N6AMT1;CREBBP;PRMT5;EZH2;SMYD2;SMYD1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.19851429965985778,0.4353924988352243,0.9863713798977853,1.0,1.0,3/16,12.93%,MEIOB;RMI1;ERCC4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.16190356288555946,0.4350642131166845,1.0,1.0,1.0,56/56,83.87%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.16190356288555946,0.4350642131166845,1.0,1.0,1.0,56/56,83.87%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NUBPL;NDUFS8;NDUFB7;ECSIT;NDUFAF8;NDUFA6;NDUFA2;ACAD9;NDUFA5;DMAC1;NDUFA3;NDUFB2;NDUFAB1;TMEM126B;NDUFAF4;NDUFS1;NDUFA13;NDUFB4;NDUFAF5;NDUFB6;NDUFB8;OXA1L;TMEM126A;NDUFS5;NDUFB5;NDUFS3;NDUFB3;BCS1L;NDUFB11;NDUFA1;NDUFAF2;FOXRED1;NDUFV2;TIMMDC1;NDUFAF3;NDUFB10;NDUFS7;NDUFA9;NDUFC2;TIMM21;NDUFAF1;NDUFV1;NDUFAF6;NDUFA11;NDUFA12;NDUFV3;DMAC2;NDUFAF7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.16094438070496908,0.431711572518969,1.0,1.0,1.0,14/53,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;BCKDK;PSMC3;PSMD3;PSMA3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20717764235299613,0.4314054744101594,0.9909747292418772,0.9998055912580192,1.0,3/12,20.51%,HUS1;CHEK2;RAD17
prerank,tRNA 5'-end processing (GO:0099116),0.20136950559448558,0.4303620942927367,0.9982668977469671,0.9995284940518866,1.0,6/15,27.99%,RPP30;RPP25;PRORP;TRMT10C;RPP38;RPP14
prerank,serine family amino acid catabolic process (GO:0009071),-0.1969998304586344,-0.42898886615286946,0.9938271604938271,1.0,1.0,5/10,40.37%,CBS;GLDC;THNSL2;AMT;SHMT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.1485517790874734,-0.4249430983851541,1.0,1.0,1.0,10/29,33.81%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.1485517790874734,-0.4249430983851541,1.0,1.0,1.0,10/29,33.81%,ACOT11;ACAT1;ACSF2;DBI;ACOT9;ACOT8;MLYCD;ACOT1;GPAT4;ACOT7
prerank,regulation of cellular amine metabolic process (GO:0033238),0.15755902865607263,0.4196802730548316,1.0,1.0,1.0,13/50,24.92%,PSMA2;PSMA8;PSMA6;PSME1;PSMA4;PSMF1;PSMB7;PSMB1;PSMD2;PSMA5;PSMC3;PSMD3;PSMA3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.16409422572322888,0.41374426247807555,0.9952153110047847,1.0,1.0,34/35,78.53%,RPA1;UNG;PARG;MPG;RFC3;MBD4;RFC5;POLL;RPA3;APEX1;RFC2;POLD4;RFC4;PNKP;PCNA;OGG1;POLD3;XRCC1;SMUG1;LIG3;PARP1;FEN1;RPA2;ADPRS;LIG1;NEIL1;POLD2;POLB;POLD1;NTHL1;TDG;POLG;MUTYH;POLE
prerank,ATP synthesis coupled proton transport (GO:0015986),0.18509705749769087,0.4129840221456524,0.9965095986038395,1.0,1.0,6/17,28.63%,ATP5PD;VPS9D1;ATP5MC2;STOML2;ATP5F1B;ATP5F1C
prerank,DNA packaging (GO:0006323),0.18888020043028528,0.41214818526244823,0.9947183098591549,0.9997468446295473,1.0,2/16,15.11%,HAT1;KAT6A
prerank,negative regulation of inclusion body assembly (GO:0090084),0.20449409992467993,0.4116812809548855,0.9947183098591549,0.999383695455783,1.0,10/10,79.56%,DNAJB1;DNAJB6;HSPA1B;DNAJA4;DNAJB8;HSPA1A;SORL1;SACS;HSPA2;DNAJB2
prerank,global genome nucleotide-excision repair (GO:0070911),0.16796240155660555,0.4074467806596755,0.9967897271268058,0.9993351205118005,1.0,13/26,32.68%,ERCC4;GTF2H4;CETN2;CHD1L;GTF2H1;RNF111;CUL4B;GTF2H5;GTF2H2;XPA;RBX1;RPS27A;UBA52
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.16543867725757258,0.40704193027448,0.9984101748807631,0.998965249326366,1.0,13/29,31.70%,RPA1;GTF2H4;CETN2;CHD1L;GTF2H1;CCNH;CUL4B;GTF2H5;RPA3;GTF2H2;XPA;RBX1;RPS27A
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.18549216893956594,0.4050240100494404,0.9965694682675815,0.9983327187813051,1.0,3/15,17.01%,AP3B1;AP3S1;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),0.18549216893956594,0.4050240100494404,0.9965694682675815,0.9983327187813051,1.0,3/15,17.01%,AP3B1;AP3S1;BLOC1S5
prerank,positive regulation of cilium assembly (GO:0045724),-0.15729408498381528,-0.40171480978212354,0.9975124378109452,1.0,1.0,7/18,35.60%,FUZ;HTT;ARHGAP35;SEPTIN9;CROCC;CCP110;KCTD17
prerank,protein localization to microtubule organizing center (GO:1905508),-0.1642693123617032,-0.4005807562180947,1.0,1.0,1.0,4/15,25.31%,CEP192;PCM1;C2CD3;STIL
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.1800828833354263,0.3993304574550028,0.9947552447552448,0.9983441088107992,1.0,16/16,82.01%,ATP5PD;ATP5MC2;STOML2;ATP5F1B;ATP5F1C;ATP5F1A;ATP5F1E;ATP5MF;ATP5MC1;ATP5F1D;ATP5MC3;DMAC2L;ATP5MG;ATP5ME;ATP5PF;ATP5PO
prerank,peptidyl-lysine acetylation (GO:0018394),0.20091639467737885,0.397562840715504,0.9962546816479401,0.998073032646791,1.0,10/10,79.92%,KAT2B;CREBBP;KAT7;EP300;KAT2A;ESCO1;SIRT1;BLOC1S1;BAG6;KAT5
prerank,N-terminal protein amino acid modification (GO:0031365),0.17972128532739284,0.3874294178802359,0.9982332155477032,0.9983044929872118,1.0,8/14,32.78%,NAA11;NAA16;NAA35;PDF;NAA50;METAP1D;AANAT;METAP2
prerank,tRNA modification (GO:0006400),-0.11270015973264232,-0.3757549038149854,1.0,1.0,1.0,19/62,35.38%,TARBP1;PUS3;GTPBP3;DUS2;MTO1;TPRKB;ELP5;THUMPD3;ANKRD16;SSB;METTL1;BCDIN3D;ADAT2;QTRT1;TRMT61A;AARS1;METTL2A;METTL2B;URM1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.15902729378329492,-0.3749493126281963,1.0,0.9994073792102571,1.0,4/12,30.71%,PLK5;TP53;PRKDC;RPA2
prerank,regulation of protein acetylation (GO:1901983),0.17427206071783571,0.36603736629590283,0.9962476547842402,0.9989081447264275,1.0,4/12,26.51%,CEP295;RAPGEF3;TAOK1;GSK3B
